<SEC-DOCUMENT>0001140361-25-022325.txt : 20250612
<SEC-HEADER>0001140361-25-022325.hdr.sgml : 20250612
<ACCEPTANCE-DATETIME>20250612164623
ACCESSION NUMBER:		0001140361-25-022325
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		40
CONFORMED PERIOD OF REPORT:	20250612
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Completion of Acquisition or Disposition of Assets
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
ITEM INFORMATION:		Changes in Control of Registrant
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
ITEM INFORMATION:		Change in Shell Company Status
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250612
DATE AS OF CHANGE:		20250612

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			XCF Global, Inc.
		CENTRAL INDEX KEY:			0002019793
		STANDARD INDUSTRIAL CLASSIFICATION:	INDUSTRIAL ORGANIC CHEMICALS [2860]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42687
		FILM NUMBER:		251043517

	BUSINESS ADDRESS:	
		STREET 1:		611 PERU DRIVE
		CITY:			MCCARRAN
		STATE:			NV
		ZIP:			89434
		BUSINESS PHONE:		408-332-2264

	MAIL ADDRESS:	
		STREET 1:		611 PERU DRIVE
		CITY:			MCCARRAN
		STATE:			NV
		ZIP:			89434

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Focus Impact BH3 NewCo, Inc.
		DATE OF NAME CHANGE:	20240415
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ef20050548_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2025" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:currency="http://xbrl.sec.gov/currency/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2025" xmlns:sic="http://xbrl.sec.gov/sic/2025" xmlns:stpr="http://xbrl.sec.gov/stpr/2025" xmlns:exch="http://xbrl.sec.gov/exch/2025" xmlns:cef="http://xbrl.sec.gov/cef/2025" xmlns:cyd="http://xbrl.sec.gov/cyd/2025" xmlns:none="http://bh3ac.com/20250612" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html"/>
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_7c2e3c621d784798969845408fdbacdc" contextRef="c20250612to20250612" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:CurrentFiscalYearEndDate" id="Fact_a6ecb5d6d7714eecac4d22fa43703cdb" contextRef="c20250612to20250612" format="ixt:date-month-day">12-31</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_b8b82106a2ef4415b4816cca3515efd2" contextRef="c20250612to20250612">0002019793</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="none-20250612.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="c20250612to20250612"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0002019793</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-06-12</xbrli:startDate><xbrli:endDate>2025-06-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20250612to20250612_EntityAddressesAddressTypeAxis_FormerAddressMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0002019793</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:FormerAddressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-06-12</xbrli:startDate><xbrli:endDate>2025-06-12</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
<div style="line-height: initial;">
  <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

  <div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt;">
      <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/>
<div><span style="font-size: 14pt; font-family: 'Times New Roman'; font-weight: bold;">UNITED STATES</span></div>
</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: 400;"> <br/>
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">
      <hr style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 20%; color: #000000; text-align: center; margin-left: auto; margin-right: auto;"/></div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">
<div>FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_63aa2dfb42e34d92afa2f0d261cd8115" contextRef="c20250612to20250612">8-K</ix:nonNumeric></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: 400; text-align: left;"><br/>
      </div>

    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">
      <hr style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 20%; color: #000000; text-align: center; margin-left: auto; margin-right: auto;"/></div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Date of Report (date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_b3d134ac11f24caead496e3c0b486f17" contextRef="c20250612to20250612" format="ixt:date-monthname-day-year-en">June 12, 2025</ix:nonNumeric><br/>
      <br/>
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">
      <hr style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 20%; color: #000000; text-align: center; margin-left: auto; margin-right: auto;"/></div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 24pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_2f680ad08bc54072a5521e49366e36a5" contextRef="c20250612to20250612">XCF GLOBAL, INC.</ix:nonNumeric><br/>
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Exact name of registrant as specified in its charter)</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br/>
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">
      <hr style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 20%; color: #000000; text-align: center; margin-left: auto; margin-right: auto;"/></div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 37%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_49473010d7d34465ad83f87bcc3cb91e" contextRef="c20250612to20250612" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br/>
            </div>
          </td>

    <td style="width: 26%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_d492ee6e08f344faa65a9f7d92798d7c" contextRef="c20250612to20250612">001-42687</ix:nonNumeric><br/>
            </div>
          </td>

    <td style="width: 37%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_7d13ade3e94f4df5bde6d14f60739f9d" contextRef="c20250612to20250612">33-4582264</ix:nonNumeric><br/>
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 37%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">(State or other jurisdiction of incorporation)</div>
          </td>

    <td style="width: 26%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">(Commission File Number)</div>
          </td>

    <td style="width: 37%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">(IRS Employer Identification No.)</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_08051322919d497ba6db10cefada67a7" contextRef="c20250612to20250612">2500 CityWest Blvd</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" id="Fact_94d67de56f3348db813ee5cd797ca52f" contextRef="c20250612to20250612">Suite 150-138</ix:nonNumeric></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_752c079c3ca2443699b03b2b0be7d261" contextRef="c20250612to20250612">Houston</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_2c79a203ce7442fc8a7fa82348e5714c" contextRef="c20250612to20250612">TX</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_e1085a2dee1e411a99c212cedc8ce836" contextRef="c20250612to20250612">77042</ix:nonNumeric></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(Address of principal executive offices, including zip code)</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_cfb54ab18f734839b66b45d14b0d827e" contextRef="c20250612to20250612">346</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_0c09c5919a4b4d2eb927c3afa2f0d2c4" contextRef="c20250612to20250612">630-4724</ix:nonNumeric></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(Registrant&#8217;s telephone number, including area code)</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityInformationFormerLegalOrRegisteredName" id="Fact_9f837030c3de46788eb82b7224d47d20" contextRef="c20250612to20250612">Focus Impact BH3 NewCo, Inc.</ix:nonNumeric><br/>
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_5a52859e01134cb0a0bfbd63a4bb7587" contextRef="c20250612to20250612_EntityAddressesAddressTypeAxis_FormerAddressMember">345 Avenue of the Americas</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" id="Fact_f690fa624f8e45e5b0be0f647a6458bd" contextRef="c20250612to20250612_EntityAddressesAddressTypeAxis_FormerAddressMember">33rd Floor</ix:nonNumeric></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_f732edc5329f408c88d35afe4df50a4d" contextRef="c20250612to20250612_EntityAddressesAddressTypeAxis_FormerAddressMember">New York</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_60342a28170942eeacef0c49208a5bfd" contextRef="c20250612to20250612_EntityAddressesAddressTypeAxis_FormerAddressMember">NY</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_73c00f970d6c4790841205781251957e" contextRef="c20250612to20250612_EntityAddressesAddressTypeAxis_FormerAddressMember">10105</ix:nonNumeric></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(Former name or former address, if changed since last report)</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions
      (see General Instructions A.2. below):</div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br/>
      </span></div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 21.6pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_550d77537ba640c9a0be027700ff0913" contextRef="c20250612to20250612" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
          </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
          </td>

  </tr>


</table>
    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br/>
      </span></div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 21.6pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_cf868b0f6e6a4d9f89f68dda2af7c3da" contextRef="c20250612to20250612" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
          </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
          </td>

  </tr>


</table>
    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br/>
      </span></div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 21.6pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_8e0e7cd4c396499db488f5feb12bde21" contextRef="c20250612to20250612" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
          </td>

  </tr>


</table>
    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br/>
      </span></div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 21.6pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_caa5da7aaa4148c397589409863e84e2" contextRef="c20250612to20250612" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 37%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; font-weight: bold;"><span style="text-decoration: underline;">Title of each class</span></div>
          </td>

    <td style="width: 26%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; font-weight: bold;"><span style="text-decoration: underline;">Trading Symbol(s)</span></div>
          </td>

    <td style="width: 37%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; font-weight: bold;"><span style="text-decoration: underline;">Name of each exchange on which registered</span></div>
          </td>

  </tr>

  <tr>

    <td style="width: 37%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_233753cc5e854d2ab9b2cb4d685aa145" contextRef="c20250612to20250612">Class A Common Stock, par value $0.0001 per share</ix:nonNumeric><br/>
            </div>
          </td>

    <td style="width: 26%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; text-align: center;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_569e1628a5d848f28b0caaa8dd4b4bae" contextRef="c20250612to20250612">SAFX</ix:nonNumeric><br/>
          </td>

    <td style="width: 37%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; text-align: center;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_2ddc42a3faa44045bcdcd83fe11f537d" contextRef="c20250612to20250612" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric><br/>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; margin-right: 16.75pt; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this
      chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).&#160;&#160; Emerging growth company&#160;&#160; <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_507ed48adf55436788e0469429b725d1" contextRef="c20250612to20250612" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
      financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160; <ix:nonNumeric name="dei:EntityExTransitionPeriod" id="Fact_7c77b3466c2f494b831469c11d452d3e" contextRef="c20250612to20250612" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;">
      <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/></div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <!--PROfilePageNumberReset%Num%1%%%-->
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">INTRODUCTORY NOTE</div>

    <div style="text-align: center;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br/>
      </span></div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Business Combination</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Unless otherwise stated herein or unless the context otherwise requires, the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and &#8220;New XCF&#8221; refer to XCF Global, Inc. (formerly
      known as Focus Impact BH3 NewCo, Inc.), a Delaware corporation, after giving effect to the Business Combination (as defined below) and following the Closing Date (as defined below). In addition, unless otherwise stated herein or unless the context
      otherwise requires (i) references to &#8220;NewCo&#8221; refer to Focus Impact BH3 NewCo, Inc. prior to the Closing Date, (ii) references to &#8220;XCF&#8221; refer to XCF Global, Inc., a Nevada corporation, prior to the Closing Date and (iii) references to &#8220;Focus Impact&#8221;
      refer to Focus Impact BH3 Acquisition Company, a Delaware corporation.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Terms used in this Current Report on Form 8-K but not defined herein, or for which definitions are not otherwise incorporated by reference herein, shall
      have the meanings given to such terms in the Proxy Statement/Prospectus filed with the Securities and Exchange Commission (&#8220;SEC&#8221;) by Focus Impact, NewCo and XCF on February 6, 2025 (the &#8220;Proxy Statement/Prospectus&#8221;), and such definitions are
      incorporated herein by reference.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">This Current Report on Form 8-K also incorporates by reference certain information from reports and other documents that were previously filed with the
      SEC, including certain information from the Proxy Statement/Prospectus. To the extent there is a conflict between the information contained in this Current Report on Form 8-K and the information contained in such prior reports and documents that has
      been incorporated by reference herein, the information in this Current Report on Form 8-K controls.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On March 11, 2024, Focus Impact, NewCo, Focus Impact BH3 Merger Sub 1, LLC, a Delaware limited liability company and wholly owned subsidiary of NewCo
      (&#8220;Merger Sub 1&#8221;), Focus Impact BH3 Merger Sub 2, Inc., a Delaware corporation and wholly owned subsidiary of NewCo (&#8220;Merger Sub 2&#8221;), and XCF entered into a business combination agreement (as amended, the &#8220;Business Combination Agreement&#8221;), pursuant to
      which Focus Impact agreed to combine with XCF in a series of transactions that would result in NewCo becoming a publicly-traded company (collectively, the &#8220;Business Combination&#8221;), and in connection with the closing of the Business Combination, NewCo
      would change its name to &#8220;XCF Global, Inc.&#8221;</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On June 6, 2025 (the &#8220;Closing Date&#8221;), the parties to the Business Combination Agreement completed the Business Combination.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The terms of the Business Combination Agreement provided that the Business Combination would be completed on the Closing Date in two steps, with (i)
      Focus Impact merging with and into Merger Sub 1 (the &#8220;NewCo Merger&#8221;), with Merger Sub 1 surviving the NewCo Merger as a direct wholly owned subsidiary of NewCo and (ii) immediately following the NewCo Merger, Merger Sub 2 merging with and into XCF
      (the &#8220;Company Merger&#8221;), with XCF surviving the Company Merger as a direct wholly owned subsidiary of NewCo. In connection with the closing of the Business Combination, NewCo changed its name to &#8220;XCF Global, Inc.&#8221;</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the terms of the Business Combination Agreement:</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 36pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>in connection with the completion of the NewCo Merger (i) each share of Focus Impact Class A common stock, par value $0.0001 per share outstanding immediately prior to the effectiveness of the NewCo Merger was converted into the right to
              receive one share of New XCF Class A common stock, par value $0.0001 per share (&#8220;New XCF Common Stock&#8221;) (rounded down to the nearest whole share), (ii) each share of Focus Impact Class B common stock, par value $0.0001 per share outstanding
              immediately prior to the effectiveness of the NewCo Merger was converted into the right to receive one share of New XCF Common Stock and (iii) each warrant of Focus Impact outstanding immediately prior to the effectiveness of the NewCo Merger
              was converted into the right to receive one New XCF Warrant, with New XCF assuming Focus Impact&#8217;s rights and obligations under the existing warrant agreement; and</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">1</span></div>

      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 36pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>in connection with the completion of the Company Merger, each share of common stock of XCF outstanding immediately prior to the effectiveness of the Company Merger was converted into the right to receive shares of New XCF Common Stock
              (rounded down to the nearest whole share) determined in accordance with the Business Combination Agreement based on a pre-money equity value of XCF of $1,750,000,000, subject to adjustments for net debt and transaction expenses, and a price
              of $10.00 per share of New XCF Common Stock.</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">At the closing of the Business Combination, NewCo issued an aggregate of 142,120,364 shares of New XCF Common Stock to equityholders of XCF in exchange
      for their equity interests in XCF. In addition, pursuant to certain non-redemption agreements between Focus Impact and certain Focus Impact stockholders (the &#8220;Non-Redeeming Stockholders&#8221;), the Non-Redeeming Stockholders received 389,359 shares of New
      XCF Common Stock at the closing of the Business Combination. An&#160; aggregate of 1,200,000 shares of New XCF Common Stock were also issued at the closing of the Business Combination to Polar Multi-Strategy Master Fund, pursuant to the terms of a
      subscription agreement, dated as of November 3, 2025 between Focus Impact and Polar Multi-Strategy Master Fund.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;">
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">As of the closing of the Business Combination and after giving effect to the NewCo Merger and Company Merger, New XCF had approximately 149.3 million
        shares of New XCF Common Stock outstanding. On a fully diluted basis, calculated using the treasury stock method and assuming the net exercise of all warrants that are in-the-money based on the closing price of Focus Impact on June 6, 2025, the
        fully diluted share count is approximately 157.8 million shares. The fully diluted share count does not include any out-of-the-money warrants. This share count is provided solely for the purpose of estimating market capitalization and may differ
        from accounting treatment under GAAP or from other financial metrics used in our public filings.</div>

    </div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 57.6pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 1.01</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="font-weight: bold;">Entry into a Material Definitive Agreement.</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The disclosure set forth in the &#8220;Introductory Note&#8221; above is incorporated into this Item 1.01 by reference.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Registration Rights Agreements</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On the Closing Date, New XCF, Focus Impact BHAC Sponsor, LLC (the &#8220;Sponsor&#8221;) and certain legacy equity holders of XCF (the &#8220;Core Company Equityholders&#8221;)
      entered into a Registration Agreement (the &#8220;Core Company Equityholders Agreement&#8221;), pursuant to which, among other things, the parties thereto were granted customary registration rights with respect to shares of New XCF Common Stock held by the
      parties to the agreement, including shares of New XCF Common Stock issuable upon the exercise of certain outstanding warrants assumed by New XCF in the Business Combination. Pursuant to the Core Company Equityholders Agreement, New XCF has agreed to
      file (at its sole cost and expense) a shelf registration statement with the SEC registering the resale of certain shares of New XCF Common Stock and shares underlying the assumed warrants from time to time, and New XCF shall use commercially
      reasonable efforts to have such resale registration statement declared effective and maintain its effectiveness in accordance with the terms of the Core Company Equityholders Agreement. The parties to the Core Company Equityholders Agreement are also
      entitled to customary piggyback rights and may demand underwritten offerings, including block trades, of their registrable securities by New XCF from time to time.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On the Closing Date, New XCF and certain other legacy equity holders of XCF and certain legacy equity holders of Focus Impact entered into a Registration
      Rights Agreement (the &#8220;Resale Shelf Registration Rights Agreement&#8221;), pursuant to which, among other things, the parties thereto were granted customary registration rights with respect to shares of New XCF Common Stock receive or entitled to be
      received in connection with the Business Combination. Pursuant to the Resale Registration Rights Agreement, New XCF has agreed to file (at its sole cost and expense) a shelf registration statement with the SEC (which can be the same registration
      statement filed in connection with the Core Company Equityholders Agreement) registering the resale of certain shares of New XCF Common Stock, including shares of New XCF Common Stock issuable upon the exercise of certain outstanding warrants assumed
      by New XCF in the Business Combination, and New XCF shall use commercially reasonable efforts to have such resale registration statement declared effective and maintain its effectiveness in accordance with the terms of the Resale Shelf Registration
      Rights Agreement.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The foregoing descriptions of the Core Company Equityholders Agreement and the Resale Shelf Registration Rights Agreement do not purport to be complete
      and are qualified in their entirety by the terms and conditions thereof, the forms of which are filed herewith as Exhibit 10.51 and Exhibit 10.52, and are incorporated into this Item 1.01 by reference.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">2</span></div>

      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Agreement Regarding Board Nomination Rights</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On the Closing Date, New XCF and the Sponsor entered into an Agreement Regarding Board Nomination Rights (the &#8220;Board Agreement&#8221;), which provided that for
      as long as the Sponsor maintains minimum ownership levels of New XCF Common Stock, the Sponsor will be entitled to designate up to two directors, and also obligates New XCF to take certain actions to assure that the Sponsor designees are nominated as
      directors. Under the terms of the Board Agreement, the Sponsor currently is able to designate one director and that right will increase to a right to designate a second director in the event New XCF&#8217;s board of directors (the &#8220;Board&#8221;) is expanded to
      nine directors from six and the designation would not otherwise create adverse issues under Nasdaq listing requirements regarding board independence. If the Sponsor&#8217;s ownership level drops below certain specified levels, it will either be limited to
      designating one director, subject to the other terms of the Board Agreement, or will lose its designation right entirely. In addition, under the terms of the Board Agreement, Carl Stanton, who has served as a Partner and Co-Founder of Focus Impact
      Partners, LLC will become a Board observer.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The foregoing description of the Board Agreement does not purport to be complete and is qualified in its entirety by the terms and conditions thereof,
      the form of which is filed herewith as Exhibit 10.53, and is incorporated into this Item 1.01 by reference.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Voting Agreements</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On the Closing Date, New XCF and each of the Core Company Equityholders entered into separate&#160; agreements (the &#8220;Voting Agreements&#8221;) pursuant to which
      each of the Core Company Equityholders agreed to vote such Core Company Equityholder&#8217;s shares of New XCF Common Stock at any meeting of stockholders of New XCF, or take all actions by written consent in lieu of any such meeting as may be necessary,
      at which the designees of the Sponsor, Mihir Dange, New XCF&#8217;s Chief Executive Officer or Gregory Surette, New XCF&#8217;s Chief Strategy Officer are nominated as directors, in each case in favor of the election of such nominees.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The foregoing description of the Voting Agreements does not purport to be complete and is qualified in its entirety by the terms and conditions thereof,
      the form of which is filed herewith as Exhibit 10.54, and is incorporated into this Item 1.01 by reference.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Indemnification Agreements</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On the Closing Date, New XCF entered into indemnification agreements (the &#8220;Indemnification Agreements&#8221;) with each of its directors and executive
      officers. Each Indemnification Agreement provides for indemnification and advancements by New XCF, subject to the limitations and exclusions provided therein, of certain expenses, including attorneys&#8217; fees, judgments, fines and settlement amounts,
      incurred by a director or executive officer in any action or proceeding arising out of their services as one of New XCF&#8217;s directors or executive officers or any other company or enterprise to which the person is or was serving or providing services
      at New XCF&#8217;s request.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The foregoing description of the Indemnification Agreements does not purport to be complete and is qualified in its entirety by the terms and conditions
      thereof, a form of which is filed herewith as Exhibit 10.55, and is incorporated into this Item 1.01 by reference.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Lock-Up Waivers</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In connection with the execution by the parties of the Business Combination Agreement, certain equityholders of XCF entered into Support Agreements with
      Focus Impact and NewCo, which include lock-up provisions limiting the circumstances under which such equityholders were permitted to sell or otherwise transfer the shares of New XCF Common Stock received as consideration in the Business Combination.
      In addition, certain transferees of XCF securities receiving those securities from the initial signatories to the Support Agreements were required to become parties to the Support Agreements and be governed by the relevant lock-up provisions.&#160; On the
      Closing Date, Focus Impact, NewCo and XCF entered into an agreement providing for the waiver of all lock-up terms of the Support Agreements (the &#8220;Waiver Agreement&#8221;), as a result of which, no holders of New XCF Common Stock are subject to contractual
      restrictions on the sale or other disposition of their shares of New XCF Common Stock.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">3</span></div>

      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The foregoing description of the Waiver Agreement does not purport to be complete and is qualified in its entirety by the terms and conditions thereof, a
      form of which is filed herewith as Exhibit 10.56, and is incorporated into this Item 1.01 by reference.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Employment Agreements with Officers</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The information relating to the employment agreements with our officers in Item 5.02 is incorporated into this Item 1.01 by reference.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Twain Forbearance Agreement</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">
<div>As previously disclosed by XCF in Item 2.04 its Current Report on Form 8-K filed on June 2, 2025, New Rise Renewables Reno, LLC (&#8220;New Rise Reno&#8221;), a
      subsidiary of New XCF, and party to a Ground Lease effective as of March 29, 2022 with Twain GL XXVIII, LLC (&#8220;Twain&#8221;), as the Landlord, has provided notices to New Rise Reno asserting that New Rise Reno is in default of the terms of the Ground Lease
      for its failure to make certain payments that are due and owing thereunder. On June 11, 2025, New XCF, New Rise Reno and Twain entered into a Forbearance Agreement (the &#8220;Twain Forbearance Agreement&#8221;), pursuant to which Twain has agreed to forbear
      from exercising its rights and remedies under the Ground Lease and related documents and/or applicable law with respect to any alleged defaults or alleged events of default until September 3, 2025, subject to certain conditions and exceptions
      provided in the Twain Forbearance Agreement. In consideration of Twain&#8217;s forbearance, New XCF will issue 4,000,000 shares of New XCF Common Stock (the &#8220;Landlord Shares&#8221;) to Twain and use its reasonable best efforts to file a registration statement on
      appropriate form with the SEC to register the Landlord Shares for resale. The net proceeds of any sale of the Landlord Shares are to be credited on a dollar-for-dollar basis against any remaining principal, interest, and penalties owed by New Rise
      Reno to Twain.
      </div>
<div>&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The foregoing description of the Twain Forbearance Agreement does not purport to be complete and is qualified in its entirety by the terms and conditions thereof, the
        form of which is filed herewith as Exhibit 10.66, and is incorporated into this Item 1.01 by reference. The information regarding New Rise Reno&#8217;s ground lease with Twain included in Item 2.04 of XCF&#8217;s Current Report on Form 8-K filed on June 2,
        2025 is incorporated into this Item 1.01 by reference.</div>

    </div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 57.6pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 2.01</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="font-weight: bold;">Completion of Acquisition or Disposition of Assets.</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The disclosure set forth in the &#8220;Introductory Note&#8221; above is incorporated by reference into this Item 2.01. In addition, the material terms of the
      Business Combination are described in greater detail in the Proxy Statement/Prospectus in the section titled &#8220;Proposal No. 1 &#8211; The Business Combination Proposal &#8211; The Business Combination Agreement&#8221; beginning on page 172 thereof, which is
      incorporated into this Item 2.01 by reference.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Focus Impact&#8217;s stockholders considered, adopted and approved, among other matters, the Business Combination at a special meeting of Focus Impact&#8217;s
      stockholders held on February 27, 2025. The Business Combination was subsequently consummated on June 6, 2025.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Following the closing of the Business Combination, Focus Impact&#8217;s Class A common stock, units and public warrants ceased trading on the OTC Pink
      Marketplace, and New XCF&#8217;s Common Stock began trading on The Nasdaq Stock Market (&#8220;Nasdaq&#8221;) on June 9, 2025, under the symbol &#8220;SAFX.&#8221; There is no public trading market for the public warrants that remain outstanding.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">FORM 10 INFORMATION</div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br/>
      </span></div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to Item 2.01(f) of Form 8-K, if the registrant was a shell company, as NewCo was immediately before the Business Combination, then the
      registrant must disclose the information that would be required if the registrant were filing a registration statement on Form 10. As a result of the completion of the Business Combination, NewCo ceased to be a shell company. Therefore, New XCF is
      providing below the information that would be included in a Form 10 if New XCF were to file a Form 10. Please note that the information provided below relates to the combined company after the completion of the Business Combination, unless otherwise
      specifically indicated or the context otherwise requires.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">4</span></div>

      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Cautionary Note Regarding Forward-Looking Statements</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">This Current Report on Form 8-K includes &#8220;forward-looking statements&#8221; within the meaning of the &#8220;safe harbor&#8221; provisions of the United States Private
      Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terminology such as &#8220;may&#8221;, &#8220;should&#8221;, &#8220;expect&#8221;, &#8220;intend&#8221;, &#8220;will&#8221;, &#8220;estimate&#8221;, &#8220;anticipate&#8221;, &#8220;believe&#8221;, &#8220;predict&#8221;, &#8220;potential&#8221; or &#8220;continue&#8221;, or the
      negatives of these terms or variations of them or similar terminology. These forward-looking statements, including, without limitation, statements regarding New XCF&#8217;s expectations with respect to future performance and anticipated financial impacts
      of the Business Combination, estimates and forecasts of other financial and performance metrics, and projections of market opportunity and market share, are subject to risks and uncertainties, which could cause actual results to differ materially
      from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by New XCF and its management, are inherently uncertain and subject to
      material change. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or
      probability. New risks and uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties. Factors that may cause actual results to differ materially from current expectations include, but are not limited
      to: (1) changes in domestic and foreign business, market, financial, political, and legal conditions; (2) unexpected increases in New XCF&#8217;s expenses resulting from potential inflationary pressures and rising interest rates, including manufacturing
      and operating expenses and interest expenses; (3) the occurrence of any event, change or other circumstances that could give rise to the termination of negotiations and any agreements with regard to New XCF&#8217;s offtake arrangements; (4) the outcome of
      any legal proceedings that may be instituted against the parties to the Business Combination Agreement or others; (5) New XCF&#8217;s ability to meet Nasdaq&#8217;s continued listing standards; (6) New XCF&#8217;s ability to integrate the operations of New Rise and
      implement its business plan on its anticipated timeline; (7) New XCF&#8217;s ability to raise financing in the future and the terms of any such financing; (8) New Rise&#8217;s ability to produce the anticipated quantities of SAF without interruption or material
      changes to the SAF production process; (9) New XCF&#8217;s ability to resolve current disputes between New Rise and its landlord with respect to the ground lease for the New Rise Reno facility; (10) New XCF&#8217;s ability to resolve current disputes between New
      Rise and its primary lender with respect to loans outstanding that were used in the development of the New Rise Reno facility; (11) costs related to the Business Combination and the New Rise acquisitions; (12) the risk of disruption to the current
      plans and operations of New XCF as a result of the consummation of the Business Combination; (13) New XCF&#8217;s ability to recognize the anticipated benefits of the Business Combination and the New Rise acquisitions, which may be affected by, among other
      things, competition, the ability of New XCF to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its management and key employees; (14) changes in applicable laws or regulations; (15) risks related to
      extensive regulation, compliance obligations and rigorous enforcement by federal, state, and non-U.S. governmental authorities; (16) the possibility that New XCF may be adversely affected by other economic, business, and/or competitive factors; (17)
      the availability of tax credits and other federal, state or local government support; (18) risks relating to New XCF&#8217;s and New Rise&#8217;s key intellectual property rights; (19) the risk that New XCF&#8217;s reporting and compliance obligations as a
      publicly-traded company divert management resources from business operations&#894; (20) the effects of increased costs associated with operating as a public company&#894; and (21) various factors beyond management&#8217;s control, including general economic
      conditions and other risks, uncertainties and factors set forth in New XCF&#8217;s filings with the Securities and Exchange Commission (&#8220;SEC&#8221;) , including the final proxy statement/prospectus relating to the Business Combination filed with the SEC on
      February 6, 2025, this Current Report on Form 8-K and other filings New XCF makes with the SEC in the future. If any of the risks actually occur, either alone or in combination with other events or circumstances, or New XCF&#8217;s assumptions prove
      incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that New XCF does not presently know or that it currently believes are not material that could also cause
      actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect New XCF&#8217;s expectations, plans or forecasts of future events and views as of the date of this Current Report on Form 8-K.
      These forward-looking statements should not be relied upon as representing New XCF&#8217;s assessments as of any date subsequent to the date of this Current Report on Form 8-K. Accordingly, undue reliance should not be placed upon the forward-looking
      statements. While New XCF may elect to update these forward-looking statements at some point in the future, New XCF specifically disclaims any obligation to do so.</div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"> </span><span style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </span></div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">5</span></div>

      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Business</div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br/>
      </span></div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Our business is described in the Proxy Statement/Prospectus in the section titled &#8220;Information about XCF Global Capital, Inc.&#8221; beginning on page 193 of
      the Proxy Statement/Prospectus and that information is incorporated into this Item 2.01 by reference. In addition, certain developments related to production at our Reno, Nevada facility are described in Item 8.01 of XCF&#8217;s Current Report on Form 8-K
      filed on June 2, 2025, which information is incorporated into this Item 2.01 by reference.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">As explained in the sections titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations of XCF Global &#8211; Liquidity and
      Capital Resources&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations of New Rise &#8211; Liquidity and Capital Resources&#8221; in the Proxy Statement/Prospectus, management does not believe current cash and cash
      equivalents are sufficient to fund operations for at least the next 12 months from the issuance date of the financial statements of XCF and New Rise, which management believes raises substantial doubt about our ability to continue as a going concern.
      For additional information also see &#8220;Risk Factors - Risks Related to Our Operations, Business and Industry - Although we currently expect to have sufficient funds available to consummate the Business Combination, as of the date of this proxy
      statement/prospectus, we have not obtained sufficient funding to meet all of our obligations in connection with closing, nor have we obtained sufficient funding to execute our business plan. In addition, XCF&#8217;s management and New Rise&#8217;s management
      each has identified conditions that raise substantial doubt about each of XCF&#8217;s and New Rise&#8217;s ability to continue as a going concern,&#8221; which can be found beginning on page 57 of the Proxy Statement/Prospectus, and which is incorporated herein by
      reference.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The mailing address of our principal executive offices is 2500 CityWest Blvd, Suite 150-138, Houston, TX 77042 and our telephone number at such address
      is (346) 630-4724.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Risk Factors</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The risk factors related to New XCF, our business and operations and the Business Combination are set forth in the Proxy Statement/Prospectus in the
      section titled &#8220;Risk Factors&#8221; beginning on page 57 of the Proxy Statement/Prospectus and that information is incorporated into this Item 2.01 by reference.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Financial Information</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">As previously disclosed in XCF&#8217;s Current Report on Form 8-K filed April 7, 2025 and Notifications of Late Filing on Form 12b-25 filed on May 7, 2025 and
      May 16, 2025, there have been delays in&#160; preparing (i) the audited financial statements for XCF and New Rise for the fiscal year ended December 31, 2024 and (ii) the unaudited quarterly financial statements for XCF and New Rise for the quarterly
      period ended March 31, 2025. New XCF is working diligently to finalize these financial statements, provide updated &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; disclosure for the year ended December 31, 2024
      and the quarterly period ended March 31, 2025 and the acquired business pro forma financial information required to be filed with this Current Report on Form 8-K as required by Item 9.01. New XCF expects to file an amendment to this Current Report on
      Form 8-K to add the required financial information as soon as practicable.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Properties</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Our properties are described in the Proxy Statement/Prospectus in the section titled &#8220;Information about XCF Global Capital, Inc. &#8211; Properties&#8221; beginning
      on page 212 of the Proxy Statement/Prospectus and that information is incorporated into this Item 2.01 by reference. In addition, we have relocated New XCF&#8217;s principal executive offices to Houston, Texas. Those offices are located at 2500 CityWest
      Blvd, Suite 150-138, Houston, TX 77042.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The information regarding New Rise&#8217;s ground lease with Twain GL XXVIII, LLC included in Item 2.04 of XCF&#8217;s Current Report on Form 8-K filed on June 2,
      2025 is incorporated into this Item 2.01 by reference.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">6</span></div>

      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Directors and Executive Officers</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The following table sets forth the names, ages and positions of the executive officers and directors of New XCF.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left; font-weight: bold;">Name</div>
          </td>

    <td style="width: 8%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; font-weight: bold;">Age</div>
          </td>

    <td style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left; font-weight: bold;">Position(s)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left; font-style: italic; font-weight: bold;">Executive Officers:</div>
          </td>

    <td style="width: 8%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Mihir Dange</div>
          </td>

    <td style="width: 8%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">45</div>
          </td>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Chief Executive Officer; Director; Board Chair</div>
          </td>

  </tr>

  <tr>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Simon Oxley</div>
          </td>

    <td style="width: 8%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">47</div>
          </td>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Chief Financial Officer</div>
          </td>

  </tr>

  <tr>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Gregory R. Surette</div>
          </td>

    <td style="width: 8%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">41</div>
          </td>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Chief Strategy Officer; Secretary</div>
          </td>

  </tr>

  <tr>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Gregory P. Savarese</div>
          </td>

    <td style="width: 8%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">41</div>
          </td>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Chief Marketing Officer</div>
          </td>

  </tr>

  <tr>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Pamela Abowd</div>
          </td>

    <td style="width: 8%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">45</div>
          </td>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Chief Accounting Officer</div>
          </td>

  </tr>

  <tr>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Jae Ryu</div>
          </td>

    <td style="width: 8%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">51</div>
          </td>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Head of Land Development</div>
          </td>

  </tr>

  <tr>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 8%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left; font-style: italic; font-weight: bold;">Non-Employee Directors:</div>
          </td>

    <td style="width: 8%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Anne Anderson</div>
          </td>

    <td style="width: 8%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">55</div>
          </td>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Director</div>
          </td>

  </tr>

  <tr>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Sanford Cockrell</div>
          </td>

    <td style="width: 8%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">66</div>
          </td>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Director</div>
          </td>

  </tr>

  <tr>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Si-Yeon Kim</div>
          </td>

    <td style="width: 8%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">54</div>
          </td>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Director</div>
          </td>

  </tr>

  <tr>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Carter McCain</div>
          </td>

    <td style="width: 8%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">61</div>
          </td>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Director</div>
          </td>

  </tr>

  <tr>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Wray Thorn</div>
          </td>

    <td style="width: 8%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">54</div>
          </td>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Director</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Executive Officers</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Mihir Dange</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Mr. Mihir Dange served as XCF&#8217;s Chief Executive Officer since November 2023 and as a member of its board of directors in March 2024, and now serves as
      New XCF&#8217;s Chief Executive Officer and as Chair of the Board of Directors of New XCF. Mr. Dange has over 25 years of experience in commodities trading and public markets. Since 2016, he has also served as Co-CEO of Wapanda, Inc. (&#8220;Wapanda&#8221;). At
      Wapanda, Mr. Dange created and implemented the first NYC-approved E-Hail mobile application for taxicabs which provided consumers with upfront pricing. He also worked with the Tusk Organization on regulatory bill LS 16081 to improve taxi efficiencies
      around debt restructuring of medallion financial assets and bolster taxi stability as well as the initiation of legislation Int. 2432-2021 to create the first autonomous vehicle ownership structure within tax medallion assets in New York City. From
      2006 to 2014, Mr. Dange served as co-founder and Head of Trading for Arbitrage Capital, LLC, trading futures and options for FX, equities, and commodities. Mr. Dange evaluated dynamic trading strategies, improved trading practices, conducted
      portfolio analysis, created performance reports, and maintained relationships with multiple brokers. Mr. Dange has been a frequent guest analyst on CNBC, Bloomberg, BNN, and other major media outlets. Mr. Dange holds a Bachelor of Science in Finance
      and Marketing from the Leonard Stern School of Business at New York University. Mr. Dange is the brother-in-law of Gregory R. Surette. We believe that Mr. Dange&#8217;s significant experience in commodities trading and public markets and his experience as
      a co-chief executive officer of a company makes him well qualified to serve as a member of our Board.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Simon Oxley</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Mr. Simon Oxley served as XCF&#8217;s Chief Financial Officer since February 2024 and now serves as New XCF&#8217;s Chief Financial Officer. He served as the Chief
      Financial Officer of Tellurian, Inc., a Houston based liquified natural gas development company, from June 2023 until Woodside Energy&#8217;s $1.2 billion acquisition of Tellurian was completed in October 2024. From May 2016 to May 2023, Mr. Oxley served
      as Managing Director and Co-Head of Oil &amp; Gas Investment Banking for Europe, the Middle East, and Africa (EMEA) at Barclays Investment Bank, where he led a number of LNG-related transactions due to his extensive knowledge of the LNG business.
      From September 2009 to May 2023, he held positions of increasing responsibility with Barclays Investment Bank, where he was involved with numerous energy client transactions across exploration and production, refining and petrochemical, retail
      stations and pipelines as well as gas and LNG. From 2001 to 2009, Mr. Oxley as an investment banker at Citigroup Global Markets Inc. Mr. Oxley holds a Bachelor of Engineering in Chemical Engineering from The University of Edinburgh and a Master of
      Science in Corporate and International Finance from Durham University Business School.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">7</span></div>

      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Gregory R. Surette</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Mr. Gregory R. Surette served as XCF&#8217;s Chief Strategy Officer since February 2024 and now serves as New XCF&#8217;s Chief Strategy Officer and Corporate
      Secretary. Prior to becoming XCF&#8217;s Chief Strategy Officer in February 2024, he served as Interim Chief Strategy Officer since March 2024 and as Co-Head of Feedstock from November 2023 until March 2024. Mr. Surette brings over 18 years of extensive
      corporate finance and accounting expertise, with a specialized emphasis on energy and resources, as well as manufacturing and distribution. Mr. Surette has served as Chief Financial and Operating Officer of The Ricci Group Limited (&#8220;Ricci&#8221;) since
      2019, managing Ricci&#8217;s coffee and hospitality investments in Mainland China. Mr. Surette was integral in creating Ricci&#8217;s global supply chain, focusing on coffee importation and distribution for the launch and expansion of four coffee brands.
      Starting his professional journey at Deloitte and Touche LLP in 2006, Mr. Surette served as an auditor for both public and private companies, with a significant focus on manufacturing and software enterprises. Transitioning to Deloitte&#8217;s London
      office from 2010 to 2013, Mr. Surette provided advisory services for international transactions, high-yield debt offerings, IPOs, and global note programs, working on transactions ranging from $100 million to $1.5 billion across various sectors, and
      gaining experience with regulatory frameworks and securities listings, SEC rules and listing rules of the United Kingdom Listing Authority, the Luxembourg Bourse and the Irish Stock Exchange. From 2013 to 2019, Mr. Surette continued his career with
      Deloitte &amp; Touche LLP in its Mergers and Acquisitions Transaction Services Group in New York, leading diverse teams in multi-billion dollar investments for private equity clients, with a particular focus on the Energy and Resources industry. Mr.
      Surette holds a CPA designation and earned his Bachelor of Science in Accounting from Fairfield University&#8217;s Dolan School of Business. He has served on the Board of Directors of SinoTaste Technology (Shanghai) Co., Ltd. since 2024. Mr. Surette is the
      brother-in-law of Mihir Dange.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Gregory P. Savarese</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Mr. Gregory P. Savarese served as XCF&#8217;s Chief Marketing Officer since February 2024 and now serves as New XCF&#8217;s Chief Marketing Officer. Prior to
      becoming XCF&#8217;s Chief Marketing Officer in February 2024, he served as Interim Chief Marketing Officer since March 2024 and as Co-Head of Feedstock from November 2023 until March 2024. Mr. Savarese leverages 18 years of experience leading strategic
      planning, business development, and marketing and communications initiatives within fast-growth businesses operating in East Asia. Mr. Savarese has served as Co-Founder and Chief Executive Officer at The Ricci Group Limited (&#8220;Ricci&#8221;) since 2009. Mr.
      Savarese&#8217;s responsibilities have included driving strategy, revenue, business growth, and profitability across Ricci&#8217;s manufacturing, sales and marketing, distribution, and hospitality businesses, successfully bringing six award-winning brands to
      market in the packaged coffee and hospitality markets, executing brand and marketing development strategies for both corporate-facing and consumer-facing products, and leading high-performing business management teams operating across more than 40
      cities in China. In 2019, a subsidiary company was the recipient of a Transform APAC region silver medal for best visual identity in the FMCG sector. Mr. Savarese earned a Bachelor of Arts in Communication from Loyola University Maryland and was
      inducted into Lambda Pi Eta, the National Communication Honor Society, in 2006. Mr. Savarese has served on the Board of Directors of The Ricci Group Limited and subsidiaries since 2010 and SinoTaste Technology (Shanghai) Co., Ltd. since 2024.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Pamela M. Abowd</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Ms. Pamela M. Abowd served as XCF&#8217;s Chief Accounting officer since April 2025 and now serves as New XCF&#8217;s Chief Accounting Officer. Ms. Abowd&#160; most
      recently managed the post-merger accounting and tax integration between Woodside Energy and Tellurian from October 2024 to April 2025. From 2018 to 2024, she served as Vice President, Corporate Controller and Head of Accounting Operations (2022-2024)
      and Tax Director (2018-2022) at Tellurian. In these roles, she led all aspects of accounting operations, financial reporting, tax accounting and compliance, and ERP system implementation. Prior to Tellurian, Ms. Abowd held senior tax leadership roles
      at Cheniere Energy from 2009 to 2018, where she oversaw the company&#8217;s global tax strategy, ensuring compliance with all tax regulations, and optimized tax efficiencies. She led the tax team and the company&#8217;s tax strategy initiatives. She began her
      career in public accounting at Grant Thornton and UHY Advisors. Ms. Abowd holds a BBA in Accounting and a Master of Accountancy from the University of Houston and is a Certified Public Accountant licensed in Texas.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">8</span></div>

      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Jae Ryu</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Mr. Jae Ryu served as XCF&#8217;s Head of Land Development since March 2024 and now serves as New XCF&#8217;s Head of Land Development. He also served as XCF&#8217;s Chief
      Investment Officer from November 2023 to March 2024, and as XCF&#8217;s Interim Chief Financial Officer from July 2024 to February 2025. Mr. Ryu brings over 25 years of extensive experience in finance and real estate at both public and private companies to
      his most current role at XCF, with a proven track record as an advisor, consultant, and in-house subject expert. Mr. Ryu has experience and expertise in municipal financing, federal subsidized tax credit programs, and strategic initiatives within
      both the real estate and renewable energy sectors. Notably, Mr. Ryu has facilitated the raising of over $1.5 billion in project development financing. Mr. Ryu has served as Managing Director and Chief of Staff to the Chairman at Crown Power Inc.
      since September 2022, where he has spearheaded day-to-day operations and established robust operational, accounting, and financial procedures. From 2008 to July 2022, Mr. Ryu served as a Senior Partner at SDC Companies, where he provided professional
      development, construction, and advisory services. Mr. Ryu&#8217;s responsibilities included project financing and structuring, pre-acquisition valuation and due diligence, acquisition and partnership structuring, project pro forma analysis, and
      relationships with project lenders. Before his time at SDC Companies, Mr. Ryu held the position of Project Manager and Vice President of Corporate Finance at Empire Land in California from 2004 to 2009. In this role, Mr. Ryu oversaw the entire
      lifecycle of individual projects, from acquisition and entitlement to construction, sales, and project closure. Mr. Ryu earned his Bachelor of Arts in International Business Management - Finance from the University of San Francisco.</div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Executive Compensation</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">A description of the compensation of the named executive officers of XCF before the consummation of the Business Combination is set forth in the Proxy
      Statement/Prospectus in the section titled &#8220;Executive and Director Compensation of XCF&#8221; beginning on page 215 of the Proxy Statement/Prospectus, which is incorporated into this Item 2.01 by reference.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On February 14, 2025 and April 16, 2025, XCF entered into employment agreements with its executive officers, certain of which were subject to amendment
      prior to the closing of the Business Combination. These employment agreements were effective as of February 14, 2025 for Messrs. Dange, Oxley, Surette, Savarese and Ryu and April 16, 2025 for Ms. Abowd. The material terms of the agreements are
      summarized in (i) the Current Report on Form 8-K of Focus Impact, filed on February 21, 2025, under the caption &#8220;XCF Employment Agreements&#8221; and (ii) the Current Report on Form 8-K of XCF, filed on June 2, 2025, under the captions &#8220;Appointment of
      Chief Accounting Officer&#8221; and &#8220;Employment Agreement Amendments,&#8221; which descriptions are incorporated by reference into this Item 2.01.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On the Closing Date, New XCF entered into employment agreements with each of its Executive Officers (the &#8220;New Employment Agreements&#8221;), which became
      effective upon the closing of the Business Combination. The description of the materials terms of the New Employment Agreements is included in Item 5.02 of this Current Report on Form 8-K under the caption &#8220;Executive Officer Employment Agreements&#8221; is
      incorporated by reference into this Item 2.01.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">XCF also entered into separation agreements with two of its executive officers. The description of the materials terms of these agreements is included in
      the Current Report on Form 8-K of XCF, filed on June 2, 2025, under the caption &#8220;Departure of Directors and Executive Officers,&#8221; which description is incorporated by reference into this Item 2.01.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Board of Directors</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Non-Employee Directors</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Anne Anderson</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">9</span></div>

      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Ms. Anne Anderson is a seasoned business executive and board member with extensive experience in strategy, operational leadership, and commercial
      dealmaking across the energy and chemicals industries. Over her 16-year career at Shell Oil and its affiliates, she held several senior leadership roles, including serving as Vice President, Chemicals Americas of Shell Chemical LP from July 2019 to
      August 2021, Senior Vice President Global Marketing, Growth, Sustainability and Transformation from August 2021 until April 2022, and as Special Advisor from April 2022 to November 2022. Ms. Anderson also served as Vice President, Shell Oil Company
      and Shell Petroleum Inc. from April 2020 until June 2022. Prior to those positions, she helped lead Shell&#8217;s global sales of fuels and lubricants to the aviation industry as Shell International Petroleum Company&#8217;s Vice President, Aviation. Ms.
      Anderson has a proven track record of leading large-scale commercial transactions, optimizing global operations, and driving growth initiatives. She has successfully negotiated $1 billion+ transactions, enhanced operational excellence, and
      implemented continuous improvement strategies to maximize efficiency and profitability. She also brings deep expertise in portfolio and performance management, having served as a board member for Shell Midstream Partners LP (NYSE: SHLX) from April
      2020 until June 2022, overseeing strategy and governance for a publicly traded midstream company. Since January 2025 she has served as an advisor to EQT AB, and from December 2022 until December 2024 she focused on volunteer work. Ms. Anderson holds
      a Bachelor of Science in Chemical Engineering degree from The Florida State University and a Master of Business Administration degree from Washington University in St. Louis. We believe Ms. Anderson&#8217;s extensive experience in global energy, aviation
      fuels, and business transformation makes her well qualified to serve as a member of our Board.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Sanford (Sandy) Cockrell</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Mr. Sanford (Sandy) Cockrell is a seasoned strategy and financial executive with over 40 years of experience advising senior executives, management
      teams, and boards of directors of large multinational companies. His expertise spans complex financial accounting and taxation, corporate strategy, capital deployment, operational execution, and investor and regulatory relations. During his career
      with Deloitte LLP, from July 1984 to May 2021, Mr. Cockrell served in a variety of key roles, including service on Deloitte&#8217;s U.S. and global boards of directors (including as Vice Chair of the U.S. board), as Advisory Partner to several of
      Deloitte&#8217;s largest public company attest clients, as Partner and Global Leader, CXO and Board Programs, as Partner and Global Leader, CFO Program and as Lead Partner of the New York office of the Special Acquisition Services Group. His extensive
      experience working with c-suite executives and boards allows him to provide key insights into best-in-class executive team execution and valuable interactions with boards of directors. After retiring from Deloitte, from August 2021 to June 2023 he
      served as Executive Vice President and CFO of Flipt, LLC, where he was responsible for all aspects of financial management and strategy for a next-generation pharmacy benefits manager. In addition, from May 2023 to present, Mr. Cockrell has served as
      a Client Advisory Council Member for CAPTRUST, where he provides strategic advice regarding coverage and penetrating the professional services marketplace in providing investment advisory services. He earned his B.S. in Business Administration from
      the University of North Carolina at Chapel Hill and is a member of the American Institute of CPAs. We believe Mr. Cockrell&#8217;s extensive leadership in accounting, taxation, corporate governance, financial strategy, and executive advisory makes him well
      qualified to serve as a member of our Board.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Si-Yeon Kim</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Ms. Si-Yeon Kim is an experienced executive and corporate board member, private equity advisor, and global risk expert with over 20 years of experience
      in M&amp;A, private equity, and international operations across travel, payments, industrials, and decarbonization. She has held leadership roles at American Express, JPMorgan Chase &amp; Co., and Avon, advising public and private boards on risk
      management, cybersecurity, regulatory compliance, and strategic growth initiatives. From 2014 to 2022, Ms. Kim served as EVP, Chief Risk &amp; Compliance Officer / Executive Chair of ESG for American Express Global Business Travel (Amex GBT), where
      she played a key role in Amex GBT&#8217;s $5.3 billion public listing (NYSE: GBTG), leading $1 billion in capital deployment for digital transformation and M&amp;A integration. She also helped launch the first-ever blockchain-based SAF platform in
      partnership with Shell Aviation and represented GBT at COP26 to advance corporate climate strategies. Prior to her time with American Express, she served as Chief Compliance Officer, OEP / Assistant General Counsel for One Equity Partners (the
      private equity arm of JPMorgan Chase &amp; Co.) and as Assistant GC, Global M&amp;A and Corporate Strategy / GC, Avon - Asia Pacific for Avon Products, Inc. Her experience spans IPO preparation, business transformation, governance, and emerging clean
      technologies. Ms. Kim holds a B.A. from Seoul National University, an A.M. from Harvard University and a J.D from Columbia University Law School. We believe Ms. Kim&#8217;s extensive leadership in corporate governance, M&amp;A, and sustainability makes her
      well qualified to serve as a member of our Board.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">10</span></div>

      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Carter McCain</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Mr. Carter McCain is a highly accomplished attorney and business leader with a long and distinguished career with over 37 years of experience advising
      clients on a variety of matters including international business, alternative finance and funding and financial instruments. Mr. McCain is the Founder and is a principal in McCain Law P.A and McCain Family Office since 2015. Mr. McCain has also
      served since May 2017 as Director and General Counsel of Vermilion LLC, a family-owned private investment company focused on fuel trading and gold arbitrage. In addition, from 2018 to present, Mr. McCain has served as General Counsel and Director of
      ANS Capital Partners, LLC. Mr. McCain holds a B.S.B.A. from the University of Florida and a J.D. from Stetson University College of Law. We believe his experience in international transactions and investments and his legal expertise makes him well
      qualified to serve as a member of our Board.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Wray T. Thorn</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Mr. Wray Thorn has been a Partner and Co-Founder of Focus Impact Partners, LLC since 2021 and currently serves as the Chief Investment Officer of Focus
      Impact Acquisition Corp.,&#160;and prior to the completion of the Business Combination, served as the Chief Investment Officer and director of Focus Impact BH3 Acquisition Company. He also currently serves on the board of DevvStream Corp.&#160; Also since
      2021, Mr. Thorn has been the Founder and Chief Executive of Clear Heights Capital. From 2012 to 2021, Mr. Thorn was a Managing Director and Chief Investment Officer - Private Investments at Two Sigma Investments, where he architected and led the
      firm&#8217;s private equity, venture capital and impact investment businesses and was a leader in the creation of Hamilton Insurance Group and the incubation of Two Sigma&#8217;s insurance technology activities. With approximately three decades of experience as
      a chief investment officer, investment leader and lead director, Mr. Thorn has firsthand knowledge of investment firm leadership, private investing and company value creation. Mr. Thorn has built and led businesses to source, structure, finance and
      make private investments, to allocate and risk manage capital across private investment strategies and to help companies, organizations and executives realize their growth and development objectives. Mr. Thorn has also been at the forefront of
      proactive impact investing principals, putting people first in private investing as well as applying data and technology to innovate private investing. Mr. Thorn also serves as Co-Chair of the Board of Youth, INC and Vice Chair of the Board and Chair
      of the Investment Committee for Futures and Options, both of which are Non-Profit Organizations. We believe his significant experience and leadership in private equity makes him well qualified to serve as a member of our Board.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Board Composition</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">New XCF&#8217;s business and affairs will be organized under the direction of the Board. The Board consists of six members. Pursuant to the terms of the
      Business Combination Agreement, the Board was intended to be comprised of nine members, with (i) XCF having the right to designate five of the initial members of the Board, (ii) Focus Impact having the right to designate two of the initial members of
      the Board and (iii) the other two initial members of the Board being subject to the mutual agreement of XCF and Focus Impact. The parties to the Business Combination subsequently agreed to a Board that would initially be comprised of six members,
      with (i) XCF having the right to designate four members of the Board, (ii) Focus Impact having the right to designate one member of the Board and (iii) the remaining member of the Board to subject to the mutual agreement of XCF and Focus Impact. As
      described in Item 1.01 with respect to the Board Agreement, the intent is to expand the Board to nine members and, if their appointment does not conflict with Nasdaq rules concerning board independence, add Mr. Carl Stanton, who is currently serving
      as a Board observer, and Mr. Gregory R. Surette, who is New XCF&#8217;s Chief Strategy Officer and Corporate Secretary, to the Board along with an additional director meeting the independence and other requirements for service on our Board.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Mihir Dange, Anne Anderson, Si-Yeon Kim and Sanford Cockrell have been designated by XCF. Wray Thorn has been designated by Focus Impact. Carter McCain
      has been designated by agreement between XCF and Focus Impact. Following these initial designations, as described in Item 1.01 with respect to the Board Agreement, the Sponsor has certain rights to designate up to two member to serve on our Board.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">11</span></div>

      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In accordance with the terms of our certificate of incorporation, the Board is divided into three classes, Class I, Class II and Class III, with only one
      class of directors being elected in each year and each class serving a three-year term, except that:</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 36pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>Class I directors will serve an initial term to expire at our first annual meeting of stockholders (to be held in 2026), and subsequently will be elected to serve three-year terms;</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 36pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>Class II directors will serve an initial term to expire at our second annual meeting of stockholders (to be held in 2027), and subsequently will be elected to serve three-year terms; and</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 36pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>Class III directors will serve an initial term to expire at our third annual meeting of stockholders (to be held in 2028), and subsequently will be elected to serve three-year terms.</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">There is no cumulative voting with respect to the election of directors. Subject to the rights of the holders of one or more series of preferred stock,
      voting separately by class or series, to elect directors pursuant to the terms of one or more series of preferred stock, the election of directors shall be determined by a plurality of the votes cast by our stockholders present in person or
      represented by proxy at the meeting and entitled to vote thereon.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The directors that will serve in each class are as follows:</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 36pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>Class I &#8211; Mihir Dange and Anne Anderson;</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 36pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>Class II &#8211; Sanford Cockrell and Si-Yeon Kim; and</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 36pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>Class III &#8211; Wray Thorn and Carter McCain.</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Directors will serve for their elected or appointed terms or until their successors are duly elected and qualified or their earlier resignation,
      retirement or removal. The classification of our Board may have the effect of delaying or preventing potential changes of control in the Board.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Director Independence</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Under Nasdaq listing requirements and rules, our Board must be comprised of a majority of independent directors. In addition, subject to certain
      exception, Nasdaq rules also require that each member of our Audit Committee, Compensation Committee and Nominating and Governance Committee be independent, and our Audit Committee members must also satisfy additional independence criteria set forth
      in Rule 10A-3 under the Exchange Act.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Under Nasdaq rules, a director will only qualify as an &#8220;independent director&#8221; if, in the opinion of our Board, that person does not have a relationship
      that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. In order to be considered independent for purposes of Rule 10A-3 of the Exchange Act, a member of an audit committee of a listed
      company may not, other than in his or her capacity as a member of the audit committee, the board of directors, or any other board committee, accept, directly or indirectly, any consulting, advisory, or other compensatory fee from the listed company
      or any of its subsidiaries or otherwise be an affiliated person of the listed company or any of its subsidiaries.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Our Board has reviewed the composition of the Board and the Audit Committee, Compensation Committee and Nominating and Governance Committee and the
      independence of each director. Based upon information requested from and provided by each director concerning the director&#8217;s background, employment and affiliations, including family relationships, our Board of Directors has determined that each of
      Anne Anderson, Sanford Cockrell, Si-Yeon Kim and Carter McCain is an &#8220;independent director&#8221; under Nasdaq rules and that Sanford Cockrell, Anne Anderson and Si-Yeon Kim, who will comprise our Audit Committee, also satisfy the independence standards
      for audit committees established by the SEC. In making such determinations, the Board considered the relationships that each such director has with our company and all other facts and circumstances the Board deemed relevant in determining
      independence.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">12</span></div>

      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Director Compensation</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">A description of the compensation of the directors of XCF before the consummation of the Business Combination is set forth in the section of the Proxy
      Statement/Prospectus titled &#8220;Executive and Director Compensation,&#8221; on page 215 thereof, which is incorporated into this Item 2.01 by reference.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Non-employee directors of New XCF will receive annual compensation of $150,000 in New XCF Common Stock restricted stock units with 1-year cliff vesting
      and $100,000 in cash or shares of New XCF Common Stock at the director&#8217;s option, with such restricted stock units vesting on the first anniversary of the grant. The annual compensation, including both the cash portion and restricted stock units
      portion, will be pro-rated during the directors&#8217; first year of service. Non-employee directors will also receive an initial grant of 100,000 New XCF Common Stock restricted stock units, with one-quarter of the units vesting on the anniversary of the
      grant over four years. The Lead Independent Director will receive additional annual compensation in the amount of $175,000, which the director may receive in either New XCF Common Stock restricted stock units or cash, at the director&#8217;s option. The
      Chair of the Audit Committee will receive additional annual compensation in the amount of $50,000, the Chair of the Compensation Committee will receive additional annual compensation in the amount of $25,000 and the Chair of the Nominating and
      Governance Committee will receive additional annual compensation in the amount of $25,000. In each case, the committee Chairs may receive, at his or her option, this additional compensation in New XCF Common Stock restricted stock units or cash.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Although Mr. Thorn is not an employee of New XCF, he will not receive the non-employee director compensation summarized above for so long as the
      Strategic Consulting Agreement, dated as of February 19, 2025, by and between XCF and the Sponsor, is in effect.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Board Leadership Structure</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Mihir Dange, our Chief Executive Officer, will serve as Chair of the Board. The Board will not have a policy regarding whether the role of the Chair of
      the board and Chief Executive Officer should be separate or combined, and the Board intends to maintain the flexibility to select the Board Chair and Chief Executive Officer and reorganize the leadership structure, from time to time, based on
      criteria that are in the best interests of New XCF and its stockholders.</div>

    <div style="text-align: left; text-indent: 20pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br/>
      </span></div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Our bylaws provide that at any time when the Chair is not an independent director, the Board will designate a lead independent director. The Board has
      designated Anne Anderson as the lead independent director, and in that role, the lead independent director has responsibility for (i) presiding at meetings of the Board at which the Chair is not present, including executive sessions of the
      independent directors, (ii) approving information sent to the Board, (iii) approving the agenda and schedule for Board meetings to provide that there is sufficient time for discussion of all agenda items, (iv) serving as liaison between the Chair and
      the independent directors, (v) communicating with significant stockholders, when circumstances warrant and (vi) performing such other designated duties as the Board may determine from time to time.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Committees of the Board</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">We have three standing committees of the Board &#8211; an Audit Committee, a Compensation Committee and a Nominating and Governance Committee. The composition
      and responsibilities of each committee are described below. Committee members will serve on these committees until their resignation or until otherwise determined by the Board.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Audit Committee</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Audit Committee consists of&#160;Sanford Cockrell, Anne Anderson and Si-Yeon Kim. The Board has determined that each member of the Audit Committee meets
      the &#8220;independence&#8221; requirements of Nasdaq and Rule 10A-3 under the Exchange Act. The Chair of the Audit Committee is Mr. Cockrell. The Board has determined that each of the members of the Audit Committee meet the applicable financial literacy
      requirements under Nasdaq and SEC rules and also has determined that Mr. Cockrell qualifies as an &#8220;audit committee financial expert&#8221; as such term is defined in Item 407(d)(5) of the SEC&#8217;s Regulation S-K.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">13</span></div>

      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The purpose of the Audit Committee is to assist the Board in its oversight of:</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 36pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>the quality and integrity of New XCF&#8217;s financial statements;</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 36pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>the accounting and financial reporting processes, including the effectiveness of&#160; New XCF&#8217;s internal controls over financial reporting;</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 36pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>New XCF&#8217;s compliance with legal and regulatory requirements;</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 36pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>the quality and integrity of the annual audit, including the independent auditor&#8217;s qualifications and independence;</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 36pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>the performance of New XCF&#8217;s independent auditor; and</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 36pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>the design and implementation of New XCF&#8217;s internal audit function, and the performance of the internal audit function after it has been established.</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Audit Committee has adopted a charter that is available on New XCF&#8217;s website.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Compensation Committee</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Compensation Committee consists of&#160;Carter McCain, Sanford Cockrell and Si-Yeon Kim. The Chair of the Compensation Committee is Mr. McCain. The Board
      has determined that each member of the Compensation Committee meets the &#8220;independence&#8221; requirements of Nasdaq and that each committee member is a &#8220;non-employee director&#8221; as defined in Rule 16b-3 under the Exchange Act.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The purpose of the Compensation Committee is to assist the Board in its oversight of the compensation of New XCF&#8217;s executive officers and non-employee
      directors. Specific responsibilities of the Compensation Committee include:</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 36pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>review and approve the goals and objectives with respect to the compensation of the Chief Executive Officer, evaluate the performance of the Chief Executive Officer in light of the goals and objectives and, based upon this evaluation, and
              review and set, or make recommendations to the Board regarding the compensation of the Chief Executive Officer;</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 36pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>oversee an evaluation of the individuals, other than the Chief Executive Officer, who are &#8220;officers&#8221; under Rule 16a-1(f) of the Exchange Act, and, after considering such evaluation, will review and set, or make recommendations to the Board
              regarding the compensation of such officers;</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 36pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>review and make recommendations to the Board regarding compensation of the Board&#8217;s non-employee directors, including equity-based awards;</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 36pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>review and approve New XCF&#8217;s overall compensation philosophy and related compensation and benefit programs, policies, and practices;</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 36pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>review and approve or make recommendations to the Board regarding New XCF&#8217;s incentive compensation, equity- based plans, and other benefit plans; and</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 36pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>oversee all matters relating to stockholder approval of executive compensation, including advisory votes on executive compensation (&#8220;say-on-pay&#8221; votes), the frequency of such votes (&#8220;say-when-on-pay&#8221; votes), and the appropriate Committee
              or recommended Board response to such votes.</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Compensation Committee has adopted a charter that is available on New XCF&#8217;s website.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">14</span></div>

      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Nominating and Corporate Governance Committee</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Nominating and Corporate Governance Committee consists of&#160;Si-Yeon Kim, Anne Anderson and Carter McCain. The Chair of the Nominating and Governance
      Committee is Ms. Kim. The Board has determined that each member of the Nominating and Corporate Governance Committee meets the &#8220;independence&#8221; requirements of Nasdaq.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 36pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>identify individuals qualified to become members of the Board consistent with criteria approved by the Board and to recommend that the Board select the director nominees for the next annual meeting of stockholders;</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 36pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>develop and recommend to the Board a set of Corporate Governance Guidelines;</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 36pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>oversee the evaluation of the Board and committees of the Board; and</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 36pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>assist the Board with corporate governance matters.</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Nominating and Corporate Governance Committee has adopted a charter that is available on New XCF&#8217;s website.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Compensation Committee Interlocks and Insider Participation</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">None of New XCF&#8217;s executive officers serve, or have served during the last year, as a member of the board of directors, compensation committee, or other
      board committee performing equivalent functions of any other entity that has one or more executive officers serving as one of our directors or on either company&#8217;s compensation committee.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Role of the Board in Risk Oversight</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Board has an active role, as a whole and also at the committee level, in overseeing the management of our risks. The Board is responsible for general
      oversight of risks and regular review of information regarding our risks, including credit risks, liquidity risks and operational risks. The Audit Committee is responsible for overseeing the management of risks relating to our financial reporting,
      accounting, and auditing matters, including our major financial risk exposures; cybersecurity and data privacy risk. The Compensation Committee is responsible for overseeing the management of risks relating to our executive compensation plans and
      arrangements. The Nominating and Corporate Governance Committee is responsible for overseeing the management of risks associated with the independence of the Board, as well as risks concerning environmental and social matters. Although each committee
      is responsible for evaluating certain risks and overseeing the management of such risks, the entire Board is regularly informed through discussions with committee members and regular reports from management about such risks, as well as the actions
      taken by management to adequately address those risks.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Indemnification of Officers and Directors</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">New XCF&#8217;s bylaws require that we indemnify our directors and officers to the fullest extent permitted by the Delaware General Corporation Law. In
      addition, New XCF&#8217;s certificate of incorporation provides that our directors will not be liable for monetary damages for breach of fiduciary duty to the fullest extent permitted by the Delaware General Corporation Law.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">New XCF has entered into indemnification agreements with its directors and executive officers. The information set forth above under Item 1.01 of this
      Current Report on Form 8-K regarding the indemnification agreements is incorporated into this Item 2.01 by reference.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">15</span></div>

      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <!--PROfilePageNumberReset%Num%16%%%-->
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Code of Ethics and Business Conduct</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Board has adopted a written Code of Ethics and Business Conduct that applies to our all employees, officers and directors of New XCF, including New
      XCF&#8217;s principal executive officer, principal financial officer and principal accounting officer or controller (or persons performing similar functions to the aforementioned officers). A current copy of the Code of Ethics and Business Conduct will be
      posted on the investor section of our corporate website. We intend to make any legally required disclosures regarding amendments to, or waivers of, provisions of our Code of Ethics and Business Conduct on our website rather than by filing a Current
      Report on Form 8-K.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Security Ownership of Certain Beneficial Owners and Management</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;">
      <div>
        <div>
          <div> <br/>
          </div>

          <div style="text-align: justify; text-indent: 36pt;">The following table sets forth information regarding the beneficial ownership of shares of New XCF Common Stock, as of June 6, 2025, following the consummation of the Business Combination, by:</div>

          <div><br/>
          </div>

          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 36pt;">&#160;</td>

    <td style="width: 26.35pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
                  <div>each person known by New XCF to be the beneficial owner of more than 5% of a class of voting securities on June 6, 2025;</div>
                </td>

  </tr>


</table>
          <div>&#160;</div>

          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 36pt;"><br/>
                </td>

    <td style="width: 26.35pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
                  <div>each of New XCF&#8217;s executive officers and directors; and</div>
                </td>

  </tr>


</table>
          <div>&#160;</div>

          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 36pt;"><br/>
                </td>

    <td style="width: 26.35pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
                  <div>all executive officers and directors of New XCF as a group.</div>
                </td>

  </tr>


</table>
          <div>&#160;</div>

          <div style="text-align: justify; text-indent: 36pt;">Beneficial ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security if he, she or it possesses sole or shared
            voting or investment power over that security, including options and warrants that are currently exercisable or exercisable within 60 days. Shares of common stock issuable pursuant to options or warrants that are currently exercisable or
            exercisable within 60 days are deemed to be outstanding for purposes of computing the beneficial ownership percentage of the person or group holding such options or warrants but are not deemed to be outstanding for purposes of computing the
            beneficial ownership percentage of any other person.</div>

          <div><br/>
          </div>

          <div style="text-align: justify; text-indent: 36pt;">Subject to the paragraph above, percentage ownership of New XCF Common Stock is based on 149,264,936 shares of New XCF Common Stock outstanding upon consummation of the Business Combination on
            June 6, 2025.</div>

          <div><br/>
          </div>

          <div style="text-align: justify; text-indent: 36pt;">Unless otherwise indicated, we believe that all persons named in the table have sole voting and investment power with respect to all shares of common stock owned by them.</div>

          <div><br/>
          </div>

          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">16</span></div>

            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

          </div>

          <!--PROfilePageNumberReset%Num%17%%%-->
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 40.1%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div><span style="color: #000000;">&#160;</span><span style="font-weight: bold; color: #000000;">Name and Address of</span><span style="font-weight: bold;">&#160;</span><span style="font-weight: bold; color: #000000;">Beneficial Owners</span></div>
                </td>

    <td style="width: 2.79%; vertical-align: middle;"><br/>
                </td>

    <td style="width: 27.95%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Number of Shares of Common Stock Beneficially Owned</div>
                </td>

    <td style="width: 2.79%; vertical-align: middle;"><br/>
                </td>

    <td style="width: 26.37%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">% of Class</div>
                </td>

  </tr>

  <tr>

    <td style="width: 40.1%; vertical-align: middle;">
                  <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Five Percent Holders</div>
                </td>

    <td style="width: 2.79%; vertical-align: middle;"><br/>
                </td>

    <td style="width: 27.95%; vertical-align: middle; white-space: nowrap;"><br/>
                </td>

    <td style="width: 2.79%; vertical-align: middle;"><br/>
                </td>

    <td style="width: 26.37%; vertical-align: middle; white-space: nowrap;"><br/>
                </td>

  </tr>

  <tr>

    <td style="width: 40.1%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0);">RESC Renewables Holdings, LLC<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)(2)</sup></div>
                </td>

    <td style="width: 2.79%; vertical-align: middle; background-color: rgb(204, 238, 255);"><br/>
                </td>

    <td style="width: 27.95%; vertical-align: middle; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: right; color: rgb(0, 0, 0);">66,932,417</div>
                </td>

    <td style="width: 2.79%; vertical-align: middle; background-color: rgb(204, 238, 255);"><br/>
                </td>

    <td style="width: 26.37%; vertical-align: middle; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: center; color: rgb(0, 0, 0);">44.84%</div>
                </td>

  </tr>

  <tr>

    <td style="width: 40.1%; vertical-align: middle;">
                  <div style="color: rgb(0, 0, 0);">Randy Soule<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)(2)</sup></div>
                </td>

    <td style="width: 2.79%; vertical-align: middle;"><br/>
                </td>

    <td style="width: 27.95%; vertical-align: middle; white-space: nowrap;">
                  <div style="text-align: right; color: rgb(0, 0, 0);">7,950,653</div>
                </td>

    <td style="width: 2.79%; vertical-align: middle;"><br/>
                </td>

    <td style="width: 26.37%; vertical-align: middle; white-space: nowrap;">
                  <div style="text-align: center; color: rgb(0, 0, 0);">5.33%</div>
                </td>

  </tr>

  <tr>

    <td style="width: 40.1%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0);">GL Part SPV I, LLC<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)(4)</sup></div>
                </td>

    <td style="width: 2.79%; vertical-align: middle; background-color: rgb(204, 238, 255);"><br/>
                </td>

    <td style="width: 27.95%; vertical-align: middle; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: right; color: rgb(0, 0, 0);">5,530,437</div>
                </td>

    <td style="width: 2.79%; vertical-align: middle; background-color: rgb(204, 238, 255);"><br/>
                </td>

    <td style="width: 26.37%; vertical-align: middle; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: center; color: rgb(0, 0, 0);">3.71%</div>
                </td>

  </tr>

  <tr>

    <td style="width: 40.1%; vertical-align: middle;">
                  <div style="color: rgb(0, 0, 0);">GL Part SPV II, LLC<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)(4)</sup></div>
                </td>

    <td style="width: 2.79%; vertical-align: middle;"><br/>
                </td>

    <td style="width: 27.95%; vertical-align: middle; white-space: nowrap;">
                  <div style="text-align: right; color: rgb(0, 0, 0);">20,586,575</div>
                </td>

    <td style="width: 2.79%; vertical-align: middle;"><br/>
                </td>

    <td style="width: 26.37%; vertical-align: middle; white-space: nowrap;">
                  <div style="text-align: center; color: rgb(0, 0, 0);">13.79%</div>
                </td>

  </tr>

  <tr>

    <td style="width: 40.1%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Directors and Executive Officers<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(5)</sup></div>
                </td>

    <td style="width: 2.79%; vertical-align: middle; background-color: rgb(204, 238, 255);"><br/>
                </td>

    <td style="width: 27.95%; vertical-align: middle; background-color: rgb(204, 238, 255); white-space: nowrap;"><br/>
                </td>

    <td style="width: 2.79%; vertical-align: middle; background-color: rgb(204, 238, 255);"><br/>
                </td>

    <td style="width: 26.37%; vertical-align: middle; background-color: rgb(204, 238, 255); white-space: nowrap;"><br/>
                </td>

  </tr>

  <tr>

    <td style="width: 40.1%; vertical-align: middle;">
                  <div style="color: rgb(0, 0, 0);">Mihir Dange</div>
                </td>

    <td style="width: 2.79%; vertical-align: middle;"><br/>
                </td>

    <td style="width: 27.95%; vertical-align: middle; white-space: nowrap;">
                  <div style="text-align: right; color: rgb(0, 0, 0);">12,349,086</div>
                </td>

    <td style="width: 2.79%; vertical-align: middle;"><br/>
                </td>

    <td style="width: 26.37%; vertical-align: middle; white-space: nowrap;">
                  <div style="text-align: center; color: rgb(0, 0, 0);">8.27%</div>
                </td>

  </tr>

  <tr>

    <td style="width: 40.1%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0);">Simon Oxley</div>
                </td>

    <td style="width: 2.79%; vertical-align: middle; background-color: rgb(204, 238, 255);"><br/>
                </td>

    <td style="width: 27.95%; vertical-align: middle; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: right; color: rgb(0, 0, 0);">231</div>
                </td>

    <td style="width: 2.79%; vertical-align: middle; background-color: rgb(204, 238, 255);"><br/>
                </td>

    <td style="width: 26.37%; vertical-align: middle; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: center; color: rgb(0, 0, 0);">*</div>
                </td>

  </tr>

  <tr>

    <td style="width: 40.1%; vertical-align: middle;">
                  <div style="color: rgb(0, 0, 0);">Pamela Abowd<sup style="font-style: italic; font-weight: bold; vertical-align: text-top; line-height: 1; font-size: smaller;">(6)</sup></div>
                </td>

    <td style="width: 2.79%; vertical-align: middle;"><br/>
                </td>

    <td style="width: 27.95%; vertical-align: middle; white-space: nowrap;">
                  <div style="text-align: right; color: rgb(0, 0, 0);">&#8212;</div>
                </td>

    <td style="width: 2.79%; vertical-align: middle;"><br/>
                </td>

    <td style="width: 26.37%; vertical-align: middle; white-space: nowrap;">
                  <div style="text-align: center; color: rgb(0, 0, 0);">*</div>
                </td>

  </tr>

  <tr>

    <td style="width: 40.1%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0);">Jae Ryu</div>
                </td>

    <td style="width: 2.79%; vertical-align: middle; background-color: rgb(204, 238, 255);"><br/>
                </td>

    <td style="width: 27.95%; vertical-align: middle; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: right; color: rgb(0, 0, 0);">122,075</div>
                </td>

    <td style="width: 2.79%; vertical-align: middle; background-color: rgb(204, 238, 255);"><br/>
                </td>

    <td style="width: 26.37%; vertical-align: middle; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: center; color: rgb(0, 0, 0);">*</div>
                </td>

  </tr>

  <tr>

    <td style="width: 40.1%; vertical-align: middle;">
                  <div style="color: rgb(0, 0, 0);">Gregory R. Surette</div>
                </td>

    <td style="width: 2.79%; vertical-align: middle;"><br/>
                </td>

    <td style="width: 27.95%; vertical-align: middle; white-space: nowrap;">
                  <div style="text-align: right; color: rgb(0, 0, 0);">500,020</div>
                </td>

    <td style="width: 2.79%; vertical-align: middle;"><br/>
                </td>

    <td style="width: 26.37%; vertical-align: middle; white-space: nowrap;">
                  <div style="text-align: center; color: rgb(0, 0, 0);">*</div>
                </td>

  </tr>

  <tr>

    <td style="width: 40.1%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0);">Gregory P. Savarese</div>
                </td>

    <td style="width: 2.79%; vertical-align: middle; background-color: rgb(204, 238, 255);"><br/>
                </td>

    <td style="width: 27.95%; vertical-align: middle; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: right; color: rgb(0, 0, 0);">460,181</div>
                </td>

    <td style="width: 2.79%; vertical-align: middle; background-color: rgb(204, 238, 255);"><br/>
                </td>

    <td style="width: 26.37%; vertical-align: middle; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: center; color: rgb(0, 0, 0);">*</div>
                </td>

  </tr>

  <tr>

    <td style="width: 40.1%; vertical-align: middle;">
                  <div style="color: rgb(0, 0, 0);">Anne Anderson<sup style="font-style: italic; font-weight: bold; vertical-align: text-top; line-height: 1; font-size: smaller;">(7)</sup></div>
                </td>

    <td style="width: 2.79%; vertical-align: middle;"><br/>
                </td>

    <td style="width: 27.95%; vertical-align: middle; white-space: nowrap;">
                  <div style="text-align: right; color: rgb(0, 0, 0);">&#160;&#8212;</div>
                </td>

    <td style="width: 2.79%; vertical-align: middle;"><br/>
                </td>

    <td style="width: 26.37%; vertical-align: middle; white-space: nowrap;">
                  <div style="text-align: center; color: rgb(0, 0, 0);">*</div>
                </td>

  </tr>

  <tr>

    <td style="width: 40.1%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0);">Carter B. McCain<sup style="font-style: italic; font-weight: bold; vertical-align: text-top; line-height: 1; font-size: smaller;">(7)</sup></div>
                </td>

    <td style="width: 2.79%; vertical-align: middle; background-color: rgb(204, 238, 255);"><br/>
                </td>

    <td style="width: 27.95%; vertical-align: middle; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: right; color: rgb(0, 0, 0);">&#8212;</div>
                </td>

    <td style="width: 2.79%; vertical-align: middle; background-color: rgb(204, 238, 255);"><br/>
                </td>

    <td style="width: 26.37%; vertical-align: middle; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: center; color: rgb(0, 0, 0);">*</div>
                </td>

  </tr>

  <tr>

    <td style="width: 40.1%; vertical-align: middle;">
                  <div style="color: rgb(0, 0, 0);">Sanford Cockrell<sup style="font-style: italic; font-weight: bold; vertical-align: text-top; line-height: 1; font-size: smaller;">(7)</sup></div>
                </td>

    <td style="width: 2.79%; vertical-align: middle;"><br/>
                </td>

    <td style="width: 27.95%; vertical-align: middle; white-space: nowrap;">
                  <div style="text-align: right; color: rgb(0, 0, 0);">&#8212;</div>
                </td>

    <td style="width: 2.79%; vertical-align: middle;"><br/>
                </td>

    <td style="width: 26.37%; vertical-align: middle; white-space: nowrap;">
                  <div style="text-align: center; color: rgb(0, 0, 0);">*</div>
                </td>

  </tr>

  <tr>

    <td style="width: 40.1%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0);">Si-Yeon Kim<sup style="font-style: italic; font-weight: bold; vertical-align: text-top; line-height: 1; font-size: smaller;">(7)</sup></div>
                </td>

    <td style="width: 2.79%; vertical-align: middle; background-color: rgb(204, 238, 255);"><br/>
                </td>

    <td style="width: 27.95%; vertical-align: middle; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: right; color: rgb(0, 0, 0);">&#8212;</div>
                </td>

    <td style="width: 2.79%; vertical-align: middle; background-color: rgb(204, 238, 255);"><br/>
                </td>

    <td style="width: 26.37%; vertical-align: middle; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: center; color: rgb(0, 0, 0);">*</div>
                </td>

  </tr>

  <tr>

    <td style="width: 40.1%; vertical-align: middle;">
                  <div style="color: rgb(0, 0, 0);">Wray Thorn<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(8)</sup></div>
                </td>

    <td style="width: 2.79%; vertical-align: middle;"><br/>
                </td>

    <td style="width: 27.95%; vertical-align: middle; white-space: nowrap;">
                  <div style="text-align: right; color: rgb(0, 0, 0);">&#160; 257,332</div>
                </td>

    <td style="width: 2.79%; vertical-align: middle;"><br/>
                </td>

    <td style="width: 26.37%; vertical-align: middle; white-space: nowrap;">
                  <div style="text-align: center; color: rgb(0, 0, 0);">*</div>
                </td>

  </tr>

  <tr>

    <td style="width: 40.1%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0); font-style: italic;">All directors and officers as a group (11 persons)</div>
                </td>

    <td style="width: 2.79%; vertical-align: middle; background-color: rgb(204, 238, 255);"><br/>
                </td>

    <td style="width: 27.95%; vertical-align: middle; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: right; color: rgb(0, 0, 0);">13,946,258</div>
                </td>

    <td style="width: 2.79%; vertical-align: middle; background-color: rgb(204, 238, 255);"><br/>
                </td>

    <td style="width: 26.37%; vertical-align: middle; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: center; color: rgb(0, 0, 0);">8.99%</div>
                </td>

  </tr>


</table>
          <div><br/>
          </div>

          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">*</td>

    <td style="width: auto; vertical-align: top;">
                  <div style="color: rgb(0, 0, 0);">Less than one percent.</div>
                </td>

  </tr>


</table>
          <div> <br/>
          </div>

          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">(1)</td>

    <td style="width: auto; vertical-align: top;">
                  <div style="color: rgb(0, 0, 0);">The business address of RESC Renewables Holdings, LLC is 14830 Kivett Lane, Reno, NV 89521. Randy Soule owns all of the membership interests in RESC Renewables Holdings, LLC and will have sole voting and
                    investment authority over the shares of New XCF Common Stock received in the Business Combination.</div>
                </td>

  </tr>


</table>
          <div>&#160;</div>

          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">(2)</td>

    <td style="width: auto; vertical-align: top;">
                  <div style="color: rgb(0, 0, 0);">The business address of Mr. Soule is 14830 Kivett Lane, Reno, NV 89521. In addition to the shares he received in the Business Combination, Mr. Soule, through his ownership of all of the membership
                    interests in RESC Renewables Holdings, LLC, also beneficially owns the shares of New XCF Common Stock received by RESC Renewables Holdings, LLC in the Business Combination.</div>
                </td>

  </tr>


</table>
          <div>&#160;</div>

          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">(3)</td>

    <td style="width: auto; vertical-align: top;">
                  <div style="color: rgb(0, 0, 0);">The business address of GL Part SPV I, LLC is 30 N Gould Street, Suite R, Sheridan, Wyoming 82801. Majique Ladnier is the sole member of GL Part SPV I, LLC and will have sole voting and investment
                    authority over the shares of New XCF Comon Stock. GL Part SPV I, LLC owns membership interests in Southeast Renewables, LLC, which also received shares of New XCF Common Stock in the Business Combination as a result of Southeast
                    Renewables, LLC&#8217;s ownership of XCF common stock that was exchanged for shares of New XCF Common Stock in the Business Combination. The reported shares include shares of New XCF Common Stock issued in the Business Combination as a result
                    of the distribution of XCF common stock to GL Part SPV I, LLC by Southeast Renewables, LLC.</div>
                </td>

  </tr>


</table>
          <div>&#160;</div>

          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">(4)</td>

    <td style="width: auto; vertical-align: top;">
                  <div style="color: rgb(0, 0, 0);">The business address of GL Part SPV II, LLC is 30 N Gould Street, Suite R, Sheridan, Wyoming 82801. Majique Ladnier is the sole member of GL Part SPV II, LLC and will have sole voting and investment
                    authority over the shares of New XCF Common Stock.. The reported shares include shares of New XCF Common Stock issued to GL Part SPV II, LLC in the Business Combination as a result of the distribution of XCF common stock to GL Part SPV
                    II, LLC by GL Part SPV I, LLC.</div>
                </td>

  </tr>


</table>
          <div>&#160;</div>

          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">(5)</td>

    <td style="width: auto; vertical-align: top;">
                  <div style="color: rgb(0, 0, 0);">Unless otherwise noted, the business address of each of XCF&#8217;s directors and officers 2500 CityWest Boulevard, Suite 150 - 138, Houston, TX 77042.</div>
                </td>

  </tr>


</table>
          <div>&#160;</div>

          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">(6)</td>

    <td style="width: auto; vertical-align: top;">
                  <div style="color: rgb(0, 0, 0);">Upon closing of the Business Combination, Ms. Abowd received an award of restricted stock units representing 45,000 shares of New XCF Common Stock. The restricted stock units will vest over a period of
                    five years with the first vesting to occur on the first anniversary of the award.</div>
                </td>

  </tr>


</table>
          <div>&#160;</div>

          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">(7)</td>

    <td style="width: auto; vertical-align: top;">
                  <div style="color: rgb(0, 0, 0);">Each of these member of the Board of Directors will receive an award of restricted stock units representing 100,000 shares of New XCF Common Stock in connection with their joining the Board of Directors
                    immediately following the closing of the Business Combination. The restricted stock units will vest over a period of four years with the first vesting to occur on the first anniversary of the award.</div>
                </td>

  </tr>


</table>
          <div>&#160;</div>

          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">(8)</td>

    <td style="width: auto; vertical-align: top;">
                  <div style="color: rgb(0, 0, 0);">Following the Business Combination, Focus Impact Partners, LLC beneficially owns 257,332 shares of New XCF Class A Common Stock. Mr. Thorn is a Partner and Co-Founder of Focus Impact Partners, LLC and, as
                    a result, may be deemed to share beneficial ownership of the shares held by Focus Impact Partners, LLC.</div>
                </td>

  </tr>


</table>
          <div> <br/>
          </div>

        </div>

      </div>

    </div>

  </div>

  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">17</span></div>

    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

  </div>

  <div>
<div><span style="font-weight: bold;">Certain Relationships and Related Transactions, and Director Independence </span></div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"> </span><span style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </span></div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Certain relationships and related person transactions are described in the Proxy Statement/Prospectus in the section titled &#8220;Certain Relationships and
      Related Person Transactions,&#8221; beginning on page 262 of the Proxy Statement/Prospectus and that information is incorporated herein by reference. In addition, the following information is also incorporated herein by reference:</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 36pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>Information relating to the Core Company Equityholders Agreement, the Resale Shelf Registration Rights Agreement and the Board Agreement included in Item 1.01 of this Current Report on Form 8-K;</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 36pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>Information in Item 5.02 of this Current Report on Form 8-K under the caption &#8220;Executive Officer Employment Agreements;&#8221;</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 36pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>Information in Item 1.01 of the Current Report on Form 8-K filed by XCF on June 2, 2025 under the captions &#8220;GL Notes&#8221; and &#8220;Soule Agreement;&#8221;</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 36pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>Information in Item 5.02 of the Current Report on Form 8-K filed by XCF on June 2, 2025 under the caption &#8220;Employment Agreement Amendments;&#8221; and</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 36pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>Information in Item 8.01 of the Current Report on Form 8-K filed by Focus Impact on February 21, 2025 under the captions &#8220;Note with GL Part SPV I, LLC,&#8221; &#8220;New Rise Closing,&#8221; &#8220;Consulting Agreement with Focus Impact Partners&#8221; and &#8220;XCF
              Employment Agreements.&#8221;</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In addition, information regarding director independence is included above under &#8220;Director Independence&#8221; in this Item 2.01.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Legal Proceedings</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">We have been involved in various claims and legal actions that arose in the ordinary course of business and were not material to our operations or
      financial results, and in the future we may be a party to various claims and routine litigation arising in the ordinary course of business.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Our subsidiary, New Rise Renewables Reno, LLC (&#8220;New Rise Reno&#8221;) is involved in certain litigation described below. In addition, as previously disclosed
      in Item 2.04 to XCF&#8217;s Current Report on Form 8-K filed on June 2, 2025, New Rise Reno is involved in certain disputes with a lender and with its landlord under a ground lease. The information included under &#8220;Greater Nevada Credit Union Loan&#8221; and
      &#8220;Twain Ground Lease&#8221; in that Item 2.04 is incorporated herein by reference. The disputes described therein do not currently involve any litigation or other court, arbitration, mediation, administrative or regulatory proceeding.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">18</span></div>

      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In March 2024, Polaris Processing, LLC (&#8220;Polaris&#8221;), which provided operations and maintenance services to New Rise Reno, under an Operations and
      Maintenances Services Agreement dated May 10, 2022 (the &#8220;Services Agreement&#8221;), filed an arbitration demand against New Rise Reno due to New Rise Reno&#8217;s failure to timely pay invoices and for hiring employees who were subject to the Services
      Agreement&#8217;s non-solicitation provision. In April 2024, Polaris and New Rise Reno settled the disputes and as settlement, New Rise Reno agreed to pay a lump sum settlement to Polaris in the amount of $1.70 million. Subsequent to the settlement, New
      Rise Reno made all payments through its law firm for settlement of the outstanding amount. In September 2024, New Rise Reno was informed that approximately $0.95 million in payments had not been received by Polaris and remained outstanding. Upon
      further investigation, New Rise Reno was informed by their legal counsel that wire instruction information provided by their legal counsel was incorrect and compromised as a result of a hack of the legal counsel&#8217;s computer system. New Rise Reno&#8217;s
      counsel is in the process of filing insurance claims to cover the payment; however New Rise Reno remains liable for the outstanding payment that remains due to Polaris. On October 11, 2024, Polaris filed a subsequent complaint against New Rise Reno
      requesting summary judgment on the remaining amount due. No amount has been recorded on New Rise Reno&#8217;s balance sheet as it expects to be fully reimbursed by its legal counsel for this matter. However, we cannot assure you that such reimbursement
      shall take place.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Market Price and Dividends on the Registrant&#8217;s Common Equity and Related Stockholder Matters</div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"> </span><span style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </span></div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The shares of New XCF Common Stock began trading on the Nasdaq Capital Market under the symbol &#8220;SAFX&#8221; on June 9, 2025. Prior to June 9, 2025, shares of
      Class A common stock, warrants and the related units of Focus Impact traded on the OTC Pink market under the symbols &#8220;BHAC,&#8221; &#8220;BHACW&#8221; and &#8220;BHACU,&#8221; respectively.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Immediately following the completion of the Business Combination, New XCF had 149,264,936 shares of New XCF Common Stock issued and outstanding, held of record by
        approximately 500 holders.</div>

    </div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Neither XCF nor New XCF has paid any cash dividends on its capital stock. Any decision of New XCF to declare and pay dividends in the future will be made
      at the sole discretion of the Board and will depend on, among other things, New XCF&#8217;s results of operations, cash requirements, financial condition, contractual restrictions and other factors that the Board may deem relevant.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Recent Sales of Unregistered Securities</div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br/>
      </span></div>

    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Information about unregistered sales of New XCF&#8217;s equity securities is set forth under Item 3.02 of this Current Report on Form 8-K, which is
      incorporated herein by reference.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">&#160;<span style="font-weight: bold;">Description of Registrant&#8217;s Securities</span></div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">A description of New XCF&#8217;s securities is included in the Proxy Statement/Prospectus in the section &#8220;Description of Newco Securities&#8221; beginning on page
      282 thereof, which is incorporated herein by reference.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Financial Statements and Exhibits</div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br/>
      </span></div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The information set forth above under the section entitled &#8220;Financial Information&#8221; in this Item 2.01 of this Current Report on Form 8-K is incorporated
      herein by reference.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 57.6pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 3.02</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="font-weight: bold;">Unregistered Sales of Equity Securities.</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The information included in Item 1.01 under &#8220;Twain Forbearance Agreement&#8221; is incorporated into this Item 3.02 by reference. The issuance of the shares of
      New XCF Common Stock to Twain was not registered under the Securities Act, in reliance on an exemption from registration under Section 4(a)(2) of the Securities Act of 1933, as amended, because the issuance of the shares does not involve a public
      offering.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 57.6pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 3.03</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="font-weight: bold;">Material Modification to Rights of Security Holders.</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On June 6, 2025, in connection with the closing of the Business Combination, each of New XCF&#8217;s certificate of incorporation and bylaws was amended (the
      &#8220;A&amp;R Charter&#8221; and the &#8220;A&amp;R Bylaws&#8221;), respectively. The material terms of each of the A&amp;R Charter and the A&amp;R Bylaws and the general effect upon the rights of holders of New XCF&#8217;s securities are described in the Proxy
      Statement/Prospectus in the sections &#8220;Description of Newco Securities&#8221; and &#8220;Comparison of Corporate Governance and Stockholders&#8217; Rights&#8221; beginning on pages 282 and 293 thereof, respectively, which are incorporated herein by reference. </div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">19</span></div>

      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Copies of the A&amp;R Charter and the A&amp;R Bylaws are included as Exhibit 3.1 and Exhibit 3.2 to this Current Report on Form 8-K, respectively, and
      are incorporated herein by reference.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 57.6pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 5.01</td>

    <td style="vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="font-weight: bold;">Changes in Control of Registrant.</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The information set forth above under the &#8220;Introductory Note&#8221; and in Item 2.01 of this Current Report on Form 8-K is incorporated herein by reference. As
      a result of the completion of the Business Combination pursuant to the Business Combination Agreement, a change of control of Focus Impact and NewCo occurred. Following the Business Combination, former Focus Impact shareholders own approximately 0.4%
      of the issued and outstanding shares of New XCF Common Stock, the Sponsor owns approximately 2.2% of the issued and outstanding shares of New XCF Common Stock, Randy Soule (directly and indirectly) owns approximately 50.2% of the issued and
      outstanding shares of New XCF Common Stock, GL Part SPV I and II owns approximately 17.5% of the issued and outstanding shares of New XCF Common Stock and Mihir Dange, New XCF&#8217;s Chief Executive Officer owns approximately 8.3% of the issued and
      outstanding shares of New XCF Common Stock.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 57.6pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 5.02</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="font-weight: bold;">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Directors and Executive Officers</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Effective upon the closing of the Business Combination, Wray Thorn resigned as the sole director of NewCo and Mihir Dange, Anne Anderson, Sanford
      Cockrell, Si-Yeon Kim, Wray Thorn and Carter McCain were appointed as directors of New XCF. In addition, effective upon closing of the Business Combination, the following persons were appointed as executive officers of New XCF:</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">Mihir Dange</div>
          </td>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">Chief Executive Officer</div>
          </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">Simon Oxley</div>
          </td>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">Chief Financial Officer</div>
          </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">Gregory R. Surette</div>
          </td>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">Chief Strategy Officer and Secretary</div>
          </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">Gregory P. Savarese</div>
          </td>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">Chief Marketing Officer</div>
          </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">Jae Ryu</div>
          </td>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">Head of Land Development</div>
          </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">Pamela M. Abowd</div>
          </td>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">Chief Accounting Officer</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The information set forth in the sections entitled &#8220;Directors and Executive Officers,&#8221; &#8220;Executive Officers,&#8221; &#8220;Executive Compensation&#8221; and &#8220;Board of
      Directors in Item 2.01 of this Current Report on Form 8-K is incorporated herein by reference.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Executive Officer Employment Agreements</div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br/>
      </span></div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">New XCF has entered into employment agreements with its executive officers that became effective immediately following the closing of the Business
      Combination. The material terms of the agreements are summarized below.</div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br/>
      </span></div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Mihir Dange, Chief Executive Officer</div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br/>
      </span></div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The agreement with Mr. Dange provides for an annual base salary of $825,000 and a target bonus of 100% to 200% of base salary, with both the base salary and the target
        bonus subject to annual review by the Board, with the recommendation of the Compensation Committee. In connection with the 2025 Equity Incentive Plan, Mr. Dange has the ability to earn 400-700% of base salary in restricted stock units. An initial
        award of 330,000 restricted stock units was made under the 2025 Equity Incentive Plan, with such restricted stock units to vest over three years (no vesting during the first six months (the &#8220;cliff period&#8221;). After the six-month cliff period, the
        restricted stock units will vest in equal monthly installments over 30 months, subject to continued service with New XCF). Mr. Dange will be eligible to participate in benefits programs available to executives generally, including participation in
        the 2025 Employee Stock Purchase Plan and 401(k) matching contribution, and to benefit from certain perquisites including a vehicle allowance and club membership reimbursement. In addition, in connection with (a) a termination without cause or with
        good reason (other than in connection with a change-in-control of New XCF) he will be entitled to severance in the amount of three times his then-applicable base salary plus any unpaid bonus from a previous period and three times the full amount of
        his target bonus for the fiscal year and continuation of certain insurance benefits, and (b) a termination without cause or with good reason in connection with a change-in-control of New XCF, he will be entitled to severance in the amount of three
        times his then-applicable base salary plus any unpaid bonus from a previous period and three times the full amount of his target bonus for the then- current fiscal year, immediate vesting of any restricted stock, restricted stock units, options, or
        other equity grants or awards not vested at the time of termination, and continuation of certain insurance benefits.</div>

    </div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">20</span></div>

      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Upon the closing of the Business Combination, New XCF assumed an obligation to Sky MD, LLC, an entity controlled by Mr. Dange, in the amount of $928,125
      relating to contractor services provided prior to Mr. Dange&#8217;s signing of an employment agreement with XCF. Such amount shall be payable in cash no later than September 30, 2025, unless New XCF and Sky MD, LLC mutually agree in writing, on or before
      such date, to extend the payment deadline to no later than December 31, 2025 due to New XCF&#8217;s reasonable cash constraints. In addition, within 30 days after the closing of the Business Combination, New XCF shall issue to Sky MD, LLC a grant of
      restricted shares of New XCF&#8217;s Common Stock under the 2025 Equity Incentive Plan in aggregate value equal to the obligation assumed by New XCF for the assumed liability. This grant shall be separate from, and not in lieu of, the assumed liability and
      be calculated based on the 20 day volume-weighted average price of the Common Stock following the closing of the Business Combination. The restricted shares shall vest ratably on a monthly basis over a period of three (3) years and shall be subject
      to the terms and conditions of the 2025 Equity Incentive Plan and the applicable award agreement.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Simon Oxley, Chief Financial Officer</div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br/>
      </span></div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">
      <div style="text-align: left; font-family: 'Times New Roman';">The agreement with Mr. Oxley provides for an annual base salary of $500,000 and a target bonus of 100% to 200% of base salary, with both the base salary and the target bonus subject to
        annual review by the Board, with the recommendation of the Compensation Committee. He will also receive an initial award of 675,000 restricted stock units, with such restricted stock units to vest over five years (one-fifth of such restricted stock
        units to vest on each of the succeeding annual anniversaries of the award). In connection with the 2025 Equity Incentive Plan, Mr. Oxley has the ability to earn 300-600% of base salary in restricted stock units. An initial award of 150,000
        restricted stock units was made under the 2025 Equity Incentive Plan, with such restricted stock units to vest over three years (no vesting during the first six months (the &#8220;cliff period&#8221;). After the six-month cliff period, the restricted stock
        units will vest in equal monthly installments over 30 months, subject to continued service with the Company). Mr. Oxley will be eligible to participate in benefits programs available to executives generally, including participation in the 2025
        Employee Stock Purchase Plan and 401(k) matching contribution, and to benefit from certain perquisites including a vehicle allowance and club membership reimbursement. In addition, in connection with (a) a termination without cause or with good
        reason (other than in connection with a change-in-control of New XCF) he will be entitled to severance in the amount of three times his then-applicable base salary plus any unpaid bonus from a previous period and three times the full amount of his
        target bonus for the fiscal year and continuation of certain insurance benefits, and (b) a termination without cause or with good reason in connection with a change-in-control of New XCF, he will be entitled to severance in the amount of three
        times his then-applicable base salary plus any unpaid bonus from a previous period and three times the full amount of his target bonus for the then-current fiscal year, immediate vesting of any restricted stock, restricted stock units, options, or
        other equity grants or awards not vested at the time of termination, and continuation of certain insurance benefits.</div>

    </div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Upon the closing of the Business Combination, New XCF assumed an obligation to Mr. Oxley, in the amount of $41,667 relating to contractor services
      provided prior to Mr. Oxley&#8217;s signing of an employment agreement with XCF. Such amount shall be payable in cash no later than September 30, 2025, unless New XCF and Mr. Oxley mutually agree in writing, on or before such date, to extend the payment
      deadline to no later than December 31, 2025 due to New XCF&#8217;s reasonable cash constraints. In addition, within 30 days after the closing of the Business Combination, New XCF shall issue to Mr. Oxley a grant of restricted shares of New XCF&#8217;s Common
      Stock under the 2025 Equity Incentive Plan in aggregate value equal to the obligation assumed by New XCF for the assumed liability. This grant shall be separate from, and not in lieu of, the assumed liability and be calculated based on the 20 day
      volume-weighted average price of the New XCF Common Stock following the closing of the Business Combination. The restricted shares shall vest ratably on a monthly basis over a period of three (3) years and shall be subject to the terms and conditions
      of the 2025 Equity Incentive Plan and the applicable award agreement.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">21</span></div>

      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Gregory R. Surette, Chief Strategy Officer</div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br/>
      </span></div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">
      <div style="text-align: left; font-family: 'Times New Roman';">The agreement with Mr. Surette provides for an annual base salary of $480,000 and a target bonus of 100% to 200% of base salary, with both the base salary and the target bonus subject to
        annual review by the Board, with the recommendation of the Compensation Committee. He will also receive an initial award of 300,000 restricted stock units, with such restricted stock units to vest on a monthly basis over three years beginning on
        July 6, 2026. In connection with the 2025 Equity Incentive Plan, Mr. Surette has the ability to earn 300-600% of base salary in restricted stock units. An initial award of 144,000 restricted stock units was made under the 2025 Equity Incentive
        Plan, with such restricted stock units to vest over three years (no vesting during the first six months (the &#8220;cliff period&#8221;). After the six-month cliff period, the restricted stock units will vest in equal monthly installments over 30 months,
        subject to continued service with the Company). Mr. Surette will be eligible to participate in benefits programs available to executives generally, including participation in the 2025 Employee Stock Purchase Plan and 401(k) matching contribution,
        and to benefit from certain perquisites including a vehicle allowance and club membership reimbursement. In addition, in connection with (a) a termination without cause or with good reason (other than in connection with a change-in-control of New
        XCF) he will be entitled to severance in the amount of three times his then-applicable base salary plus any unpaid bonus from a previous period and three times the full amount of his target bonus for the fiscal year and continuation of certain
        insurance benefits, and (b) a termination without cause or with good reason in connection with a change-in-control of New XCF, he will be entitled to severance in the amount of three times his then-applicable base salary plus any unpaid bonus from
        a previous period and three times the full amount of his target bonus for the then- current fiscal year, immediate vesting of any restricted stock, restricted stock units, options, or other equity grants or awards not vested at the time of
        termination, and continuation of certain insurance benefits. His agreement also provides that if Mr. Surette changes his duties and is appointed as the Chief Operating Officer, his base salary will be set at $640,000.</div>

    </div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Upon the closing of the Business Combination, New XCF assumed an obligation to Remosa, LLC, an entity controlled by Mr. Surette, in the amount of
      $540,000 relating to contractor services provided prior to Mr. Surette&#8217;s signing of an employment agreement with XCF. Such amount shall be payable in cash no later than September 30, 2025, unless New XCF and Remosa, LLC mutually agree in writing, on
      or before such date, to extend the payment deadline to no later than December 31, 2025 due to New XCF&#8217;s reasonable cash constraints. In addition, within 30 days after the closing of the Business Combination, New XCF shall issue to Remosa, LLC a grant
      of restricted shares of New XCF Common Stock under the 2025 Equity Incentive Plan in aggregate value equal to the obligation assumed by New XCF for the assumed liability. This grant shall be separate from, and not in lieu of, the assumed liability
      and be calculated based on the 20 day volume-weighted average price of the New XCF Common Stock following the closing of the Business Combination. The restricted shares shall vest ratably on a monthly basis over a period of three (3) years and shall
      be subject to the terms and conditions of the 2025 Equity Incentive Plan and the applicable award agreement.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Pamela Abowd, Chief Accounting Officer</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">
      <div style="text-align: left; font-family: 'Times New Roman';">The agreement with Ms. Abowd provides for an annual base salary of $300,000 and a target bonus of 50% to 100% of base salary, with both the base salary and the target bonus subject to
        annual review by the Board, with the recommendation of the Compensation Committee. She will also receive an initial award of 45,000 restricted stock units, with such restricted stock units to vest over five years (one-fifth of such restricted stock
        units to vest on each of the succeeding annual anniversaries of the award). In connection with the 2025 Equity Incentive Plan, Ms. Abowd has the ability to earn 200-400% of base salary in restricted stock units. An initial award of 60,000
        restricted stock units was made under the 2025 Equity Incentive Plan, with such restricted stock units to vest over three years (no vesting during the first six months (the &#8220;cliff period&#8221;). After the six-month cliff period, the restricted stock
        units will vest in equal monthly installments over 30 months, subject to continued service with the Company). Ms. Abowd will be eligible to participate in benefits programs available to executives generally, including participation in the 2025
        Employee Stock Purchase Plan and 401(k) matching contribution, and to benefit from certain perquisites including a vehicle allowance. In addition, in connection with (a) a termination without cause or with good reason (other than in connection with
        a change-in-control of New XCF) he will be entitled to severance in the amount of two times her then-applicable base salary plus any unpaid bonus from a previous period and two times the full amount of her target bonus for the fiscal year and
        continuation of certain insurance benefits, and (b) a termination without cause or with good reason in connection with a change-in-control of New XCF, she will be entitled to severance in the amount of three times her then-applicable base salary
        plus any unpaid bonus from a previous period and three times the full amount of her target bonus for the then-current fiscal year, immediate vesting of any restricted stock, restricted stock units, options, or other equity grants or awards not
        vested at the time of termination, and continuation of certain insurance benefits.</div>

    </div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">22</span></div>

      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Gregory P. Savarese, Chief Marketing Officer</div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br/>
      </span></div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">
      <div style="text-align: left; font-family: 'Times New Roman';">The agreement with Mr. Savarese provides for an annual base salary of $300,000 and a target bonus of 100 to 200% of base salary, with both the base salary and the target bonus subject to
        annual review by the Board, with the recommendation of the Compensation Committee. He will also receive an initial award of 335,000 restricted stock units, with such restricted stock units to vest on a monthly basis over three years beginning on
        July 6, 2026. In connection with the 2025 Equity Incentive Plan, Mr. Savarese has the ability to earn 300-600% of base salary in restricted stock units. An initial award of 90,000 restricted stock units was made under the 2025 Equity Incentive
        Plan, with such restricted stock units to vest over three years (no vesting during the first six months (the &#8220;cliff period&#8221;). After the six-month cliff period, the restricted stock units will vest in equal monthly installments over 30 months,
        subject to continued service with the Company). Mr. Savarese will be eligible to participate in benefits programs available to executives generally, including participation in the 2025 Employee Stock Purchase Plan and 401(k) matching contribution,
        and to benefit from certain perquisites including a vehicle allowance. In addition, in connection with (a) a termination without cause or with good reason (other than in connection with a change-in-control of New XCF) he will be entitled to
        severance in the amount of three times his then-applicable base salary plus any unpaid bonus from a previous period and three times the full amount of his target bonus for the fiscal year and continuation of certain insurance benefits, and (b) a
        termination without cause or with good reason in connection with a change-in-control of New XCF, he will be entitled to severance in the amount of three times his then-applicable base salary plus any unpaid bonus from a previous period and three
        times the full amount of his target bonus for the then-current fiscal year, immediate vesting of any restricted stock, restricted stock units, options, or other equity grants or awards not vested at the time of termination, and continuation of
        certain insurance benefits.</div>

    </div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Upon the closing of the Business Combination, New XCF assumed an obligation to Cornell Management Group, LLC, an entity controlled by Mr. Savarese, in
      the amount of $337,500 relating to contractor services provided prior to Mr. Savarese&#8217;s signing of an employment agreement with XCF. Such amount shall be payable in cash no later than September 30, 2025, unless New XCF and Cornell Management Group,
      LLC mutually agree in writing, on or before such date, to extend the payment deadline to no later than December 31, 2025 due to New XCF&#8217;s reasonable cash constraints. In addition, within 30 days after the closing of the Business Combination, New XCF
      shall issue to Cornell Management Group, LLC a grant of restricted shares of New XCF&#8217;s Common Stock under the 2025 Equity Incentive Plan in aggregate value equal to the obligation assumed by New XCF for the assumed liability. This grant shall be
      separate from, and not in lieu of, the assumed liability and be calculated based on the 20 day volume-weighted average price of the New XCF Common Stock following the closing of the Business Combination. The restricted shares shall vest ratably on a
      monthly basis over a period of three (3) years and shall be subject to the terms and conditions of the 2025 Equity Incentive Plan and the applicable award agreement.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Jae Ryu, Head of Land Development</div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br/>
      </span></div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">
      <div style="text-align: left; font-family: 'Times New Roman';">The agreement with Mr. Ryu provides for an annual base salary of $200,000 and a target bonus of 50% to 100% of base salary, with both the base salary and the target bonus subject to
        annual review by the Board, with the recommendation of the Compensation Committee. In connection with the 2025 Equity Incentive Plan, Mr. Ryue has the ability to earn 200-400% of base salary in restricted stock units. An initial award of 40,000
        restricted stock units was made under the 2025 Equity Incentive Plan, with such restricted stock units to vest over three years (no vesting during the first six months (the &#8220;cliff period&#8221;). After the six-month cliff period, the restricted stock
        units will vest in equal monthly installments over 30 months, subject to continued service with the Company). Mr. Ryu will be eligible to participate in benefits programs available to executives generally, including participation in the 2025
        Employee Stock Purchase Plan and 401(k) matching contribution, and to benefit from certain perquisites including a vehicle allowance. In addition, in connection with (a) a termination without cause or with good reason (other than in connection with
        a change-in-control of New XCF) he will be entitled to severance in the amount of 12 months of his then-applicable base salary plus any unpaid bonus from a previous period and the full amount of his target bonus for the fiscal year and continuation
        of certain insurance benefits, and (b) a termination without cause or with good reason in connection with a change-in-control of New XCF, he will be entitled to severance in the amount of two times his then- applicable base salary plus any unpaid
        bonus from a previous period and the full amount of his target bonus for the then-current fiscal year, immediate vesting of any restricted stock, restricted stock units, options, or other equity grants or awards not vested at the time of
        termination, and continuation of certain insurance benefits.</div>

    </div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">23</span></div>

      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Upon the closing of the Business Combination, New XCF assumed an obligation to WT Real Estate Advisors LLC, an entity controlled by Mr. Ryu, in the
      amount of $357,707 relating to contractor services provided prior to Mr. Ryu&#8217;s signing of an employment agreement with XCF. Such amount shall be payable in cash no later than September 30, 2025, unless New XCF and WT Real Estate Advisors LLC mutually
      agree in writing, on or before such date, to extend the payment deadline to no later than December 31, 2025 due to New XCF&#8217;s reasonable cash constraints. In addition, within 30 days after the closing of the Business Combination, New XCF shall issue
      to WT Real Estate Advisors LLC a grant of restricted shares of New XCF&#8217;s Common Stock under the 2025 Equity Incentive Plan in aggregate value equal to the obligation assumed by New XCF for the assumed liability. This grant shall be separate from, and
      not in lieu of, the assumed liability and be calculated based on the 20 day volume-weighted average price of the New XCF Common Stock following the closing of the Business Combination. The restricted shares shall vest ratably on a monthly basis over
      a period of three (3) years and shall be subject to the terms and conditions of the 2025 Equity Incentive Plan and the applicable award agreement.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">A copy of each of these employment agreements is filed with this Current Report on Form 8-K as Exhibits 10.57, 10.58, 10.59, 10.60, 10.61 and 10.62 and
      is incorporated herein by reference, and the foregoing descriptions of the employment agreements are qualified in their entirety by reference thereto.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Separation Agreements</div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br/>
      </span></div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">XCF also entered into separation agreements with two of its executive officers. The description of the materials terms of these agreements is included in
      the Current Report on Form 8-K of XCF, filed on June 2, 2025, under the caption &#8220;Departure of Directors and Executive Officers,&#8221; which description is incorporated by reference into this Item 5.02.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2025 Equity Incentive Plan</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In connection with the closing of the Business Combination, NewCo adopted the XCF Global, Inc. 2025 Equity Incentive Plan (the &#8220;2025 Equity Incentive
      Plan&#8221;), which is described in the section of the Proxy Statement/Prospectus titled &#8220;Equity Benefit Plans &#8211; 2025 Equity Incentive Plan&#8221; beginning on page 217 thereof, which is incorporated into this Item 5.02 by reference. A copy of the 2025 Equity
      Incentive Plan is attached to this Current Report on Form 8-K as Exhibit 10.63.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2025 Employee Stock Purchase Plan</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In connection with the closing of the Business Combination, NewCo adopted the XCF Global, Inc. 2025 Employee Stock Purchase Plan (the &#8220;2025 ESPP&#8221;), which
      is described in the section of the Proxy Statement/Prospectus titled &#8220;Equity Benefit Plans &#8211; 2025 Employee Stock Purchase Plan beginning on page 220 thereof, which is incorporated into this Item 5.02 by reference. A copy of the 2025 ESPP is attached
      to this Current Report on Form 8-K as Exhibit 10.64.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 57.6pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 5.03</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="font-weight: bold;">Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The information set forth in Item 3.03 of this Current Report on Form 8-K is incorporated by reference into this Item 5.03.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 57.6pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-weight: bold;">Item 5.05</span></td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="font-weight: bold;">Amendments to the Registrant&#8217;s Code of Ethics, or Waiver of a Provision of the Code of Ethics.</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On June 8, 2025, the New XCF board of directors approved and adopted a Code of Ethics and Business Conduct applicable to all employees, officers and
      directors of New XCF, including New XCF&#8217;s principal executive officer, principal financial officer and principal accounting officer or controller (or persons performing similar functions to the aforementioned officers). A copy of the Code of Ethics
      and Business Conduct is attached to this Current Report on Form 8-K as Exhibit 14.1.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">24</span></div>

      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 57.6pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 5.06</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="font-weight: bold;">Change in Shell Company Status.</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">As a result of the completion of the Business Combination, each of Focus Impact and NewCo ceased being a shell company. The material terms of the
      Business Combination are described in the Proxy Statement/Prospectus in the section &#8220;Proposal No. 1&#8201;-&#8201;The Business Combination Proposal&#8221; beginning on page 135 of the Proxy Statement/Prospectus, which is incorporated herein by reference. In addition,
      the information set forth in the &#8220;Introductory Note&#8221; and under Item 2.01 of this Current Report on Form 8-K is incorporated herein by reference.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 57.6pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 7.01</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="font-weight: bold;">Regulation FD Disclosure.</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On June 6, 2025, XCF and Focus Impact issued a joint press release announcing the consummation of the Business Combination. A copy of the press release
      is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On June 9, 2025, New XCF issued a press release announcing that New XCF Common Stock would begin trading at market open today on the Nasdaq Capital
      Market on June 9, 2025 under the ticker symbol &#8220;SAFX.&#8221; A copy of the press release is filed as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated herein by reference.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The information in this Item 7.01, including Exhibit 99.1 and Exhibit 99.2, is furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of
      the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to liabilities under that section, and shall not be deemed to be incorporated by reference in any filing under the Securities Act, or the Exchange Act,
      regardless of any general incorporation language in any such filing.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 57.6pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 9.01</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="font-weight: bold;">Financial Statements and Exhibits.</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: right; font-weight: bold;">(a)</div>
          </td>

    <td style="width: 4.51%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 90%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left; font-style: italic; font-weight: bold;">Financial statements of businesses acquired.</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The information set forth in Item 2.01 under the section entitled &#8220;Financial Information&#8221; is incorporated herein by reference and New XCF will be filing
      an amendment to this Current Report on Form 8-K to supplement this Item 9.01(a) of this Current Report on Form 8-K as soon as practicable.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: right; font-weight: bold;">(b)</div>
          </td>

    <td style="width: 4.51%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 90%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left; font-style: italic; font-weight: bold;">Pro forma financial information.</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The information set forth in Item 2.01 under the section entitled &#8220;Financial Information&#8221; is incorporated herein by reference and New XCF will be filing
      an amendment to this Current Report on Form 8-K to supplement this Item 9.01 (b) of this Current Report on Form 8-K as soon as practicable.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: right; font-weight: bold;">(d)</div>
          </td>

    <td style="width: 4.51%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 90%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left; font-style: italic; font-weight: bold;">Exhibits.</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 12.47%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit</div>
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">No.</div>
          </td>

    <td style="width: 2%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; font-weight: bold;">Description</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/1851612/000114036124012745/ef20023810_ex2-1.htm">2.1+</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Business Combination Agreement, dated March 11, 2024, by and among Focus Impact, NewCo, Merger Sub 1, Merger Sub 2 and XCF (incorporated by reference to Exhibit 2.1 to the Current Report on Form 8-K of Focus
              Impact BH3 Acquisition Company filed with the SEC on March 12, 2024)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/1851612/000114036124048481/ef20039612_ex2-1.htm">2.2</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Amendment No. 1 to the Business Combination Agreement, dated as of November 29, 2024, by and among Focus Impact, NewCo, Merger Sub 1, Merger Sub 2 and XCF (incorporated by reference to Exhibit 2.1 to the Current
              Report on Form 8-K of Focus Impact BH3 Acquisition Company filed with the SEC on December 5, 2024)</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">25</span></div>

      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 12.47%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/1851612/000114036125012399/ef20046931_ex2-1.htm">2.3</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Amendment No. 2 to the Business Combination Agreement, dated as of April 4, 2025, by and among Focus Impact, NewCo, Merger Sub 1, Merger Sub 2 and XCF (incorporated by reference to Exhibit 2.1 to the Current
              Report on Form 8-K of Focus Impact BH3 Acquisition Company filed with the SEC on April 7, 2025)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/1851612/000114036125021317/ef20050111_ex2-1.htm">2.4</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Amendment No. 3 to the Business Combination Agreement, dated as of April 4, 2025, by and among Focus Impact, NewCo, Merger Sub 1, Merger Sub 2 and XCF (incorporated by reference to Exhibit 2.1 to the Current
              Report on Form 8-K of Focus Impact BH3 Acquisition Company filed with the SEC on June 3, 2025)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/1851612/000114036125021619/ef20050281_ex10-1.htm">2.5</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Waiver of Closing Conditions dated as of June 5, 2025, by and among Focus Impact, NewCo, Merger Sub 1, Merger Sub 2 and XCF (incorporated by reference to Exhibit 2.1 to the Current Report on Form 8-K of Focus
              Impact BH3 Acquisition Company filed with the SEC on June 6, 2025)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/2019793/000114036124034989/ny20027344x3_ex10-24.htm">2.6</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Membership Interest Purchase Agreement by and among RESC Renewables Holdings, LLC and XCF Global Capital, Inc. (incorporated by reference to Exhibit 10.24 to the Form S-4 Registration Statement of Focus Impact BH3
              NewCo, Inc. and XCF Global Capital, Inc. initially filed with the SEC on July 31, 2024)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/2019793/000114036124034989/ny20027344x3_ex10-25.htm">2.7</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Membership Interest Purchase Agreement by and among Randy Soule and GL Part I SPV, LLC and XCF Global Capital, Inc. (incorporated by reference to Exhibit 10.25 to the Form S-4 Registration Statement of Focus
              Impact BH3 NewCo, Inc. and XCF Global Capital, Inc. initially filed with the SEC on July 31, 2024)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/2019793/000114036124034989/ny20027344x3_ex10-26.htm">2.8</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Security Agreement-Pledge between XCF Global Capital, Inc. and RESC Renewables Holdings, LLC (incorporated by reference to Exhibit 10.26 to the Form S-4 Registration Statement of Focus Impact BH3 NewCo, Inc. and
              XCF Global Capital, Inc. initially filed with the SEC on July 31, 2024)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/2019793/000114036124034989/ny20027344x3_ex10-27.htm">2.10+</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Asset Purchase Agreement by and between XCF Global Capital, Inc. and Good Steward Biofuels FL, LLC (incorporated by reference to Exhibit 10.27 to the Form S-4 Registration Statement of Focus Impact BH3 NewCo, Inc.
              and XCF Global Capital, Inc. initially filed with the SEC on July 31, 2024)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/2019793/000114036124034989/ny20027344x3_ex10-28.htm">2.11+</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Asset Purchase Agreement by and between XCF Global Capital, Inc. and Southeast Renewables LLC (incorporated by reference to Exhibit 10.28 to the Form S-4 Registration Statement of Focus Impact BH3 NewCo, Inc. and
              XCF Global Capital, Inc. initially filed with the SEC on July 31, 2024)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="ef20050548_ex3-1.htm">3.1</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Amended and Restated Certificate of Incorporation of XCF Global, Inc.</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="ef20050548_ex3-2.htm">3.2</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Amended and Restated Bylaws of XCF Global, Inc.</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="ef20050548_ex4-1.htm">4.1</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Specimen Class A Common Stock Certificate</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/1851612/000119312521294264/d223314dex41.htm">4.2</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><br/>
          </td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Warrant Agreement dated as of October 4, 2021 between Focus Impact BH3 Acquisition Company (formerly known as Crixus BH3 Acquisition Company) and Continental Stock Transfer &amp; Trust Company (incorporated by
              reference to Exhibit 4.1 to the Current Report on Form 8-K of Focus Impact BH3 Acquisition Company filed with the SEC on October 7, 2021)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: center;" rowspan="1"><a href="ef20050548_ex4-3.htm">4.3<br/>
            </a></td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;" rowspan="1">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;" rowspan="1">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;" rowspan="1">
            <div style="text-align: left; font-family: 'Times New Roman';">Warrant Assignment and Assumption Agreement</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/2019793/000114036124034989/ny20027344x3_ex10-30.htm">10.1+**</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">License Agreement by and between Axens North America, Inc. and New Rise Renewables Reno, LLC (incorporated by reference to Exhibit 10.30 to the Form S-4 Registration Statement of Focus Impact BH3 NewCo, Inc. and
              XCF Global Capital, Inc. initially filed with the SEC on July 31, 2024)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/2019793/000114036124034989/ny20027344x3_ex10-31.htm">10.2+**</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Operation and Maintenance Agreement (Reno, Nevada Facilities) by and between Orion Plant Services, Inc., and New Rise Renewables Reno, LLC (incorporated by reference to Exhibit 10.31 to the Form S-4 Registration
              Statement of Focus Impact BH3 NewCo, Inc. and XCF Global Capital, Inc. initially filed with the SEC on July 31, 2024)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/2019793/000114036124034989/ny20027344x3_ex10-32.htm">10.3**</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Supply and Offtake Agreement Between Ryze Renewables Reno, LLC and Phillips 66 Company (incorporated by reference to Exhibit 10.32 to the Form S-4 Registration Statement of Focus Impact BH3 NewCo, Inc. and XCF
              Global Capital, Inc. initially filed with the SEC on July 31, 2024)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/2019793/000114036124034989/ny20027344x3_ex10-33.htm">10.4</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Addendum 1 to Supply and Offtake Agreement Between Ryze Renewables Reno, LLC and Phillips 66 Company (incorporated by reference to Exhibit 10.33 to the Form S-4 Registration Statement of Focus Impact BH3 NewCo,
              Inc. and XCF Global Capital, Inc. initially filed with the SEC on July 31, 2024)</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">26</span></div>

      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 12.47%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/2019793/000114036124034989/ny20027344x3_ex10-34.htm">10.5</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Addendum 2 to Supply and Offtake Agreement Between Ryze Renewables Reno, LLC and Phillips 66 Company (incorporated by reference to Exhibit 10.34 to the Form S-4 Registration Statement of Focus Impact BH3 NewCo,
              Inc. and XCF Global Capital, Inc. initially filed with the SEC on July 31, 2024)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/2019793/000114036124034989/ny20027344x3_ex10-35.htm">10.6</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Addendum 3 to Supply and Offtake Agreement Between Ryze Renewables Reno, LLC and Phillips 66 Company (incorporated by reference to Exhibit 10.35 to the Form S-4 Registration Statement of Focus Impact BH3 NewCo,
              Inc. and XCF Global Capital, Inc. initially filed with the SEC on July 31, 2024)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/2019793/000114036124034989/ny20027344x3_ex10-36.htm">10.7</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Addendum 4 to Supply and Offtake Agreement Between New Rise Renewables Reno, LLC (as successor to Ryze Renewables Reno, LLC) and Phillips 66 Company (incorporated by reference to Exhibit 10.28 to the Form S-4
              Registration Statement of Focus Impact BH3 NewCo, Inc. and XCF Global Capital, Inc. initially filed with the SEC on July 31, 2024)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/2019793/000114036124034989/ny20027344x3_ex10-37.htm">10.8</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Addendum 5 to Supply and Offtake Agreement Between New Rise Renewables Reno, LLC (as successor to Ryze Renewables Reno, LLC) and Phillips 66 Company (incorporated by reference to Exhibit 10.28 to the Form S-4
              Registration Statement of Focus Impact BH3 NewCo, Inc. and XCF Global Capital, Inc. initially filed with the SEC on July 31, 2024)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/2019793/000114036124034989/ny20027344x3_ex10-38.htm">10.9**</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Addendum 6 to Supply and Offtake Agreement Between New Rise Renewables Reno, LLC (as successor to Ryze Renewables Reno, LLC) and Phillips 66 Company (incorporated by reference to Exhibit 10.28 to the Form S-4
              Registration Statement of Focus Impact BH3 NewCo, Inc. and XCF Global Capital, Inc. initially filed with the SEC on July 31, 2024)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/2019793/000114036124034989/ny20027344x3_ex10-39.htm">10.10**</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Addendum 7 to Supply and Offtake Agreement Between New Rise Renewables Reno, LLC (as successor to Ryze Renewables Reno, LLC) and Phillips 66 Company (incorporated by reference to Exhibit 10.39 to the Form S-4
              Registration Statement of Focus Impact BH3 NewCo, Inc. and XCF Global Capital, Inc. initially filed with the SEC on July 31, 2024)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/2019793/000114036124044780/ny20027344x5_ex10-40.htm">10.11+**</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Development Services Contract for Sustainable Aviation Fuel Facility between New Rise SAF Renewables LLC and Encore Management and Consulting LLC (incorporated by reference to Exhibit 10.40 to the Form S-4
              Registration Statement of Focus Impact BH3 NewCo, Inc. and XCF Global Capital, Inc. initially filed with the SEC on July 31, 2024)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/2019793/000114036124044780/ny20027344x5_ex10-41.htm">10.12+**</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Construction Services Contract for Plant Conversion to &#8216;SAF&#8217; (Sustainable Aviation Fuel) between New Rise Renewables Reno, LLC and Encore DEC LLC (incorporated by reference to Exhibit 10.41 to the Form S-4
              Registration Statement of Focus Impact BH3 NewCo, Inc. and XCF Global Capital, Inc. initially filed with the SEC on July 31, 2024)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/2019793/000114036124044780/ny20027344x5_ex10-42.htm">10.13+**</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Purchase and Sale Agreement by and between Twain GL XXVIII, LLC, as Buyer, and New Rise Renewables Reno, LLC (f/k/a Ryze Renewables Reno, LLC), as Seller (incorporated by reference to Exhibit 10.42 to the Form S-4
              Registration Statement of Focus Impact BH3 NewCo, Inc. and XCF Global Capital, Inc. initially filed with the SEC on July 31, 2024)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/2019793/000114036124044780/ny20027344x5_ex10-43.htm">10.14+**</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Ground Lease by and between Twain GL XXVIII, LLC, as Landlord and New Rise Renewables Reno, LLC, as Tenant (incorporated by reference to Exhibit 10.43 to the Form S-4 Registration Statement of Focus Impact BH3
              NewCo, Inc. and XCF Global Capital, Inc. initially filed with the SEC on July 31, 2024)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/2019793/000114036124044780/ny20027344x5_ex10-44.htm">10.15+**</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Loan Agreement, effective as of December 6, 2017, by and between Jefferson Financial Federal Credit Union, as Lender, Ryze Renewables Reno, LLC, , as Borrower and Ryze Renewables, LLC, as Guarantor (incorporated
              by reference to Exhibit 10.44 to the Form S-4 Registration Statement of Focus Impact BH3 NewCo, Inc. and XCF Global Capital, Inc. initially filed with the SEC on July 31, 2024)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/2019793/000114036124044780/ny20027344x5_ex10-45.htm">10.16</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Promissory Note 1A, dated December 6, 2017, by Ryze Renewables Reno, LLC, as maker, to Jefferson Financial Federal Credit Union, as lender (incorporated by reference to Exhibit 10.45 to the Form S-4 Registration
              Statement of Focus Impact BH3 NewCo, Inc. and XCF Global Capital, Inc. initially filed with the SEC on July 31, 2024)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/2019793/000114036124044780/ny20027344x5_ex10-46.htm">10.17</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Promissory Note 1B, dated December 6, 2017, by Ryze Renewables Reno, LLC, as maker, to Jefferson Financial Federal Credit Union, as lender (incorporated by reference to Exhibit 10.46 to the Form S-4 Registration
              Statement of Focus Impact BH3 NewCo, Inc. and XCF Global Capital, Inc. initially filed with the SEC on July 31, 2024)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/2019793/000114036124044780/ny20027344x5_ex10-47.htm">10.18</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Promissory Note 2A, dated December 6, 2017, by Ryze Renewables Reno, LLC, as maker, to Jefferson Financial Federal Credit Union, as lender (incorporated by reference to Exhibit 10.47 to the Form S-4 Registration
              Statement of Focus Impact BH3 NewCo, Inc. and XCF Global Capital, Inc. initially filed with the SEC on July 31, 2024)</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">27</span></div>

      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 12.47%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/2019793/000114036124044780/ny20027344x5_ex10-48.htm">10.19</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Promissory Note 2B, dated December 6, 2017, by Ryze Renewables Reno, LLC, as maker, to Jefferson Financial Federal Credit Union, as lender (incorporated by reference to Exhibit 10.48 to the Form S-4 Registration
              Statement of Focus Impact BH3 NewCo, Inc. and XCF Global Capital, Inc. initially filed with the SEC on July 31, 2024)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/2019793/000114036124049658/ny20027344x8_ex10-50.htm">10.20</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Convertible Promissory Note dated November 15, 2024 between XCF Global Capital, Inc., as Maker, and GL Part SPV I, LLC, as Holder (incorporated by reference to Exhibit 10.50 to the Form S-4 Registration Statement
              of Focus Impact BH3 NewCo, Inc. and XCF Global Capital, Inc. initially filed with the SEC on July 31, 2024)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/2019793/000114036124049658/ny20027344x8_ex10-51.htm">10.21</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Convertible Promissory Note dated December 6, 2024 between XCF Global Capital, Inc., as Maker, and GL Part SPV I, LLC, as Holder (incorporated by reference to Exhibit 10.51 to the Form S-4 Registration Statement
              of Focus Impact BH3 NewCo, Inc. and XCF Global Capital, Inc. initially filed with the SEC on July 31, 2024)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/2019793/000114036125001348/ny20027344x10_ex10-52.htm">10.22</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Convertible Promissory Note dated December 31, 2024 between XCF Global Capital, Inc., as Maker, and GL Part SPV I, LLC, as Holder (incorporated by reference to Exhibit 10.52 to the Form S-4 Registration Statement
              of Focus Impact BH3 NewCo, Inc. and XCF Global Capital, Inc. initially filed with the SEC on July 31, 2024)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/2019793/000114036125001348/ny20027344x10_ex10-53.htm">10.23</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Convertible Promissory Note dated January 14, 2025 between XCF Global Capital, Inc., as Maker, and GL Part SPV I, LLC, as Holder (incorporated by reference to Exhibit 10.53 to the Form S-4 Registration Statement
              of Focus Impact BH3 NewCo, Inc. and XCF Global Capital, Inc. initially filed with the SEC on July 31, 2024)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/2019793/000114036125001348/ny20027344x10_ex10-54.htm">10.24</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Convertible Promissory Note dated January 14, 2025 between XCF Global Capital, Inc., as Maker, and Focus Impact Partners, LLC, as Holder (incorporated by reference to Exhibit 10.54 to the Form S-4 Registration
              Statement of Focus Impact BH3 NewCo, Inc. and XCF Global Capital, Inc. initially filed with the SEC on July 31, 2024)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/2019793/000114036125001348/ny20027344x10_ex10-55.htm">10.25</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Convertible Promissory Note dated January 14, 2025 between XCF Global Capital, Inc., as Maker, and Sky MD, LLC, as Holder (incorporated by reference to Exhibit 10.55 to the Form S-4 Registration Statement of Focus
              Impact BH3 NewCo, Inc. and XCF Global Capital, Inc. initially filed with the SEC on July 31, 2024)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/1851612/000114036125005334/ef20044048_ex99-1.htm">10.26</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Promissory Note dated February 13, 2025, between XCF Global Capital, Inc. as Maker, and GL Part SPV I, LLC, as Holder (incorporated by reference to Exhibit 99.1 to the Current Report on Form 8-K of Focus Impact
              BH3 Acquisition Company filed with the SEC on February 21, 2025)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/1851612/000114036125005334/ef20044048_ex99-2.htm">10.27</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Promissory Note dated February 19, 2025 between XCF Global Capital, Inc. as Maker, and RESC Renewables Holdings, LLC, as Holder (incorporated by reference to Exhibit 99.3 to the Current Report on Form 8-K of Focus
              Impact BH3 Acquisition Company filed with the SEC on February 21, 2025)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/2019793/000114036125002233/ny20027344x14_ex10-56.htm">10.28</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Simon Oxley Employment Term Sheet (incorporated by reference to Exhibit 10.56 to the Form S-4 Registration Statement of Focus Impact BH3 NewCo, Inc. and XCF Global Capital, Inc. initially filed with the SEC on
              July 31, 2024)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/1851612/000114036125005334/ef20044048_ex99-3.htm">10.29</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Strategic Consulting Agreement dated February 19, 2025, between XCF Global Capital, Inc. and Focus Impact Partners, LLC (incorporated by reference to Exhibit 99.3 to the Current Report on Form 8-K of Focus Impact
              BH3 Acquisition Company filed with the SEC on February 21, 2025)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/1851612/000114036125005334/ef20044048_ex99-4.htm">10.30</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Employment Agreement dated February 14, 2025, between XCF Global Capital, Inc. and Mihir Dange (incorporated by reference to Exhibit 99.4 to the Current Report on Form 8-K of Focus Impact BH3 Acquisition Company
              filed with the SEC on February 21, 2025)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/1851612/000114036125005334/ef20044048_ex99-5.htm">10.31</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Employment Agreement dated February 14, 2025, between XCF Global Capital, Inc. and Simon Oxley (incorporated by reference to Exhibit 99.5 to the Current Report on Form 8-K of Focus Impact BH3 Acquisition Company
              filed with the SEC on February 21, 2025)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/1851612/000114036125005334/ef20044048_ex99-6.htm">10.32</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Employment Agreement dated February 14, 2025, between XCF Global Capital, Inc. and Gregory Surette (incorporated by reference to Exhibit 99.6 to the Current Report on Form 8-K of Focus Impact BH3 Acquisition
              Company filed with the SEC on February 21, 2025)</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">28</span></div>

      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 12.47%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/1851612/000114036125005334/ef20044048_ex99-7.htm">10.33</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Employment Agreement dated February 14, 2025, between XCF Global Capital, Inc. and Gregory Savarese (incorporated by reference to Exhibit 99.7 to the Current Report on Form 8-K of Focus Impact BH3 Acquisition
              Company filed with the SEC on February 21, 2025)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/1851612/000114036125005334/ef20044048_ex99-8.htm">10.34</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Employment Agreement dated February 14, 2025, between XCF Global Capital, Inc. and Jae Ryu (incorporated by reference to Exhibit 99.8 to the Current Report on Form 8-K of Focus Impact BH3 Acquisition Company filed
              with the SEC on February 21, 2025)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/1851612/000114036125021317/ef20049660_ex10-2.htm">10.35</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">First Amendment, dated April 17, 2025, to Promissory Note dated February 13, 2025, between XCF Global Capital, Inc. as Maker, and GL Part SPV I, LLC, as Holder (incorporated by reference to Exhibit 10.2 to the
              Current Report on Form 8-K of Focus Impact BH3 Acquisition Company filed with the SEC on June 3, 2025)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/1851612/000114036125021317/ef20049660_ex10-3.htm">10.36</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Promissory Note dated April 17, 2025, between XCF Global Capital, Inc. as Maker, and GL Part SPV I, LLC, as Holder (incorporated by reference to Exhibit 10.3 to the Current Report on Form 8-K of Focus Impact BH3
              Acquisition Company filed with the SEC on June 3, 2025)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/1851612/000114036125021317/ef20049660_ex10-4.htm">10.37</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Promissory Note dated January 31, 2025, between XCF Global Capital, Inc. as Maker, and Innovativ Media Group, Inc., as Holder (incorporated by reference to Exhibit 10.4 to the Current Report on Form 8-K of Focus
              Impact BH3 Acquisition Company filed with the SEC on June 3, 2025)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/1851612/000114036125021317/ef20049660_ex10-5.htm">10.38</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">First Amendment, dated April 17, 2025, to Promissory Note dated January 31, 2025, between XCF Global Capital, Inc. as Maker, and Innovativ Media Group, Inc., as Holder (incorporated by reference to Exhibit 10.5 to
              the Current Report on Form 8-K of Focus Impact BH3 Acquisition Company filed with the SEC on June 3, 2025)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/1851612/000114036125021317/ef20049660_ex10-6.htm">10.39</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Promissory Note dated May 1, 2025, between XCF Global Capital, Inc. as Maker, and Narrow Road Capital, Ltd., as Holder (incorporated by reference to Exhibit 10.6 to the Current Report on Form 8-K of Focus Impact
              BH3 Acquisition Company filed with the SEC on June 3, 2025)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/1851612/000114036125021317/ef20049660_ex10-7.htm">10.40</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Promissory Note dated May 14, 2025, between XCF Global Capital, Inc. as Maker, and Gregory Segars Cribb, as Holder (incorporated by reference to Exhibit 10.7 to the Current Report on Form 8-K of Focus Impact BH3
              Acquisition Company filed with the SEC on June 3, 2025)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/1851612/000114036125021317/ef20049660_ex10-8.htm">10.41</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Purchase Agreement dated May 30, 2025, by and between Helena Global Investment Opportunities I Ltd, Focus Impact BH3 NewCo, Inc. and XCF Global Capital, Inc. (incorporated by reference to Exhibit 10.8 to the
              Current Report on Form 8-K of Focus Impact BH3 Acquisition Company filed with the SEC on June 3, 2025)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/1851612/000114036125021317/ef20049660_ex10-9.htm">10.42</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Promissory Note dated May 30, 2025, by and between Focus Impact BH3 NewCo, Inc., aa Borrower, XCF Global Capital, Inc. and Helena Global Investment Opportunities I Ltd (incorporated by reference to Exhibit 10.9 to
              the Current Report on Form 8-K of Focus Impact BH3 Acquisition Company filed with the SEC on June 3, 2025)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/1851612/000114036125021317/ef20049660_ex10-10.htm">10.43</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Share Issuance Agreement dated as of May 30, 2025 between XCF Global Capital, Inc. and Randall Soule (incorporated by reference to Exhibit 10.10 to the Current Report on Form 8-K of Focus Impact BH3 Acquisition
              Company filed with the SEC on June 3, 2025)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/1851612/000114036125021317/ef20049660_ex10-11.htm">10.44</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Employment Agreement dated April 16, 2025, between XCF Global Capital, Inc. and Pamela M. Abowd (incorporated by reference to Exhibit 10.11 to the Current Report on Form 8-K of Focus Impact BH3 Acquisition Company
              filed with the SEC on June 3, 2025)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/1851612/000114036125021317/ef20049660_ex10-12.htm">10.45</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Employment Agreement dated February 14, 2025, between XCF Global Capital, Inc. and Jonathan Seeley. (incorporated by reference to Exhibit 10.12 to the Current Report on Form 8-K of Focus Impact BH3 Acquisition
              Company filed with the SEC on June 3, 2025)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/1851612/000114036125021317/ef20049660_ex10-13.htm">10.46</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Addendum, dated April 13, 2025, to Employment Agreement dated February 14, 2025, between XCF Global Capital, Inc. and Jonathan Seeley (incorporated by reference to Exhibit 10.13 to the Current Report on Form 8-K
              of Focus Impact BH3 Acquisition Company filed with the SEC on June 3, 2025)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/1851612/000114036125021317/ef20049660_ex10-14.htm">10.47</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Addendum, dated April 13, 2025, to Employment Agreement dated February 14, 2025, between XCF Global Capital, Inc. and Gregory R. Surette (incorporated by reference to Exhibit 10.14 to the Current Report on Form
              8-K of Focus Impact BH3 Acquisition Company filed with the SEC on June 3, 2025)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/1851612/000114036125021317/ef20049660_ex10-15.htm">10.48</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Addendum, dated April 13, 2025, to Employment Agreement dated February 14, 2025, between XCF Global Capital, Inc. and Gregory P. Savarese (incorporated by reference to Exhibit 10.15 to the Current Report on Form
              8-K of Focus Impact BH3 Acquisition Company filed with the SEC on June 3, 2025)</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">29</span></div>

      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 12.47%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/1851612/000114036125021317/ef20049660_ex10-16.htm">10.49</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Separation Agreement between XCF Global Capital, Inc. and Joseph F. Cunningham (incorporated by reference to Exhibit 10.16 to the Current Report on Form 8-K of Focus Impact BH3 Acquisition Company filed with the
              SEC on June 3, 2025)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/1851612/000114036125021317/ef20049660_ex10-17.htm">10.50</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Separation Agreement between XCF Global Capital, Inc. and Stephen Goodwin (incorporated by reference to Exhibit 10.17 to the Current Report on Form 8-K of Focus Impact BH3 Acquisition Company filed with the SEC on
              June 3, 2025)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="ef20050548_ex10-51.htm">10.51</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Registration Rights Agreement dated as of June 6, 2025 by and among XCF Global, Inc., Focus Impact BHAC Sponsor, LLC, and the Core Equityholders named therein</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="ef20050548_ex10-52.htm">10.52</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Resale Shelf Registration Rights Agreement dated as of June 6, 2025 by and among XCF Global, Inc. and the Holders named therein</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="ef20050548_ex10-53.htm">10.53</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Agreement Regarding Board Nomination Rights dated as of June 6, 2025 by and between XCF Global, Inc. and Focus Impact BHAC Sponsor, LLC</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="ef20050548_ex10-54.htm">10.54</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Form of Voting Agreement</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="ef20050548_ex10-55.htm">10.55</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Form of Director and Officer Indemnification Agreement</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="ef20050548_ex10-56.htm">10.56</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Form of Lock-up Waiver Agreement</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="ef20050548_ex10-57.htm">10.57</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Employment Agreement between XCF Global, Inc. and Mihir Dange</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="ef20050548_ex10-58.htm">10.58</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Employment Agreement between XCF Global, Inc. and Simon Oxley</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="ef20050548_ex10-59.htm">10.59</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Employment Agreement between XCF Global, Inc. and Gregory Surette</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="ef20050548_ex10-60.htm">10.60</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Employment Agreement between XCF Global, Inc. and Gregory Savarese</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="ef20050548_ex10-61.htm">10.61</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Employment Agreement between XCF Global, Inc. and Pamela Abowd</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="ef20050548_ex10-62.htm">10.62</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Employment Agreement between XCF Global, Inc. and Jae Ryu</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="ef20050548_ex10-63.htm">10.63</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">2025 Equity Incentive Plan</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="ef20050548_ex10-64.htm">10.64</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">2025 Employee Stock Purchase Plan</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="ef20050548_ex10-65.htm">10.65</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Employment Agreement between XCF Global, Inc. and Jonathan Seeley</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;" rowspan="1">
            <div style="text-align: center;"><a href="ef20050548_ex10-66.htm">10.66</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;" rowspan="1"><br/>
          </td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;" rowspan="1"><br/>
          </td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;" rowspan="1">
            <div>Forbearance Agreement by and between Twain GL XXVIII, LLC, New Rise Renewables Reno, LLC and XCF Global, Inc.</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="ef20050548_ex14-1.htm">14.1</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Code of Ethics and Business Conduct</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="ef20050548_ex19-1.htm">19.1</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Insider Trading Policy</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="ef20050548_ex21-1.htm">21.1</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">List of Subsidiaries</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;"><a href="ef20050548_ex99-1.htm">99.1</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Press Release, dated June 6, 2025, announcing closing of the Business Combination</div>
          </td>

  </tr>

  <tr>

    <td style="width: 12.47%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;"><a href="ef20050548_ex99-2.htm">99.2</a></div>
          </td>

    <td style="width: 2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 84.66%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left;">Press Release, dated June 9, 2025, announcing first day of trading of XCF Global Class A Common Stock on Nasdaq</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 20pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">+</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>Certain of the exhibits and schedules to this exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5). The Registrant agrees to furnish a copy of all omitted exhibits and schedules to the SEC upon its request.</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">**</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>Pursuant to Item 601(b)(10) of Regulation S-K, portions of this exhibit have been omitted (indicated by &#8220;[***]&#8221;) as the registrant has determined that the omitted information (i) is not material and (ii) the type of information that the
              registrant customarily and actually treats as private or confidential.</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">30</span></div>

      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SIGNATURE</div>

    <div style="text-align: center;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"> </span><span style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </span></div>

    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the
      undersigned hereunto duly authorized.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="vertical-align: top;" colspan="3">
            <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">XCF GLOBAL, INC.</div>
          </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;" rowspan="1">&#160;</td>

    <td style="vertical-align: top;" colspan="3" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">&#160;</td>

    <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
            <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">By:</div>
          </td>

    <td style="width: 16%; vertical-align: top; border-bottom: 2px solid black;">
            <div style="text-align: justify;"><span style="font-size: 10pt; font-family: 'Times New Roman';">/s/ Mihir Dange&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div>
          </td>

    <td style="width: 31%; vertical-align: top; padding-bottom: 2px;">&#160;</td>

  </tr>


</table>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: justify;">Title:</div>
          </td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: justify;">Mihir Dange</div>
          </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 5%; vertical-align: top;">
            <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Name:</div>
          </td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: justify;">Chief Executive Officer</div>
          </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top;">
            <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Date:&#160;&#160;&#160;&#160; June 12, 2025</span></div>
          </td>

    <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">31</span> </div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;">
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

  </div>

</div>
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>ef20050548_ex3-1.htm
<DESCRIPTION>EXHIBIT 3.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; font-size: 12pt; font-weight: bold;"> <font style="font-size: 10pt;">Exhibit 3.1<br>
        </font></div>
      <div style="text-align: center; font-size: 12pt; font-weight: bold;"> <font style="font-size: 10pt;"><br>
        </font></div>
      <div style="text-align: center; font-weight: bold;">AMENDED AND RESTATED</div>
      <div style="text-align: center; font-weight: bold;">CERTIFICATE OF INCORPORATION</div>
      <div style="text-align: center; font-weight: bold;">OF</div>
      <div style="text-align: center; font-weight: bold;">FOCUS IMPACT BH3 NEWCO, INC.</div>
      <div>&#160;</div>
      <div style="text-align: center;">June 6, 2025</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">Focus Impact BH3 NewCo, Inc., a corporation organized and existing under the laws of the State of Delaware (the &#8220;<font style="font-weight: bold; font-style: italic;">Corporation</font>&#8221;), does
        hereby certify as follows:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The name of the Corporation is &#8220;Focus Impact BH3 NewCo, Inc.&#8221;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Corporation filed its original certificate of incorporation with the Secretary of State of the State of Delaware on March 6, 2024 (the &#8220;<font style="font-weight: bold; font-style: italic;">Original Certificate</font>&#8221;).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">3.&#160;&#160;&#160;&#160;&#160; &#160; &#160; This Amended and Restated Certificate of Incorporation (this &#8220;<font style="font-weight: bold; font-style: italic;">Amended and Restated Certificate</font>&#8221;), which both restates and
        amends the provisions of the Original Certificate, was duly adopted in accordance with Sections 242 and 245 of the General Corporation Law of the State of Delaware, as amended from time to time (the &#8220;<font style="font-weight: bold; font-style: italic;">DGCL</font>&#8221;).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This Amended and Restated Certificate shall become effective on the date of filing with the Secretary of State of the State of Delaware.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The text of the Original Certificate is hereby restated and amended in its entirety to read as follows:</div>
      <div>&#160;</div>
      <div style="text-align: center; color: rgb(1, 0, 0); font-weight: bold;">ARTICLE I</div>
      <div style="text-align: center; font-weight: bold;">NAME</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The name of the corporation is XCF Global, Inc. (the &#8220;<font style="font-weight: bold; font-style: italic;">Corporation</font>&#8221;).</div>
      <div>&#160;</div>
      <div style="text-align: center; color: rgb(1, 0, 0); font-weight: bold;">ARTICLE II</div>
      <div style="text-align: center; font-weight: bold;">PURPOSE</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The purpose of the Corporation is to engage in any lawful act or activity for which corporations may be organized under the DGCL. In addition to the powers and privileges conferred upon the
        Corporation by law and those incidental thereto, the Corporation shall possess and may exercise all the powers and privileges that are necessary or convenient to the conduct, promotion or attainment of the business or purposes of the Corporation.</div>
      <div>&#160;</div>
      <div style="text-align: center; color: rgb(1, 0, 0); font-weight: bold;">ARTICLE III</div>
      <div style="text-align: center; font-weight: bold;">REGISTERED AGENT</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The address of the Corporation&#8217;s registered office in the State of Delaware is 251 Little Falls Drive, Wilmington, County of New Castle, Delaware 19808, and the name of the Corporation&#8217;s registered
        agent at such address is Corporation Service Company.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-align: center; color: rgb(1, 0, 0); font-weight: bold;">ARTICLE IV</div>
      <div style="text-align: center; font-weight: bold;">CAPITALIZATION</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 4.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Authorized Capital Stock</u></font>. The total number of shares of all classes
        of capital stock which the Corporation is authorized to issue is 550,000,000 shares, each with a par value $0.0001 per share, consisting of (a) 500,000,000 shares of Class A Common Stock, par value $0.0001 per share (the &#8220;<font style="font-weight: bold; font-style: italic;">Common Stock</font>&#8221;), and (b) 50,000,000 shares of preferred stock, par value $0.0001 per share (the &#8220;<font style="font-weight: bold; font-style: italic;">Preferred Stock</font>&#8221;). Subject to the rights of the holders
        of any one or more series of Preferred Stock then outstanding, the number of authorized shares of any class of the Common Stock or the Preferred Stock may be increased or decreased, in each case by the affirmative vote of the holders of a majority
        of the total voting power of the issued and outstanding shares of capital stock of the Corporation entitled to vote thereon, voting together as a single class, irrespective of the provisions of Section 242(b)(2) of the DGCL, and no vote of the
        holders of any class of the Common Stock or the Preferred Stock voting separately as a class will be required therefor.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 4.2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Existing Common Stock</u></font>. Upon this Amended and Restated Certificate
        becoming effective pursuant to the DGCL, each share of the Corporation&#8217;s common stock, par value $0.0001 per share, issued and outstanding or held in treasury shall automatically and without any action on the part of the holder thereof become one
        share of Common Stock under this Amended and Restated Certificate.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 4.3</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Preferred Stock</u></font>. The Board of Directors of the Corporation (the &#8220;<font style="font-weight: bold; font-style: italic;">Board</font>&#8221;) is hereby expressly authorized to provide out of the unissued shares of the Preferred Stock for one or more series of Preferred Stock and to establish from time to time the number of
        shares to be included in each such series and to fix the voting rights, if any, designations, powers, preferences and relative, participating, optional, special and other rights, if any, of each such series and any qualifications, limitations and
        restrictions thereof, as shall be stated in the resolution or resolutions adopted by the Board providing for the issuance of such series and included in a certificate of designation (a &#8220;<font style="font-weight: bold; font-style: italic;">Preferred
          Stock Designation</font>&#8221;) filed pursuant to the DGCL, and the Board is hereby expressly vested with the authority to the full extent provided by law, now or hereafter, to adopt any such resolution or resolutions. Except as required by the DGCL,
        any Preferred Stock Designation or this Amended and Restated Certificate, a series of Preferred Stock may be authorized, and the terms of any series of Preferred Stock may be amended, without the consent, approval or other action of the holders of
        the shares of Common Stock, of any other series of Preferred Stock or of any other class of capital stock of the Corporation.</div>
      <div style="text-align: justify; text-indent: 36pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 4.4</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Common Stock</u></font><u>.</u></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Voting.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: rgb(1, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Except as otherwise required by law or this Amended and Restated Certificate (including any Preferred Stock Designation),
        the holders of the shares of Common Stock shall exclusively possess all voting power with respect to the Corporation.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: rgb(1, 0, 0);">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Except as otherwise required by law or this Amended and Restated Certificate (including any Preferred Stock Designation),
        the holders of the shares of Common Stock shall be entitled to one vote for each such share on each matter properly submitted to the stockholders of the Corporation on which the holders of the shares of Common Stock are entitled to vote. The
        holders of the shares of Common Stock shall vote together as a single class on all matters on which the holders of the shares of Common Stock are entitled to vote.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: rgb(1, 0, 0);">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; Except as otherwise required by law or this Amended and Restated Certificate (including any Preferred Stock Designation),
        at any annual or special meeting of the stockholders of the Corporation, the holders of the shares of Common Stock shall have the exclusive right to vote for the election of directors and on all other matters properly submitted to a vote of the
        stockholders of the Corporation. Notwithstanding the foregoing, except as otherwise required by law or this Amended and Restated Certificate (including any Preferred Stock Designation), the holders of the shares of Common Stock shall not be
        entitled to vote on any amendment to this Amended and Restated Certificate (including any amendment to any Preferred Stock Designation) that relates solely to the terms of one or more outstanding series of Preferred Stock if the holders of such
        affected series of Preferred Stock are entitled, either separately or together with the holders of one or more other such series, to vote thereon pursuant to this Amended and Restated Certificate (including any Preferred Stock Designation) or the
        DGCL.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>Dividends</u>. Subject to applicable law and the rights, if any, of the holders of any outstanding series of the
        Preferred Stock, the holders of the shares of Common Stock shall be entitled to receive such dividends and other distributions (payable in cash, property or capital stock of the Corporation) when, as and if declared thereon by the Board from time
        to time out of any assets or funds of the Corporation legally available therefor and shall share equally on a per share basis in such dividends and distributions.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(c)</font>&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>Liquidation Dissolution or Winding Up of the Corporation</u>. Subject to applicable law, and the rights, if any, of the
        holders of any outstanding series of the Preferred Stock, in the event of any voluntary or involuntary liquidation, dissolution or winding up of the Corporation, after payment or provision for payment of the debts and other liabilities of the
        Corporation, the holders of the shares of Common Stock shall be entitled to receive all the remaining assets of the Corporation available for distribution to its stockholders, ratably in proportion to the number of shares of Common Stock held by
        them.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 4.5</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Rights and Options</u></font>. The Corporation has the authority to create and
        issue rights, warrants and options entitling the holders thereof to purchase shares of any class or series of the Corporation&#8217;s capital stock or other securities of the Corporation, and such rights, warrants and options shall be evidenced by
        instrument(s) approved by the Board. The Board is empowered to set the exercise price, duration, times for exercise and other terms and conditions of such rights, warrants or options; provided, however, that the consideration to be received for any
        shares of capital stock subject thereto may not be less than the par value thereof.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; color: rgb(1, 0, 0); font-weight: bold;">ARTICLE V</div>
      <div style="text-align: center; font-weight: bold;">BOARD OF DIRECTORS</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 5.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Board Powers</u></font>. The business and affairs of the Corporation shall be
        managed by, or under the direction of, the Board. In addition to the powers and authority expressly conferred upon the Board by statute, this Amended and Restated Certificate or the Bylaws of the Corporation (&#8220;<font style="font-weight: bold; font-style: italic;">Bylaws</font>&#8221;), the Board is hereby empowered to exercise all such powers and do all such acts and things as may be exercised or done by the Corporation, subject, nevertheless, to the provisions of the DGCL, this Amended and
        Restated Certificate, and any Bylaws adopted by the stockholders of the Corporation; provided, however, that no Bylaws hereafter adopted by the stockholders of the Corporation shall invalidate any prior act of the Board that would have been valid
        if such Bylaws had not been adopted.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 5.2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Number, Election and Term</u></font><u>.</u></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The number of directors of the Corporation, other than those who may be elected by the holders of one or more series of the
        Preferred Stock voting separately by class or series, shall be fixed from time to time exclusively by the Board pursuant to a resolution adopted by a majority of the Board.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; Subject to <u>Section 5.5</u> hereof, the Board shall be divided into three classes, as nearly equal in number as possible
        and designated Class I, Class II and Class III. The Board is authorized to assign members of the Board already in office to Class I, Class II or Class III. The term of the initial Class I Directors shall expire at the first annual meeting of the
        stockholders of the Corporation following the effectiveness of this Amended and Restated Certificate, the term of the initial Class II Directors shall expire at the second annual meeting of the stockholders of the Corporation following the
        effectiveness of this Amended and Restated Certificate and the term of the initial Class III Directors shall expire at the third annual meeting of the stockholders of the Corporation following the effectiveness of this Amended and Restated
        Certificate. At each succeeding annual meeting of the stockholders of the Corporation, beginning with the first annual meeting of the stockholders of the Corporation following the effectiveness of this Amended and Restated Certificate, each of the
        successors elected to replace the class of directors whose term expires at that annual meeting shall be elected for a three-year term or until the election and qualification of their respective successors in office, subject to their earlier death,
        resignation, retirement, disqualification or removal. Subject to <u>Section 5.5</u> hereof, if the number of directors that constitutes the Board is changed, any increase or decrease shall be apportioned by the Board among the classes so as to
        maintain the number of directors in each class as nearly equal as possible, but in no case shall a decrease in the number of directors constituting the Board shorten the term of any incumbent director. Subject to the rights of the holders of one or
        more series of Preferred Stock, voting separately by class or series, to elect directors pursuant to the terms of one or more series of Preferred Stock, the election of directors shall be determined by a plurality of the votes cast by the
        stockholders present in person or represented by proxy at the meeting and entitled to vote thereon. The Board is hereby expressly authorized, by resolution or resolutions thereof, to assign members of the Board already in office to the aforesaid
        classes at the time this Amended and Restated Certificate (and therefore such classification) becomes effective in accordance with the DGCL.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Subject to <u>Section 5.5</u> hereof, a director shall hold office until the annual meeting for the year in which his or
        her term expires and until his or her successor has been elected and qualified, subject, however, to such director&#8217;s earlier death, resignation, retirement, disqualification or removal.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Unless and except to the extent that the Bylaws shall so require, the election of directors need not be by written ballot.
        There shall be no cumulative voting in the election of directors.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 5.3</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Newly Created Directorships and Vacancies</u></font>. Subject to Section 5.5
        hereof, newly created directorships resulting from an increase in the number of directors and any vacancies on the Board resulting from death, resignation, retirement, disqualification, removal or other cause may be filled solely and exclusively by
        a majority vote of the remaining directors then in office, even if less than a quorum, or by a sole remaining director (and not by stockholders), and any director so chosen shall hold office for the remainder of the full term of the class of
        directors to which the new directorship was added or in which the vacancy occurred and until his or her successor has been elected and qualified, subject, however, to such director&#8217;s earlier death, resignation, retirement, disqualification or
        removal.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 5.4</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-weight: bold;"><u>Removal</u></font>. Subject to Section 5.5 hereof, any or all of the directors
        may be removed from office at any time, but only for cause and only by the affirmative vote of holders of 66-2/3% of the voting power of all then outstanding shares of capital stock of the Corporation entitled to vote generally in the election of
        directors, voting together as a single class.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 5.5</font>&#160;&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-weight: bold;"><u>Preferred Stock - Directors</u></font>. Notwithstanding any other provision of
        this Article V, and except as otherwise required by law, whenever the holders of one or more series of the Preferred Stock shall have the right, voting separately by class or series, to elect one or more directors, the term of office, the filling
        of vacancies, the removal from office and other features of such directorships shall be governed by the terms of such series of the Preferred Stock as set forth in this Amended and Restated Certificate (including any Preferred Stock Designation),
        and such directors shall not be included in any of the classes created pursuant to this Article V unless expressly provided by such terms.</div>
      <div>&#160;</div>
      <div style="text-align: center; color: rgb(1, 0, 0); font-weight: bold;">ARTICLE VI</div>
      <div style="text-align: center; font-weight: bold;">BYLAWS</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">In furtherance and not in limitation of the powers conferred upon it by law, the Board shall have the power and is expressly authorized to adopt, amend, alter or repeal the Bylaws by the
        affirmative vote of a majority of the total number of directors present at a regular or special meeting of the Board at which there is a quorum or by unanimous written consent. The Bylaws also may be adopted, amended, altered or repealed by the
        stockholders of the Corporation; provided, however, that in addition to any vote of the holders of any class or series of capital stock of the Corporation required by law or by this Amended and Restated Certificate (including any Preferred Stock
        Designation), the affirmative vote of the holders of at least 66-2/3% of the voting power of all then outstanding shares of capital stock of the Corporation entitled to vote generally in the election of directors, voting together as a single class,
        shall be required for the stockholders of the Corporation to adopt, amend, alter or repeal the Bylaws; and provided further, however, that no Bylaws hereafter adopted by the stockholders of the Corporation shall invalidate any prior act of the
        Board that would have been valid if such Bylaws had not been adopted.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">5</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; color: rgb(1, 0, 0); font-weight: bold;">ARTICLE VII</div>
      <div style="text-align: center; font-weight: bold;">SPECIAL MEETINGS OF STOCKHOLDERS; ACTION BY WRITTEN CONSENT</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 7.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Special Meetings</u></font>. Subject to the rights, if any, of the holders of
        any outstanding series of the Preferred Stock, and to the requirements of applicable law, special meetings of stockholders of the Corporation may be called only by the Chairperson of the Board, the Chief Executive Officer of the Corporation, or the
        Board pursuant to a resolution adopted by a majority of the Board, and the ability of the stockholders of the Corporation to call a special meeting is hereby specifically denied. Except as provided in the foregoing sentence, special meetings of
        stockholders of the Corporation may not be called by another person or persons.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 7.2</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">&#160;&#160; <u>Advance Notice</u></font>. Advance notice of stockholder nominations for the
        election of directors and of business to be brought by stockholders before any meeting of the stockholders of the Corporation shall be given in the manner provided in the Bylaws.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 7.3</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Action by Written Consent</u></font>. Except as may be otherwise provided for
        or fixed pursuant to this Amended and Restated Certificate (including any Preferred Stock Designation) relating to the rights of the holders of any outstanding series of Preferred Stock, any action required or permitted to be taken by the
        stockholders of the Corporation must be effected by a duly called annual or special meeting of such stockholders and may not be effected by written consent of the stockholders of the Corporation.</div>
      <div>&#160;</div>
      <div style="text-align: center; color: rgb(1, 0, 0); font-weight: bold;">ARTICLE VIII</div>
      <div style="text-align: center; font-weight: bold;">LIMITED LIABILITY; INDEMNIFICATION</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 8.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Limitation of Director and Officer Liability</u></font>. To the fullest extent
        that the DGCL or any other law of the State of Delaware (as any such law exists on the date hereof or as it may hereafter be amended) permits the limitation or elimination of the liability of directors or officers, no current or former director or
        officer of the Corporation shall be liable to the Corporation or any of its stockholders for monetary damages for breach of fiduciary duty as a director or officer. If, after this Amended and Restated Certificate is filed with the Secretary of
        State of the State of Delaware, the DGCL or any such other law is amended to authorize corporate action further eliminating or limiting the personal liability of directors or officers, then the liability of a current or former director or officer
        of the Corporation shall be eliminated or limited to the fullest extent permitted by the DGCL or such other law, as so amended. No amendment to, or modification or repeal of, this Article VIII shall adversely affect any right or protection of, or
        increase the liability of, any current or former director or officer of the Corporation existing hereunder with respect to any state of facts existing or any act or omission occurring, or any cause of action, suit or claim that, but for this
        Article VIII, would accrue or arise, prior to such amendment, modification or repeal. For purposes of this Article VIII, references to &#8220;director&#8221; shall include any person who has served as a director of Focus Impact BH3 Acquisition Company, a
        Delaware corporation.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">6</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 8.2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Indemnification and Advancement of Expenses</u></font><u>.</u></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; To the fullest extent permitted by the DGCL or any other applicable law, as the same exists or may hereafter be amended, the
        Corporation shall indemnify, defend and hold harmless each person who is or was made a party or is threatened to be made a party to or is otherwise involved in any threatened, pending or completed action, suit or proceeding, whether civil,
        criminal, administrative or investigative (a &#8220;<font style="font-weight: bold; font-style: italic;">proceeding</font>&#8221;) by reason of the fact that he or she is or was a director or officer of the Corporation or, while a director or officer of the
        Corporation, is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation or of a partnership, joint venture, trust, other enterprise or nonprofit entity, including service with respect to an
        employee benefit plan (an &#8220;<font style="font-weight: bold; font-style: italic;">indemnitee</font>&#8221;), whether the basis of such proceeding is alleged action in an official capacity as a director, officer, employee or agent, or in any other capacity
        while serving as a director, officer, employee or agent, against all liability and loss suffered and expenses (including, without limitation, attorneys&#8217; fees, judgments, fines, ERISA excise taxes and penalties and amounts paid in settlement)
        reasonably incurred by such indemnitee in connection with such proceeding. The Corporation shall to the fullest extent not prohibited by applicable law pay the expenses (including attorneys&#8217; fees) incurred by an indemnitee in defending or otherwise
        participating in any proceeding in advance of its final disposition; provided, however, that, to the extent required by applicable law, such payment of expenses in advance of the final disposition of the proceeding shall be made only upon receipt
        of an undertaking, by or on behalf of the indemnitee, to repay all amounts so advanced if it shall ultimately be determined that the indemnitee is not entitled to be indemnified under this <u>Section 8.2</u> or otherwise. The rights to
        indemnification and advancement of expenses conferred by this <u>Section 8.2</u> shall be contract rights and such rights shall continue as to an indemnitee who has ceased to be a director, officer, employee or agent and shall inure to the benefit
        of his or her heirs, executors and administrators. Notwithstanding the foregoing provisions of this <u>Section 8.2(a)</u>, except for proceedings to enforce rights to indemnification and advancement of expenses, the Corporation shall indemnify and
        advance expenses to an indemnitee in connection with a proceeding (or part thereof) initiated by such indemnitee only if such proceeding (or part thereof) was authorized by the Board.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; The rights to indemnification and advancement of expenses conferred on any indemnitee by this <u>Section 8.2</u> shall not
        be exclusive of any other rights that any indemnitee may have or hereafter acquire under law, this Amended and Restated Certificate, the Bylaws, agreements, vote of stockholders or disinterested directors, or otherwise.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; Any repeal or amendment of this <u>Section 8.2</u> by the stockholders of the Corporation or by changes in law, or the
        adoption of any other provision of this Amended and Restated Certificate inconsistent with this <u>Section 8.2</u>, shall, unless otherwise required by law, be prospective only (except to the extent such amendment or change in law permits the
        Corporation to provide broader indemnification rights on a retroactive basis than permitted prior thereto), and shall not in any way diminish or adversely affect any right or protection existing at the time of such repeal or amendment or adoption
        of such inconsistent provision in respect of any proceeding (regardless of when such proceeding is first threatened, commenced or completed) arising out of, or related to, any act or omission occurring prior to such repeal or amendment or adoption
        of such inconsistent provision.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">7</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; This <u>Section 8.2</u> shall not limit the right of the Corporation, to the extent and in the manner authorized or
        permitted by law, to indemnify and to advance expenses to persons other than indemnitees.</div>
      <div>&#160;</div>
      <div style="text-align: center; color: rgb(1, 0, 0); font-weight: bold;">ARTICLE IX</div>
      <div style="text-align: center; font-weight: bold;">AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF</div>
      <div style="text-align: center; font-weight: bold;"> INCORPORATION</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The Corporation reserves the right, at any time and from time to time to amend, alter, change or repeal any provision contained in this Amended and Restated Certificate (including any Preferred
        Stock Designation), and other provisions authorized by the laws of the State of Delaware at the time in force that may be added or inserted, in the manner now or hereafter prescribed by this Amended and Restated Certificate and the DGCL; and,
        except as set forth in Article&#8194;VIII, all rights, preferences and privileges of whatever nature herein conferred upon stockholders, directors or any other persons by and pursuant to this Amended and Restated Certificate in its present form or as
        hereafter amended are granted subject to the right reserved in this Article IX. Notwithstanding the foregoing, the provisions set forth in <u>Section 4.4</u> of Article IV and Articles&#8194;V, VI, VII, VIII, this Article IX, Article X and Article XI
        (and any defined terms referenced therein and herein) may not be repealed or amended in any respect, and no other provision may be adopted, amended or repealed which would have the effect of modifying or permitting the circumvention of the
        provisions set forth therein, unless such action is approved by the affirmative vote of the holders of not less than 66-2/3% of the total voting power of the issued and outstanding shares of capital stock of the Corporation entitled to vote
        thereon, voting together as a single class.</div>
      <div>&#160;</div>
      <div style="text-align: center; color: rgb(1, 0, 0); font-weight: bold;">ARTICLE X</div>
      <div style="text-align: center; font-weight: bold;">EXCLUSIVE FORUM FOR CERTAIN LAWSUITS</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 10.1</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Forum</u></font>. Unless the Corporation consents in writing to the selection of
        an alternative forum, the Court of Chancery of the State of Delaware shall be the sole and exclusive forum for any stockholder (including a beneficial owner) to bring (i) any derivative action or proceeding brought on behalf of the Corporation,
        (ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee of the Corporation to the Corporation or the Corporation&#8217;s stockholders, (iii) any action asserting a claim against the Corporation, its
        directors, officers or employees arising pursuant to any provision of the DGCL or this Amended and Restated Certificate or the Bylaws, (iv) any action asserting a claim against the Corporation, its directors, officers or employees governed by the
        internal affairs doctrine or (v) any action to interpret, apply, enforce or determine the validity of this Amended and Restated Certificate, except for, as to each of (i) through (v) above, any claim as to which the Court of Chancery determines
        that there is an indispensable party not subject to the jurisdiction of the Court of Chancery (and the indispensable party does not consent to the personal jurisdiction of the Court of Chancery within ten days following such determination), which
        is vested in the exclusive jurisdiction of a court or forum other than the Court of Chancery, or for which the Court of Chancery does not have subject matter jurisdiction. Unless the Corporation consents in writing to the selection of an
        alternative forum, the federal district courts of the United States of America shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act of 1933, as amended, and the rules and
        regulations thereunder. This Article X shall not apply to suits brought to enforce a duty or liability created by the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder or any other claim for which the federal
        courts have exclusive jurisdiction.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">8</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 10.2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Consent to Jurisdiction</u></font>. If any action the subject matter of which
        is within the scope of Section 10.1 immediately above is filed in a court other than a court located within the State of Delaware (a &#8220;<font style="font-weight: bold; font-style: italic;">Foreign Action</font>&#8221;) in the name of any stockholder, such
        stockholder shall be deemed to have consented to (i) the personal jurisdiction of the state and federal courts located within the State of Delaware in connection with any action brought in any such court to enforce Section 10.1 immediately above
        (an &#8220;<font style="font-weight: bold; font-style: italic;">FSC Enforcement Action</font>&#8221;) and (ii) having service of process made upon such stockholder in any such FSC Enforcement Action by service upon such stockholder&#8217;s counsel in the Foreign
        Action as agent for such stockholder.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 10.3</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Notice</u></font>. To the fullest extent permitted by applicable law, any
        person holding, owning or otherwise acquiring any interest in shares of capital stock or other security of the Corporation shall be deemed to have notice of and consented to all of the provisions of this Amended and Restated Certificate.</div>
      <div>&#160;</div>
      <div style="text-align: center; color: rgb(1, 0, 0); font-weight: bold;">ARTICLE XI</div>
      <div style="text-align: center; font-weight: bold;">COMPETITION AND CORPORATE OPPORTUNITIES</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 11.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Definitions</u></font><u>. For purposes of this Article XI:</u></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Affiliate&#8221; shall mean, with respect to any Person, any other Person that controls, is controlled by or is under common
        control with such Person;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; Affiliated Entity&#8221; shall mean (i) any Person (other than the Corporation and any Person that is controlled by the
        Corporation) of which a Non-Employee Director serves as a director, manager, officer, employee, agent or other representative, (ii) any direct or indirect partner, stockholder, member, manager or other representative of such Person or (iii) any
        Person that controls, is controlled by or is under common control with any of the foregoing, including any investment fund or vehicle under common management with any of the foregoing;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Identified Person&#8221; shall mean any Non-Employee Director or any of his or her Affiliates or Affiliated Entities;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Non-Employee Director&#8221; shall mean any director who is not an employee of the Corporation; and</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">9</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160; Person&#8221; shall mean any individual, corporation, general or limited partnership, limited liability company, joint venture,
        trust, association or any other entity.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 11.2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u></u><font style="font-weight: bold;"><u>Non-Employee Directors</u></font> . In recognition and anticipation that
        Non-Employee Directors and their respective Affiliates and Affiliated Entities may now or in the future engage (whether by investment, by providing services as a director or advisor or in any other capacity, or otherwise) in the same or similar
        activities or related lines of business as those in which the Corporation, directly or indirectly, may engage, or other business activities that overlap with or compete with those in which the Corporation, directly or indirectly, may engage, the
        provisions of this Article XI are set forth to regulate and define the conduct of certain affairs of the Corporation with respect to certain classes or categories of business opportunities as they may involve any of the Non-Employee Directors or
        their respective Affiliates and the powers, rights, duties and liabilities of the Corporation and its stockholders, directors and officers in connection therewith.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 11.3</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>No Duty to Refrain, Communicate or Offer</u></font>. To the fullest extent
        permitted by law, no Identified Person shall have any duty to refrain from directly or indirectly (a) engaging in the same or similar business activities or lines of business in which the Corporation or any of its Affiliates has historically
        engaged, now engages or proposes to engage at any time or (b) otherwise competing with the Corporation or any of its Affiliates, and, to the fullest extent permitted by applicable law, no Identified Person shall be liable to the Corporation or any
        of its stockholders or to any Affiliate of the Corporation for breach of any fiduciary duty solely by reason of the fact that such Identified Person engages in any such activities. To the fullest extent permitted by applicable law, the Corporation
        hereby renounces any interest or expectancy in, or right to be offered an opportunity to participate in, any transaction or business opportunity which may be a corporate opportunity for an Identified Person and for the Corporation or any of its
        Affiliates, except as provided in Section 11.4 of this Article XI. Subject to Section 11.4 of this Article XI, in the event that any Identified Person acquires knowledge of a potential transaction or business opportunity which may be a corporate
        opportunity for itself, herself or himself and for the Corporation or any of its Affiliates, such Identified Person shall, to the fullest extent permitted by applicable law, have no duty to communicate or offer such transaction or business
        opportunity to the Corporation or any of its Affiliates and, to the fullest extent permitted by applicable law, shall not be liable to the Corporation or any of its stockholders or to any Affiliate of the Corporation for breach of any fiduciary
        duty as a stockholder, director or officer of the Corporation solely by reason of the fact that such Identified Person pursues or acquires such corporate opportunity for itself, herself or himself, or offers or directs such corporate opportunity to
        another Person.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 11.4</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Business Opportunities</u></font>. In addition to and notwithstanding the
        foregoing provisions of this Article XI, a transaction or business opportunity shall not be deemed to be a corporate opportunity for the Corporation if it is a transaction or business opportunity (a) that the Corporation is not financially or
        legally able or contractually permitted to undertake, (b) that, by its nature, is not in the line of the Corporation&#8217;s business or is of no practical advantage to the Corporation or (c) in which the Corporation has no interest or reasonable
        expectancy.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">10</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 11.5</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Amendments</u></font>. Any amendment, repeal or modification of this Article
        XI, or adoption, amendment or modification of any other provision of this Amended and Restated Certificate (or of any Preferred Stock Designation) that is inconsistent with this Article XI, shall not eliminate or reduce the effect of this Article
        XI with respect to any transaction or business opportunity first identified or any other matter occurring, or any cause of action, suit or claim that, but for this Article XI, would accrue or arise, prior to such amendment, repeal, modification or
        adoption. This Article XI shall not limit any protections or defenses available to, or indemnification or advancement rights of, any director or officer of the Corporation under this Amended and Restated Certificate, the Bylaws or any other
        agreement or instrument by the Corporation or any of its subsidiaries providing for indemnification or advancement of expenses to such director or officer, or applicable law.</div>
      <div>&#160;</div>
      <div style="text-align: center; color: rgb(1, 0, 0); font-weight: bold;">ARTICLE XII</div>
      <div style="text-align: center; font-weight: bold;">Miscellaneous</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 12.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Severability</u></font>. If any provision or provisions (or any part thereof)
        of this Amended and Restated Certificate shall be held to be invalid, illegal or unenforceable as applied to any person, entity or circumstance for any reason whatsoever, then, to the fullest extent permitted by law, (i)&#8194;the validity, legality and
        enforceability of such provisions in any other circumstance and of the remaining provisions of this Amended and Restated Certificate (including, without limitation, each portion of any paragraph of this Amended and Restated Certificate containing
        any such provision held to be invalid, illegal or unenforceable that is not itself held to be invalid, illegal or unenforceable) and the application of such provision to other persons or entities and circumstances shall not in any way be affected
        or impaired thereby, and (ii) the provisions of this Amended and Restated Certificate (including, without limitation, each portion of any paragraph of this Amended and Restated Certificate containing any such provision held to be invalid, illegal
        or unenforceable) shall be construed so as to permit the Corporation to protect its directors, officers, employees and agents from personal liability in respect of their good faith service or for the benefit of the Corporation to the fullest extent
        permitted by law.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 12.2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Facts Ascertainable</u></font>. When the terms of this Amended and Restated
        Certificate refer to a specific agreement or other document or a decision by any body, person or entity to determine the meaning or operation of a provision hereof, the secretary of the Corporation shall maintain a copy of such agreement, document
        or decision at the principal executive offices of the Corporation and a copy thereof shall be provided free of charge to any stockholder of the Corporation who makes a request therefor.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">11</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">IN WITNESS WHEREOF, Focus Impact BH3 NewCo, Inc. has caused this Amended and Restated Certificate to be duly executed and acknowledged in its name and on its behalf by an authorized officer as of
        the date first set forth above.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z0dd3bea762894cc5b588712dcc4aba39">

          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td colspan="2" style="vertical-align: top;">
              <div>Focus Impact BH3 NewCo, Inc.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td style="width: 3%; vertical-align: top;"><br>
            </td>
            <td style="width: 47%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; padding-bottom: 2px;"><br>
            </td>
            <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
              <div>By:</div>
            </td>
            <td style="width: 47%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>/s/ Carl Stanton</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div>Name:</div>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div>Carl Stanton</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div>Title:</div>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div>Chief Executive Officer</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div><br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.2
<SEQUENCE>3
<FILENAME>ef20050548_ex3-2.htm
<DESCRIPTION>EXHIBIT 3.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; font-weight: bold;">Exhibit 3.2</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">AMENDED AND RESTATED BYLAWS</div>
      <div style="text-align: center; font-weight: bold;">OF</div>
      <div style="text-align: center; font-weight: bold;">FOCUS IMPACT BH3 NEWCO, INC.</div>
      <div style="text-align: center; font-weight: bold;">(THE &#8220;CORPORATION&#8221;)</div>
      <div>&#160;</div>
      <div style="text-align: center; color: rgb(1, 0, 0); font-weight: bold;">ARTICLE I</div>
      <div style="text-align: center; font-weight: bold;">OFFICES</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 1.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Registered Office</u></font>. The registered office of the Corporation within
        the State of Delaware shall be located at either (a) the principal place of business of the Corporation in the State of Delaware or (b) the office of the corporation or individual acting as the Corporation&#8217;s registered agent in Delaware.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(1, 0, 0);">Section 1.2</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-weight: bold;"><u>Additional
              Offices</u></font>. The Corporation may, in addition to its registered office in the State of Delaware, have such other offices and places of business, both within and outside the State of Delaware, as the Board of Directors of the
          Corporation (the &#8220;</font><font style="font-size: 10pt; font-weight: bold; font-style: italic;">Board</font><font style="font-size: 10pt;">&#8221;) may from time to time determine or as the business and affairs of the Corporation may require.</font></div>
      <div>&#160;</div>
      <div style="text-align: center; color: rgb(1, 0, 0); font-weight: bold;">ARTICLE II</div>
      <div style="text-align: center; font-weight: bold;">STOCKHOLDERS MEETINGS</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 2.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Annual Meetings</u></font>. The annual meeting of stockholders shall be held at
        such place, either within or without the State of Delaware, and at such time and on such date as shall be determined by the Board and stated in the notice of the meeting, provided that the Board may in its sole discretion determine that the meeting
        shall not be held at any place, but may instead be held solely by means of remote communication pursuant to Section 9.5(a). At each annual meeting, the stockholders entitled to vote on such matters shall elect those directors of the Corporation to
        fill any term of a directorship that expires on the date of such annual meeting and may transact any other business as may properly be brought before the meeting.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(1, 0, 0);">Section 2.2</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160; <u></u><font style="font-weight: bold;"><u>Special
              Meetings</u></font>. Subject to the rights of the holders of any outstanding series of the preferred stock of the Corporation (&#8220;</font><font style="font-size: 10pt; font-weight: bold; font-style: italic;">Preferred Stock</font><font style="font-size: 10pt;">&#8221;), and to the requirements of applicable law, special meetings of stockholders, for any purpose or purposes, may be called only by the chairperson of the Board (the &#8220;</font><font style="font-size: 10pt; font-weight: bold; font-style: italic;">Chairperson of the Board</font><font style="font-size: 10pt;">&#8221;), by the Chief Executive Officer, or by the Board pursuant to a resolution adopted by a majority of the Board. Special meetings of stockholders shall be
          held at such place, either within or without the State of Delaware, and at such time and on such date as shall be determined by the Board and stated in the Corporation&#8217;s notice of the meeting; provided that the Board may in its sole discretion
          determine that the meeting shall not be held at any place, but may instead be held solely by means of remote communication pursuant to Section 9.5(a).</font></div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-align: justify; text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(1, 0, 0);">Section 2.3</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Notices</u></font>.
          Notice of each stockholders meeting stating the place, if any, date, and time of the meeting, and the means of remote communication, if any, by which stockholders and proxy holders may be deemed to be present in person and vote at such meeting
          and the record date for determining the stockholders entitled to vote at the meeting, if such date is different from the record date for determining stockholders entitled to notice of the meeting, shall be given in the manner permitted by Section
          9.3 to each stockholder entitled to vote thereat as of the record date for determining the stockholders entitled to notice of the meeting, by the Corporation not less than 10 nor more than 60 days before the date of the meeting, unless otherwise
          required by the General Corporation Law of the State of Delaware (the &#8220;</font><font style="font-size: 10pt; font-weight: bold; font-style: italic;">DGCL</font><font style="font-size: 10pt;">&#8221;). If said notice is for a stockholders meeting other
          than an annual meeting, it shall in addition state the purpose or purposes for which the meeting is called, and the business transacted at such meeting shall be limited to the matters so stated in the Corporation&#8217;s notice of meeting (or any
          supplement thereto). Any meeting of stockholders as to which notice has been given may be postponed, and any special meeting of stockholders as to which notice has been given may be cancelled, by the Board upon public announcement (as defined in
          Section 2.7(c)) given before the date previously scheduled for such meeting.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(1, 0, 0);">Section 2.4</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Quorum</u></font>.
          Except as otherwise provided by applicable law, the Corporation&#8217;s Amended and Restated Certificate of Incorporation, as the same may be further amended or restated from time to time (the &#8220;</font><font style="font-size: 10pt; font-weight: bold; font-style: italic;">Certificate of Incorporation</font><font style="font-size: 10pt;">&#8221;), or these Amended and Restated Bylaws, as the same may be further amended or restated from time to time (these &#8220;</font><font style="font-size: 10pt; font-weight: bold; font-style: italic;">Bylaws</font><font style="font-size: 10pt;">&#8221;), the presence, in person or by proxy, at a stockholders meeting of the holders of shares of outstanding capital stock of the Corporation representing not less
          than thirty-three and a third percent (33 1/3%) of the voting power of all outstanding shares of capital stock of the Corporation entitled to vote at such meeting shall constitute a quorum for the transaction of business at such meeting, except
          that when specified business is to be voted on by a class or series of stock voting as a class, the holders of shares representing not less than thirty-three and a third percent (33 1/3%) of the voting power of the outstanding shares of such
          class or series shall constitute a quorum of such class or series for the transaction of such business. If a quorum shall not be present or represented by proxy at any meeting of the stockholders of the Corporation, the chairperson of the meeting
          may adjourn the meeting from time to time in the manner provided in Section 2.6 until a quorum shall attend. The stockholders present at a duly convened meeting may continue to transact business until adjournment, notwithstanding the withdrawal
          of enough stockholders to leave less than a quorum. Shares of its own stock belonging to the Corporation or to another corporation, if a majority of the voting power of the shares entitled to vote in the election of directors of such other
          corporation is held, directly or indirectly, by the Corporation, shall neither be entitled to vote nor be counted for quorum purposes; provided, however, that the foregoing shall not limit the right of the Corporation or any such other
          corporation to vote shares held by it in a fiduciary capacity.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 2.5</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Voting of Shares</u></font>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Voting Lists</u>. The officer who has charge of the stock ledger of the Corporation shall prepare, at least 10 days
        before every meeting of stockholders, a complete list of the stockholders of record entitled to vote at such meeting and showing the address and the number and class of shares registered in the name of each stockholder. Nothing contained in this <u>Section
          2.5(a)</u> shall require the Corporation to include electronic mail addresses or other electronic contact information on such list. Such list shall be open to the examination of any stockholder, for any purpose germane to the meeting, during
        ordinary business hours for a period of at least 10 days prior to the meeting: (i) on a reasonably accessible electronic network, provided that the information required to gain access to such list is provided with the notice of the meeting; or (ii)
        during ordinary business hours, at the principal place of business of the Corporation. In the event that the Corporation determines to make the list available on an electronic network, the Corporation may take reasonable steps to ensure that such
        information is available only to stockholders of the Corporation. If the meeting is to be held at a place, then the list shall be produced and kept at the time and place of the meeting during the whole time thereof, and may be inspected by any
        stockholder who is present. If a meeting of stockholders is to be held solely by means of remote communication as permitted by <u>Section 9.5(a)</u>, the list shall be open to the examination of any stockholder during the whole time of the meeting
        on a reasonably accessible electronic network, and the information required to access such list shall be provided with the notice of meeting. The stock ledger shall be the only evidence as to who are the stockholders entitled to examine the list
        required by this <u>Section 2.5(a)</u> or to vote in person or by proxy at any meeting of stockholders.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Manner of Voting</u>. At any stockholders meeting, every stockholder entitled to vote may vote in person or by proxy. If
        authorized by the Board, the voting by stockholders or proxy holders at any meeting conducted by remote communication may be effected by a ballot submitted by electronic transmission (as defined in <u>Section 9.3</u>), provided that any such
        electronic transmission must either set forth or be submitted with information from which the Corporation can determine that the electronic transmission was authorized by the stockholder or proxy holder. The Board, in its discretion, or the
        chairperson of the meeting of stockholders, in such person&#8217;s discretion, may require that any votes cast at such meeting shall be cast by written ballot.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(c)</font>&#160;&#160;&#160;&#160; &#160;&#160; <u>Proxies</u>. Each stockholder entitled to vote at a meeting of stockholders or to express consent or dissent to corporate
        action in writing without a meeting may authorize another person or persons to act for such stockholder by proxy, but no such proxy shall be voted or acted upon after three years from its date, unless the proxy provides for a longer period. Proxies
        need not be filed with the Secretary of the Corporation until the meeting is called to order, but shall be filed with the Secretary before being voted. Without limiting the manner in which a stockholder may authorize another person or persons to
        act for such stockholder as proxy, either of the following shall constitute a valid means by which a stockholder may grant such authority.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: rgb(1, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (i)&#8194;A stockholder may execute a writing authorizing another person or persons to act for such stockholder as proxy.
        Execution may be accomplished by the stockholder or such stockholder&#8217;s authorized officer, director, employee or agent signing such writing or causing such person&#8217;s signature to be affixed to such writing by any reasonable means, including, but not
        limited to, by facsimile or electronic signature.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: rgb(1, 0, 0);">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; (ii)&#8194;A stockholder may authorize another person or persons to act for such stockholder as proxy by transmitting or
        authorizing the transmission of an electronic transmission to the person who will be the holder of the proxy or to a proxy solicitation firm, proxy support service organization or like agent duly authorized by the person who will be the holder of
        the proxy to receive such transmission; provided that any such electronic transmission must either set forth or be submitted with information from which it can be determined that the electronic transmission was authorized by the stockholder. Any
        copy, facsimile telecommunication or other reliable reproduction of the writing or transmission authorizing another person or persons to act as proxy for a stockholder may be substituted or used in lieu of the original writing or transmission for
        any and all purposes for which the original writing or transmission could be used; provided that such copy, facsimile telecommunication or other reproduction shall be a complete reproduction of the entire original writing or transmission.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Required Vote</u>. Subject to the rights of the holders of one or more series of Preferred Stock, voting separately by
        class or series, to elect directors pursuant to the terms of one or more series of Preferred Stock, the election of directors shall be determined by a plurality of the votes cast by the stockholders present in person or represented by proxy at the
        meeting, in which such matter is being voted upon at which a quorum is present, and entitled to vote thereon. All other matters presented to the stockholders at a meeting at which a quorum is present shall be determined by the vote of a majority of
        the votes cast by the holders of common stock present in person or represented by proxy at the meeting and entitled to vote thereon, unless the matter is one upon which, by applicable law, the Certificate of Incorporation, these Bylaws or
        applicable stock exchange rules, a different vote is required, in which case such provision shall govern and control the decision of such matter. For purposes of this <u>Section 2.5(d)</u>, a majority of the votes cast shall mean that the number
        of shares voted &#8220;for&#8221; a matter exceeds the number of votes cast &#8220;against&#8221; such matter.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Inspectors of Election</u>. The Board may, and shall if required by law, in advance of any meeting of stockholders,
        appoint one or more persons as inspectors of election, who may be employees of the Corporation or otherwise serve the Corporation in other capacities, to act at such meeting of stockholders or any adjournment thereof and to make a written report
        thereof. The Board may appoint one or more persons as alternate inspectors to replace any inspector who fails to act. If no inspectors of election or alternates are appointed by the Board, the chairperson of the meeting shall appoint one or more
        inspectors to act at the meeting. Each inspector, before discharging his or her duties, shall take and sign an oath faithfully to execute the duties of inspector with strict impartiality and according to the best of his or her ability. The
        inspectors shall ascertain and report the number of outstanding shares and the voting power of each; determine the number of shares present in person or represented by proxy at the meeting and the validity of proxies and ballots; count all votes
        and ballots and report the results; determine and retain for a reasonable period a record of the disposition of any challenges made to any determination by the inspectors; and certify their determination of the number of shares represented at the
        meeting and their count of all votes and ballots. No person who is a candidate for an office at an election may serve as an inspector at such election. Each report of an inspector shall be in writing and signed by the inspector or by a majority of
        them if there is more than one inspector acting at such meeting. If there is more than one inspector, the report of a majority shall be the report of the inspectors.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 2.6</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Adjournments</u></font>. Any meeting of stockholders, annual or special, may be
        adjourned by the chairperson of the meeting (including due to a technical failure to convene or continue the meeting by remote communication), from time to time, whether or not there is a quorum, to reconvene at the same or some other place. Notice
        need not be given of any such adjourned meeting if the date, time, and place, if any, thereof, and the means of remote communication, if any, by which stockholders and proxy holders may be deemed to be present in person and vote at such adjourned
        meeting are announced at the meeting at which the adjournment is taken. At the adjourned meeting the stockholders, or the holders of any class or series of stock entitled to vote separately as a class, as the case may be, may transact any business
        that might have been transacted at the original meeting. If the adjournment is for more than 30 days, or if after the adjournment a new record date is fixed for the adjourned meeting, notice of the adjourned meeting shall be given to each
        stockholder of record entitled to vote at the meeting.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 2.7</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Advance Notice for Business</u></font>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Annual Meetings of Stockholders</u>. No business may be transacted at an annual meeting of stockholders, other than
        business that is either (i) specified in the Corporation&#8217;s notice of meeting (or any supplement thereto) given by or at the direction of the Board, (ii) otherwise properly brought before the annual meeting by or at the direction of the Board or
        (iii) otherwise properly brought before the annual meeting by any stockholder of the Corporation (x) who is a stockholder of record entitled to vote at such annual meeting on the date of the giving of the notice provided for in this <u>Section
          2.7(a)</u> and on the record date for the determination of stockholders entitled to vote at such annual meeting and (y) who complies with the notice procedures set forth in this <u>Section 2.7(a)</u>. Notwithstanding anything in this <u>Section
          2.7(a)</u> to the contrary, only persons nominated for election as a director to fill any term of a directorship that expires on the date of the annual meeting pursuant to <u>Section 3.2</u> will be considered for election at such meeting.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: rgb(1, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160; In addition to any other applicable requirements, for business (other than nominations) to be properly brought before an
        annual meeting by a stockholder, such stockholder must have given timely notice thereof in proper written form to the Secretary of the Corporation, or such other person as the Corporation may designate, and such business must otherwise be a proper
        matter for stockholder action. Subject to <u>Section 2.7(a)(iii)</u>, a stockholder&#8217;s notice to the Secretary with respect to such business, to be timely, must be received by the Secretary at the principal executive offices of the Corporation not
        later than the close of business on the 120th day nor earlier than the close of business on the 150th day before the first anniversary date of the immediately preceding annual meeting of stockholders; provided, however, that in the event that the
        annual meeting is advanced more than 30 days prior to such anniversary date or delayed more than 70 days after such anniversary date, notice by the stockholder to be timely must be so received not earlier than the close of business on the 150th day
        before the meeting and not later than the later of (x) the close of business on the 120th day before the meeting or (y) the close of business on the 10th day following the day on which public announcement of the date of the annual meeting is first
        made by the Corporation. The public announcement of an adjournment or postponement of an annual meeting shall not commence a new time period (or extend any time period) for the giving of a stockholder&#8217;s notice as described in this <u>Section
          2.7(a)</u>.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">5</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: rgb(1, 0, 0);">(ii)</font>&#160;&#160;&#160;&#160; &#160;&#160; &#160; To be in proper written form, a stockholder&#8217;s notice to the Secretary with respect to any business (other than
        nominations) must set forth as to each such matter such stockholder proposes to bring before the annual meeting (A) a brief description of the business desired to be brought before the annual meeting, the text of the proposal or business (including
        the text of any resolutions proposed for consideration and in the event such business includes a proposal to amend these Bylaws, the language of the proposed amendment) and the reasons for conducting such business at the annual meeting, (B) the
        name and record address of such stockholder and the name and address of the beneficial owner, if any, on whose behalf the proposal is made, (C) the class or series and number of shares of any capital stock of the Corporation that are owned
        beneficially and of record by such stockholder and the beneficial owner, if any, on whose behalf the proposal is made, (D) a description of all agreements, arrangements or understandings between such stockholder and the beneficial owner, if any, on
        whose behalf the proposal is made, any of their respective affiliates or associates and any other person or persons (including their names) in connection with the proposal of such business by such stockholder, (E) any material interest of such
        stockholder and the beneficial owner, if any, on whose behalf the proposal is made in such business, (F) a representation that such stockholder is a holder of record of the shares of capital stock entitled to vote at such meeting and intends to
        appear in person or by proxy at the annual meeting to bring such business before the meeting, (G) a description of all agreements, arrangements or understandings (including any derivative or short positions, profit interests, options, warrants,
        convertible securities, stock appreciation or similar rights, hedging transactions and borrowed or loaned shares) that have been entered into as of the date of the stockholder&#8217;s notice by, or on behalf of, such stockholder and the beneficial owner,
        if any, on whose behalf the proposal is made, whether or not such instrument or right shall be subject to settlement in underlying shares of stock, the effect or intent of which is to mitigate loss to, manage risk or benefit of share price changes
        for, or increase or decrease the voting power of, such stockholder or such beneficial owner, if any, with respect to securities of the Corporation, (H) a representation as to whether such stockholder or the beneficial owner, if any, on whose behalf
        the proposal is made has complied with all state and other legal requirements in connection with the stockholder&#8217;s and/or beneficial owner&#8217;s acquisition of shares of capital stock or other securities of the Corporation and/or the stockholder&#8217;s
        and/or beneficial owner&#8217;s acts or omissions as a stockholder of the Corporation, (I) any direct or indirect material interest or any material contract or agreement between such stockholder or the beneficial owner, if any, on whose behalf the
        proposal is made with the Corporation, any affiliate of the Corporation or any entity that provides products or services that compete with or are alternative to the principal products produces or services provided by the Corporation or its
        affiliates (a &#8220;<font style="font-weight: bold; font-style: italic;">Competitor</font>&#8221;) (including, in any such case, any employment agreement, collective bargaining agreement or consulting agreement), (J) any material pending or threatened legal
        proceeding in which such stockholder or the beneficial owner, if any, on whose behalf the proposal is made is a party or material participant involving the Corporation or any of its officers or directors, or any affiliate of the Corporation, (K)
        any other material relationship between such stockholder or the beneficial owner, if any, on whose behalf the proposal is made, on the one hand, and the Corporation, or any affiliate of the Corporation or any Competitor, on the other hand, and (L)
        any other information relating to such stockholder and the beneficial owner, if any, on whose behalf the proposal is made required to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies
        for such business pursuant to and in accordance with Section 14A of the Exchange Act of 1934, as amended (the &#8220;<font style="font-weight: bold; font-style: italic;">Exchange Act</font>&#8221;), and the rules and regulations promulgated thereunder, and (M)
        the written consent of such stockholder and the beneficial owner, if any, on whose behalf the proposal is made to the public disclosure of information provided to the Corporation pursuant to this <u>Section 2.7</u>.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">6</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: rgb(1, 0, 0);">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; The foregoing notice requirements of this <u>Section 2.7(a)</u> shall be deemed satisfied by a stockholder as to any
        proposal (other than nominations) if the stockholder has notified the Corporation of such stockholder&#8217;s intention to present such proposal at an annual meeting in compliance with Rule 14a-8 (or any successor thereof) of the Exchange Act and such
        stockholder has complied with the requirements of Rule 14a-8 for inclusion of such proposal in a proxy statement prepared by the Corporation to solicit proxies for such annual meeting. No business shall be conducted at the annual meeting of
        stockholders except business brought before the annual meeting in accordance with the procedures set forth in this <u>Section 2.7(a)</u>, provided, however, that once business has been properly brought before the annual meeting in accordance with
        such procedures, nothing in this <u>Section 2.7(a)</u> shall be deemed to preclude discussion by any stockholder of any such business. If the Board or the chairperson of the annual meeting determines that any stockholder proposal was not made in
        accordance with the provisions of this <u>Section 2.7(a)</u> or the Exchange Act or that the information provided in a stockholder&#8217;s notice does not satisfy the information requirements of this <u>Section 2.7(a)</u> or the Exchange Act, such
        proposal shall not be presented for action at the annual meeting. Notwithstanding the foregoing provisions of this <u>Section 2.7(a)</u>, if the stockholder (or a qualified representative of the stockholder) does not appear at the annual meeting
        of stockholders of the Corporation to present the proposed business, such proposed business shall not be transacted, notwithstanding that proxies in respect of such matter may have been received by the Corporation.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: rgb(1, 0, 0);">(iv)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; In addition to the provisions of this <u>Section 2.7(a)</u>, a stockholder shall also comply with all applicable
        requirements of the Exchange Act and the rules and regulations thereunder with respect to the matters set forth herein. Nothing in this <u>Section 2.7(a)</u> shall be deemed to affect any rights of stockholders to request inclusion of proposals in
        the Corporation&#8217;s proxy statement pursuant to Rule 14a-8 under the Exchange Act.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">7</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Special Meetings of Stockholders</u>. Only such business shall be conducted at a special meeting of stockholders as shall
        have been brought before the meeting pursuant to the Corporation&#8217;s notice of meeting. Nominations of persons for election to the Board may be made only at a special meeting of stockholders at which directors are to be elected pursuant to the
        Corporation&#8217;s notice of meeting pursuant to <u>Section 3.2</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Public Announcement</u>. For purposes of these Bylaws, &#8220;<font style="font-weight: bold; font-style: italic;">public
          announcement</font>&#8221; shall mean disclosure in a press release reported by the Dow Jones News Service, Associated Press or comparable national news service or in a document publicly filed or furnished by the Corporation with the Securities and
        Exchange Commission (the &#8220;<font style="font-weight: bold; font-style: italic;">Commission</font>&#8221;) pursuant to Section 13, 14 or 15(d) of the Exchange Act.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 2.8</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Conduct of Meetings</u></font>. The chairperson of each annual and special
        meeting of stockholders shall be the Chairperson of the Board, if any, or, in the absence (or inability or refusal to act) of the Chairperson of the Board, the Chief Executive Officer (if he or she shall be a director), if any, or, in the absence
        (or inability or refusal to act) of the Chief Executive Officer or if the Chief Executive Officer is not a director, the President (if he or she shall be a director), if any, or, in the absence (or inability or refusal to act) of the President or
        if the President is not a director, such other person as shall be appointed by the Board. The date and time of the opening and the closing of the polls for each matter upon which the stockholders will vote at a meeting shall be announced at the
        meeting by the chairperson of the meeting. The Board may adopt such rules and regulations for the conduct of the meeting of stockholders as it shall deem appropriate. Except to the extent inconsistent with these Bylaws or such rules and regulations
        as adopted by the Board, the chairperson of any meeting of stockholders shall have the right and authority to convene and to adjourn the meeting, to prescribe such rules, regulations and procedures and to do all such acts as, in the judgment of
        such chairperson, are appropriate for the proper conduct of the meeting. Such rules, regulations or procedures, whether adopted by the Board or prescribed by the chairperson of the meeting, may include, without limitation, the following: (a) the
        establishment of an agenda or order of business for the meeting; (b) rules and procedures for maintaining order at the meeting and the safety of those present; (c) limitations on attendance at or participation in the meeting to stockholders of
        record of the Corporation, their duly authorized and constituted proxies or such other persons as the chairperson of the meeting shall determine; (d) restrictions on entry to the meeting after the time fixed for the commencement thereof; and (e)
        limitations on the time allotted to questions or comments by participants. Unless and to the extent determined by the Board or the chairperson of the meeting, meetings of stockholders shall not be required to be held in accordance with the rules of
        parliamentary procedure. The secretary of each annual and special meeting of stockholders shall be the Secretary, if any, or, in the absence (or inability or refusal to act) of the Secretary, an Assistant Secretary so appointed to act by the
        chairperson of the meeting. In the absence (or inability or refusal to act) of the Secretary and all Assistant Secretaries, the chairperson of the meeting may appoint any person to act as secretary of the meeting.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">8</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; color: rgb(1, 0, 0); font-weight: bold;">ARTICLE III</div>
      <div style="text-align: center; font-weight: bold;">DIRECTORS</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 3.1</font>&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-weight: bold;"><u>Powers</u></font>. The business and affairs of the Corporation shall be managed
        by or under the direction of the Board, which may exercise all such powers of the Corporation and do all such lawful acts and things as are not by statute or by the Certificate of Incorporation or by these Bylaws required to be exercised or done by
        the stockholders. Directors need not be stockholders or residents of the State of Delaware.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 3.2</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-weight: bold;"><u>Advance Notice for Nomination of Directors</u></font>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160; Only persons who are nominated in accordance with the following procedures shall be eligible for election as directors of the
        Corporation, except as may be otherwise provided by the terms of one or more series of Preferred Stock with respect to the rights of holders of one or more series of Preferred Stock to elect directors. Nominations of persons for election to the
        Board at any annual meeting of stockholders, or at any special meeting of stockholders called for the purpose of electing directors as set forth in the Corporation&#8217;s notice of such special meeting, may be made (i) by or at the direction of the
        Board, or (ii) by any stockholder of the Corporation (x) who is a stockholder of record entitled to vote in the election of directors on the date of the giving of the notice provided for in this <u>Section 3.2</u> and on the record date for the
        determination of stockholders entitled to vote at such meeting and (y) who complies with the notice procedures set forth in this <u>Section 3.2</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160; &#160; In addition to any other applicable requirements, for a nomination to be made by a stockholder, such stockholder must have
        given timely notice thereof in proper written form to the Secretary of the Corporation. To be timely, a stockholder&#8217;s notice to the Secretary must be received by the Secretary at the principal executive offices of the Corporation (i) in the case of
        an annual meeting, not later than the close of business on the 120th day nor earlier than the close of business on the 150th day before the first anniversary date of the immediately preceding annual meeting of stockholders; provided, however, that
        in the event that the annual meeting is advanced more than 30 days prior to such anniversary date or delayed more than 70 days after such anniversary date, notice by the stockholder to be timely must be so received not earlier than the close of
        business on the 150th day before the meeting and not later than the later of (x) the close of business on the 120th day before the meeting or (y) the close of business on the 10th day following the day on which public announcement of the date of
        the annual meeting was first made by the Corporation; and (ii) in the case of a special meeting of stockholders called for the purpose of electing directors, not later than the close of business on the 10th day following the day on which public
        announcement of the date of the special meeting is first made by the Corporation. In no event shall the public announcement of an adjournment or postponement of an annual meeting or special meeting commence a new time period (or extend any time
        period) for the giving of a stockholder&#8217;s notice as described in this <u>Section 3.2</u>.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">9</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; Notwithstanding anything in paragraph (b) of this <u>Section 3.2</u> to the contrary, in the event that the number of
        directors to be elected to the Board at an annual meeting is greater than the number of directors whose terms expire on the date of the annual meeting and there is no public announcement by the Corporation naming all of the nominees for the
        additional directors to be elected or specifying the size of the increased Board before the close of business on the 120th day prior to the anniversary date of the immediately preceding annual meeting of stockholders, a stockholder&#8217;s notice
        required by this <u>Section 3.2</u> shall also be considered timely, but only with respect to nominees for the additional directorships created by such increase that are to be filled by election at such annual meeting, if it shall be received by
        the Secretary at the principal executive offices of the Corporation not later than the close of business on the 10th day following the date on which such public announcement was first made by the Corporation.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160; To be in proper written form, a stockholder&#8217;s notice to the Secretary must set forth (i) as to each person whom the
        stockholder proposes to nominate for election as a director (A) the name, age, business address and residence address of the person, (B) the principal occupation or employment of the person, (C) the class or series and number of shares of any
        capital stock of the Corporation that are owned beneficially or of record by the person, (D) the person&#8217;s written consent (x) to being named in the proxy statement, proxy card and ballot as a nominee and to serving as a director of the Corporation
        if elected and (y) the Corporation&#8217;s engaging in a background check of such person (including through a third party investigation firm), in a manner consistent with background checks customarily engaged in by the Corporation for prospective new
        members of the Board, (E) the information reasonably necessary to complete such background check, (F) all other information relating to the person that would be required to be disclosed in a proxy statement or other filings required to be made in
        connection with solicitations of proxies for election of directors pursuant to <u>Section 14</u> of the Exchange Act and the rules and regulations promulgated thereunder, including, without limitation, the requirements of Rule 14a-19, and (G) such
        other information regarding the person as may reasonably be requested by the Board in writing prior to the meeting of stockholders at which such candidate&#8217;s nomination is to be acted upon in order for the Board to determine the eligibility of such
        candidate for nomination to be an independent director of the Corporation in accordance with listing requirements and applicable stock exchange rules; (ii) with respect to each nominee for election to the Board, the completed and signed
        questionnaire, representation and agreement required by <u>Section 3.3</u> of these Bylaws; and (iii) as to the stockholder giving the notice (A) the name and record address of such stockholder as they appear in the Corporation&#8217;s books and the
        name and address of the beneficial owner, if any, on whose behalf the nomination is made, (B) the class or series and number of shares of capital stock of the Corporation that are owned beneficially and of record by such stockholder and the
        beneficial owner, if any, on whose behalf the nomination is made, (C) a description of all agreements, arrangements or understandings relating to the nomination to be made by such stockholder among such stockholder, the beneficial owner, if any, on
        whose behalf the nomination is made, any of such stockholder&#8217;s and/or beneficial owner&#8217;s respective affiliates or associates, each proposed nominee and any other person or persons (including their names), (D) a description of all agreements,
        arrangements or understandings (including any derivative or short positions, profit interests, options, warrants, convertible securities, stock appreciation or similar rights, hedging transactions, and borrowed or loaned shares) that have been
        entered into as of the date of such stockholder&#8217;s notice by, or on behalf of, such stockholder and the beneficial owner, if any, on whose behalf the nomination is made, whether or not such instrument or right shall be subject to settlement in
        underlying shares of stock, the effect or intent of which is to mitigate loss to, manage risk or benefit of share price changes for, or increase or decrease the voting power of, such stockholder or such beneficial owner, if any, with respect to
        securities of the Corporation, (E) a representation that such stockholder is a holder of record of the shares of capital stock entitled to vote at such meeting and intends to appear in person or by proxy at the meeting to nominate the persons named
        in its notice, (F) a representation whether such stockholder or the beneficial owner, if any, on whose behalf the nomination is made intends or is part of a group which intends to (x) solicit proxies or votes from stockholders in support of such
        proposed nomination and/or (y) solicit proxies in support of such proposed nomination of persons for election to the Board other than the Corporation&#8217;s nominees for election to the Board from the holders of capital stock of the Corporation
        representing at least sixty-seven percent (67%) of the voting power of the capital stock entitled to vote generally in the election of directors in accordance with Rule 14a-19 of the Exchange Act, (G) a representation as to whether such stockholder
        or the beneficial owner, if any, on whose behalf the nomination is made has complied with all state and other legal requirements in connection with the stockholder&#8217;s and/or beneficial owner&#8217;s acquisition of shares of capital stock or other
        securities of the Corporation and/or the stockholder&#8217;s and/or beneficial owner&#8217;s acts or omissions as a stockholder of the Corporation, (H) any direct or indirect material interest or any material contract or agreement between such stockholder or
        beneficial owner, if any, on whose behalf the nomination is made with the Corporation, any affiliate of the Corporation or any Competitor (including, in any such case, any employment agreement, collective bargaining agreement or consulting
        agreement), (I) any material pending or threatened legal proceeding in which such stockholder or the beneficial owner, if any, on whose behalf the nomination is made is a party or material participant involving the Corporation or any of its
        officers or directors, or any affiliate of the Corporation, (J) any other material relationship between such stockholder or the beneficial owner, if any, on whose behalf the nomination is made, on the one hand, and the Corporation, or any affiliate
        of the Corporation or any Competitor, on the other hand, (K) any other information relating to (i) such stockholder and the beneficial owner, if any, on whose behalf the nomination is made, and (ii) each person whom the stockholder proposes to
        nominate for election as a director that would be required to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies for election of directors pursuant to <u>Section 14</u> of the
        Exchange Act and the rules and regulations promulgated thereunder and (L) the written consent of such stockholder and the beneficial owner, if any, on whose behalf the nomination is made to public disclosure of information provided to the
        Corporation pursuant to this <u>Section 3.2</u>.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">10</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(e)</font>&#160;&#160;&#160;&#160;&#160; &#160; If the Board or the chairperson of the meeting of stockholders determines that any nomination was not made in accordance with
        the provisions of this <u>Section 3.2</u> or the Exchange Act, including, without limitation, Rule 14a-19, or that the information provided in a stockholder&#8217;s notice does not satisfy the information requirements of this <u>Section 3.2</u> or the
        Exchange Act, then such nomination shall not be considered at the meeting in question. Notwithstanding the foregoing provisions of this <u>Section 3.2</u>, if the stockholder (or a qualified representative of the stockholder) (i) fails to comply
        with the requirements of Rule 14a-19(a)(2) or Rule 14a-19(a)(3) under the Exchange Act or (ii) does not appear at the meeting of stockholders of the Corporation to present the nomination, such nomination shall be disregarded, notwithstanding that
        proxies in respect of such nomination may have been received by the Corporation.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160; In addition to the provisions of this <u>Section 3.2</u>, a stockholder shall also comply with all of the applicable
        requirements of the Exchange Act and the rules and regulations thereunder, including, without limitation, Rule 14a-19, with respect to the matters set forth herein, and if any stockholder provides notice pursuant to Rule 14a-19(b) under the
        Exchange Act, such stockholder shall deliver to the Corporation, no later than five (5) business days prior to the applicable meeting, reasonable evidence that it has met the requirements of Rule 14a-19(a)(3) under the Exchange Act.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 3.3</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Submission of Questionnaire, Representation and Agreement</u></font>. To be
        eligible to be a nominee for election as a director of the Corporation, the candidate for nomination must have previously delivered (in accordance with the time periods prescribed for delivery of notice under Section 3.2 of these Bylaws), to the
        Secretary at the principal executive offices of the Corporation, (a) a completed written questionnaire (in a form provided by the Corporation) with respect to the background, qualifications, stock ownership and independence of such proposed
        nominee, (b) a written representation and agreement (in the form provided by the Corporation) that such candidate for nomination (i) unless previously disclosed to the Corporation, the nominee is not and will not become a party to any voting
        agreement, arrangement or understanding with any person or entity as to how such nominee, if elected as a director, will vote on any issue or that could interfere with such person&#8217;s ability to comply, if elected as a director, with his/her
        fiduciary duties under applicable law, (ii) is not, and will not become a party to, any agreement, arrangement or understanding with any person or entity other than the Corporation with respect to any direct or indirect compensation or
        reimbursement for service as a director, and (iii) if elected as a director of the Corporation, will comply with all applicable corporate governance, conflict of interest, confidentiality, stock ownership and trading and other policies and
        guidelines of the Corporation applicable to directors and in effect during such person&#8217;s term in office as a director of the Corporation (and, if requested by any candidate for nomination, the Secretary of the Corporation shall provide to such
        candidate for nomination all such policies and guidelines then in effect). At the request of the Board, any person nominated by the Board for election as a director shall furnish to the Secretary of the Corporation the information that is required
        to be set forth in a stockholder&#8217;s notice of nomination that pertains to the nominee (as if such nominee were the stockholder), as set forth in Section 3.2(d).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 3.4</font>&#160;&#160;&#160; &#160;&#160; <font style="font-weight: bold;"><u>Proxy Card</u></font>. Any stockholder directly or indirectly soliciting proxies
        from other stockholders (other than on behalf the Corporation) must use a proxy card color other than white, which shall be reserved for exclusive use by the Corporation.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 3.5</font>&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-weight: bold;"><u>Compensation</u></font>. Unless otherwise restricted by the Certificate of
        Incorporation or these Bylaws, the Board shall have the authority to fix the compensation of directors. The directors may be reimbursed their expenses, if any, of attendance at each meeting of the Board, including for service on a committee of the
        Board, and may be paid either a fixed sum for attendance at each meeting of the Board or other compensation as director. No such payment shall preclude any director from serving the Corporation in any other capacity and receiving compensation
        therefor. Members of committees of the Board may be allowed like compensation and reimbursement of expenses for service on the committee.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">11</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 3.6</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Chairperson of the Board</u></font>. The Chairperson of the Board shall be a
        member of the Board and may or may not be an officer and/or employee of the Corporation. The Chairperson of the Board, if any, shall preside when present at all meetings of the stockholders and the Board. The Chairperson of the Board shall have
        general supervision and control of the acquisition activities of the Corporation subject to the ultimate authority of the Board, and shall be responsible for the execution of the policies of the Board with respect to such matters. In the absence
        (or inability or refusal to act) of the Chairperson of the Board, the Chief Executive Officer (if he or she shall be a director) shall preside when present at all meetings of the stockholders and the Board. The powers and duties of the Chairperson
        of the Board shall not include supervision or control of the preparation of the financial statements of the Corporation (other than through participation as a member of the Board). The position of Chairperson of the Board and Chief Executive
        Officer may be held by the same person.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(1, 0, 0);">Section 3.7</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Lead
              Independent Director</u></font>. If at any time the Chairperson of the Board is not independent as that term is defined under the then applicable rules and regulations of each national securities exchange upon which shares of the stock of the
          Corporation are listed for trading and of the Commission, the independent directors may designate from among them a lead independent director (the &#8220;</font><font style="font-size: 10pt; font-weight: bold; font-style: italic;">Lead Independent
          Director</font><font style="font-size: 10pt;">&#8221;) having the duties and responsibilities determined by the Board from time to time.</font></div>
      <div>&#160;</div>
      <div style="text-align: center; color: rgb(1, 0, 0); font-weight: bold;">ARTICLE IV</div>
      <div style="text-align: center; font-weight: bold;">BOARD MEETINGS</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 4.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Annual Meetings</u></font>. The Board shall meet as soon as practicable after
        the adjournment of each annual stockholders meeting at the place of the annual stockholders meeting or, if such meeting is held solely by means of remote communication, then by means of remote communication, unless the Board shall fix another time
        and place and give notice thereof in the manner required herein for special meetings of the Board. No notice to the directors shall be necessary to legally convene this meeting, except as provided in this Section 4.1.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 4.2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Regular Meetings</u></font>. Regularly scheduled, periodic meetings of the Board
        may be held without notice at such times, dates and places (within or without the State of Delaware) as shall from time to time be determined by the Board, provided that the Board may in its sole discretion determine that the meeting shall not be
        held at any place, but may instead be held solely by means of remote communication pursuant to Section 9.5(b).</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">12</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 4.3</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Special Meetings</u></font>. Special meetings of the Board (a) may be called by
        the Chairperson of the Board, Lead Independent Director, Chief Executive Officer or President and (b) shall be called by the Chairperson of the Board, Lead Independent Director, Chief Executive Officer, President or Secretary on the written request
        of at least a majority of directors then in office, or the sole director, as the case may be, and shall be held at such time, date and place (within or without the State of Delaware) as may be determined by the person calling the meeting or, if
        called upon the request of directors or the sole director, as specified in such written request. Notice of each special meeting of the Board shall be given to each director (i) at least 24 hours before the meeting if such notice is oral notice
        given personally or by telephone or written notice given by hand delivery or by means of a form of electronic transmission and delivery; (ii) at least two days before the meeting if such notice is sent by a nationally recognized overnight delivery
        service; and (iii) at least five days before the meeting if such notice is sent through the United States mail. If the Secretary shall fail or refuse to give such notice, then the notice may be given by the officer who called the meeting or the
        directors who requested the meeting. Any and all business that may be transacted at a regular meeting of the Board may be transacted at a special meeting. Except as may be otherwise expressly provided by applicable law, the Certificate of
        Incorporation, or these Bylaws, neither the business to be transacted at, nor the purpose of, any special meeting need be specified in the notice or waiver of notice of such meeting. A special meeting may be held at any time without notice if all
        the directors are present or if those not present waive notice of the meeting in accordance with Section 9.4.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 4.4</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Quorum; Required Vote</u></font>. A majority of the Board shall constitute a
        quorum for the transaction of business at any meeting of the Board, and the act of a majority of the directors present at any meeting at which there is a quorum shall be the act of the Board, except as may be otherwise specifically provided by
        applicable law, the Certificate of Incorporation or these Bylaws. If a quorum shall not be present at any meeting, a majority of the directors present may adjourn the meeting from time to time, without notice other than announcement at the meeting,
        until a quorum is present.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 4.5</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Consent In Lieu of Meeting</u></font>. Unless otherwise provided in the
        Certificate of Incorporation or these Bylaws, any action required or permitted to be taken at any meeting of the Board or of any committee thereof may be taken without a meeting, if all the members of the Board or such committee, as the case may
        be, consent thereto in writing or by electronic transmission. Any person, whether or not then a director, may provide, through instruction to an agent or otherwise, that a consent to action will be effective at a future time (including a time
        determined upon the happening of an event) no later than sixty (60) days after such instruction is given or such provision is made and such consent shall be deemed to have been given at such effective time so long as such person is then a director
        and did not revoke the consent prior to such time. Any such consent shall be revocable prior to its becoming effective. After an action is taken, the consent or consents relating thereto shall be filed with the minutes of the proceedings of the
        Board, or the committee thereof, in the same paper or electronic form as the minutes are maintained.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 4.6</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Organization</u></font>. The chairperson of each meeting of the Board shall be
        the Chairperson of the Board, if any, or, in the absence (or inability or refusal to act) of the Chairperson of the Board, the Lead Independent Director, if any, or, in the absence (or inability or refusal to act) of the Lead Independent Director,
        the Chief Executive Officer, if any (if he or she shall be a director), or, in the absence (or inability or refusal to act) of the Chief Executive Officer or if the Chief Executive Officer is not a director, the President, if any (if he or she
        shall be a director), or in the absence (or inability or refusal to act) of the President or if the President is not a director, a chairperson elected from the directors present. The Secretary, if any, shall act as secretary of all meetings of the
        Board. In the absence (or inability or refusal to act) of the Secretary, an Assistant Secretary, if any, shall perform the duties of the Secretary at such meeting. In the absence (or inability or refusal to act) of the Secretary and all Assistant
        Secretaries, the chairperson of the meeting may appoint any person to act as secretary of the meeting.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">13</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; color: rgb(1, 0, 0); font-weight: bold;">ARTICLE V</div>
      <div style="text-align: center; font-weight: bold;">COMMITTEES OF DIRECTORS</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 5.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Establishment</u></font>. The Board may by resolution passed by a majority of
        the Board designate one or more committees, each committee to consist of one or more of the directors of the Corporation. Each committee shall keep regular minutes of its meetings and report the same to the Board when required. The Board shall have
        the power at any time to fill vacancies in, to change the membership of, or to dissolve any such committee.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 5.2</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Available Powers</u></font>. Any committee established pursuant to Section 5.1
        hereof, to the extent permitted by applicable law and by resolution of the Board, shall have and may exercise all of the powers and authority of the Board in the management of the business and affairs of the Corporation, and may authorize the seal
        of the Corporation to be affixed to all papers that may require it.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 5.3</font>&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-weight: bold;"><u>Alternate Members</u></font>. The Board may designate one or more directors as
        alternate members of any committee, who may replace any absent or disqualified member at any meeting of such committee.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 5.4</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Procedures</u></font>. Unless the Board otherwise provides, the time, date,
        place, if any, and notice of meetings of a committee shall be determined by such committee. At meetings of a committee, a majority of the number of members of the committee (but not including any alternate member, unless such alternate member has
        replaced any absent or disqualified member at the time of, or in connection with, such meeting) shall constitute a quorum for the transaction of business. The act of a majority of the members present at any meeting at which a quorum is present
        shall be the act of the committee, except as otherwise specifically provided by applicable law, the Certificate of Incorporation, these Bylaws or the Board. If a quorum is not present at a meeting of a committee, the members present may adjourn the
        meeting from time to time, without notice other than an announcement at the meeting, until a quorum is present. Unless the Board otherwise provides and except as provided in these Bylaws, each committee designated by the Board may make, alter,
        amend and repeal rules for the conduct of its business. In the absence of such rules each committee shall conduct its business in the same manner as the Board is authorized to conduct its business pursuant to Article III and Article IV of these
        Bylaws.</div>
      <div>&#160;</div>
      <div style="text-align: center; color: rgb(1, 0, 0); font-weight: bold;">ARTICLE VI</div>
      <div style="text-align: center; font-weight: bold;">OFFICERS</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 6.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Officers</u></font>. The officers of the Corporation elected by the Board shall
        be a Chief Executive Officer and such other officers (which may include, without limitation, a Chief Financial Officer, a Secretary, a President, Vice Presidents, Assistant Secretaries and a Treasurer) as the Board from time to time may determine.
        Officers elected by the Board shall each have such powers and duties as generally pertain to their respective offices, subject to the specific provisions of this Article VI. Such officers shall also have such powers and duties as from time to time
        may be conferred by the Board. The Chief Executive Officer or President may also appoint such other officers (which may include, without limitation, one or more Vice Presidents and Controllers) as may be necessary or desirable for the conduct of
        the business of the Corporation. Such other officers shall have such powers and duties and shall hold their offices for such terms as may be provided in these Bylaws or as may be prescribed by the Board or, if such officer has been appointed by the
        Chief Executive Officer or President, as may be prescribed by the appointing officer.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">14</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>Chief Executive Officer</u>. The Chief Executive Officer shall be the chief executive officer of the Corporation, shall
        have general supervision of the affairs of the Corporation and general control of all of its business subject to the ultimate authority of the Board, and shall be responsible for the execution of the policies of the Board with respect to such
        matters, except to the extent any such powers and duties have been prescribed to the Chairperson of the Board pursuant to <u>Section 3.7</u> above. In the absence (or inability or refusal to act) of both the Chairperson of the Board and the Lead
        Independent Director, the Chief Executive Officer (if he or she shall be a director) shall preside when present at all meetings of the stockholders and the Board. The position of Chief Executive Officer and President may be held by the same person.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(b)</font>&#160;&#160; &#160;&#160;&#160;&#160; <u>President</u>. The President, if any, shall make recommendations to the Chief Executive Officer on all operational
        matters that would normally be reserved for the final executive responsibility of the Chief Executive Officer. In the absence (or inability or refusal to act) of the Chairperson of the Board and Chief Executive Officer, the President (if he or she
        shall be a director) shall preside when present at all meetings of the stockholders and the Board. The President shall also perform such duties and have such powers as shall be designated by the Board. The position of President and Chief Executive
        Officer may be held by the same person.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Vice Presidents</u>. In the absence (or inability or refusal to act) of the President, the Vice President, if any (or in
        the event there be more than one Vice President, the Vice Presidents in the order designated by the Board), shall perform the duties and have the powers of the President. Any one or more of the Vice Presidents may be given an additional designation
        of rank or function.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Secretary.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: rgb(1, 0, 0);">(i)</font>&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; The Secretary, if any, shall attend all meetings of the stockholders, the Board and (as required) committees of the Board
        and shall record the proceedings of such meetings in books to be kept for that purpose. The Secretary shall give, or cause to be given, notice of all meetings of the stockholders and special meetings of the Board and shall perform such other duties
        as may be prescribed by the Board, the Chairperson of the Board, Chief Executive Officer or President.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: rgb(1, 0, 0);">(ii)</font>&#160;&#160;&#160;&#160; &#160; &#160;&#160; The Secretary, if any, shall keep, or cause to be kept, at the principal executive office of the Corporation or at the
        office of the Corporation&#8217;s transfer agent or registrar, if one has been appointed, a stock ledger, or duplicate stock ledger, showing the names of the stockholders and their addresses, and the number and classes of shares held by each.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">15</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(e)</font>&#160;&#160;&#160;&#160; &#160;&#160; <u>Assistant Secretaries</u>. The Assistant Secretary, if any, or, if there be more than one, the Assistant Secretaries in
        the order determined by the Board shall, in the absence (or inability or refusal to act) of the Secretary, perform the duties and have the powers of the Secretary.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Chief Financial Officer</u>. The Chief Financial Officer, if any, shall perform all duties commonly incident to that
        office (including, without limitation, in respect of the care and custody of the funds and securities of the Corporation, including the deposit of the funds of the Corporation in such banks or trust companies as the Board, the Chief Executive
        Officer or the President may authorize).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(g)</font>&#160;&#160;&#160;&#160;&#160; &#160; <u>Treasurer</u>. The Treasurer, if any, shall, in the absence (or inability or refusal to act) of the Chief Financial
        Officer, perform the duties and exercise the powers of the Chief Financial Officer.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 6.2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Term of Office; Removal; Vacancies</u></font>. The elected officers of the
        Corporation shall be appointed by the Board and shall hold office until their successors are duly elected and qualified by the Board or until their earlier death, resignation, retirement, disqualification or removal from office. Any officer may be
        removed, with or without cause, at any time by the Board. Any officer appointed by the Chief Executive Officer or President may also be removed, with or without cause, by the Chief Executive Officer or President, as the case may be, unless the
        Board otherwise provides. Any vacancy occurring in any elected office of the Corporation may be filled by the Board. Any vacancy occurring in any office appointed by the Chief Executive Officer or President may be filled by the Chief Executive
        Officer, or President, as the case may be, unless the Board then determines that such office shall thereupon be elected by the Board, in which case the Board shall elect such officer.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 6.3</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Other Officers</u></font>. The Board may delegate the power to appoint such
        other officers and agents, and may also remove such officers and agents or delegate the power to remove same, as it shall from time to time deem necessary or desirable.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 6.4</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Multiple Officeholders; Stockholder and Director Officers</u></font>. Any number
        of offices may be held by the same person unless the Certificate of Incorporation or these Bylaws otherwise provide. Officers need not be stockholders or residents of the State of Delaware.</div>
      <div>&#160;</div>
      <div style="text-align: center; color: rgb(1, 0, 0); font-weight: bold;">ARTICLE VII</div>
      <div style="text-align: center; font-weight: bold;">SHARES</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 7.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Uncertificated Shares</u></font>. The shares of any class or series of capital
        stock of the Corporation shall be uncertificated and registered in book-entry form.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">16</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 7.2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Multiple Classes of Stock</u></font>. If the Corporation shall be authorized to
        issue more than one class of stock or more than one series of any class, the Corporation shall, within a reasonable time after the issuance or transfer of such shares, send to the registered owner thereof a written notice containing a summary of
        the powers, designations, preferences and relative, participating, optional or other special rights of each class of stock or series thereof and the qualifications, limitations or restrictions of such preferences and/or rights; provided, however,
        that, except as otherwise provided by applicable law, in lieu of the foregoing requirements, there may be set forth on such written notice a statement that the Corporation will furnish without charge to each stockholder who so requests the powers,
        designations, preferences and relative, participating, optional or other special rights of each class of stock or series thereof and the qualifications, limitations or restrictions of such preferences or rights.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 7.3</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Consideration and Payment for Shares</u></font>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Subject to applicable law and the Certificate of Incorporation, shares of stock may be issued for such consideration, having
        in the case of shares with par value a value not less than the par value thereof, and to such persons, as determined from time to time by the Board. The consideration may consist of any tangible or intangible property or any benefit to the
        Corporation including cash, promissory notes, services performed, contracts for services to be performed or other securities, or any combination thereof.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; Subject to applicable law and the Certificate of Incorporation, shares may not be issued until the full amount of the
        consideration has been paid, unless upon the books and records of the Corporation, there shall have been set forth the total amount of the consideration to be paid therefor and the amount paid thereon up to and including the time said shares are
        issued.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 7.4</font>&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-weight: bold;"><u>Transfer of Stock</u></font>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; Subject to the restrictions set forth in <u>Section 7.6</u>, all transfers of shares shall be made on the books of the
        Corporation, by the holder of the shares, in person or by his or her attorney, in such manner as the Board may prescribe and subject to any applicable law, rule or regulation. The Corporation shall be entitled to treat the holder of record of any
        shares of its capital stock as the holder in fact thereof and, accordingly, shall not be bound to recognize any equitable or other claim to or interest in such share or on the part of any other person, whether or not it shall have express or other
        notice thereof, except as otherwise provided by the laws of the State of Delaware.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; Whenever any transfer of shares shall be made for collateral security and not absolutely, the Corporation shall so record
        such fact in the entry of transfer if, when the instruction for registration of transfer thereof is presented to the Corporation, both the transferor and transferee request the Corporation to do so.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 7.5</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Registered Stockholders</u></font>. Before due presentment of an instruction
        requesting registration of transfer of uncertificated shares, the Corporation may treat the registered owner as the person exclusively entitled to inspect for any proper purpose the stock ledger and the other books and records of the Corporation,
        vote such shares, receive dividends or notifications with respect to such shares and otherwise exercise all the rights and powers of the owner of such shares, except that a person who is the beneficial owner of such shares (if held in a voting
        trust or by a nominee on behalf of such person) may, upon providing documentary evidence of beneficial ownership of such shares and satisfying such other conditions as are provided under applicable law, may also so inspect the books and records of
        the Corporation.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">17</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 7.6</font>&#160;&#160;&#160; &#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Effect of the Corporation&#8217;s Restriction on Transfer</u></font>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(a) A written restriction on the transfer or registration of transfer of shares of the Corporation or on the amount of shares of the Corporation that may be owned by any person or group of persons,
        if permitted by the DGCL and contained in a notice, offering circular or prospectus sent by the Corporation to the registered owner of such shares within a reasonable time prior to or after the issuance or transfer of such shares, may be enforced
        against the holder of such shares or any successor or transferee of the holder, including an executor, administrator, trustee, guardian or other fiduciary entrusted with like responsibility for the person or estate of the holder.</div>
      <div style="text-align: justify;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(b) A restriction imposed by the Corporation on the transfer or the registration of shares of the Corporation or on the amount of shares of the Corporation that may be owned by any person or group
        of persons, even if otherwise lawful, is ineffective against a person without actual knowledge of such restriction unless such restriction was contained in a notice, offering circular or prospectus sent by the Corporation to the registered owner of
        such shares prior to or within a reasonable time after the issuance or transfer of such shares.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 7.7</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Regulations</u></font>. The Board shall have power and authority to make such
        additional rules and regulations, subject to any applicable requirement of law, as the Board may deem necessary and appropriate with respect to the issue, transfer or registration of transfer of shares of stock or certificates representing shares.
        The Board may appoint one or more transfer agents or registrars.</div>
      <div>&#160;</div>
      <div style="text-align: center; color: rgb(1, 0, 0); font-weight: bold;">ARTICLE VIII</div>
      <div style="text-align: center; font-weight: bold;">INDEMNIFICATION</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(1, 0, 0);">Section 8.1</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Right to
              Indemnification</u></font>. To the fullest extent permitted by applicable law, as the same exists or may hereafter be amended, the Corporation shall indemnify and hold harmless each person who was or is made a party or is threatened to be
          made a party to or is otherwise involved in any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (hereinafter a &#8220;</font><font style="font-size: 10pt; font-weight: bold; font-style: italic;">Proceeding</font><font style="font-size: 10pt;">&#8221;), by reason of the fact that he or she is or was a director or officer of the Corporation or, while a director or officer of the Corporation, is or was serving at the request
          of the Corporation as a director, officer, employee or agent of another corporation or of a partnership, joint venture, trust, other enterprise or nonprofit entity, including service with respect to an employee benefit plan (hereinafter an &#8220;</font><font style="font-size: 10pt; font-weight: bold; font-style: italic;">Indemnitee</font><font style="font-size: 10pt;">&#8221;), whether the basis of such Proceeding is alleged action in an official capacity as a director, officer, employee or agent, or in
          any other capacity while serving as a director, officer, employee or agent, against all liability and loss suffered and expenses (including, without limitation, attorneys&#8217; fees, judgments, fines, Employment Retirement Income Security Act of 1974
          excise taxes and penalties and amounts paid in settlement) reasonably incurred by such Indemnitee in connection with such Proceeding; provided, however, that, except as provided in Section 8.3 with respect to Proceedings to enforce rights to
          indemnification, the Corporation shall indemnify an Indemnitee in connection with a Proceeding (or part thereof) initiated by such Indemnitee only if such Proceeding (or part thereof) was authorized by the Board.</font></div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">18</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(1, 0, 0);">Section 8.2</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-weight: bold;"><u>Right to
              Advancement of Expenses</u></font></font><font style="font-size: 10pt; font-weight: bold;">.</font><font style="font-size: 10pt;"> In addition to the right to indemnification conferred in Section 8.1, an Indemnitee shall also have the right
          to be paid by the Corporation to the fullest extent not prohibited by applicable law the expenses (including, without limitation, attorneys&#8217; fees) incurred in defending or otherwise participating in any such Proceeding in advance of its final
          disposition (hereinafter an &#8220;</font><font style="font-size: 10pt; font-weight: bold; font-style: italic;">advancement of expenses</font><font style="font-size: 10pt;">&#8221;); provided, however, that, if the DGCL requires, an advancement of expenses
          incurred by an Indemnitee in his or her capacity as a director or officer of the Corporation (and not in any other capacity in which service was or is rendered by such Indemnitee, including, without limitation, service to an employee benefit
          plan) shall be made only upon the Corporation&#8217;s receipt of an undertaking (hereinafter an &#8220;</font><font style="font-size: 10pt; font-weight: bold; font-style: italic;">undertaking</font><font style="font-size: 10pt;">&#8221;), by or on behalf of such
          Indemnitee, to repay all amounts so advanced if it shall ultimately be determined that such Indemnitee is not entitled to be indemnified under this Article VIII or otherwise.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(1, 0, 0);">Section 8.3</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Right of
              Indemnitee to Bring Suit</u></font></font><font style="font-size: 10pt; font-weight: bold;">.</font><font style="font-size: 10pt;"> If a claim under Section 8.1 or Section 8.2 is not paid in full by the Corporation within 60 days after a
          written claim therefor has been received by the Corporation, except in the case of a claim for an advancement of expenses, in which case the applicable period shall be 20 days, the Indemnitee may at any time thereafter bring suit against the
          Corporation to recover the unpaid amount of the claim. If successful in whole or in part in any such suit, or in a suit brought by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the Indemnitee shall
          also be entitled to be paid the expense of prosecuting or defending such suit. In (a) any suit brought by the Indemnitee to enforce a right to indemnification hereunder (but not in a suit brought by an Indemnitee to enforce a right to an
          advancement of expenses) it shall be a defense that, and (b) in any suit brought by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the Corporation shall be entitled to recover such expenses upon a
          final judicial decision from which there is no further right to appeal that, the Indemnitee has not met any applicable standard for indemnification set forth in the DGCL. Neither the failure of the Corporation (including its directors who are not
          parties to such action, a committee of such directors, independent legal counsel, or its stockholders) to have made a determination prior to the commencement of such suit that indemnification of the Indemnitee is proper in the circumstances
          because the Indemnitee has met the applicable standard of conduct set forth in the DGCL, nor an actual determination by the Corporation (including a determination by its directors who are not parties to such action, a committee of such directors,
          independent legal counsel, or its stockholders) that the Indemnitee has not met such applicable standard of conduct, shall create a presumption that the Indemnitee has not met the applicable standard of conduct or, in the case of such a suit
          brought by the Indemnitee, shall be a defense to such suit. In any suit brought by the Indemnitee to enforce a right to indemnification or to an advancement of expenses hereunder, or by the Corporation to recover an advancement of expenses
          pursuant to the terms of an undertaking, the burden of proving that the Indemnitee is not entitled to be indemnified, or to such advancement of expenses, under this Article VIII or otherwise shall be on the Corporation.</font></div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">19</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(1, 0, 0);">Section 8.4</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-weight: bold;"><u>Non-Exclusivity
              of Rights</u></font></font><font style="font-size: 10pt; font-weight: bold;">.</font><font style="font-size: 10pt;"> The rights provided to any Indemnitee pursuant to this Article VIII shall not be exclusive of any other right, which such
          Indemnitee may have or hereafter acquire under applicable law, the Certificate of Incorporation, these Bylaws, an agreement, a vote of stockholders or disinterested directors, or otherwise.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(1, 0, 0);">Section 8.5</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-weight: bold;"><u>Insurance</u></font></font><font style="font-size: 10pt; font-weight: bold;">.</font><font style="font-size: 10pt;"> The Corporation may maintain insurance, at its expense, to protect itself and/or any director, officer, employee or agent of the Corporation or another
          corporation, partnership, joint venture, trust or other enterprise against any expense, liability or loss, whether or not the Corporation would have the power to indemnify such person against such expense, liability or loss under the DGCL.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(1, 0, 0);">Section 8.6</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Indemnification
              of Other Persons</u></font></font><font style="font-size: 10pt; font-weight: bold;">.</font><font style="font-size: 10pt;"> This Article VIII shall not limit the right of the Corporation to the extent and in the manner authorized or permitted
          by law to indemnify and to advance expenses to persons other than Indemnitees. Without limiting the foregoing, the Corporation may, to the extent authorized from time to time by the Board, grant rights to indemnification and to the advancement of
          expenses to any employee or agent of the Corporation and to any other person who is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation or of a partnership, joint venture, trust or
          other enterprise, including service with respect to an employee benefit plan, to the fullest extent of the provisions of this Article VIII with respect to the indemnification and advancement of expenses of Indemnitees under this Article VIII.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(1, 0, 0);">Section 8.7</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Amendments</u></font></font><font style="font-size: 10pt; font-weight: bold;">.</font><font style="font-size: 10pt;"> Any repeal or amendment of this Article VIII by the Board or the stockholders of the Corporation or by changes in applicable law, or the adoption of any other
          provision of these Bylaws inconsistent with this Article VIII, will, to the extent permitted by applicable law, be prospective only (except to the extent such amendment or change in applicable law permits the Corporation to provide broader
          indemnification rights to Indemnitees on a retroactive basis than permitted prior thereto), and will not in any way diminish or adversely affect any right or protection existing hereunder in respect of any act or omission occurring prior to such
          repeal or amendment or adoption of such inconsistent provision.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(1, 0, 0);">Section 8.8</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Certain
              Definitions</u></font></font><font style="font-size: 10pt; font-weight: bold;">.</font><font style="font-size: 10pt;"> For purposes of this Article VIII, (a) references to &#8220;</font><font style="font-size: 10pt; font-weight: bold; font-style: italic;">other enterprise</font><font style="font-size: 10pt;">&#8221; shall include any employee benefit plan; (b) references to &#8220;</font><font style="font-size: 10pt; font-weight: bold; font-style: italic;">fines</font><font style="font-size: 10pt;">&#8221;
          shall include any excise taxes assessed on a person with respect to an employee benefit plan; (c) references to &#8220;</font><font style="font-size: 10pt; font-weight: bold; font-style: italic;">serving at the request of the Corporation</font><font style="font-size: 10pt;">&#8221; shall include any service that imposes duties on, or involves services by, a person with respect to any employee benefit plan, its participants, or beneficiaries; and (d) a person who acted in good faith and in a manner
          such person reasonably believed to be in the interest of the participants and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner &#8220;</font><font style="font-size: 10pt; font-weight: bold; font-style: italic;">not
          opposed to the best interest of the Corporation</font><font style="font-size: 10pt;">&#8221; for purposes of Section 145 of the DGCL.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(1, 0, 0);">Section 8.9</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Contract Rights</u></font></font><font style="font-size: 10pt; font-weight: bold;">.</font><font style="font-size: 10pt;"> The rights provided to Indemnitees pursuant to this Article VIII shall be contract rights and such rights shall continue as to an Indemnitee who has ceased to be
          a director, officer, agent or employee and shall inure to the benefit of the Indemnitee&#8217;s heirs, executors and administrators.</font></div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">20</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(1, 0, 0);">Section 8.10</font><font style="font-size: 10pt;">&#160;&#160; &#160; &#160;&#160; <font style="font-weight: bold;"><u>Severability</u></font></font><font style="font-size: 10pt; font-weight: bold;">.</font><font style="font-size: 10pt;"> If any provision or provisions of this Article VIII shall be held to be invalid, illegal or unenforceable for any reason whatsoever: (a) the validity, legality
          and enforceability of the remaining provisions of this Article VIII shall not in any way be affected or impaired thereby; and (b) to the fullest extent possible, the provisions of this Article VIII (including, without limitation, each such
          portion of this Article VIII containing any such provision held to be invalid, illegal or unenforceable) shall be construed so as to give effect to the intent manifested by the provision held invalid, illegal or unenforceable.</font></div>
      <div>&#160;</div>
      <div style="text-align: center; color: rgb(1, 0, 0); font-weight: bold;">ARTICLE IX</div>
      <div style="text-align: center; font-weight: bold;">MISCELLANEOUS</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 9.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Place of Meetings</u></font>. If the place of any meeting of stockholders, the
        Board or committee of the Board for which notice is required under these Bylaws is not designated in the notice of such meeting, such meeting shall be held at the principal business office of the Corporation; provided, however, if the Board has, in
        its sole discretion, determined that a meeting shall not be held at any place, but instead shall be held by means of remote communication pursuant to Section 9.5 hereof, then such meeting shall not be held at any place.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 9.2</font>&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-weight: bold;"><u>Fixing Record Dates</u></font>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(a)</font>&#160;&#160; &#160;&#160; &#160;&#160; In order that the Corporation may determine the stockholders entitled to notice of or to vote at any meeting of stockholders
        or any adjournment thereof, the Board may fix a record date, which shall not precede the date upon which the resolution fixing the record date is adopted by the Board, and which record date shall not be more than 60 nor less than 10 days before the
        date of such meeting. If no record date is fixed by the Board, the record date for determining stockholders entitled to notice of or to vote at a meeting of stockholders shall be at the close of business on the business day next preceding the day
        on which notice is given. A determination of stockholders of record entitled to notice of or to vote at a meeting of stockholders shall apply to any adjournment of the meeting; provided, however, that the Board may fix a new record date for the
        adjourned meeting.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; In order that the Corporation may determine the stockholders entitled to receive payment of any dividend or other
        distribution or allotment of any rights or the stockholders entitled to exercise any rights in respect of any change, conversion or exchange of stock, or for the purpose of any other lawful action, the Board may fix a record date, which record date
        shall not precede the date upon which the resolution fixing the record date is adopted, and which record date shall be not more than 60 days prior to such action. If no record date is fixed, the record date for determining stockholders for any such
        purpose shall be at the close of business on the day on which the Board adopts the resolution relating thereto.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">21</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 9.3</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-weight: bold;"><u>Means of Giving Notice</u></font>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Notice to Stockholders</u>. Whenever under applicable law, the Certificate of Incorporation or these Bylaws notice is
        required to be given to any stockholder, such notice may be given (i) in writing and sent either by hand delivery, through the United States mail, or by a nationally recognized overnight delivery service for next day delivery, or (ii) by means of a
        form of electronic transmission consented to by the stockholder, to the extent permitted by, and subject to the conditions set forth in <u>Section 232</u> of the DGCL. A notice to a stockholder shall be deemed given as follows: (i) if given by
        hand delivery, when actually received by the stockholder, (ii) if sent through the United States mail, when deposited in the United States mail, with postage and fees thereon prepaid, addressed to the stockholder at the stockholder&#8217;s address
        appearing on the stock ledger of the Corporation, (iii) if sent for next day delivery by a nationally recognized overnight delivery service, when deposited with such service, with fees thereon prepaid, addressed to the stockholder at the
        stockholder&#8217;s address appearing on the stock ledger of the Corporation, and (iv) if given by a form of electronic transmission consented to by the stockholder to whom the notice is given and otherwise meeting the requirements set forth above, (A)
        if by facsimile transmission, when directed to a number at which the stockholder has consented to receive notice, (B) if by electronic mail, when directed to an electronic mail address at which the stockholder has consented to receive notice, (C)
        if by a posting on an electronic network together with separate notice to the stockholder of such specified posting, upon the later of (1) such posting and (2) the giving of such separate notice, and (D) if by any other form of electronic
        transmission, when directed to the stockholder. A stockholder may revoke such stockholder&#8217;s consent to receiving notice by means of electronic communication by giving written notice of such revocation to the Corporation. Any such consent shall be
        deemed revoked if (1) the Corporation is unable to deliver by electronic transmission two consecutive notices given by the Corporation in accordance with such consent and (2) such inability becomes known to the Secretary or an Assistant Secretary
        or to the Corporation&#8217;s transfer agent, or other person responsible for the giving of notice; provided, however, the inadvertent failure to treat such inability as a revocation shall not invalidate any meeting or other action.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160; <u>Electronic Transmission</u>. &#8220;<font style="font-weight: bold; font-style: italic;">Electronic transmission</font>&#8221; means
        any form of communication, not directly involving the physical transmission of paper, that creates a record that may be retained, retrieved and reviewed by a recipient thereof, and that may be directly reproduced in paper form by such a recipient
        through an automated process, including but not limited to transmission by telex, facsimile telecommunication, electronic mail, telegram and cablegram.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Notice to Stockholders Sharing Same Address</u>. Without limiting the manner by which notice otherwise may be given
        effectively by the Corporation to stockholders, any notice to stockholders given by the Corporation under any provision of the DGCL, the Certificate of Incorporation or these Bylaws shall be effective if given by a single written notice to
        stockholders who share an address if consented to by the stockholders at that address to whom such notice is given. A stockholder may revoke such stockholder&#8217;s consent by delivering written notice of such revocation to the Corporation. Any
        stockholder who fails to object in writing to the Corporation within 60 days of having been given written notice by the Corporation of its intention to send such a single written notice shall be deemed to have consented to receiving such single
        written notice.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">22</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Exceptions to Notice Requirements</u>. Whenever notice is required to be given, under the DGCL, the Certificate of
        Incorporation or these Bylaws, to any person with whom communication is unlawful, the giving of such notice to such person shall not be required and there shall be no duty to apply to any governmental authority or agency for a license or permit to
        give such notice to such person. Any action or meeting that shall be taken or held without notice to any such person with whom communication is unlawful shall have the same force and effect as if such notice had been duly given. In the event that
        the action taken by the Corporation is such as to require the filing of a certificate with the Secretary of State of Delaware, the certificate shall state, if such is the fact and if notice is required, that notice was given to all persons entitled
        to receive notice except such persons with whom communication is unlawful.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">Whenever notice is required to be given by the Corporation, under any provision of the DGCL, the Certificate of Incorporation or these Bylaws, to any stockholder to whom (1) notice of two
        consecutive annual meetings of stockholders and all notices of stockholder meetings or of the taking of action by written consent of stockholders without a meeting to such stockholder during the period between such two consecutive annual meetings,
        or (2) all, and at least two payments (if sent by first-class mail) of dividends or interest on securities during a 12-month period, have been mailed addressed to such stockholder at such stockholder&#8217;s address as shown on the records of the
        Corporation and have been returned undeliverable, the giving of such notice to such stockholder shall not be required. Any action or meeting that shall be taken or held without notice to such stockholder shall have the same force and effect as if
        such notice had been duly given. If any such stockholder shall deliver to the Corporation a written notice setting forth such stockholder&#8217;s then current address, the requirement that notice be given to such stockholder shall be reinstated. In the
        event that the action taken by the Corporation is such as to require the filing of a certificate with the Secretary of State of Delaware, the certificate need not state that notice was not given to persons to whom notice was not required to be
        given pursuant to <u>Section 230(b)</u> of the DGCL. The exception in subsection (1) of the first sentence of this paragraph to the requirement that notice be given shall not be applicable to any notice returned as undeliverable if the notice was
        given by electronic transmission.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 9.4</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Waiver of Notice</u></font>. Whenever any notice is required to be given under
        applicable law, the Certificate of Incorporation, or these Bylaws, a written waiver of such notice, signed before or after the date of such meeting by the person or persons entitled to said notice, or a waiver by electronic transmission by the
        person entitled to said notice, shall be deemed equivalent to such required notice. All such waivers shall be kept with the books of the Corporation. Attendance at a meeting shall constitute a waiver of notice of such meeting, except where a person
        attends for the express purpose of objecting to the transaction of any business on the ground that the meeting was not lawfully called or convened.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 9.5</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Meeting Attendance via Remote Communication Equipment</u></font>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(a)</font>&#160; &#160; &#160; &#160;&#160; <u>Stockholder Meetings</u>. If authorized by the Board in its sole discretion, and subject to such guidelines and
        procedures as the Board may adopt, stockholders entitled to vote at such meeting and proxy holders not physically present at a meeting of stockholders may, by means of remote communication:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: rgb(1, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#160; participate in a meeting of stockholders; and</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">23</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: rgb(1, 0, 0);">(ii)</font>&#160;&#160;&#160;&#160; &#160; &#160;&#160; be deemed present in person and vote at a meeting of stockholders, whether such meeting is to be held at a designated
        place or solely by means of remote communication; provided that (A) the Corporation shall implement reasonable measures to verify that each person deemed present and permitted to vote at the meeting by means of remote communication is a stockholder
        or proxy holder, (B) the Corporation shall implement reasonable measures to provide such stockholders and proxy holders a reasonable opportunity to participate in the meeting and to vote on matters submitted to the stockholders, including an
        opportunity to read or hear the proceedings of the meeting substantially concurrently with such proceedings, and (C) if any stockholder or proxy holder votes or takes other action at the meeting by means of remote communication, a record of such
        votes or other action shall be maintained by the Corporation.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(1, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Board Meetings</u>. Unless otherwise restricted by applicable law, the Certificate of Incorporation or these Bylaws,
        members of the Board or any committee thereof may participate in a meeting of the Board or any committee thereof by means of conference telephone, videoconference or other communications equipment by means of which all persons participating in the
        meeting can hear each other. Such participation in a meeting shall constitute presence in person at the meeting, except where a person participates in the meeting for the express purpose of objecting to the transaction of any business on the ground
        that the meeting was not lawfully called or convened.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 9.6</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Dividends</u></font>. The Board may from time to time declare, and the
        Corporation may pay, dividends (payable in cash, property or shares of the Corporation&#8217;s capital stock) on the Corporation&#8217;s outstanding shares of capital stock, subject to applicable law and the Certificate of Incorporation.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 9.7</font>&#160; &#160; &#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Reserves</u></font>. The Board may set apart out of the funds of the
        Corporation available for dividends a reserve or reserves for any proper purpose and may abolish any such reserve.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 9.8</font>&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-weight: bold;"><u>Contracts and Negotiable Instruments</u></font>. Except as otherwise provided
        by applicable law, the Certificate of Incorporation or these Bylaws, any contract, bond, deed, lease, mortgage or other instrument may be executed and delivered in the name and on behalf of the Corporation by such officer or officers or other
        employee or employees of the Corporation as the Board may from time to time authorize. Such authority may be general or confined to specific instances as the Board may determine. The Chairperson of the Board, the Chief Executive Officer, the
        President, the Chief Financial Officer, the Treasurer or any Vice President may execute and deliver any contract, bond, deed, lease, mortgage or other instrument in the name and on behalf of the Corporation. Subject to any restrictions imposed by
        the Board, the Chairperson of the Board Chief Executive Officer, President, the Chief Financial Officer, the Treasurer or any Vice President may delegate powers to execute and deliver any contract, bond, deed, lease, mortgage or other instrument in
        the name and on behalf of the Corporation to other officers or employees of the Corporation under such person&#8217;s supervision and authority, it being understood, however, that any such delegation of power shall not relieve such officer of
        responsibility with respect to the exercise of such delegated power.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">24</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 9.9</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Fiscal Year</u></font>. The fiscal year of the Corporation shall be fixed by
        the Board.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 9.10</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Seal</u></font>. The Board may adopt a corporate seal, which shall be in such
        form as the Board determines. The seal may be used by causing it or a facsimile thereof to be impressed, affixed or otherwise reproduced.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 9.11</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Books and Records</u></font>. The books and records of the Corporation may be
        kept within or outside the State of Delaware at such place or places as may from time to time be designated by the Board.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 9.12</font>&#160; &#160;&#160; <u></u><font style="font-weight: bold;"><u>Resignation</u></font>. Any director, committee member or officer may
        resign by giving notice thereof in writing or by electronic transmission to the Chairperson of the Board, the Chief Executive Officer, the President or the Secretary. The resignation shall take effect at the time specified therein, or at the time
        of receipt of such notice if no time is specified or the specified time is earlier than the time of such receipt. Unless otherwise specified therein, the acceptance of such resignation shall not be necessary to make it effective.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 9.13</font>&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Surety Bonds</u></font>. Such officers, employees and agents of the Corporation
        (if any) as the Chairperson of the Board, Chief Executive Officer, President or the Board may direct, from time to time, shall be bonded for the faithful performance of their duties and for the restoration to the Corporation, in case of their
        death, resignation, retirement, disqualification or removal from office, of all books, papers, vouchers, money and other property of whatever kind in their possession or under their control belonging to the Corporation, in such amounts and by such
        surety companies as the Chairperson of the Board, Chief Executive Officer, President or the Board may determine. The premiums on such bonds shall be paid by the Corporation and the bonds so furnished shall be in the custody of the Secretary.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 9.14</font>&#160;&#160;&#160; <font style="font-weight: bold;"><u>Securities of Other Corporations</u></font>. Powers of attorney, proxies, waivers
        of notice of meeting, consents in writing and other instruments relating to securities owned by the Corporation may be executed in the name of and on behalf of the Corporation by the Chairperson of the Board, Chief Executive Officer, President or
        any Vice President or any other officer authorized by the Board. Any such officer, may, in the name of and on behalf of the Corporation, take all such action as any such officer may deem advisable to vote in person or by proxy at any meeting of
        security holders of any corporation in which the Corporation may own securities, or to consent in writing, in the name of the Corporation as such holder, to any action by such corporation, and at any such meeting or with respect to any such consent
        shall possess and may exercise any and all rights and power incident to the ownership of such securities and which, as the owner thereof, the Corporation might have exercised and possessed. The Board may from time to time confer like powers upon
        any other person or persons.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(1, 0, 0);">Section 9.15</font>&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Amendments</u></font>. The Board shall have the power to adopt, amend, alter or
        repeal the Bylaws. The affirmative vote of a majority of the Board shall be required to adopt, amend, alter or repeal the Bylaws. The Bylaws also may be adopted, amended, altered or repealed by the stockholders; provided, however, that in addition
        to any vote of the holders of any class or series of capital stock of the Corporation required by applicable law or the Certificate of Incorporation, the affirmative vote of the holders of at least 66 2/3% of the voting power of all outstanding
        shares of capital stock of the Corporation entitled to vote generally in the election of directors, voting together as a single class, shall be required for the stockholders to adopt, amend, alter or repeal the Bylaws; and provided further,
        however, that no Bylaws hereafter adopted by the stockholders of the Corporation shall invalidate any prior act of the Board that would have been valid if such Bylaws had not been adopted.</div>
      <div>&#160;</div>
      <div>&#160;</div>
      <div style="text-align: center;"> <font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">25</font></div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>4
<FILENAME>ef20050548_ex4-1.htm
<DESCRIPTION>EXHIBIT 4.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 4.1</font><br>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zd7f0b04946e942de92250ed2c381714b">

          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 49%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>NUMBER</div>
            </td>
            <td style="width: 48%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
              <div style="text-align: right;">SHARES</div>
            </td>
            <td colspan="1" style="width: 2%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 49%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>C-</div>
            </td>
            <td style="width: 48%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: right;">CUSIP [&#9679;]</div>
            </td>
            <td colspan="1" style="width: 2%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: center;">SEE REVERSE FOR CERTAIN DEFINITIONS</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">XCF GLOBAL, INC.</div>
      <div><br>
      </div>
      <div style="text-align: center; font-weight: bold;">INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE</div>
      <div style="text-align: center; font-weight: bold;">CLASS A COMMON STOCK</div>
      <div>&#160;</div>
      <div style="text-align: center;">This Certifies that _________________________ is the owner of&#160; _______________</div>
      <div>&#160;</div>
      <div style="text-align: center;">FULLY PAID AND NON-ASSESSABLE SHARES OF THE CLASS A COMMON STOCK<font style="font-weight: bold;">, </font>PAR VALUE OF $0.0001 PER SHARE, OF</div>
      <div style="text-align: center; font-weight: bold;">XCF GLOBAL, INC.</div>
      <div style="text-align: center;">(THE &#8220;COMPANY&#8221;)</div>
      <div>&#160;</div>
      <div style="text-align: center;">transferable on the books of the Company in person or by duly authorized attorney upon surrender of this certificate properly endorsed.</div>
      <div>&#160;</div>
      <div style="text-align: center;">This certificate is not valid unless countersigned by the Transfer Agent and registered by the Registrar.</div>
      <div>&#160;</div>
      <div style="text-align: center;">Witness the facsimile seal of the Company and the facsimile signatures of its duly authorized officers.</div>
      <div style="text-align: center;"> <br>
      </div>
      <div style="text-align: center;">[Corporate Seal]</div>
      <div style="text-align: center;">Delaware</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zaf51c5fde40d4f5ebc155d02bc5a889b">

          <tr>
            <td style="width: 25%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
            <td style="width: 10%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 28.57%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 23%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div><br>
              </div>
            </td>
            <td style="width: 13%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top;">
              <div>Chief Executive Officer</div>
            </td>
            <td style="width: 28.57%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">
              <div>Secretary</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;">XCF GLOBAL, INC.</div>
      <div><br>
      </div>
      <div>The Company will furnish without charge to each stockholder who so requests the powers, designations, preferences and relative, participating, optional or other special rights of each class of stock or series thereof of the Company and the
        qualifications, limitations, or restrictions of such preferences and/or rights. This certificate and the shares represented thereby are issued and shall be held subject to all the provisions of the Company&#8217;s amended and restated certificate of
        incorporation and all amendments thereto and resolutions of the Company&#8217;s Board of Directors providing for the issue of securities (copies of which may be obtained from the secretary of the Company), to all of which the holder of this certificate
        by acceptance hereof assents.</div>
      <div><br>
      </div>
      <div>The following abbreviations, when used in the inscription on the face of this certificate, shall be construed as though they were written out in full according to applicable laws or regulations:</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z42e7ee5fa39a4a56be25b1bff031ab52">

          <tr>
            <td style="width: 12.11%; vertical-align: top;">
              <div>TEN COM</div>
            </td>
            <td style="width: 5.07%; vertical-align: top;">
              <div>&#8212;</div>
            </td>
            <td style="width: 82.82%; vertical-align: top;">
              <div>as tenants in common</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12.11%; vertical-align: top;">&#160;</td>
            <td style="width: 5.07%; vertical-align: top;">&#160;</td>
            <td style="width: 82.82%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 12.11%; vertical-align: top;">
              <div>TEN ENT</div>
            </td>
            <td style="width: 5.07%; vertical-align: top;">
              <div>&#8212;</div>
            </td>
            <td style="width: 82.82%; vertical-align: top;">
              <div>as tenants by the entireties</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12.11%; vertical-align: top;">&#160;</td>
            <td style="width: 5.07%; vertical-align: top;">&#160;</td>
            <td style="width: 82.82%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 12.11%; vertical-align: top;">
              <div>JT TEN</div>
            </td>
            <td style="width: 5.07%; vertical-align: top;">
              <div>&#8212;</div>
            </td>
            <td style="width: 82.82%; vertical-align: top;">
              <div>as joint tenants with right of survivorship and not as tenants in common</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="ze94f5c46423e4d438f66b1205fb82f8b">

          <tr>
            <td style="width: 20%; vertical-align: top; padding-bottom: 2px;">
              <div>UNIF GIFT MIN ACT</div>
            </td>
            <td style="width: 3.6%; vertical-align: top; padding-bottom: 2px;">
              <div style="text-align: center;">&#8212;</div>
            </td>
            <td style="width: 20%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center;"><br>
              </div>
            </td>
            <td style="width: 20%; vertical-align: top; padding-bottom: 2px;">
              <div style="text-align: center;">Custodian</div>
            </td>
            <td style="width: 20.01%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center;"><br>
              </div>
            </td>
            <td style="width: 16.4%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top;">&#160;</td>
            <td style="width: 3.6%; vertical-align: top;">&#160;</td>
            <td style="width: 20%; vertical-align: top;">
              <div style="text-align: center;">(Cust)</div>
            </td>
            <td style="width: 20%; vertical-align: top;">&#160;</td>
            <td style="width: 20.01%; vertical-align: top;">
              <div style="text-align: center;">(Minor)</div>
            </td>
            <td style="width: 16.4%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 100%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div style="text-align: center;">(State)</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div>Additional abbreviations may also be used though not in the above list.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z0ffefca66c204b8cb743b4778f99bd18">

          <tr>
            <td style="width: 100%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="margin-left: 36pt;">For value received, _______________ hereby sells, assigns and transfers unto ______________________________</div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div style="text-align: center;">(PLEASE INSERT SOCIAL SECURITY OR OTHER IDENTIFYING NUMBER(S) OF ASSIGNEE(S))</div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div style="text-align: center;">(PLEASE PRINT OR TYPEWRITE NAME(S) AND ADDRESS(ES), INCLUDING ZIP CODE, OF ASSIGNEE(S))</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 100%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <div>____________________ shares of the Class A common stock represented by the within Certificate, and hereby irrevocably constitutes and appoints</div>
      <div>____________________ Attorney to transfer the said stock on the books of the within named Company with full power of substitution in the premises.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z0f9f2a1a775e4c0eb11ecfaf0ef116d5">

          <tr>
            <td style="width: 20.02%; vertical-align: top; padding-bottom: 2px;">
              <div>Dated: _______________</div>
            </td>
            <td style="width: 21.1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 58.75%; vertical-align: top; padding-bottom: 2px;">
              <div>NOTICE: THE SIGNATURE(S) TO THIS ASSIGNMENT MUST CORRESPOND WITH THE NAME AS WRITTEN UPON THE FACE OF THE CERTIFICATE IN EVERY PARTICULAR, WITHOUT ALTERATION OR ENLARGEMENT OR ANY CHANGE WHATEVER.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z7cc38fc9fd674fba8314b8c4c2075515">

          <tr>
            <td style="vertical-align: top;" colspan="3">
              <div>Signature(s) Guaranteed:</div>
            </td>
            <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td rowspan="1" style="vertical-align: top;" colspan="3">&#160;</td>
            <td colspan="1" rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
              <div>By:<br>
              </div>
            </td>
            <td style="width: 23.5%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
            <td style="width: 23%; vertical-align: top; padding-bottom: 2px;"><br>
            </td>
            <td colspan="1" style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top;" colspan="3">
              <div>THE SIGNATURE(S) MUST BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO U.S.
                SECURITIES AND EXCHANGE COMMISSION RULE 17Ad-15 (OR ANY SUCCESSOR RULE) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED).</div>
            </td>
            <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <div>&#160;</div>
      <div><br>
      </div>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>5
<FILENAME>ef20050548_ex4-3.htm
<DESCRIPTION>EXHIBIT 4.3
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">


  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: right;"> <font style="font-weight: bold;">Exhibit 4.3</font><br>
    </div>
    <div> <br>
    </div>
    <div>
      <div style="text-align: center; font-weight: bold;"><u>WARRANT ASSIGNMENT AND ASSUMPTION AGREEMENT</u></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">This Warrant Assignment and Assumption Agreement (this &#8220;<u>Warrant Assumption Agreement</u>&#8221;) is entered into as of June 6, 2025, by and among Focus Impact BH3 Acquisition Company, a Delaware
        corporation (&#8220;<u>Focus Impact</u>&#8221; or &#8220;<u>BHAC</u>&#8221;), Focus Impact BH3 NewCo, Inc., a Delaware corporation and wholly owned subsidiary of Focus Impact (&#8220;<u>NewCo</u>&#8221;), and Continental Stock Transfer &amp; Trust Company, a New York corporation, as
        warrant agent (the &#8220;<u>Warrant Agent</u>&#8221;). Capitalized terms used but not otherwise defined herein shall have the meanings given to such terms in the Business Combination Agreement (as defined below).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">WHEREAS, Focus Impact BH3 Acquisition Company, a Delaware corporation (formerly known as Crixus BH3 Acquisition Company) and the Warrant Agent are parties to that certain Warrant Agreement, dated
        as of October 4, 2021 (the &#8220;<u>Warrant Agreement</u>&#8221;);</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">WHEREAS, Focus Impact, NewCo, Focus Impact BH3 Merger Sub 1, LLC, a Delaware limited liability company and wholly owned subsidiary of NewCo (&#8220;<u>Merger Sub 1</u>&#8221;), Focus Impact BH3 Merger Sub 2,
        Inc., a Delaware corporation and wholly owned subsidiary of NewCo (&#8220;<u>Merger Sub 2</u>&#8221;) and XCF Global Capital, Inc., a Nevada corporation (&#8220;XCF&#8221;) are parties to that certain Business Combination Agreement, dated as of March 11, 2024 (as amended
        pursuant to that certain Amendment No. 1 dated November 28, 2024 and as it may be amended, supplemented or otherwise modified from time to time, the &#8220;<u>Business Combination Agreement</u>&#8221;), pursuant to which, on the terms and subject to the
        conditions set forth therein, among other things: (i) Focus Impact will merge with and into Merger Sub 1 (the &#8220;<u>NewCo Merger</u>&#8221;), with Merger Sub 1 being the surviving entity of the NewCo Merger as a direct wholly owned subsidiary of NewCo, as
        a result of which, among other things, (a) each share of Focus Impact Class A common stock, par value $0.0001 per share (&#8220;<u>Focus Impact Class A Common Stock</u>&#8221;) outstanding immediately prior to the effectiveness of the NewCo Merger will be
        converted into the right of the holder thereof to receive one share of NewCo&#8217;s Class A common stock, par value $0.0001 per share (&#8220;<u>NewCo Class A Common Stock</u>&#8221;), (b) each share of Focus Impact Class B common stock, par value $0.0001 per share
        (&#8220;<u>Focus Impact Class B Common Stock</u>&#8221;) outstanding immediately prior to the effectiveness of the NewCo Merger will be converted into the right of the holder thereof to receive one share of&#160; NewCo Class A Common Stock, and (c) each warrant of
        Focus Impact outstanding immediately prior to the effectiveness of the NewCo Merger will be converted into the right to receive one warrant of NewCo (each, a &#8220;NewCo Warrant&#8221;), with NewCo assuming Focus Impact&#8217;s rights and obligations under the
        existing warrant agreement and (ii) immediately following the NewCo Merger, Merger Sub 2 will merge with and into XCF (the &#8220;<u>Company Merger</u>&#8221;), with XCF being the surviving entity of the Company Merger as a direct wholly owned subsidiary of
        NewCo, as a result of which, among other things, each share of common stock of XCF outstanding immediately prior to the effectiveness of the Company Merger will be converted into the right to receive shares of NewCo Class A Common Stock determined
        in accordance with the Business Combination Agreement and NewCo will change its registered name with the Secretary of State of Delaware to &#8220;XCF Global, Inc.&#8221;;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">WHEREAS, pursuant to the terms and conditions of each of the Warrant Agreement and the Business Combination Agreement, upon the NewCo Merger Effective Time, each BHAC Warrant issued and outstanding
        immediately prior to the NewCo Merger Effective Time will automatically become a NewCo Warrant at the same exercise price per share and on the same terms in effect immediately prior to the NewCo Merger Effective Time, and the rights and obligations
        of Focus Impact under the Warrant Agreement will be irrevocably assigned and assumed by NewCo; and</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-align: justify; text-indent: 36pt;">WHEREAS, as a result of this Warrant Assignment and Assumption Agreement, at the NewCo Merger Effective Time, NewCo will assume all of the obligations of Focus Impact with respect to each BHAC
        Warrant, each of which will, at the NewCo Merger Effective Time, become a warrant to purchase NewCo Class A Common Stock pursuant to the terms and conditions of the Warrant Agreement.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Focus Impact, NewCo and the Warrant
        Agent hereby agree as follows:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">1.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Assignment and Assumption</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(a)</font>&#160; &#160; &#160;&#160;&#160;&#160;&#160; Upon and subject to the occurrence of the NewCo Merger Effective Time, Focus Impact hereby assigns, and NewCo hereby assumes, the rights and
        obligations of Focus Impact under the Warrant Agreement and the BHAC Warrants (which shall be converted into NewCo Warrants), including the obligation to issue NewCo Class A Common Stock upon the exercise of the NewCo Warrants, and NewCo hereby
        agrees to faithfully perform, satisfy and discharge when due, the liabilities and obligations of Focus Impact under the Warrant Agreement and the BHAC Warrants (which shall be converted into NewCo Warrants). As a result of the NewCo Merger, upon
        and subject to the occurrence of the NewCo Merger Effective Time, each BHAC Warrant will be automatically and irrevocably modified, pursuant to and in accordance with Section 4.4 of the Warrant Agreement, with the effect that, at the NewCo Merger
        Effective Time, each BHAC Warrant will be exchanged for a warrant to purchase shares of NewCo Class A Common Stock pursuant to the terms and conditions of the Warrant Agreement.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160; NewCo acknowledges and agrees that, subject to the terms of the Warrant Agreement, the BHAC Warrants and this Warrant Assignment and Assumption
        Agreement, the Warrant Agreement and the BHAC Warrants (which shall be converted into NewCo Warrants) shall continue in full force and effect following the NewCo Merger Effective Time and that, from and after the NewCo Merger Effective Time, all of
        Focus Impact&#8217;s obligations thereunder shall be valid and enforceable as against NewCo and shall not be impaired or limited by the execution or effectiveness of this Warrant Assignment and Assumption Agreement.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; This Warrant Assignment and Assumption Agreement is being executed and delivered pursuant and subject to the Warrant Agreement. Nothing in this
        Warrant Assignment and Assumption Agreement shall, or shall be deemed to, defeat, limit, alter, impair, enhance or enlarge any right, obligation, claim or remedy created by the Warrant Agreement or any other document or instrument delivered
        pursuant to or in connection with it.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(d)</font>&#160;&#160;&#160; &#160;&#160; The choice of law and jurisdiction provisions set forth in the Warrant Agreement and this Warrant Assignment and Assumption Agreement shall
        continue to govern the rights and obligations of the parties to the Warrant Agreement and this Warrant Assignment and Assumption Agreement in all respects. Focus Impact hereby waives any objection to the jurisdiction provision governing the terms
        of the Warrant Agreement and this Warrant Assignment and Assumption Agreement.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">2</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">2.</font>&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160; <u>Miscellaneous</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160; &#160; <u>Governing Law and Jurisdiction</u>. The validity, interpretation, and performance of this Warrant Assignment and Assumption Agreement shall
        be governed in all respects by the laws of the State of New York, without giving effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction. Focus Impact hereby agrees that any action,
        proceeding or claim against it arising out of or relating in any way to this Warrant Assignment and Assumption Agreement shall be brought and enforced in the courts of the State of New York or the United States District Court for the Southern
        District of New York, and irrevocably submits to such jurisdiction. Focus Impact hereby waives any objection to such jurisdiction and that such courts represent an inconvenient forum. Any such process or summons to be served upon NewCo may be
        served by transmitting a copy thereof by registered or certified mail, return receipt requested, postage prepaid, addressed to XCF Global, Inc. at the address set forth below:</div>
      <div>&#160;</div>
      <div style="margin-left: 72pt; color: rgb(0, 0, 0);">XCF Global, Inc.</div>
      <div style="margin-left: 72pt; color: rgb(0, 0, 0);">5170 Golden Foothill Parkway</div>
      <div style="margin-left: 72pt; color: rgb(0, 0, 0);">El Dorado Hills, CA 95762</div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="z8408173ac3bb47cdbe6874c004c67441" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="width: 72pt;">&#160;</td>
              <td style="text-align: right; vertical-align: top; width: 54pt;">
                <div style="text-align: left;"><font style="color: rgb(0, 0, 0);">Attention:</font></div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div><font style="color: rgb(0, 0, 0);">Mihir Dange, Chief Executive Officer</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="z7c54119b6a074b3ba43cc2bee4bdef23" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="width: 72pt;">&#160;</td>
              <td style="text-align: right; vertical-align: top; width: 54pt;">
                <div style="text-align: left;"><font style="color: rgb(0, 0, 0);">Email:</font></div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: left;"><font style="color: rgb(0, 0, 0);">m.dange@xcf.global</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div><br>
      </div>
      <div style="margin-left: 72pt; color: rgb(0, 0, 0);">with a copy to:</div>
      <div><br>
      </div>
      <div style="margin-left: 72pt; color: rgb(0, 0, 0);">Stradley Ronon Stevens &amp; Young, LLP</div>
      <div style="margin-left: 72pt; color: rgb(0, 0, 0);">2005 Market Street</div>
      <div style="margin-left: 72pt; color: rgb(0, 0, 0);">Philadelphia, PA 20036</div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="za324587d58154c018ed8a7f46acf0afc" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="width: 72pt;">&#160;</td>
              <td style="text-align: right; vertical-align: top; width: 54pt;">
                <div style="text-align: left;"><font style="color: rgb(0, 0, 0);">Attention:</font></div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div><font style="color: rgb(0, 0, 0);">Thomas L. Hanley</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="z32ea7930f1ef4247baf584847d0226be" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="width: 72pt;">&#160;</td>
              <td style="text-align: right; vertical-align: top; width: 54pt;">
                <div style="text-align: left;"><font style="color: rgb(0, 0, 0);">E-mail:</font></div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div><font style="color: rgb(0, 0, 0);">t.hanley@stradley.com</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div><br>
      </div>
      <div style="text-align: justify;">or to such other address or addresses as the parties may from time to time designate in writing.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160; &#160; &#160;&#160; <u>Binding Effect</u>. This Warrant Assignment and Assumption Agreement shall be binding upon and inure to the benefit of the parties hereto
        and to their respective successors and assigns.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Entire Agreement</u>. This Warrant Assignment and Assumption Agreement sets forth the entire agreement and understanding between the
        parties as to the subject matter thereof and merges and supersedes all prior discussions, agreements and understandings of any and every nature among them. Except as expressly set forth in this Warrant Assignment and Assumption Agreement,
        provisions of the Warrant Agreement which are not inconsistent with this Warrant Assignment and Assumption Agreement shall remain in full force and effect. This Warrant Assignment and Assumption Agreement may be executed in any number of original
        or facsimile counterparts and each of such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">3</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Severability</u>. This Warrant Assignment and Assumption Agreement shall be deemed severable, and the invalidity or unenforceability of any
        term or provision hereof shall not affect the validity or enforceability of this Warrant Assignment and Assumption Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable term or provision, the
        parties hereto intend that there shall be added as a part of this Warrant Assignment and Assumption Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Amendment</u>. This Warrant Assignment and Assumption Agreement may not be amended, except by an instrument in writing signed by each party
        hereto.</div>
      <div>&#160;</div>
      <div style="text-align: center; font-style: italic; font-weight: bold;">[SIGNATURE PAGES FOLLOW]</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">4</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">IN WITNESS WHEREOF</font><font style="font-size: 10pt;">, the parties hereto have executed this Warrant Assignment and Assumption
          Agreement as of the date first written above.</font></div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z6ae67a99945e465bbbec9868522f57f4">

          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td colspan="2" rowspan="1" style="width: 5%; vertical-align: top;">
              <div style="font-weight: bold;">FOCUS IMPACT BH3 ACQUSITION COMPANY</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%; vertical-align: top;"><br>
            </td>
            <td colspan="2" rowspan="1" style="width: 5%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div>By:</div>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div><u>/s/ Carl Stanton</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div>Name:</div>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div>Carl Stanton</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div>Title:</div>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div>Chief Executive Officer</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%; vertical-align: top;"><br>
            </td>
            <td colspan="2" rowspan="1" style="width: 5%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td colspan="2" rowspan="1" style="width: 5%; vertical-align: top;">
              <div style="font-weight: bold;">XCF GLOBAL, INC.</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%; vertical-align: top;"><br>
            </td>
            <td colspan="2" rowspan="1" style="width: 5%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div>By:</div>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div><u>/s/ Mihir Dange</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div>Name:</div>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div>Mihir Dange</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div>Title:</div>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div>Chief Executive Officer</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%; vertical-align: top;"><br>
            </td>
            <td colspan="2" rowspan="1" style="width: 5%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td colspan="2" rowspan="1" style="width: 5%; vertical-align: top;">
              <div style="font-weight: bold;">CONTINENTAL STOCK TRANSFER &amp; TRUST COMPANY</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%; vertical-align: top;"><br>
            </td>
            <td colspan="2" rowspan="1" style="width: 5%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div>By:</div>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div><u>/s/ Steven Vacante</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div>Name:</div>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div>Steven Vacante</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div>Title:</div>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div>Vice President</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div>
        <div style="text-align: center;">[Signature Page to Warrant Assumption Agreement]</div>
        <div style="text-align: center;"><br>
          <br>
        </div>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.51
<SEQUENCE>6
<FILENAME>ef20050548_ex10-51.htm
<DESCRIPTION>EXHIBIT 10.51
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 10.51</font><br>
    </div>
    <div> <br>
    </div>
    <div>
      <div style="text-align: right; font-weight: bold;">EXECUTION COPY</div>
      <div>&#160;</div>
      <div style="text-align: center; margin-right: 2.9pt; font-weight: bold;">REGISTRATION RIGHTS AGREEMENT</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 45pt;">This Registration and Stockholder Rights Agreement (as it may be amended, supplemented or restated from time to time in accordance with the terms hereof, this &#8220;<font style="font-weight: bold; font-style: italic;">Agreement</font>&#8221;), dated as of June 6, 2025, is made and entered into by and among XCF Global, Inc., a Delaware corporation (formerly known as Focus Impact BH3 NewCo, Inc., the &#8220;<font style="font-weight: bold; font-style: italic;">Company</font>&#8221;), Focus Impact BHAC Sponsor, LLC, a Delaware limited liability company (the &#8220;<font style="font-weight: bold; font-style: italic;">Sponsor</font>&#8221;), and the undersigned parties listed under &#8220;Holder&#8221; on the signature page
        hereto (each such party, the Sponsor and any person or entity who hereafter becomes a party to this Agreement pursuant to <u>Section 6.2</u> of this Agreement, a <font style="font-style: italic;">&#8220;</font><font style="font-weight: bold; font-style: italic;">Holder</font>&#8221; and collectively the &#8220;<font style="font-weight: bold; font-style: italic;">Holders</font>&#8221;). Except as otherwise stated, capitalized terms used but not otherwise defined herein shall have the meanings provided
        in the Business Combination Agreement (as defined below).</div>
      <div>&#160;</div>
      <div style="text-align: center; margin-right: 2.9pt; font-weight: bold;">RECITALS</div>
      <div>&#160;</div>
      <div style="text-align: justify; font-size: 12pt; text-indent: 45pt;"><font style="font-size: 10pt; font-weight: bold;">WHEREAS</font><font style="font-size: 10pt;">, the Company, Focus Impact BH3 Acquisition Company, a Delaware corporation, Focus
          Impact BH3 Merger Sub 1, LLC, a Delaware limited liability company and wholly owned subsidiary of the Company, Focus Impact BH3 Merger Sub 2, Inc., a Delaware corporation and wholly owned subsidiary of the Company, and XCF Global Capital, Inc., a
          Nevada corporation, entered into that certain Business Combination Agreement, dated as of March 11, 2024 (as amended on November 29, 2024, the &#8220;<font style="font-weight: bold; font-style: italic;">Business Combination Agreement</font>&#8221;), pursuant
          to which the parties to the Business Combination Agreement undertook the transactions described therein (the &#8220;<font style="font-weight: bold; font-style: italic;">Business Combination</font>&#8221;);</font></div>
      <div style="text-indent: 45pt;">&#160;</div>
      <div style="text-indent: 45pt; text-align: justify;"><font style="font-weight: bold;">WHEREAS</font>, as of the date hereof as a result of the closing of the Business Combination (the &#8220;<font style="font-weight: bold; font-style: italic;">Closing</font>&#8221;),
        the Holders own shares of the Company&#8217;s Class A common stock, par value $0.0001 per share (the &#8220;<font style="font-weight: bold; font-style: italic;">Common Stock</font>&#8221;), and the Sponsor owns warrants to purchase shares of Common Stock (the &#8220;<font style="font-weight: bold; font-style: italic;">Private Placement Warrants</font>&#8221;);</div>
      <div style="text-indent: 45pt;">&#160;</div>
      <div style="text-align: justify; font-size: 12pt; text-indent: 45pt;"><font style="font-size: 10pt; font-weight: bold;">NOW</font><font style="font-size: 10pt;">, <font style="font-weight: bold;">THEREFORE</font>, in consideration of the mutual
          representations, covenants and agreements contained herein, and certain other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as
          follows:</font></div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">ARTICLE I </div>
      <div style="text-align: center; font-weight: bold;">DEFINITIONS</div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-indent: 45pt; text-align: justify;">1.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Definitions</u></font>. The terms defined in this <u>Article I</u> shall, for all purposes of this Agreement, have the respective meanings set
        forth below:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Adverse Disclosure</font>&#8221; means any public disclosure of material non-public information, which disclosure, in the good faith judgment of (i)
        either the Chief Executive Officer or Chief Financial Officer and (ii) the Board of the Company, after consultation with counsel to the Company, (i) would be required to be made in any Registration Statement or Prospectus in order for the
        applicable Registration Statement or Prospectus not to contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements contained therein (in the case of any Prospectus, in the light of the
        circumstances under which they were made) not misleading, (ii) would not be required to be made at such time if the Registration Statement were not being filed, declared effective or used, as the case may be, and (iii) the Company has a bona fide
        business purpose for not making such information public.</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-align: justify; text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Affiliate</font>&#8221; means as to any Person, other than an individual Holder, any other Person who directly, or indirectly through one or more
        intermediaries, controls, is controlled by or is under common control with such Person. As used in this definition, the term &#8220;control,&#8221; including the correlative terms &#8220;controlling,&#8221; &#8220;controlled by&#8221; and &#8220;under common control with,&#8221; means
        possession, directly or indirectly, of the power to direct or cause the direction of management or policies (whether through ownership of securities or any partnership or other ownership interest, by contract or otherwise) of a Person. For the
        avoidance of doubt, for purposes of this Agreement, the Company, on the one hand, and the Holders, on the other hand, shall not be considered Affiliates.</div>
      <div style="text-indent: 45pt;">&#160;</div>
      <div style="text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Agreement</font>&#8221; has the meaning given in the Preamble hereto.</div>
      <div style="text-indent: 45pt;">&#160;</div>
      <div style="text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Beneficially Owns</font>&#8221; has the meaning set forth in Rule 13d-3 promulgated under the Exchange Act.</div>
      <div style="text-indent: 45pt;">&#160;</div>
      <div style="text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Block Trade</font>&#8221; has the meaning given in <u>Section 2.3.1</u>.</div>
      <div style="text-indent: 45pt;"> <br>
      </div>
      <div style="text-indent: 45pt;"> &#8220;<font style="font-weight: bold; font-style: italic;">Board</font>&#8221; means the board of directors of the Company.</div>
      <div style="text-indent: 45pt;"> <br>
      </div>
      <div style="text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Business Combination</font>&#8221; has the meaning given in the Recitals hereto.</div>
      <div style="text-indent: 45pt;">&#160;</div>
      <div style="text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Business Combination Agreement</font>&#8221; has the meaning given in the Recitals hereto. </div>
      <div style="text-indent: 45pt;"> <br>
      </div>
      <div style="text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Commission</font>&#8221; means the Securities and Exchange Commission.</div>
      <div style="text-indent: 45pt;"> <br>
      </div>
      <div style="text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Common Stock</font>&#8221; has the meaning given in the Recitals hereto.</div>
      <div style="text-indent: 45pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Company</font>&#8221; has the meaning given in the Preamble hereto and includes the Company&#8217;s successors by recapitalization, merger, consolidation,
        spin-off, reorganization or similar transaction.</div>
      <div style="text-indent: 45pt;">&#160;</div>
      <div style="text-indent: 45pt; text-align: justify;">&#8220;<font style="font-weight: bold; font-style: italic;">Core Company Equityholders</font>&#8221; means Encore DEC, GL Part SPV I, LLC, Randy Soule, RESC Renewables Holdings, LLC and Sky MD, LLC.</div>
      <div style="text-indent: 45pt;">&#160;</div>
      <div style="text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Demanding Holder</font>&#8221; has the meaning given in <u>Section 2.1.4</u>. </div>
      <div style="text-indent: 45pt;"> <br>
      </div>
      <div style="text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Effectiveness Period</font>&#8221; has the meaning given in <u>Section 3.1.1</u>.</div>
      <div style="text-indent: 45pt;"> <br>
      </div>
      <div style="text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Exchange Act</font>&#8221; means the Securities Exchange Act of 1934, as it may be amended from time to time.</div>
      <div style="text-indent: 45pt;">&#160;</div>
      <div style="text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Holder Indemnified Persons</font>&#8221; has the meaning given in <u>Section 4.1</u>. </div>
      <div style="text-indent: 45pt;"> <br>
      </div>
      <div style="text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Holder Information</font>&#8221; has the meaning given in <u>Section 4.2</u>.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">2</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Holders</font>&#8221; has the meaning given in the Preamble hereto, for so long as such Person holds any Registrable Securities.</div>
      <div style="text-indent: 45pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">In-Kind Distribution</font>&#8221; has the meaning given in <u>Section 6.12</u>.</div>
      <div style="text-indent: 45pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Maximum Number of Securities</font>&#8221; has the meaning given in <u>Section 2.1.5</u>. </div>
      <div style="text-align: justify; text-indent: 45pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Minimum Takedown Threshold</font>&#8221; has the meaning given in <u>Section 2.1.4</u>.</div>
      <div style="text-align: justify; text-indent: 45pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Misstatement</font>&#8221; means an untrue statement of a material fact or an omission to state a material fact required to be stated in a
        Registration Statement or Prospectus or necessary to make the statements in a Registration Statement or Prospectus (in the case of a Prospectus, in the light of the circumstances under which they were made) not misleading.</div>
      <div style="text-indent: 45pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">New Registration Statement</font>&#8221; has the meaning given in <u>Section 2.1.1</u>. </div>
      <div style="text-align: justify; text-indent: 45pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Other Coordinated Offering</font>&#8221; has the meaning given in <u>Section 2.3.1</u>.</div>
      <div style="text-align: justify; text-indent: 45pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Person</font>&#8221; means an individual, a corporation, a partnership, limited liability entity, an association, a trust or any other entity or
        organization, including a government, a political subdivision or an agency or instrumentality thereof.</div>
      <div style="text-indent: 45pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Piggyback Registration</font>&#8221; has the meaning given in <u>Section 2.2.1</u>.</div>
      <div style="text-indent: 45pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Private Placement Warrants</font>&#8221; has the meaning given in the Recitals hereto.</div>
      <div style="text-align: justify; text-indent: 45pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Pro Rata</font>&#8221; has the meaning given in <u>Section 2.1.5</u>.</div>
      <div style="text-align: justify; text-indent: 45pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Prospectus</font>&#8221; means the prospectus included in any Registration Statement, as supplemented by any and all prospectus supplements and as
        amended by any and all post-effective amendments and including all material incorporated by reference in such prospectus.</div>
      <div style="text-indent: 45pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Registrable Security</font>&#8221; means (a) any Private Placement Warrants (including any shares of Common Stock issued or issuable upon the
        exercise, tender or redemption of any such Private Placement Warrants) held by a Holder from time to time, (b) any shares of Common Stock or any other equity security (including the shares of Common Stock issued or issuable upon the exercise or
        settlement of any other security or equity award) of the Company held by a Holder from time to time and (c) any other equity security of the Company issued or issuable with respect to any Registrable Security by way of a stock dividend or stock
        split or in connection with a recapitalization, merger, consolidation, spin-off, reorganization or similar transaction held by a Holder from time to time; <u>provided</u>, <u>however</u>, that, as to any particular Registrable Securities, such
        securities shall cease to be Registrable Securities upon the earliest to occur of: (A) a Registration Statement with respect to the sale of such securities shall have become effective under the Securities Act and such securities shall have been
        sold, transferred, disposed of or exchanged in accordance with such Registration Statement by the applicable Holder; (B) such securities shall have ceased to be outstanding; or (C) such securities have been (x) repurchased by the Company or a
        subsidiary of the Company, (y) sold to, or through, a broker, dealer or underwriter in a public distribution or other public securities transaction, including pursuant to Rule 144, or (z) otherwise transferred to a Person who is not entitled to the
        registration and other rights hereunder, with new certificates not bearing a legend restricting further transfer, and subsequent public distribution of such securities shall not require registration under the Securities Act.</div>
      <div style="text-align: justify; text-indent: 45pt;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">3</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Registration</font>&#8221; means a registration, including any related Underwritten Shelf Takedown, effected by preparing and filing a Registration
        Statement, Prospectus or similar document in compliance with the requirements of the Securities Act, and the applicable rules and regulations promulgated thereunder, and such Registration Statement becoming effective.</div>
      <div style="text-indent: 45pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Registration Expenses</font>&#8221; means the out-of-pocket expenses of a Registration, including, without limitation, the following:</div>
      <div style="text-align: justify; text-indent: 45pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 45pt;">(A)&#160;&#160;&#160;&#160;&#160;&#160;&#160; all registration and filing fees (including fees with respect to filings required to be made with the Financial Industry Regulatory Authority, Inc. and any national securities exchange
        on which the Common Stock or Private Placement Warrants are then listed);</div>
      <div style="text-align: justify; text-indent: 45pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 45pt;">(B)&#160;&#160;&#160;&#160;&#160; &#160;&#160; fees and expenses of compliance with securities or blue sky laws (including fees and disbursements of outside counsel for the Underwriters in connection with blue sky qualifications of
        Registrable Securities);</div>
      <div style="text-align: justify; text-indent: 45pt;"> <br>
      </div>
      <div>
        <div style="text-indent: 45pt;">(C)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; printing, messenger, telephone and delivery expenses;</div>
        <div style="text-indent: 45pt;"> <br>
        </div>
      </div>
      <div>
        <div style="text-indent: 45pt;">(D)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; fees and disbursements of counsel for the Company;</div>
        <div style="text-indent: 45pt;"> <br>
        </div>
      </div>
      <div style="text-align: justify; text-indent: 45pt;">(E)&#160;&#160;&#160;&#160;&#160;&#160;&#160; fees and disbursements of all independent registered public accountants of the Company incurred specifically in connection with such Registration (including the expenses or costs
        associated with any annual, quarterly or special audit required and the delivery of any opinions or comfort letters expenses of any annual audit or quarterly review);</div>
      <div style="text-align: justify; text-indent: 45pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 45pt;">(F)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; reasonable fees and expenses of one (1) legal counsel selected jointly by the majority-in-interest of Registrable Securities held by the Demanding Holders initiating an Underwritten
        Offering, the Requesting Holders participating in an Underwritten Offering and the Holders participating in a Piggyback Registration, as applicable;</div>
      <div style="text-align: justify; text-indent: 45pt;"> <br>
      </div>
      <div>
        <div style="text-indent: 45pt;">(G)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; all expenses related to any &#8220;road show&#8221;; and</div>
        <div style="text-indent: 45pt;"> <br>
        </div>
      </div>
      <div style="text-align: justify; text-indent: 45pt;">(H)&#160;&#160;&#160;&#160;&#160;&#160; &#160; the expense of any Securities Act liability insurance or similar insurance, solely to the extent if purchased by the Company in its discretion.</div>
      <div style="text-indent: 45pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Registration Statement</font>&#8221; means any registration statement under the Securities Act that covers the Registrable Securities pursuant to the
        provisions of this Agreement, including the Prospectus included in such registration statement, amendments (including post-effective amendments) and supplements to such registration statement, and all exhibits to and all material incorporated by
        reference in such registration statement.</div>
      <div style="text-indent: 45pt;">&#160;</div>
      <div style="text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Requesting Holders</font>&#8221; has the meaning given in <u>Section 2.1.4</u>.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">4</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Rule 144</font>&#8221; means Rule 144 promulgated under the Securities Act, as amended from time to time, or any similar successor rule thereto that
        may be promulgated by the Commission.</div>
      <div style="text-indent: 45pt;">&#160;</div>
      <div style="text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">SEC Guidance</font>&#8221; has the meaning given in <u>Section 2.1.1</u>.</div>
      <div style="text-indent: 45pt;">&#160;</div>
      <div style="text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Securities Act</font>&#8221; means the Securities Act of 1933, as amended from time to time. </div>
      <div style="text-indent: 45pt;"> <br>
      </div>
      <div style="text-indent: 45pt; text-align: justify;">&#8220;<font style="font-weight: bold; font-style: italic;">Shelf</font>&#8221; means a Shelf Registration on Form S-1, a Shelf Registration on Form S-3 or any Subsequent Shelf Registration, as the case may
        be.</div>
      <div style="text-indent: 45pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Shelf Registration</font>&#8221; means a Registration of Registrable Securities pursuant to a Registration Statement filed with the Commission in
        accordance with and pursuant to Rule 415 promulgated under the Securities Act (or any successor rule then in effect).</div>
      <div style="text-indent: 45pt;">&#160;</div>
      <div style="text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Shelf Takedown Request</font>&#8221; has the meaning given in <u>Section 2.1.4</u>. </div>
      <div style="text-indent: 45pt;"> <br>
      </div>
      <div style="text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Sponsor</font>&#8221; has the meaning given in the Preamble hereto.</div>
      <div style="text-indent: 45pt;"> <br>
      </div>
      <div style="text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Subsequent Shelf Registration</font>&#8221; has the meaning given in <u>Section 2.1.2</u>.</div>
      <div style="text-indent: 45pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Transfer</font>&#8221; means the (a) sale of, offer to sell, contract or agreement to sell, hypothecate, pledge, grant of any option to purchase or
        otherwise dispose of or agreement to dispose of, directly or indirectly, or establishment or increase of a put equivalent position or liquidation with respect to or decrease of a call equivalent position within the meaning of Section 16 of the
        Exchange Act with respect to, any security, (b) entry into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any security, whether any such transaction is to be settled by
        delivery of such securities, in cash or otherwise, or (c) public announcement of any intention to effect any transaction specified in clause (a) or (b).</div>
      <div style="text-indent: 45pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Transferees</font>&#8221; means any person or entity to whom a Holder of Registrable Securities has transferred Registrable Securities (other than in
        connection with a public sale pursuant to a Registration Statement, Rule 144 or otherwise) and has signed a joinder to this Agreement.</div>
      <div style="text-indent: 45pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Underwriter</font>&#8221; means a securities dealer who purchases any Registrable Securities as principal in an Underwritten Offering or as broker,
        placement agent or sales agent pursuant to a Registration and not as part of such dealer&#8217;s market-making activities.</div>
      <div style="text-indent: 45pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Underwritten Offering</font>&#8221; means a Registration in which securities of the Company are sold to an Underwriter in a firm commitment
        underwriting for distribution to the public, including by way of a Block Trade.</div>
      <div style="text-indent: 45pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Underwritten Shelf Takedown</font>&#8221; shall have the meaning given in <u>Section 2.1.4</u>. </div>
      <div style="text-align: justify; text-indent: 45pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 45pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Withdrawal Notice</font>&#8221; has the meaning given in <u>Section 2.1.6</u>.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">5</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;">ARTICLE II </div>
      <div style="text-align: center; font-weight: bold;">REGISTRATIONS AND OFFERINGS</div>
      <div>&#160;</div>
      <div>
        <div style="text-align: justify; text-indent: 45pt;">2.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Registration</u></font>.</div>
        <div style="text-align: justify; text-indent: 45pt;"> <br>
        </div>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">2.1.1&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Shelf Registration</u>. The Company shall, as promptly as reasonably practicable, but in no event later than thirty (30) calendar days from the date of this Agreement, use its
        commercially reasonable efforts to file (at the Company&#8217;s sole cost and expense) a Registration Statement for a Shelf Registration covering the resale of all Registrable Securities (determined as of two (2) business days prior to such filing) on a
        delayed or continuous basis, and shall use its commercially reasonable efforts to cause such Registration Statement to become effective under the Securities Act as soon as reasonably practicable after the filing thereof, but no later than the
        earlier of (i) ninety (90) calendar days (or one-hundred twenty (120) calendar days if the SEC notifies the Company that it will &#8220;review&#8221; the Registration Statement) after the filing thereof and (ii) ten (10) business days after the Company is
        notified (orally or in writing, whichever is earlier) by the SEC that the Registration Statement will not be &#8220;reviewed&#8221; or will not be subject to further review. Such Shelf Registration shall provide for the resale of the Registrable Securities
        included therein pursuant to any method or combination of methods legally available to, and requested by, any Holder named therein. The Company shall maintain the Shelf in accordance with the terms hereof, and shall prepare and file with the
        Commission such amendments, including post-effective amendments, and supplements as may be necessary to keep such Shelf continuously effective, available for use and in compliance with the provisions of the Securities Act until such time as there
        are no longer any Registrable Securities. Subject to the limitations contained in this Agreement, the Company shall effect any Shelf Registration on such appropriate registration form of the Commission (a) as shall be selected by the Company and
        (b) as shall permit the resale or other disposition of the Registrable Securities by the Holders. In the event the Company files a Shelf Registration on Form S-1, the Company shall use its commercially reasonable efforts to convert the Shelf
        Registration on Form S-1 (and any Subsequent Shelf Registration) to a Shelf Registration on Form S-3 as soon as practicable after the Company is eligible to use Form S-3. Notwithstanding the obligations set forth in this <u>Section 2.1.1</u>, in
        the event the Commission informs the Company that all of the Registrable Securities cannot, as a result of the application of Rule 415, be registered for resale as a secondary offering on a single Registration Statement, the Company agrees to
        promptly (x) inform each of the Holders thereof and use its commercially reasonable efforts to file amendments to the Shelf as required by the Commission and/or (y) withdraw the Shelf and file a new registration statement (a &#8220;<font style="font-weight: bold; font-style: italic;">New Registration Statement</font>&#8221;) on Form S-3, or if Form S-3 is not then available to the Company for such registration statement, on such other form available to register for resale the
        Registrable Securities as a secondary offering; <u>provided</u>, <u>however</u>, that prior to filing such amendment or New Registration Statement, the Company shall use its commercially reasonable efforts to advocate with the Commission for the
        registration of all of the Registrable Securities in accordance with any publicly-available written or oral guidance, comments, requirements or requests of the Commission staff (the &#8220;<font style="font-weight: bold; font-style: italic;">SEC Guidance</font>&#8221;).


        Notwithstanding any other provision of this Agreement, if any SEC Guidance sets forth a limitation on the number of Registrable Securities permitted to be registered on a particular Registration Statement as a secondary offering (and
        notwithstanding that the Company used diligent efforts to advocate with the Commission for the registration of all or a greater number of Registrable Securities), unless otherwise directed in writing by a Holder as to further limit its Registrable
        Securities to be included on the Registration Statement, the number of Registrable Securities to be registered on such Registration Statement will be reduced on a pro rata basis based on the total number of Registrable Securities held by the
        Holders, subject to a determination by the Commission that certain Holders must be reduced first based on the number of Registrable Securities held by such Holders. In the event the Company amends the Shelf or files a New Registration Statement, as
        the case may be, under clauses (x) or (y) above, the Company will use its commercially reasonable efforts to file with the Commission, as promptly as allowed by Commission or SEC Guidance provided to the Company or to registrants of securities in
        general, one or more Registration Statements on Form S-3 or such other form available to register for resale those Registrable Securities that were not registered for resale on the Shelf, as amended, or the New Registration Statement.</div>
      <div style="text-align: justify; text-indent: 72pt; margin-right: 7.8pt; margin-left: 5pt;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">6</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">2.1.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Subsequent Shelf Registration</u>. If any Shelf ceases to be effective under the Securities Act for any reason at any time while Registrable Securities are still outstanding, the
        Company shall, subject to <u>Section 3.4</u>, use its commercially reasonable efforts to as promptly as is reasonably practicable cause such Shelf to again become effective under the Securities Act (including using its commercially reasonable
        efforts to obtain the prompt withdrawal of any order suspending the effectiveness of such Shelf), and shall use its commercially reasonable efforts to as promptly as is reasonably practicable amend such Shelf in a manner reasonably expected to
        result in the withdrawal of any order suspending the effectiveness of such Shelf or file an additional Registration Statement as a Shelf Registration (a &#8220;<font style="font-weight: bold; font-style: italic;">Subsequent Shelf Registration</font>&#8221;)
        registering the resale of all Registrable Securities from time to time (determined as of two (2) business days prior to such filing), and pursuant to any method or combination of methods legally available to, and requested by, any Holder named
        therein. If a Subsequent Shelf Registration is filed, the Company shall use its commercially reasonable efforts to (i) cause such Subsequent Shelf Registration to become effective under the Securities Act as promptly as is reasonably practicable
        after the filing thereof (it being agreed that the Subsequent Shelf Registration shall be an automatic shelf registration statement (as defined in Rule 405 promulgated under the Securities Act) if the Company is a &#8220;well-known seasoned issuer&#8221; (as
        defined in Rule 405 promulgated under the Securities Act) at the most recent applicable eligibility determination date) and (ii) keep such Subsequent Shelf Registration continuously effective, available for use to permit the Holders named therein
        to sell their Registrable Securities included therein and in compliance with the provisions of the Securities Act until such time as there are no longer any Registrable Securities. Any such Subsequent Shelf Registration shall be a Shelf
        Registration on Form S-3 to the extent that the Company is eligible to use such form. Otherwise, such Subsequent Shelf Registration shall be on another appropriate form. The Company&#8217;s obligation under this <u>Section 2.1.2</u>, shall, for the
        avoidance of doubt, be subject to <u>Section 3.4</u>.</div>
      <div style="text-align: justify; text-indent: 81pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">2.1.3&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Additional Registrable Securities</u>. In the event that any Holder holds Registrable Securities that are not registered for resale on a delayed or continuous basis, the Company,
        upon written request by such Holder, shall use its commercially reasonable efforts to promptly cause the resale of such Registrable Securities to be covered, at the Company&#8217;s option, by any then available Registration Statement (including by means
        of a prospectus supplement or post-effective amendment) or by filing a Subsequent Shelf Registration (and cause the same to become effective as soon as practicable after such filing) and such Registration Statement or Subsequent Shelf Registration
        shall be subject to the terms hereof; <u>provided</u>, <u>however</u>, that the Company shall only be required to cause such Registrable Securities to be so covered twice per calendar year for the Holders.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">7</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">2.1.4&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Requests for Underwritten Shelf Takedowns</u>. At any time and from time to time when an effective Shelf is on file with the Commission, subject to the provisions of <u>Section
          2.1.5</u> and <u>Section 3.4</u>, a Holder or a group of Holders (such Holder or group of Holders being in such case, a &#8220;<font style="font-weight: bold; font-style: italic;">Demanding Holder</font>&#8221;) may make a written request (a &#8220;<font style="font-weight: bold; font-style: italic;">Shelf Takedown Request</font>&#8221;) to sell all or any portion of its, his, hers or their Registrable Securities in an Underwritten Offering that is registered pursuant to a Shelf in accordance with <u>Section



          2.1.1</u> (each, an &#8220;<font style="font-weight: bold; font-style: italic;">Underwritten Shelf Takedown</font>&#8221;); <u>provided</u>, that the Company shall only be obligated to effect an Underwritten Shelf Takedown if such offering shall include
        Registrable Securities proposed to be sold by the Demanding Holder representing total gross offering proceeds reasonably expected to exceed, in the aggregate (and taking into account all Registrable Securities of other Persons that will be included
        in such Underwritten Shelf Takedown), ten million dollars ($10,000,000) (the &#8220;<font style="font-weight: bold; font-style: italic;">Minimum Takedown Threshold</font>&#8221;). All requests for Underwritten Shelf Takedowns shall be made by giving written
        notice to the Company at least ten (10) business days prior to the public announcement of such Underwritten Shelf Takedown, which shall specify the approximate number of Registrable Securities proposed to be sold in the Underwritten Shelf Takedown.
        The Company shall, within two (2) business days of receiving a Shelf Takedown Request, notify, in writing, all other Holders of such Shelf Takedown Request, and each Holder who thereafter requests to include all or a portion of such Holder&#8217;s
        Registrable Securities in such Underwritten Shelf Takedown (the &#8220;<font style="font-weight: bold; font-style: italic;">Requesting Holders</font>&#8221;) shall so notify the Company, in writing, within two (2) business days (one (1) business day if such
        offering is an overnight or bought Underwritten Offering) of receiving such notice. Upon receipt by the Company of any such written notification from a Requesting Holder(s), such Requesting Holder(s) shall be entitled to have their Registrable
        Securities included in such Underwritten Shelf Takedown pursuant to such Shelf Takedown Request. In such event, the right of any Holder or Requesting Holder to sell Registrable Securities pursuant to this <u>Section</u><u> 2.1.4</u> shall be
        conditioned upon such Holder&#8217;s or Requesting Holder&#8217;s participation in such underwriting and the inclusion of such Holder&#8217;s or Requesting Holder&#8217;s Registrable Securities in the underwriting to the extent provided herein. Notwithstanding the
        foregoing, the Company is not obligated to effect more than one (1) Underwritten Shelf Takedown within ninety (90) calendar days after the closing of an Underwritten Offering (other than a Block Trade or Other Coordinated Offering), provided that
        the Holders participating in the proposed Underwritten Shelf Takedown are not subject to a market stand-off or similar prohibition or limitation in effect as a result of such Underwritten Offering separately entered into by such Holders and the
        Company. The Demanding Holder or Requesting Holder with the greatest number of Registrable Securities included in an Underwritten Shelf Takedown shall have the right to select any managing underwriter(s) (which shall consist of one or more
        reputable nationally recognized investment banks) in connection with such Underwritten Shelf Takedown; <u>provided</u>, that such selection shall be subject to the consent of the Company, which consent shall not be unreasonably withheld and the
        Company shall have no responsibility for engaging any underwriter(s) for an Underwritten Shelf Takedown. For the avoidance of doubt, the provisions of this <u>Section 2.1.4</u> shall not apply to a Piggyback Registration conducted in accordance
        with <u>Section 2.2.1</u> or Block Trades or Other Coordinated Offerings conducted in accordance with <u>Section 2.3</u>.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">8</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">2.1.5&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Reduction of Underwritten Offering</u>. If the managing Underwriter or Underwriters in an Underwritten Shelf Takedown, in good faith, advises or advise the Company, the Demanding
        Holders and the Requesting Holders (if any) in writing that the dollar amount or number of Registrable Securities that the Demanding Holders and the Requesting Holders (if any) desire to sell, taken together with all other shares of Common Stock or
        other equity securities that the Company desires to sell and all other shares of Common Stock or other equity securities, if any, which have been requested to be sold in such Underwritten Offering pursuant to separate written contractual piggy-back
        registration rights held by any other stockholders, exceeds the maximum dollar amount or maximum number of equity securities of the Company that can be sold in the Underwritten Offering without adversely affecting the proposed offering price, the
        timing, the distribution method, or the probability of success of such offering (such maximum dollar amount or maximum number of such securities, as applicable, the &#8220;<font style="font-weight: bold; font-style: italic;">Maximum Number of Securities</font>&#8221;),



        then the Company shall include in such Underwritten Offering, as follows: (i) first, the Registrable Securities of the Demanding Holders and the Requesting Holders (pro rata based on the respective number of Registrable Securities that each such
        Holder has requested be included in such Underwritten Shelf Takedown and the aggregate number of Registrable Securities that all such Holders have requested be included in such Underwritten Shelf Takedown (such proportion is referred to herein as &#8220;<font style="font-weight: bold; font-style: italic;">Pro Rata</font>&#8221;)) that can be sold without exceeding the Maximum Number of Securities; (ii) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing <u>clause



          (i)</u>, the shares of Common Stock or other equity securities of the Company that the Company desires to sell and that can be sold without exceeding the Maximum Number of Securities; and (ii) third, to the extent that the Maximum Number of
        Securities has not been reached under the foregoing <u>clauses (i) and (ii)</u>, the shares of Common Stock or other equity securities of the Company held by other persons or entities that the Company is obligated to register in a Registration
        pursuant to separate written contractual arrangements with such persons or entities and that can be sold without exceeding the Maximum Number of Securities.</div>
      <div style="text-align: justify; text-indent: 81pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">2.1.6&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Underwritten Offering Withdrawal</u>. Prior to the filing of the applicable &#8220;red herring&#8221; prospectus or prospectus supplement used for marketing such Underwritten Shelf Takedown, a
        Holder shall have the right to withdraw from such Underwritten Shelf Takedown for any or no reason whatsoever upon written notification (a &#8220;<font style="font-weight: bold; font-style: italic;">Withdrawal Notice</font>&#8221;) to the Company and the
        Underwriter or Underwriters (if any) of their intention to withdraw from such Underwritten Shelf Takedown; <u>provided</u> that the other Holders participating in such Underwritten Shelf Takedown may elect to have the Company continue an
        Underwritten Shelf Takedown if the Minimum Takedown Threshold would still be satisfied by the Registrable Securities proposed to be sold in the Underwritten Shelf Takedown by such Holders. If withdrawn, a demand for an Underwritten Offering shall
        constitute a demand for an Underwritten Offering by the withdrawing Demanding Holder for purposes of <u>Section 2.1.4</u>, unless either (i) such Demanding Holder reimburses the Company for all Registration Expenses with respect to such
        Underwritten Offering (or, if there is more than one Demanding Holder, a pro rata portion of such Registration Expenses based on the respective number of Registrable Securities that each Demanding Holder has requested be included in such
        Underwritten Offering), or (ii) the non-withdrawing Holders elect to have the Company continue the Underwritten Shelf Takedown. Following the receipt of any Withdrawal Notice, the Company shall promptly forward such Withdrawal Notice to any other
        Holders that had elected to participate in such Underwritten Shelf Takedown. Notwithstanding anything to the contrary in this Agreement, the Company shall be responsible for the Registration Expenses incurred in connection with an Underwritten
        Shelf Takedown prior to its withdrawal under this <u>Section 2.1.6</u>, other than if a Demanding Holder elects to pay such Registration Expenses pursuant to clause (ii) of the second sentence of this <u>Section 2.1.6</u>.</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">9</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div>
        <div style="text-align: justify; text-indent: 45pt;">2.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Piggyback Registration</u></font>.</div>
        <div style="text-align: justify; text-indent: 45pt;"> <br>
        </div>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">2.2.1&#160;&#160;&#160; &#160;&#160; <u>Piggyback Rights</u>. Subject to the provisions of <u>Section 2.2.2</u>, and <u>Section&#160;2.3.3</u>, if the Company proposes, for its own account or for the account of
        securityholders of the Company that are not Holders, to conduct a registered offering of, or if the Company proposes to file a Registration Statement that may be used for any registration of its securities (other than a Registration Statement (or
        any registered offering with respect thereto) (i) filed in connection with any employee stock option or other benefit plan, (ii) pursuant to a Registration Statement on Form S-4 (or similar form that relates to a transaction subject to Rule 145
        under the Securities Act or any successor rule thereto), (iii) for an offering of non-convertible debt securities of the Company or (iv) for a dividend reinvestment plan), for its own account or for the account of securityholders of the Company
        (but not including an Underwritten Shelf Takedown pursuant to <u>Section 2.1</u> or a Block Trade or Other Coordinated Offering pursuant to <u>Section 2.3</u>) then the Company shall give prompt written notice of such proposed offering to all of
        the Holders of Registrable Securities as soon as practicable, which notice shall (A) describe the amount and type of securities to be included in such offering, the intended method(s) of distribution, and the name of the proposed managing
        Underwriter or Underwriters, if any, in such offering, and (B) offer to all of the Holders of Registrable Securities the opportunity to include in such registered offering such number of Registrable Securities as such Holders may request in writing
        within two (2) business days (one (1) business day if such offering is an overnight or bought Underwritten Offering), in each case, after receipt of such written notice (such Registration, a &#8220;<font style="font-weight: bold; font-style: italic;">Piggyback

          Registration</font>&#8221;). Subject to <u>Section 2.2.2</u>, the Company shall cause the Registrable Securities proposed to be included in such Piggyback Registration by a Holder to be included in such Piggyback Registration and, if applicable, shall
        use its commercially reasonable efforts to cause the managing Underwriter or Underwriters of such Piggyback Registration to permit the Registrable Securities requested by such Holders pursuant to this <u>Section 2.2.1</u> to be included therein on
        the same terms and conditions as any similar securities of the Company included in such Piggyback Registration and to permit the resale or other disposition of such Registrable Securities in accordance with the intended method(s) of distribution
        thereof. For the avoidance of doubt, the provisions set forth in this <u>Section 2.2.1</u> shall not apply to an Underwritten Shelf Takedown conducted in accordance with <u>Section 2.1.4</u> or Block Trades or Other Coordinated Offerings
        conducted in accordance with <u>Section 2.3</u>. </div>
      <div style="text-align: justify; margin-right: 7.85pt; margin-left: 5pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">2.2.2&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Reduction of Piggyback Registration</u>. If the managing Underwriter or Underwriters in an Underwritten Offering that is to be a Piggyback Registration, in good faith, advises the
        Company and the Holders participating in the Piggyback Registration in writing that the dollar amount or number of shares of Common Stock or other equity securities of the Company that the Company desires to sell, taken together with (i) the shares
        of Common Stock or other equity securities of the Company, if any, as to which the Underwritten Offering has been demanded pursuant to separate written contractual arrangements with Persons other than the Holders of Registrable Securities
        hereunder, (ii) the Registrable Securities as to which a Piggyback Registration has been requested pursuant to <u>Section 2.2</u> hereof, and (iii) the shares of Common Stock or other equity securities of the Company, if any, as to which inclusion
        in the Underwritten Offering has been requested pursuant to separate written contractual piggy-back registration rights of other stockholders of the Company, exceeds the Maximum Number of Securities, then:</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">10</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 126pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160; If the Underwritten Offering is undertaken for the Company&#8217;s account, the Company shall include in any such Underwritten Offering (A) first, the shares of Common Stock or other equity
        securities of the Company that the Company desires to sell, which can be sold without exceeding the Maximum Number of Securities; (B) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing <u>clause
          (A)</u>, the Registrable Securities of Holders requesting a Piggyback Registration pursuant to <u>Section 2.2.1</u>, Pro Rata, which can be sold without exceeding the Maximum Number of Securities; (C) third, to the extent that the Maximum Number
        of Securities has not been reached under the foregoing <u>clauses (A)</u> and <u>(B)</u>, the shares of Common Stock or other equity securities of the Company, if any, as to which inclusion in the Underwritten Offering has been requested pursuant
        to written contractual piggy-back registration rights of other stockholders of the Company, which can be sold without exceeding the Maximum Number of Securities; and</div>
      <div style="text-align: justify; text-indent: 117pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 126pt;">(b)&#160;&#160;&#160;&#160;&#160; If the Underwritten Offering is pursuant to a request by Persons other than the Holders of Registrable Securities, then the Company shall include in any such Underwritten Offering (A)
        first, the shares of Common Stock or other equity securities of the Company, if any, of such requesting Persons, other than the Holders of Registrable Securities, which can be sold without exceeding the Maximum Number of Securities; (B) second, to
        the extent that the Maximum Number of Securities has not been reached under the foregoing <u>clause (A)</u>, the Registrable Securities of Holders requesting a Piggyback Registration pursuant to <u>Section 2.2.1</u>, Pro Rata, which can be sold
        without exceeding the Maximum Number of Securities; (C) third, to the extent that the Maximum Number of Securities has not been reached under the foregoing <u>clauses (A)</u> and <u>(B)</u>, the shares of Common Stock or other equity securities
        of the Company that the Company desires to sell, which can be sold without exceeding the Maximum Number of Securities; and (D) fourth, to the extent that the Maximum Number of Securities has not been reached under the foregoing <u>clauses (A)</u>,
        <u>(B)</u> and <u>(C)</u>, the shares of Common Stock or other equity securities of the Company for the account of other Persons that the Company is obligated to register pursuant to separate written contractual arrangements with such Persons,
        which can be sold without exceeding the Maximum Number of Securities.</div>
      <div style="text-align: justify; text-indent: 117pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">2.2.3&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Piggyback Registration Withdrawal</u>. Any Holder shall have the right to withdraw from a Piggyback Registration for any or no reason whatsoever upon written notification to the
        Company and the Underwriter or Underwriters (if any) of his, her or its intention to withdraw from such Piggyback Registration prior to the filing of the applicable &#8220;red herring&#8221; prospectus or prospectus supplement with respect to such Piggyback
        Registration used for marketing such transaction. The Company (whether on its own good faith determination or as the result of a request for withdrawal by Persons pursuant to separate written contractual obligations) may withdraw a Registration
        Statement filed with the Commission in connection with a Piggyback Registration (which, in no circumstance, shall include the Shelf) at any time prior to the effectiveness of such Registration Statement. Notwithstanding anything to the contrary in
        this Agreement, the Company shall be responsible for the Registration Expenses incurred in connection with the Piggyback Registration prior to its withdrawal under this <u>Section 2.2.3</u>.</div>
      <div style="text-align: justify; text-indent: 81pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">2.2.4&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Unlimited Piggyback Registration Rights</u>. For purposes of clarity, any Piggyback Registration effected pursuant to <u>Section 2.2</u> hereof shall not be counted
        as a demand for an Underwritten Shelf Takedown effected pursuant to a Shelf Takedown Request under <u>Section</u><u> 2.1.4</u> hereof.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">11</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div>
        <div style="text-align: justify; text-indent: 45pt;">2.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Block Trades; Other Coordinated Offerings</u></font>.</div>
        <div style="text-align: justify; text-indent: 45pt;"> <br>
        </div>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">2.3.1&#160;&#160;&#160;&#160; &#160; &#160; Notwithstanding any other provision of this <u>Article II</u>, but subject to <u>Section</u>&#160;<u>3.4</u>, at any time and from time to time when an effective Shelf is on file with
        the Commission, if a Holder wishes to engage in (a) an Underwritten Offering not involving a &#8220;road show,&#8221; and not requiring the delivery of a comfort letter or an opinion of counsel by the Company to the underwriter or underwriters of such
        Underwritten Offering (a &#8220;<font style="font-weight: bold; font-style: italic;">Block Trade</font>&#8221;) or (b) an &#8220;at the market&#8221; or similar registered offering through a broker, sales agent or distribution agent, whether as agent or principal with a
        total offering price reasonably expected to exceed, in the aggregate, either (x) five million dollars ($5,000,000) or (y) all remaining Registrable Securities held by such Demanding Holder (an &#8220;<font style="font-weight: bold; font-style: italic;">Other


          Coordinated Offering</font>&#8221;), then notwithstanding the time periods provided for in <u>Section 2.2.1</u>, if such Demanding Holder requires any assistance from the Company pursuant to this <u>Section 2.3</u> such Holder only needs to notify
        the Company of the Block Trade or Other Coordinated Offering at least five (5) business days prior to the day such offering is to commence and the Company shall as promptly as is reasonably practicable, use its commercially reasonable efforts to
        facilitate such Block Trade or Other Coordinated Offering; <u>provided</u> that the Holder wishing to engage in the Block Trade or Other Coordinated Offering shall use its commercially reasonable efforts to work with the Company and any
        Underwriters prior to making such request in order to facilitate preparation of the registration statement, prospectus and other offering documentation related to such Block Trade or Other Coordinated Offering.</div>
      <div style="text-align: justify; text-indent: 81pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">2.3.2&#160;&#160;&#160;&#160;&#160;&#160;&#160; Prior to pricing of any Block Trade or the filing of the applicable &#8220;red herring&#8221; prospectus or prospectus supplement used in connection with an Other Coordinated Offering, the Holder
        that initiated such Block Trade or Other Coordinated Offering shall have the right to submit a Withdrawal Notice to the Company and the Underwriter or Underwriters (if any) of their intention to withdraw from such Block Trade or Other Coordinated
        Offering. Notwithstanding anything to the contrary in this Agreement, the Company shall be responsible for the Registration Expenses incurred in connection with a Block Trade or Other Coordinated Offering prior to its withdrawal under this <u>Section



          2.3.2</u>.</div>
      <div style="text-align: justify; text-indent: 81pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">2.3.3&#160;&#160;&#160;&#160;&#160;&#160; &#160; Notwithstanding anything to the contrary in this Agreement, <u>Section 2.2</u> hereof shall not apply to a Block Trade or Other Coordinated Offering initiated by a Holder pursuant to
        this Agreement.</div>
      <div style="text-align: justify; text-indent: 81pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">2.3.4&#160;&#160;&#160;&#160;&#160;&#160;&#160; A Holder wishing to engage in a Block Trade or Other Coordinated Offering shall have the right to select the Underwriters (which shall consist of one or more reputable nationally
        recognized investment banks) in connection with such Block Trade or Other Coordinated Offering, <u>provided</u> that such selection shall be subject to the consent of the Company, which consent shall not be unreasonably withheld.</div>
      <div style="text-align: justify; text-indent: 81pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">2.3.5&#160;&#160;&#160;&#160;&#160;&#160;&#160; For the avoidance of doubt, any Block Trade or Other Coordinated Offering effected pursuant to this <u>Section 2.3</u> shall not be counted as a demand for an Underwritten Offering
        pursuant to <u>Section 2.1.4</u>.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">12</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 45pt;">2.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Market Stand-off</u>. </font>In connection with any Underwritten Offering of equity securities of the Company (other than a Block Trade or Other
        Coordinated Offering), if reasonably requested by the Underwriters, each Holder that directly or indirectly holds more than 5% of the outstanding Common Stock (giving effect to the exercise of any equity or equity-linked securities held by such
        Holder) agrees that it shall not Transfer any shares of Common Stock or other equity securities of the Company (other than those included in such offering pursuant to this Agreement), without the prior written consent of the Company, during the
        ninety (90) calendar day period (or such shorter time agreed to by the Underwriters) beginning on the date of pricing of such offering; <u>provided</u> that each such Holder shall only be subject to the restriction set forth in this <u>Section
          2.4</u> if the directors and officers of the Company are subject to a lock-up obligation to the Underwriters managing the offering and the length of such lock-up for such Holder shall be no longer than the shortest lock-up of any such directors
        and officers; <u>provided</u>, <u>further</u>, that if the Company or the underwriters of such Underwritten Offering waive or shorten the lock-up period for any of the Company&#8217;s officers, directors or stockholders, then (i) all Holders subject to
        such lock-up shall receive notice of such waiver or modification no later than two (2) business days following such waiver or modification, and (ii) such lock-up will be similarly waived or shortened for each such Holder. Each Holder, if
        applicable, agrees to execute a customary lock-up agreement in favor of the Underwriters to such effect (in each case on substantially the same terms and conditions as all such Holders).</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">ARTICLE III </div>
      <div style="text-align: center; font-weight: bold;">COMPANY PROCEDURES</div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 45pt;">3.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>General Procedures</u></font>. The Company shall use its commercially reasonable efforts to effect such Registration or Underwritten Offering to
        permit the resale or other disposition of such Registrable Securities in accordance with the intended plan of distribution thereof, and pursuant thereto the Company shall:</div>
      <div style="text-align: justify; text-indent: 45pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">3.1.1&#160;&#160;&#160;&#160;&#160; &#160;&#160; prepare and file with the Commission as soon as is reasonably practicable a Registration Statement with respect to such Registrable Securities and use its commercially reasonable
        efforts to cause such Registration Statement to become effective in accordance with <u>Section 2.1</u> and remain effective until all Registrable Securities covered by such Registration Statement have ceased to be Registrable
        Securities (such period, the &#8220;<font style="font-weight: bold; font-style: italic;">Effectiveness Period</font>&#8221;);</div>
      <div style="text-align: justify; text-indent: 81pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">3.1.2&#160;&#160;&#160;&#160;&#160;&#160; prepare and file with the Commission such amendments and post-effective amendments to the Registration Statement, and such supplements to the Prospectus, as may be reasonably requested
        by the Holders or any Underwriter of Registrable Securities or as may be required by the rules, regulations or instructions applicable to the registration form used by the Company or by the Securities Act or rules and regulations thereunder to keep
        the Registration Statement effective until all Registrable Securities covered by such Registration Statement are sold in accordance with the plan of distribution set forth in such Registration Statement or supplement to the Prospectus or are no
        longer outstanding;</div>
      <div style="text-align: justify; text-indent: 81pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">3.1.3&#160;&#160;&#160;&#160;&#160;&#160; &#160; prior to filing a Registration Statement or Prospectus, or any amendment or supplement thereto, furnish without charge to the Underwriters, if any, and the Holders of Registrable
        Securities included in such Registration or Underwritten Offering or Block Trade, and such Holders&#8217; legal counsel, copies of such Registration Statement as proposed to be filed, each amendment and supplement to such Registration Statement (in each
        case including all exhibits thereto and documents incorporated by reference therein), the Prospectus included in such Registration Statement (including each preliminary Prospectus), and such other documents as the Underwriters and the Holders of
        Registrable Securities included in such Registration or Underwritten Offering or the legal counsel for any such Holders may reasonably request in order to facilitate the disposition of the Registrable Securities owned by such Holders; <u>provided</u>
        that the Company will not have any obligation to provide any document pursuant to this <u>Section 3.1.3</u> that is available on the Commission&#8217;s Electronic Data Gathering, Analysis and Retrieval (&#8220;<font style="font-weight: bold; font-style: italic;">EDGAR</font>&#8221;) System;
        <div><br>
        </div>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">13</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">3.1.4&#160;&#160;&#160;&#160;&#160; &#160; prior to any Underwritten Offering of Registrable Securities, use its commercially reasonable efforts to (i) register or qualify the Registrable Securities covered by the Registration
        Statement under such securities or &#8220;<font style="font-weight: bold; font-style: italic;">blue sky</font>&#8221; laws of such jurisdictions in the United States as the Holders of Registrable Securities included in such Registration Statement (in light of
        their intended plan of distribution) may request (or provide evidence satisfactory to such Holders that the Registrable Securities are exempt from such registration or qualification) and (ii) take such action necessary to cause such Registrable
        Securities covered by the Registration Statement to be registered with or approved by such other governmental authorities as may be necessary by virtue of the business and operations of the Company and do any and all other acts and things that may
        be necessary or advisable to enable the Holders of Registrable Securities included in such Registration Statement to consummate the disposition of such Registrable Securities in such jurisdictions; <u>provided</u>, <u>however</u>, that the
        Company shall not be required to qualify generally to do business in any jurisdiction where it would not otherwise be required to qualify or take any action to which it would be subject to general service of process or taxation in any such
        jurisdiction where it is not then otherwise so subject;</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">3.1.5&#160;&#160;&#160;&#160;&#160; &#160;&#160; cause all such Registrable Securities to be listed on each national securities exchange on which similar securities issued by the Company are then listed;</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">3.1.6&#160;&#160;&#160;&#160; &#160;&#160; provide a transfer agent or warrant agent, as applicable, and registrar for all such Registrable Securities no later than the effective date of such Registration Statement or
        Underwritten Offering;</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">3.1.7&#160;&#160;&#160;&#160;&#160; &#160;&#160; advise each seller of such Registrable Securities, promptly after it shall receive notice or obtain knowledge thereof, of the issuance of any stop order by the Commission suspending
        the effectiveness of such Registration Statement or the initiation or threatening of any proceeding for such purpose and promptly use its commercially reasonable efforts to prevent the issuance of any stop order or to obtain its withdrawal if such
        stop order should be issued;</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">3.1.8&#160;&#160;&#160;&#160;&#160;&#160; &#160; during the Effectiveness Period (or such shorter period of time as may be necessary in order to comply with the Securities Act, the Exchange Act, and the rules and regulations
        promulgated under the Securities Act or Exchange Act, as applicable), furnish a conformed copy of each filing of any Registration Statement or Prospectus or any amendment or supplement to such Registration Statement or Prospectus to each seller of
        such Registrable Securities or its counsel (excluding any exhibits thereto and any filing made under the Exchange Act that is to be incorporated by reference therein); <u>provided</u> that the Company will not have any obligation to provide any
        document pursuant to this <u>Section 3.1.8</u> that is available on the Commission&#8217;s EDGAR System;</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">14</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">3.1.9&#160;&#160;&#160;&#160;&#160;&#160; notify the Holders at any time when a Prospectus relating to such Registration Statement is required to be delivered under the Securities Act, of the happening of any event as a result
        of which the Prospectus included in such Registration Statement, as then in effect, includes a Misstatement, and then to correct such Misstatement as set forth in <u>Section 3.4</u> hereof;</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">3.1.10&#160;&#160; &#160; &#160; in the event of an Underwritten Offering, a Block Trade or an Other Coordinated Offering, permit a representative of the Holders (such representative to be selected by a majority of
        the Holders), the Underwriters, if any, and any attorney or accountant retained by such Holders or Underwriter to participate, at each such Person&#8217;s own expense, in the preparation of the Registration Statement or the Prospectus, and cause the
        Company&#8217;s officers, directors and employees to supply all information reasonably requested by any such representative, Underwriter, attorney or accountant in connection with the Registration; <u>provided</u>, <u>however</u>, that such
        representatives or Underwriters agree to confidentiality arrangements in form and substance reasonably satisfactory to the Company, prior to the release or disclosure of any such information;</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">3.1.11 &#160;&#160; &#160;&#160; obtain a comfort letter from the Company&#8217;s independent registered public accountants in the event of an Underwritten Offering (other than a Block Trade) or Other Coordinated Offering,
        in customary form and covering such matters of the type customarily covered by comfort letters as the managing Underwriter may reasonably request, and reasonably satisfactory to a majority-in-interest of the participating Holders;</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">3.1.12&#160;&#160; &#160;&#160; in connection with an Underwritten Offering (other than a Block Trade) or Other Coordinated Offering, on the date the Registrable Securities are delivered for sale pursuant to such
        Registration, obtain an opinion, dated such date, of counsel representing the Company for the purposes of such Registration, addressed to the participating Holders, the placement agent or sales agent, if any, and the Underwriters, if any, covering
        such legal matters with respect to the Registration in respect of which such opinion is being given as the participating Holders, placement agent, sales agent, or Underwriter may reasonably request and as are customarily included in such opinions
        and negative assurance letters, and reasonably satisfactory to a majority- in-interest of the participating Holders;</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">3.1.13&#160; &#160; &#160; in the event of any Underwritten Offering or Other Coordinated Offering, enter into and perform its obligations under an underwriting agreement or similar agreement, in usual and
        customary form, with the managing Underwriter of such offering;</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">3.1.14&#160;&#160; &#160;&#160; make available to its security holders, as soon as reasonably practicable, an earnings statement covering the period of at least twelve (12) months beginning with the first day of the
        Company&#8217;s first full calendar quarter after the effective date of the Registration Statement which satisfies the provisions of Section 11(a) of the Securities Act and Rule 158 thereunder (or any successor rule promulgated thereafter by the
        Commission);</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">3.1.15&#160;&#160;&#160;&#160;&#160; with respect to an Underwritten Shelf Takedown pursuant to <u>Section 2.1.4</u> involving gross proceeds in excess of the Minimum Takedown Threshold, use its commercially reasonable
        efforts to make available senior executives of the Company to participate in customary &#8220;road show&#8221; presentations that may be reasonably requested by the Underwriter in such Underwritten Shelf Takedown; and</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">15</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">3.1.16&#160;&#160;&#160;&#160; otherwise, in good faith, cooperate reasonably with, and take such customary actions as may reasonably be requested by the participating Holders, consistent with the terms of this
        Agreement, in connection with such Registration.</div>
      <div style="text-align: justify; text-indent: 81pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 81pt;">Notwithstanding the foregoing, the Company shall not be required to provide any documents or information to an Underwriter if such Underwriter has not then been named with respect to the applicable
        Underwritten Offering or other offering involving a registration as an Underwriter.</div>
      <div style="text-align: justify; text-indent: 81pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 45pt;">3.2&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-weight: bold;"><u>Registration Expenses</u>. </font>The Registration Expenses in respect of all Registrations shall be borne by the Company. It is acknowledged by
        the Holders that the Holders shall bear all incremental selling expenses relating to the sale of Registrable Securities, such as Underwriters&#8217; commissions and discounts, brokerage fees, Underwriter marketing costs and, other than as set forth in
        the definition of &#8220;<font style="font-weight: bold; font-style: italic;">Registration Expenses</font>,&#8221; all reasonable fees and expenses of any legal counsel representing the Holders.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 45pt;">3.3&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Requirements for Participation in Underwritten Offerings</u>. </font>Notwithstanding anything in this Agreement to the contrary, if any Holder does
        not provide the Company with its requested Holder Information within two (2) business days prior to the filing of the applicable &#8220;red herring&#8221; prospectus or prospectus supplement, the Company may exclude such Holder&#8217;s Registrable Securities from
        the applicable Registration Statement or Prospectus if the Company determines, based on the advice of counsel, that such information is necessary to effect the registration and such Holder continues thereafter to withhold such information. No
        Person may participate in any Underwritten Offering for equity securities of the Company pursuant to a Registration initiated by the Company hereunder unless such Person (i) agrees to sell such Person&#8217;s securities on the basis provided in any
        underwriting arrangements approved by the Company and (ii) completes and executes all customary questionnaires, powers of attorney, indemnities, lock-up agreements, custody agreements, underwriting agreements and other customary documents as may be
        reasonably required under the terms of such underwriting arrangements.</div>
      <div style="text-align: justify; text-indent: 81pt;">&#160;</div>
      <div>
        <div style="text-indent: 45pt;">3.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Suspension of Sales; Adverse Disclosure</u></font>.</div>
        <div style="text-indent: 45pt;"> <br>
        </div>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">3.4.1&#160;&#160;&#160;&#160;&#160;&#160;&#160; Upon receipt of written notice from the Company that a Registration Statement or Prospectus contains a Misstatement, each of the Holders shall forthwith discontinue disposition of
        Registrable Securities until it has received copies of a supplemented or amended Registration Statement or Prospectus correcting the Misstatement (it being understood that the Company hereby covenants to prepare and file such supplement or
        amendment as soon as practicable after the time of such notice), or until he, she or it is advised in writing by the Company that the use of the Registration Statement or Prospectus may be resumed.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">16</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">3.4.2&#160;&#160;&#160;&#160;&#160;&#160;&#160; Subject to <u>Section 3.4.3</u>, if the filing, initial effectiveness (other than with regard to the filing and initial effectiveness of the Shelf required under <u>Section 2.1</u>)
        or continued use of a Registration Statement in respect of any Registration or Underwritten Offering at any time would (a) require the Company to make an Adverse Disclosure, (b) require the inclusion in such Registration Statement of financial
        statements that are unavailable to the Company for reasons beyond the Company&#8217;s control, or (c) in the good faith judgment of the majority of the Board such Registration be seriously detrimental to the Company and the majority of the Board
        concludes as a result that it is essential to defer such filing, initial effectiveness or continued use at such time, the Company may, upon giving prompt written notice of such action to the Holders, delay the filing or initial effectiveness of, or
        suspend use of, such Registration Statement for the shortest period of time determined in good faith by the Company to be necessary for such purpose. In the event the Company exercises its rights under this <u>Section 3.4.2</u>, the Holders agree
        to suspend, immediately upon their receipt of the notice referred to above, their use of the Registration Statement or Prospectus relating to any Registration in connection with any resale or other disposition of Registrable Securities. In
        addition, the Company may delay or suspend continued use of a Registration Statement or Prospectus in respect of a Registration or an Underwritten Offering in order to file and make effective a post-effective amendment to such Registration
        Statement in connection with the filing of the Company&#8217;s Annual Report on Form 10-K.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">3.4.3&#160; &#160;&#160; &#160;&#160; The right to delay or suspend any filing, initial effectiveness or continued use of a Registration Statement pursuant to <u>Section 3.4.2</u> shall be exercised by the Company, in the
        aggregate, not more than two (2) times in any twelve-month period, and any such delay or suspension shall last for no more than sixty (60) consecutive calendar days.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 45pt;">3.5&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-weight: bold;"><u>Reporting Obligations</u>. </font>As long as any Holder shall own Registrable Securities, the Company, at all times while it shall be a reporting
        company under the Exchange Act, covenants to file timely (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to Sections 13(a) or 15(d)
        of the Exchange Act and to promptly furnish the Holders with true and complete copies of all such filings; <u>provided</u> that any documents publicly filed or furnished with the Commission pursuant to the EDGAR System shall be deemed to have been
        furnished or delivered to the Holders pursuant to this <u>Section 3.5</u>. The Company further covenants that it shall take such further action as any Holder may reasonably request, all to the extent required from time to time to enable such
        Holder to resell or otherwise dispose of Registrable Securities held by such Holder without registration under the Securities Act within the limitation of the exemptions provided by Rule 144 promulgated under the Securities Act (or any successor
        rule promulgated thereafter by the Commission), including making available at all times information necessary to enable such Holder to comply with Rule 144. Upon the request of any Holder, the Company shall deliver to such Holder a written
        certification of a duly authorized officer as to whether it has complied with such requirements.</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">ARTICLE IV </div>
      <div style="text-align: center; font-weight: bold;">INDEMNIFICATION AND CONTRIBUTION</div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 45pt;">4.1&#160;&#160;&#160;&#160;&#160; &#160;&#160; The Company agrees to indemnify and hold harmless, to the extent permitted by law, each Holder of Registrable Securities, its officers, directors and agents and each person who controls
        such Holder (within the meaning of the Securities Act) (collectively, the &#8220;<font style="font-weight: bold; font-style: italic;">Holder Indemnified Persons</font>&#8221;) against all losses, claims, damages, liabilities and out-of-pocket expenses
        (including reasonable outside attorneys&#8217; fees) resulting from any Misstatement or alleged Misstatement, except insofar as the same are caused by or contained in any information or affidavit so furnished in writing to the Company by or on behalf of
        such Holder Indemnified Person expressly for use therein.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">17</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 45pt;">4.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In connection with any Registration Statement in which a Holder of Registrable Securities is participating, such Holder shall furnish to the Company in writing such information and
        affidavits with respect to such Holder as the Company reasonably requests for use in connection with any such Registration Statement or Prospectus covering Registrable Securities of such Holder (the &#8220;<font style="font-weight: bold; font-style: italic;">Holder Information</font>&#8221;) and, to the extent permitted by law, shall indemnify the Company, its directors, officers, employees, advisors, representatives and agents and each person who controls the Company (within the meaning of the
        Securities Act) against all losses, claims, damages, liabilities and expenses (including reasonable outside attorneys&#8217; fees and inclusive of all reasonable attorneys&#8217; fees arising out of the enforcement of each such persons&#8217; rights under this <u>Article



          IV</u>) resulting from any Misstatement or alleged Misstatement, but only to the extent that the same are made in reliance on and in conformity with information relating to the Holder so furnished in writing by or on behalf of such Holder
        expressly for use therein; provided, however, that the obligation to indemnify shall be several, not joint and several, among such Holders of Registrable Securities, and the liability of each such selling Holder of Registrable Securities shall be
        in proportion to and limited to the net proceeds received by such selling Holder from the sale of Registrable Securities pursuant to such Registration Statement giving rise to such indemnification obligation.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 45pt;">4.3&#160;&#160;&#160;&#160; &#160; Any Person entitled to indemnification herein shall (i) give prompt written notice to the indemnifying party of any claim with respect to which it seeks indemnification (provided that the
        failure to give prompt notice shall not impair any person&#8217;s right to indemnification hereunder to the extent such failure has not materially prejudiced the indemnifying party) and (ii) unless in such indemnified party&#8217;s reasonable judgment a
        conflict of interest between such indemnified and indemnifying parties may exist with respect to such claim or there may be reasonable defenses available to the indemnified party that are different from or additional to those available to the
        indemnifying party, permit such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the indemnified party. If such defense is assumed, the indemnifying party shall not be subject to any liability for any
        settlement made by the indemnified party without its consent (but such consent shall not be unreasonably withheld). An indemnifying party who is not entitled to, or elects not to, assume the defense of a claim shall not be obligated to pay the fees
        and expenses of more than one counsel for all parties indemnified by such indemnifying party with respect to such claim, unless in the reasonable judgment of any indemnified party a conflict of interest may exist between such indemnified party and
        any other of such indemnified parties with respect to such claim. No indemnifying party shall, without the consent of the indemnified party, not to be unreasonably withheld or delayed, consent to the entry of any judgment or enter into any
        settlement which cannot be settled in all respects by the payment of money (and such money is so paid by the indemnifying party pursuant to the terms of such settlement) or which settlement includes a statement or admission of fault and culpability
        on the part of such indemnified party or which settlement does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability in respect to such claim or litigation.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 45pt;">4.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The indemnification provided for under this Agreement shall remain in full force and effect regardless of any investigation made by or on behalf of the indemnified party or any officer,
        director, employee, advisor, agent, representative, member or controlling person or entity of such indemnified party and shall survive the transfer of securities. The Company and each Holder of Registrable Securities participating in an offering
        also agrees to make such provisions as are reasonably requested by any indemnified party for contribution to such party in the event the Company&#8217;s or such Holder&#8217;s indemnification is unavailable for any reason.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">18</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 45pt;">4.5&#160;&#160;&#160;&#160;&#160;&#160; &#160; If the indemnification provided under <u>Article IV</u> hereof is held by a court of competent jurisdiction to be unavailable to an indemnified party in respect of any losses, claims,
        damages, liabilities and expenses referred to herein, then the indemnifying party, in lieu of indemnifying the indemnified party, shall to the extent permitted by law contribute to the amount paid or payable by the indemnified party as a result of
        such losses, claims, damages, liabilities and expenses in such proportion as is appropriate to reflect the relative fault of the indemnifying party and the indemnified party, as well as any other relevant equitable considerations. The relative
        fault of the indemnifying party and indemnified party shall be determined by a court of law by reference to, among other things, whether the Misstatement or alleged Misstatement relates to information supplied by, such indemnifying party or such
        indemnified party, and the indemnifying party&#8217;s and indemnified party&#8217;s relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission; provided, however, that the liability of any Holder under
        this <u>Section 4.5</u> shall be limited to the amount of the net proceeds received by such Holder in such offering giving rise to such liability. The amount paid or payable by a party as a result of the losses or other liabilities referred to
        above shall be deemed to include, subject to the limitations set forth in <u>Sections 4.1</u>, <u>4.2</u> and <u>4.3</u> above, any legal or other fees, charges or expenses reasonably incurred by such party in connection with any investigation
        or proceeding. The parties hereto agree that it would not be just and equitable if contribution pursuant to this <u>Section 4.5</u> were determined by pro rata allocation or by any other method of allocation, which does not take account of the
        equitable considerations referred to in this <u>Section 4.5</u>. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution pursuant to this <u>Section 4.5</u>
        from any person who was not guilty of such fraudulent misrepresentation.</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">ARTICLE V </div>
      <div style="text-align: center; font-weight: bold;">MISCELLANEOUS</div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 45pt;">5.1&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Notices</u></font>. Any notice or communication under this Agreement must be in writing and given by (i) deposit in the United States mail, addressed
        to the party to be notified, postage prepaid and registered or certified with return receipt requested, (ii) delivery in person or by courier service or sent by overnight mail via a reputable overnight carrier, in each case providing evidence of
        delivery, or (iii) transmission by hand delivery, electronic mail or facsimile. Each notice or communication that is mailed, delivered, or transmitted in the manner described above shall be deemed sufficiently given, served, sent, and received, in
        the case of mailed notices, on the third business day following the date on which it is mailed and, in the case of notices delivered by courier service, hand delivery or overnight, at such time as it is delivered to the addressee (with the delivery
        receipt or the affidavit of messenger) or at such time as delivery is refused by the addressee upon presentation, and in the case of notices delivered by electronic mail, at such time as it is successfully transmitted to the addressee. Any notice
        or communication under this Agreement must be addressed, if to the Company, to: XCF Global, Inc., 2500 CityWest Blvd, Suite 150-138, Houston, TX 77042, Attention: Chief Executive Officer, or by electronic mail to ir@xcf.global, and, if to any
        Holder, at such Holder&#8217;s address as set forth in the Company&#8217;s books and records or such other address as may be designated in writing by such Holder (including on the signature pages hereto). Any party may change its address for notice at any time
        and from time to time by written notice to the other parties hereto, and such change of address shall become effective thirty (30) calendar days after delivery of such notice as provided in this <u>Section 6.1</u>.</div>
      <div style="text-indent: 45pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">19</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">
        <div>
          <div style="text-indent: 45pt;">5.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Assignment; No Third Party Beneficiaries</u></font>.</div>
          <div style="text-indent: 45pt;"> <br>
          </div>
        </div>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">5.2.1&#160;&#160;&#160; &#160; &#160;&#160; This Agreement and the rights, duties and obligations of the Company hereunder may not be assigned or delegated by the Company in whole or in part.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 81pt;">5.2.2&#160;&#160;&#160; &#160;&#160; &#160; Subject to <u>Section 6.2.5</u>, this Agreement and the rights, duties and obligations of a Holder hereunder may be assigned in whole or in part to such Holder&#8217;s Transferees to which
        it transfers Registrable Securities.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">5.2.3&#160;&#160;&#160;&#160;&#160; &#160;&#160; This Agreement and the provisions hereof shall be binding upon and shall inure to the benefit of each of the parties and its successors, which shall include Transferees.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">5.2.4&#160;&#160;&#160;&#160;&#160;&#160;&#160; This Agreement shall not confer any rights or benefits on any Persons that are not parties hereto, other than as expressly set forth in this Agreement and <u>Sections 4</u> and <u>5.3</u>
        hereof.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">5.2.5&#160;&#160; &#160; &#160; &#160; No assignment by any party hereto of such party&#8217;s rights, duties and obligations hereunder shall be binding upon or obligate the Company unless and until the Company shall have
        received (i) written notice of such assignment as provided in <u>Section 6.1</u> hereof and (ii) the written agreement of the assignee, in a form reasonably satisfactory to the Company, to be bound by the terms and provisions of this Agreement
        (which may be accomplished by an addendum or certificate of joinder to this Agreement). Any assignment made other than as provided in this <u>Section 6.2.5</u> shall be null and void.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 45pt;">5.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Counterparts; Electronic Delivery</u></font>. This Agreement (and any other agreements, certificates, instruments and documents delivered pursuant
        to this Agreement) may be executed and delivered in one or more counterparts (including facsimile, electronic mail or other electronic transmission or PDF counterparts), each of which shall be deemed an original, and all of which together shall
        constitute one and the same instrument, but only one of which need be produced. No party shall raise the use of a fax machine or electronic mail to deliver a signature or the fact that any signature or agreement or instrument was transmitted or
        communicated through the use of a fax machine or electronic mail as a defense to the formation or enforceability of a contract and each party forever waives any such defense.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 45pt;">5.4&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Governing Law; Venue</u></font>. NOTWITHSTANDING THE PLACE WHERE THIS AGREEMENT MAY BE EXECUTED BY ANY OF THE PARTIES HERETO, THE PARTIES EXPRESSLY
        AGREE THAT (1) THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, WITHOUT GIVING EFFECT TO ANY CHOICE OF LAW OR CONFLICT OF LAW RULES OR PROVISIONS AND (2) THE VENUE FOR ANY ACTION TAKEN WITH
        RESPECT TO THIS AGREEMENT SHALL BE ANY STATE OR FEDERAL COURT IN THE STATE OF NEW YORK.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 45pt;">5.5&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>TRIAL BY JURY</u></font>. EACH PARTY HERETO ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE
        COMPLICATED AND DIFFICULT ISSUES, AND, THEREFORE, EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT TO ANY ACTION DIRECTLY OR
        INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT.</div>
      <div style="text-align: justify; text-indent: 45pt;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">20</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 45pt;">5.6&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Amendments and Modifications</u>. </font>Upon the written consent of (a) the Company and (b) the Holders of at least a majority in interest of the
        Registrable Securities held by the Holders at the time in question, compliance with any of the provisions, covenants and conditions set forth in this Agreement may be waived, or any of such provisions, covenants or conditions may be amended or
        modified; and provided, however, that notwithstanding the foregoing, (i) any amendment hereto or waiver hereof that adversely affects any Holder, solely in his, her or its capacity as a holder of the shares of capital stock of the Company, in a
        manner that is materially different from the other Holders (in such capacity) shall require the consent of each such Holder so affected and (ii) any amendment or waiver hereof that adversely affects the rights expressly granted to the Sponsor shall
        require the consent of the Sponsor. No course of dealing between any Holder or the Company and any other party hereto or any failure or delay on the part of a Holder or the Company in exercising any rights or remedies under this Agreement shall
        operate as a waiver of any rights or remedies of any Holder or the Company. No single or partial exercise of any rights or remedies under this Agreement by a party shall operate as a waiver or preclude the exercise of any other rights or remedies
        hereunder or thereunder by such party.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 45pt;">5.7&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Other Registration Rights</u></font>. The Company represents and warrants that no Person, other than (i) those Persons that are party to that certain
        registration rights agreement dated as of June 6, 2025, by and among the Company and certain parties thereto and (ii) certain non-redeeming stockholders who have registration rights pursuant to their respective non-redemption agreements, dated as
        of July 31, 2024, with respect to equity securities of the Company issued in the Closing, has any right to require the Company to register any securities of the Company for sale or to include such securities of the Company in any Registration
        Statement filed by the Company for the sale of securities for its own account or for the account of any other person. Further, the Company represents and warrants that this Agreement supersedes any other registration rights agreement or agreement
        with similar terms and conditions and in the event of a conflict between any such agreement or agreements and this Agreement, the terms of this Agreement shall prevail. The Sponsor agrees that this Agreement supersedes the Registration and
        Stockholder Rights Agreement, dated as of October 4, 2021, by and among the SPAC and other parties thereto and the Sponsor shall not have any rights pursuant to such agreement.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 45pt;">5.8&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-weight: bold;"><u>Term</u></font>. This Agreement shall terminate with respect to any Holder on the date that such Holder no longer holds any Registrable Securities.
        The provisions of Article IV shall survive any termination.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 45pt;">5.9&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Holder Information</u></font>. Each Holder agrees, if requested in writing, to represent to the Company the total number of Registrable Securities
        held by such Holder in order for the Company to make determinations hereunder.</div>
      <div><br>
      </div>
      <div style="text-indent: 45pt; text-align: justify;">5.10&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Entire Agreement</u></font>. This Agreement constitutes the entire agreement among the parties with respect to the subject matter hereof and thereof
        and supersede all prior and contemporaneous agreements, understandings and discussions, whether oral or written, relating to such subject matter in any way and there are no warranties, representations or other agreements among the parties in
        connection with such subject matter except as set forth in this Agreement and therein.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">21</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 45pt;">5.11&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Severability</u></font>. It is the desire and intent of the parties that the provisions of this Agreement be enforced to the fullest extent
        permissible under the laws and public policies applied in each jurisdiction in which enforcement is sought. Accordingly, if any particular provision of this Agreement shall be adjudicated by a court of competent jurisdiction to be invalid,
        prohibited or unenforceable for any reason, such provision, as to such jurisdiction, shall be ineffective, without invalidating the remaining provisions of this Agreement or affecting the validity or enforceability of this Agreement or affecting
        the validity or enforceability of such provision in any other jurisdiction. Notwithstanding the foregoing, if such provision could be more narrowly drawn so as not to be invalid, prohibited or unenforceable in such jurisdiction, it shall, as to
        such jurisdiction, be so narrowly drawn, without invalidating the remaining provisions of this Agreement or affecting the validity or enforceability of such provision in any other jurisdiction.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 45pt;">5.12&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>In-Kind Distribution</u></font>. If the Sponsor seeks to effectuate an in-kind distribution of all or part of its Registrable Securities to its
        direct or indirect equityholders (an &#8220;<font style="font-weight: bold; font-style: italic;">In-Kind Distribution</font>&#8221;), the Company will use reasonable best efforts to work with the Sponsor to facilitate such In-Kind Distribution in the manner
        reasonably requested, and shall (i) ensure that the In-Kind Distribution is recorded on the books of the Company&#8217;s transfer agent within two (2) business days of the Sponsor providing notice and the required documentation of the In-Kind
        Distribution and (ii) file a prospectus supplement listing the distributes as the &#8220;selling securityholders&#8221; of the Registrable Securities within ten (10) business days of the receipt of such notice and required documentation. Prior to any In-Kind
        Distribution, each distributee shall deliver to the Company a written acknowledgment and agreement in form and substance reasonably satisfactory to the Company that the distributee will be bound by, and will be a party to, this Agreement; provided,
        however, that a failure by a distributee to deliver such acknowledgment and agreement shall not render such distribution to such distributee void, but such distributee shall not be entitled to the benefits of this Agreement until such time as such
        acknowledgment and agreement is delivered. Upon any In-Kind Distribution, (i) in the event of a distribution of all of the Sponsor&#8217;s Registrable Securities, the distributees holding Registrable Securities equal to a majority-in-interest of the
        Registrable Securities then held by the Sponsor at the time of such distribution shall thereafter be entitled to exercise and enforce the rights specifically granted to the Sponsor hereunder and (ii) each distributee shall be considered a &#8220;Holder&#8221;
        hereunder. </div>
      <div>&#160;</div>
      <div style="text-align: center; margin-right: 2.9pt;">[<font style="font-style: italic;">Signature pages follow</font>]</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">22</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">IN WITNESS WHEREOF, </font><font style="font-size: 10pt;">the undersigned have caused this Agreement to be executed as of the date first written above.</font></div>
      <div style="margin-left: 5pt; font-size: 12pt;"><font style="font-size: 10pt;"> <br>
        </font></div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z087e40f33e0f4f97bb2ce64fd288bbf8">

          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">
              <div style="font-weight: bold;">COMPANY:</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 55%; vertical-align: top;">&#160;</td>
            <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">XCF Global, Inc.</font><font style="font-size: 10pt;">, a Delaware corporation</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 2%; vertical-align: top; padding-bottom: 2px;">
              <div style="margin-right: 5.1pt;">By:</div>
            </td>
            <td style="width: 43%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">/s/ Mihir Dange</td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">
              <div>Name: Mihir Dange</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">
              <div style="text-align: justify; margin-right: 7.85pt;">Title: Chief executive Officer</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt; font-size: 8pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div style="text-align: center; font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">[Signature Page to Registration Rights Agreement]</div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div><font style="font-weight: bold;">IN WITNESS WHEREOF, </font>the undersigned have caused this Agreement to be executed as of the date first written above.</div>
      <div> <br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z61cad449f22f4839b9a6f6aa9caf66ad">

          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">
              <div style="font-weight: bold;">SPONSOR:</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 55%; vertical-align: top;">&#160;</td>
            <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">Focus Impact BHAC Sponsor, LLC</font><font style="font-size: 10pt;">, a Delaware limited liability company</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;">
              <div style="margin-right: 5.1pt;">By:</div>
            </td>
            <td style="width: 43%; vertical-align: top;">
              <div style="margin-right: 5.1pt;"><u>/s/ Wray Thorn</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">
              <div style="margin-right: 5.1pt;">Name: Wray Thorn</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">
              <div>Title: Authorized Signatory</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt; font-size: 8pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div style="text-align: center; font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">[Signature Page to Registration Rights Agreement]</div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">IN WITNESS WHEREOF, </font><font style="font-size: 10pt;">the undersigned have caused this Agreement to be executed as of the date first written above.</font></div>
      <div style="font-size: 12pt;"><font style="font-size: 10pt;"> <br>
        </font></div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zef5a0b188c23479582d1f2583f33f2db">

          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">
              <div style="font-weight: bold;">HOLDER:</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 55%; vertical-align: top;">&#160;</td>
            <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">
              <div style="font-weight: bold;">Encore DEC, LLC</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;">
              <div style="margin-right: 5.1pt;">By:</div>
            </td>
            <td style="width: 43%; vertical-align: top;">
              <div style="margin-right: 5.1pt;"><u>/s/ Randy Soule</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">
              <div style="margin-right: 5.1pt;">Name: Randy Soule</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">
              <div>Title: Manager</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt; font-size: 8pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div style="text-align: center; font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">[Signature Page to Registration Rights Agreement]</div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">IN WITNESS WHEREOF, </font><font style="font-size: 10pt;">the undersigned have caused this Agreement to be executed as of the date first written above.</font></div>
      <div style="font-size: 12pt;"><font style="font-size: 10pt;"> <br>
        </font></div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z414d3c19039f4587963118571c220662">

          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">
              <div style="font-weight: bold;">HOLDER:</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 55%; vertical-align: top;">&#160;</td>
            <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">
              <div style="font-weight: bold;">GL Part SPV I, LLC</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;">
              <div style="margin-right: 5.1pt;">By:</div>
            </td>
            <td style="width: 43%; vertical-align: top;">
              <div style="margin-right: 5.1pt;"><u>/s/ Majique Ladnier</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">
              <div style="margin-right: 5.1pt;">Name: Majique Ladnier</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">
              <div>Title: Sole Member</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt; font-size: 8pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div style="text-align: center; font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">[Signature Page to Registration Rights Agreement]</div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">IN WITNESS WHEREOF, </font><font style="font-size: 10pt;">the undersigned have caused this Agreement to be executed as of the date first written above.</font></div>
      <div style="font-size: 12pt;"><font style="font-size: 10pt;"> <br>
        </font></div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zef8e1610f99d48bba526c93e64224562">

          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td style="width: 45%; vertical-align: top;">
              <div style="font-weight: bold;">HOLDER:</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 55%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 45%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td style="width: 45%; vertical-align: top;">
              <div style="font-weight: bold;">Randy Soule</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 55%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 45%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td style="width: 45%; vertical-align: top;">
              <div><u>/s/ Randy Soule</u></div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt; font-size: 8pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div style="text-align: center; font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">[Signature Page to Registration Rights Agreement]</div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">IN WITNESS WHEREOF, </font><font style="font-size: 10pt;">the undersigned have caused this Agreement to be executed as of the date first written above.</font></div>
      <div style="font-size: 12pt;"><font style="font-size: 10pt;"> <br>
        </font></div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z78f11ecbb9eb40ecb3ed670873dabfa6">

          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">
              <div style="font-weight: bold;">HOLDER:</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 55%; vertical-align: top;">&#160;</td>
            <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">
              <div style="font-weight: bold;">RESC Renewables Holdings, LLC</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;">
              <div style="margin-right: 5.1pt;">By:</div>
            </td>
            <td style="width: 43%; vertical-align: top;">
              <div style="margin-right: 5.1pt;"><u>/s/ Randy Soule</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">
              <div style="margin-right: 5.1pt;">Name: Randy Soule</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">
              <div>Title: Manager</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt; font-size: 8pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div style="text-align: center; font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">[Signature Page to Registration Rights Agreement]</div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">IN WITNESS WHEREOF, </font><font style="font-size: 10pt;">the undersigned have caused this Agreement to be executed as of the date first written above.</font></div>
      <div style="font-size: 12pt;"><font style="font-size: 10pt;"> <br>
        </font></div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z36d0f9e9a4604efbbb470bb507531492">

          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">
              <div style="font-weight: bold;">HOLDER:</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 55%; vertical-align: top;">&#160;</td>
            <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">
              <div style="font-weight: bold;">Sky MD, LLC</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;">
              <div style="margin-right: 5.1pt;">By:</div>
            </td>
            <td style="width: 43%; vertical-align: top;">
              <div style="margin-right: 5.1pt;"><u>/s/ Mihir Dange</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">
              <div style="margin-right: 5.1pt;">Name: Mihir Dange</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">
              <div>Title: Sole Member</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt; font-size: 8pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div style="text-align: center; font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">[Signature Page to Registration Rights Agreement]</div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">IN WITNESS WHEREOF, </font><font style="font-size: 10pt;">the undersigned have caused this Agreement to be executed as of the date first written above.</font></div>
      <div style="font-size: 12pt;"><font style="font-size: 10pt;"> <br>
        </font></div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zf4183c921fcf44a2bff789ed637a7d35">

          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">
              <div style="font-weight: bold;">HOLDER:</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 55%; vertical-align: top;">&#160;</td>
            <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">
              <div style="font-weight: bold;">GL Part SPV II, LLC</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td style="width: 2%; vertical-align: top;">
              <div style="margin-right: 5.1pt;">By:</div>
            </td>
            <td style="width: 43%; vertical-align: top;">
              <div style="margin-right: 5.1pt;"><u>/s/ Majique Ladnier</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">
              <div style="margin-right: 5.1pt;">Name: Majique Ladnier</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">
              <div>Title: Sole Member</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div><br>
      </div>
    </div>
    <div class="BRPFPageFooter" style="width: 100%;">
      <div style="text-align: center; font-weight: normal; color: rgb(0, 0, 0); font-size: 8pt; font-style: normal; font-variant: normal; text-transform: none;">[Signature Page to Registration Rights Agreement]</div>
      <div style="text-align: center; font-weight: normal; color: rgb(0, 0, 0); font-size: 8pt; font-style: normal; font-variant: normal; text-transform: none;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;"> </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.52
<SEQUENCE>7
<FILENAME>ef20050548_ex10-52.htm
<DESCRIPTION>EXHIBIT 10.52
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 10.52</font><br>
    </div>
    <div style="text-align: right;"><font style="font-weight: bold;"> <br>
      </font></div>
    <div>
      <div style="text-align: right; font-style: italic; font-weight: bold;">Execution Version</div>
      <div><br>
      </div>
      <div style="text-align: center; font-weight: bold;">REGISTRATION RIGHTS AGREEMENT</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">This Registration Rights Agreement (as it may be amended, supplemented or restated from time to time in accordance with the terms hereof, this &#8220;<font style="font-weight: bold; font-style: italic;">Agreement</font>&#8221;),


        dated as of June 6, 2025, is made and entered into by and among XCF Global, Inc., a Delaware corporation (formerly known as Focus Impact BH3 NewCo, Inc., the &#8220;<font style="font-weight: bold; font-style: italic;">Company</font>&#8221;) and the undersigned
        parties listed under &#8220;Holder&#8221; on the signature page hereto (each such party, and any person or entity who hereafter becomes a party to this Agreement pursuant to <u>Section 5.2</u> of this Agreement, a <font style="font-style: italic;">&#8220;</font><font style="font-weight: bold; font-style: italic;">Holder</font>&#8221; and collectively the &#8220;<font style="font-weight: bold; font-style: italic;">Holders</font>&#8221;). Except as otherwise stated, capitalized terms used but not otherwise defined herein shall
        have the meanings provided in the Business Combination Agreement (as defined below).</div>
      <div><br>
      </div>
      <div style="text-align: center; font-weight: bold;">RECITALS</div>
      <div><br>
      </div>
      <div style="text-align: justify; font-size: 12pt; text-indent: 36pt;"><font style="font-size: 10pt; font-weight: bold;">WHEREAS</font><font style="font-size: 10pt;">, the Company, Focus Impact BH3 Acquisition Company, a Delaware corporation, Focus
          Impact BH3 Merger Sub 1, LLC, a Delaware limited liability company and wholly owned subsidiary of the Company, Focus Impact BH3 Merger Sub 2, Inc., a Delaware corporation and wholly owned subsidiary of the Company, and XCF Global Capital, Inc., a
          Nevada corporation, entered into that certain Business Combination Agreement, dated as of March 11, 2024 (as amended on November 29, 2024, the &#8220;<font style="font-weight: bold; font-style: italic;">Business Combination Agreement</font>&#8221;), pursuant
          to which the parties to the Business Combination Agreement undertook the transactions described therein (the &#8220;<font style="font-weight: bold; font-style: italic;">Business Combination</font>&#8221;);</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; font-size: 12pt; text-indent: 36pt;"><font style="font-size: 10pt; font-weight: bold;">WHEREAS</font><font style="font-size: 10pt;">, as of the date hereof as a result of the closing of the Business Combination (the &#8220;<font style="font-weight: bold; font-style: italic;">Closing</font>&#8221;), the Holders own shares of the Company&#8217;s Class A common stock, par value $0.0001 per share (the &#8220;<font style="font-weight: bold; font-style: italic;">Common Stock</font>&#8221;); </font></div>
      <div><br>
      </div>
      <div style="text-align: justify; font-size: 12pt; text-indent: 36pt;"><font style="font-size: 10pt; font-weight: bold;">NOW</font><font style="font-size: 10pt;">, <font style="font-weight: bold;">THEREFORE</font>, in consideration of the mutual
          representations, covenants and agreements contained herein, and certain other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as
          follows:</font></div>
      <div><br>
      </div>
      <div style="text-align: center; font-weight: bold;">ARTICLE I </div>
      <div style="text-align: center; font-weight: bold;">DEFINITIONS</div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-indent: 36pt;">1.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Definitions</u></font>. The terms defined in this <u>Article I</u> shall, for all purposes of this Agreement, have the respective meanings set forth below:</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Adverse Disclosure</font>&#8221; means any public disclosure of material non-public information, which disclosure, in the good faith judgment of (i)
        either the Chief Executive Officer or Chief Financial Officer and (ii) the Board of the Company, after consultation with counsel to the Company, (i) would be required to be made in any Registration Statement or Prospectus in order for the
        applicable Registration Statement or Prospectus not to contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements contained therein (in the case of any Prospectus, in the light of the
        circumstances under which they were made) not misleading, (ii) would not be required to be made at such time if the Registration Statement were not being filed, declared effective or used, as the case may be, and (iii) the Company has a bona fide
        business purpose for not making such information public.</div>
      <div style="text-align: justify; text-indent: 36pt;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Agreement</font>&#8221; has the meaning given in the Preamble hereto. </div>
      <div style="text-indent: 36pt;"> <br>
      </div>
      <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Board</font>&#8221; means the board of directors of the Company.</div>
      <div style="margin-right: 112.1pt; margin-left: 41pt;"> <br>
      </div>
      <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Business Combination</font>&#8221; has the meaning given in the Recitals hereto.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Business Combination Agreement</font>&#8221; has the meaning given in the Recitals hereto. </div>
      <div style="margin-left: 41pt;"> <br>
      </div>
      <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Commission</font>&#8221; means the Securities and Exchange Commission.</div>
      <div style="margin-left: 41pt;"> <br>
      </div>
      <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Common Stock</font>&#8221; has the meaning given in the Recitals hereto.</div>
      <div style="margin-left: 41pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Company</font>&#8221; has the meaning given in the Preamble hereto and includes the Company&#8217;s successors by recapitalization, merger, consolidation,
        spin-off, reorganization or similar transaction.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Effectiveness Period</font>&#8221; has the meaning given in <u>Section 3.1.1</u>.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Exchange Act</font>&#8221; means the Securities Exchange Act of 1934, as it may be amended from time to time.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Holder Indemnified Persons</font>&#8221; has the meaning given in <u>Section 4.1</u>. </div>
      <div style="margin-right: 68.95pt; margin-left: 41pt;"> <br>
      </div>
      <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Holder Information</font>&#8221; has the meaning given in <u>Section 4.2</u>.</div>
      <div style="margin-right: 68.95pt; margin-left: 41pt;"> <br>
      </div>
      <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Holders</font>&#8221; has the meaning given in the Preamble hereto, for so long as such Person holds any Registrable Securities.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Misstatement</font>&#8221; means an untrue statement of a material fact or an omission to state a material fact required to be stated in a
        Registration Statement or Prospectus or necessary to make the statements in a Registration Statement or Prospectus (in the case of a Prospectus, in the light of the circumstances under which they were made) not misleading.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold; font-style: italic;">New Registration Statement</font>&#8221; has the meaning given in <u>Section 2.1.1</u>.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Person</font>&#8221; means an individual, a corporation, a partnership, limited liability entity, an association, a trust or any other entity or
        organization, including a government, a political subdivision or an agency or instrumentality thereof.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Prospectus</font>&#8221; means the prospectus included in any Registration Statement, as supplemented by any and all prospectus supplements and as
        amended by any and all post-effective amendments and including all material incorporated by reference in such prospectus.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-right: 7.9pt; margin-left: 5pt;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Registrable Security</font>&#8221; means (a) any shares of Common Stock or any other equity security (including the shares of Common Stock issued or
        issuable upon the exercise or settlement of any other security or equity award) of the Company held by a Holder from time to time and (b) any other equity security of the Company issued or issuable with respect to any Registrable Security by way of
        a stock dividend or stock split or in connection with a recapitalization, merger, consolidation, spin-off, reorganization or similar transaction held by a Holder from time to time;<u> provided</u>, <u>however</u>, that, as to any particular
        Registrable Securities, such securities shall cease to be Registrable Securities upon the earliest to occur of: (A) a Registration Statement with respect to the sale of such securities shall have become effective under the Securities Act and such
        securities shall have been sold, transferred, disposed of or exchanged in accordance with such Registration Statement by the applicable Holder; (B) such securities shall have ceased to be outstanding; or (C) such securities have been (x)
        repurchased by the Company or a subsidiary of the Company, (y) sold to, or through, a broker, dealer or underwriter in a public distribution or other public securities transaction, including pursuant to Rule 144, or (z) otherwise transferred to a
        Person who is not entitled to the registration and other rights hereunder, with new certificates not bearing a legend restricting further transfer, and subsequent public distribution of such securities shall not require registration under the
        Securities Act. </div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Registration</font>&#8221; means a registration effected by preparing and filing a Registration Statement, Prospectus or similar document in
        compliance with the requirements of the Securities Act, and the applicable rules and regulations promulgated thereunder, and such Registration Statement becoming effective.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Registration Expenses</font>&#8221; means the out-of-pocket expenses of a Registration, including, without limitation, the following:</div>
      <div style="text-align: justify; text-indent: 36pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">(A)&#160;&#160;&#160;&#160; &#160;&#160; all registration and filing fees (including fees with respect to filings required to be made with the Financial Industry Regulatory Authority, Inc. and any national securities exchange
        on which the Common Stock is then listed);</div>
      <div>
        <div>(B)fees and expenses of compliance with securities or blue sky laws;</div>
        <div> <br>
        </div>

      </div>
      <div>
        <div style="margin-left: 72pt;">(C)&#160;&#160;&#160;&#160;&#160; &#160; &#160; printing, messenger, telephone and delivery expenses;</div>
        <div> <br>
        </div>

      </div>
      <div>
        <div style="margin-left: 72pt;">(D)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; fees and disbursements of counsel for the Company;</div>
        <div> <br>
        </div>

      </div>
      <div style="text-align: justify; text-indent: 72pt;">(E)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;fees and disbursements of all independent registered public accountants of the Company incurred specifically in connection with such Registration (including the expenses or costs
        associated with any annual, quarterly or special audit required and the delivery of any opinions or comfort letters expenses of any annual audit or quarterly review); and</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">(H) &#160; &#160; &#160;&#160; &#160; the expense of any Securities Act liability insurance or similar insurance, solely to the extent if purchased by the Company in its discretion.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Registration Statement</font>&#8221; means any registration statement under the Securities Act that covers the Registrable Securities pursuant to the
        provisions of this Agreement, including the Prospectus included in such registration statement, amendments (including post-effective amendments) and supplements to such registration statement, and all exhibits to and all material incorporated by
        reference in such registration statement.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Rule 144</font>&#8221; means Rule 144 promulgated under the Securities Act, as amended from time to time, or any similar successor rule thereto that
        may be promulgated by the Commission.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold; font-style: italic;">SEC Guidance</font>&#8221; has the meaning given in <u>Section 2.1.1</u>.</div>
      <div style="text-indent: 36pt;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Securities Act</font>&#8221; means the Securities Act of 1933, as amended from time to time.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Shelf</font>&#8221; means a Shelf Registration on Form S-1, a Shelf Registration on Form S-3 or any Subsequent Shelf Registration, as the case may
        be.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Shelf Registration</font>&#8221; means a Registration of Registrable Securities pursuant to a Registration Statement filed with the Commission in
        accordance with and pursuant to Rule 415 promulgated under the Securities Act (or any successor rule then in effect).</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Subsequent Shelf Registration</font>&#8221; has the meaning given in <u>Section 2.1.2</u>.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Transfer</font>&#8221; means the (a) sale of, offer to sell, contract or agreement to sell, hypothecate, pledge, grant of any option to purchase or
        otherwise dispose of or agreement to dispose of, directly or indirectly, or establishment or increase of a put equivalent position or liquidation with respect to or decrease of a call equivalent position within the meaning of Section 16 of the
        Exchange Act with respect to, any security, (b) entry into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any security, whether any such transaction is to be settled by
        delivery of such securities, in cash or otherwise, or (c) public announcement of any intention to effect any transaction specified in clause (a) or (b).</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">&#8220;<font style="font-weight: bold; font-style: italic;">Transferees</font>&#8221; means any person or entity to whom a Holder of Registrable Securities has transferred Registrable Securities (other than in
        connection with a public sale pursuant to a Registration Statement, Rule 144 or otherwise) and has signed a joinder to this Agreement.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-right: 7.85pt; margin-left: 5pt;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="font-weight: bold; text-align: center;">ARTICLE II </div>
      <div style="font-weight: bold; text-align: center;">REGISTRATIONS AND OFFERINGS</div>
      <div><br>
      </div>
      <div>
        <div style="margin-left: 36pt;">2.1<font style="font-weight: bold;">&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Registration</u></font>.</div>

      </div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.1.1&#160;&#160;&#160;&#160;&#160;&#160; <u>Shelf Registration</u>. The Company shall, as promptly as reasonably practicable, but in no event later than thirty (30) calendar days from the date of this Agreement, use its
        commercially reasonable efforts to file (at the Company&#8217;s sole cost and expense) a Registration Statement for a Shelf Registration covering the resale of all Registrable Securities (determined as of two (2) business days prior to such filing) on a
        delayed or continuous basis, and shall use its commercially reasonable efforts to cause such Registration Statement to become effective under the Securities Act as soon as reasonably practicable after the filing thereof, but no later than the
        earlier of (i) ninety (90) calendar days (or one-hundred twenty (120) calendar days if the SEC notifies the Company that it will &#8220;review&#8221; the Registration Statement) after the filing thereof and (ii) ten (10) business days after the Company is
        notified (orally or in writing, whichever is earlier) by the SEC that the Registration Statement will not be &#8220;reviewed&#8221; or will not be subject to further review. Such Shelf Registration shall provide for the resale of the Registrable Securities
        included therein pursuant to any method or combination of methods legally available to, and requested by, any Holder named therein. The Company shall maintain the Shelf in accordance with the terms hereof, and shall prepare and file with the
        Commission such amendments, including post-effective amendments, and supplements as may be necessary to keep such Shelf continuously effective, available for use and in compliance with the provisions of the Securities Act until such time as there
        are no longer any Registrable Securities. Subject to the limitations contained in this Agreement, the Company shall effect any Shelf Registration on such appropriate registration form of the Commission (a) as shall be selected by the Company and
        (b) as shall permit the resale or other disposition of the Registrable Securities by the Holders. In the event the Company files a Shelf Registration on Form S-1, the Company shall use its commercially reasonable efforts to convert the Shelf
        Registration on Form S-1 (and any Subsequent Shelf Registration) to a Shelf Registration on Form S-3 as soon as practicable after the Company is eligible to use Form S-3. Notwithstanding the obligations set forth in this <u>Section 2.1.1</u>, in
        the event the Commission informs the Company that all of the Registrable Securities cannot, as a result of the application of Rule 415, be registered for resale as a secondary offering on a single Registration Statement, the Company agrees to
        promptly (x) inform each of the Holders thereof and use its commercially reasonable efforts to file amendments to the Shelf as required by the Commission and/or (y) withdraw the Shelf and file a new registration statement (a &#8220;<font style="font-weight: bold; font-style: italic;">New Registration Statement</font>&#8221;) on Form S-3, or if Form S-3 is not then available to the Company for such registration statement, on such other form available to register for resale the
        Registrable Securities as a secondary offering; <u>provided</u>, <u>however</u>, that prior to filing such amendment or New Registration Statement, the Company shall use its commercially reasonable efforts to advocate with the Commission for the
        registration of all of the Registrable Securities in accordance with any publicly-available written or oral guidance, comments, requirements or requests of the Commission staff (the &#8220;<font style="font-weight: bold; font-style: italic;">SEC Guidance</font>&#8221;).


        Notwithstanding any other provision of this Agreement, if any SEC Guidance sets forth a limitation on the number of Registrable Securities permitted to be registered on a particular Registration Statement as a secondary offering (and
        notwithstanding that the Company used diligent efforts to advocate with the Commission for the registration of all or a greater number of Registrable Securities), unless otherwise directed in writing by a Holder as to further limit its Registrable
        Securities to be included on the Registration Statement, the number of Registrable Securities to be registered on such Registration Statement will be reduced on a pro rata basis based on the total number of Registrable Securities held by the
        Holders, subject to a determination by the Commission that certain Holders must be reduced first based on the number of Registrable Securities held by such Holders. In the event the Company amends the Shelf or files a New Registration Statement, as
        the case may be, under clauses (x) or (y) above, the Company will use its commercially reasonable efforts to file with the Commission, as promptly as allowed by Commission or SEC Guidance provided to the Company or to registrants of securities in
        general, one or more Registration Statements on Form S-3 or such other form available to register for resale those Registrable Securities that were not registered for resale on the Shelf, as amended, or the New Registration Statement. </div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 5pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.1.2&#160;&#160;&#160;&#160;&#160;&#160; <u>Subsequent Shelf Registration</u>. If any Shelf ceases to be effective under the Securities Act for any reason at any time while Registrable Securities are still outstanding, the
        Company shall, subject to <u>Section 3.3</u>, use its commercially reasonable efforts to as promptly as is reasonably practicable cause such Shelf to again become effective under the Securities Act (including using its commercially reasonable
        efforts to obtain the prompt withdrawal of any order suspending the effectiveness of such Shelf), and shall use its commercially reasonable efforts to as promptly as is reasonably practicable amend such Shelf in a manner reasonably expected to
        result in the withdrawal of any order suspending the effectiveness of such Shelf or file an additional Registration Statement as a Shelf Registration (a &#8220;<font style="font-weight: bold; font-style: italic;">Subsequent Shelf Registration</font>&#8221;)
        registering the resale of all Registrable Securities from time to time (determined as of two (2) business days prior to such filing), and pursuant to any method or combination of methods legally available to, and requested by, any Holder named
        therein. If a Subsequent Shelf Registration is filed, the Company shall use its commercially reasonable efforts to (i) cause such Subsequent Shelf Registration to become effective under the Securities Act as promptly as is reasonably practicable
        after the filing thereof (it being agreed that the Subsequent Shelf Registration shall be an automatic shelf registration statement (as defined in Rule 405 promulgated under the Securities Act) if the Company is a &#8220;well-known seasoned issuer&#8221; (as
        defined in Rule 405 promulgated under the Securities Act) at the most recent applicable eligibility determination date) and (ii) keep such Subsequent Shelf Registration continuously effective, available for use to permit the Holders named therein
        to sell their Registrable Securities included therein and in compliance with the provisions of the Securities Act until such time as there are no longer any Registrable Securities. Any such Subsequent Shelf Registration shall be a Shelf
        Registration on Form S-3 to the extent that the Company is eligible to use such form. Otherwise, such Subsequent Shelf Registration shall be on another appropriate form. The Company&#8217;s obligation under this <u>Section 2.1.2</u>, shall, for the
        avoidance of doubt, be subject to <u>Section 3.3</u>. </div>
      <div style="text-align: justify; text-indent: 72pt;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">5</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">2.1.3&#160;&#160;&#160;&#160;&#160;&#160; <u>Additional Registrable Securities</u>. In the event that any Holder holds Registrable Securities that are not registered for resale on a delayed or continuous basis, the Company,
        upon written request by such Holder, shall use its commercially reasonable efforts to promptly cause the resale of such Registrable Securities to be covered, at the Company&#8217;s option, by any then available Registration Statement (including by means
        of a prospectus supplement or post-effective amendment) or by filing a Subsequent Shelf Registration (and cause the same to become effective as soon as practicable after such filing) and such Registration Statement or Subsequent Shelf Registration
        shall be subject to the terms hereof; <u>provided</u>, <u>however</u>, that the Company shall only be required to cause such Registrable Securities to be so covered twice per calendar year for the Holders.</div>
      <div><br>
      </div>
      <div style="font-weight: bold; text-align: center;">ARTICLE III </div>
      <div style="font-weight: bold; text-align: center;">COMPANY PROCEDURES</div>
      <div style="font-weight: bold;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.1 &#160; &#160;&#160;&#160;&#160; <u></u><font style="font-weight: bold;"><u>General Procedures</u></font>. The Company shall use its commercially reasonable efforts to effect such Registration to permit the resale or
        other disposition of such Registrable Securities in accordance with the intended plan of distribution thereof, and pursuant thereto the Company shall:</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">3.1.1&#160;&#160; &#160; &#160; prepare and file with the Commission as soon as is reasonably practicable a Registration Statement with respect to such Registrable Securities and use its commercially reasonable
        efforts to cause such Registration Statement to become effective in accordance with <u>Section 2.1 </u>and remain effective until all Registrable Securities covered by such Registration Statement have ceased to be Registrable Securities (such
        period, the &#8220;<font style="font-weight: bold; font-style: italic;">Effectiveness Period</font>&#8221;);</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">3.1.2&#160;&#160;&#160;&#160; prepare and file with the Commission such amendments and post-effective amendments to the Registration Statement, and such supplements to the Prospectus, as may be reasonably requested by
        the Holders or as may be required by the rules, regulations or instructions applicable to the registration form used by the Company or by the Securities Act or rules and regulations thereunder to keep the Registration Statement effective until all
        Registrable Securities covered by such Registration Statement are sold in accordance with the plan of distribution set forth in such Registration Statement or supplement to the Prospectus or are no longer outstanding;</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">6</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">3.1.3&#160;&#160; &#160;&#160; &#160; cause all such Registrable Securities to be listed on each national securities exchange on which similar securities issued by the Company are then listed;</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">3.1.4&#160;&#160; &#160; &#160; provide a transfer agent or warrant agent, as applicable, and registrar for all such Registrable Securities no later than the effective date of such Registration Statement;</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">3.1.5&#160;&#160;&#160;&#160;&#160;&#160; advise each seller of such Registrable Securities, promptly after it shall receive notice or obtain knowledge thereof, of the issuance of any stop order by the Commission suspending the
        effectiveness of such Registration Statement or the initiation or threatening of any proceeding for such purpose and promptly use its commercially reasonable efforts to prevent the issuance of any stop order or to obtain its withdrawal if such stop
        order should be issued;</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">3.1.6&#160;&#160;&#160;&#160; &#160; notify the Holders at any time when a Prospectus relating to such Registration Statement is required to be delivered under the Securities Act, of the happening of any event as a result
        of which the Prospectus included in such Registration Statement, as then in effect, includes a Misstatement, and then to correct such Misstatement as set forth in <u>Section 3.3</u> hereof;<br>
        <br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">3.1.7&#160;&#160;&#160; &#160;&#160; make available to its security holders, as soon as reasonably practicable, an earnings statement covering the period of at least twelve (12) months beginning with the first day of the
        Company&#8217;s first full calendar quarter after the effective date of the Registration Statement which satisfies the provisions of Section 11(a) of the Securities Act and Rule 158 thereunder (or any successor rule promulgated thereafter by the
        Commission);</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">3.1.8&#160;&#160; &#160; &#160;&#160; otherwise, in good faith, cooperate reasonably with, and take such customary actions as may reasonably be requested by the participating Holders, consistent with the terms of this
        Agreement, in connection with such Registration.</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Registration Expenses</u>. </font>The Registration Expenses in respect of all Registrations shall be borne by the Company. It is acknowledged by
        the Holders that the Holders shall bear all incremental selling expenses relating to the sale of Registrable Securities including the fees of any broker and all fees and expenses of any legal counsel representing the Holders.</div>
      <div><br>
      </div>
      <div>
        <div style="text-indent: 36pt;">3.3<font style="font-weight: bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Suspension of Sales; Adverse Disclosure</u></font>.</div>
        <div style="font-size: 12pt;"><font style="font-size: 10pt;"> <br>
          </font></div>

      </div>
      <div style="text-align: justify; text-indent: 72pt;">3.3.1&#160;&#160;&#160;&#160;&#160;&#160; Upon receipt of written notice from the Company that a Registration Statement or Prospectus contains a Misstatement, each of the Holders shall forthwith discontinue disposition of
        Registrable Securities until it has received copies of a supplemented or amended Registration Statement or Prospectus correcting the Misstatement (it being understood that the Company hereby covenants to prepare and file such supplement or
        amendment as soon as practicable after the time of such notice), or until he, she or it is advised in writing by the Company that the use of the Registration Statement or Prospectus may be resumed.</div>
      <div style="text-align: justify; text-indent: 72pt;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">7</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">3.3.2&#160;&#160;&#160;&#160;&#160;&#160; Subject to <u>Section 3.3.3</u>, if the filing, initial effectiveness (other than with regard to the filing and initial effectiveness of the Shelf required under <u>Section 2.1</u>)
        or continued use of a Registration Statement at any time would (a) require the Company to make an Adverse Disclosure, (b) require the inclusion in such Registration Statement of financial statements that are unavailable to the Company for reasons
        beyond the Company&#8217;s control, or (c) in the good faith judgment of the majority of the Board such Registration be seriously detrimental to the Company and the majority of the Board concludes as a result that it is essential to defer such filing,
        initial effectiveness or continued use at such time, the Company may, upon giving prompt written notice of such action to the Holders, delay the filing or initial effectiveness of, or suspend use of, such Registration Statement for the shortest
        period of time determined in good faith by the Company to be necessary for such purpose. In the event the Company exercises its rights under this <u>Section</u>&#160;<u>3.3.2</u>, the Holders agree to suspend, immediately upon their receipt of the
        notice referred to above, their use of the Registration Statement or Prospectus in connection with any resale or other disposition of Registrable Securities. In addition, the Company may delay or suspend continued use of a Registration Statement or
        Prospectus in order to file and make effective a post-effective amendment to such Registration Statement in connection with the filing of the Company&#8217;s Annual Report on Form 10-K. </div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 5pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">3.3.3&#160; &#160; &#160;&#160; The right to delay or suspend any filing, initial effectiveness or continued use of a Registration Statement pursuant to <u>Section 3.3.2</u> shall be exercised by the Company, in the
        aggregate, not more than two (2) times in any twelve-month period, and any such delay or suspension shall last for no more than sixty (60) consecutive calendar days.</div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 5pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">3.4&#160;&#160;&#160; &#160;&#160; &#160; <u></u><font style="font-weight: bold;"><u>Reporting Obligations</u>. </font>As long as any Holder shall own Registrable Securities, the Company, at all times while it shall be a
        reporting company under the Exchange Act, covenants to file timely (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to Sections
        13(a) or 15(d) of the Exchange Act and to promptly furnish the Holders with true and complete copies of all such filings; <u>provided</u> that any documents publicly filed or furnished with the Commission pursuant to the EDGAR System shall be
        deemed to have been furnished or delivered to the Holders pursuant to this <u>Section 3.4</u>. The Company further covenants that it shall take such further action as any Holder may reasonably request, all to the extent required from time to time
        to enable such Holder to resell or otherwise dispose of Registrable Securities held by such Holder without registration under the Securities Act within the limitation of the exemptions provided by Rule 144 promulgated under the Securities Act (or
        any successor rule promulgated thereafter by the Commission), including making available at all times information necessary to enable such Holder to comply with Rule 144. Upon the request of any Holder, the Company shall deliver to such Holder a
        written certification of a duly authorized officer as to whether it has complied with such requirements.</div>
      <div><br>
      </div>
      <div style="font-weight: bold; text-align: center;">ARTICLE IV </div>
      <div style="font-weight: bold; text-align: center;">INDEMNIFICATION AND CONTRIBUTION</div>
      <div style="font-weight: bold; text-align: center;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">4.1&#160;&#160;&#160; &#160; &#160;&#160; The Company agrees to indemnify and hold harmless, to the extent permitted by law, each Holder of Registrable Securities, its officers, directors and agents and each person who controls
        such Holder (within the meaning of the Securities Act) (collectively, the &#8220;<font style="font-weight: bold; font-style: italic;">Holder Indemnified Persons</font>&#8221;) against all losses, claims, damages, liabilities and out-of-pocket expenses
        (including reasonable outside attorneys&#8217; fees) resulting from any Misstatement or alleged Misstatement, except insofar as the same are caused by or contained in any information or affidavit so furnished in writing to the Company by or on behalf of
        such Holder Indemnified Person expressly for use therein.</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">8</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">4.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; In connection with any Registration Statement in which a Holder of Registrable Securities is participating, such Holder shall furnish to the Company in writing such information and
        affidavits with respect to such Holder as the Company reasonably requests for use in connection with any such Registration Statement or Prospectus covering Registrable Securities of such Holder (the &#8220;<font style="font-weight: bold; font-style: italic;">Holder Information</font>&#8221;) and, to the extent permitted by law, shall indemnify the Company, its directors, officers, employees, advisors, representatives and agents and each person who controls the Company (within the meaning of the
        Securities Act) against all losses, claims, damages, liabilities and expenses (including reasonable outside attorneys&#8217; fees and inclusive of all reasonable attorneys&#8217; fees arising out of the enforcement of each such persons&#8217; rights under this <u>Article


          IV</u>) resulting from any Misstatement or alleged Misstatement, but only to the extent that the same are made in reliance on and in conformity with information relating to the Holder so furnished in writing by or on behalf of such Holder
        expressly for use therein; provided, however, that the obligation to indemnify shall be several, not joint and several, among such Holders of Registrable Securities, and the liability of each such selling Holder of Registrable Securities shall be
        in proportion to and limited to the net proceeds received by such selling Holder from the sale of Registrable Securities pursuant to such Registration Statement giving rise to such indemnification obligation.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 5pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">4.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Any Person entitled to indemnification herein shall (i) give prompt written notice to the indemnifying party of any claim with respect to which it seeks indemnification (provided that
        the failure to give prompt notice shall not impair any person&#8217;s right to indemnification hereunder to the extent such failure has not materially prejudiced the indemnifying party) and (ii) unless in such indemnified party&#8217;s reasonable judgment a
        conflict of interest between such indemnified and indemnifying parties may exist with respect to such claim or there may be reasonable defenses available to the indemnified party that are different from or additional to those available to the
        indemnifying party, permit such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the indemnified party. If such defense is assumed, the indemnifying party shall not be subject to any liability for any
        settlement made by the indemnified party without its consent (but such consent shall not be unreasonably withheld). An indemnifying party who is not entitled to, or elects not to, assume the defense of a claim shall not be obligated to pay the fees
        and expenses of more than one counsel for all parties indemnified by such indemnifying party with respect to such claim, unless in the reasonable judgment of any indemnified party a conflict of interest may exist between such indemnified party and
        any other of such indemnified parties with respect to such claim. No indemnifying party shall, without the consent of the indemnified party, not to be unreasonably withheld or delayed, consent to the entry of any judgment or enter into any
        settlement which cannot be settled in all respects by the payment of money (and such money is so paid by the indemnifying party pursuant to the terms of such settlement) or which settlement includes a statement or admission of fault and culpability
        on the part of such indemnified party or which settlement does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability in respect to such claim or litigation.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 5pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">4.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The indemnification provided for under this Agreement shall remain in full force and effect regardless of any investigation made by or on behalf of the indemnified party or any officer,
        director, employee, advisor, agent, representative, member or controlling person or entity of such indemnified party and shall survive the transfer of securities. The Company and each Holder of Registrable Securities participating in an offering
        also agrees to make such provisions as are reasonably requested by any indemnified party for contribution to such party in the event the Company&#8217;s or such Holder&#8217;s indemnification is unavailable for any reason. </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 5pt;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">9</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">4.5&#160; &#160; &#160; &#160;&#160; If the indemnification provided under <u>Article IV</u> hereof is held by a court of competent jurisdiction to be unavailable to an indemnified party in respect of any losses, claims,
        damages, liabilities and expenses referred to herein, then the indemnifying party, in lieu of indemnifying the indemnified party, shall to the extent permitted by law contribute to the amount paid or payable by the indemnified party as a result of
        such losses, claims, damages, liabilities and expenses in such proportion as is appropriate to reflect the relative fault of the indemnifying party and the indemnified party, as well as any other relevant equitable considerations. The relative
        fault of the indemnifying party and indemnified party shall be determined by a court of law by reference to, among other things, whether the Misstatement or alleged Misstatement relates to information supplied by, such indemnifying party or such
        indemnified party, and the indemnifying party&#8217;s and indemnified party&#8217;s relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission; provided, however, that the liability of any Holder under
        this <u>Section 4.5</u> shall be limited to the amount of the net proceeds received by such Holder in such offering giving rise to such liability. The amount paid or payable by a party as a result of the losses or other liabilities referred to
        above shall be deemed to include, subject to the limitations set forth in <u>Sections 4.1</u>, <u>4.2</u> and <u>4.3</u> above, any legal or other fees, charges or expenses reasonably incurred by such party in connection with any investigation
        or proceeding. The parties hereto agree that it would not be just and equitable if contribution pursuant to this <u>Section 4.5</u> were determined by pro rata allocation or by any other method of allocation, which does not take account of the
        equitable considerations referred to in this <u>Section 4.5</u>. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution pursuant to this <u>Section 4.5</u>
        from any person who was not guilty of such fraudulent misrepresentation.</div>
      <div><br>
      </div>
      <div style="text-align: center; font-weight: bold;">ARTICLE V </div>
      <div style="text-align: center; font-weight: bold;">MISCELLANEOUS</div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">5.1&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-weight: bold;"><u>Notices</u></font>. Any notice or communication under this Agreement must be in writing and given by (i) deposit in the United States mail,
        addressed to the party to be notified, postage prepaid and registered or certified with return receipt requested, (ii) delivery in person or by courier service or sent by overnight mail via a reputable overnight carrier, in each case providing
        evidence of delivery, or (iii) transmission by hand delivery, electronic mail or facsimile. Each notice or communication that is mailed, delivered, or transmitted in the manner described above shall be deemed sufficiently given, served, sent, and
        received, in the case of mailed notices, on the third business day following the date on which it is mailed and, in the case of notices delivered by courier service, hand delivery or overnight, at such time as it is delivered to the addressee (with
        the delivery receipt or the affidavit of messenger) or at such time as delivery is refused by the addressee upon presentation, and in the case of notices delivered by electronic mail, at such time as it is successfully transmitted to the addressee.
        Any notice or communication under this Agreement must be addressed, if to the Company, to: XCF Global, Inc., 2500 CityWest Blvd, Suite 150-138, Houston, TX 77042, Attention: Chief Executive Officer, or by electronic mail to ir@xcf.global, and, if
        to any Holder, at such Holder&#8217;s address as set forth in the Company&#8217;s books and records or such other address as may be designated in writing by such Holder (including on the signature pages hereto). Any party may change its address for notice at
        any time and from time to time by written notice to the other parties hereto, and such change of address shall become effective thirty (30) calendar days after delivery of such notice as provided in this <u>Section 5.1</u>. </div>
      <div style="text-align: justify; text-indent: 36pt; margin-right: 7.8pt; margin-left: 5pt;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">10</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div>
        <div style="text-indent: 36pt;">5.2<font style="font-weight: bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Assignment; No Third Party Beneficiaries</u></font>.</div>
        <div> <br>
        </div>

      </div>
      <div style="text-align: justify; text-indent: 72pt;">5.2.1&#160;&#160;&#160;&#160; &#160;&#160; This Agreement and the rights, duties and obligations of the Company hereunder may not be assigned or delegated by the Company in whole or in part.</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">5.2.2&#160;&#160;&#160; &#160;&#160; Subject to <u>Section 5.2.5</u>, this Agreement and the rights, duties and obligations of a Holder hereunder may be assigned in whole or in part to such Holder&#8217;s Transferees to which
        it transfers Registrable Securities.</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">5.2.3&#160;&#160;&#160; &#160;&#160; This Agreement and the provisions hereof shall be binding upon and shall inure to the benefit of each of the parties and its successors, which shall include Transferees.</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">5.2.4&#160;&#160;&#160;&#160;&#160;&#160; This Agreement shall not confer any rights or benefits on any Persons that are not parties hereto, other than as expressly set forth in this Agreement and <u>Section 4</u> hereof.</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">5.2.5&#160;&#160;&#160;&#160;&#160;&#160; No assignment by any party hereto of such party&#8217;s rights, duties and obligations hereunder shall be binding upon or obligate the Company unless and until the Company shall have received
        (i) written notice of such assignment as provided in <u>Section 5.1</u> hereof and (ii) the written agreement of the assignee, in a form reasonably satisfactory to the Company, to be bound by the terms and provisions of this Agreement (which may
        be accomplished by an addendum or certificate of joinder to this Agreement). Any assignment made other than as provided in this <u>Section 5.2.5</u> shall be null and void.</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">5.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Counterparts; Electronic Delivery</u></font>. This Agreement (and any other agreements, certificates, instruments and documents delivered pursuant
        to this Agreement) may be executed and delivered in one or more counterparts (including facsimile, electronic mail or other electronic transmission or PDF counterparts), each of which shall be deemed an original, and all of which together shall
        constitute one and the same instrument, but only one of which need be produced. No party shall raise the use of a fax machine or electronic mail to deliver a signature or the fact that any signature or agreement or instrument was transmitted or
        communicated through the use of a fax machine or electronic mail as a defense to the formation or enforceability of a contract and each party forever waives any such defense.</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">5.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Governing Law; Venue</u></font>. NOTWITHSTANDING THE PLACE WHERE THIS AGREEMENT MAY BE EXECUTED BY ANY OF THE PARTIES HERETO, THE PARTIES EXPRESSLY
        AGREE THAT (1) THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, WITHOUT GIVING EFFECT TO ANY CHOICE OF LAW OR CONFLICT OF LAW RULES OR PROVISIONS AND (2) THE VENUE FOR ANY ACTION TAKEN WITH
        RESPECT TO THIS AGREEMENT SHALL BE ANY STATE OR FEDERAL COURT IN THE STATE OF NEW YORK.</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">11</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">5.5&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>TRIAL BY JURY</u></font>. EACH PARTY HERETO ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE
        COMPLICATED AND DIFFICULT ISSUES, AND, THEREFORE, EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT TO ANY ACTION DIRECTLY OR
        INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT. </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 5pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">5.6&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Amendments and Modifications</u>. </font>Upon the written consent of (a) the Company and (b) the Holders of at least a majority in interest of the
        Registrable Securities held by the Holders at the time in question, compliance with any of the provisions, covenants and conditions set forth in this Agreement may be waived, or any of such provisions, covenants or conditions may be amended or
        modified; and provided, however, that notwithstanding the foregoing, (i) any amendment hereto or waiver hereof that adversely affects any Holder, solely in his, her or its capacity as a holder of the shares of capital stock of the Company, in a
        manner that is materially different from the other Holders (in such capacity) shall require the consent of each such Holder so affected and (ii) any amendment or waiver hereof that adversely affects the rights expressly granted to the Sponsor shall
        require the consent of the Sponsor. No course of dealing between any Holder or the Company and any other party hereto or any failure or delay on the part of a Holder or the Company in exercising any rights or remedies under this Agreement shall
        operate as a waiver of any rights or remedies of any Holder or the Company. No single or partial exercise of any rights or remedies under this Agreement by a party shall operate as a waiver or preclude the exercise of any other rights or remedies
        hereunder or thereunder by such party.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 5pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">5.7&#160;&#160;&#160;&#160;&#160; &#160;&#160;<u></u><font style="font-weight: bold;"><u>Other Registration Rights</u></font>. The Company represents and warrants that no Person, other than (i) those Persons that are party to that
        certain registration and stockholder rights agreement dated as of [&#9679;], 2025, by and among the Company and certain parties thereto and (ii) certain non-redeeming stockholders who have registration rights pursuant to their respective non- redemption
        agreements, dated as of July 31, 2024, with respect to equity securities of the Company issued in the Closing, has any right to require the Company to register any securities of the Company for sale or to include such securities of the Company in
        any Registration Statement filed by the Company for the sale of securities for its own account or for the account of any other person. Further, the Company represents and warrants that this Agreement supersedes any other registration rights
        agreement or agreement with similar terms and conditions and in the event of a conflict between any such agreement or agreements and this Agreement, the terms of this Agreement shall prevail. The Holders agree that this Agreement supersedes the
        Registration and Stockholder Rights Agreement, dated as of October 4, 2021, by and among the SPAC and other parties thereto and the Holders party thereto shall not have any rights pursuant to such agreement.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-right: 7.8pt; margin-left: 5pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">5.8&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-weight: bold;"><u>Term</u></font>. This Agreement shall terminate with respect to any Holder on the date that such Holder no longer holds any Registrable Securities.
        The provisions of Article IV shall survive any termination.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 5pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">5.9&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Holder Information</u></font>. Each Holder agrees, if requested in writing, to represent to the Company the total number of Registrable Securities
        held by such Holder in order for the Company to make determinations hereunder.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-right: 7.9pt; margin-left: 5pt;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">12</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">5.10&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Entire Agreement</u></font>. This Agreement constitutes the entire agreement among the parties with respect to the subject matter hereof and thereof
        and supersede all prior and contemporaneous agreements, understandings and discussions, whether oral or written, relating to such subject matter in any way and there are no warranties, representations or other agreements among the parties in
        connection with such subject matter except as set forth in this Agreement and therein. </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 5pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">5.11&#160;&#160;&#160;&#160;&#160;&#160; <u></u><font style="font-weight: bold;"><u>Severability</u></font>. It is the desire and intent of the parties that the provisions of this Agreement be enforced to the fullest extent
        permissible under the laws and public policies applied in each jurisdiction in which enforcement is sought. Accordingly, if any particular provision of this Agreement shall be adjudicated by a court of competent jurisdiction to be invalid,
        prohibited or unenforceable for any reason, such provision, as to such jurisdiction, shall be ineffective, without invalidating the remaining provisions of this Agreement or affecting the validity or enforceability of this Agreement or affecting
        the validity or enforceability of such provision in any other jurisdiction. Notwithstanding the foregoing, if such provision could be more narrowly drawn so as not to be invalid, prohibited or unenforceable in such jurisdiction, it shall, as to
        such jurisdiction, be so narrowly drawn, without invalidating the remaining provisions of this Agreement or affecting the validity or enforceability of such provision in any other jurisdiction.</div>
      <div><br>
      </div>
      <div style="text-align: center;">[<font style="font-style: italic;">Signature pages follow</font>]</div>
      <div style="text-align: center; margin-right: 2.9pt;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">13</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">IN WITNESS WHEREOF, </font><font style="font-size: 10pt;">the undersigned have caused this Agreement to be executed as of the date first written above.</font></div>
      <div><br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" id="z4bff2a03fa894e74958975dc778dc303" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 50%;"><br>
              </td>
              <td colspan="2" rowspan="1" style="font-weight: bold;">COMPANY:</td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 50%;">&#160;</td>
              <td colspan="2" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%;"><br>
              </td>
              <td colspan="2" rowspan="1">
                <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">XCF Global, Inc.</font><font style="font-size: 10pt;">, a Delaware corporation</font></div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%;"><br>
              </td>
              <td style="width: 3%;"><br>
              </td>
              <td style="width: 47%;"><br>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 50%;"><br>
              </td>
              <td rowspan="1" style="width: 3%;">By:</td>
              <td rowspan="1" style="width: 47%;"><u>/s/ Mihir Dange</u></td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 50%;"><br>
              </td>
              <td colspan="2" rowspan="1">
                <div>Name: Mihir Dange</div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 50%;"><br>
              </td>
              <td colspan="2" rowspan="1">
                <div>Title: Chief executive Officer</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <div>&#160;</div>
        <div style="text-align: center;">[<font style="font-style: italic;">Signature Page to Registration Rights Agreement</font>]</div>
        <div style="margin-left: 1pt;"> <br>
        </div>
      </div>
      <div style="margin-right: 5.1pt; margin-left: 257pt;"><u></u></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">IN WITNESS WHEREOF, </font><font style="font-size: 10pt;">the undersigned have caused this Agreement to be executed as of the date first written above.</font></div>
      <div style="font-size: 12pt;"><font style="font-size: 10pt;"> <br>
        </font></div>
    </div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" id="z4bff2a03fa894e74958975dc778dc303" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 50%;"><br>
              </td>
              <td colspan="2" rowspan="1" style="font-weight: bold;">
                <div style="font-weight: bold;">HOLDER:</div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 50%;">&#160;</td>
              <td colspan="2" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 50%; padding-bottom: 2px;"><br>
              </td>
              <td rowspan="1" style="width: 3%; padding-bottom: 2px;">By:</td>
              <td rowspan="1" style="width: 47%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 50%;"><br>
              </td>
              <td colspan="2" rowspan="1">
                <div>Name:<br>
                </div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 50%;"><br>
              </td>
              <td colspan="2" rowspan="1">
                <div>Title:<br>
                </div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div>
      <div><br>
      </div>
      <div style="text-align: center;">[<font style="font-style: italic;">Signature Page to Registration Rights Agreement</font>]</div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.53
<SEQUENCE>8
<FILENAME>ef20050548_ex10-53.htm
<DESCRIPTION>EXHIBIT 10.53
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="font-weight: bold; text-align: right;">Exhibit 10.53<br>
      </div>
      <div>&#160;</div>
      <div>June 6, 2025</div>
      <div><br>
      </div>
      <div>Focus Impact BH3 Sponsor, LLC</div>
      <div>1345 Avenue of the Americas, 33rd Floor </div>
      <div>New York, NY 10105</div>
      <div> <br>
      </div>
      <div>Attention: Carl Stanton and Wray Thorn</div>
      <div>&#160;</div>
      <div>Re: Agreement Regarding Board Nomination Rights (the &#8220;<font style="font-weight: bold;">Agreement</font>&#8221;)</div>
      <div>&#160;</div>
      <div>
        <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; color: #000000; text-align: center;"></div>
      <div> <br>
      </div>
      <div>Dear Messrs. Stanton and Thorn,</div>
      <div>&#160;</div>
      <div>Reference is made to the business combination agreement (as amended to date, the &#8220;<font style="font-weight: bold;">Business Combination Agreement</font>&#8221;) by and among Focus Impact BH3 Acquisition Company (&#8220;<font style="font-weight: bold;">Focus</font>&#8221;),
        XCF Global Capital, Inc., a Nevada corporation (&#8220;<font style="font-weight: bold;">XCF</font>&#8221;), XCF Global, Inc. a Delaware corporation (formerly known as Focus Impact BH3 NewCo, Inc., the &#8220;<font style="font-weight: bold;">Company</font>&#8221;), and
        certain other parties.</div>
      <div>&#160;</div>
      <div>Pursuant to the Business Combination Agreement, Focus, XCF and the Company agreed that upon the closing (the &#8220;<font style="font-weight: bold;">Closing</font>&#8221;) of the business combination contemplated by the Business Combination Agreement (the &#8220;<font style="font-weight: bold;">Business Combination</font>&#8221;), the Company&#8217;s board of directors (the &#8220;<font style="font-weight: bold;">Board</font>&#8221;) would be comprised of nine (9) directors, with (i) Focus Impact BH3 Sponsor, LLC (the &#8220;<font style="font-weight: bold;">Sponsor</font>&#8221;) having the right to designate two (2) representatives to serve on the Board, (ii) XCF having the right to designate five (5) representatives to serve on the Board and (iii) the remaining two (2) members
        of the Board to be mutually agreed upon by XCF and Focus.</div>
      <div>&#160;</div>
      <div style="text-align: justify;">In connection with the Closing of the Business Combination and as an inducement to the Company and Focus to complete the transactions contemplated thereby, the Company and the Sponsor hereby agree as follows:</div>
      <div>&#160;</div>
      <div>
        <div style="font-weight: bold;">1. Board Designation Right</div>
      </div>
      <div>&#160;</div>
      <div style="text-align: justify;">Effective as of the Closing, and following the initial election (or appointment) of Carl Stanton and Wray Thorn (the &#8220;<font style="font-weight: bold;">Initial Designated Directors</font>&#8221;) to the Board in connection
        with the Closing:</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd6d6ace2b48c4a3fbbfb7694cca48835">

          <tr>
            <td style="width: 27pt;">&#160;</td>
            <td style="width: 21pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top;">
              <div>Subject to (i) the Sponsor meeting the beneficial ownership thresholds set forth in sub-paragraph (b) below and (ii) the terms of paragraphs 2 and 3(h) below, (x) the Initial Designated Directors shall continue to serve on the Board
                until their death, disability, resignation or removal and (y) if an Initial Designated Director no longer serves on the Board, the Sponsor shall have the right to designate an individual (each, a &#8220;<font style="font-weight: bold;">Designated
                  Director</font>&#8221;) to replace the such director, subject to customary background checks, director eligibility standards, and governance policies applicable to all members of the Board.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z91a83dc571ad464fb0b1d15530f6a7b9">

          <tr>
            <td style="width: 27pt;"><br>
            </td>
            <td style="width: 21pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top;">
              <div>Subject to the terms of paragraph 2 below (i) for so long as the Sponsor beneficially owns a minimum of 1,653,472 shares of common stock of the Company (the &#8220;<font style="font-weight: bold;">Common Stock</font>&#8221;) (subject to appropriate
                adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to the Common Stock and including shares of Common Stock underlying the Private Placement Warrants (as defined below) on
                an as-exchanged basis (collectively, the &#8220;<font style="font-weight: bold;">Adjustments</font>&#8221;)), the Sponsor shall be entitled to designate two Designated Directors; (ii) for so long as the Sponsor beneficially owns a minimum of 165,347
                shares of Common Stock (subject to any applicable Adjustments), the Sponsor&#8217;s right to designate a director shall be reduced from two Designated Directors to one Designated Director; and (iii) in the event that the Sponsor beneficially owns
                fewer than 165,347 shares of Common Stock (subject to any applicable Adjustments), the Sponsor shall not be entitled to nominate any individual to the Board pursuant to the Business Combination Agreement or this Agreement. For the avoidance
                of doubt, each Initial Designated Director shall count as a Designated Director for the purposes of this sub-paragraph.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0360c0759ecf4c5fbb5a79cf14a6f3e3">

          <tr>
            <td style="width: 27pt;"><br>
            </td>
            <td style="width: 21pt; vertical-align: top;">(c)</td>
            <td style="width: auto; vertical-align: top;">
              <div>In the event that the Sponsor&#8217;s right to nominate Designated Directors is reduced from two Designated Directors to one Designated Director, the Designated Director whose term is first to expire will not be nominated for reelection,
                unless otherwise determined by the Company, once such Designated Director&#8217;s then-current term as a director expires; provided, however, that in the event that the Designated Directors are members of the same class of the Board, the Sponsor
                will designate which of the two Designated Directors will not be nominated for reelection.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za05d398c57214bd19f45aafb799e10fd">

          <tr>
            <td style="width: 27pt;"><br>
            </td>
            <td style="width: 21pt; vertical-align: top;">(d)</td>
            <td style="width: auto; vertical-align: top;">
              <div>In the event that the Sponsor&#8217;s right to nominate Designated Directors is terminated entirely (i) if there are two Designated Directors serving on the Board at the time of such termination, each of the directors will not be nominated for
                reelection, unless otherwise determined by the Company, once each such Designated Director&#8217;s then-current term as a director expires and (ii) if there is one Designated Director serving on the Board at the time of such termination, such
                director will not be nominated for reelection, unless otherwise determined by the Company, once such Designated Director&#8217;s then-current term as a director expires.</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0119e00fff3346d1b7920dfeb007ad14">

          <tr>
            <td style="width: 27pt;"><br>
            </td>
            <td style="width: 21pt; vertical-align: top;">(e)</td>
            <td style="width: auto; vertical-align: top;">
              <div>The Company hereby agrees to take all necessary action to (i) call, or cause the Board to call, a meeting of stockholders of the Company as may be necessary to cause the election as directors of the Designated Directors in accordance
                with the provisions of this Agreement and (ii) include in the slate of nominees recommended by the Board for election at any meeting of stockholders (and in any election by written consent) called for the purpose of electing as directors a
                Designated Director and to nominate and recommend each such individual to be elected as a director as provided herein, and to use the same efforts to cause the election of such nominees as it uses to cause other nominees recommended by the
                Board to be elected, including soliciting proxies or consents in favor thereof.</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z988f849130394aebbf6296ce106c3d31">

          <tr>
            <td style="width: 27pt;"><br>
            </td>
            <td style="width: 21pt; vertical-align: top;">(f)</td>
            <td style="width: auto; vertical-align: top;">
              <div>For purposes of this Agreement, &#8220;beneficially owns&#8221; has the meaning set forth in Rule 13d-3 promulgated under the Securities Exchange Act of 1934, as amended.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5af49822c1ba420ab2052be79b3ef318">

          <tr>
            <td style="width: 27pt;"><br>
            </td>
            <td style="width: 21pt; vertical-align: top;">(g)</td>
            <td style="width: auto; vertical-align: top;">
              <div>For purposes of this Agreement, &#8220;Private Placement Warrants&#8221; means the warrants to purchase Common Stock owned by the Sponsor.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div>
        <div style="font-weight: bold;">2. Future Financing and Board Composition Review</div>
      </div>
      <div>&#160;</div>
      <div>In the event that the Company undertakes any future material financing, merger, acquisition, strategic partnership, or similar corporate transaction that results in a significant change to, or a requirement to change, the Board composition
        (including an increase in the number of Board seats or a right for another investor or merger or acquisition partner to appoint or nominate one or more directors), the Company and the Sponsor agree to revisit and negotiate in good faith the terms
        of this Agreement with respect to the Sponsor&#8217;s Board designation rights currently in place, and may reduce the Sponsor&#8217;s Board designation rights to ensure that the Sponsor maintains proportional and fair board representation relative to its
        ownership interest.</div>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div>In the event of a shareholder proposal, change in control, or material financing transaction, determinations specifically concerning board independence (e.g., composition of independent committees or classification of directors as independent)
        shall be made solely by the independent directors, in accordance with applicable law and fiduciary duties. This provision does not limit any director&#8217;s general rights or responsibilities under Delaware law or the company&#8217;s governing documents.</div>
      <div>&#160;</div>
      <div>
        <div style="font-weight: bold;">3. Miscellaneous</div>
      </div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4413272c1b444353a5cf2d66eeb7bd5e">

          <tr>
            <td style="width: 27pt;"><br>
            </td>
            <td style="width: 21pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top;">
              <div>If the Sponsor is entitled to designate a director pursuant to this Agreement, the Sponsor may notify the Company that it desires to remove a Designated Director at any time. Upon such notice, the Board will take all necessary action to
                cause the removal of such Designated Director, subject to the terms of the certificate of incorporation or bylaws of the Company, as each may be amended, restated or otherwise modified from time to time. In the event that a vacancy is
                created on the Board at any time due to the death, disability, retirement, resignation, or removal of any Initial Designated Director or Designated Director, then the Sponsor shall have the right to designate an individual to fill such
                vacancy and the Company shall promptly take all necessary action as will result in the election or appointment of such individual as a director to fill such vacancy, and such person shall thereafter be deemed a Designated Director under
                this Agreement.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z13ffe69a0fe8440ab17069b36b062996">

          <tr>
            <td style="width: 27pt;"><br>
            </td>
            <td style="width: 21pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>During the period Designated Director is a member of the Board, (i) the Company shall provide such director with the same expense reimbursement, cash and non-cash compensation, benefits, indemnity, exculpation and other arrangements
                provided to any other director on the Board and (ii) the Company shall not amend, alter or repeal any right to indemnification or exculpation covering or benefiting such Designated Director as and to the extent consistent with applicable
                law, the certificate of incorporation or bylaws of the Company and any indemnification agreements with directors (whether such right is contained in such organizational documents or another document) (except to the extent such amendment or
                alteration permits the Company to provide broader or substantially similar indemnification or exculpation rights on a retroactive basis than permitted prior thereto); provided, however, that the Initial Designated Directors will not be
                entitled to receive any cash or non-cash compensation for such Initial Designated Director&#8217;s services as a director, for so long as the Strategic Consulting Agreement, dated as of February 19, 2025, by and between the Company and Focus is
                in effect.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z78de747d74d144c880bb07cf3bed28ca">

          <tr>
            <td style="width: 27pt;"><br>
            </td>
            <td style="width: 21pt; vertical-align: top;">(c)</td>
            <td style="width: auto; vertical-align: top;">
              <div>This Agreement shall automatically terminate upon the Sponsor ceasing to beneficially own Common Stock representing less than 165,347 of the Company&#8217;s then outstanding shares of Common Stock (subject to any applicable Adjustments);
                provided, however, that the terms of paragraphs 3(b) and 3(d) shall apply to the continued services of the applicable Designated Director(s) during the remaining term(s) of such Designated Director(s).</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z42ef71cbf09d4ddabfa8dc1fd4ee8809">

          <tr>
            <td style="width: 27pt;"><br>
            </td>
            <td style="width: 21pt; vertical-align: top;">(d)</td>
            <td style="width: auto; vertical-align: top;">
              <div>The Company shall (i) purchase directors&#8217; and officers&#8217; liability insurance in an amount determined by the Board to be reasonable and customary and (ii) for so long as a Designated Director serves as a director on the Board, maintain
                such coverage with respect to such Designated Director; provided that upon removal or resignation of such Designated Director for any reason, the Company shall take all actions reasonably necessary to extend such directors&#8217; and officers&#8217;
                liability insurance coverage for a period of not less than six (6) years from any such event in respect of any act or omission occurring at or prior to such event.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2092c7b7cd2c4a9babb63558545c4cae">

          <tr>
            <td style="width: 27pt;"><br>
            </td>
            <td style="width: 21pt; vertical-align: top;">(e)</td>
            <td style="width: auto; vertical-align: top;">
              <div>This Agreement constitutes the entire agreement between the Company and the Sponsor with respect to the subject matter hereof and supersedes all prior discussions, understandings or agreements of the parties.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4d663624ea2c41bd848330884fd4c9e0">

          <tr>
            <td style="width: 27pt;"><br>
            </td>
            <td style="width: 21pt; vertical-align: top;">(f)</td>
            <td style="width: auto; vertical-align: top;">
              <div>If the Sponsor conducts an in-kind distribution of all of its shares of Common Stock to its direct or indirect equityholders, the distributees holding shares of Common Stock equal to a majority-in- interest of the shares of Common Stock
                then held by the Sponsor at the time of such distribution shall thereafter be entitled to exercise and enforce the rights specifically granted to the Sponsor hereunder.</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0d13ef3edd4a445399445918483db812">

          <tr>
            <td style="width: 27pt;"><br>
            </td>
            <td style="width: 21pt; vertical-align: top;">(g)</td>
            <td style="width: auto; vertical-align: top;">
              <div>Notwithstanding the place where this Agreement may be executed by any of the parties hereto, the parties expressly agree that (i) this Agreement shall be governed by and construed in accordance with the laws of the State of Delaware,
                without giving effect to any choice of law or conflict of law rules or provisions and (ii) the venue for any action taken with respect to this agreement shall be the courts of the State of Delaware; provided that if subject matter
                jurisdiction over such action is vested exclusively in the United States federal courts, such action shall be heard in the United States District Court for the District of Delaware.</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5ffd6a939eba48a9b57d33559964a260">

          <tr>
            <td style="width: 27pt;"><br>
            </td>
            <td style="width: 21pt; vertical-align: top;">(h)</td>
            <td style="width: auto; vertical-align: top;">
              <div>The parties acknowledge and agree that due to circumstances beyond their control and beyond the control of XCF and Focus, neither the Sponsor nor XCF will be able, in connection with the Closing and the listing of the shares of the
                Company&#8217;s Class A Common Stock on The Nasdaq Stock Market (&#8220;<font style="font-weight: bold;">Nasdaq</font>&#8221;), to appoint its nominees to the Board in the manner the parties intended under the terms of the Business Combination Agreement.
                Therefore, to the extent that the service of (i) the two Initial Designated Directors (or their substitutes) and (ii) one non-independent director intended to be designated to the Board by XCF at Closing shall cause the Company to fail to
                comply with the independence requirements of Nasdaq (or any other national securities exchange upon which the Company&#8217;s securities are listed) at Closing or any other time during the term of this Agreement, the Company and the Sponsor agree
                that the Sponsor may only appoint one Initial Designated Director (or substitute) until such time as (A) the Board has taken action to expand the size of the Board to nine (9) members, (B) the Board has appointed as a director one person
                recommended by the Company&#8217;s Chief Executive Officer (the &#8220;<font style="font-weight: bold;">Management Designee</font>&#8221;) and (C) the service of two Initial Designated Directors along with the Management Designee no longer causes such
                failure of compliance with the applicable independence requirements; and until such time as the above conditions are met and the other Initial Designated Director is appointed to the Board, such other Initial Designated Director shall be
                entitled to be a board observer during such period.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div>Sincerely,</div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zf35eb8424d8a4110b08e6cf1b30f28fb">

            <tr>
              <td style="width: 100%; vertical-align: top;">
                <div style="font-weight: bold;">XCF Global, Inc.</div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 100%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 100%; vertical-align: top;">
                <div>By: <u>Mihir Dange</u></div>
              </td>
            </tr>
            <tr>
              <td style="width: 100%; vertical-align: top;">
                <div>Name: Mihir Dange</div>
              </td>
            </tr>
            <tr>
              <td style="width: 100%; vertical-align: top;">
                <div>Title: Chief Executive Officer</div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 100%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 100%; vertical-align: top;">
                <div style="font-weight: bold;">AGREED AND ACCEPTED:</div>
              </td>
            </tr>
            <tr>
              <td style="width: 100%; vertical-align: top;">
                <div style="font-weight: bold;">Focus Impact BH3 Sponsor, LLC</div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 100%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 100%; vertical-align: top;">
                <div>By: <u>Wray Thorn</u></div>
              </td>
            </tr>
            <tr>
              <td style="width: 100%; vertical-align: top;">
                <div>Name: Wray Thorn</div>
              </td>
            </tr>
            <tr>
              <td style="width: 100%; vertical-align: top;">
                <div>Title: Authorized Signatory</div>
              </td>
            </tr>

        </table>
      </div>
      <div><br>
      </div>
      <div style="text-align: center; font-style: italic;">[Signature Page to Side Letter Agreement - Board Nomination Rights]</div>
      <div>&#160;</div>
      <div> <br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.54
<SEQUENCE>9
<FILENAME>ef20050548_ex10-54.htm
<DESCRIPTION>EXHIBIT 10.54
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; font-weight: bold;">Exhibit 10.54</div>
      <div><br>
      </div>
      <div style="text-align: right;">EXECUTION COPY</div>
      <div><br>
      </div>
      <div>June 6, 2025</div>
      <div><br>
      </div>
      <div>XCF Global, Inc.</div>
      <div>2500 CityWest Blvd, Suite 150-138</div>
      <div>Houston, TX 77042</div>
      <div><br>
      </div>
      <div>Ladies and Gentlemen:</div>
      <div><br>
      </div>
      <div>The undersigned stockholder understands that XCF Global, Inc., a Delaware corporation (formerly known as Focus Impact BH3 NewCo, Inc., the &#8220;<font style="font-weight: bold;">Company</font>&#8221;) has entered into certain agreements that include
        provisions regarding the nomination and recommendation for election to the Board of Directors of the Company (the &#8220;<font style="font-weight: bold;">Board</font>&#8221;) of (i) certain individuals to be designated by Focus Impact BH3 Sponsor, LLC (the &#8220;<font style="font-weight: bold;">Sponsor</font>&#8221;), pursuant to the terms of an agreement dated as of June 5, 2025 between the Company and the Sponsor (the &#8220;<font style="font-weight: bold;">Board Representation Rights Agreement</font>&#8221;) and (ii) Mr.
        Mihir Dagne and Mr. Gregory Surette, pursuant to Employment Agreements dated as of June 5, 2025 between the Company and each of Mr. Dange and Mr. Surette (the &#8220;<font style="font-weight: bold;">Employment Agreements</font>&#8221;).</div>
      <div><br>
      </div>
      <div>In connection with the Company&#8217;s obligations under the Board Representation Rights Agreement and the Employment Agreements, the Company has requested that the undersigned stockholder agree to vote such stockholder&#8217;s shares at any meeting of
        stockholders of the Company, or take all actions by written consent in lieu of any such meeting as may be necessary, at which (i) the designees of the Sponsor are nominated in accordance with the terms of the Board Representation Rights Agreement
        and/or (ii) Mr. Dange and/or Mr. Surette are nominated in accordance with the terms of each of their respective Employment Agreements, in each case in favor of such nominees.</div>
      <div><br>
      </div>
      <div>As an inducement to the Company and the undersigned stockholder to enter into the Registration Rights Agreement dated as of June 5, 2025, by and among the Company, the Sponsor and the other parties thereto identified as &#8220;Holders&#8221; therein
        (including the undersigned stockholder), the undersigned stockholder hereby agrees to take all necessary action to, and to vote all voting securities of the Company owned or held of record by such stockholder, at such meeting of stockholders of the
        Company, or take all actions by written consent in lieu of any such meeting as may be necessary, at which the Sponsor designees and/or Messrs. Dange and Surette have been nominated by the Board for election as directors, in favor of such
        nominees..&#160; The undersigned stockholder also agrees vote such stockholder&#8217;s shares at any meeting of stockholders of the Company, or take all actions by written consent in lieu of any such meeting as may be necessary, to elect as directors those
        individuals included in the slate of nominees proposed by the Board to the Company&#8217;s stockholders for each election of directors.</div>
      <div><br>
      </div>
      <div>In addition, the undersigned stockholder agrees that such stockholder shall not grant any proxy or enter into or agree to be bound by any voting agreement or voting trust with respect to such stockholder&#8217;s voting&#160; securities of the Company, nor
        shall the undersigned stockholder enter into any other agreements or arrangements of any kind with any person with respect to its voting securities of the Company on terms that conflict with the provisions of this letter agreement).</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: right;"> EXECUTION COPY</div>
      <div> <br>
      </div>
      <div>The obligations of the undersigned stockholder under this letter agreement shall terminate and be of no further force or effect (i) with respect to obligations relating to nominees of the Sponsor, at the time the Sponsor no longer has any rights
        under the Board Representation Rights Agreement to designate nominees and (ii) with respect to obligations relating to the Employment Agreements, at the time Mr. Dange&#8217;s Employment Agreement or Mr. Surette&#8217;s Employment Agreement, as applicable, no
        longer includes a requirement that Mr. Dange or Mr. Surette be nominated for election as a director.</div>
      <div><br>
      </div>
      <div>This letter agreement constitutes the entire agreement between the Company and the undersigned stockholder with respect to the subject matter hereof and supersedes all prior discussions, understandings or agreements of the parties.</div>
      <div><br>
      </div>
      <div>Notwithstanding the place where this letter agreement may be executed by any of the parties hereto, the parties expressly agree that (i) this letter agreement shall be governed by and construed in accordance with the laws of the State of
        Delaware, without giving effect to any choice of law or conflict of law rules or provisions and (ii) the venue for any action taken with respect to this agreement shall be the courts of the State of Delaware; provided that if subject matter
        jurisdiction over such action is vested exclusively in the United States federal courts, such action shall be heard in the United States District Court for the District of Delaware.</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z8538c1f32c2840b58f5b4ffa7ee0a2d2">

          <tr>
            <td colspan="2" style="vertical-align: top;">
              <div>Sincerely,</div>
            </td>
            <td style="width: 25%; vertical-align: top;"><br>
            </td>
            <td colspan="2" style="vertical-align: top;">
              <div>AGREED AND ACCEPTED:</div>
            </td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top;">&#160;</td>
            <td style="width: 25%; vertical-align: top;"><br>
            </td>
            <td colspan="2" style="vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top;">
              <div>[STOCKHOLDER (INDIVIDUAL) NAME]</div>
            </td>
            <td style="width: 25%; vertical-align: top;"><br>
            </td>
            <td colspan="2" style="vertical-align: top;">
              <div>XCF Global, Inc.</div>
            </td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top;">&#160;</td>
            <td style="width: 25%; vertical-align: top;"><br>
            </td>
            <td colspan="2" style="vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); width: 25%;">
              <div><br>
              </div>
            </td>
            <td style="vertical-align: top; width: 10%; padding-bottom: 2px;">&#160;</td>
            <td style="width: 25%; vertical-align: top; padding-bottom: 2px;"><br>
            </td>
            <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
              <div>By:<br>
              </div>
            </td>
            <td style="width: 37%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">/s/ Mihir Dange </td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top;">
              <div>Signature</div>
            </td>
            <td style="width: 25%; vertical-align: top;"><br>
            </td>
            <td colspan="2" style="vertical-align: top;">
              <div>Name: Mihir Dange</div>
            </td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top;">&#160;</td>
            <td style="width: 25%; vertical-align: top;"><br>
            </td>
            <td colspan="2" style="vertical-align: top;">
              <div>Title: Chief Executive Officer</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); width: 25%;">
              <div><br>
              </div>
            </td>
            <td style="vertical-align: top; width: 10%; padding-bottom: 2px;">&#160;</td>
            <td style="width: 25%; vertical-align: top; padding-bottom: 2px;"><br>
            </td>
            <td colspan="2" style="vertical-align: top; padding-bottom: 2px;"><br>
            </td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top;">
              <div>Print Name</div>
            </td>
            <td style="width: 25%; vertical-align: top;"><br>
            </td>
            <td colspan="2" style="vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top;">&#160;</td>
            <td style="width: 25%; vertical-align: top;"><br>
            </td>
            <td colspan="2" style="vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top;">
              <div>OR</div>
            </td>
            <td style="width: 25%; vertical-align: top;"><br>
            </td>
            <td colspan="2" style="vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top;">&#160;</td>
            <td style="width: 25%; vertical-align: top;"><br>
            </td>
            <td colspan="2" style="vertical-align: top;"><br>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td colspan="2" style="vertical-align: top;">
              <div>[STOCKHOLDER (ENTITY) NAME]</div>
            </td>
            <td style="width: 14.25%; vertical-align: top;"><br>
            </td>
            <td style="vertical-align: top; width: 50.89%;"><br>
            </td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top;">&#160;</td>
            <td style="width: 14.25%; vertical-align: top;"><br>
            </td>
            <td style="vertical-align: top; width: 50.89%;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 3.18%; vertical-align: top; padding-bottom: 2px;">
              <div>By: <br>
              </div>
            </td>
            <td style="width: 31.55%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
            <td style="width: 14.25%; vertical-align: top; padding-bottom: 2px;"><br>
            </td>
            <td style="vertical-align: top; padding-bottom: 2px; width: 50.89%;"><br>
            </td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top;">
              <div>Name:</div>
            </td>
            <td style="width: 14.25%; vertical-align: top;"><br>
            </td>
            <td style="vertical-align: top; width: 50.89%;"><br>
            </td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top;">
              <div>Title:</div>
            </td>
            <td style="width: 14.25%; vertical-align: top;"><br>
            </td>
            <td style="vertical-align: top; width: 50.89%;"><br>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div><br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.55
<SEQUENCE>10
<FILENAME>ef20050548_ex10-55.htm
<DESCRIPTION>EXHIBIT 10.55
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">


  <div>
    <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade">
    <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 10.55</font><br>
    </div>
    <div><br>
    </div>
    <div>
      <div style="text-align: center; font-weight: bold;"><u>XCF GLOBAL, INC.</u></div>
      <div style="text-align: center; font-weight: bold;"><u>INDEMNIFICATION AGREEMENT</u></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">THIS INDEMNIFICATION AGREEMENT (this &#8220;<u>Agreement</u>&#8221;) is made and entered into as of June 6, 2025 between XCF Global, Inc., a Delaware corporation (the &#8220;<u>Company</u>&#8221;), and [&#9679;] (the &#8220;<u>Indemnitee</u>&#8221;).
        Capitalized terms used but not otherwise defined herein shall have the meaning set forth in <u>Section 13</u> hereof.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">WHEREAS, highly competent persons have become more reluctant to serve corporations as directors or officers or in other capacities unless they are provided with adequate protection through insurance or adequate
        indemnification against inordinate risks of claims and actions against them arising out of their service to and activities on behalf of the corporation;</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">WHEREAS, the amended and restated bylaws of the Company (as amended, restated, modified and/or supplemented from to time, the &#8220;<u>Bylaws</u>&#8221;) require indemnification of the directors and officers of the Company;</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">WHEREAS, the amended and restated certificate of incorporation of the Company (as amended, restated, modified and/or supplemented from to time, the &#8220;<u>Charter</u>&#8221;), the Bylaws and the General Corporation Law of the
        State of Delaware (the &#8220;<u>DGCL</u>&#8221;) expressly contemplate that contracts may be entered into between the Company and members of the Board of Directors of the Company (the &#8220;<u>Board</u>&#8221;), officers of the Company and other persons with respect to
        indemnification and advancement of Expenses;</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">WHEREAS, the uncertainties relating to insurance and indemnification have increased the difficulty of attracting and retaining directors and officers;</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">WHEREAS, the Board has determined that the increased difficulty in attracting and retaining directors and officers is detrimental to the best interests of the Company and its stockholders and that the Company should
        act to assure such persons that there will be increased certainty of such protection in the future;</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">WHEREAS, it is reasonable, prudent and necessary for the Company to indemnify, and to advance Expenses on behalf of, the Company&#8217;s directors and officers to the Fullest Extent Permitted By Applicable Law; and</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">WHEREAS, the Indemnitee may not be willing to serve or continue to serve as an officer or director without adequate protection, and the Company desires the Indemnitee to serve or continue to serve in such capacity.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">NOW, THEREFORE, each party hereto, intending to be legally bound hereby, agrees as follows:</div>
      <div>&#160;</div>
      <table id="zba768a05322e4c60a5239c610ba18ff5" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">1.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Indemnity of the Indemnitee</u>. On the terms and subject to the conditions set forth in this Agreement, the Company hereby agrees to hold harmless and indemnify the Indemnitee
                  to the Fullest Extent Permitted By Applicable Law. In furtherance of the foregoing indemnification, and without limiting the generality thereof:</font></div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <table id="z6656d3115dce429fba84d50cd7025748" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(a)</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Proceedings Other Than Proceedings by or in the Right of the Company</u>. The Indemnitee shall be entitled to the rights of indemnification provided in this <u>Section </u><font style="color: rgb(0, 0, 0);"><u>1(a</u></font><u>)</u> if the Indemnitee has been or is, or is threatened to be made, a party to or participant in, or otherwise becomes involved in, any Proceeding other than a Proceeding by or in the
                  right of the Company. Pursuant to this <u>Section </u><font style="color: rgb(0, 0, 0);"><u>1(a</u></font><u>)</u>, the Indemnitee shall be indemnified to the Fullest Extent Permitted By Applicable Law against all Losses and Expenses
                  actually and reasonably incurred by the Indemnitee or on the Indemnitee&#8217;s behalf in connection with such Proceeding or any claim, issue or matter therein, if the Indemnitee acted in good faith and in a manner the Indemnitee reasonably
                  believed to be in or not opposed to the best interests of the Company, and with respect to any criminal Proceeding, had no reasonable cause to believe the Indemnitee&#8217;s conduct was unlawful.</font></div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="z181e5dd6e60c4032847b29ff7c60a448" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(b)</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Proceedings by or in the Right of the Company</u>. The Indemnitee shall be entitled to the rights of indemnification provided in this <u>Section </u><font style="color: rgb(0, 0, 0);"><u>1(b</u></font><u>)</u> if the Indemnitee has been or is, or is threatened to be made, a party to or participant in, or otherwise becomes involved in, any Proceeding brought by or in the right of the Company. Pursuant to this
                  <u>Section </u><font style="color: rgb(0, 0, 0);"><u>1(b</u></font><u>)</u>, the Indemnitee shall be indemnified to the Fullest Extent Permitted By Applicable Law against all Expenses actually and reasonably incurred by the Indemnitee or
                  on the Indemnitee&#8217;s behalf in connection with such Proceeding or any claim, issue or matter therein if the Indemnitee acted in good faith and in a manner the Indemnitee reasonably believed to be in or not opposed to the best interests of
                  the Company; <u>provided</u>, <u>however</u>, if applicable law so provides, no indemnification against such Expenses shall be made in respect of any claim, issue or matter in such Proceeding as to which the Indemnitee shall have been
                  adjudged to be liable to the Company unless and only to the extent that the Chancery Court of the State of Delaware (the &#8220;<u>Delaware Court</u>&#8221;) or the court in which such Proceeding was brought shall determine that the Indemnitee is
                  fairly and reasonably entitled to such indemnification.</font></div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="zc8725d4113ad4f148b8331783e35e151" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(c)</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Indemnification for Expenses of a Party Who is Wholly or Partly Successful</u>. Notwithstanding any other provision of this Agreement (other than <u>Section </u><u>9</u>), to
                  the extent that the Indemnitee is successful, on the merits or otherwise, in defense of any Proceeding, the Indemnitee shall be indemnified to the Fullest Extent Permitted By Applicable Law against all Expenses actually and reasonably
                  incurred by the Indemnitee or on the Indemnitee&#8217;s behalf in connection therewith. If the Indemnitee is not wholly successful in such Proceeding but is successful, on the merits or otherwise, as to one or more but less than all claims,
                  issues or matters in such Proceeding, the Company shall indemnify the Indemnitee against all Expenses actually and reasonably incurred by the Indemnitee or on the Indemnitee&#8217;s behalf in connection with each successfully resolved claim,
                  issue or matter. For purposes of this <u>Section </u><font style="color: rgb(0, 0, 0);"><u>1(c</u></font><u>)</u> and without limitation, the termination of any claim, issue or matter in such a Proceeding by dismissal, with or without
                  prejudice, on substantive or procedural grounds, shall be deemed to be a successful result as to such claim, issue or matter.</font></div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <table id="z2281596d50f741da830081ab7cf78574" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">2.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Additional Indemnity</u>. Notwithstanding any limitations in <u>Section </u><u>1</u> of this Agreement, the Company shall indemnify the Indemnitee to the Fullest Extent
                  Permitted By Applicable Law if the Indemnitee is, or is threatened to be made, a party to or a participant in any Proceeding (including a Proceeding by or in the right of the Company to procure a judgment in its favor) for all Losses and
                  Expenses actually and reasonably incurred by the Indemnitee or on the Indemnitee&#8217;s behalf.</font></div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="ze5fa79a0df1041e2818645142bd072d3" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">3.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Contribution</u>.</font></div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="z92214dfb29064b7aa61bbd0b119a41a7" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(a)</td>
            <td style="width: auto; vertical-align: top;">
              <div>Whether or not the indemnification provided in <u>Sections </u><u>1</u> and <u>Section </u><u>2</u> hereof is available, in respect of any threatened, pending or completed Proceeding in which the Company is jointly liable with the
                Indemnitee (or would be if joined in such Proceeding), to the Fullest Extent Permitted By Applicable Law, the Company shall pay, in the first instance, the entire amount of any judgment or settlement of such Proceeding without requiring the
                Indemnitee to contribute to such payment and the Company hereby waives and relinquishes any right of contribution it may have against the Indemnitee. The Company shall not enter into any settlement of any Proceeding in which the Company is
                jointly liable with the Indemnitee (or would be if joined in such Proceeding) unless such settlement (i) provides for a full and final release of all claims asserted against the Indemnitee and (ii) does not impose any Loss, Expense or
                limitation on the Indemnitee.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="zc676322b9046427d997c98d147ce957e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(b)</td>
            <td style="width: auto; vertical-align: top;">
              <div>Without diminishing or impairing the obligations of the Company set forth in the preceding subsection, if, for any reason, the Indemnitee shall elect or be required to pay all or any portion of any judgment or settlement in any
                threatened, pending or completed Proceeding in which the Company is jointly liable with the Indemnitee (or would be if joined in such Proceeding), to the Fullest Extent Permitted By Applicable Law, the Company shall contribute to the amount
                of Losses and Expenses actually and reasonably incurred and paid or payable by the Indemnitee in proportion to the relative benefits received by the Company and all officers, directors or employees of the Company, other than the Indemnitee,
                who are jointly liable with the Indemnitee (or would be if joined in such Proceeding), on the one hand, and the Indemnitee, on the other hand, from the transaction or events from which such Proceeding arose; <u>provided</u>, <u>however</u>,
                that the proportion determined on the basis of relative benefit may, to the extent necessary to conform to law, be further adjusted by reference to the relative fault of the Company and all officers, directors or employees of the Company,
                other than the Indemnitee, who are jointly liable with the Indemnitee (or would be if joined in such Proceeding), on the one hand, and the Indemnitee, on the other hand, in connection with the transaction or events that resulted in such
                Losses or Expenses, as well as any other equitable considerations which applicable law may require to be considered. The relative fault of the Company and all officers, directors or employees of the Company, other than the Indemnitee, who
                are jointly liable with the Indemnitee (or would be if joined in such Proceeding), on the one hand, and the Indemnitee, on the other hand, shall be determined by reference to, among other things, the degree to which their actions were
                motivated by intent to gain personal profit or advantage, the degree to which their liability is primary or secondary and the degree to which their conduct is active or passive.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <table id="zf4247f1d70694c8e96027211bf85883c" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(c)</td>
            <td style="width: auto; vertical-align: top;">
              <div>To the Fullest Extent Permitted By Applicable Law, the Company hereby agrees to fully indemnify and hold the Indemnitee harmless from any claims of contribution that may be brought by officers, directors or employees of the Company,
                other than the Indemnitee, who may be jointly liable with the Indemnitee.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="z146527e51be44f5d95f0a156d68f226e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(d)</td>
            <td style="width: auto; vertical-align: top;">
              <div>To the Fullest Extent Permitted By Applicable Law, if the indemnification provided for in this Agreement is unavailable to the Indemnitee for any reason whatsoever, the Company, in lieu of indemnifying the Indemnitee, shall contribute to
                the amount incurred by the Indemnitee, whether for Losses and/or for Expenses, in connection with any claim relating to an indemnifiable event under this Agreement, in such proportion as is deemed fair and reasonable in light of all of the
                circumstances of such Proceeding in order to reflect (i) the relative benefits received by the Company and the Indemnitee as a result of the event(s) and/or transaction(s) giving cause to such Proceeding, and/or (ii) the relative fault of
                the Company (and its directors, officers, employees and agents) and the Indemnitee in connection with such event(s) and/or transaction(s).</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="z7c579d11c7e944d39ed5453401088108" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">4.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Indemnification for Expenses of a Witness</u>. Notwithstanding any other provision of this Agreement (other than <u>Section </u><u>9</u>), to the Fullest Extent Permitted By
                  Applicable Law and to the extent that the Indemnitee is a witness, or is made (or asked) to respond to discovery requests, in any Proceeding to which the Indemnitee is not a party, the Indemnitee shall be indemnified against all Expenses
                  actually and reasonably incurred by the Indemnitee or on the Indemnitee&#8217;s behalf in connection therewith.</font></div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="z75e6313260ef49dcb35caa9e54069aa0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">5.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Advancement of Expenses</u>. Notwithstanding any other provision of this Agreement, the Company shall advance, to the Fullest Extent Permitted By Applicable Law, all Expenses
                  incurred by or on behalf of the Indemnitee in connection with any Proceeding within twenty (20) days after the receipt by the Company of a statement or statements from the Indemnitee requesting such advance or advances from time to time,
                  whether prior to or after final disposition of such Proceeding. Such statement or statements shall reasonably evidence the Expenses incurred by the Indemnitee. The Indemnitee&#8217;s execution and delivery to the Company of this Agreement shall
                  constitute an undertaking providing that the Indemnitee undertakes to repay the amounts advanced by the Company pursuant to this Agreement, if and only to the extent that it is ultimately determined that the Indemnitee is not entitled to
                  be indemnified by the Company. No other form of undertaking shall be required other than the execution of this Agreement. Any advances and undertakings to repay pursuant to this Agreement shall be unsecured and interest free.</font></div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="z75853a7ce0f14112916567579c2ba233" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">6.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Procedures and Presumptions for Determination of Entitlement to Indemnification</u>. It is the intent of this Agreement to secure for the Indemnitee rights of indemnity that are
                  as favorable as may be permitted under the DGCL and the public policy of the State of Delaware. Accordingly, the parties agree that the following procedures and presumptions shall apply in the event of any question as to whether the
                  Indemnitee is entitled to indemnification under this Agreement:</font></div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <div></div>
      <table id="z0590b0b8e3be46789f4fb2096284d32e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(a)</td>
            <td style="width: auto; vertical-align: top;">
              <div>To obtain indemnification under this Agreement, the Indemnitee shall submit to the Company a written request, including therein or therewith such documentation and information as is reasonably available to the Indemnitee and is
                reasonably necessary to determine whether and to what extent the Indemnitee is entitled to indemnification. The Secretary of the Company shall, promptly upon receipt of such a request for indemnification, advise the Board in writing that
                the Indemnitee has requested indemnification. Notwithstanding the foregoing, any failure of the Indemnitee to provide such a request to the Company, or to provide such a request in a timely fashion, shall not relieve the Company of any
                liability that it may have to the Indemnitee unless, and to the extent that, such failure actually and materially prejudices the interests of the Company.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="z7c54462420854f33b31d2c388be9005d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(b)</td>
            <td style="width: auto; vertical-align: top;">
              <div>Upon written request by the Indemnitee for indemnification pursuant to the first sentence of <u>Section </u><font style="color: rgb(0, 0, 0);"><u>6(a</u></font><u>)</u> hereof, a determination with respect to the Indemnitee&#8217;s
                entitlement thereto shall be made in the specific case by one of the following four methods, which shall be at the election of the Board: (i) by a majority vote of the Disinterested Directors, even though less than a quorum of the Board,
                (ii) by a committee of Disinterested Directors designated by a majority vote of the Disinterested Directors, even though less than a quorum of the Board, (iii) if there are no Disinterested Directors or if the Disinterested Directors so
                direct, by Independent Counsel in a written opinion to the Board, a copy of which shall be delivered to the Indemnitee, or (iv) if so directed by the Board, by the stockholders of the Company; <u>provided</u>, <u>however</u>, that if a
                Change in Control has occurred, the determination with respect to the Indemnitee&#8217;s entitlement to indemnification shall be made by Independent Counsel.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="z73f04988239b425ebd35e5fa795df89a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(c)</td>
            <td style="width: auto; vertical-align: top;">
              <div>If the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to <u>Section </u><font style="color: rgb(0, 0, 0);"><u>6(b</u></font><u>)</u> hereof, the Independent Counsel shall be selected as
                provided in this <u>Section </u><font style="color: rgb(0, 0, 0);"><u>6(c</u></font><u>)</u>. If a Change in Control has not occurred, the Independent Counsel shall be selected by the Board, and the Company shall give written notice to
                the Indemnitee advising the Indemnitee of the identity of the Independent Counsel so selected. The Indemnitee may, within ten (10) days after such written notice of selection shall have been given, deliver to the Company a written objection
                to such selection; <u>provided</u>,<u> however</u>, that such objection may be asserted only on the ground that the Independent Counsel so selected does not meet the requirements of &#8220;Independent Counsel&#8221; as defined in <u>Section </u><u>13</u>
                of this Agreement, and the objection shall set forth with particularity the factual basis of such assertion. Absent a proper and timely objection, the person so selected shall act as Independent Counsel. If a written objection is made and
                substantiated, the Independent Counsel selected may not serve as Independent Counsel unless and until such objection is withdrawn or a court has determined that such objection is without merit. If a Change in Control has occurred, the
                Independent Counsel shall be selected by the Indemnitee (unless the Indemnitee requests that such selection be made by the Board, in which event the preceding sentence shall apply) and approved by the Board (which approval shall not be
                unreasonably withheld). If (i) an Independent Counsel is to make the determination of entitlement pursuant to this <u>Section </u><u>6</u>, and (ii) within twenty (20) days after submission by the Indemnitee of a written request for
                indemnification pursuant to <u>Section </u><font style="color: rgb(0, 0, 0);"><u>6(a</u></font><u>)</u> hereof, no Independent Counsel shall have been selected (and not objected to), either the Company or the Indemnitee may petition the
                Delaware Court or other court of competent jurisdiction for resolution of any objection which shall have been made by the Indemnitee to the Company&#8217;s selection of Independent Counsel and/or for the appointment as Independent Counsel of a
                person selected by the court or by such other person as the court shall designate, and the person with respect to whom all objections are so resolved or the person so appointed shall act as Independent Counsel under <u>Section </u><font style="color: rgb(0, 0, 0);"><u>6(b</u></font><u>)</u> hereof. The Company shall pay any and all reasonable fees and expenses of Independent Counsel incurred by such Independent Counsel in connection with acting pursuant to <u>Section </u><font style="color: rgb(0, 0, 0);"><u>6(b</u></font><u>)</u> hereof, and the Company shall pay all reasonable fees and expenses incident to the procedures of this <u>Section </u><font style="color: rgb(0, 0, 0);"><u>6(c</u></font><u>)</u>,
                regardless of the manner in which such Independent Counsel was selected or appointed.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">5</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <table id="z62eca4a082254d95abb7cb67fbf0fb99" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(d)</td>
            <td style="width: auto; vertical-align: top;">
              <div>In making a determination with respect to entitlement to indemnification hereunder, the person or persons or entity making such determination shall, to the Fullest Extent Permitted By Applicable Law, presume that the Indemnitee is
                entitled to indemnification under this Agreement, and the burden of proof and the burden of persuasion by clear and convincing evidence to overcome this presumption shall be on the Company. Neither the failure of the Company (including by
                its directors or Independent Counsel) to have made a determination prior to the commencement of any action pursuant to this Agreement that indemnification is proper in the circumstances because the Indemnitee has met the applicable standard
                of conduct, nor an actual determination by the Company (including by its directors or Independent Counsel) that the Indemnitee has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that
                the Indemnitee has not met the applicable standard of conduct.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="z698938b5a9d540f2a1fea359d0f3bf85" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(e)</td>
            <td style="width: auto; vertical-align: top;">
              <div>The Indemnitee shall be deemed to have acted in good faith if the Indemnitee&#8217;s action is based on the records or books of account of the Enterprise, including financial statements, on information supplied to the Indemnitee by the
                officers of the Enterprise in the course of their duties, on the advice of legal counsel for the Enterprise, or on information or records given or reports made to the Enterprise by an independent certified public accountant or by an
                appraiser or other expert selected with reasonable care by the Enterprise. In addition, the knowledge and/or actions, or failure to act, of any other director, officer, agent or employee of the Enterprise shall not be imputed to the
                Indemnitee for purposes of determining the right to indemnification under this Agreement. Whether or not the foregoing provisions of this <u>Section </u><font style="color: rgb(0, 0, 0);"><u>6(e</u></font><u>)</u> are satisfied, it shall
                in any event be presumed that the Indemnitee has at all times acted in good faith and in a manner the Indemnitee reasonably believed to be in or not opposed to the best interests of the Company and the burden of proof and the burden of
                persuasion by clear and convincing evidence to overcome this presumption shall be on the Company.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">6</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <table id="zd64d9c9de17e4a48b73be663db11fdf8" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(f)</td>
            <td style="width: auto; vertical-align: top;">
              <div>If the person, persons or entity empowered or selected under <u>Section </u><u>6</u> to determine whether the Indemnitee is entitled to indemnification shall not have made a determination within sixty (60) days after receipt by the
                Company of the request therefor, the requisite determination of entitlement to indemnification shall, to the Fullest Extent Permitted By Applicable Law, be deemed to have been made and the Indemnitee shall be entitled to such
                indemnification absent (i) a misstatement by the Indemnitee of a material fact, or an omission of a material fact necessary to make the Indemnitee&#8217;s statement not materially misleading, in connection with the request for indemnification,
                (ii) a prohibition of such indemnification under applicable law or (iii) if the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to <u>Section </u><font style="color: rgb(0, 0, 0);"><u>6(b</u></font><u>)</u>
                of this Agreement; <u>provided</u>, <u>however</u>, that such 60-day period may be extended for a reasonable time, not to exceed an additional thirty (30) days, if the person, persons or entity making such determination with respect to
                entitlement to indemnification in good faith requires such additional time to obtain or evaluate documentation and/or information relating thereto; and <u>provided</u>, <u>further</u>, that the foregoing provisions of this <u>Section </u><font style="color: rgb(0, 0, 0);"><u>6(f</u></font><u>)</u> shall not apply if the determination of entitlement to indemnification is to be made by the stockholders pursuant to <u>Section </u><font style="color: rgb(0, 0, 0);"><u>6(b</u></font><u>)</u>
                of this Agreement and if (A) within fifteen (15) days after receipt by the Company of the request for such determination, the Board or the Disinterested Directors, if appropriate, resolve to submit such determination to the stockholders for
                their consideration at an annual meeting thereof to be held within seventy-five (75) days after such receipt and such determination is made thereat, or (B) a special meeting of stockholders is called within fifteen (15) days after such
                receipt for the purpose of making such determination, such meeting is held for such purpose within sixty (60) days after having been so called and such determination is made thereat.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="zeaf29effbc38440eae69ae683b5038a5" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(g)</td>
            <td style="width: auto; vertical-align: top;">
              <div>The Indemnitee shall cooperate with the person, persons or entity making such determination with respect to the Indemnitee&#8217;s entitlement to indemnification, including providing to such person, persons or entity upon reasonable advance
                request any documentation or information that is not privileged or otherwise protected from disclosure and that is reasonably available to the Indemnitee and reasonably necessary to such determination. Any Independent Counsel, member of the
                Board or stockholder of the Company shall act reasonably and in good faith in making a determination regarding the Indemnitee&#8217;s entitlement to indemnification under this Agreement. Any costs or expenses (including attorneys&#8217; fees and
                disbursements) incurred by the Indemnitee in so cooperating with the person, persons or entity making such determination shall be borne by the Company (irrespective of the determination as to the Indemnitee&#8217;s entitlement to indemnification)
                and the Company hereby indemnifies and agrees to hold the Indemnitee harmless therefrom.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">7</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <table id="z4d583ee68f524359876ea136ef11e700" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(h)</td>
            <td style="width: auto; vertical-align: top;">
              <div>The Company acknowledges that a settlement or other disposition of any action, claim or proceeding to which the Indemnitee is a party or potential party short of final judgment may be successful on the merits or otherwise if it permits
                the Indemnitee to avoid the expense, delay, distraction, disruption and uncertainty of litigation. In the event that any action, claim or proceeding to which the Indemnitee is a party is resolved in any manner other than by adverse judgment
                against the Indemnitee (including, without limitation, settlement of such action, claim or proceeding with or without payment of money or other consideration), it shall to the Fullest Extent Permitted By Applicable Law be presumed that the
                Indemnitee has been successful on the merits or otherwise in such Proceeding, and the burden of proof and the burden of persuasion by clear and convincing evidence to overcome this presumption shall be on the Company.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="za44c028b6d4b40c8bc00adfacfe1d493" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(i)</td>
            <td style="width: auto; vertical-align: top;">
              <div>The termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, or upon a plea of nolo contendere or its equivalent, shall not (except as otherwise expressly provided in this
                Agreement) of itself adversely affect the right of the Indemnitee to indemnification or create a presumption that the Indemnitee did not act in good faith and in a manner which the Indemnitee reasonably believed to be in, or not opposed to,
                the best interests of the Company or, with respect to any criminal Proceeding, that the Indemnitee had reasonable cause to believe that the Indemnitee&#8217;s conduct was unlawful.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="z66041e0e04ae4bd7bf3970e29f066698" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(j)</td>
            <td style="width: auto; vertical-align: top;">
              <div>The Company shall not, without Indemnitee&#8217;s prior written consent, enter into any such settlement of any Proceeding (in whole or in part) unless such settlement (i) provides for a full and final release of all claims asserted against
                Indemnitee and (ii) does not impose any Expense, judgment, fine, penalty or limitation on Indemnitee.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="z7fa091028be546bc8643609b33ca3ead" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(k)</td>
            <td style="width: auto; vertical-align: top;">
              <div>The Company will be entitled to participate in the Proceeding at its own expense.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="zd2caa8f890a34dd28ae8896a0c9d300a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">7.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Remedies of the Indemnitee</u>.</font></div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="z51081024773a4abfaddbe9703e19470e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(a)</td>
            <td style="width: auto; vertical-align: top;">
              <div>In the event that (i) a determination is made pursuant to <u>Section </u><u>6</u> of this Agreement that the Indemnitee is not entitled to indemnification under this Agreement, (ii) advancement of Expenses is not timely made pursuant
                to <u>Section </u><u>5</u> of this Agreement, (iii) no determination of entitlement to indemnification is made pursuant to <u>Section </u><font style="color: rgb(0, 0, 0);"><u>6(b</u></font><u>)</u> of this Agreement within ninety (90)
                days after receipt by the Company of the request for indemnification, (iv) if no determination is required to be made by the Company pursuant to <u>Section </u><font style="color: rgb(0, 0, 0);"><u>1(c</u></font><u>)</u> of this
                Agreement, payment of indemnification is not made pursuant to <u>Section </u><font style="color: rgb(0, 0, 0);"><u>1(c</u></font><u>)</u> of this Agreement within thirty (30) days after receipt by the Company of a written request therefor
                or (v) payment of indemnification is not made within thirty (30) days after a determination has been made that the Indemnitee is entitled to indemnification or such determination is deemed to have been made pursuant to <u>Section </u><u>6</u>
                of this Agreement, the Indemnitee shall be entitled to an adjudication in an appropriate court, pursuant to <u>Section </u><u>21</u> of this Agreement, of the Indemnitee&#8217;s entitlement to such indemnification, contribution or advancement
                of Expenses.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">8</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <table id="z009549d11ded413893105b972bc6a979" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(b)</td>
            <td style="width: auto; vertical-align: top;">
              <div>In the event that a determination shall have been made pursuant to <u>Section </u><font style="color: rgb(0, 0, 0);"><u>6(b</u></font><u>)</u> of this Agreement that the Indemnitee is not entitled to indemnification, any judicial
                proceeding or arbitration commenced pursuant to this <u>Section </u><u>7</u> shall be conducted in all respects as a de novo trial, or arbitration, on the merits, and the Indemnitee shall not be prejudiced by reason of the adverse
                determination under <u>Section </u><font style="color: rgb(0, 0, 0);"><u>6(b</u></font><u>)</u>. In any judicial proceeding or arbitration commenced pursuant to this <u>Section </u><u>7</u>, the Indemnitee shall be presumed to be
                entitled to indemnification under this Agreement and the Company shall have the burden of proving the Indemnitee is not entitled to indemnification or advancement of Expenses, as the case may be. If the Indemnitee commences a judicial
                proceeding or arbitration pursuant to this <u>Section </u><u>7</u>, the Indemnitee shall not be required to reimburse the Company for any advances pursuant to <u>Section </u><u>5</u> until a final determination is made with respect to
                the Indemnitee&#8217;s entitlement to indemnification (as to which all rights of appeal have been exhausted or lapsed).</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="z85b0ef06ee604c2bb816cb88c5eedc2f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(c)</td>
            <td style="width: auto; vertical-align: top;">
              <div>If a determination shall have been made pursuant to <u>Section </u><font style="color: rgb(0, 0, 0);"><u>6(b</u></font><u>)</u> of this Agreement that the Indemnitee is entitled to indemnification, the Company shall be bound by such
                determination in any judicial proceeding or arbitration commenced pursuant to this <u>Section </u><u>7</u>, absent (i) a misstatement by the Indemnitee of a material fact, or an omission of a material fact, necessary to make the
                Indemnitee&#8217;s misstatement not materially misleading in connection with the application for indemnification, or (ii) a prohibition of such indemnification under applicable law.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="z89bd628399a94af9b8588dd10a574788" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(d)</td>
            <td style="width: auto; vertical-align: top;">
              <div>In the event that the Indemnitee, pursuant to this <u>Section </u><u>7</u>, incurs costs in a judicial or arbitration proceeding or otherwise seeking to enforce the Indemnitee&#8217;s rights under, or to recover damages for breach of, this
                Agreement, or to recover under any directors&#8217; and officers&#8217; liability insurance policies maintained by the Company, the Company shall, to the Fullest Extent Permitted By Applicable Law, indemnify the Indemnitee against any and all Expenses
                and, if requested by the Indemnitee, shall (within ten (10) days after receipt by the Company of a written request therefor) advance, to the Fullest Extent Permitted By Applicable Law, such Expenses to the Indemnitee that are incurred by or
                on behalf of the Indemnitee in connection with any action brought by the Indemnitee for indemnification or advancement of Expenses from the Company under this Agreement or under any directors&#8217; and officers&#8217; liability insurance policies
                maintained by the Company.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="margin-left: 72pt;">In the case of any action brought by the Indemnitee for indemnification, if the Indemnitee (i) is wholly successful, on the merits or otherwise, on the underlying claims, the Company shall indemnify the Indemnitee to
        the Fullest Extent Permitted By Applicable Law, against all Expenses actually and reasonably incurred by the Indemnitee or on the Indemnitee&#8217;s behalf in connection therewith, or (ii) is not wholly successful on the underlying claims but is
        successful, on the merits or otherwise, as to one or more but less than all claims, the Company shall indemnify the Indemnitee against all Expenses actually and reasonably incurred by the Indemnitee or on the Indemnitee&#8217;s behalf in connection with
        each successfully resolved claim.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">9</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <table id="z083ccf249adf49899fc3519662b074e3" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(e)</td>
            <td style="width: auto; vertical-align: top;">
              <div>The Company agrees that it shall not assert in any judicial or arbitral proceeding commenced pursuant to this <u>Section </u><u>7</u> that the procedures and presumptions of this Agreement are not valid, binding and enforceable and
                shall stipulate in any such court or before any such arbitrator that the Company is bound by all the provisions of this Agreement.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="z2e76442b6571408da9d2aabfabc329b9" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(f)</td>
            <td style="width: auto; vertical-align: top;">
              <div>Notwithstanding anything in this Agreement to the contrary, no determination as to entitlement to indemnification under this Agreement shall be required to be made prior to the final disposition of the Proceeding.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="z1999b24d38e441e2a1253748610fe179" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">8.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Non-Exclusivity; Survival of Rights; Insurance; Subrogation</u>.</font></div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="z834cfd8963554f069286a5745be713ce" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(a)</td>
            <td style="width: auto; vertical-align: top;">
              <div>The rights of indemnification and to receive advancement of Expenses as provided by this Agreement shall not be deemed exclusive of any other rights to which the Indemnitee may at any time be entitled under applicable law, the Charter,
                any agreement, a vote of stockholders, a resolution of directors of the Company, or otherwise; <u>provided</u>, <u>however</u>, that this Agreement shall supersede and replace any rights and obligations of the Company and the Indemnitee
                with respect to indemnification and the advancement of Expenses that are granted pursuant to the Bylaws, and, for so long as this Agreement is in effect, the Indemnitee waives any right to indemnification or advancement of Expenses from the
                Company under the Bylaws that is not permitted or provided by this Agreement. No amendment, alteration or repeal of this Agreement or of any provision hereof shall eliminate, reduce or otherwise adversely affect any right or protection of
                the Indemnitee under this Agreement with respect to any Proceeding involving any action or omission that occurred or allegedly occurred prior to such amendment, alteration or repeal. To the extent that a change in the DGCL, whether by
                statute or judicial decision, permits greater indemnification than would be afforded currently under the Charter, the Bylaws and this Agreement, it is the intent of the parties hereto that the Indemnitee shall enjoy by this Agreement the
                greater benefits so afforded by such change, and the scope of indemnification provided by this Agreement shall be automatically extended to include such greater indemnification rights. No right or remedy herein conferred is intended to be
                exclusive of any other right or remedy, and every other right and remedy shall be cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise. The assertion or
                employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other right or remedy.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">10</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <table id="z7f7b1957b28b450190996219d0fa587f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(b)</td>
            <td style="width: auto; vertical-align: top;">
              <div>The Company shall make commercially reasonable efforts to obtain and maintain in effect during the entire period for which the Company is obligated to indemnify the Indemnitee under this Agreement, one or more policies of insurance with
                reputable insurance companies to provide the directors and officers of the Company with commercially reasonable coverage for losses from wrongful acts and omissions and to ensure the Company&#8217;s performance of its indemnification obligations
                under this Agreement. The Indemnitee shall be covered by such policy or policies in accordance with its or their terms to the maximum extent of the coverage available for any director or officer under such policy or policies. In all such
                insurance policies, the Indemnitee shall be named as an insured in such a manner as to provide the Indemnitee with the same rights and benefits as are accorded to the most favorably insured of the Company&#8217;s directors and officers. At the
                time of the receipt of a notice of a claim pursuant to the terms hereof, the Company shall give prompt notice of the commencement of such proceeding to the insurers in accordance with the procedures set forth in the respective policies. The
                Company shall thereafter take all necessary or desirable action to cause such insurers to pay, on behalf of the Indemnitee, all amounts payable as a result of such proceeding in accordance with the terms of such policies.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="z7cadd4d8f745433cac7e34345f703e58" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(c)</td>
            <td style="width: auto; vertical-align: top;">
              <div>The Company shall not be liable under this Agreement to make any payment of amounts otherwise indemnifiable (or for which advancement of Expenses is provided) hereunder if and to the extent that the Indemnitee has otherwise actually
                received such payment under any insurance policy, contract, agreement or otherwise.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="zbda1190f5ff548d0b917ca1cd57e6712" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">9.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Exception to Right of Indemnification</u>. Notwithstanding any provision in this Agreement, the Charter or the Bylaws, the Company shall not be obligated under this Agreement,
                  the Charter or the Bylaws to make any indemnity or advancement of Expenses in connection with any claim made against the Indemnitee:</font></div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="z8ab9e8f98d6340f798e4d72f5320b5ec" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(a)</td>
            <td style="width: auto; vertical-align: top;">
              <div>for which payment has actually been made to or on behalf of the Indemnitee under any insurance policy or other indemnity provision, except with respect to any excess beyond the amount paid under any insurance policy or other indemnity
                provision; or</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="z09231dae41364a76bf3511228b90c57f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(b)</td>
            <td style="width: auto; vertical-align: top;">
              <div>for an accounting of profits made from the purchase and sale (or sale and purchase) by the Indemnitee of securities of the Company within the meaning of Section 16(b) of the Exchange Act, or similar provisions of state statutory law or
                common law; or</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="zfee0f7f661554af88c46268b6902e37e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(c)</td>
            <td style="width: auto; vertical-align: top;">
              <div>for reimbursement to the Company of any bonus or other incentive-based or equity-based compensation or of any profits realized by the Indemnitee from the sale of securities of the Company, in each case as required under the Exchange Act
                (including any such reimbursements that arise from an accounting restatement of the Company pursuant to Section 304 of the Sarbanes-Oxley Act of 2002, as amended (the &#8220;<u>Sarbanes-Oxley Act</u>&#8221;), or Section 954 of the Dodd-Frank Wall
                Street Reform and Consumer Protection Act in connection with an accounting restatement of the Company or the payment to the Company of profits arising from the purchase and sale by the Indemnitee of securities in violation of Section 306 of
                the Sarbanes-Oxley Act); or</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="zb30804c29a8348928794830a5a31d4d4" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(d)</td>
            <td style="width: auto; vertical-align: top;">
              <div>in connection with any Proceeding (or any part of any Proceeding) initiated by the Indemnitee, including any Proceeding (or any part of any Proceeding) initiated by the Indemnitee against the Company or its directors, officers, employees
                or other indemnitees, unless (i) the Board authorized the Proceeding (or any such part of any Proceeding) prior to its initiation, (ii) the Company provides the indemnification, in its sole discretion, pursuant to the powers vested in the
                Company under applicable law, or (iii) the Proceeding is one to enforce the Indemnitee&#8217;s rights under this Agreement; or</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">11</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <table id="zcca49966cc2649749566bc11e4848d61" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(e)</td>
            <td style="width: auto; vertical-align: top;">
              <div>reimbursement of the Company (such Proceeding, a &#8220;<u>Clawback Proceeding</u>&#8221;) by the Indemnitee of any compensation pursuant to any compensation recoupment or clawback policy adopted by the Board or the compensation committee of the
                Board, including but not limited to any such policy adopted to comply with stock exchange listing requirements implementing Section 10D of the Exchange Act (a &#8220;<u>Clawback Policy</u>&#8221;).</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="ze0a42f9049a44e78b10f3b8e584ac279" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(f)</td>
            <td style="width: auto; vertical-align: top;">
              <div>In furtherance of paragraph (e) of this <u>Section </u><u>9</u>, the Indemnitee hereby agrees to abide by the terms of any Clawback Policy, including, without limitation, by returning any compensation to the Company to the extent
                required by, and in a manner permitted by, the Clawback Policy, and hereby understands and agrees that Indemnitee shall not be entitled to any (x) indemnification for any liability (including any amounts owed by the Indemnitee in a judgment
                or settlement of any Clawback Proceeding) or Losses incurred by the Indemnitee in connection with any Clawback Proceeding or (y) indemnification or advancement of Expenses from the Company or any subsidiary of the Company incurred by the
                Indemnitee in connection with any Clawback Proceeding; <u>provided</u>, <u>however</u>, that if the Indemnitee is successful on the merits in the defense of any claim asserted against the Indemnitee in a Clawback Proceeding, the
                Indemnitee shall be indemnified for the Expenses that the Indemnitee reasonably incurred to defend such claim. The Indemnitee hereby knowingly, voluntarily and intentionally waives, and agrees not to assert any claim regarding, all
                indemnification, advancement of Expenses and other rights to which the Indemnitee is now or becomes entitled to under this Agreement, the Charter, the Bylaws, the governing documents of each subsidiary of the Company and the DGCL, in each
                case to the extent such waiver and agreement is necessary to give effect to the preceding sentence of this paragraph. The Indemnitee agrees and acknowledges that the compensation the Indemnitee has or will receive from the Company or any of
                its subsidiaries constitutes fair and adequate consideration in exchange for the waiver and agreement provided by the Indemnitee in this paragraph.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="zf1aa985cb90d4384b7302b4654d89319" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">10.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Duration of Agreement</u>. All agreements and obligations of the Company contained herein shall continue after the Indemnitee has ceased to be a director, officer, partner,
                  trustee, member, manager, employee, agent or fiduciary of the Company or of any other Enterprise. This Agreement shall be binding upon and inure to the benefit of and be enforceable by the parties hereto and their respective successors
                  (including any direct or indirect successor by purchase, merger, consolidation or otherwise to all, substantially all or a substantial part of the business and/or assets of the Company), assigns, spouses, heirs, executors, administrators
                  and personal and legal representatives.</font></div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">12</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <table id="z0241d75633db4a86a5fa2ff36b896342" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">11.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Security</u>. To the extent requested by the Indemnitee and approved by the Board, the Company may at any time and from time to time provide security to the Indemnitee for the
                  Company&#8217;s obligations hereunder through an irrevocable bank line of credit, funded trust or other collateral. Any such security, once provided to the Indemnitee, may not be revoked or released without the prior written consent of the
                  Indemnitee.</font></div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="z504fe41c2c1d4a9ba5360e39178a63d5" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">12.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Enforcement</u>.</font></div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="z8a92d0d078d3454eba7f4ade3a985c31" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(a)</td>
            <td style="width: auto; vertical-align: top;">
              <div>The Company expressly confirms and agrees that it has entered into this Agreement and assumes the obligations imposed on it hereby in order to induce the Indemnitee to serve and to continue to serve as a director or officer of the
                Company, and the Company acknowledges that the Indemnitee is relying upon this Agreement in serving and continuing to serve as a director or officer of the Company.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="z75db2dca473a442689cb7b53d5d803b1" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(b)</td>
            <td style="width: auto; vertical-align: top;">
              <div>This Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and supersedes all prior agreements and understandings, oral, written and implied, between the parties hereto with
                respect to the subject matter hereof.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="zba85ab8eaecc4a1ca9baaa7c70866ac4" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(c)</td>
            <td style="width: auto; vertical-align: top;">
              <div>The Company shall not seek from a court, or agree to, a &#8220;bar order&#8221; that would have the effect of prohibiting or limiting the Indemnitee&#8217;s rights to receive advancement of Expenses under this Agreement.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="z1c7214678a3141888c4f9b9675eb5a04" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(d)</td>
            <td style="width: auto; vertical-align: top;">
              <div>The Company shall require and cause any successor (including any direct or indirect successor by purchase, merger, consolidation or otherwise to all, substantially all or a substantial part of the business and/or assets of the Company)
                to expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform if no such succession had taken place.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="zaef666ec47284bddbb4252c7ad6f2715" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(e)</td>
            <td style="width: auto; vertical-align: top;">
              <div>The Company and the Indemnitee agree herein that a monetary remedy for breach of this Agreement, at some later date, may be inadequate, impracticable and difficult of proof, and further agree that such breach may cause the Indemnitee
                irreparable harm. Accordingly, the parties hereto agree that the Indemnitee may enforce this Agreement by seeking injunctive relief and/or specific performance hereof, without any necessity of showing actual damage or irreparable harm and
                that by seeking injunctive relief and/or specific performance, the Indemnitee shall not be precluded from seeking or obtaining any other relief to which the Indemnitee may be entitled. The Company and the Indemnitee further agree that the
                Indemnitee shall be entitled to such specific performance and injunctive relief, including temporary restraining orders, preliminary injunctions and permanent injunctions, without the necessity of posting bonds or other undertaking in
                connection therewith. The Company acknowledges that in the absence of a waiver, a bond or undertaking may be required of the Indemnitee by the court, and the Company hereby waives any such requirement of such a bond or undertaking.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">13</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <table id="za6a1765f76fd4a38a4b80d9bb4f08e51" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">13.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Definitions</u>. For purposes of this Agreement:</font></div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="ze96cfb1f865a44d6adccb240ef2e0065" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(a)</td>
            <td style="width: auto; vertical-align: top;">
              <div>&#8220;<u>Beneficial Owner</u>&#8221; shall have the meaning given to such term in Rule 13d-3 under the Exchange Act.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="zff27a97541f146c5bec458af10538984" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(b)</td>
            <td style="width: auto; vertical-align: top;">
              <div>&#8220;<u>Change in Control</u>&#8221; shall be deemed to occur upon the earliest to occur after the date of this Agreement of any of the following events (provided, however that, the business combination contemplated by the registration statement
                on Form S-4 (File No. 333-281116) shall in no event be deemed a Change in Control):</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="z54fdc0315dd24c368ab46e3b53f00223" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(i)</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt; color: rgb(0, 0, 0);">a change in ownership or control of the Company effected through a transaction or series of transactions (other than an offering of shares to the general public
                  through a registration statement filed with the U.S. Securities and Exchange Commission or similar non-U.S. regulatory agency) whereby any &#8220;person,&#8221; as such term is used in Sections 13(d) and 14(d) of the Exchange Act (other than the
                  Company, Randy Soule and his affiliates, any trustee or other fiduciary holding securities under any employee benefit plan of the Company, or any company owned, directly or indirectly, by the stockholders of the Company in substantially
                  the same proportions as their ownership of the Company), becomes the Beneficial Owner, directly or indirectly, of securities of the Company representing 50% or more of the combined voting power of the Company&#8217;s then-outstanding
                  securities, excluding for purposes herein, acquisitions pursuant to a Business Combination that does not constitute a Change in Control as defined in <u>Section </u><u>13(b)(ii)</u></font><font style="font-size: 10pt;">;</font></div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="z542c40bb71bc4c94810f2e5d2960ed3f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(ii)</td>
            <td style="width: auto; vertical-align: top;">
              <div>the consummation of a merger, reorganization or consolidation of the Company with or into the Company or in which equity securities of the Company are issued (each, a &#8220;<u>Business Combination</u>&#8221;), other than a merger, reorganization or
                consolidation that would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or
                its direct or indirect parent) more than 50% of the combined voting power of the voting securities of the Company or such surviving entity (or, as applicable, a direct or indirect parent of the Company or such surviving entity), outstanding
                immediately after such merger, reorganization or consolidation; <u>provided</u>, <u>however</u>, that a merger, reorganization or consolidation effected to implement a recapitalization of the Company (or similar transaction) in which no
                person (other than those covered by the exceptions in <u>Section </u><font style="color: rgb(0, 0, 0);"><u>13(b)(i</u></font><u>)</u>) acquires more than 50% of the combined voting power of the Company&#8217;s then-outstanding securities shall
                not constitute a Change in Control;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">14</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <table id="z1619741aac0d420085047d504af91f8c" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(iii)</td>
            <td style="width: auto; vertical-align: top;">
              <div>the date, within any consecutive two-year period commencing on or after the date of this Agreement, upon which individuals who, at the beginning of such period, constitute the Board together with any new director(s) (other than a
                director designated by a person who has entered into an agreement with the Company to effect a transaction described in <u>Section </u><font style="color: rgb(0, 0, 0);"><u>13(b)(i</u></font><u>)</u>, <font style="color: rgb(0, 0, 0);"><u>13(b)(ii</u></font><u>)</u>
                or <font style="color: rgb(0, 0, 0);"><u>13(b)(iv</u></font><u>)</u> of this Agreement) whose election by the Board or nomination for election by the Company&#8217;s stockholders was approved by a vote of at least two-thirds of the directors
                then in office who either were directors at the beginning of the two-year period or whose election or nomination for election was previously so approved, cease for any reason to constitute a majority thereof;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="z4c409fde0757465388a7eac73b2fc629" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(iv)</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt; color: rgb(59, 56, 56);">a </font><font style="font-size: 10pt; color: rgb(0, 0, 0);">complete liquidation or dissolution of the Company or the consummation of a sale or disposition
                  by the Company of all or substantially all of the Company&#8217;s assets other than the sale or disposition of all or substantially all of the assets of the Company to a person or persons who beneficially own, directly or indirectly, 50% or
                  more of the combined voting power of the outstanding voting securities of the Company at the time of the sale</font><font style="font-size: 10pt;">; or</font></div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="z130f93cc4c9e4fc697e7a3b0897f5484" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(v)</td>
            <td style="width: auto; vertical-align: top;">
              <div>the occurrence of any other event of a nature that would be required to be reported in response to Item 6(e) of Schedule 14A of Regulation 14A (or a response to any similar item on any similar schedule or form) promulgated under the
                Exchange Act, whether or not the Company is then subject to such reporting requirement, except the completion of the Company&#8217;s initial public offering shall not be considered a Change in Control.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="margin-left: 108pt; color: #000000; font-size: 12pt;"><font style="font-size: 10pt;">Notwithstanding anything contained herein, a transaction shall not constitute a &#8220;Change in Control&#8221; for the purposes of this definition if (1) the
          Company becomes a direct or indirect wholly owned subsidiary of a holding company and (2) the direct or indirect holders of the voting stock of such holding company immediately following that transaction are substantially the same as the holders
          of the Company&#8217;s voting stock immediately prior to that transaction.</font></div>
      <div>&#160;</div>
      <table id="z57128b9b98e04f2db9812e8af8b3167f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(c)</td>
            <td style="width: auto; vertical-align: top;">
              <div>&#8220;<u>Corporate Status</u>&#8221; describes the status of a person who is or was a director, officer, partner, trustee, member, manager, employee, agent or fiduciary of the Company or of any other Enterprise.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="z56030bdab7444179b729bc5420a82026" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(d)</td>
            <td style="width: auto; vertical-align: top;">
              <div>&#8220;<u>Disinterested Director</u>&#8221; means a director of the Company who is not and was not a party to the Proceeding in respect of which indemnification is sought by the Indemnitee.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="z8251bf2142af40698b75031e839fe243" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(e)</td>
            <td style="width: auto; vertical-align: top;">
              <div>&#8220;<u>Enterprise</u>&#8221; shall mean the Company and any corporation, partnership, joint venture, trust, limited liability company, employee benefit plan or other enterprise that the Indemnitee is or was serving at the request of the Company
                as a director, officer, trustee, partner, member, manager, employee, agent or fiduciary.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="zd36b25c007f04aed84ef33b16aa814ab" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(f)</td>
            <td style="width: auto; vertical-align: top;">
              <div>&#8220;<u>Exchange Act</u>&#8221; means the Securities Exchange Act of 1934, as amended.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">15</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <table id="zaf01d546fb4149a1ac8196c7d704ce04" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(g)</td>
            <td style="width: auto; vertical-align: top;">
              <div>&#8220;<u>Expenses</u>&#8221; shall mean all reasonable direct and indirect costs, fees and expenses of any type or nature whatsoever and shall specifically include, without limitation, all reasonable attorneys&#8217; fees, retainers, court costs,
                transcript costs, fees and costs of experts and other professionals, witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees and all other disbursements or expenses of
                the types customarily incurred in connection with prosecuting, defending, preparing to prosecute or defend, investigating, participating, or being or preparing to be a witness in, or otherwise participating in, a Proceeding, or responding
                to, or objecting to, a request to provide discovery in any Proceeding. Expenses also shall include Expenses incurred in connection with any appeal resulting from any Proceeding, including without limitation the premium, security for, and
                other costs relating to any cost bond, supersedeas bond, or other appeal bond or its equivalent, and any federal, state, local or foreign taxes imposed on the Indemnitee as a result of the actual or deemed receipt of any payments under this
                Agreement, as well as all reasonable attorneys&#8217; fees and all other expenses incurred by or on behalf of the Indemnitee in connection with preparing and submitting any requests or statements for indemnification, advancement, contribution or
                any other right provided by this Agreement. Expenses, however, shall not include amounts paid in settlement by the Indemnitee or the amount of judgments or fines against the Indemnitee.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="zd6b4deae163a46e89be75d1ff2a23052" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(h)</td>
            <td style="width: auto; vertical-align: top;">
              <div>&#8220;<u>Fullest Extent Permitted By Applicable Law</u>&#8221; includes, but is not limited to: (a) to the fullest extent permitted by the applicable provision of the DGCL, or the corresponding provision of any amendment to or replacement of the
                DGCL, and (b) to the fullest extent authorized or permitted by any amendments to or replacements of the DGCL adopted after the date of this Agreement that increase the extent to which a corporation may indemnify its directors and officers.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="z2864b5464e4d4fa49c838307bc74f0cf" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(i)</td>
            <td style="width: auto; vertical-align: top;">
              <div>&#8220;<u>Independent Counsel</u>&#8221; means a law firm, or a member of a law firm, that is experienced in matters of Delaware corporation law and neither presently is, nor in the past five (5) years has been, retained to represent: (i) the
                Company or the Indemnitee in any matter material to either such party (other than with respect to matters concerning the Indemnitee under this Agreement, or of other indemnitees under similar indemnification agreements), or (ii) any other
                party to the Proceeding giving rise to a claim for indemnification hereunder. Notwithstanding the foregoing, the term &#8220;Independent Counsel&#8221; shall not include any person who, under the applicable standards of professional conduct then
                prevailing, would have a conflict of interest in representing either the Company or the Indemnitee in an action to determine the Indemnitee&#8217;s rights under this Agreement.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="za9854b19b70c4f4dbdb69e27760b3a22" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(j)</td>
            <td style="width: auto; vertical-align: top;">
              <div>&#8220;<u>Losses</u>&#8221; means all liabilities, judgments, fines, penalties, costs, losses, excise taxes or penalties under the Employee Retirement Income Security Act of 1974, as amended from time to time, amounts paid in settlement (including
                all interest assessments and other charges paid or payable in connection with or in respect of such liabilities, losses, judgements, fines, excise taxes, penalties and costs) and other amounts that the Indemnitee reasonably incurs and that
                result from, arise in connection with or are by reason of the Indemnitee&#8217;s Corporate Status.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">16</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <table id="z7ded9d3f7ca641c78c5c231e6efbe877" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(k)</td>
            <td style="width: auto; vertical-align: top;">
              <div>&#8220;<u>Proceeding</u>&#8221; includes any threatened, pending or completed action, suit, claim, counterclaim, cross claim, arbitration, mediation, alternate dispute resolution mechanism, investigation, inquiry, administrative hearing or any other
                actual, threatened or completed proceeding, whether brought by or in the right of the Company or otherwise and whether civil, criminal, administrative or investigative, in which the Indemnitee was, is or will be involved as a party,
                potential party, non-party witness or otherwise, by reason of the Indemnitee&#8217;s Corporate Status or by reason of any action taken by the Indemnitee or of any inaction on the Indemnitee&#8217;s part while acting in the Indemnitee&#8217;s Corporate
                Status, in each case whether or not the Indemnitee is acting or serving in any such capacity at the time any liability or expense is incurred for which indemnification or Advancement of Expenses can be provided under this Agreement, and
                including one pending on or before the date of this Agreement, but excluding one initiated by an Indemnitee pursuant to <u>Section </u><u>7</u> of this Agreement to enforce the Indemnitee&#8217;s rights under this Agreement.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="z738ca904f45146b3adf2bd604f7d1550" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">14.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Severability</u>. If any provision or provisions of this Agreement shall be held to be invalid, illegal or unenforceable for any reason whatsoever: (i) the validity, legality and
                  enforceability of the remaining provisions of this Agreement (including, without limitation, each portion of any section, paragraph or sentence of this Agreement containing any such provision held to be invalid, illegal or unenforceable,
                  that is not itself invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby and shall remain enforceable to the Fullest Extent Permitted By Applicable Law, (ii) such provision or provisions shall be deemed
                  reformed to the fullest extent necessary to conform to applicable law and to give the maximum effect to the intent of the parties hereto, and (iii) to the Fullest Extent Permitted By Applicable Law, the provisions of this Agreement
                  (including, without limitation, each portion of any section, paragraph or sentence of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall
                  be construed so as to give effect to the intent manifested thereby. Without limiting the generality of the foregoing, this Agreement is intended to confer upon the Indemnitee indemnification rights to the Fullest Extent Permitted By
                  Applicable Law.</font></div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="zf9f0f1d0e6c149e58b0b25c65536c77f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">15.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Modification and Waiver</u>. No supplement, modification, termination or amendment of this Agreement shall be binding unless executed in writing by both of the parties hereto. No
                  waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions hereof (whether or not similar) nor shall such waiver constitute a continuing waiver.</font></div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="z1a533aa7810445de8f3953ca34095d03" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">16.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Notice By the Indemnitee</u>. The Indemnitee agrees to promptly notify the Company in writing upon being served with or otherwise receiving any summons, citation, subpoena,
                  complaint, indictment, information or other document relating to any Proceeding or matter which may be subject to indemnification or advancement of Expenses covered hereunder. The written notification to the Company shall include a
                  description of the nature of the Proceeding and the facts underlying the Proceeding. The failure to so notify the Company shall not relieve the Company of any obligation which it may have to the Indemnitee under this Agreement or
                  otherwise unless and only to the extent that such failure or delay materially prejudices the interests of the Company.</font></div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">17</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <table id="z230d810a6fbc420981a89e6689dee54b" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">17.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Notices</u>. All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed effectively given: (i) upon personal delivery
                  to the party to be notified, (ii) when sent by confirmed electronic mail or facsimile if sent during normal business hours of the recipient, and if not so confirmed, then on the next business day, (iii) five (5) days after having been
                  sent by registered or certified mail, return receipt requested, postage prepaid, or (iv) one (1) day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. All
                  communications shall be sent:</font></div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="z20ad73bb97ec4741bbbc615c83f555be" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(a)</td>
            <td style="width: auto; vertical-align: top;">
              <div>To the Indemnitee at the address set forth below the Indemnitee&#8217;s signature hereto.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="zedd73485207c40c0947923771db0ee96" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">(b)</td>
            <td style="width: auto; vertical-align: top;">
              <div>To the Company at:</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="margin-left: 72pt;">XCF Global, Inc.</div>
      <div style="margin-left: 72pt;">2500 CityWest Blvd, Suite 150-138</div>
      <div style="margin-left: 72pt;">Houston, TX 77042</div>
      <div style="margin-left: 72pt;">Attention:&#160;&#160;&#160;&#160;&#160; Mihir Dange, CEO</div>
      <div style="margin-left: 72pt;">E-mail:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;m.dange@xcf.global</div>
      <div>&#160;</div>
      <div style="margin-left: 36pt;">or to such other address as may have been furnished to the Indemnitee by the Company or to the Company by the Indemnitee, as the case may be.</div>
      <div>&#160;</div>
      <table id="z8c16c644fff0443080f650e424111b06" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">18.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Construction</u>. Whenever required by the context, as used in this Agreement the singular number shall include the plural, the plural shall include the singular, and all words
                  herein in any gender shall be deemed to include (as appropriate) the masculine, feminine and neuter genders. References to &#8220;day&#8221; shall mean a calendar day unless expressly stated to the contrary.</font></div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="ze0b505bc96a44c659adb1490aacf2769" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">19.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Counterparts</u>. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the
                  same Agreement. Counterparts may be delivered via facsimile, electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, <font style="font-style: italic;">e.g.</font>, www.docusign.com)
                  or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.</font></div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table id="z291ebe4dca1c46f3a6f7f640642a8548" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">20.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Headings</u>. The headings of the paragraphs of this Agreement are inserted for convenience only and shall not be deemed to constitute part of this Agreement or to affect the
                  construction thereof.</font></div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">18</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <table id="zc85e03f859be4aa89379f527921919d9" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: rgb(1, 0, 0);">21.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Governing Law and Consent to Jurisdiction</u>. This Agreement and the legal relations among the parties shall be governed by, and construed and enforced in accordance with, the
                  laws of the State of Delaware, without regard to its conflict of laws rules. The Company and the Indemnitee hereby irrevocably and unconditionally (i) agree that any action or proceeding arising out of or in connection with this Agreement
                  shall, unless the Company consents in writing to the selection of an alternate forum, be brought only in the Delaware Court (or, if and only if the Delaware Court lacks subject matter jurisdiction, any state court located within the State
                  of Delaware or, if and only if all such state courts lack subject matter jurisdiction, the federal district court for the District of Delaware), (ii) generally and unconditionally consent to submit to the exclusive jurisdiction of the
                  Delaware Court for purposes of any action or proceeding arising out of or in connection with this Agreement, (iii) irrevocably appoint, to the extent such party is not otherwise subject to service of process in the State of Delaware,
                  Corporation Service Company, 251 Little Falls Drive, Wilmington, County of New Castle, Delaware 19809, as its agent in the State of Delaware as such party&#8217;s agent for acceptance of legal process in connection with any such action or
                  proceeding against such party with the same legal force and validity as if such party had been personally served within the State of Delaware, (iv) waive any objection to the laying of venue of any such action or proceeding in the
                  Delaware Court, and (v) waive, and agree not to plead or to make, any claim that any such action or proceeding brought in the Delaware Court has been brought in an improper or inconvenient forum.</font></div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">[SIGNATURE PAGE FOLLOWS]</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">19</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <div style="text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">IN WITNESS WHEREOF</font><font style="font-size: 10pt;">, the parties hereto have executed this Agreement on and as of the day and year first above
          written.</font></div>
      <div>&#160;</div>
      <div>
        <div>
          <table style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" border="0" cellpadding="0" cellspacing="0">

              <tr>
                <td style="width: 50%;"><br>
                </td>
                <td rowspan="1" colspan="2">
                  <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">XCF Global, Inc.</font></div>
                </td>
              </tr>
              <tr>
                <td style="width: 50%;"><br>
                </td>
                <td style="width: 3%;"><br>
                </td>
                <td style="width: 47%;"><br>
                </td>
              </tr>
              <tr>
                <td style="width: 50%; padding-bottom: 2px;" rowspan="1"><br>
                </td>
                <td style="width: 3%; padding-bottom: 2px;" rowspan="1">By:</td>
                <td style="width: 47%; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">/s/ Mihir Dange</td>
              </tr>
              <tr>
                <td style="width: 50%;" rowspan="1"><br>
                </td>
                <td rowspan="1"> <br>
                </td>
                <td rowspan="1">Name: Mihir Dange</td>
              </tr>
              <tr>
                <td style="width: 50%;" rowspan="1"><br>
                </td>
                <td rowspan="1"> <br>
                </td>
                <td rowspan="1">Title:&#160;&#160; Chief Executive Officer</td>
              </tr>

          </table>
        </div>
      </div>
      <div>&#160;</div>
      <div>
        <table id="zf8778a6548534e54a3c11fcfc05c06dc" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" border="0" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 50.00%;"><br>
              </td>
              <td style="width: 50%;">
                <div style="font-weight: bold;">INDEMNITEE</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; padding-bottom: 2px;"><br>
              </td>
              <td style="width: 50%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 50.00%;"><br>
              </td>
              <td style="width: 50%;">
                <div>Name:</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50.00%;"><br>
              </td>
              <td style="width: 50.00%;"><br>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 50.00%;"><br>
              </td>
              <td rowspan="1" style="width: 50%;">
                <div>Address:</div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 50%; padding-bottom: 2px;"><br>
              </td>
              <td rowspan="1" style="width: 50%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 50%; padding-bottom: 2px;"><br>
              </td>
              <td rowspan="1" style="width: 50%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 50%; padding-bottom: 2px;"><br>
              </td>
              <td rowspan="1" style="width: 50%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 50%; padding-bottom: 2px;"><br>
              </td>
              <td rowspan="1" style="width: 50%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>

        </table>
      </div>
      <div><br>
      </div>
      <div style="text-align: center;">[<font style="font-style: italic;">Signature Page to Indemnification Agreement</font>]</div>
      <div style="text-align: center;"> <br>
      </div>
      <div style="text-align: center;"> <br>
      </div>
    </div>
    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.56
<SEQUENCE>11
<FILENAME>ef20050548_ex10-56.htm
<DESCRIPTION>EXHIBIT 10.56
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; font-size: 12pt; font-weight: bold;"> <font style="font-size: 10pt;">Exhibit 10.56<br>
        </font></div>
      <div style="font-size: 12pt; font-weight: bold;"> <font style="font-size: 10pt;"><br>
        </font></div>
      <div style="text-align: center; font-weight: bold;">Lock-Up Waiver</div>
      <div><br>
      </div>
      <div style="text-align: center;">June 6, 2025</div>
      <div><br>
      </div>
      <div>Core Company Securityholders listed on <u>Exhibit A</u> attached hereto</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z83b790bbdd9d4acbbad72e2cfe7c9243" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-weight: bold;">Re:</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-weight: bold;">XCF Global Capital, Inc. (the &#8220;<u>Company</u>&#8221;)</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div>Ladies and Gentlemen:</div>
      <div>&#160;</div>
      <div>Reference is made to the Support Agreements listed on <u>Exhibit A</u> attached hereto (as may be amended, supplemented or otherwise modified from time to time, collectively, the &#8220;<u>Support Agreements</u>&#8221;) by and among the Company, Focus
        Impact BH3 Acquisition Company, a Delaware corporation (the &#8220;<u>SPAC</u>&#8221;), Focus Impact BH3 Newco, Inc., a Delaware corporation (&#8220;<u>NewCo</u>&#8221;), and the respective Core Company Securityholders listed on <u>Exhibit A</u> attached hereto.&#160;
        Capitalized terms used but not otherwise defined herein shall have the meanings ascribed thereto in the applicable Support Agreement.</div>
      <div>&#160;</div>
      <div>Under Section 4.01(b) of the applicable Support Agreement (the &#8220;<u>Lock-up Provision</u>&#8221;), you agreed that you would not, except for Permitted Transfers, Transfer or permit any Transfer of any Covered Shares that you own for the duration of the
        Lock-up Period.</div>
      <div>&#160;</div>
      <div>This letter confirms that, contingent upon and effective as of the consummation of the transactions contemplated under the BCA, each of the Company, the SPAC, and NewCo hereby waives the application of the Lock-up Provision with respect to your
        Covered Shares.&#160; For the avoidance of doubt, the foregoing waiver shall also apply to the Covered Shares held by any transferee of your Covered Shares in a Permitted Transfer.</div>
      <div>&#160;</div>
      <div>Except as expressly provided herein, the Support Agreements shall otherwise remain in full force and effect and constitute legal and binding obligations of all parties thereto in accordance with their terms.&#160; This letter is limited precisely as
        written and shall not be deemed to be an amendment, modification or waiver of any other term or condition of the Support Agreements.</div>
      <div>&#160;</div>
      <div style="text-align: center;">&#160;[Signature page follows]</div>
      <div>&#160;</div>
      <div style="text-align: center; font-style: italic;">[Signature Page to Support Agreements Lock-up Waiver]</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: -18pt; margin-right: 234pt; margin-left: 18pt;">Very truly yours,</div>
      <div style="text-indent: -18pt; margin-right: 234pt; margin-left: 18pt;"> <br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" id="z226c461c0630472c94e818fde00e1a31" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="vertical-align: top;" rowspan="1" colspan="2">
                <div style="font-weight: bold;">XCF GLOBAL CAPITAL, INC.</div>
              </td>
              <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align: top;" rowspan="1" colspan="2">&#160;</td>
              <td style="width: 50%; vertical-align: top;" colspan="1" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 3%; vertical-align: top;">
                <div>By:</div>
              </td>
              <td style="width: 47%; vertical-align: top;">
                <div><u>/s/ Mihir Dange</u></div>
              </td>
              <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 3%; vertical-align: top;"><br>
              </td>
              <td style="width: 47%; vertical-align: top;">Name: Mihir Dange</td>
              <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 3%; vertical-align: top;"><br>
              </td>
              <td style="width: 47%; vertical-align: top;">
                <div>Title: Chief Executive Officer</div>
              </td>
              <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 3%; vertical-align: top;">&#160;</td>
              <td style="width: 47%; vertical-align: top;">&#160;</td>
              <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align: top;" rowspan="1" colspan="2">
                <div style="font-weight: bold;">FOCUS IMPACT BH3 ACQUISITION COMPANY</div>
              </td>
              <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align: top;" rowspan="1" colspan="2">&#160;</td>
              <td style="width: 50%; vertical-align: top;" colspan="1" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 3%; vertical-align: top;">
                <div>By:</div>
              </td>
              <td style="width: 47%; vertical-align: top;">
                <div><u>/s/ Carl Stanton</u></div>
              </td>
              <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 3%; vertical-align: top;"><br>
              </td>
              <td style="width: 47%; vertical-align: top;">
                <div>Name: Carl Stanton</div>
              </td>
              <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 3%; vertical-align: top;"><br>
              </td>
              <td style="width: 47%; vertical-align: top;">
                <div>Title: Chief Executive Officer</div>
              </td>
              <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 3%; vertical-align: top;">&#160;</td>
              <td style="width: 47%; vertical-align: top;">&#160;</td>
              <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align: top;" rowspan="1" colspan="2">
                <div style="font-weight: bold;">FOCUS IMPACT BH3 NEWCO, INC.</div>
              </td>
              <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align: top;" rowspan="1" colspan="2">&#160;</td>
              <td style="width: 50%; vertical-align: top;" colspan="1" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 3%; vertical-align: top;">
                <div>By:</div>
              </td>
              <td style="width: 47%; vertical-align: top;">
                <div><u>/s/ Carl Stanton</u></div>
              </td>
              <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 3%; vertical-align: top;"><br>
              </td>
              <td style="width: 47%; vertical-align: top;">
                <div>Name: Carl Stanton</div>
              </td>
              <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 3%; vertical-align: top;"><br>
              </td>
              <td style="width: 47%; vertical-align: top;">
                <div>Title: Chief Executive Officer</div>
              </td>
              <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
            </tr>

        </table>
      </div>
      <div>&#160;</div>
      <div>
        <div style="text-align: center; font-style: italic;">[Signature Page to Support Agreements Lock-up Waiver]</div>
        <div style="text-align: center; font-style: italic;"> <br>
        </div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;">
        <div style="font-weight: bold;"><u>EXHIBIT A</u></div>
      </div>
      <div style="text-align: center; font-weight: bold;">SUPPORT AGREEMENTS</div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.57
<SEQUENCE>12
<FILENAME>ef20050548_ex10-57.htm
<DESCRIPTION>EXHIBIT 10.57
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">



  <font style="font-size: 10pt;"> </font>
  <div style="font-family: 'Times New Roman'; font-size: 10pt;">
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit 10.57</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">XCF Global, Inc.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Employment Agreement</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">This Employment Agreement (this &#8220;Agreement&#8221;), dated as of June 6, 2025, is made by and between XCF Global, Inc. (the &#8220;Company&#8221;) and Mihir Dange
        (&#8220;Executive&#8221;) (the Company and Executive are collectively referred to herein as the &#8220;Parties,&#8221; or each individually referred to as a &#8220;Party&#8221;).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">RECITALS</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">WHEREAS</font><font style="font-size: 10pt;">, Executive has been
          serving as the Chief Executive Officer of XCF Global Capital, Inc. (&#8220;XCF Global Capital&#8221;);</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">WHEREAS</font><font style="font-size: 10pt;">, on March 11, 2024,
          XCF Global Capital, Focus Impact BH3 Acquisition Company (&#8220;Focus Impact&#8221;), Focus Impact BH3 NewCo, Inc. (&#8220;NewCo&#8221;), Focus Impact BH3 Merger Sub 1, LLC and Focus Impact BH3 Merger Sub 2, Inc. entered into a business combination agreement (as it may
          be amended or restated from time to time, the &#8220;Business Combination Agreement&#8221;), pursuant to which Focus Impact agreed to combine with XCF Global Capital in a series of transactions that will result in NewCo becoming a publicly-traded company
          (collectively, the &#8220;Business Combination&#8221;), and at the closing of the Business Combination (the &#8220;Closing&#8221;), NewCo will change its name to &#8220;XCF Global, Inc.&#8221;; and</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">WHEREAS</font><font style="font-size: 10pt;">, Executive and the
          Company desire to enter into this Agreement to set out the terms and conditions of the employment relationship between the Company and the Executive following the Closing of the Business Combination, with this Agreement to become effective upon
          the Closing of the Business Combination and continue until terminated by either Party in accordance with its terms (such period during which this Agreement is in effect, the &#8220;Term&#8221;) and will be null and void if the Closing of the Business
          Combination does not occur; and</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">WHEREAS</font><font style="font-size: 10pt;">, except as otherwise
          provided herein, Executive and the Company intend and confirm that this Agreement supersedes in all respects all prior agreements, arrangements or understandings between Executive and the Company regarding the subject matter herein, including
          without limitation, any offer letter, employment agreement, consulting agreement or severance agreement as of the effective date of this Agreement.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">NOW, THEREFORE</font><font style="font-size: 10pt;">, in
          consideration of the foregoing recitals, the mutual covenants and agreements set forth herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and Executive agree as follows:</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">1.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Employment</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>At-Will Employment</u></font>. Executive and the Company acknowledge that Executive&#8217;s employment is and shall continue to be at-will, as defined under applicable law, and that Executive&#8217;s employment
            with the Company may be terminated by either Party at any time for any or no reason (subject to the notice requirements of <font style="font-family: 'Times New Roman';"><u>Section 3(b)</u></font>). If Executive&#8217;s employment terminates for any
            reason, Executive shall only be entitled to those payments, benefits, awards or compensation as specifically provided in this Agreement or as otherwise agreed to in writing by the Company, or as provided by applicable law, and Executive shall
            not be entitled to any other payments, benefits, damages, award or compensation.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Title; Responsibilities</u></font>. The Company shall continue to employ Executive in the position of Chief Executive Officer reporting to the Board of Directors of the Company (the &#8220;Board&#8221;), and
            Executive hereby accepts such continued employment. During the Term, Executive shall have and perform such duties, responsibilities and authorities as are customarily associated with this position, as well as any other duties that may be
            assigned to Executive from time to time by the Board that are not inconsistent with service as an officer of the Company, including duties for any Company subsidiary or affiliate. Executive agrees to serve as a member of the Board during the
            Term, without additional compensation, until Executive&#8217;s successor is duly appointed or elected in accordance with the Company&#8217;s certificate of incorporation and bylaws. The Board shall nominate Executive for election to serve as a director at
            each annual meeting of the Company&#8217;s stockholders (or, in the case of a classified Board, at such annual meeting as the Executive&#8217;s assigned class of directors will stand for election) that occurs during the Term, provided, that the foregoing
            will not be required to the extent prohibited by legal or regulatory requirements. Upon termination of Executive&#8217;s employment for any reason, Executive shall be deemed to have resigned from the Board and any other directorships held with any
            subsidiaries of the Company.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Exclusive Employment</u></font>. During the Term, Executive shall devote substantially all of Executive&#8217;s business time, skills and best efforts to Executive&#8217;s employment hereunder and may not,
            without the prior written consent of the Board, participate in the management, operation, or control of, or act as an employee, officer, director, consultant, advisor, agent or representative of, any other business or service (&#8220;Other Service&#8221;);
            provided, however, that Executive may (i) engage in civic and charitable activities (including service on the board of directors or advisory board of civic and charitable organizations), (ii) make and manage outside passive personal and family
            investments and manage personal and family affairs and (iii) serve on the board of directors of the for-profit businesses or trade organizations (including advisory boards), provided, that none of the foregoing (x) materially interferes with
            Executive&#8217;s performance of Executive&#8217;s duties hereunder, (y) poses an actual or perceived conflict of interest or violates any other obligations of Executive hereunder (including, without limitation, <font style="font-family: 'Times New Roman';"><u>Sections 5</u></font> and <font style="font-family: 'Times New Roman';"><u>6</u></font> hereof) or (z) is prohibited by or conflicts with any applicable law or regulation (including the rules of any securities exchange on which
            the Company&#8217;s securities are listed) or any Company policy applicable to Executive. <font style="font-family: 'Times New Roman';"><u>Exhibit A</u></font> hereto identifies (i) any Other Service with respect to which the Board had provided its
            consent and (ii) any board of directors of any for-profit businesses or trade organizations (including advisory boards) on which Executive serves (as such Exhibit may be amended from time to time during the Term by mutual agreement of the
            Executive and the Board).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Compliance</u></font>. Executive agrees to comply with all applicable laws, rules, regulations and policies relating to the performance of Executive&#8217;s duties and responsibilities as an employee of
            the Company, including, without limitation, compliance with the Company&#8217;s Code of Ethics and Business Conduct. Executive is prohibited from receiving economic benefits from any other person or entity other than the Company in connection with
            the services provided to the Company hereunder (for purposes of clarity, receipt of economic benefits from ownership of securities of the Company would not be prohibited under this provision, but would, for the avoidance of doubt, be subject to
            any insider trading policy maintained by the Company).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Employment Location</u></font>. Executive may work remotely from Executive&#8217;s residence or from such other location as Executive shall inform the Company. Notwithstanding the foregoing, Executive
            understands and agrees that in connection with the performance of Executive&#8217;s duties and responsibilities under this Agreement, the Company may require Executive to spend designated days per month in a designated Company office, provided, that
            the Company shall notify the Executive in advance of such requirement. In addition, Executive understands and agrees that in connection with the performance of Executive&#8217;s duties and responsibilities under this Agreement, Executive may be
            required to travel on Company business from time-to-time.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">2</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">2.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Compensation</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Base Salary</u></font>. During the Term, Executive shall receive an annualized base salary in the amount of $825,000 (&#8220;Base Salary&#8221;), which will be paid in accordance with the Company&#8217;s customary
            payroll procedures as established and modified from time-to-time. The Base Salary will be reviewed annually and may be changed in the sole discretion of the Board and as recommended by the Board&#8217;s Compensation Committee (provided, however, if
            pursuant to the listing requirements of any securities exchange on which the Company&#8217;s securities are then listed, Executive&#8217;s compensation must be set or approved in a different manner, Executive&#8217;s compensation shall be set or approved in
            accordance with such requirements), and any such revised Base Salary shall then constitute &#8220;Base Salary&#8221; for purposes of this Agreement.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Annual Bonus</u></font>. In addition to the Base Salary, Executive shall be eligible for an annual bonus for each completed fiscal year of employment during the Term (&#8220;Annual Bonus&#8221;).&#160; The terms of
            Executive&#8217;s initial Annual Bonus are as set forth on <font style="font-family: 'Times New Roman';"><u>Exhibit B</u></font> to this Agreement, and the terms of the Annual Bonus for subsequent years shall be determined by the Board, upon the
            recommendation of the Board&#8217;s Compensation Committee for each such subsequent year of employment as set forth herein. Executive understands and agrees that this Agreement does not guarantee the payment of any Annual Bonus and that the actual
            Annual Bonus payable will be based on the achievement of performance objectives and/or other criteria as determined by the Board and recommended by the Board&#8217;s Compensation Committee and such other factors as the Compensation Committee, in its
            discretion, deems relevant (provided, however, if pursuant to the listing requirements of any securities exchange on which the Company&#8217;s securities are then listed, Executive&#8217;s compensation, including any bonus compensation, must be set or
            approved in a different manner, Executive&#8217;s compensation shall be set or approved in accordance with such requirements). Unless otherwise agreed by the Parties and subject to <font style="font-family: 'Times New Roman';"><u>Section 4(c)(ii)</u></font>,
            if an Annual Bonus is awarded, such Annual Bonus shall be deemed &#8220;earned&#8221; and Executive is entitled to receive payment of such Annual Bonus only if Executive is employed by the Company on the date the Annual Bonus is paid. Any Annual Bonus
            payable in accordance with this <font style="font-family: 'Times New Roman';"><u>Section 2(b)</u></font> shall be paid to Executive no later than March 15<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> of
            the calendar year following the year to which it relates. Executive&#8217;s Annual Bonus for 2025 (to the extent earned) will be prorated to reflect the portion of the year from the Closing of the Business Combination.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Equity Compensation</u></font>.&#160; As soon as practicable following the Closing of the Business Combination and subject to Board approval, Executive shall receive an initial award of restricted stock
            units as set forth on <font style="font-family: 'Times New Roman';"><u>Exhibit B</u></font>, subject to Executive&#8217;s continued employment through the date of grant, which award shall be subject in all respect to the term and conditions of the
            Company&#8217;s 2025 Equity Incentive Plan (the &#8220;2025 Plan&#8221;) and the applicable award agreement to be delivered separately to Executive. In addition, Executive shall be eligible to receive additional equity compensation pursuant to the 2025 Plan or
            such other plans or arrangements as determined by the Board or Compensation Committee from time to time. The complete terms and conditions of any future equity compensation award made pursuant to the 2025 Plan or any other equity plan adopted
            by the Company, including vesting, exercise and forfeiture terms, shall be set forth in an award agreement and any such award shall be subject to the terms and conditions set forth in such award agreement and the 2025 Plan or such other equity
            plan adopted by the Company.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Benefits</u></font>. During the Term, Executive shall be eligible to participate in such health, group insurance, welfare, pension, and other employee benefit plans, programs, and arrangements as are
            made generally available from time to time to senior executives of the Company (which shall include customary health, life insurance, and disability plans). Executive also shall be eligible to participate in the Company&#8217;s 2025 Employee Stock
            Purchase Plan or any similar or replacement plan adopted in the future during the Term. Executive also shall be eligible for 25 days of paid time off (&#8220;PTO&#8221;) per calendar year during the Term (prorated for partial years) in accordance with the
            Company&#8217;s vacation and PTO policy in effect from time to time, inclusive of vacation days and sick days and excluding standard paid Company holidays.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Expenses and Allowances</u></font>. Executive shall receive reimbursement from the Company for all reasonable, necessary, and documented business expenses incurred in connection with Executive&#8217;s
            employment hereunder, provided, that such expenses are timely submitted for reimbursement with supporting documentation in accordance with the Company&#8217;s expense reimbursement policies and procedures. In addition, Executive will receive
            reimbursement for the additional fees and expenses incurred by Executive as set forth on <font style="font-family: 'Times New Roman';"><u>Exhibit B</u></font> (subject to Executive provided sufficient documentation for such reimbursements).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">3</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">3.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Termination</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Termination Circumstances</u></font>.&#160; Executive&#8217;s employment hereunder may be terminated by the Company or Executive, as applicable, under the following circumstances, and the Term will end on the
            Date of Termination:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Death</font>. Executive&#8217;s employment hereunder shall terminate automatically upon Executive&#8217;s death.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Disability</font>. If Executive has incurred a Disability, the Company may terminate Executive&#8217;s employment.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Termination for Cause</font>. The Company may terminate Executive&#8217;s employment for Cause.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(iv)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Termination without Cause</font>. The Company may terminate Executive&#8217;s employment without Cause for any reason or no reason.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(v)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Resignation from the Company with Good Reason</font>. Executive may resign Executive&#8217;s employment with the Company with Good Reason.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(vi)</font><font style="font-size: 10pt;">&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Resignation from the Company without Good Reason</font>. Executive may resign Executive&#8217;s employment with the Company for any reason other than Good Reason or for no
            reason.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160; &#160;&#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Notice of Termination</u></font>. Any termination of Executive&#8217;s employment by the Company or by Executive under this <font style="font-family: 'Times New Roman';"><u>Section 3</u></font> (other
            than termination as a result of Executive&#8217;s death) shall be communicated by a written notice by the terminating Party to the other Party hereto (i) indicating the specific termination provision in this Agreement being relied upon, (ii) setting
            forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of employment under the provision so indicated, if applicable, and (iii) specifying a Date of Termination (such notice, a &#8220;Notice of
            Termination&#8221;).&#160; If the Notice of Termination is submitted by Executive, such Notice of Termination shall be given at least thirty (30) days prior to the Date of Termination; provided, however, that in the event that Executive delivers a Notice
            of Termination to the Company, the Company may, in its sole discretion, change the Date of Termination to any date that occurs following the date of the Company&#8217;s receipt of such Notice of Termination and which is prior to the date specified by
            Executive in such Notice of Termination, but such termination still shall be considered a resignation by Executive, unless the Company has determined that Cause exists as of such earlier Date of Termination. A Notice of Termination submitted by
            the Company may provide for a Date of Termination on the date Executive receives the Notice of Termination or any date thereafter elected by the Company. The failure by either Party to set forth in the Notice of Termination any fact or
            circumstance which contributes to a showing of Cause or Good Reason shall not waive any right of the Party hereunder or preclude the Party from asserting such fact or circumstance in enforcing the Party&#8217;s rights hereunder.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">4</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Company Obligations upon Termination</u></font>. Upon termination of Executive&#8217;s employment pursuant to any of the circumstances set forth in this <font style="font-family: 'Times New Roman';"><u>Section
                3</u></font>, Executive (or Executive&#8217;s estate) shall be entitled to receive the sum of (i) the portion of Executive&#8217;s Base Salary earned for the applicable year through the Date of Termination, but not yet paid to Executive, payable on the
            pay date immediately following the Date of Termination in accordance with the Company&#8217;s regular payroll practices (or such earlier date as required by applicable law), (ii) any expense reimbursements owed to Executive pursuant to this
            Agreement, payable in accordance with the Company&#8217;s expense reimbursement policy and (iii) any amount accrued and arising from Executive&#8217;s participation in, or benefits accrued under any employee benefit plans, programs or arrangements, which
            amounts shall be payable in accordance with the terms and conditions of such employee benefit plans, programs or arrangements (the &#8220;Company Arrangements&#8221; and the entitlements referenced in the foregoing clauses (i) through (iii), collectively,
            the &#8220;Accrued Benefits&#8221;).</font></font></div>
      <div style="font-size: 10pt;">&#160; <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u></u><font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Effect on Equity Awards</u></font>. The effect of Executive&#8217;s termination on any equity awards received by Executive prior to such termination shall be determined in accordance with the terms of the
            2025 Plan (or any other equity plan adopted by the Company pursuant to which such awards were made), the award agreement relating to any such award and/or <font style="font-family: 'Times New Roman';"><u>Section 4(b)</u></font> below, and in
            the case of a termination relating to a Change in Control, <font style="font-family: 'Times New Roman';"><u>Section 4(c)</u></font> below.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">4.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Severance Payments</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Termination Upon Death or Disability</u></font>. In the event of Executive&#8217;s termination of employment due to death or Disability (as defined below) during the Term, the Company shall pay to or for
            the benefit of Executive or Executive&#8217;s estate, as applicable, the Accrued Benefits and, to the extent unpaid as of the Date of Termination, the Company shall pay Executive the amount of Executive&#8217;s Annual Bonus for the prior year, paid as set
            forth in <font style="font-family: 'Times New Roman';"><u>Section 2(b)</u></font> as if no such termination had occurred.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Termination for Cause; Resignation from the Company Without Good Reason</u></font>. If Executive&#8217;s employment shall terminate for Cause, or due to Executive&#8217;s resignation from the Company without
            Good Reason, then Executive shall receive the Accrued Benefits.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Termination without Cause, or Resignation from the Company with Good Reason</u></font>. If Executive&#8217;s employment is terminated without Cause or due to Executive&#8217;s resignation with Good Reason (in
            each case, a &#8220;Qualifying Termination&#8221;) that does not occur during the CIC Period (as defined below), in addition to the Accrued Benefits, Executive shall be entitled to the following payments and benefits:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">The Company shall pay Executive an amount in cash equal to, in the aggregate, 300% of the Executive&#8217;s annual base salary in effect as of the Date of the Termination, payable in equal monthly installments over the 12 month period
            following the Date of Termination, in accordance with the Company&#8217;s normal payroll practices;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">To the extent unpaid as of the Date of Termination, the Company shall pay Executive the amount of Executive&#8217;s Annual Bonus for any unpaid prior period, paid as set forth in <font style="font-family: 'Times New Roman';"><u>Section 2(b)</u></font>
            as if no such termination had occurred;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Company shall pay Executive an amount in cash equal to three times the amount of the annual bonus that Executive would have earned for the year in which the Date of Termination occurs as if Executive had not been terminated and as
            if such annual bonus was fully earned (i.e., any relevant performance criteria shall be deemed fully achieved)(such payment, the (&#8220;Termination Bonus Payment&#8221;), which amount will be paid in a lump sum within thirty (30) days following the date
            Executive&#8217;s Release becomes effective and irrevocable, provided that to the extent the annual bonus for the year in which the Date of Termination occurs has been pro-rated to reflect that portion of the year from the Closing of the Business
            Combination to the end of such year, or in the event of any other partial-year calculation, the annual bonus amount for such year shall be adjusted for purposes of calculating the Termination Bonus Payment so as to reflect the bonus amount that
            would have been paid for a full year as if there had there been no such pro-ration (the &#8220;Full-Year Equivalent&#8221;) and in no event shall the Termination Bonus Payment be calculated based on an amount other than the Full-Year Equivalent,
            irrespective of partial-year employment;</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">5</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(iv)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">If Executive timely elects continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (&#8220;COBRA&#8221;), then the Company shall directly pay, or reimburse Executive for, the COBRA premiums for
            Executive&#8217;s and Executive&#8217;s covered dependents&#8217; continued participation under the Company&#8217;s group health plan (to the extent permitted under applicable law and the terms of such plan), less the amount Executive would have had to pay to receive
            such coverage as an active employee based on the cost sharing levels in effect on the Date of Termination, during the period commencing on the Date of Termination and ending upon the earliest of (A) eighteen (18) months following the Date of
            Termination, (B) the date that Executive and/or Executive&#8217;s covered dependents become no longer eligible for COBRA or (C) the date that Executive becomes eligible to receive group health benefits from a subsequent employer (and Executive agrees
            to promptly notify the Company of such eligibility); provided, that the Company may modify the continuation coverage contemplated this <font style="font-family: 'Times New Roman';"><u>Section 4(c)(iv)</u></font> to the extent reasonably
            necessary, as determined by the Company in its sole discretion, to avoid potentially violating applicable law or incurring an excise tax for failure to comply with applicable law (including, without limitation, Section 2716 of the Public Health
            Service Act; Section 105(h) of the Internal Revenue Code of 1986, as amended; the Patient Protection and Affordable Care Act of 2010, as amended; and/or the Health Care and Education Reconciliation Act of 2010, as amended, and in each case, the
            regulations and guidance promulgated thereunder (to the extent applicable)).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(d)</font><font style="font-size: 10pt;"> &#160; &#160;&#160;&#160;&#160;&#160; <u></u><font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Qualifying Termination in Connection with Change in Control</u></font>. In the event of a Qualifying Termination that occurs (i) not more than three (3) months prior to a Change in Control or (ii) on
            or within twelve (12) months after a Change in Control (such period, the &#8220;CIC Period&#8221;), Executive shall be entitled to receive, in addition to the Accrued Benefits, the following payments and benefits set forth in (i) through (iv) below, in
            each case, subject to (v) below:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">The Company shall pay Executive an amount in cash equal to, in the aggregate, 300% of the Executive&#8217;s annual base salary in effect as of the Date of the Termination, payable as a one-time payment to be made by the Company to the
            Executive (A) within thirty (30) days of the Release Effective Date, if the termination occurs following the Change of Control, or (B) within thirty (30) days of the consummation of the Change of Control (or such later date that is thirty (30)
            days following the Release Effective Date), if the termination occurred prior to the Change in Control;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">To the extent unpaid as of the Date of Termination (or, if later, the consummation of the Change in Control), the Company shall pay Executive the amount of Executive&#8217;s Annual Bonus for any unpaid prior period, paid as set forth in <font style="font-family: 'Times New Roman';"><u>Section 2(b)</u></font>, as if no such termination had occurred;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Company shall pay Executive an amount in cash equal to the Termination Bonus Payment, payable as a one-time payment to be made by the Company to the Executive (A) within thirty (30) days of the date Executive&#8217;s Release becomes
            effective and irrevocable, if the termination occurs following the Change of Control, or (B) within thirty (30) days of the date of the Change of Control (or such later date that is thirty (30) days following the date Executive&#8217;s Release
            becomes effective and irrevocable), if the termination occurred prior to the Change of Control, provided that to the extent the annual bonus for the year in which the Date of Termination occurs has been pro-rated to reflect that portion of the
            year from the Closing of the Business Combination to the end of such year, or in the event of any other partial-year calculation, the annual bonus amount for such year shall be adjusted for purposes of calculating the Termination Bonus Payment
            so as to reflect the bonus amount that would have been paid for a full year as if there had there been no such pro-ration (the &#8220;Full-Year Equivalent&#8221;) and in no event shall the Termination Bonus Payment be calculated based on an amount other
            than the Full-Year Equivalent, irrespective of partial-year employment;</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">6</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(iv)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Any restricted stock, restricted stock units, options, or other equity grants or awards not vested at the time of termination shall be accelerated and become immediately vested (and, for any such awards as to which vesting is based on
            meeting specified performance criteria, such awards will be considered vested as if the relevant performance criteria was fully achieved), such that Executive will thereafter be 100% vested in any restricted stock, restricted stock units,
            options, or other equity grants awarded by the Company to Executive during the Term; and</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(v)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">The COBRA continuation benefits set forth in <font style="font-family: 'Times New Roman';"><u>Section 4(c)(iv)</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(vi)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Non-Duplication of Payment or Benefits</font>.&#160; If (A) Executive&#8217;s Qualified Termination occurs prior to a Change in Control that qualifies the Executive for severance
            payments and benefits under <font style="font-family: 'Times New Roman';"><u>Section 4(d)</u></font> and (B) a Change in Control occurs within the six (6)-month period following the Executive&#8217;s Qualified Termination that qualifies the
            Executive for severance payments and benefits under <font style="font-family: 'Times New Roman';"><u>Section 4(c)</u></font>, then (1) the Executive will cease receiving any further payments or benefits under <font style="font-family: 'Times New Roman';"><u>Section 4(c)</u></font> and (2) the Executive will receive the payments and benefits under <font style="font-family: 'Times New Roman';"><u>Section 4(d)</u></font> instead but each of the payments and benefits otherwise
            payable under <font style="font-family: 'Times New Roman';"><u>Section 4(d)</u></font> will be offset by the corresponding payments or benefits the Executive already received under <font style="font-family: 'Times New Roman';"><u>Section 4(c)</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Release; Exclusive Remedy; Resignation</u></font>.&#160; Executive&#8217;s right to receive the payments and benefits specified in <font style="font-family: 'Times New Roman';"><u>Section 4(a)</u></font>, <font style="font-family: 'Times New Roman';"><u>Section 4(b)</u></font> and <font style="font-family: 'Times New Roman';"><u>Section 4(c)</u></font> (collectively, the &#8220;Severance Benefits&#8221;) are subject to (i) Executive&#8217;s continued compliance with
            all restrictive covenant obligations with respect to the Company and its affiliates (including, without limitation, <font style="font-family: 'Times New Roman';"><u>Sections 5</u></font> and <font style="font-family: 'Times New Roman';"><u>6</u></font>
            hereof) and (ii) Executive (or Executive&#8217;s estate, as applicable) signing and delivering to the Company and not revoking a separation agreement and release of any claims against the Company, its affiliates, and their employees, officers,
            directors, and shareholders arising out of Executive&#8217;s employment or termination in a form reasonably acceptable to the Company that becomes effective and irrevocable within sixty (60) days following the Date of Termination (such agreement, the
            &#8220;Release&#8221; and such date the Release becomes effective and irrevocable, the &#8220;Release Effective Date&#8221;). The first payment of any Severance Benefits will include all amounts that otherwise would have been due prior thereto under the terms of this
            Agreement had such payments commenced immediately upon the Date of Termination. Any delay in the payment of the Severance Benefits will not extend the period of time that the Severance Benefits are payable pursuant to <font style="font-family: 'Times New Roman';"><u>Section 4</u></font>. During such time that the Executive is receiving the Severance Benefits, if (A) the Company discovers grounds constituting Cause existed before the Executive&#8217;s termination or (B) Executive breaches
            any of the covenants set forth in <font style="font-family: 'Times New Roman';"><u>Sections 5</u></font> and <font style="font-family: 'Times New Roman';"><u>6</u></font>, the Executive&#8217;s right to receive the Severance Benefits will
            immediately cease and be forfeited.&#160; Except as otherwise expressly required by law (e.g., COBRA) or as specifically provided in this Agreement, all of Executive&#8217;s rights to salary, severance, benefits, bonuses and other compensatory amounts
            hereunder (if any) shall cease upon the termination of Executive&#8217;s employment hereunder, and the amounts payable to Executive following termination pursuant to <font style="font-family: 'Times New Roman';"><u>Sections 3</u></font> and <font style="font-family: 'Times New Roman';"><u>4</u></font> hereof will be in full and complete satisfaction of Executive&#8217;s rights under this Agreement and any other claims that Executive may have in respect of employment with the Company or any
            of its affiliates, and Executive acknowledges that such amount amounts are fair and reasonable and are Executive&#8217;s sole and exclusive remedy, in lieu of all other remedies at law or in equity, with respect to the termination of the Term or any
            breach of this Agreement by the Company. Upon any termination of the Term, Executive will promptly resign, and will be deemed to have automatically resigned, from all positions that Executive holds as a member of the Board, officer, director or
            fiduciary of the Company or any of its affiliates, and Executive will take all actions reasonably requested by the Company or its affiliates to give effect to the foregoing.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">7</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">5.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Confidentiality; Intellectual Property</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Confidentiality</u></font>. Executive recognizes and acknowledges that the continued success of the Company depends upon the use and protection of Confidential Information, which constitutes valuable
            trade secrets of the Company. Executive agrees to use the Confidential Information only during the Term in connection with the proper performance of Executive&#8217;s duties as an employee hereunder; otherwise, Executive shall not, directly or
            indirectly, use or disclose the Confidential Information for any other purpose or to any third party. The restrictions set forth herein are in addition to and not in lieu of any obligations Executive may have by law with respect to the
            Confidential Information, including any fiduciary duties or other obligations Executive may owe under any applicable trade secrets statutes or other state or federal laws.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Intellectual Property</u></font>. Executive acknowledges and agrees that all inventions, know-how, trade secrets, technology, programming, software, processes, innovations, ideas, improvements,
            developments, methods, algorithms, designs, analyses, writings, audiovisual works, works of authorship, concepts, drawings, reports and all similar, related, or derivative information or works (whether or not patentable or subject to
            copyright), including but not limited to all resulting patent applications, issued patents, copyrights, copyright applications and registrations in and to any of the foregoing, along with the right to practice, employ, exploit, use, develop,
            reproduce, copy, distribute copies, publish, license, or create works derivative of any of the foregoing, and the right to choose not to do or permit any of the aforementioned actions, that are conceived, authored, reduced to practice, created,
            or otherwise developed by Executive during the Term (whether alone or jointly with others) (collectively, the &#8220;Work Product&#8221;) belong to the Company, and not Executive; provided that Work Product excludes, and this <font style="font-family: 'Times New Roman';"><u>Section 5(b)</u></font> does not apply to an invention for which no equipment, supplies, facilities, or trade secret information of the Company or its affiliates (whether existing now or in the future) and which was
            developed entirely on Executive&#8217;s own time, unless (i) the invention relates (A) to the business of the Company or its affiliates (whether existing now or in the future), or (B) to the Company&#8217;s (or its affiliates&#8217; (whether existing now or in
            the future)) actual or demonstrably anticipated research or development, or (ii) the invention results from any work performed by Executive for the Company or its affiliates (whether existing now or in the future). Executive further
            acknowledges and agrees that to the extent relevant, this Agreement constitutes a &#8220;work for hire agreement&#8221; under the United States Copyright Act of 1976, as amended (&#8220;Copyright Act&#8221;), and that any copyrightable work (&#8220;Creation&#8221;) constitutes a
            &#8220;work made for hire&#8221; under the Copyright Act such that the Company is the copyright owner of the Creation. Executive hereby irrevocably assigns and agrees to assign to the Company all right, title and interest in and to all Work Product and, to
            the extent any Creation or portion thereof is not a &#8220;work for hire&#8221;, all Creations. Executive will promptly disclose and deliver such Work Product and Creations to the Company and, at the Company&#8217;s expense, perform all actions reasonably
            requested by the Company (whether during or after the Term to effectuate, establish, confirm, record or protect such ownership, or to protect or enforce the Company&#8217;s rights therein (including, without limitation, the execution of assignments,
            copyright registrations, consents, licenses, powers of attorney and other instruments).</font></font></div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';"> <br>
          </font></font></div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">8</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Permitted Disclosures</u></font>. Nothing in this Agreement shall be construed to prevent disclosure of Confidential Information as may be required by applicable law or regulation, or pursuant to the
            valid order of a court of competent jurisdiction or an authorized government agency, provided that the disclosure does not exceed the extent of disclosure required by such law, regulation, or order, or in connection with an investigation by or
            report to any regulatory agency with jurisdiction over the Company, law enforcement, or any other federal or state regulatory or self-regulatory authority. In compliance with 18 U.S.C. &#167; 1833(b), as established by the Defend Trade Secrets Act
            of 2016, Executive is given notice of the following: (i) that an individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that (A) is made (1) in confidence to a
            Federal, State, or local government official, either directly or indirectly, or to an attorney; and (2) solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document filed in
            a lawsuit or other proceeding, if such filing is made under seal; and (ii) that an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the attorney of the
            individual and use the trade secret information in the court proceeding, if the individual (A) files any document containing the trade secret under seal; and (B) does not disclose the trade secret, except pursuant to court order.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Return of Property</u></font>. Upon separation from employment or earlier request from the Company, Executive shall return to the Company any and all Company property, including keys, access cards,
            identification cards, credit cards, business cards, laptop, smartphone, other electronic equipment, reports, files, manuals, Work Product, Creations, emails, recordings, thumb drives or other removable information storage devices, and data and
            all Company documents and materials belonging to the Company and stored in any fashion, including but not limited to those that constitute or contain any Confidential Information or Work Product, Creations, that are in the possession or control
            of the Executive, relating to Executive&#8217;s employment by the Company. Without limiting the foregoing or Executive&#8217;s obligations under <font style="font-family: 'Times New Roman';"><u>Section 5(a)</u></font>, upon separation from employment or
            earlier request from the Company, Executive shall not retain possession or control of any Confidential Information and shall instead return such Confidential Information to the Company or destroy it.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">6.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Restrictive Covenants</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>No Solicitation of Customers</u></font>. Executive agrees that, both during the Term and for the period ending on the date that is eighteen (18) months from the date of the termination of the
            Executive&#8217;s employment with the Company at any time and for any reason (the &#8220;Restricted Period&#8221;), Executive will not solicit any Restricted Business (as defined below) from any person or entity that is, or in the prior twelve (12) months was a
            customer of the Company or any of its affiliates or any prospective customer of the Company or any of its affiliates with respect to which the Company or its affiliates actively solicits or has solicited the sale of Company products and
            services. For purposes of this Agreement, &#8220;Restricted Business&#8221; shall mean the business of manufacturing, marketing and selling renewable fuels (including, but not limited to, renewable diesel fuel and sustainable aviation fuel (SAF)) and
            constructing, acquiring, investing in and/or operation facilities for the production of renewable fuels (including, but not limited to, renewable diesel fuel and sustainable aviation fuel (SAF)). Notwithstanding the foregoing, Executive shall
            not be prohibited from the passive ownership of up to two percent (2%) of the securities of any entity engaged in any Restricted Business, where the securities of such entity are traded on a national securities exchange.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>No Solicitation of Employees</u></font>. Executive agrees that during the Restricted Period, Executive will not, directly or indirectly, on behalf of himself or any other person or entity, hire,
            solicit, take away or attempt to hire, solicit or take away any person who is (or in the preceding six months was), at the time of such solicitation, an employee, director or independent contractor of the Company or any of its affiliates,
            either on behalf of himself or any other person or entity. This includes, but is not limited to, inducing or attempting to induce, or influencing or attempting to influence, any person employed by the Company or its affiliates to terminate his
            or her employment with the Company or any such affiliate.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">9</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Importance of Executive&#8217;s Services; Intent of the Parties; Enforcement</u></font>. Executive acknowledges and agrees that the services to be provided by Executive under this Agreement are of a
            special, unique and extraordinary nature. Executive further acknowledges and agrees that the covenants and restrictions contained in <font style="font-family: 'Times New Roman';"><u>Section 5</u></font> and <font style="font-family: 'Times New Roman';"><u>Section 6</u></font> are necessary to prevent the use and disclosure of Confidential Information and to protect other legitimate business interests of the Company and its affiliates. Executive acknowledges that all of the
            covenants and restrictions in <font style="font-family: 'Times New Roman';"><u>Section 5</u></font> and <font style="font-family: 'Times New Roman';"><u>Section 6</u></font> are reasonable in all respects, including duration, territory and
            scope of activity. Executive acknowledges and agrees that the Company competes with businesses on a world-wide basis and that the geographic restrictions contained herein are therefore reasonable and necessary to protect the Company&#8217;s
            legitimate business interests. Executive agrees that the covenants and restrictions contained in <font style="font-family: 'Times New Roman';"><u>Section 5</u></font> and <font style="font-family: 'Times New Roman';"><u>Section 6</u></font>
            shall be construed as separate agreements independent of any other provision of this Agreement or any other agreement between Executive and the Company. Executive agrees that the existence of any claim or cause of action by Executive against
            the Company or its affiliates, whether predicated on this Agreement or otherwise, shall not constitute a defense to the enforcement by the Company of the covenants and restrictions in <font style="font-family: 'Times New Roman';"><u>Section 5</u></font>
            and <font style="font-family: 'Times New Roman';"><u>Section 6</u></font>. Executive agrees that the restrictive covenants contained in <font style="font-family: 'Times New Roman';"><u>Section 5</u></font> and <font style="font-family: 'Times New Roman';"><u>Section 6</u></font> are a material part of Executive&#8217;s obligations under this Agreement for which the Company has agreed to compensate the Executive as provided in this Agreement. The Executive agrees that the injury
            the Company will suffer in the event of the breach by Executive of any clause of <font style="font-family: 'Times New Roman';"><u>Section 5</u></font> and <font style="font-family: 'Times New Roman';"><u>Section 6</u></font> will cause the
            Company and its affiliates irreparable injury that cannot be adequately compensated by monetary damages alone. Therefore, Executive agrees that the Company, without limiting any other legal or equitable remedies available to it, shall be
            entitled to obtain equitable relief by injunction or otherwise from any court of competent jurisdiction, including, without limitation, injunctive relief to prevent Executives&#8217; failure to comply with the terms and conditions of <font style="font-family: 'Times New Roman';"><u>Section 5</u></font> and <font style="font-family: 'Times New Roman';"><u>Section 6</u></font>. The time year periods referenced in <font style="font-family: 'Times New Roman';"><u>Section 5</u></font>
            and <font style="font-family: 'Times New Roman';"><u>Section 6</u></font> shall be extended on a day-for-day basis for each day during which Executive violates the provisions of <font style="font-family: 'Times New Roman';"><u>Section 5</u></font>
            and <font style="font-family: 'Times New Roman';"><u>Section 6</u></font> in any respect, so that Executive is restricted from engaging in the activities prohibited by <font style="font-family: 'Times New Roman';"><u>Section 5</u></font> and
            <font style="font-family: 'Times New Roman';"><u>Section 6</u></font> for the full time period, as applicable.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Whistleblower Protection</u></font>.&#160; Notwithstanding anything to the contrary contained herein, no provision of this Agreement or any other agreement or Company policy will be interpreted so as to
            impede Executive (or any other individual) from (i) making any disclosure of relevant and necessary information or documents in any action, investigation, or proceeding relating to this Agreement, or as required by law or legal process,
            including with respect to possible violations of law, (ii) participating, cooperating, or testifying in any action, investigation, or proceeding with, or providing information to, any governmental agency, legislative body or any self-regulatory
            organization, including, but not limited to, the Department of Justice, the Securities and Exchange Commission, the Congress, and any agency Inspector General, (iii) seeking or accepting any U.S. Securities and Exchange Commission awards or
            other relief in connection with protected whistleblower activity, or (iv) making other disclosures under the whistleblower provisions of federal law or regulation. In addition, nothing in this Agreement or any other agreement or Company policy
            prohibits or restricts Executive from initiating communications with, or responding to any inquiry from, any administrative, governmental, regulatory or supervisory authority regarding any good faith concerns about possible violations of law or
            regulation. Executive does not need the prior authorization of the Company to make any such reports or disclosures and the Executive will not be required to notify the Company that such reports or disclosures have been made.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">7.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160;&#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Other Agreements</u></font>. Executive represents and agrees that Executive&#8217;s performance of Executive&#8217;s duties for the Company shall not violate any agreements, obligations or understandings that Executive may have with any
            third party or prior employer. Without limiting the foregoing, Executive represents and agrees that Executive is not bound by any non-compete or non-solicitation agreement or any other type of agreement that would prohibit Executive&#8217;s
            employment with the Company. Executive agrees not to make any unauthorized disclosure or use, on behalf of the Company, of any confidential information belonging to any of Executive&#8217;s former employers. Executive also represents that Executive
            is not in unauthorized possession of any materials containing a third party&#8217;s confidential and proprietary information.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">10</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">8.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Cooperation with Company</u></font>. During Executive&#8217;s employment by the Company and thereafter, Executive will cooperate with the Company and its affiliates in any internal investigation or administrative, regulatory or
            judicial proceeding that relates to events occurring during Executive&#8217;s employment hereunder and as reasonably requested by the Company (including being available upon reasonable notice from the Company for interviews and factual investigations
            and appearing at the Company&#8217;s request to give testimony without requiring service of a subpoena or other legal process, all at times and on schedules that are reasonably consistent with Executive&#8217;s other permitted activities and commitments).
            In the event the Company requires Executive&#8217;s cooperation in accordance with this <font style="font-family: 'Times New Roman';"><u>Section 8</u></font> following the termination of Executive&#8217;s employment, the Company (or its applicable
            affiliate) will reimburse Executive for reasonable expenses incurred by Executive in connection therewith.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">9.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Tax Provisions</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Withholding</u></font>. All amounts payable to Executive under this Agreement will be subject to all required tax and other designated or required withholdings and deductions. In the event that the
            Company fails to withhold any taxes required to be withheld by applicable law or regulation, Executive agrees to indemnify the Company for any taxes of Executive that should have been withheld.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Section 280G</u></font>. To the extent that any amount payable to Executive hereunder, as well as any other &#8220;parachute payment&#8221; as such term is defined under Section 280G (collectively with the
            regulations promulgated thereunder, &#8220;Section 280G&#8221;) of the Code, payable to Executive ( the &#8220;Covered Payments&#8221;), exceeds the limitations&#160; of Section 280G such that an excise tax will be imposed under Section 4999 of the Code (the &#8220;Excise Tax&#8221;),
            then, before making the Covered Payments, a calculation will be made comparing (i) the Net Benefit (as defined below) to Executive of the Covered Payments after payment of the Excise Tax to (ii) the Net Benefit to Executive if the Covered
            Payments are limited to the extent necessary to avoid being subject to the Excise Tax. Only if the amount calculated under (i) above is less than the amount under (ii) above will the Covered Payments be reduced to the minimum extent necessary
            to ensure that no portion of the Covered Payments is subject to the Excise Tax. &#8220;Net Benefit&#8221; will mean the present value of the Covered Payments net of all federal, state, local, foreign income, employment and excise taxes. Any such reduction
            will be made by the Company in its sole discretion consistent with the requirements of Section 409A of the Code. If two economically equivalent amounts are subject to reduction but are payable at different times, the amounts will be reduced
            (but not below zero) on a pro rata basis. Notwithstanding the foregoing, the Board (or a committee of the Board composed entirely of independent directors) may, in its sole discretion and on a case-by-case basis, approve a gross-up payment (a
            &#8220;Limited Gross-Up&#8221;) to Executive in an amount sufficient to place Executive in the same after-tax position as if no Excise Tax had been imposed, but only to the extent the Excise Tax results from a reduced base amount due to (i) a limited
            period of service with the Company prior to the Change in Control, or (ii) other structural features not attributable to Executive&#8217;s actions or compensation demands. Any such Limited Gross-Up shall be subject to compliance with Section 409A of
            the Code, and may be conditioned upon Executive providing reasonable cooperation with tax planning or mitigation strategies.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Section 409A</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">To the extent required by Section 409A of the Code, all references to &#8220;termination of employment&#8221; and correlative phrases for purposes of this Agreement shall be construed to require a &#8220;separation from service&#8221; (as defined in Section
            1.409A-1(h) of the Treasury regulations after giving effect to the presumptions contained therein).</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">11</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Notwithstanding any provision in this Agreement to the contrary, to the extent that (i) any payments or benefits to which Executive becomes entitled under this Agreement or any other agreement, policy, plan, program or arrangement with
            the Company, in connection with Executive&#8217;s termination of employment with the Company constitute &#8220;nonqualified deferred compensation&#8221; subject to Section 409A of the Code and (ii) Executive is deemed at the time of such termination of
            employment to be a &#8220;specified employee&#8221; under Section 409A of the Code, then such payments or benefits shall not be made or commence until the earliest of (1) the expiration of the six (6) month and one day period measured from the date of
            Executive&#8217;s separation from service (as defined in <font style="font-family: 'Times New Roman';"><u>Section 9(c)(i)</u></font> above) from the Company or (2) the date of Executive&#8217;s death following such separation from service; provided,
            however, that such deferral shall only be effected to the extent required to avoid adverse tax treatment to Executive, including (without limitation) the additional twenty-percent (20%) tax for which Executive would otherwise be liable under
            Section 409A(a)(1)(b) of the Code in absence of such deferral. Upon the expiration of the applicable deferral period, any payments which would have otherwise been made during that period (whether in a single sum or in installments) in the
            absence of this <font style="font-family: 'Times New Roman';"><u>Section 9(b)</u></font> shall be paid to Executive or Executive&#8217;s beneficiary in one lump sum. For purposes of this <font style="font-family: 'Times New Roman';"><u>Section 9(b)</u></font>,
            the term &#8220;specified employee&#8221; means an individual determined by the Company to be a specified employee under Treasury regulation Section 1.409A-1(i) in accordance with the policies of the Company.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(iii)</font><font style="font-size: 10pt;">&#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman';">It is intended that each installment of any benefits or payments provided hereunder constitute a separate payment for purposes of Treasury Regulation Section 1.409A-2(b)(2)(i). The Company and Executive intend that all the benefits and
            payments provided under this Agreement shall be exempt from, or comply with, the requirements of Section 409A of the Code and the provisions of the Agreement shall be read in accordance with that intent. It is further intended that payments
            hereunder satisfy, to the greatest extent possible, the exemptions from the application of Section 409A of the Code (and any state law of similar effect) provided under Treasury Regulations Section 1.409A-1(b)(4) (as a &#8220;short-term deferral&#8221;)
            and Section 1.409A-1(b)(9) (as &#8220;separation pay due to involuntary separation&#8221;). To the extent that any provision hereof is modified in order to comply with Section 409A, such modification will be made in good faith and will, to the maximum
            extent reasonably possible, maintain the original intent and economic benefit to Executive and the Company of the applicable provision without violating the provisions of Section 409A. The Company makes no representation or warranty and shall
            have no liability to Executive or any other person if any provisions of this Agreement are determined to constitute deferred compensation subject to Section 409A of the Code but do not satisfy an exemption from, or comply with the conditions
            of, such Section.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(iv)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Except as otherwise expressly provided herein, to the extent any expense reimbursement or the provision of any in-kind benefit under this Agreement is determined to constitute &#8220;nonqualified deferred compensation&#8221; subject to Section
            409A of the Code, the amount of any such expenses eligible for reimbursement, or the provision of any in-kind benefit, in one calendar year shall not affect the expenses eligible for reimbursement in any other taxable year (except for any
            lifetime or other aggregate limitation applicable to medical expenses), in no event shall any expenses be reimbursed after the last day of the calendar year following the calendar year in which Executive incurred such expenses, and in no event
            shall any right to reimbursement or the provision of any in-kind benefit be subject to liquidation or exchange for another benefit.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(v)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';">Whenever a payment under this Agreement specifies a payment period with reference to a number of days, the actual date of payment within the specified period is within the sole discretion of the Company.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(vi)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Notwithstanding
            any provision in this Agreement to the contrary, to the extent that any payments or benefits to which Executive becomes entitled under this Agreement or any other agreement, policy, plan, program or arrangement with the Company, in connection
            with Executive&#8217;s termination of employment with the Company constitute &#8220;nonqualified deferred compensation&#8221; subject to Section 409A of the Code, then each such payment which is conditioned upon Executive&#8217;s execution of a release and which is to
            be paid or provided during a designated period that begins in one taxable year and ends in a second taxable year shall be paid or provided in the later of the two taxable years.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">12</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">10.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Certain Definitions</u></font>. As used in this Agreement, the following terms shall have the following meanings:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Cause</u></font>. &#8220;Cause&#8221; means any of the following: (i) Executive&#8217;s commission of an act of fraud, embezzlement or dishonesty, or the commission of some other illegal act by Executive, that could
            reasonably be expected to have an adverse impact on the Company or any successor or affiliate; (ii) Executive&#8217;s conviction of, or plea of &#8220;guilty&#8221; or &#8220;no contest&#8221; to, a felony or any crime involving fraud, dishonesty or moral turpitude under
            the laws of the United States or any state thereof (or international equivalent); (iii) any intentional, unauthorized use or disclosure by Executive of Confidential Information or trade secrets of the Company or any successor or affiliate; (iv)
            Executive&#8217;s gross negligence or material violation of any duty of loyalty to the Company or any successor or affiliate thereof, or any other demonstrable material misconduct on Executive&#8217;s part in connection with the performance of Executive&#8217;s
            duties for the Company; (v) Executive&#8217;s ongoing and repeated failure or refusal to perform or neglect of Executive&#8217;s duties as required by this Agreement or Executive&#8217;s ongoing and repeated failure or refusal to comply with the instructions
            given to Executive by the Board, which failure, refusal or neglect continues for fifteen (15) days following Executive&#8217;s receipt of written notice from the Board stating with specificity the nature of such failure, refusal or neglect; or (vi)
            Executive&#8217;s material breach of any material Company policy or any material provision of this Agreement, which breach is not cured (if capable of being cured) within fifteen (15) days following Executive&#8217;s receipt of written notice from the
            Board stating with specificity the nature of such material breach; provided, that the foregoing cure right shall not apply to any breach by Executive of <font style="font-family: 'Times New Roman';"><u>Section 5</u></font> or <font style="font-family: 'Times New Roman';"><u>Section 6</u></font> hereof.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Change in Control</u></font>. &#8220;Change in Control&#8221; shall have the meaning set forth in the 2025 XCF Global, Inc. Equity Incentive Plan. For purposes of clarity, consummation of (i) the transactions
            contemplated in the BCA or (ii) the New Rise Acquisitions (as defined in the BCA) shall not constitute a Change in Control.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Code</u></font>. &#8220;Code&#8221; shall mean the Internal Revenue Code of 1986, as amended, and the regulations and guidance promulgated thereunder.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Confidential Information</u></font>. &#8220;Confidential Information&#8221; means the Company&#8217;s trade secrets as defined under applicable law, as well as any other information or material which is not generally
            known to the public, and which: (i) is generated, collected by or utilized in the operations of the Company&#8217;s business and relates to the actual or anticipated business of the Company; or (ii) results from any task assigned to Executive by the
            Company, or work performed by Executive for or on behalf of the Company. Confidential Information shall not be considered generally known to the public if Executive or others improperly reveal such information to the public without the
            Company&#8217;s express written consent and/or in violation of an obligation of confidentiality owed to the Company. Confidential Information includes, without limitation, the information, observations and data obtained by Executive while employed by
            the Company concerning the business or affairs of the Company, including without limitation: information concerning investment or acquisition opportunities in or reasonably related to the Company; the identities of and other information (such
            as databases) relating to the current, former or prospective employees, customers, or investors of the Company; development, transition and transformation plans; methodologies and methods of doing business; strategic, marketing and expansion
            plans; financial and business plans, financial data; pricing information; employee, customer, or vendor lists and telephone numbers; investment terms; and requirements and costs of providing service. Confidential Information also includes
            information that the Company receives from third parties subject to a duty to maintain the confidentiality of such information and to use it only for certain limited purposes.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">13</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Date of Termination</u></font>. &#8220;Date of Termination&#8221; shall mean (i) if Executive&#8217;s employment is terminated by Executive&#8217;s death, the date of Executive&#8217;s death or (ii) if Executive&#8217;s employment is
            terminated pursuant to <font style="font-family: 'Times New Roman';"><u>Section 3(a)(ii)</u></font> &#8211; <font style="font-family: 'Times New Roman';"><u>(iv)</u></font> either the date indicated in the Notice of Termination or the date
            specified by the Company pursuant to <font style="font-family: 'Times New Roman';"><u>Section 3(b)</u></font>, whichever is earlier.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Disability</u></font>. &#8220;Disability&#8221; shall mean, at any time the Company or any of its affiliates sponsors a long-term disability plan for the Company&#8217;s employees, &#8220;disability&#8221; as defined in such
            long-term disability plan for the purpose of determining a participant&#8217;s eligibility for benefits;&#160; provided, however, if the long-term disability plan contains multiple definitions of disability, &#8220;Disability&#8221; shall refer to that definition of
            disability which, if Executive qualified for such disability benefits, would provide coverage for the longest period of time. The determination of whether Executive has a Disability shall be made by the person or persons required to make
            disability determinations under the long-term disability plan. At any time the Company does not sponsor a long-term disability plan for its employees, &#8220;Disability&#8221; shall mean Executive&#8217;s inability to perform, with or without reasonable
            accommodation, the essential functions of Executive&#8217;s positions hereunder for a total of three months during any six-month period as a result of incapacity due to mental or physical illness as determined by the Board in its sole good faith
            discretion.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(g)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Good Reason</u></font>. &#8220;Good Reason&#8221; means any of the following without Executive&#8217;s written consent: (i) a material diminution in Executive&#8217;s authority, duties or responsibilities; (ii) a material
            diminution in Executive&#8217;s base salary or target Annual Bonus (and Executive and the Company agree that any diminution of 10% or more shall be considered material for this purpose, regardless of whether such diminution occurs due to a single
            reduction or a series of reductions), other than in connection with an across-the-board reduction which applies in a comparable manner to other senior officers of the Company; (iii) any change in the Company&#8217;s remote work policy that would
            require Executive to be physically present in one of the Company&#8217;s offices more than 20 days each month, (iv) Executive is not nominated as a director of the Company pursuant to Section 1(b) and (v) the Company&#8217;s breach of a material provision
            of this Agreement. Notwithstanding the foregoing, no Good Reason will have occurred unless and until Executive has (A) provided the Company, within thirty (30) days of Executive&#8217;s knowledge of the occurrence of the facts and circumstances
            underlying the Good Reason event, written notice stating with specificity the applicable facts and circumstances underlying such finding of Good Reason, (B) provided the Company with an opportunity to cure the same within thirty (30) days after
            the receipt of such notice and (C) the Company shall have failed to so cure within such period. Executive&#8217;s termination of employment by reason of resignation from employment with the Company for Good Reason must occur within 30 days following
            the expiration of the foregoing 30-day cure period.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">11.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Miscellaneous Provisions</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Contractor Period Payment</u></font>. The parties understand that the existing employment agreement between the Executive and XCF Global Capital, Inc. provides that the Executive is to be paid, at
            the Closing of the Business Combination the amount specified in such employment agreement for services the Executive provided to XCF Global Capital, Inc. as an independent contractor for the period January 1, 2024 until the date of execution of
            such employment agreement (the &#8220;Contractor Period Payment&#8221;).&#160; The parties further acknowledge and agree that upon Closing of the Business Combination, the Company shall (i) assume the obligation to make the Contractor Period Payment and shall
            make such payment in cash no later than September 30, 2025, unless the Company and Executive mutually agree in writing, on or before such date, to extend the payment deadline to no later than December 31, 2025 due to the Company&#8217;s reasonable
            cash constraints. Any such extension shall not modify the Company&#8217;s obligation to make full payment nor be deemed a waiver of Executive&#8217;s rights. In addition, within 30 days after the Closing of the Business Combination, the Company shall issue
            to Executive a grant of restricted shares of the Company&#8217;s Class A Common Stock under the Company&#8217;s 2025 Equity Incentive Plan in aggregate value equal to the obligation assumed by the Company for the Contractor Period Payment. This grant shall
            be separate from, and not in lieu of, the Contractor Period Payment and be calculated based on the 20 day volume-weighted average price for the Company&#8217;s Class A Common Stock following the Closing of the Business Combination. The restricted
            shares shall vest ratably on a monthly basis over a period of three (3) years and shall be subject to the terms and conditions of the Company&#8217;s 2025 Equity Incentive Plan and the applicable award agreement.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">14</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Governing Law</u></font>. This Agreement shall be governed, construed, interpreted and enforced in accordance with its express terms, and otherwise in accordance with the substantive laws of the
            State of Delaware without reference to the principles of conflicts of law of the State of Delaware or any other jurisdiction that would result in the application of the laws of a jurisdiction other than the State of Delaware, and where
            applicable, the laws of the United States.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Arbitration</u></font>. Any dispute, controversy, or claim arising out of or relating to this Agreement or any breach of this Agreement or Executive&#8217;s employment, whether the claim arises in
            contract, tort, or statute, shall be submitted to and decided by binding arbitration, except as set forth in <font style="font-family: 'Times New Roman';"><u>Section 6(c)</u></font>. Arbitration shall be administered exclusively by the
            American Arbitration Association at a location in Wilmington, Delaware and shall be conducted consistent with the employment arbitration rules, regulations, and requirements thereof as well as any requirements imposed by state law. Any arbitral
            award determination shall be final and binding upon the Parties, and judgment may be entered thereon in any court of competent jurisdiction. Notwithstanding anything to the contrary, this Agreement does not prevent Executive from filing a
            complaint or charge with the National Relations Labor Board, the Equal Employment Opportunity Commission, or any similar federal or state administrative agency, including claims for workers&#8217; compensation or unemployment insurance benefits. By
            entering into this Agreement, the Parties are waiving all rights to have their disputes heard or decided by a jury or in a court trial and the right to pursue any class or representative claims against each other in court, arbitration, or any
            other proceeding. The arbitrator shall have no jurisdiction or authority to compel any class or collective claim, or to consolidate different arbitration proceedings with or join any other party to an arbitration between the Parties. The
            arbitrator, and not any court, shall have exclusive authority to resolve any dispute relating to the enforceability or formation of this Agreement and the arbitrability of dispute between the parties, except for any dispute relating to the
            enforceability or scope of the class and collective action waiver, which shall be determined by a court of competent jurisdiction. THE PARTIES FULLY UNDERSTAND AND AGREE THAT THEY ARE GIVING UP CERTAIN RIGHTS OTHERWISE AFFORDED TO THEM BY CIVIL
            COURT ACTIONS, INCLUDING BUT NOT LIMITED TO THE RIGHT TO A JURY OR COURT TRIAL AND THE RIGHT TO BRING ANY CLAIM AS A CLASS OR COLLECTIVE ACTION. Costs of arbitration shall be split evenly between the parties, provided, that the arbitrator shall
            have the ability to award attorneys&#8217; fees and previously paid arbitration expenses to the prevailing party.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Venue; Waiver of Jury Trial</u></font>.&#160; Except for claims subject to the arbitration provisions herein, the Parties agree that all litigation arising out of or relating to this agreement must be
            brought exclusively in any state or federal court located in Wilmington, Delaware (collectively the &#8220;Designated Courts&#8221;). Each Party consents and submits to the exclusive jurisdiction of the Designated Courts with respect to litigation under
            this Agreement, each Party hereby irrevocably waives all claims or defenses of lack of personal jurisdiction or any other jurisdiction defense, and any objection which such Party may now or hereafter have to the laying of venue of any suit,
            action or proceeding in any Designated Court, including any right to object on the basis that any dispute, action, suit, or proceeding brought in the Designated Courts has been brought in an improper or inconvenient forum or venue.&#160; IN THE
            EVENT OF LITIGATION HEREUNDER, THE COMPANY AND EXECUTIVE EACH WAIVE THEIR RESPECTIVE RIGHT TO A TRIAL BY JURY OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF OR RELATED TO ANY ACTION, PROCEEDING, OR OTHER LITIGATION OF ANY TYPE
            BROUGHT BY ANY OF THE PARTIES AGAINST ANY OTHER PARTY OR ANY AFFILIATE OF ANY OTHER SUCH PARTY. THE COMPANY AND EXECUTIVE EACH AGREE THAT ANY SUCH CLAIM OR CAUSE OF ACTION WILL BE TRIED BY A COURT TRIAL WITHOUT A JURY. WITHOUT LIMITING THE
            FOREGOING, THE PARTIES FURTHER AGREE THAT THEIR RESPECTIVE RIGHT TO A TRIAL BY JURY IS WAIVED BY OPERATION OF THIS SECTION AS TO ANY ACTION, COUNTERCLAIM, OR OTHER PROCEEDING WHICH SEEKS, IN WHOLE OR IN PART, TO CHALLENGE THE VALIDITY OR
            ENFORCEABILITY OF THIS AGREEMENT. THIS WAIVER WILL APPLY TO ANY SUBSEQUENT AMENDMENTS, RENEWALS, SUPPLEMENTS, OR MODIFICATIONS TO THIS AGREEMENT.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">15</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Validity; Severability</u></font>. Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under applicable law, but if any provision of
            this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability will not affect any other provision or any action in any other
            jurisdiction, but this Agreement will be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had never been contained herein.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Notices</u></font>. Any notice, request, claim, demand, document and other communication hereunder to any Party shall be effective upon receipt (or refusal of receipt) and shall be in writing and
            delivered personally or sent by facsimile or certified or registered mail, postage prepaid, (i) if to the Company, to the Chief Executive Officer of the Company at the Company&#8217;s headquarters, (ii) if to Executive, to the last address that the
            Company has in its personnel records for Executive, or (iii) at any other address as any Party shall have specified by notice in writing to the other Party.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(g)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Counterparts</u></font>. This Agreement may be executed in several counterparts, each of which shall be deemed to be an original, but all of which together will constitute one and the same Agreement.
            Signatures delivered by facsimile or .pdf format shall be deemed effective for all purposes.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(h)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Entire Agreement</u></font>. The terms of this Agreement are intended by the Parties to be the final expression of their agreement with respect to the subject matter hereof and supersede all prior
            understandings and agreements, whether written or oral, including any prior employment offer letter, employment agreement or consulting agreement between Executive and the Company. The Parties further intend that this Agreement shall constitute
            the complete and exclusive statement of their terms and that no extrinsic evidence whatsoever may be introduced in any judicial, administrative, or other legal proceeding to vary the terms of this Agreement.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Amendments; Waivers</u></font>. This Agreement may not be modified, amended, or terminated except by an instrument in writing, signed by Executive and a duly authorized officer of Company. By an
            instrument in writing similarly executed, Executive or a duly authorized officer of the Company may waive compliance by the other Party with any specifically identified provision of this Agreement that such other Party was or is obligated to
            comply with or perform; provided, however, that such waiver shall not operate as a waiver of, or estoppel with respect to, any other or subsequent failure. No failure to exercise and no delay in exercising any right, remedy, or power hereunder
            will preclude any other or further exercise of any other right, remedy, or power provided herein or by law or in equity.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(j)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Successors and Assigns</u></font>. The Company may assign its rights and obligations under this Agreement to any of its affiliates or to any successor to all or substantially all of the business or
            the assets of the Company (by merger or otherwise, including, without limitation, to the surviving entity in the Business Combination), and may assign or encumber this Agreement and its rights hereunder as security for indebtedness of the
            Company and its affiliates. This Agreement shall be binding upon and inure to the benefit of the Company, Executive and their respective successors, assigns, personnel and legal representatives, executors, administrators, heirs, distributees,
            devisees, and legatees, as applicable. None of Executive&#8217;s rights or obligations may be assigned or transferred by Executive, other than Executive&#8217;s rights to payments hereunder, which may be transferred only by will or operation of law.
            Notwithstanding the foregoing, Executive shall be entitled, to the extent permitted under applicable law and applicable Company Arrangements, to select and change a beneficiary or beneficiaries to receive compensation hereunder following
            Executive&#8217;s death by giving written notice thereof to the Company.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">16</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(k)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Indemnification</u></font>. The Company and Executive shall enter into a Director and Officer Indemnification Agreement substantially in the form of <font style="font-family: 'Times New Roman';"><u>Exhibit
                C</u></font> attached hereto.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(l)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>D&amp;O Insurance</u></font>. The Company will cover Executive under directors&#8217; and officers&#8217; liability insurance policy (or policies) during the Term and thereafter to the same extent as the Company
            covers its other current or former directors or officers of the Company.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(m)</font><font style="font-size: 10pt;">&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Clawback</u></font>. Notwithstanding any other provisions in this Agreement to the contrary, any incentive-based or other compensation paid to the Executive under this Agreement or any other
            agreement or arrangement with the Company that is subject to recovery under any applicable law, government regulation, or stock exchange rule or listing requirement will be subject to such deductions and clawback as may be required or permitted
            to be made pursuant to such law, government regulation, or stock exchange rule or listing requirement or any policy adopted by the Company.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(n)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Construction</u></font>. This Agreement shall be deemed drafted equally by both the Parties. Its language shall be construed as a whole and according to its fair meaning. Any presumption or principle
            that the language is to be construed against any Party shall not apply. The headings in this Agreement are only for convenience and are not intended to affect construction or interpretation. Any references to paragraphs, subparagraphs, sections
            or subsections are to those parts of this Agreement, unless the context clearly indicates to the contrary. Also, unless the context clearly indicates to the contrary, (i) the plural includes the singular and the singular includes the plural,
            (ii) &#8220;and&#8221; and &#8220;or&#8221; are each used both conjunctively and disjunctively, (iii) &#8220;any,&#8221; &#8220;all,&#8221; &#8220;each,&#8221; or &#8220;every&#8221; means &#8220;any and all,&#8221; and &#8220;each and every,&#8221; (iv) &#8220;includes&#8221; and &#8220;including&#8221; are each &#8220;without limitation,&#8221; (v) &#8220;herein,&#8221; &#8220;hereof,&#8221;
            &#8220;hereunder&#8221; and other similar compounds of the word &#8220;here&#8221; refer to the entire Agreement and not to any particular paragraph, subparagraph, section or subsection and (vi) all pronouns and any variations thereof shall be deemed to refer to the
            masculine, feminine, neuter, singular or plural as the identity of the entities or persons referred to may require.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[SIGNATURE PAGE FOLLOWS]</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">17</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">IN WITNESS WHEREOF</font><font style="font-size: 10pt;">, the
          Parties hereto have executed this Agreement as of the date first written above. The signatories below represent that they are duly authorized to enter into this Agreement.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="ze95dfe2c5806472ba59e660de92428aa">

          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">XCF GLOBAL, INC.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">By:</div>
            </td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';"><u>/s/ Simon Oxley</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Name:</div>
            </td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Simon Oxley</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Title:</div>
            </td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Chief Financial Officer</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">EXECUTIVE</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">By:</div>
            </td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';"><u>/s/ Mihir Dange</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Name:</div>
            </td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Mihir Dange</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">18</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit A</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">None.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit B</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Compensation Terms</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(attached)</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Executive is solely responsible for any tax liability incurred as a result of any benefit set forth in this table being treated as a taxable benefit
        under federal, state or local law.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Mihir Dange</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit B &#8211; Compensation Terms</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z58813dc3104942d585c7f27e2a4e5d4d">

          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; border-top: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman';">Base Salary</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; border-top: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman';">$825,000, Eight Hundred Twenty-Five Thousand Dollars</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Annual Bonus</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Target Bonus set at 100-200% of Base Salary, based on actual achievement</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">If &lt;50% of key evaluation metrics achieved, Annual Bonus is 0%</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(in each case, pro-rated for partial first year)</div>
              <div style="font-size: 10pt;">&#160;</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Key evaluation metrics (subject to adjustment each year):</div>
              <div style="text-align: left; text-indent: -18pt; margin-left: 18pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8226;</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">25% discretionary
                    established by the Board</font></font></div>
              <div style="text-align: left; text-indent: -18pt; margin-left: 18pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8226;</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">25% Individual
                    performance metrics to be set by the Board</font></font></div>
              <div style="text-align: left; margin-left: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">50% Transaction success fee (de-SPAC/IPO) (first year only)</div>
              <div style="font-size: 10pt;">&#160;</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Opportunity to elect cash or stock for bonus payment, subject to limits set by Board or Compensation Committee</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">2025 Equity Plan Participation</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Executive eligible to receive additional equity compensation pursuant to the Company&#8217;s 2025 Equity Incentive Plan</div>
              <div style="font-size: 10pt;">&#160;</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Target 400-700% of Base Salary with an initial grant of 330,000 shares; vesting period over three years (no vesting during the first six months (the &#8220;cliff
                period&#8221;)). After the six-month cliff period, the restricted stock units will vest in equal monthly installments over 30 months, subject to continued service with New XCF)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Contractor Period Payment</div>
              <div style="font-size: 10pt;">&#160;</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Mihir Dange</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(Sky MD, LLC)</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">$928,125 payment in cash no later than September 30, 2025, unless the Company and Executive mutually agree in writing, on or before such date, to extend the
                payment deadline to no later than December 31, 2025</div>
              <div style="font-size: 10pt;">&#160;</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">$928,125 in restricted shares of the Company&#8217;s Class A Common Stock under the Company&#8217;s 2025 Equity Incentive Plan. Calculated based on the 20 day volume-weighted
                average price for the Company&#8217;s Class A Common Stock following the Closing of the Business Combination. The restricted shares shall vest ratably on a monthly basis over a period of three (3) years and shall be subject to the terms and
                conditions of the Company&#8217;s 2025 Equity Incentive Plan and the applicable award agreement</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Benefits:</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Health/Group insurance</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Minimum 80% of premiums paid by Company</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; margin-left: 18pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8226;</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Life insurance</font></font></div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Up to 2x Base Salary, not to exceed $1 million; Employee may elect to add additional coverage at their own expense</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; margin-left: 18pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8226;</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Phone subsidy</font></font></div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Based on actual and reasonable phone bill incurred each month, with invoice</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; text-indent: -18pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8226;</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Fitness and wellness subsidy</font></font></div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">$3,500 per year, based on actual amount incurred with invoice</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; text-indent: -18pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8226;</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Retirement
                    benefits (401(k) or other retirement plan as established by the Company)</font></font></div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; border-top: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman';">3% automatic match; 100% match on first 3% EE contributions</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; margin-left: 18pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8226;</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Car allowance</font></font></div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">$1,500 per month or $18,000 per year</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; margin-left: 18pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8226;</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Club membership</font></font></div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">One-time membership fees paid once (based on actual amount, with invoice)</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Monthly club membership fees thereafter (up to $2,500 per month, based on actual amount incurred with invoice)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; margin-left: 18pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8226;</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Tax and estate planning</font></font></div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Based on actual expenses incurred</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; text-indent: -18pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8226;</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Relocation
                    benefits (if at the Company&#8217;s request)</font></font></div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Based on actual expenses incurred and will cover:</div>
              <div style="text-align: left; text-indent: -18pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">1.&#160;&#160;&#160;&#160; One-way flight costs for employee, spousal equivalent and dependents</div>
              <div style="text-align: left; text-indent: -18pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">2.&#160;&#160;&#160;&#160; One-month temporary housing, based on actual amount, with invoice</div>
              <div style="text-align: left; text-indent: -18pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">3.&#160;&#160;&#160;&#160;&#160; Moving costs (sea freight) for personnel effects, based on actual amount, with invoice</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit C</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Form of Indemnification Agreement</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(attached)</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
  <font style="font-size: 10pt;"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.58
<SEQUENCE>13
<FILENAME>ef20050548_ex10-58.htm
<DESCRIPTION>EXHIBIT 10.58
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">



  <font style="font-size: 10pt;"> </font>
  <div style="font-family: 'Times New Roman'; font-size: 10pt;">
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit 10.58</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">XCF Global, Inc.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Employment Agreement</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">This Employment Agreement (this &#8220;Agreement&#8221;), dated as of June 6, 2025, is made by and between XCF Global, Inc. (the &#8220;Company&#8221;) and Simon Oxley
        (&#8220;Executive&#8221;) (the Company and Executive are collectively referred to herein as the &#8220;Parties,&#8221; or each individually referred to as a &#8220;Party&#8221;).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">RECITALS</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">WHEREAS</font><font style="font-size: 10pt;">, Executive has been
          serving as the Chief Financial Officer of XCF Global Capital, Inc. (&#8220;XCF Global Capital&#8221;);</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">WHEREAS</font><font style="font-size: 10pt;">, on March 11, 2024,
          XCF Global Capital, Focus Impact BH3 Acquisition Company (&#8220;Focus Impact&#8221;), Focus Impact BH3 NewCo, Inc. (&#8220;NewCo&#8221;), Focus Impact BH3 Merger Sub 1, LLC and Focus Impact BH3 Merger Sub 2, Inc. entered into a business combination agreement (as it may
          be amended or restated from time to time, the &#8220;Business Combination Agreement&#8221;), pursuant to which Focus Impact agreed to combine with XCF Global Capital in a series of transactions that will result in NewCo becoming a publicly-traded company
          (collectively, the &#8220;Business Combination&#8221;), and at the closing of the Business Combination (the &#8220;Closing&#8221;), NewCo will change its name to &#8220;XCF Global, Inc.&#8221;; and</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">WHEREAS</font><font style="font-size: 10pt;">, Executive and the
          Company desire to enter into this Agreement to set out the terms and conditions of the employment relationship between the Company and the Executive following the Closing of the Business Combination, with this Agreement to become effective upon
          the Closing of the Business Combination and continue until terminated by either Party in accordance with its terms (such period during which this Agreement is in effect, the &#8220;Term&#8221;) and will be null and void if the Closing of the Business
          Combination does not occur; and</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">WHEREAS</font><font style="font-size: 10pt;">, except as otherwise
          provided herein, Executive and the Company intend and confirm that this Agreement supersedes in all respects all prior agreements, arrangements or understandings between Executive and the Company regarding the subject matter herein, including
          without limitation, any offer letter, employment agreement, consulting agreement or severance agreement as of the effective date of this Agreement.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">NOW, THEREFORE</font><font style="font-size: 10pt;">, in
          consideration of the foregoing recitals, the mutual covenants and agreements set forth herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and Executive agree as follows:</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">1.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Employment</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>At-Will Employment</u></font>. Executive and the Company acknowledge that Executive&#8217;s employment is and shall continue to be at-will, as defined under applicable law, and that Executive&#8217;s employment
            with the Company may be terminated by either Party at any time for any or no reason (subject to the notice requirements of <font style="font-family: 'Times New Roman';"><u>Section 3(b)</u></font>). If Executive&#8217;s employment terminates for any
            reason, Executive shall only be entitled to those payments, benefits, awards or compensation as specifically provided in this Agreement or as otherwise agreed to in writing by the Company, or as provided by applicable law, and Executive shall
            not be entitled to any other payments, benefits, damages, award or compensation.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Title; Responsibilities</u></font>. The Company shall continue to employ Executive in the position of Chief Financial Officer reporting to the Chief Executive Officer of the Company and Executive
            hereby accepts such continued employment. During the Term, Executive shall have and perform such duties, responsibilities and authorities as are customarily associated with this position, as well as any other duties that may be assigned to
            Executive from time to time by the Chief Executive Officer or the Board of Directors (the &#8220;Board&#8221;) that are not inconsistent with service as an officer of the Company, including duties for any Company subsidiary or affiliate.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160; &#160; &#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Exclusive Employment</u></font>. During the Term, Executive shall devote substantially all of Executive&#8217;s business time, skills and best efforts to Executive&#8217;s employment hereunder and may not,
            without the prior written consent of the Board, participate in the management, operation, or control of, or act as an employee, officer, director, consultant, advisor, agent or representative of, any other business or service (&#8220;Other Service&#8221;);
            provided, however, that Executive may (i) engage in civic and charitable activities (including service on the board of directors or advisory board of civic and charitable organizations), (ii) make and manage outside passive personal and family
            investments and manage personal and family affairs and (iii) serve on the board of directors of the for-profit businesses or trade organizations (including advisory boards), provided, that none of the foregoing (x) materially interferes with
            Executive&#8217;s performance of Executive&#8217;s duties hereunder, (y) poses an actual or perceived conflict of interest or violates any other obligations of Executive hereunder (including, without limitation, <font style="font-family: 'Times New Roman';"><u>Sections 5</u></font> and <font style="font-family: 'Times New Roman';"><u>6</u></font> hereof) or (z) is prohibited by or conflicts with any applicable law or regulation (including the rules of any securities exchange on which
            the Company&#8217;s securities are listed) or any Company policy applicable to Executive. <font style="font-family: 'Times New Roman';"><u>Exhibit A</u></font> hereto identifies (i) any Other Service with respect to which the Board had provided its
            consent and (ii) any board of directors of any for-profit businesses or trade organizations (including advisory boards) on which Executive serves (as such Exhibit may be amended from time to time during the Term by mutual agreement of the
            Executive and the Board).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Compliance</u></font>. Executive agrees to comply with all applicable laws, rules, regulations and policies relating to the performance of Executive&#8217;s duties and responsibilities as an employee of
            the Company, including, without limitation, compliance with the Company&#8217;s Code of Ethics and Business Conduct. Executive is prohibited from receiving economic benefits from any other person or entity other than the Company in connection with
            the services provided to the Company hereunder (for purposes of clarity, receipt of economic benefits from ownership of securities of the Company would not be prohibited under this provision, but would, for the avoidance of doubt, be subject to
            any insider trading policy maintained by the Company).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Employment Location</u></font>. Executive may work remotely from Executive&#8217;s residence or from such other location as Executive shall inform the Company. Notwithstanding the foregoing, Executive
            understands and agrees that in connection with the performance of Executive&#8217;s duties and responsibilities under this Agreement, the Company may require Executive to spend designated days per month in a designated Company office, provided, that
            the Company shall notify the Executive in advance of such requirement. In addition, Executive understands and agrees that in connection with the performance of Executive&#8217;s duties and responsibilities under this Agreement, Executive may be
            required to travel on Company business from time-to-time.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">2.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Compensation</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Base Salary</u></font>. During the Term, Executive shall receive an annualized base salary in the amount of $500,000 (&#8220;Base Salary&#8221;), which will be paid in accordance with the Company&#8217;s customary
            payroll procedures as established and modified from time-to-time. The Base Salary will be reviewed annually and may be changed in the sole discretion of the Board and as recommended by the Board&#8217;s Compensation Committee (provided, however, if
            pursuant to the listing requirements of any securities exchange on which the Company&#8217;s securities are then listed, Executive&#8217;s compensation must be set or approved in a different manner, Executive&#8217;s compensation shall be set or approved in
            accordance with such requirements), and any such revised Base Salary shall then constitute &#8220;Base Salary&#8221; for purposes of this Agreement.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">2</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Annual Bonus</u></font>. In addition to the Base Salary, Executive shall be eligible for an annual bonus for each completed fiscal year of employment during the Term (&#8220;Annual Bonus&#8221;).&#160; The terms of
            Executive&#8217;s initial Annual Bonus are as set forth on <font style="font-family: 'Times New Roman';"><u>Exhibit B</u></font> to this Agreement, and the terms of the Annual Bonus for subsequent years shall be determined by the Board, upon the
            recommendation of the Board&#8217;s Compensation Committee for each such subsequent year of employment as set forth herein. Executive understands and agrees that this Agreement does not guarantee the payment of any Annual Bonus and that the actual
            Annual Bonus payable will be based on the achievement of performance objectives and/or other criteria as determined by the Board and recommended by the Board&#8217;s Compensation Committee and such other factors as the Compensation Committee, in its
            discretion, deems relevant (provided, however, if pursuant to the listing requirements of any securities exchange on which the Company&#8217;s securities are then listed, Executive&#8217;s compensation, including any bonus compensation, must be set or
            approved in a different manner, Executive&#8217;s compensation shall be set or approved in accordance with such requirements). Unless otherwise agreed by the Parties and subject to <font style="font-family: 'Times New Roman';"><u>Section 4(c)(ii)</u></font>,
            if an Annual Bonus is awarded, such Annual Bonus shall be deemed &#8220;earned&#8221; and Executive is entitled to receive payment of such Annual Bonus only if Executive is employed by the Company on the date the Annual Bonus is paid. Any Annual Bonus
            payable in accordance with this <font style="font-family: 'Times New Roman';"><u>Section 2(b)</u></font> shall be paid to Executive no later than March 15<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> of
            the calendar year following the year to which it relates. Executive&#8217;s Annual Bonus for 2025 (to the extent earned) will be prorated to reflect the portion of the year from the Closing of the Business Combination.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Equity Compensation</u></font>.&#160; As soon as practicable following the Closing of the Business Combination and subject to Board approval, Executive shall receive an initial award of restricted stock
            units as set forth on <font style="font-family: 'Times New Roman';"><u>Exhibit B</u></font>, subject to Executive&#8217;s continued employment through the date of grant, which award shall be subject in all respect to the term and conditions of the
            Company&#8217;s 2025 Equity Incentive Plan (the &#8220;2025 Plan&#8221;) and the applicable award agreement to be delivered separately to Executive. In addition, Executive shall be eligible to receive additional equity compensation pursuant to the 2025 Plan or
            such other plans or arrangements as determined by the Board or Compensation Committee from time to time. The complete terms and conditions of any future equity compensation award made pursuant to the 2025 Plan or any other equity plan adopted
            by the Company, including vesting, exercise and forfeiture terms, shall be set forth in an award agreement and any such award shall be subject to the terms and conditions set forth in such award agreement and the 2025 Plan or such other equity
            plan adopted by the Company.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Benefits</u></font>. During the Term, Executive shall be eligible to participate in such health, group insurance, welfare, pension, and other employee benefit plans, programs, and arrangements as are
            made generally available from time to time to senior executives of the Company (which shall include customary health, life insurance, and disability plans). Executive also shall be eligible to participate in the Company&#8217;s 2025 Employee Stock
            Purchase Plan or any similar or replacement plan adopted in the future during the Term. Executive also shall be eligible for 25 days of paid time off (&#8220;PTO&#8221;) per calendar year during the Term (prorated for partial years) in accordance with the
            Company&#8217;s vacation and PTO policy in effect from time to time, inclusive of vacation days and sick days and excluding standard paid Company holidays.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160; &#160;&#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Expenses and Allowances</u></font>. Executive shall receive reimbursement from the Company for all reasonable, necessary, and documented business expenses incurred in connection with Executive&#8217;s
            employment hereunder, provided, that such expenses are timely submitted for reimbursement with supporting documentation in accordance with the Company&#8217;s expense reimbursement policies and procedures. In addition, Executive will receive
            reimbursement for the additional fees and expenses incurred by Executive as set forth on <font style="font-family: 'Times New Roman';"><u>Exhibit B</u></font> (subject to Executive provided sufficient documentation for such reimbursements).</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">3</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">3.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Termination</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Termination Circumstances</u></font>.&#160; Executive&#8217;s employment hereunder may be terminated by the Company or Executive, as applicable, under the following circumstances, and the Term will end on the
            Date of Termination:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Death</font>. Executive&#8217;s employment hereunder shall terminate automatically upon Executive&#8217;s death.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Disability</font>. If Executive has incurred a Disability, the Company may terminate Executive&#8217;s employment.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Termination for Cause</font>. The Company may terminate Executive&#8217;s employment for Cause.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(iv)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Termination without Cause</font>. The Company may terminate Executive&#8217;s employment without Cause for any reason or no reason.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(v)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Resignation from the Company with Good Reason</font>. Executive may resign Executive&#8217;s employment with the Company with Good Reason.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(vi)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Resignation from the Company without Good Reason</font>. Executive may resign Executive&#8217;s employment with the Company for any reason other than Good Reason or for no
            reason.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160; &#160;&#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Notice of Termination</u></font>. Any termination of Executive&#8217;s employment by the Company or by Executive under this <font style="font-family: 'Times New Roman';"><u>Section 3</u></font> (other
            than termination as a result of Executive&#8217;s death) shall be communicated by a written notice by the terminating Party to the other Party hereto (i) indicating the specific termination provision in this Agreement being relied upon, (ii) setting
            forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of employment under the provision so indicated, if applicable, and (iii) specifying a Date of Termination (such notice, a &#8220;Notice of
            Termination&#8221;).&#160; If the Notice of Termination is submitted by Executive, such Notice of Termination shall be given at least thirty (30) days prior to the Date of Termination; provided, however, that in the event that Executive delivers a Notice
            of Termination to the Company, the Company may, in its sole discretion, change the Date of Termination to any date that occurs following the date of the Company&#8217;s receipt of such Notice of Termination and which is prior to the date specified by
            Executive in such Notice of Termination, but such termination still shall be considered a resignation by Executive, unless the Company has determined that Cause exists as of such earlier Date of Termination. A Notice of Termination submitted by
            the Company may provide for a Date of Termination on the date Executive receives the Notice of Termination or any date thereafter elected by the Company. The failure by either Party to set forth in the Notice of Termination any fact or
            circumstance which contributes to a showing of Cause or Good Reason shall not waive any right of the Party hereunder or preclude the Party from asserting such fact or circumstance in enforcing the Party&#8217;s rights hereunder.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Company Obligations upon Termination</u></font>. Upon termination of Executive&#8217;s employment pursuant to any of the circumstances set forth in this <font style="font-family: 'Times New Roman';"><u>Section
                3</u></font>, Executive (or Executive&#8217;s estate) shall be entitled to receive the sum of (i) the portion of Executive&#8217;s Base Salary earned for the applicable year through the Date of Termination, but not yet paid to Executive, payable on the
            pay date immediately following the Date of Termination in accordance with the Company&#8217;s regular payroll practices (or such earlier date as required by applicable law), (ii) any expense reimbursements owed to Executive pursuant to this
            Agreement, payable in accordance with the Company&#8217;s expense reimbursement policy and (iii) any amount accrued and arising from Executive&#8217;s participation in, or benefits accrued under any employee benefit plans, programs or arrangements, which
            amounts shall be payable in accordance with the terms and conditions of such employee benefit plans, programs or arrangements (the &#8220;Company Arrangements&#8221; and the entitlements referenced in the foregoing clauses (i) through (iii), collectively,
            the &#8220;Accrued Benefits&#8221;).</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">4</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160; &#160; <u></u><font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Effect on Equity Awards</u></font>. The effect of Executive&#8217;s termination on any equity awards received by Executive prior to such termination shall be determined in accordance with the terms of the
            2025 Plan (or any other equity plan adopted by the Company pursuant to which such awards were made), the award agreement relating to any such award and/or <font style="font-family: 'Times New Roman';"><u>Section 4(b)</u></font> below, and in
            the case of a termination relating to a Change in Control, <font style="font-family: 'Times New Roman';"><u>Section 4(c)</u></font> below.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">4.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Severance Payments</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Termination Upon Death or Disability</u></font>. In the event of Executive&#8217;s termination of employment due to death or Disability (as defined below) during the Term, the Company shall pay to or for
            the benefit of Executive or Executive&#8217;s estate, as applicable, the Accrued Benefits and, to the extent unpaid as of the Date of Termination, the Company shall pay Executive the amount of Executive&#8217;s Annual Bonus for the prior year, paid as set
            forth in <font style="font-family: 'Times New Roman';"><u>Section 2(b)</u></font> as if no such termination had occurred.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Termination for Cause; Resignation from the Company Without Good Reason</u></font>. If Executive&#8217;s employment shall terminate for Cause, or due to Executive&#8217;s resignation from the Company without
            Good Reason, then Executive shall receive the Accrued Benefits.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Termination without Cause, or Resignation from the Company with Good Reason</u></font>. If Executive&#8217;s employment is terminated without Cause or due to Executive&#8217;s resignation with Good Reason (in
            each case, a &#8220;Qualifying Termination&#8221;) that does not occur during the CIC Period (as defined below), in addition to the Accrued Benefits, Executive shall be entitled to the following payments and benefits:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Company shall pay Executive an amount in cash equal to, in the aggregate, 300% of the Executive&#8217;s annual base salary in effect as of the Date of the Termination, payable in equal monthly installments over the 12 month period
            following the Date of Termination, in accordance with the Company&#8217;s normal payroll practices;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">To the extent unpaid as of the Date of Termination, the Company shall pay Executive the amount of Executive&#8217;s Annual Bonus for any unpaid prior period, paid as set forth in <font style="font-family: 'Times New Roman';"><u>Section 2(b)</u></font>
            as if no such termination had occurred;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Company shall pay Executive an amount in cash equal to three times the amount of the annual bonus that Executive would have earned for the year in which the Date of Termination occurs as if Executive had not been terminated and as
            if such annual bonus was fully earned (i.e., any relevant performance criteria shall be deemed fully achieved)(such payment, the (&#8220;Termination Bonus Payment&#8221;), which amount will be paid in a lump sum within thirty (30) days following the date
            Executive&#8217;s Release becomes effective and irrevocable, provided that to the extent the annual bonus for the year in which the Date of Termination occurs has been pro-rated to reflect that portion of the year from the Closing of the Business
            Combination to the end of such year, or in the event of any other partial-year calculation, the annual bonus amount for such year shall be adjusted for purposes of calculating the Termination Bonus Payment so as to reflect the bonus amount that
            would have been paid for a full year as if there had there been no such pro-ration (the &#8220;Full-Year Equivalent&#8221;) and in no event shall the Termination Bonus Payment be calculated based on an amount other than the Full-Year Equivalent,
            irrespective of partial-year employment;</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">5</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(iv)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">If Executive timely elects continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (&#8220;COBRA&#8221;), then the Company shall directly pay, or reimburse Executive for, the COBRA premiums for
            Executive&#8217;s and Executive&#8217;s covered dependents&#8217; continued participation under the Company&#8217;s group health plan (to the extent permitted under applicable law and the terms of such plan), less the amount Executive would have had to pay to receive
            such coverage as an active employee based on the cost sharing levels in effect on the Date of Termination, during the period commencing on the Date of Termination and ending upon the earliest of (A) eighteen (18) months following the Date of
            Termination, (B) the date that Executive and/or Executive&#8217;s covered dependents become no longer eligible for COBRA or (C) the date that Executive becomes eligible to receive group health benefits from a subsequent employer (and Executive agrees
            to promptly notify the Company of such eligibility); provided, that the Company may modify the continuation coverage contemplated this <font style="font-family: 'Times New Roman';"><u>Section 4(c)(iv)</u></font> to the extent reasonably
            necessary, as determined by the Company in its sole discretion, to avoid potentially violating applicable law or incurring an excise tax for failure to comply with applicable law (including, without limitation, Section 2716 of the Public Health
            Service Act; Section 105(h) of the Internal Revenue Code of 1986, as amended; the Patient Protection and Affordable Care Act of 2010, as amended; and/or the Health Care and Education Reconciliation Act of 2010, as amended, and in each case, the
            regulations and guidance promulgated thereunder (to the extent applicable)).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Qualifying Termination in Connection with Change in Control</u></font>. In the event of a Qualifying Termination that occurs (i) not more than three (3) months prior to a Change in Control or (ii) on
            or within twelve (12) months after a Change in Control (such period, the &#8220;CIC Period&#8221;), Executive shall be entitled to receive, in addition to the Accrued Benefits, the following payments and benefits set forth in (i) through (iv) below, in
            each case, subject to (v) below:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Company shall pay Executive an amount in cash equal to, in the aggregate, 300% of the Executive&#8217;s annual base salary in effect as of the Date of the Termination, payable as a one-time payment to be made by the Company to the
            Executive (A) within thirty (30) days of the Release Effective Date, if the termination occurs following the Change of Control, or (B) within thirty (30) days of the consummation of the Change of Control (or such later date that is thirty (30)
            days following the Release Effective Date), if the termination occurred prior to the Change in Control;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">To the extent unpaid as of the Date of Termination (or, if later, the consummation of the Change in Control), the Company shall pay Executive the amount of Executive&#8217;s Annual Bonus for any unpaid prior period, paid as set forth in <font style="font-family: 'Times New Roman';"><u>Section 2(b)</u></font>, as if no such termination had occurred;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Company shall pay Executive an amount in cash equal to the Termination Bonus Payment, payable as a one-time payment to be made by the Company to the Executive (A) within thirty (30) days of the date Executive&#8217;s Release becomes
            effective and irrevocable, if the termination occurs following the Change of Control, or (B) within thirty (30) days of the date of the Change of Control (or such later date that is thirty (30) days following the date Executive&#8217;s Release
            becomes effective and irrevocable), if the termination occurred prior to the Change of Control, provided that to the extent the annual bonus for the year in which the Date of Termination occurs has been pro-rated to reflect that portion of the
            year from the Closing of the Business Combination to the end of such year, or in the event of any other partial-year calculation, the annual bonus amount for such year shall be adjusted for purposes of calculating the Termination Bonus Payment
            so as to reflect the bonus amount that would have been paid for a full year as if there had there been no such pro-ration (the &#8220;Full-Year Equivalent&#8221;) and in no event shall the Termination Bonus Payment be calculated based on an amount other
            than the Full-Year Equivalent, irrespective of partial-year employment;</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">6</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(iv)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Any restricted stock, restricted stock units, options, or other equity grants or awards not vested at the time of termination shall be accelerated and become immediately vested (and, for any such awards as to which vesting is based on
            meeting specified performance criteria, such awards will be considered vested as if the relevant performance criteria was fully achieved), such that Executive will thereafter be 100% vested in any restricted stock, restricted stock units,
            options, or other equity grants awarded by the Company to Executive during the Term; and</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(v)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">The COBRA continuation benefits set forth in <font style="font-family: 'Times New Roman';"><u>Section 4(c)(iv)</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(vi)</font><font style="font-size: 10pt;">&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Non-Duplication of Payment or Benefits</font>.&#160; If (A) Executive&#8217;s Qualified Termination occurs prior to a Change in Control that qualifies the Executive for severance
            payments and benefits under <font style="font-family: 'Times New Roman';"><u>Section 4(d)</u></font> and (B) a Change in Control occurs within the six (6)-month period following the Executive&#8217;s Qualified Termination that qualifies the
            Executive for severance payments and benefits under <font style="font-family: 'Times New Roman';"><u>Section 4(c)</u></font>, then (1) the Executive will cease receiving any further payments or benefits under <font style="font-family: 'Times New Roman';"><u>Section 4(c)</u></font> and (2) the Executive will receive the payments and benefits under <font style="font-family: 'Times New Roman';"><u>Section 4(d)</u></font> instead but each of the payments and benefits otherwise
            payable under <font style="font-family: 'Times New Roman';"><u>Section 4(d)</u></font> will be offset by the corresponding payments or benefits the Executive already received under <font style="font-family: 'Times New Roman';"><u>Section 4(c)</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Release; Exclusive Remedy; Resignation</u></font>.&#160; Executive&#8217;s right to receive the payments and benefits specified in <font style="font-family: 'Times New Roman';"><u>Section 4(a)</u></font>, <font style="font-family: 'Times New Roman';"><u>Section 4(b)</u></font> and <font style="font-family: 'Times New Roman';"><u>Section 4(c)</u></font> (collectively, the &#8220;Severance Benefits&#8221;) are subject to (i) Executive&#8217;s continued compliance with
            all restrictive covenant obligations with respect to the Company and its affiliates (including, without limitation, <font style="font-family: 'Times New Roman';"><u>Sections 5</u></font> and <font style="font-family: 'Times New Roman';"><u>6</u></font>
            hereof) and (ii) Executive (or Executive&#8217;s estate, as applicable) signing and delivering to the Company and not revoking a separation agreement and release of any claims against the Company, its affiliates, and their employees, officers,
            directors, and shareholders arising out of Executive&#8217;s employment or termination in a form reasonably acceptable to the Company that becomes effective and irrevocable within sixty (60) days following the Date of Termination (such agreement, the
            &#8220;Release&#8221; and such date the Release becomes effective and irrevocable, the &#8220;Release Effective Date&#8221;). The first payment of any Severance Benefits will include all amounts that otherwise would have been due prior thereto under the terms of this
            Agreement had such payments commenced immediately upon the Date of Termination. Any delay in the payment of the Severance Benefits will not extend the period of time that the Severance Benefits are payable pursuant to <font style="font-family: 'Times New Roman';"><u>Section 4</u></font>. During such time that the Executive is receiving the Severance Benefits, if (A) the Company discovers grounds constituting Cause existed before the Executive&#8217;s termination or (B) Executive breaches
            any of the covenants set forth in <font style="font-family: 'Times New Roman';"><u>Sections 5</u></font> and <font style="font-family: 'Times New Roman';"><u>6</u></font>, the Executive&#8217;s right to receive the Severance Benefits will
            immediately cease and be forfeited.&#160; Except as otherwise expressly required by law (e.g., COBRA) or as specifically provided in this Agreement, all of Executive&#8217;s rights to salary, severance, benefits, bonuses and other compensatory amounts
            hereunder (if any) shall cease upon the termination of Executive&#8217;s employment hereunder, and the amounts payable to Executive following termination pursuant to <font style="font-family: 'Times New Roman';"><u>Sections 3</u></font> and <font style="font-family: 'Times New Roman';"><u>4</u></font> hereof will be in full and complete satisfaction of Executive&#8217;s rights under this Agreement and any other claims that Executive may have in respect of employment with the Company or any
            of its affiliates, and Executive acknowledges that such amount amounts are fair and reasonable and are Executive&#8217;s sole and exclusive remedy, in lieu of all other remedies at law or in equity, with respect to the termination of the Term or any
            breach of this Agreement by the Company. Upon any termination of the Term, Executive will promptly resign, and will be deemed to have automatically resigned, from all positions that Executive holds as a member of the Board, officer, director or
            fiduciary of the Company or any of its affiliates, and Executive will take all actions reasonably requested by the Company or its affiliates to give effect to the foregoing.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">7</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">5.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Confidentiality; Intellectual Property</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Confidentiality</u></font>. Executive recognizes and acknowledges that the continued success of the Company depends upon the use and protection of Confidential Information, which constitutes valuable
            trade secrets of the Company. Executive agrees to use the Confidential Information only during the Term in connection with the proper performance of Executive&#8217;s duties as an employee hereunder; otherwise, Executive shall not, directly or
            indirectly, use or disclose the Confidential Information for any other purpose or to any third party. The restrictions set forth herein are in addition to and not in lieu of any obligations Executive may have by law with respect to the
            Confidential Information, including any fiduciary duties or other obligations Executive may owe under any applicable trade secrets statutes or other state or federal laws.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Intellectual Property</u></font>. Executive acknowledges and agrees that all inventions, know-how, trade secrets, technology, programming, software, processes, innovations, ideas, improvements,
            developments, methods, algorithms, designs, analyses, writings, audiovisual works, works of authorship, concepts, drawings, reports and all similar, related, or derivative information or works (whether or not patentable or subject to
            copyright), including but not limited to all resulting patent applications, issued patents, copyrights, copyright applications and registrations in and to any of the foregoing, along with the right to practice, employ, exploit, use, develop,
            reproduce, copy, distribute copies, publish, license, or create works derivative of any of the foregoing, and the right to choose not to do or permit any of the aforementioned actions, that are conceived, authored, reduced to practice, created,
            or otherwise developed by Executive during the Term (whether alone or jointly with others) (collectively, the &#8220;Work Product&#8221;) belong to the Company, and not Executive; provided that Work Product excludes, and this <font style="font-family: 'Times New Roman';"><u>Section 5(b)</u></font> does not apply to an invention for which no equipment, supplies, facilities, or trade secret information of the Company or its affiliates (whether existing now or in the future) and which was
            developed entirely on Executive&#8217;s own time, unless (i) the invention relates (A) to the business of the Company or its affiliates (whether existing now or in the future), or (B) to the Company&#8217;s (or its affiliates&#8217; (whether existing now or in
            the future)) actual or demonstrably anticipated research or development, or (ii) the invention results from any work performed by Executive for the Company or its affiliates (whether existing now or in the future). Executive further
            acknowledges and agrees that to the extent relevant, this Agreement constitutes a &#8220;work for hire agreement&#8221; under the United States Copyright Act of 1976, as amended (&#8220;Copyright Act&#8221;), and that any copyrightable work (&#8220;Creation&#8221;) constitutes a
            &#8220;work made for hire&#8221; under the Copyright Act such that the Company is the copyright owner of the Creation. Executive hereby irrevocably assigns and agrees to assign to the Company all right, title and interest in and to all Work Product and, to
            the extent any Creation or portion thereof is not a &#8220;work for hire&#8221;, all Creations. Executive will promptly disclose and deliver such Work Product and Creations to the Company and, at the Company&#8217;s expense, perform all actions reasonably
            requested by the Company (whether during or after the Term to effectuate, establish, confirm, record or protect such ownership, or to protect or enforce the Company&#8217;s rights therein (including, without limitation, the execution of assignments,
            copyright registrations, consents, licenses, powers of attorney and other instruments).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Permitted Disclosures</u></font>. Nothing in this Agreement shall be construed to prevent disclosure of Confidential Information as may be required by applicable law or regulation, or pursuant to the
            valid order of a court of competent jurisdiction or an authorized government agency, provided that the disclosure does not exceed the extent of disclosure required by such law, regulation, or order, or in connection with an investigation by or
            report to any regulatory agency with jurisdiction over the Company, law enforcement, or any other federal or state regulatory or self-regulatory authority. In compliance with 18 U.S.C. &#167; 1833(b), as established by the Defend Trade Secrets Act
            of 2016, Executive is given notice of the following: (i) that an individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that (A) is made (1) in confidence to a
            Federal, State, or local government official, either directly or indirectly, or to an attorney; and (2) solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document filed in
            a lawsuit or other proceeding, if such filing is made under seal; and (ii) that an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the attorney of the
            individual and use the trade secret information in the court proceeding, if the individual (A) files any document containing the trade secret under seal; and (B) does not disclose the trade secret, except pursuant to court order.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">8</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Return of Property</u></font>. Upon separation from employment or earlier request from the Company, Executive shall return to the Company any and all Company property, including keys, access cards,
            identification cards, credit cards, business cards, laptop, smartphone, other electronic equipment, reports, files, manuals, Work Product, Creations, emails, recordings, thumb drives or other removable information storage devices, and data and
            all Company documents and materials belonging to the Company and stored in any fashion, including but not limited to those that constitute or contain any Confidential Information or Work Product, Creations, that are in the possession or control
            of the Executive, relating to Executive&#8217;s employment by the Company. Without limiting the foregoing or Executive&#8217;s obligations under <font style="font-family: 'Times New Roman';"><u>Section 5(a)</u></font>, upon separation from employment or
            earlier request from the Company, Executive shall not retain possession or control of any Confidential Information and shall instead return such Confidential Information to the Company or destroy it.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">6.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Restrictive Covenants</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>No Solicitation of Customers</u></font>. Executive agrees that, both during the Term and for the period ending on the date that is eighteen (18) months from the date of the termination of the
            Executive&#8217;s employment with the Company at any time and for any reason (the &#8220;Restricted Period&#8221;), Executive will not solicit any Restricted Business (as defined below) from any person or entity that is, or in the prior twelve (12) months was a
            customer of the Company or any of its affiliates or any prospective customer of the Company or any of its affiliates with respect to which the Company or its affiliates actively solicits or has solicited the sale of Company products and
            services. For purposes of this Agreement, &#8220;Restricted Business&#8221; shall mean the business of manufacturing, marketing and selling renewable fuels (including, but not limited to, renewable diesel fuel and sustainable aviation fuel (SAF)) and
            constructing, acquiring, investing in and/or operation facilities for the production of renewable fuels (including, but not limited to, renewable diesel fuel and sustainable aviation fuel (SAF)). Notwithstanding the foregoing, Executive shall
            not be prohibited from the passive ownership of up to two percent (2%) of the securities of any entity engaged in any Restricted Business, where the securities of such entity are traded on a national securities exchange.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>No Solicitation of Employees</u></font>. Executive agrees that during the Restricted Period, Executive will not, directly or indirectly, on behalf of himself or any other person or entity, hire,
            solicit, take away or attempt to hire, solicit or take away any person who is (or in the preceding six months was), at the time of such solicitation, an employee, director or independent contractor of the Company or any of its affiliates,
            either on behalf of himself or any other person or entity. This includes, but is not limited to, inducing or attempting to induce, or influencing or attempting to influence, any person employed by the Company or its affiliates to terminate his
            or her employment with the Company or any such affiliate.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">9</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Importance of Executive&#8217;s Services; Intent of the Parties; Enforcement</u></font>. Executive acknowledges and agrees that the services to be provided by Executive under this Agreement are of a
            special, unique and extraordinary nature. Executive further acknowledges and agrees that the covenants and restrictions contained in <font style="font-family: 'Times New Roman';"><u>Section 5</u></font> and <font style="font-family: 'Times New Roman';"><u>Section 6</u></font> are necessary to prevent the use and disclosure of Confidential Information and to protect other legitimate business interests of the Company and its affiliates. Executive acknowledges that all of the
            covenants and restrictions in <font style="font-family: 'Times New Roman';"><u>Section 5</u></font> and <font style="font-family: 'Times New Roman';"><u>Section 6</u></font> are reasonable in all respects, including duration, territory and
            scope of activity. Executive acknowledges and agrees that the Company competes with businesses on a world-wide basis and that the geographic restrictions contained herein are therefore reasonable and necessary to protect the Company&#8217;s
            legitimate business interests. Executive agrees that the covenants and restrictions contained in <font style="font-family: 'Times New Roman';"><u>Section 5</u></font> and <font style="font-family: 'Times New Roman';"><u>Section 6</u></font>
            shall be construed as separate agreements independent of any other provision of this Agreement or any other agreement between Executive and the Company. Executive agrees that the existence of any claim or cause of action by Executive against
            the Company or its affiliates, whether predicated on this Agreement or otherwise, shall not constitute a defense to the enforcement by the Company of the covenants and restrictions in <font style="font-family: 'Times New Roman';"><u>Section 5</u></font>
            and <font style="font-family: 'Times New Roman';"><u>Section 6</u></font>. Executive agrees that the restrictive covenants contained in <font style="font-family: 'Times New Roman';"><u>Section 5</u></font> and <font style="font-family: 'Times New Roman';"><u>Section 6</u></font> are a material part of Executive&#8217;s obligations under this Agreement for which the Company has agreed to compensate the Executive as provided in this Agreement. The Executive agrees that the injury
            the Company will suffer in the event of the breach by Executive of any clause of <font style="font-family: 'Times New Roman';"><u>Section 5</u></font> and <font style="font-family: 'Times New Roman';"><u>Section 6</u></font> will cause the
            Company and its affiliates irreparable injury that cannot be adequately compensated by monetary damages alone. Therefore, Executive agrees that the Company, without limiting any other legal or equitable remedies available to it, shall be
            entitled to obtain equitable relief by injunction or otherwise from any court of competent jurisdiction, including, without limitation, injunctive relief to prevent Executives&#8217; failure to comply with the terms and conditions of <font style="font-family: 'Times New Roman';"><u>Section 5</u></font> and <font style="font-family: 'Times New Roman';"><u>Section 6</u></font>. The time year periods referenced in <font style="font-family: 'Times New Roman';"><u>Section 5</u></font>
            and <font style="font-family: 'Times New Roman';"><u>Section 6</u></font> shall be extended on a day-for-day basis for each day during which Executive violates the provisions of <font style="font-family: 'Times New Roman';"><u>Section 5</u></font>
            and <font style="font-family: 'Times New Roman';"><u>Section 6</u></font> in any respect, so that Executive is restricted from engaging in the activities prohibited by <font style="font-family: 'Times New Roman';"><u>Section 5</u></font> and
            <font style="font-family: 'Times New Roman';"><u>Section 6</u></font> for the full time period, as applicable.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Whistleblower Protection</u></font>.&#160; Notwithstanding anything to the contrary contained herein, no provision of this Agreement or any other agreement or Company policy will be interpreted so as to
            impede Executive (or any other individual) from (i) making any disclosure of relevant and necessary information or documents in any action, investigation, or proceeding relating to this Agreement, or as required by law or legal process,
            including with respect to possible violations of law, (ii) participating, cooperating, or testifying in any action, investigation, or proceeding with, or providing information to, any governmental agency, legislative body or any self-regulatory
            organization, including, but not limited to, the Department of Justice, the Securities and Exchange Commission, the Congress, and any agency Inspector General, (iii) seeking or accepting any U.S. Securities and Exchange Commission awards or
            other relief in connection with protected whistleblower activity, or (iv) making other disclosures under the whistleblower provisions of federal law or regulation. In addition, nothing in this Agreement or any other agreement or Company policy
            prohibits or restricts Executive from initiating communications with, or responding to any inquiry from, any administrative, governmental, regulatory or supervisory authority regarding any good faith concerns about possible violations of law or
            regulation. Executive does not need the prior authorization of the Company to make any such reports or disclosures and the Executive will not be required to notify the Company that such reports or disclosures have been made.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">7.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Other Agreements</u></font>. Executive represents and agrees that Executive&#8217;s performance of Executive&#8217;s duties for the Company shall not violate any agreements, obligations or understandings that Executive may have with any
            third party or prior employer. Without limiting the foregoing, Executive represents and agrees that Executive is not bound by any non-compete or non-solicitation agreement or any other type of agreement that would prohibit Executive&#8217;s
            employment with the Company. Executive agrees not to make any unauthorized disclosure or use, on behalf of the Company, of any confidential information belonging to any of Executive&#8217;s former employers. Executive also represents that Executive
            is not in unauthorized possession of any materials containing a third party&#8217;s confidential and proprietary information.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">8.</font><font style="font-size: 10pt;">&#160;&#160;&#160; &#160; &#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Cooperation with Company</u></font>. During Executive&#8217;s employment by the Company and thereafter, Executive will cooperate with the Company and its affiliates in any internal investigation or administrative, regulatory or
            judicial proceeding that relates to events occurring during Executive&#8217;s employment hereunder and as reasonably requested by the Company (including being available upon reasonable notice from the Company for interviews and factual investigations
            and appearing at the Company&#8217;s request to give testimony without requiring service of a subpoena or other legal process, all at times and on schedules that are reasonably consistent with Executive&#8217;s other permitted activities and commitments).
            In the event the Company requires Executive&#8217;s cooperation in accordance with this <font style="font-family: 'Times New Roman';"><u>Section 8</u></font> following the termination of Executive&#8217;s employment, the Company (or its applicable
            affiliate) will reimburse Executive for reasonable expenses incurred by Executive in connection therewith.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">10</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">9.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Tax Provisions</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Withholding</u></font>. All amounts payable to Executive under this Agreement will be subject to all required tax and other designated or required withholdings and deductions. In the event that the
            Company fails to withhold any taxes required to be withheld by applicable law or regulation, Executive agrees to indemnify the Company for any taxes of Executive that should have been withheld.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Section 280G</u></font>. To the extent that any amount payable to Executive hereunder, as well as any other &#8220;parachute payment&#8221; as such term is defined under Section 280G (collectively with the
            regulations promulgated thereunder, &#8220;Section 280G&#8221;) of the Code, payable to Executive ( the &#8220;Covered Payments&#8221;), exceeds the limitations&#160; of Section 280G such that an excise tax will be imposed under Section 4999 of the Code (the &#8220;Excise Tax&#8221;),
            then, before making the Covered Payments, a calculation will be made comparing (i) the Net Benefit (as defined below) to Executive of the Covered Payments after payment of the Excise Tax to (ii) the Net Benefit to Executive if the Covered
            Payments are limited to the extent necessary to avoid being subject to the Excise Tax. Only if the amount calculated under (i) above is less than the amount under (ii) above will the Covered Payments be reduced to the minimum extent necessary
            to ensure that no portion of the Covered Payments is subject to the Excise Tax. &#8220;Net Benefit&#8221; will mean the present value of the Covered Payments net of all federal, state, local, foreign income, employment and excise taxes. Any such reduction
            will be made by the Company in its sole discretion consistent with the requirements of Section 409A of the Code. If two economically equivalent amounts are subject to reduction but are payable at different times, the amounts will be reduced
            (but not below zero) on a pro rata basis. Notwithstanding the foregoing, the Board (or a committee of the Board composed entirely of independent directors) may, in its sole discretion and on a case-by-case basis, approve a gross-up payment (a
            &#8220;Limited Gross-Up&#8221;) to Executive in an amount sufficient to place Executive in the same after-tax position as if no Excise Tax had been imposed, but only to the extent the Excise Tax results from a reduced base amount due to (i) a limited
            period of service with the Company prior to the Change in Control, or (ii) other structural features not attributable to Executive&#8217;s actions or compensation demands. Any such Limited Gross-Up shall be subject to compliance with Section 409A of
            the Code, and may be conditioned upon Executive providing reasonable cooperation with tax planning or mitigation strategies.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Section 409A</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';">To the extent required by Section 409A of the Code, all references to &#8220;termination of employment&#8221; and correlative phrases for purposes of this Agreement shall be construed to require a &#8220;separation from service&#8221; (as defined in Section
            1.409A-1(h) of the Treasury regulations after giving effect to the presumptions contained therein).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">11</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Notwithstanding any provision in this Agreement to the contrary, to the extent that (i) any payments or benefits to which Executive becomes entitled under this Agreement or any other agreement, policy, plan, program or arrangement with
            the Company, in connection with Executive&#8217;s termination of employment with the Company constitute &#8220;nonqualified deferred compensation&#8221; subject to Section 409A of the Code and (ii) Executive is deemed at the time of such termination of
            employment to be a &#8220;specified employee&#8221; under Section 409A of the Code, then such payments or benefits shall not be made or commence until the earliest of (1) the expiration of the six (6) month and one day period measured from the date of
            Executive&#8217;s separation from service (as defined in <font style="font-family: 'Times New Roman';"><u>Section 9(c)(i)</u></font> above) from the Company or (2) the date of Executive&#8217;s death following such separation from service; provided,
            however, that such deferral shall only be effected to the extent required to avoid adverse tax treatment to Executive, including (without limitation) the additional twenty-percent (20%) tax for which Executive would otherwise be liable under
            Section 409A(a)(1)(b) of the Code in absence of such deferral. Upon the expiration of the applicable deferral period, any payments which would have otherwise been made during that period (whether in a single sum or in installments) in the
            absence of this <font style="font-family: 'Times New Roman';"><u>Section 9(b)</u></font> shall be paid to Executive or Executive&#8217;s beneficiary in one lump sum. For purposes of this <font style="font-family: 'Times New Roman';"><u>Section 9(b)</u></font>,
            the term &#8220;specified employee&#8221; means an individual determined by the Company to be a specified employee under Treasury regulation Section 1.409A-1(i) in accordance with the policies of the Company.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(iii)</font><font style="font-size: 10pt;">&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';">It is intended that each installment of any benefits or payments provided hereunder constitute a separate payment for purposes of Treasury Regulation Section 1.409A-2(b)(2)(i). The Company and Executive intend that all the benefits and
            payments provided under this Agreement shall be exempt from, or comply with, the requirements of Section 409A of the Code and the provisions of the Agreement shall be read in accordance with that intent. It is further intended that payments
            hereunder satisfy, to the greatest extent possible, the exemptions from the application of Section 409A of the Code (and any state law of similar effect) provided under Treasury Regulations Section 1.409A-1(b)(4) (as a &#8220;short-term deferral&#8221;)
            and Section 1.409A-1(b)(9) (as &#8220;separation pay due to involuntary separation&#8221;). To the extent that any provision hereof is modified in order to comply with Section 409A, such modification will be made in good faith and will, to the maximum
            extent reasonably possible, maintain the original intent and economic benefit to Executive and the Company of the applicable provision without violating the provisions of Section 409A. The Company makes no representation or warranty and shall
            have no liability to Executive or any other person if any provisions of this Agreement are determined to constitute deferred compensation subject to Section 409A of the Code but do not satisfy an exemption from, or comply with the conditions
            of, such Section.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(iv)</font><font style="font-size: 10pt;">&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';">Except as otherwise expressly provided herein, to the extent any expense reimbursement or the provision of any in-kind benefit under this Agreement is determined to constitute &#8220;nonqualified deferred compensation&#8221; subject to Section
            409A of the Code, the amount of any such expenses eligible for reimbursement, or the provision of any in-kind benefit, in one calendar year shall not affect the expenses eligible for reimbursement in any other taxable year (except for any
            lifetime or other aggregate limitation applicable to medical expenses), in no event shall any expenses be reimbursed after the last day of the calendar year following the calendar year in which Executive incurred such expenses, and in no event
            shall any right to reimbursement or the provision of any in-kind benefit be subject to liquidation or exchange for another benefit.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(v)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';">Whenever a payment under this Agreement specifies a payment period with reference to a number of days, the actual date of payment within the specified period is within the sole discretion of the Company.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(vi)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Notwithstanding
            any provision in this Agreement to the contrary, to the extent that any payments or benefits to which Executive becomes entitled under this Agreement or any other agreement, policy, plan, program or arrangement with the Company, in connection
            with Executive&#8217;s termination of employment with the Company constitute &#8220;nonqualified deferred compensation&#8221; subject to Section 409A of the Code, then each such payment which is conditioned upon Executive&#8217;s execution of a release and which is to
            be paid or provided during a designated period that begins in one taxable year and ends in a second taxable year shall be paid or provided in the later of the two taxable years.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">12</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">10.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Certain Definitions</u></font>. As used in this Agreement, the following terms shall have the following meanings:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Cause</u></font>. &#8220;Cause&#8221; means any of the following: (i) Executive&#8217;s commission of an act of fraud, embezzlement or dishonesty, or the commission of some other illegal act by Executive, that could
            reasonably be expected to have an adverse impact on the Company or any successor or affiliate; (ii) Executive&#8217;s conviction of, or plea of &#8220;guilty&#8221; or &#8220;no contest&#8221; to, a felony or any crime involving fraud, dishonesty or moral turpitude under
            the laws of the United States or any state thereof (or international equivalent); (iii) any intentional, unauthorized use or disclosure by Executive of Confidential Information or trade secrets of the Company or any successor or affiliate; (iv)
            Executive&#8217;s gross negligence or material violation of any duty of loyalty to the Company or any successor or affiliate thereof, or any other demonstrable material misconduct on Executive&#8217;s part in connection with the performance of Executive&#8217;s
            duties for the Company; (v) Executive&#8217;s ongoing and repeated failure or refusal to perform or neglect of Executive&#8217;s duties as required by this Agreement or Executive&#8217;s ongoing and repeated failure or refusal to comply with the instructions
            given to Executive by the Board, which failure, refusal or neglect continues for fifteen (15) days following Executive&#8217;s receipt of written notice from the Board stating with specificity the nature of such failure, refusal or neglect; or (vi)
            Executive&#8217;s material breach of any material Company policy or any material provision of this Agreement, which breach is not cured (if capable of being cured) within fifteen (15) days following Executive&#8217;s receipt of written notice from the
            Board stating with specificity the nature of such material breach; provided, that the foregoing cure right shall not apply to any breach by Executive of <font style="font-family: 'Times New Roman';"><u>Section 5</u></font> or <font style="font-family: 'Times New Roman';"><u>Section 6</u></font> hereof.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Change in Control</u></font>. &#8220;Change in Control&#8221; shall have the meaning set forth in the 2025 XCF Global, Inc. Equity Incentive Plan. For purposes of clarity, consummation of (i) the transactions
            contemplated in the BCA or (ii) the New Rise Acquisitions (as defined in the BCA) shall not constitute a Change in Control.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Code</u></font>. &#8220;Code&#8221; shall mean the Internal Revenue Code of 1986, as amended, and the regulations and guidance promulgated thereunder.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Confidential Information</u></font>. &#8220;Confidential Information&#8221; means the Company&#8217;s trade secrets as defined under applicable law, as well as any other information or material which is not generally
            known to the public, and which: (i) is generated, collected by or utilized in the operations of the Company&#8217;s business and relates to the actual or anticipated business of the Company; or (ii) results from any task assigned to Executive by the
            Company, or work performed by Executive for or on behalf of the Company. Confidential Information shall not be considered generally known to the public if Executive or others improperly reveal such information to the public without the
            Company&#8217;s express written consent and/or in violation of an obligation of confidentiality owed to the Company. Confidential Information includes, without limitation, the information, observations and data obtained by Executive while employed by
            the Company concerning the business or affairs of the Company, including without limitation: information concerning investment or acquisition opportunities in or reasonably related to the Company; the identities of and other information (such
            as databases) relating to the current, former or prospective employees, customers, or investors of the Company; development, transition and transformation plans; methodologies and methods of doing business; strategic, marketing and expansion
            plans; financial and business plans, financial data; pricing information; employee, customer, or vendor lists and telephone numbers; investment terms; and requirements and costs of providing service. Confidential Information also includes
            information that the Company receives from third parties subject to a duty to maintain the confidentiality of such information and to use it only for certain limited purposes.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Date of Termination</u></font>. &#8220;Date of Termination&#8221; shall mean (i) if Executive&#8217;s employment is terminated by Executive&#8217;s death, the date of Executive&#8217;s death or (ii) if Executive&#8217;s employment is
            terminated pursuant to <font style="font-family: 'Times New Roman';"><u>Section 3(a)(ii)</u></font> &#8211; <font style="font-family: 'Times New Roman';"><u>(iv)</u></font> either the date indicated in the Notice of Termination or the date
            specified by the Company pursuant to <font style="font-family: 'Times New Roman';"><u>Section 3(b)</u></font>, whichever is earlier.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">13</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Disability</u></font>. &#8220;Disability&#8221; shall mean, at any time the Company or any of its affiliates sponsors a long-term disability plan for the Company&#8217;s employees, &#8220;disability&#8221; as defined in such
            long-term disability plan for the purpose of determining a participant&#8217;s eligibility for benefits;&#160; provided, however, if the long-term disability plan contains multiple definitions of disability, &#8220;Disability&#8221; shall refer to that definition of
            disability which, if Executive qualified for such disability benefits, would provide coverage for the longest period of time. The determination of whether Executive has a Disability shall be made by the person or persons required to make
            disability determinations under the long-term disability plan. At any time the Company does not sponsor a long-term disability plan for its employees, &#8220;Disability&#8221; shall mean Executive&#8217;s inability to perform, with or without reasonable
            accommodation, the essential functions of Executive&#8217;s positions hereunder for a total of three months during any six-month period as a result of incapacity due to mental or physical illness as determined by the Board in its sole good faith
            discretion.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(g)</font><font style="font-size: 10pt;">&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Good Reason</u></font>. &#8220;Good Reason&#8221; means any of the following without Executive&#8217;s written consent: (i) a material diminution in Executive&#8217;s authority, duties or responsibilities; (ii) a material
            diminution in Executive&#8217;s base salary or target Annual Bonus (and Executive and the Company agree that any diminution of 10% or more shall be considered material for this purpose, regardless of whether such diminution occurs due to a single
            reduction or a series of reductions), other than in connection with an across-the-board reduction which applies in a comparable manner to other senior officers of the Company; (iii) any change in the Company&#8217;s remote work policy that would
            require Executive to be physically present in one of the Company&#8217;s offices more than 20 days each month, and (iv) the Company&#8217;s breach of a material provision of this Agreement. Notwithstanding the foregoing, no Good Reason will have occurred
            unless and until Executive has (A) provided the Company, within thirty (30) days of Executive&#8217;s knowledge of the occurrence of the facts and circumstances underlying the Good Reason event, written notice stating with specificity the applicable
            facts and circumstances underlying such finding of Good Reason, (B) provided the Company with an opportunity to cure the same within thirty (30) days after the receipt of such notice and (C) the Company shall have failed to so cure within such
            period. Executive&#8217;s termination of employment by reason of resignation from employment with the Company for Good Reason must occur within 30 days following the expiration of the foregoing 30-day cure period.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">11.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Miscellaneous Provisions</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Contractor Period Payment</u></font>. The parties understand that the existing employment agreement between the Executive and XCF Global Capital, Inc. provides that the Executive is to be paid, at
            the Closing of the Business Combination the amount specified in such employment agreement for services the Executive provided to XCF Global Capital, Inc. as an independent contractor for the period January 1, 2024 until the date of execution of
            such employment agreement (the &#8220;Contractor Period Payment&#8221;).&#160; The parties further acknowledge and agree that upon Closing of the Business Combination, the Company shall (i) assume the obligation to make the Contractor Period Payment and shall
            make such payment in cash no later than September 30, 2025, unless the Company and Executive mutually agree in writing, on or before such date, to extend the payment deadline to no later than December 31, 2025 due to the Company&#8217;s reasonable
            cash constraints. Any such extension shall not modify the Company&#8217;s obligation to make full payment nor be deemed a waiver of Executive&#8217;s rights. In addition, within 30 days after the Closing of the Business Combination, the Company shall issue
            to Executive a grant of restricted shares of the Company&#8217;s Class A Common Stock under the Company&#8217;s 2025 Equity Incentive Plan in aggregate value equal to the obligation assumed by the Company for the Contractor Period Payment. This grant shall
            be separate from, and not in lieu of, the Contractor Period Payment and be calculated based on the 20 day volume-weighted average price for the Company&#8217;s Class A Common Stock following the Closing of the Business Combination. The restricted
            shares shall vest ratably on a monthly basis over a period of three (3) years and shall be subject to the terms and conditions of the Company&#8217;s 2025 Equity Incentive Plan and the applicable award agreement.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">14</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Governing Law</u></font>. This Agreement shall be governed, construed, interpreted and enforced in accordance with its express terms, and otherwise in accordance with the substantive laws of the
            State of Delaware without reference to the principles of conflicts of law of the State of Delaware or any other jurisdiction that would result in the application of the laws of a jurisdiction other than the State of Delaware, and where
            applicable, the laws of the United States.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Arbitration</u></font>. Any dispute, controversy, or claim arising out of or relating to this Agreement or any breach of this Agreement or Executive&#8217;s employment, whether the claim arises in
            contract, tort, or statute, shall be submitted to and decided by binding arbitration, except as set forth in <font style="font-family: 'Times New Roman';"><u>Section 6(c)</u></font>. Arbitration shall be administered exclusively by the
            American Arbitration Association at a location in Wilmington, Delaware and shall be conducted consistent with the employment arbitration rules, regulations, and requirements thereof as well as any requirements imposed by state law. Any arbitral
            award determination shall be final and binding upon the Parties, and judgment may be entered thereon in any court of competent jurisdiction. Notwithstanding anything to the contrary, this Agreement does not prevent Executive from filing a
            complaint or charge with the National Relations Labor Board, the Equal Employment Opportunity Commission, or any similar federal or state administrative agency, including claims for workers&#8217; compensation or unemployment insurance benefits. By
            entering into this Agreement, the Parties are waiving all rights to have their disputes heard or decided by a jury or in a court trial and the right to pursue any class or representative claims against each other in court, arbitration, or any
            other proceeding. The arbitrator shall have no jurisdiction or authority to compel any class or collective claim, or to consolidate different arbitration proceedings with or join any other party to an arbitration between the Parties. The
            arbitrator, and not any court, shall have exclusive authority to resolve any dispute relating to the enforceability or formation of this Agreement and the arbitrability of dispute between the parties, except for any dispute relating to the
            enforceability or scope of the class and collective action waiver, which shall be determined by a court of competent jurisdiction. THE PARTIES FULLY UNDERSTAND AND AGREE THAT THEY ARE GIVING UP CERTAIN RIGHTS OTHERWISE AFFORDED TO THEM BY CIVIL
            COURT ACTIONS, INCLUDING BUT NOT LIMITED TO THE RIGHT TO A JURY OR COURT TRIAL AND THE RIGHT TO BRING ANY CLAIM AS A CLASS OR COLLECTIVE ACTION. Costs of arbitration shall be split evenly between the parties, provided, that the arbitrator shall
            have the ability to award attorneys&#8217; fees and previously paid arbitration expenses to the prevailing party.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Venue; Waiver of Jury Trial</u></font>.&#160; Except for claims subject to the arbitration provisions herein, the Parties agree that all litigation arising out of or relating to this agreement must be
            brought exclusively in any state or federal court located in Wilmington, Delaware (collectively the &#8220;Designated Courts&#8221;). Each Party consents and submits to the exclusive jurisdiction of the Designated Courts with respect to litigation under
            this Agreement, each Party hereby irrevocably waives all claims or defenses of lack of personal jurisdiction or any other jurisdiction defense, and any objection which such Party may now or hereafter have to the laying of venue of any suit,
            action or proceeding in any Designated Court, including any right to object on the basis that any dispute, action, suit, or proceeding brought in the Designated Courts has been brought in an improper or inconvenient forum or venue.&#160; IN THE
            EVENT OF LITIGATION HEREUNDER, THE COMPANY AND EXECUTIVE EACH WAIVE THEIR RESPECTIVE RIGHT TO A TRIAL BY JURY OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF OR RELATED TO ANY ACTION, PROCEEDING, OR OTHER LITIGATION OF ANY TYPE
            BROUGHT BY ANY OF THE PARTIES AGAINST ANY OTHER PARTY OR ANY AFFILIATE OF ANY OTHER SUCH PARTY. THE COMPANY AND EXECUTIVE EACH AGREE THAT ANY SUCH CLAIM OR CAUSE OF ACTION WILL BE TRIED BY A COURT TRIAL WITHOUT A JURY. WITHOUT LIMITING THE
            FOREGOING, THE PARTIES FURTHER AGREE THAT THEIR RESPECTIVE RIGHT TO A TRIAL BY JURY IS WAIVED BY OPERATION OF THIS SECTION AS TO ANY ACTION, COUNTERCLAIM, OR OTHER PROCEEDING WHICH SEEKS, IN WHOLE OR IN PART, TO CHALLENGE THE VALIDITY OR
            ENFORCEABILITY OF THIS AGREEMENT. THIS WAIVER WILL APPLY TO ANY SUBSEQUENT AMENDMENTS, RENEWALS, SUPPLEMENTS, OR MODIFICATIONS TO THIS AGREEMENT.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">15</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Validity; Severability</u></font>. Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under applicable law, but if any provision of
            this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability will not affect any other provision or any action in any other
            jurisdiction, but this Agreement will be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had never been contained herein.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Notices</u></font>. Any notice, request, claim, demand, document and other communication hereunder to any Party shall be effective upon receipt (or refusal of receipt) and shall be in writing and
            delivered personally or sent by facsimile or certified or registered mail, postage prepaid, (i) if to the Company, to the Chief Executive Officer of the Company at the Company&#8217;s headquarters, (ii) if to Executive, to the last address that the
            Company has in its personnel records for Executive, or (iii) at any other address as any Party shall have specified by notice in writing to the other Party.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(g)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Counterparts</u></font>. This Agreement may be executed in several counterparts, each of which shall be deemed to be an original, but all of which together will constitute one and the same Agreement.
            Signatures delivered by facsimile or .pdf format shall be deemed effective for all purposes.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(h)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Entire Agreement</u></font>. The terms of this Agreement are intended by the Parties to be the final expression of their agreement with respect to the subject matter hereof and supersede all prior
            understandings and agreements, whether written or oral, including any prior employment offer letter, employment agreement or consulting agreement between Executive and the Company. The Parties further intend that this Agreement shall constitute
            the complete and exclusive statement of their terms and that no extrinsic evidence whatsoever may be introduced in any judicial, administrative, or other legal proceeding to vary the terms of this Agreement.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Amendments; Waivers</u></font>. This Agreement may not be modified, amended, or terminated except by an instrument in writing, signed by Executive and a duly authorized officer of Company. By an
            instrument in writing similarly executed, Executive or a duly authorized officer of the Company may waive compliance by the other Party with any specifically identified provision of this Agreement that such other Party was or is obligated to
            comply with or perform; provided, however, that such waiver shall not operate as a waiver of, or estoppel with respect to, any other or subsequent failure. No failure to exercise and no delay in exercising any right, remedy, or power hereunder
            will preclude any other or further exercise of any other right, remedy, or power provided herein or by law or in equity.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(j)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"> <font style="font-family: 'Times New Roman';"><u>Successors and Assigns</u></font>. The Company may assign its rights and obligations under this Agreement to any of its affiliates or to any successor to all or substantially all of the business or
            the assets of the Company (by merger or otherwise, including, without limitation, to the surviving entity in the Business Combination), and may assign or encumber this Agreement and its rights hereunder as security for indebtedness of the
            Company and its affiliates. This Agreement shall be binding upon and inure to the benefit of the Company, Executive and their respective successors, assigns, personnel and legal representatives, executors, administrators, heirs, distributees,
            devisees, and legatees, as applicable. None of Executive&#8217;s rights or obligations may be assigned or transferred by Executive, other than Executive&#8217;s rights to payments hereunder, which may be transferred only by will or operation of law.
            Notwithstanding the foregoing, Executive shall be entitled, to the extent permitted under applicable law and applicable Company Arrangements, to select and change a beneficiary or beneficiaries to receive compensation hereunder following
            Executive&#8217;s death by giving written notice thereof to the Company.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(k)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Indemnification</u></font>. The Company and Executive shall enter into a Director and Officer Indemnification Agreement substantially in the form of <font style="font-family: 'Times New Roman';"><u>Exhibit
                C</u></font> attached hereto.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">16</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(l)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>D&amp;O Insurance</u></font>. The Company will cover Executive under directors&#8217; and officers&#8217; liability insurance policy (or policies) during the Term and thereafter to the same extent as the Company
            covers its other current or former directors or officers of the Company.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(m)</font><font style="font-size: 10pt;">&#160;&#160; &#160;&#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Clawback</u></font>. Notwithstanding any other provisions in this Agreement to the contrary, any incentive-based or other compensation paid to the Executive under this Agreement or any other
            agreement or arrangement with the Company that is subject to recovery under any applicable law, government regulation, or stock exchange rule or listing requirement will be subject to such deductions and clawback as may be required or permitted
            to be made pursuant to such law, government regulation, or stock exchange rule or listing requirement or any policy adopted by the Company.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(1, 0, 0);">(n)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Construction</u></font>. This Agreement shall be deemed drafted equally by both the Parties. Its language shall be construed as a whole and according to its fair meaning. Any presumption or principle
            that the language is to be construed against any Party shall not apply. The headings in this Agreement are only for convenience and are not intended to affect construction or interpretation. Any references to paragraphs, subparagraphs, sections
            or subsections are to those parts of this Agreement, unless the context clearly indicates to the contrary. Also, unless the context clearly indicates to the contrary, (i) the plural includes the singular and the singular includes the plural,
            (ii) &#8220;and&#8221; and &#8220;or&#8221; are each used both conjunctively and disjunctively, (iii) &#8220;any,&#8221; &#8220;all,&#8221; &#8220;each,&#8221; or &#8220;every&#8221; means &#8220;any and all,&#8221; and &#8220;each and every,&#8221; (iv) &#8220;includes&#8221; and &#8220;including&#8221; are each &#8220;without limitation,&#8221; (v) &#8220;herein,&#8221; &#8220;hereof,&#8221;
            &#8220;hereunder&#8221; and other similar compounds of the word &#8220;here&#8221; refer to the entire Agreement and not to any particular paragraph, subparagraph, section or subsection and (vi) all pronouns and any variations thereof shall be deemed to refer to the
            masculine, feminine, neuter, singular or plural as the identity of the entities or persons referred to may require.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[SIGNATURE PAGE FOLLOWS]</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">17</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">IN WITNESS WHEREOF</font><font style="font-size: 10pt;">, the
          Parties hereto have executed this Agreement as of the date first written above. The signatories below represent that they are duly authorized to enter into this Agreement.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z2ac33bd6c44745d39b870a166b7a1a7b">

          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">XCF GLOBAL, INC.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">By:</div>
            </td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';"><u>/s/ Mihir Dange</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Name:</div>
            </td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Mihir Dange</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Title:</div>
            </td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Chief Executive Officer</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">EXECUTIVE</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td rowspan="1" colspan="2" style="vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">By:</div>
            </td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';"><u>/s/ Simon Oxley</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Name:</div>
            </td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Simon Oxley</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">18</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit A</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">None.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit B</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Compensation Terms</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(attached)</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Executive is solely responsible for any tax liability incurred as a result of any benefit set forth in this table being treated as a taxable benefit
        under federal, state or local law.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Simon Oxley</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit B &#8211; Compensation Terms</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z6eefbef26fa7401aabc108e6ee08751c">

          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; border-top: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman';">Base Salary</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; border-top: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman';">$500,000, Five Hundred Thousand Dollars</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Annual Bonus</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Target Bonus set at 100-200% of Base Salary<font style="font-family: 'Times New Roman';">,</font> with wings above and below the target level based on targets
                agreed upon by the Board</div>
              <div style="font-size: 10pt;">&#160;</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Key evaluation metrics (subject to adjustment each year):</div>
              <div style="text-align: left; text-indent: -18pt; margin-left: 18pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8226;</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">25% discretionary
                    established by the Board</font></font></div>
              <div style="text-align: left; text-indent: -18pt; margin-left: 18pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8226;</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">25% Individual
                    performance metrics to be set by the Board</font></font></div>
              <div style="text-align: left; margin-left: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">50% Transaction success fee (de-SPAC/IPO) (first year only)</div>
              <div style="font-size: 10pt;">&#160;</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Opportunity to elect cash or stock for bonus payment, subject to limits set by Board or Compensation Committee</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Management Equity</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">675,000 RSUs of common stock issued at closing of de-SPAC IPO</div>
              <div style="font-size: 10pt;">&#160;</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Vesting Period: Five years annually from start date, accelerated on termination without cause following a change-in-control</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">2025 Equity Incentive Plan Participation</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Executive eligible to receive additional equity compensation pursuant to the Company&#8217;s 2025 Equity Incentive Plan</div>
              <div style="font-size: 10pt;">&#160;</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Target 300-600% of Base Salary with an initial grant of 150,000 shares; vesting period over three years (no vesting during the first six months (the &#8220;cliff
                period&#8221;)). After the six-month cliff period, the restricted stock units will vest in equal monthly installments over 30 months, subject to continued service with New XCF)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Contractor Period Payment</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">$41,667 payment in cash no later than September 30, 2025, unless the Company and Executive mutually agree in writing, on or before such date, to extend the
                payment deadline to no later than December 31, 2025</div>
              <div style="font-size: 10pt;">&#160;</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">$41,667 in restricted shares of the Company&#8217;s Class A Common Stock under the Company&#8217;s 2025 Equity Incentive Plan. Calculated based on the 20 day volume-weighted
                average price for the Company&#8217;s Class A Common Stock following the Closing of the Business Combination. The restricted shares shall vest ratably on a monthly basis over a period of three (3) years and shall be subject to the terms and
                conditions of the Company&#8217;s 2025 Equity Incentive Plan and the applicable award agreement</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Benefits:</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; margin-left: 18pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8226;</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Health/Group insurance</font></font></div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Minimum 80% of premiums paid by Company</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; margin-left: 18pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8226;</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Life insurance</font></font></div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Up to 2x Base Salary, not to exceed $1 million; Employee may elect to add additional coverage at their own expense</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; margin-left: 18pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8226;</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Phone subsidy</font></font></div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; border-top: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman';">Based on actual and reasonable phone bill incurred each month, with invoice</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; margin-left: 36pt; text-indent: -18pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8226;</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Fitness and wellness subsidy</font></font></div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">$3,500 per year, based on actual amount incurred with invoice</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; text-indent: -18pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8226;</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Retirement
                    benefits (401(k) or other retirement plan as established by the Company)</font></font></div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">3% automatic match; 100% match on first 3% EE contributions</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; margin-left: 18pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8226;</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Car allowance</font></font></div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">$1,500 per month or $18,000 per year</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; margin-left: 18pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8226;</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Club membership</font></font></div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">One-time membership fees paid once (based on actual amount, with invoice)</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Monthly club membership fees thereafter (up to $2,500 per month, based on actual amount incurred with invoice)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; margin-left: 18pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8226;</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Tax and estate planning</font></font></div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Based on actual expenses incurred</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; text-indent: -18pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8226;</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Relocation
                    benefits (if at the Company&#8217;s request)</font></font></div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Based on actual expenses incurred and will cover:</div>
              <div style="text-align: left; text-indent: -18pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;One-way flight costs for employee, spousal equivalent and dependents</div>
              <div style="text-align: left; text-indent: -18pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;One-month temporary housing, based on actual amount, with invoice</div>
              <div style="text-align: left; text-indent: -18pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Moving costs (sea freight) for personnel effects, based on actual amount, with invoice</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit C</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Form of Indemnification Agreement</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(attached)</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
  <font style="font-size: 10pt;"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.59
<SEQUENCE>14
<FILENAME>ef20050548_ex10-59.htm
<DESCRIPTION>EXHIBIT 10.59
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">




  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: right;"> <font style="font-weight: bold;">Exhibit 10.59</font><br>
    </div>
    <div> <br>
    </div>
    <div>
      <div style="text-align: center; font-weight: bold;">XCF Global, Inc.</div>
      <div style="text-align: center; font-weight: bold;">Employment Agreement</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">This Employment Agreement (this &#8220;Agreement&#8221;), dated as of June 6, 2025, is made by and between XCF Global, Inc. (the &#8220;Company&#8221;) and Gregory R. Surette (&#8220;Executive&#8221;) (the Company and Executive are
        collectively referred to herein as the &#8220;Parties,&#8221; or each individually referred to as a &#8220;Party&#8221;).</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">RECITALS</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold;">WHEREAS</font>, Executive has been serving as the Chief Strategy Officer of XCF Global Capital, Inc. (&#8220;XCF Global Capital&#8221;);</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold;">WHEREAS</font>, on March 11, 2024, XCF Global Capital, Focus Impact BH3 Acquisition Company (&#8220;Focus Impact&#8221;), Focus Impact BH3 NewCo, Inc. (&#8220;NewCo&#8221;), Focus Impact
        BH3 Merger Sub 1, LLC and Focus Impact BH3 Merger Sub 2, Inc. entered into a business combination agreement (as it may be amended or restated from time to time, the &#8220;Business Combination Agreement&#8221;), pursuant to which Focus Impact agreed to combine
        with XCF Global Capital in a series of transactions that will result in NewCo becoming a publicly-traded company (collectively, the &#8220;Business Combination&#8221;), and at the closing of the Business Combination (the &#8220;Closing&#8221;), NewCo will change its name
        to &#8220;XCF Global, Inc.&#8221;; and</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold;">WHEREAS</font>, Executive and the Company desire to enter into this Agreement to set out the terms and conditions of the employment relationship between the Company
        and the Executive following the Closing of the Business Combination, with this Agreement to become effective upon the Closing of the Business Combination and continue until terminated by either Party in accordance with its terms (such period during
        which this Agreement is in effect, the &#8220;Term&#8221;) and will be null and void if the Closing of the Business Combination does not occur; and</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold;">WHEREAS</font>, except as otherwise provided herein, Executive and the Company intend and confirm that this Agreement supersedes in all respects all prior
        agreements, arrangements or understandings between Executive and the Company regarding the subject matter herein, including without limitation, any offer letter, employment agreement, consulting agreement or severance agreement as of the effective
        date of this Agreement.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold;">NOW, THEREFORE</font>, in consideration of the foregoing recitals, the mutual covenants and agreements set forth herein and for other good and valuable
        consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and Executive agree as follows:</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: #010000;">1.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Employment</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u></u><u>At-Will Employment</u>. Executive and the Company acknowledge that Executive&#8217;s employment is and shall continue to be at-will, as defined
        under applicable law, and that Executive&#8217;s employment with the Company may be terminated by either Party at any time for any or no reason (subject to the notice requirements of <u>Section </u>3(b)). If Executive&#8217;s employment terminates for any
        reason, Executive shall only be entitled to those payments, benefits, awards or compensation as specifically provided in this Agreement or as otherwise agreed to in writing by the Company, or as provided by applicable law, and Executive shall not
        be entitled to any other payments, benefits, damages, award or compensation.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(b)</font>&#160;&#160;&#160; &#160; &#160;&#160;&#160; <u>Title; Responsibilities</u>. The Company shall continue to employ Executive in the position of Chief Strategy Officer, reporting to Chief
        Executive Officer, and Executive hereby accepts such continued employment. During the Term, Executive shall have and perform such duties, responsibilities and authorities as are customarily associated with this position, as well as any other duties
        that may be assigned to Executive from time to time by the Chief Executive Officer or the Board of Directors (the &#8220;Board&#8221;) that are not inconsistent with service as an officer of the Company, including duties for any Company subsidiary or
        affiliate.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(c)</font>&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>Exclusive Employment</u>. During the Term, Executive shall devote substantially all of Executive&#8217;s business time, skills and best efforts to
        Executive&#8217;s employment hereunder and may not, without the prior written consent of the Board, participate in the management, operation, or control of, or act as an employee, officer, director, consultant, advisor, agent or representative of, any
        other business or service (&#8220;Other Service&#8221;); provided, however, that Executive may (i) engage in civic and charitable activities (including service on the board of directors or advisory board of civic and charitable organizations), (ii) make and
        manage outside passive personal and family investments and manage personal and family affairs and (iii) serve on the board of directors of the for-profit businesses or trade organizations (including advisory boards), provided, that none of the
        foregoing (x) materially interferes with Executive&#8217;s performance of Executive&#8217;s duties hereunder, (y) poses an actual or perceived conflict of interest or violates any other obligations of Executive hereunder (including, without limitation, <u>Sections

        </u>5 and 6 hereof) or (z) is prohibited by or conflicts with any applicable law or regulation (including the rules of any securities exchange on which the Company&#8217;s securities are listed) or any Company policy applicable to Executive. <u>Exhibit
          A</u> hereto identifies (i) any Other Service with respect to which the Board had provided its consent and (ii) any board of directors of any for-profit businesses or trade organizations (including advisory boards) on which Executive serves (as
        such Exhibit may be amended from time to time during the Term by mutual agreement of the Executive and the Board).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>Compliance</u>. Executive agrees to comply with all applicable laws, rules, regulations and policies relating to the performance of Executive&#8217;s
        duties and responsibilities as an employee of the Company, including, without limitation, compliance with the Company&#8217;s Code of Ethics and Business Conduct. Executive is prohibited from receiving economic benefits from any other person or entity
        other than the Company in connection with the services provided to the Company hereunder (for purposes of clarity, receipt of economic benefits from ownership of securities of the Company would not be prohibited under this provision, but would, for
        the avoidance of doubt, be subject to any insider trading policy maintained by the Company).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(e)</font>&#160;&#160;&#160; &#160; &#160; <u>Employment Location</u>. Executive may work remotely from Executive&#8217;s residence or from such other location as Executive shall inform the
        Company. Notwithstanding the foregoing, Executive understands and agrees that in connection with the performance of Executive&#8217;s duties and responsibilities under this Agreement, the Company may require Executive to spend designated days per month
        in a designated Company office, provided, that the Company shall notify the Executive in advance of such requirement. In addition, Executive understands and agrees that in connection with the performance of Executive&#8217;s duties and responsibilities
        under this Agreement, Executive may be required to travel on Company business from time-to-time.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: #010000;">2.</font>&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160; <u>Compensation</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(a)</font>&#160;&#160;&#160; &#160;&#160;&#160;&#160; <u>Base Salary</u>. During the Term, Executive shall receive an annualized base salary in the amount of $480,000 (&#8220;Base Salary&#8221;), which will be
        paid in accordance with the Company&#8217;s customary payroll procedures as established and modified from time-to-time. The Base Salary will be reviewed annually and may be changed in the sole discretion of the Board and as recommended by the Board&#8217;s
        Compensation Committee (provided, however, if pursuant to the listing requirements of any securities exchange on which the Company&#8217;s securities are then listed, Executive&#8217;s compensation must be set or approved in a different manner, Executive&#8217;s
        compensation shall be set or approved in accordance with such requirements), and any such revised Base Salary shall then constitute &#8220;Base Salary&#8221; for purposes of this Agreement. If Executive changes his duties and is appointed as the Chief
        Operating Officer, the Base Salary will be increased to $640,000.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">2</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>Annual Bonus</u>. In addition to the Base Salary, Executive shall be eligible for an annual bonus for each completed fiscal year of employment
        during the Term (&#8220;Annual Bonus&#8221;).&#160; The terms of Executive&#8217;s initial Annual Bonus are as set forth on <u>Exhibit B</u> to this Agreement, and the terms of the Annual Bonus for subsequent years shall be determined by the Board, upon the
        recommendation of the Board&#8217;s Compensation Committee for each such subsequent year of employment as set forth herein. Executive understands and agrees that this Agreement does not guarantee the payment of any Annual Bonus and that the actual Annual
        Bonus payable will be based on the achievement of performance objectives and/or other criteria as determined by the Board and recommended by the Board&#8217;s Compensation Committee and such other factors as the Compensation Committee, in its discretion,
        deems relevant (provided, however, if pursuant to the listing requirements of any securities exchange on which the Company&#8217;s securities are then listed, Executive&#8217;s compensation, including any bonus compensation, must be set or approved in a
        different manner, Executive&#8217;s compensation shall be set or approved in accordance with such requirements). Unless otherwise agreed by the Parties and subject to <u>Section </u>4(c)(ii), if an Annual Bonus is awarded, such Annual Bonus shall be
        deemed &#8220;earned&#8221; and Executive is entitled to receive payment of such Annual Bonus only if Executive is employed by the Company on the date the Annual Bonus is paid. Any Annual Bonus payable in accordance with this <u>Section </u>2(b) shall be
        paid to Executive no later than March 15<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> of the calendar year following the year to which it relates. Executive&#8217;s Annual Bonus for 2025 (to the extent earned) will
        be prorated to reflect the portion of the year from the Closing of the Business Combination.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Equity Compensation</u>.&#160; As soon as practicable following the Closing of the Business Combination and subject to Board approval, Executive shall
        receive an initial award of restricted stock units as set forth on <u>Exhibit B</u>, subject to Executive&#8217;s continued employment through the date of grant, which award shall be subject in all respect to the term and conditions of the Company&#8217;s
        2025 Equity Incentive Plan (the &#8220;2025 Plan&#8221;) and the applicable award agreement to be delivered separately to Executive. In addition, Executive shall be eligible to receive additional equity compensation pursuant to the 2025 Plan or such other
        plans or arrangements as determined by the Board or Compensation Committee from time to time. The complete terms and conditions of any future equity compensation award made pursuant to the 2025 Plan or any other equity plan adopted by the Company,
        including vesting, exercise and forfeiture terms, shall be set forth in an award agreement and any such award shall be subject to the terms and conditions set forth in such award agreement and the 2025 Plan or such other equity plan adopted by the
        Company.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(d)</font>&#160;&#160;&#160;&#160; &#160;&#160; <u>Benefits</u>. During the Term, Executive shall be eligible to participate in such health, group insurance, welfare, pension, and other employee
        benefit plans, programs, and arrangements as are made generally available from time to time to senior executives of the Company (which shall include customary health, life insurance, and disability plans). Executive also shall be eligible to
        participate in the Company&#8217;s 2025 Employee Stock Purchase Plan or any similar or replacement plan adopted in the future during the Term. Executive also shall be eligible for 25 days of paid time off (&#8220;PTO&#8221;) per calendar year during the Term
        (prorated for partial years) in accordance with the Company&#8217;s vacation and PTO policy in effect from time to time, inclusive of vacation days and sick days and excluding standard paid Company holidays.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Expenses and Allowances</u>. Executive shall receive reimbursement from the Company for all reasonable, necessary, and documented business
        expenses incurred in connection with Executive&#8217;s employment hereunder, provided, that such expenses are timely submitted for reimbursement with supporting documentation in accordance with the Company&#8217;s expense reimbursement policies and procedures.
        In addition, Executive will receive reimbursement for the additional fees and expenses incurred by Executive as set forth on <u>Exhibit B</u> (subject to Executive provided sufficient documentation for such reimbursements).</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">3</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;"><font style="color: #010000;">3.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <u>Termination</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(a)</font>&#160;&#160;&#160;&#160;&#160; &#160; <u>Termination Circumstances</u>.&#160; Executive&#8217;s employment hereunder may be terminated by the Company or Executive, as applicable, under the
        following circumstances, and the Term will end on the Date of Termination:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Death</font>. Executive&#8217;s employment hereunder shall terminate automatically upon Executive&#8217;s
        death.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Disability</font>. If Executive has incurred a Disability, the Company may terminate
        Executive&#8217;s employment.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(iii)</font>&#160;&#160;&#160; &#160; &#160; <font style="font-style: italic;">Termination for Cause</font>. The Company may terminate Executive&#8217;s employment for Cause.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(iv)</font>&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Termination without Cause</font>. The Company may terminate Executive&#8217;s employment without Cause
        for any reason or no reason.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(v)</font>&#160; &#160; &#160;&#160;&#160; <font style="font-style: italic;">Resignation from the Company with Good Reason</font>. Executive may resign Executive&#8217;s
        employment with the Company with Good Reason.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(vi)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Resignation from the Company without Good Reason</font>. Executive may resign Executive&#8217;s
        employment with the Company for any reason other than Good Reason or for no reason.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160; <u>Notice of Termination</u>. Any termination of Executive&#8217;s employment by the Company or by Executive under this <u>Section </u>3 (other than
        termination as a result of Executive&#8217;s death) shall be communicated by a written notice by the terminating Party to the other Party hereto (i) indicating the specific termination provision in this Agreement being relied upon, (ii) setting forth in
        reasonable detail the facts and circumstances claimed to provide a basis for termination of employment under the provision so indicated, if applicable, and (iii) specifying a Date of Termination (such notice, a &#8220;Notice of Termination&#8221;).&#160; If the
        Notice of Termination is submitted by Executive, such Notice of Termination shall be given at least thirty (30) days prior to the Date of Termination; provided, however, that in the event that Executive delivers a Notice of Termination to the
        Company, the Company may, in its sole discretion, change the Date of Termination to any date that occurs following the date of the Company&#8217;s receipt of such Notice of Termination and which is prior to the date specified by Executive in such Notice
        of Termination, but such termination still shall be considered a resignation by Executive, unless the Company has determined that Cause exists as of such earlier Date of Termination. A Notice of Termination submitted by the Company may provide for
        a Date of Termination on the date Executive receives the Notice of Termination or any date thereafter elected by the Company. The failure by either Party to set forth in the Notice of Termination any fact or circumstance which contributes to a
        showing of Cause or Good Reason shall not waive any right of the Party hereunder or preclude the Party from asserting such fact or circumstance in enforcing the Party&#8217;s rights hereunder.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Company Obligations upon Termination</u>. Upon termination of Executive&#8217;s employment pursuant to any of the circumstances set forth in this <u>Section

        </u>3, Executive (or Executive&#8217;s estate) shall be entitled to receive the sum of (i) the portion of Executive&#8217;s Base Salary earned for the applicable year through the Date of Termination, but not yet paid to Executive, payable on the pay date
        immediately following the Date of Termination in accordance with the Company&#8217;s regular payroll practices (or such earlier date as required by applicable law), (ii) any expense reimbursements owed to Executive pursuant to this Agreement, payable in
        accordance with the Company&#8217;s expense reimbursement policy and (iii) any amount accrued and arising from Executive&#8217;s participation in, or benefits accrued under any employee benefit plans, programs or arrangements, which amounts shall be payable in
        accordance with the terms and conditions of such employee benefit plans, programs or arrangements (the &#8220;Company Arrangements&#8221; and the entitlements referenced in the foregoing clauses (i) through (iii), collectively, the &#8220;Accrued Benefits&#8221;).</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">4</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Effect on Equity Awards</u>. The effect of Executive&#8217;s termination on any equity awards received by Executive prior to such termination shall be
        determined in accordance with the terms of the 2025 Plan (or any other equity plan adopted by the Company pursuant to which such awards were made), the award agreement relating to any such award and/or <u>Section </u>4(b) below, and in the case
        of a termination relating to a Change in Control, <u>Section </u>4(c) below.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: #010000;">4.</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>Severance Payments</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Termination Upon Death or Disability</u>. In the event of Executive&#8217;s termination of employment due to death or Disability (as defined below)
        during the Term, the Company shall pay to or for the benefit of Executive or Executive&#8217;s estate, as applicable, the Accrued Benefits and, to the extent unpaid as of the Date of Termination, the Company shall pay Executive the amount of Executive&#8217;s
        Annual Bonus for the prior year, paid as set forth in <u>Section </u>2(b) as if no such termination had occurred.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <u>Termination for Cause; Resignation from the Company Without Good Reason</u>. If Executive&#8217;s employment shall terminate for Cause, or due to
        Executive&#8217;s resignation from the Company without Good Reason, then Executive shall receive the Accrued Benefits.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Termination without Cause, or Resignation from the Company with Good Reason</u>. If Executive&#8217;s employment is terminated without Cause or due to
        Executive&#8217;s resignation with Good Reason (in each case, a &#8220;Qualifying Termination&#8221;) that does not occur during the CIC Period (as defined below), in addition to the Accrued Benefits, Executive shall be entitled to the following payments and
        benefits:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; The Company shall pay Executive an amount in cash equal to, in the aggregate, 300% of the Executive&#8217;s annual base salary in
        effect as of the Date of the Termination, payable in equal monthly installments over the 12 month period following the Date of Termination, in accordance with the Company&#8217;s normal payroll practices;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(ii)</font>&#160;&#160;&#160;&#160; &#160; To the extent unpaid as of the Date of Termination, the Company shall pay Executive the amount of Executive&#8217;s Annual Bonus for any
        unpaid prior period, paid as set forth in <u>Section </u>2(b) as if no such termination had occurred;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160; The Company shall pay Executive an amount in cash equal to three times the amount of the annual bonus that Executive would have
        earned for the year in which the Date of Termination occurs as if Executive had not been terminated and as if such annual bonus was fully earned (i.e., any relevant performance criteria shall be deemed fully achieved)(such payment, the
        (&#8220;Termination Bonus Payment&#8221;), which amount will be paid in a lump sum within thirty (30) days following the date Executive&#8217;s Release becomes effective and irrevocable, provided that to the extent the annual bonus for the year in which the Date of
        Termination occurs has been pro-rated to reflect that portion of the year from the Closing of the Business Combination to the end of such year, or in the event of any other partial-year calculation, the annual bonus amount for such year shall be
        adjusted for purposes of calculating the Termination Bonus Payment so as to reflect the bonus amount that would have been paid for a full year as if there had there been no such pro-ration (the &#8220;Full-Year Equivalent&#8221;) and in no event shall the
        Termination Bonus Payment be calculated based on an amount other than the Full-Year Equivalent, irrespective of partial-year employment;</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">5</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(iv)</font>&#160;&#160;&#160;&#160;&#160; If Executive timely elects continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended
        (&#8220;COBRA&#8221;), then the Company shall directly pay, or reimburse Executive for, the COBRA premiums for Executive&#8217;s and Executive&#8217;s covered dependents&#8217; continued participation under the Company&#8217;s group health plan (to the extent permitted under
        applicable law and the terms of such plan), less the amount Executive would have had to pay to receive such coverage as an active employee based on the cost sharing levels in effect on the Date of Termination, during the period commencing on the
        Date of Termination and ending upon the earliest of (A) eighteen (18) months following the Date of Termination, (B) the date that Executive and/or Executive&#8217;s covered dependents become no longer eligible for COBRA or (C) the date that Executive
        becomes eligible to receive group health benefits from a subsequent employer (and Executive agrees to promptly notify the Company of such eligibility); provided, that the Company may modify the continuation coverage contemplated this <u>Section </u>4(c)(iv)

        to the extent reasonably necessary, as determined by the Company in its sole discretion, to avoid potentially violating applicable law or incurring an excise tax for failure to comply with applicable law (including, without limitation, Section 2716
        of the Public Health Service Act; Section 105(h) of the Internal Revenue Code of 1986, as amended; the Patient Protection and Affordable Care Act of 2010, as amended; and/or the Health Care and Education Reconciliation Act of 2010, as amended, and
        in each case, the regulations and guidance promulgated thereunder (to the extent applicable)).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Qualifying Termination in Connection with Change in Control</u>. In the event of a Qualifying Termination that occurs (i) not more than three
        (3) months prior to a Change in Control or (ii) on or within twelve (12) months after a Change in Control (such period, the &#8220;CIC Period&#8221;), Executive shall be entitled to receive, in addition to the Accrued Benefits, the following payments and
        benefits set forth in (i) through (iv) below, in each case, subject to (v) below:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Company shall pay Executive an amount in cash equal to, in the aggregate, 300% of the Executive&#8217;s annual base salary in
        effect as of the Date of the Termination, payable as a one-time payment to be made by the Company to the Executive (A) within thirty (30) days of the Release Effective Date, if the termination occurs following the Change of Control, or (B) within
        thirty (30) days of the consummation of the Change of Control (or such later date that is thirty (30) days following the Release Effective Date), if the termination occurred prior to the Change in Control;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; To the extent unpaid as of the Date of Termination (or, if later, the consummation of the Change in Control), the Company shall
        pay Executive the amount of Executive&#8217;s Annual Bonus for any unpaid prior period, paid as set forth in <u>Section </u>2(b), as if no such termination had occurred;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(iii)</font>&#160; &#160;&#160;&#160; The Company shall pay Executive an amount in cash equal to the Termination Bonus Payment, payable as a one-time payment to be made
        by the Company to the Executive (A) within thirty (30) days of the date Executive&#8217;s Release becomes effective and irrevocable, if the termination occurs following the Change of Control, or (B) within thirty (30) days of the date of the Change of
        Control (or such later date that is thirty (30) days following the date Executive&#8217;s Release becomes effective and irrevocable), if the termination occurred prior to the Change of Control, provided that to the extent the annual bonus for the year in
        which the Date of Termination occurs has been pro-rated to reflect that portion of the year from the Closing of the Business Combination to the end of such year, or in the event of any other partial-year calculation, the annual bonus amount for
        such year shall be adjusted for purposes of calculating the Termination Bonus Payment so as to reflect the bonus amount that would have been paid for a full year as if there had there been no such pro-ration (the &#8220;Full-Year Equivalent&#8221;) and in no
        event shall the Termination Bonus Payment be calculated based on an amount other than the Full-Year Equivalent, irrespective of partial-year employment;</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">6</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(iv)</font>&#160;&#160; &#160; &#160; Any restricted stock, restricted stock units, options, or other equity grants or awards not vested at the time of termination
        shall be accelerated and become immediately vested (and, for any such awards as to which vesting is based on meeting specified performance criteria, such awards will be considered vested as if the relevant performance criteria was fully achieved),
        such that Executive will thereafter be 100% vested in any restricted stock, restricted stock units, options, or other equity grants awarded by the Company to Executive during the Term; and</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(v)</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160; The COBRA continuation benefits set forth in <u>Section </u>4(c)(iv).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(vi)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Non-Duplication of Payment or Benefits</font>.&#160; If (A) Executive&#8217;s Qualified Termination occurs
        prior to a Change in Control that qualifies the Executive for severance payments and benefits under <u>Section </u>4(d) and (B) a Change in Control occurs within the six (6)-month period following the Executive&#8217;s Qualified Termination that
        qualifies the Executive for severance payments and benefits under <u>Section </u>4(c), then (1) the Executive will cease receiving any further payments or benefits under <u>Section </u>4(c) and (2) the Executive will receive the payments and
        benefits under <u>Section </u>4(d) instead but each of the payments and benefits otherwise payable under <u>Section </u>4(d) will be offset by the corresponding payments or benefits the Executive already received under <u>Section </u>4(c).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(e)</font>&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>Release; Exclusive Remedy; Resignation</u>.&#160; Executive&#8217;s right to receive the payments and benefits specified in <u>Section </u>4(a), <u>Section

        </u>4(b) and <u>Section </u>4(c) (collectively, the &#8220;Severance Benefits&#8221;) are subject to (i) Executive&#8217;s continued compliance with all restrictive covenant obligations with respect to the Company and its affiliates (including, without limitation,
        <u>Sections </u>5 and 6 hereof) and (ii) Executive (or Executive&#8217;s estate, as applicable) signing and delivering to the Company and not revoking a separation agreement and release of any claims against the Company, its affiliates, and their
        employees, officers, directors, and shareholders arising out of Executive&#8217;s employment or termination in a form reasonably acceptable to the Company that becomes effective and irrevocable within sixty (60) days following the Date of Termination
        (such agreement, the &#8220;Release&#8221; and such date the Release becomes effective and irrevocable, the &#8220;Release Effective Date&#8221;). The first payment of any Severance Benefits will include all amounts that otherwise would have been due prior thereto under
        the terms of this Agreement had such payments commenced immediately upon the Date of Termination. Any delay in the payment of the Severance Benefits will not extend the period of time that the Severance Benefits are payable pursuant to <u>Section
        </u>4. During such time that the Executive is receiving the Severance Benefits, if (A) the Company discovers grounds constituting Cause existed before the Executive&#8217;s termination or (B) Executive breaches any of the covenants set forth in <u>Sections

        </u>5 and 6, the Executive&#8217;s right to receive the Severance Benefits will immediately cease and be forfeited.&#160; Except as otherwise expressly required by law (e.g., COBRA) or as specifically provided in this Agreement, all of Executive&#8217;s rights to
        salary, severance, benefits, bonuses and other compensatory amounts hereunder (if any) shall cease upon the termination of Executive&#8217;s employment hereunder, and the amounts payable to Executive following termination pursuant to <u>Sections </u>3
        and 4 hereof will be in full and complete satisfaction of Executive&#8217;s rights under this Agreement and any other claims that Executive may have in respect of employment with the Company or any of its affiliates, and Executive acknowledges that such
        amount amounts are fair and reasonable and are Executive&#8217;s sole and exclusive remedy, in lieu of all other remedies at law or in equity, with respect to the termination of the Term or any breach of this Agreement by the Company. Upon any
        termination of the Term, Executive will promptly resign, and will be deemed to have automatically resigned, from all positions that Executive holds as a member of the Board, officer, director or fiduciary of the Company or any of its affiliates,
        and Executive will take all actions reasonably requested by the Company or its affiliates to give effect to the foregoing.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">7</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;"><font style="color: #010000;">5.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>Confidentiality; Intellectual Property</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(a)</font>&#160; &#160;&#160;&#160;&#160; <u>Confidentiality</u>. Executive recognizes and acknowledges that the continued success of the Company depends upon the use and protection of
        Confidential Information, which constitutes valuable trade secrets of the Company. Executive agrees to use the Confidential Information only during the Term in connection with the proper performance of Executive&#8217;s duties as an employee hereunder;
        otherwise, Executive shall not, directly or indirectly, use or disclose the Confidential Information for any other purpose or to any third party. The restrictions set forth herein are in addition to and not in lieu of any obligations Executive may
        have by law with respect to the Confidential Information, including any fiduciary duties or other obligations Executive may owe under any applicable trade secrets statutes or other state or federal laws.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Intellectual Property</u>. Executive acknowledges and agrees that all inventions, know-how, trade secrets, technology, programming, software,
        processes, innovations, ideas, improvements, developments, methods, algorithms, designs, analyses, writings, audiovisual works, works of authorship, concepts, drawings, reports and all similar, related, or derivative information or works (whether
        or not patentable or subject to copyright), including but not limited to all resulting patent applications, issued patents, copyrights, copyright applications and registrations in and to any of the foregoing, along with the right to practice,
        employ, exploit, use, develop, reproduce, copy, distribute copies, publish, license, or create works derivative of any of the foregoing, and the right to choose not to do or permit any of the aforementioned actions, that are conceived, authored,
        reduced to practice, created, or otherwise developed by Executive during the Term (whether alone or jointly with others) (collectively, the &#8220;Work Product&#8221;) belong to the Company, and not Executive; provided that Work Product excludes, and this <u>Section

        </u>5(b) does not apply to an invention for which no equipment, supplies, facilities, or trade secret information of the Company or its affiliates (whether existing now or in the future) and which was developed entirely on Executive&#8217;s own time,
        unless (i) the invention relates (A) to the business of the Company or its affiliates (whether existing now or in the future), or (B) to the Company&#8217;s (or its affiliates&#8217; (whether existing now or in the future)) actual or demonstrably anticipated
        research or development, or (ii) the invention results from any work performed by Executive for the Company or its affiliates (whether existing now or in the future). Executive further acknowledges and agrees that to the extent relevant, this
        Agreement constitutes a &#8220;work for hire agreement&#8221; under the United States Copyright Act of 1976, as amended (&#8220;Copyright Act&#8221;), and that any copyrightable work (&#8220;Creation&#8221;) constitutes a &#8220;work made for hire&#8221; under the Copyright Act such that the
        Company is the copyright owner of the Creation. Executive hereby irrevocably assigns and agrees to assign to the Company all right, title and interest in and to all Work Product and, to the extent any Creation or portion thereof is not a &#8220;work for
        hire&#8221;, all Creations. Executive will promptly disclose and deliver such Work Product and Creations to the Company and, at the Company&#8217;s expense, perform all actions reasonably requested by the Company (whether during or after the Term to
        effectuate, establish, confirm, record or protect such ownership, or to protect or enforce the Company&#8217;s rights therein (including, without limitation, the execution of assignments, copyright registrations, consents, licenses, powers of attorney
        and other instruments).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Permitted Disclosures</u>. Nothing in this Agreement shall be construed to prevent disclosure of Confidential Information as may be required by
        applicable law or regulation, or pursuant to the valid order of a court of competent jurisdiction or an authorized government agency, provided that the disclosure does not exceed the extent of disclosure required by such law, regulation, or order,
        or in connection with an investigation by or report to any regulatory agency with jurisdiction over the Company, law enforcement, or any other federal or state regulatory or self-regulatory authority. In compliance with 18 U.S.C. &#167; 1833(b), as
        established by the Defend Trade Secrets Act of 2016, Executive is given notice of the following: (i) that an individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret
        that (A) is made (1) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney; and (2) solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a
        complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal; and (ii) that an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade
        secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual (A) files any document containing the trade secret under seal; and (B) does not disclose the trade secret, except pursuant to
        court order.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">8</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Return of Property</u>. Upon separation from employment or earlier request from the Company, Executive shall return to the Company any and all
        Company property, including keys, access cards, identification cards, credit cards, business cards, laptop, smartphone, other electronic equipment, reports, files, manuals, Work Product, Creations, emails, recordings, thumb drives or other
        removable information storage devices, and data and all Company documents and materials belonging to the Company and stored in any fashion, including but not limited to those that constitute or contain any Confidential Information or Work Product,
        Creations, that are in the possession or control of the Executive, relating to Executive&#8217;s employment by the Company. Without limiting the foregoing or Executive&#8217;s obligations under <u>Section </u>5(a), upon separation from employment or earlier
        request from the Company, Executive shall not retain possession or control of any Confidential Information and shall instead return such Confidential Information to the Company or destroy it.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: #010000;">6.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Restrictive Covenants</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(a)</font>&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>No Solicitation of Customers</u>. Executive agrees that, both during the Term and for the period ending on the date that is eighteen (18)
        months from the date of the termination of the Executive&#8217;s employment with the Company at any time and for any reason (the &#8220;Restricted Period&#8221;), Executive will not solicit any Restricted Business (as defined below) from any person or entity that
        is, or in the prior twelve (12) months was a customer of the Company or any of its affiliates or any prospective customer of the Company or any of its affiliates with respect to which the Company or its affiliates actively solicits or has solicited
        the sale of Company products and services. For purposes of this Agreement, &#8220;Restricted Business&#8221; shall mean the business of manufacturing, marketing and selling renewable fuels (including, but not limited to, renewable diesel fuel and sustainable
        aviation fuel (SAF)) and constructing, acquiring, investing in and/or operation facilities for the production of renewable fuels (including, but not limited to, renewable diesel fuel and sustainable aviation fuel (SAF)). Notwithstanding the
        foregoing, Executive shall not be prohibited from the passive ownership of up to two percent (2%) of the securities of any entity engaged in any Restricted Business, where the securities of such entity are traded on a national securities exchange.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <u>No Solicitation of Employees</u>. Executive agrees that during the Restricted Period, Executive will not, directly or indirectly, on behalf of
        himself or any other person or entity, hire, solicit, take away or attempt to hire, solicit or take away any person who is (or in the preceding six months was), at the time of such solicitation, an employee, director or independent contractor of
        the Company or any of its affiliates, either on behalf of himself or any other person or entity. This includes, but is not limited to, inducing or attempting to induce, or influencing or attempting to influence, any person employed by the Company
        or its affiliates to terminate his or her employment with the Company or any such affiliate.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">9</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Importance of Executive&#8217;s Services; Intent of the Parties; Enforcement</u>. Executive acknowledges and agrees that the services to be provided
        by Executive under this Agreement are of a special, unique and extraordinary nature. Executive further acknowledges and agrees that the covenants and restrictions contained in <u>Section </u>5 and <u>Section </u>6 are necessary to prevent the
        use and disclosure of Confidential Information and to protect other legitimate business interests of the Company and its affiliates. Executive acknowledges that all of the covenants and restrictions in <u>Section </u>5 and <u>Section </u>6 are
        reasonable in all respects, including duration, territory and scope of activity. Executive acknowledges and agrees that the Company competes with businesses on a world-wide basis and that the geographic restrictions contained herein are therefore
        reasonable and necessary to protect the Company&#8217;s legitimate business interests. Executive agrees that the covenants and restrictions contained in <u>Section </u>5 and <u>Section </u>6 shall be construed as separate agreements independent of
        any other provision of this Agreement or any other agreement between Executive and the Company. Executive agrees that the existence of any claim or cause of action by Executive against the Company or its affiliates, whether predicated on this
        Agreement or otherwise, shall not constitute a defense to the enforcement by the Company of the covenants and restrictions in <u>Section </u>5 and <u>Section </u>6. Executive agrees that the restrictive covenants contained in <u>Section </u>5
        and <u>Section </u>6 are a material part of Executive&#8217;s obligations under this Agreement for which the Company has agreed to compensate the Executive as provided in this Agreement. The Executive agrees that the injury the Company will suffer in
        the event of the breach by Executive of any clause of <u>Section </u>5 and <u>Section </u>6 will cause the Company and its affiliates irreparable injury that cannot be adequately compensated by monetary damages alone. Therefore, Executive
        agrees that the Company, without limiting any other legal or equitable remedies available to it, shall be entitled to obtain equitable relief by injunction or otherwise from any court of competent jurisdiction, including, without limitation,
        injunctive relief to prevent Executives&#8217; failure to comply with the terms and conditions of <u>Section </u>5 and <u>Section </u>6. The time year periods referenced in <u>Section </u>5 and <u>Section </u>6 shall be extended on a day-for-day
        basis for each day during which Executive violates the provisions of <u>Section </u>5 and <u>Section </u>6 in any respect, so that Executive is restricted from engaging in the activities prohibited by <u>Section </u>5 and <u>Section </u>6
        for the full time period, as applicable.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Whistleblower Protection</u>.&#160; Notwithstanding anything to the contrary contained herein, no provision of this Agreement or any other agreement
        or Company policy will be interpreted so as to impede Executive (or any other individual) from (i) making any disclosure of relevant and necessary information or documents in any action, investigation, or proceeding relating to this Agreement, or
        as required by law or legal process, including with respect to possible violations of law, (ii) participating, cooperating, or testifying in any action, investigation, or proceeding with, or providing information to, any governmental agency,
        legislative body or any self-regulatory organization, including, but not limited to, the Department of Justice, the Securities and Exchange Commission, the Congress, and any agency Inspector General, (iii) seeking or accepting any U.S. Securities
        and Exchange Commission awards or other relief in connection with protected whistleblower activity, or (iv) making other disclosures under the whistleblower provisions of federal law or regulation. In addition, nothing in this Agreement or any
        other agreement or Company policy prohibits or restricts Executive from initiating communications with, or responding to any inquiry from, any administrative, governmental, regulatory or supervisory authority regarding any good faith concerns about
        possible violations of law or regulation. Executive does not need the prior authorization of the Company to make any such reports or disclosures and the Executive will not be required to notify the Company that such reports or disclosures have been
        made.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: #010000;">7.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Other Agreements</u>. Executive represents and agrees that Executive&#8217;s performance of Executive&#8217;s duties for the Company shall not violate any agreements,
        obligations or understandings that Executive may have with any third party or prior employer. Without limiting the foregoing, Executive represents and agrees that Executive is not bound by any non-compete or non-solicitation agreement or any other
        type of agreement that would prohibit Executive&#8217;s employment with the Company. Executive agrees not to make any unauthorized disclosure or use, on behalf of the Company, of any confidential information belonging to any of Executive&#8217;s former
        employers. Executive also represents that Executive is not in unauthorized possession of any materials containing a third party&#8217;s confidential and proprietary information.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: #010000;">8.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Cooperation with Company</u>. During Executive&#8217;s employment by the Company and thereafter, Executive will cooperate with the Company and its affiliates in any
        internal investigation or administrative, regulatory or judicial proceeding that relates to events occurring during Executive&#8217;s employment hereunder and as reasonably requested by the Company (including being available upon reasonable notice from
        the Company for interviews and factual investigations and appearing at the Company&#8217;s request to give testimony without requiring service of a subpoena or other legal process, all at times and on schedules that are reasonably consistent with
        Executive&#8217;s other permitted activities and commitments). In the event the Company requires Executive&#8217;s cooperation in accordance with this <u>Section </u>8 following the termination of Executive&#8217;s employment, the Company (or its applicable
        affiliate) will reimburse Executive for reasonable expenses incurred by Executive in connection therewith.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">10</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;"><font style="color: #010000;">9.</font>&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160;&#160; <u>Tax Provisions</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Withholding</u>. All amounts payable to Executive under this Agreement will be subject to all required tax and other designated or required
        withholdings and deductions. In the event that the Company fails to withhold any taxes required to be withheld by applicable law or regulation, Executive agrees to indemnify the Company for any taxes of Executive that should have been withheld.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(b)</font>&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160; <u>Section 280G</u>. To the extent that any amount payable to Executive hereunder, as well as any other &#8220;parachute payment&#8221; as such term is
        defined under Section 280G (collectively with the regulations promulgated thereunder, &#8220;Section 280G&#8221;) of the Code, payable to Executive ( the &#8220;Covered Payments&#8221;), exceeds the limitations&#160; of Section 280G such that an excise tax will be imposed
        under Section 4999 of the Code (the &#8220;Excise Tax&#8221;), then, before making the Covered Payments, a calculation will be made comparing (i) the Net Benefit (as defined below) to Executive of the Covered Payments after payment of the Excise Tax to (ii)
        the Net Benefit to Executive if the Covered Payments are limited to the extent necessary to avoid being subject to the Excise Tax. Only if the amount calculated under (i) above is less than the amount under (ii) above will the Covered Payments be
        reduced to the minimum extent necessary to ensure that no portion of the Covered Payments is subject to the Excise Tax. &#8220;Net Benefit&#8221; will mean the present value of the Covered Payments net of all federal, state, local, foreign income, employment
        and excise taxes. Any such reduction will be made by the Company in its sole discretion consistent with the requirements of Section 409A of the Code. If two economically equivalent amounts are subject to reduction but are payable at different
        times, the amounts will be reduced (but not below zero) on a pro rata basis. Notwithstanding the foregoing, the Board (or a committee of the Board composed entirely of independent directors) may, in its sole discretion and on a case-by-case basis,
        approve a gross-up payment (a &#8220;Limited Gross-Up&#8221;) to Executive in an amount sufficient to place Executive in the same after-tax position as if no Excise Tax had been imposed, but only to the extent the Excise Tax results from a reduced base amount
        due to (i) a limited period of service with the Company prior to the Change in Control, or (ii) other structural features not attributable to Executive&#8217;s actions or compensation demands. Any such Limited Gross-Up shall be subject to compliance with
        Section 409A of the Code, and may be conditioned upon Executive providing reasonable cooperation with tax planning or mitigation strategies.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <u>Section 409A</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(i)</font>&#160;&#160;&#160;&#160;&#160; &#160;&#160; To the extent required by Section 409A of the Code, all references to &#8220;termination of employment&#8221; and correlative phrases for
        purposes of this Agreement shall be construed to require a &#8220;separation from service&#8221; (as defined in Section 1.409A-1(h) of the Treasury regulations after giving effect to the presumptions contained therein).</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">11</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160; Notwithstanding any provision in this Agreement to the contrary, to the extent that (i) any payments or benefits to which
        Executive becomes entitled under this Agreement or any other agreement, policy, plan, program or arrangement with the Company, in connection with Executive&#8217;s termination of employment with the Company constitute &#8220;nonqualified deferred compensation&#8221;
        subject to Section 409A of the Code and (ii) Executive is deemed at the time of such termination of employment to be a &#8220;specified employee&#8221; under Section 409A of the Code, then such payments or benefits shall not be made or commence until the
        earliest of (1) the expiration of the six (6) month and one day period measured from the date of Executive&#8217;s separation from service (as defined in <u>Section </u>9(c)(i) above) from the Company or (2) the date of Executive&#8217;s death following such
        separation from service; provided, however, that such deferral shall only be effected to the extent required to avoid adverse tax treatment to Executive, including (without limitation) the additional twenty-percent (20%) tax for which Executive
        would otherwise be liable under Section 409A(a)(1)(b) of the Code in absence of such deferral. Upon the expiration of the applicable deferral period, any payments which would have otherwise been made during that period (whether in a single sum or
        in installments) in the absence of this <u>Section </u>9(b) shall be paid to Executive or Executive&#8217;s beneficiary in one lump sum. For purposes of this <u>Section </u>9(b), the term &#8220;specified employee&#8221; means an individual determined by the
        Company to be a specified employee under Treasury regulation Section 1.409A-1(i) in accordance with the policies of the Company.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(iii)</font>&#160;&#160; &#160; &#160; It is intended that each installment of any benefits or payments provided hereunder constitute a separate payment for purposes of
        Treasury Regulation Section 1.409A-2(b)(2)(i). The Company and Executive intend that all the benefits and payments provided under this Agreement shall be exempt from, or comply with, the requirements of Section 409A of the Code and the provisions
        of the Agreement shall be read in accordance with that intent. It is further intended that payments hereunder satisfy, to the greatest extent possible, the exemptions from the application of Section 409A of the Code (and any state law of similar
        effect) provided under Treasury Regulations Section 1.409A-1(b)(4) (as a &#8220;short-term deferral&#8221;) and Section 1.409A-1(b)(9) (as &#8220;separation pay due to involuntary separation&#8221;). To the extent that any provision hereof is modified in order to comply
        with Section 409A, such modification will be made in good faith and will, to the maximum extent reasonably possible, maintain the original intent and economic benefit to Executive and the Company of the applicable provision without violating the
        provisions of Section 409A. The Company makes no representation or warranty and shall have no liability to Executive or any other person if any provisions of this Agreement are determined to constitute deferred compensation subject to Section 409A
        of the Code but do not satisfy an exemption from, or comply with the conditions of, such Section.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(iv)</font>&#160;&#160;&#160;&#160;&#160;&#160; Except as otherwise expressly provided herein, to the extent any expense reimbursement or the provision of any in-kind benefit
        under this Agreement is determined to constitute &#8220;nonqualified deferred compensation&#8221; subject to Section 409A of the Code, the amount of any such expenses eligible for reimbursement, or the provision of any in-kind benefit, in one calendar year
        shall not affect the expenses eligible for reimbursement in any other taxable year (except for any lifetime or other aggregate limitation applicable to medical expenses), in no event shall any expenses be reimbursed after the last day of the
        calendar year following the calendar year in which Executive incurred such expenses, and in no event shall any right to reimbursement or the provision of any in-kind benefit be subject to liquidation or exchange for another benefit.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(v)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; Whenever a payment under this Agreement specifies a payment period with reference to a number of days, the actual date of payment
        within the specified period is within the sole discretion of the Company.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(vi)</font>&#160;&#160;&#160;&#160;&#160; Notwithstanding any provision in this Agreement to the contrary, to the extent that any payments or benefits to which Executive
        becomes entitled under this Agreement or any other agreement, policy, plan, program or arrangement with the Company, in connection with Executive&#8217;s termination of employment with the Company constitute &#8220;nonqualified deferred compensation&#8221; subject
        to Section 409A of the Code, then each such payment which is conditioned upon Executive&#8217;s execution of a release and which is to be paid or provided during a designated period that begins in one taxable year and ends in a second taxable year shall
        be paid or provided in the later of the two taxable years.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">12</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;"><font style="color: #010000;">10.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Certain Definitions</u>. As used in this Agreement, the following terms shall have the following meanings:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Cause</u>. &#8220;Cause&#8221; means any of the following: (i) Executive&#8217;s commission of an act of fraud, embezzlement or dishonesty, or the commission of
        some other illegal act by Executive, that could reasonably be expected to have an adverse impact on the Company or any successor or affiliate; (ii) Executive&#8217;s conviction of, or plea of &#8220;guilty&#8221; or &#8220;no contest&#8221; to, a felony or any crime involving
        fraud, dishonesty or moral turpitude under the laws of the United States or any state thereof (or international equivalent); (iii) any intentional, unauthorized use or disclosure by Executive of Confidential Information or trade secrets of the
        Company or any successor or affiliate; (iv) Executive&#8217;s gross negligence or material violation of any duty of loyalty to the Company or any successor or affiliate thereof, or any other demonstrable material misconduct on Executive&#8217;s part in
        connection with the performance of Executive&#8217;s duties for the Company; (v) Executive&#8217;s ongoing and repeated failure or refusal to perform or neglect of Executive&#8217;s duties as required by this Agreement or Executive&#8217;s ongoing and repeated failure or
        refusal to comply with the instructions given to Executive by the Board, which failure, refusal or neglect continues for fifteen (15) days following Executive&#8217;s receipt of written notice from the Board stating with specificity the nature of such
        failure, refusal or neglect; or (vi) Executive&#8217;s material breach of any material Company policy or any material provision of this Agreement, which breach is not cured (if capable of being cured) within fifteen (15) days following Executive&#8217;s
        receipt of written notice from the Board stating with specificity the nature of such material breach; provided, that the foregoing cure right shall not apply to any breach by Executive of <u>Section </u>5 or <u>Section </u>6 hereof.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Change in Control</u>. &#8220;Change in Control&#8221; shall have the meaning set forth in the 2025 XCF Global, Inc. Equity Incentive Plan. For purposes of
        clarity, consummation of (i) the transactions contemplated in the BCA or (ii) the New Rise Acquisitions (as defined in the BCA) shall not constitute a Change in Control.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(c)</font>&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160; <u>Code</u>. &#8220;Code&#8221; shall mean the Internal Revenue Code of 1986, as amended, and the regulations and guidance promulgated thereunder.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Confidential Information</u>. &#8220;Confidential Information&#8221; means the Company&#8217;s trade secrets as defined under applicable law, as well as any
        other information or material which is not generally known to the public, and which: (i) is generated, collected by or utilized in the operations of the Company&#8217;s business and relates to the actual or anticipated business of the Company; or (ii)
        results from any task assigned to Executive by the Company, or work performed by Executive for or on behalf of the Company. Confidential Information shall not be considered generally known to the public if Executive or others improperly reveal such
        information to the public without the Company&#8217;s express written consent and/or in violation of an obligation of confidentiality owed to the Company. Confidential Information includes, without limitation, the information, observations and data
        obtained by Executive while employed by the Company concerning the business or affairs of the Company, including without limitation: information concerning investment or acquisition opportunities in or reasonably related to the Company; the
        identities of and other information (such as databases) relating to the current, former or prospective employees, customers, or investors of the Company; development, transition and transformation plans; methodologies and methods of doing business;
        strategic, marketing and expansion plans; financial and business plans, financial data; pricing information; employee, customer, or vendor lists and telephone numbers; investment terms; and requirements and costs of providing service. Confidential
        Information also includes information that the Company receives from third parties subject to a duty to maintain the confidentiality of such information and to use it only for certain limited purposes.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Date of Termination</u>. &#8220;Date of Termination&#8221; shall mean (i) if Executive&#8217;s employment is terminated by Executive&#8217;s death, the date of
        Executive&#8217;s death or (ii) if Executive&#8217;s employment is terminated pursuant to <u>Section </u>3(a)(ii) &#8211; (iv) either the date indicated in the Notice of Termination or the date specified by the Company pursuant to <u>Section </u>3(b), whichever
        is earlier.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">13</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Disability</u>. &#8220;Disability&#8221; shall mean, at any time the Company or any of its affiliates sponsors a long-term disability plan for the Company&#8217;s
        employees, &#8220;disability&#8221; as defined in such long-term disability plan for the purpose of determining a participant&#8217;s eligibility for benefits;&#160; provided, however, if the long-term disability plan contains multiple definitions of disability,
        &#8220;Disability&#8221; shall refer to that definition of disability which, if Executive qualified for such disability benefits, would provide coverage for the longest period of time. The determination of whether Executive has a Disability shall be made by
        the person or persons required to make disability determinations under the long-term disability plan. At any time the Company does not sponsor a long-term disability plan for its employees, &#8220;Disability&#8221; shall mean Executive&#8217;s inability to perform,
        with or without reasonable accommodation, the essential functions of Executive&#8217;s positions hereunder for a total of three months during any six-month period as a result of incapacity due to mental or physical illness as determined by the Board in
        its sole good faith discretion.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(g)</font> &#160; &#160;&#160;&#160; <u>Good Reason</u>. &#8220;Good Reason&#8221; means any of the following without Executive&#8217;s written consent: (i) a material diminution in Executive&#8217;s authority,
        duties or responsibilities; (ii) a material diminution in Executive&#8217;s base salary or target Annual Bonus (and Executive and the Company agree that any diminution of 10% or more shall be considered material for this purpose, regardless of whether
        such diminution occurs due to a single reduction or a series of reductions), other than in connection with an across-the-board reduction which applies in a comparable manner to other senior officers of the Company; (iii) any change in the Company&#8217;s
        remote work policy that would require Executive to be physically present in one of the Company&#8217;s offices more than 20 days each month and (iv) the Company&#8217;s breach of a material provision of this Agreement. Notwithstanding the foregoing, no Good
        Reason will have occurred unless and until Executive has (A) provided the Company, within thirty (30) days of Executive&#8217;s knowledge of the occurrence of the facts and circumstances underlying the Good Reason event, written notice stating with
        specificity the applicable facts and circumstances underlying such finding of Good Reason, (B) provided the Company with an opportunity to cure the same within thirty (30) days after the receipt of such notice and (C) the Company shall have failed
        to so cure within such period. Executive&#8217;s termination of employment by reason of resignation from employment with the Company for Good Reason must occur within 30 days following the expiration of the foregoing 30-day cure period.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: #010000;">11.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Miscellaneous Provisions</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Contractor Period Payment</u>. The parties understand that the existing employment agreement between the Executive and XCF Global Capital, Inc.
        provides that the Executive is to be paid, at the Closing of the Business Combination the amount specified in such employment agreement for services the Executive provided to XCF Global Capital, Inc. as an independent contractor for the period
        January 1, 2024 until the date of execution of such employment agreement (the &#8220;Contractor Period Payment&#8221;).&#160; The parties further acknowledge and agree that upon Closing of the Business Combination, the Company shall (i) assume the obligation to
        make the Contractor Period Payment and shall make such payment in cash no later than September 30, 2025, unless the Company and Executive mutually agree in writing, on or before such date, to extend the payment deadline to no later than December
        31, 2025 due to the Company&#8217;s reasonable cash constraints. Any such extension shall not modify the Company&#8217;s obligation to make full payment nor be deemed a waiver of Executive&#8217;s rights. In addition, within 30 days after the Closing of the Business
        Combination, the Company shall issue to Executive a grant of restricted shares of the Company&#8217;s Class A Common Stock under the Company&#8217;s 2025 Equity Incentive Plan in aggregate value equal to the obligation assumed by the Company for the Contractor
        Period Payment. This grant shall be separate from, and not in lieu of, the Contractor Period Payment and be calculated based on the 20 day volume-weighted average price for the Company&#8217;s Class A Common Stock following the Closing of the Business
        Combination. The restricted shares shall vest ratably on a monthly basis over a period of three (3) years and shall be subject to the terms and conditions of the Company&#8217;s 2025 Equity Incentive Plan and the applicable award agreement.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">14</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Governing Law</u>. This Agreement shall be governed, construed, interpreted and enforced in accordance with its express terms, and otherwise in
        accordance with the substantive laws of the State of Delaware without reference to the principles of conflicts of law of the State of Delaware or any other jurisdiction that would result in the application of the laws of a jurisdiction other than
        the State of Delaware, and where applicable, the laws of the United States.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Arbitration</u>. Any dispute, controversy, or claim arising out of or relating to this Agreement or any breach of this Agreement or Executive&#8217;s
        employment, whether the claim arises in contract, tort, or statute, shall be submitted to and decided by binding arbitration, except as set forth in <u>Section </u>6(c). Arbitration shall be administered exclusively by the American Arbitration
        Association at a location in Wilmington, Delaware and shall be conducted consistent with the employment arbitration rules, regulations, and requirements thereof as well as any requirements imposed by state law. Any arbitral award determination
        shall be final and binding upon the Parties, and judgment may be entered thereon in any court of competent jurisdiction. Notwithstanding anything to the contrary, this Agreement does not prevent Executive from filing a complaint or charge with the
        National Relations Labor Board, the Equal Employment Opportunity Commission, or any similar federal or state administrative agency, including claims for workers&#8217; compensation or unemployment insurance benefits. By entering into this Agreement, the
        Parties are waiving all rights to have their disputes heard or decided by a jury or in a court trial and the right to pursue any class or representative claims against each other in court, arbitration, or any other proceeding. The arbitrator shall
        have no jurisdiction or authority to compel any class or collective claim, or to consolidate different arbitration proceedings with or join any other party to an arbitration between the Parties. The arbitrator, and not any court, shall have
        exclusive authority to resolve any dispute relating to the enforceability or formation of this Agreement and the arbitrability of dispute between the parties, except for any dispute relating to the enforceability or scope of the class and
        collective action waiver, which shall be determined by a court of competent jurisdiction. THE PARTIES FULLY UNDERSTAND AND AGREE THAT THEY ARE GIVING UP CERTAIN RIGHTS OTHERWISE AFFORDED TO THEM BY CIVIL COURT ACTIONS, INCLUDING BUT NOT LIMITED TO
        THE RIGHT TO A JURY OR COURT TRIAL AND THE RIGHT TO BRING ANY CLAIM AS A CLASS OR COLLECTIVE ACTION. Costs of arbitration shall be split evenly between the parties, provided, that the arbitrator shall have the ability to award attorneys&#8217; fees and
        previously paid arbitration expenses to the prevailing party.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Venue; Waiver of Jury Trial</u>.&#160; Except for claims subject to the arbitration provisions herein, the Parties agree that all litigation arising
        out of or relating to this agreement must be brought exclusively in any state or federal court located in Wilmington, Delaware (collectively the &#8220;Designated Courts&#8221;). Each Party consents and submits to the exclusive jurisdiction of the Designated
        Courts with respect to litigation under this Agreement, each Party hereby irrevocably waives all claims or defenses of lack of personal jurisdiction or any other jurisdiction defense, and any objection which such Party may now or hereafter have to
        the laying of venue of any suit, action or proceeding in any Designated Court, including any right to object on the basis that any dispute, action, suit, or proceeding brought in the Designated Courts has been brought in an improper or inconvenient
        forum or venue.&#160; IN THE EVENT OF LITIGATION HEREUNDER, THE COMPANY AND EXECUTIVE EACH WAIVE THEIR RESPECTIVE RIGHT TO A TRIAL BY JURY OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF OR RELATED TO ANY ACTION, PROCEEDING, OR OTHER
        LITIGATION OF ANY TYPE BROUGHT BY ANY OF THE PARTIES AGAINST ANY OTHER PARTY OR ANY AFFILIATE OF ANY OTHER SUCH PARTY. THE COMPANY AND EXECUTIVE EACH AGREE THAT ANY SUCH CLAIM OR CAUSE OF ACTION WILL BE TRIED BY A COURT TRIAL WITHOUT A JURY.
        WITHOUT LIMITING THE FOREGOING, THE PARTIES FURTHER AGREE THAT THEIR RESPECTIVE RIGHT TO A TRIAL BY JURY IS WAIVED BY OPERATION OF THIS SECTION AS TO ANY ACTION, COUNTERCLAIM, OR OTHER PROCEEDING WHICH SEEKS, IN WHOLE OR IN PART, TO CHALLENGE THE
        VALIDITY OR ENFORCEABILITY OF THIS AGREEMENT. THIS WAIVER WILL APPLY TO ANY SUBSEQUENT AMENDMENTS, RENEWALS, SUPPLEMENTS, OR MODIFICATIONS TO THIS AGREEMENT.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">15</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Validity; Severability</u>. Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid
        under applicable law, but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability will not affect any
        other provision or any action in any other jurisdiction, but this Agreement will be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had never been contained herein.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(f)</font>&#160;&#160;&#160;&#160; &#160;&#160; <u>Notices</u>. Any notice, request, claim, demand, document and other communication hereunder to any Party shall be effective upon receipt (or
        refusal of receipt) and shall be in writing and delivered personally or sent by facsimile or certified or registered mail, postage prepaid, (i) if to the Company, to the Chief Executive Officer of the Company at the Company&#8217;s headquarters, (ii) if
        to Executive, to the last address that the Company has in its personnel records for Executive, or (iii) at any other address as any Party shall have specified by notice in writing to the other Party.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Counterparts</u>. This Agreement may be executed in several counterparts, each of which shall be deemed to be an original, but all of which
        together will constitute one and the same Agreement. Signatures delivered by facsimile or .pdf format shall be deemed effective for all purposes.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(h)</font>&#160;&#160;&#160; &#160;&#160;&#160;&#160; <u>Entire Agreement</u>. The terms of this Agreement are intended by the Parties to be the final expression of their agreement with respect to the
        subject matter hereof and supersede all prior understandings and agreements, whether written or oral, including any prior employment offer letter, employment agreement or consulting agreement between Executive and the Company. The Parties further
        intend that this Agreement shall constitute the complete and exclusive statement of their terms and that no extrinsic evidence whatsoever may be introduced in any judicial, administrative, or other legal proceeding to vary the terms of this
        Agreement.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(i)</font>&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Amendments; Waivers</u>. This Agreement may not be modified, amended, or terminated except by an instrument in writing, signed by Executive and
        a duly authorized officer of Company. By an instrument in writing similarly executed, Executive or a duly authorized officer of the Company may waive compliance by the other Party with any specifically identified provision of this Agreement that
        such other Party was or is obligated to comply with or perform; provided, however, that such waiver shall not operate as a waiver of, or estoppel with respect to, any other or subsequent failure. No failure to exercise and no delay in exercising
        any right, remedy, or power hereunder will preclude any other or further exercise of any other right, remedy, or power provided herein or by law or in equity.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(j)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Successors and Assigns</u>. The Company may assign its rights and obligations under this Agreement to any of its affiliates or to any successor
        to all or substantially all of the business or the assets of the Company (by merger or otherwise, including, without limitation, to the surviving entity in the Business Combination), and may assign or encumber this Agreement and its rights
        hereunder as security for indebtedness of the Company and its affiliates. This Agreement shall be binding upon and inure to the benefit of the Company, Executive and their respective successors, assigns, personnel and legal representatives,
        executors, administrators, heirs, distributees, devisees, and legatees, as applicable. None of Executive&#8217;s rights or obligations may be assigned or transferred by Executive, other than Executive&#8217;s rights to payments hereunder, which may be
        transferred only by will or operation of law. Notwithstanding the foregoing, Executive shall be entitled, to the extent permitted under applicable law and applicable Company Arrangements, to select and change a beneficiary or beneficiaries to
        receive compensation hereunder following Executive&#8217;s death by giving written notice thereof to the Company.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(k)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Indemnification</u>. The Company and Executive shall enter into a Director and Officer Indemnification Agreement substantially in the form of <u>Exhibit

          C</u> attached hereto.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">16</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(l)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>D&amp;O Insurance</u>. The Company will cover Executive under directors&#8217; and officers&#8217; liability insurance policy (or policies) during the Term
        and thereafter to the same extent as the Company covers its other current or former directors or officers of the Company.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(m)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Clawback</u>. Notwithstanding any other provisions in this Agreement to the contrary, any incentive-based or other compensation paid to the
        Executive under this Agreement or any other agreement or arrangement with the Company that is subject to recovery under any applicable law, government regulation, or stock exchange rule or listing requirement will be subject to such deductions and
        clawback as may be required or permitted to be made pursuant to such law, government regulation, or stock exchange rule or listing requirement or any policy adopted by the Company.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(n)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Construction</u>. This Agreement shall be deemed drafted equally by both the Parties. Its language shall be construed as a whole and according to
        its fair meaning. Any presumption or principle that the language is to be construed against any Party shall not apply. The headings in this Agreement are only for convenience and are not intended to affect construction or interpretation. Any
        references to paragraphs, subparagraphs, sections or subsections are to those parts of this Agreement, unless the context clearly indicates to the contrary. Also, unless the context clearly indicates to the contrary, (i) the plural includes the
        singular and the singular includes the plural, (ii) &#8220;and&#8221; and &#8220;or&#8221; are each used both conjunctively and disjunctively, (iii) &#8220;any,&#8221; &#8220;all,&#8221; &#8220;each,&#8221; or &#8220;every&#8221; means &#8220;any and all,&#8221; and &#8220;each and every,&#8221; (iv) &#8220;includes&#8221; and &#8220;including&#8221; are each
        &#8220;without limitation,&#8221; (v) &#8220;herein,&#8221; &#8220;hereof,&#8221; &#8220;hereunder&#8221; and other similar compounds of the word &#8220;here&#8221; refer to the entire Agreement and not to any particular paragraph, subparagraph, section or subsection and (vi) all pronouns and any variations
        thereof shall be deemed to refer to the masculine, feminine, neuter, singular or plural as the identity of the entities or persons referred to may require.</div>
      <div>&#160;</div>
      <div style="text-align: center;">[SIGNATURE PAGE FOLLOWS]</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">17</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold;">IN WITNESS WHEREOF</font>, the Parties hereto have executed this Agreement as of the date first written above. The signatories below represent that they are duly
        authorized to enter into this Agreement.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="z3e0ca92d00384d33b66212dc6ac3daa8" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top;" colspan="1"><br>
            </td>
            <td style="vertical-align: top;" rowspan="1" colspan="2">
              <div style="font-weight: bold;">XCF GLOBAL, INC.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;" colspan="1" rowspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top;" rowspan="1"><br>
            </td>
            <td style="width: 45%; vertical-align: top;" rowspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;" colspan="1"><br>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div>By:</div>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div><u>/s/ Mihir Dange</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;" colspan="1"><br>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div>Name:</div>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div>Mihir Dange</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;" colspan="1"><br>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div>Title:</div>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div>Chief Executive Officer</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;" colspan="1" rowspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top;" rowspan="1"><br>
            </td>
            <td style="width: 45%; vertical-align: top;" rowspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;" colspan="1"><br>
            </td>
            <td style="width: 5%; vertical-align: top;" rowspan="1" colspan="2">
              <div style="font-weight: bold;">EXECUTIVE</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;" colspan="1" rowspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top;" rowspan="1"><br>
            </td>
            <td style="width: 45%; vertical-align: top;" rowspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;" colspan="1"><br>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div>By:</div>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div><u>/s/ Gregory R. Surette</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;" colspan="1"><br>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div>Name:</div>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div>Gregory R. Surette</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">18</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;">Exhibit A</div>
      <div>&#160;</div>
      <div>Mr. Surette has an existing business commitment in a consulting capacity for The Ricci Group Limited and its subsidiaries, a Hong Kong-based holding company, with investments across the coffee value chain in Mainland China. This includes finance
        and accounting oversight and strategic involvement over the Group&#8217;s coffee brands and subsidiaries.</div>
      <div>&#160;</div>
      <div>Current Board Role:&#160; SinoTaste Technology (Shanghai) Co., Ltd.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;">Exhibit B</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">Compensation Terms</div>
      <div>&#160;</div>
      <div style="text-align: center;">(attached)</div>
      <br>
      <div style="text-align: center; font-weight: bold;">Executive is solely responsible for any tax liability incurred as a result of any benefit set forth in this table being treated as a taxable benefit under federal, state or local law.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;">Gregory Surette</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">Exhibit B &#8211; Compensation Terms</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="zdb6eae7cd0b74dd89d1617336d3eb0ba" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
              <div>Base Salary</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
              <div>$480,000, Four Hundred Eighty Thousand Dollars; $640,000 upon repatriation back to US</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>Annual Bonus</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>Target Bonus set at 100-200% of Base Salary, with wings above and below the target level based on targets agreed upon by the Board</div>
              <div>&#160;</div>
              <div>Key evaluation metrics (subject to adjustment each year):</div>
              <div style="text-indent: -18pt; margin-left: 18pt;">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;25% discretionary established by the Board</div>
              <div style="text-indent: -18pt; margin-left: 18pt;">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;25% Individual performance metrics to be set by the Board</div>
              <div style="margin-left: 18pt;">&#160;&#160;&#160; 50% Transaction success fee (de-SPAC/IPO) (first year only)</div>
              <div>&#160;</div>
              <div>Opportunity to elect cash or stock for bonus payment, subject to limits set by Board or Compensation Committee</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>Management Equity</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>300,000 RSUs of common stock issued at closing of de-SPAC IPO</div>
              <div>&#160;</div>
              <div>Vesting Period: Three years monthly from start date, accelerated on termination without cause following a change-in-control</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>2025 Equity Incentive Plan Participation</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>Executive eligible to receive additional equity compensation pursuant to the Company&#8217;s 2025 Equity Incentive Plan</div>
              <div>&#160;</div>
              <div>Target 300-600% of Base Salary with an initial grant of 144,000 shares; vesting period over three years (no vesting during the first six months (the &#8220;cliff period&#8221;)). After the six-month cliff period, the restricted stock units will vest
                in equal monthly installments over 30 months, subject to continued service with New XCF)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>Contractor Period Payment</div>
              <div>&#160;</div>
              <div>Gregory Surette</div>
              <div>(Remosa, LLC)</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>$540,000 payment in cash no later than September 30, 2025, unless the Company and Executive mutually agree in writing, on or before such date, to extend the payment deadline to no later than December 31, 2025</div>
              <div>&#160;</div>
              <div>$540,000 in restricted shares of the Company&#8217;s Class A Common Stock under the Company&#8217;s 2025 Equity Incentive Plan. Calculated based on the 20 day volume-weighted average price for the Company&#8217;s Class A Common Stock following the Closing
                of the Business Combination. The restricted shares shall vest ratably on a monthly basis over a period of three (3) years and shall be subject to the terms and conditions of the Company&#8217;s 2025 Equity Incentive Plan and the applicable award
                agreement</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>Benefits:</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: -18pt; margin-left: 36pt;">&#8226;&#160;&#160;&#160;&#160; Health/Group insurance</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>Minimum 80% of premiums paid by Company</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: -18pt; margin-left: 36pt;">&#8226;&#160;&#160;&#160;&#160; Life insurance</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>Up to 2x Base Salary, not to exceed $1 million; Employee may elect to add additional coverage at their own expense</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="zed170f260df14210b7ee4113bef6a002" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: -18pt; margin-left: 36pt;">&#8226;&#160;&#160;&#160;&#160;&#160; Phone subsidy</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>Based on actual and reasonable phone bill incurred each month, with invoice</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: -18pt; margin-left: 36pt;">&#8226;&#160;&#160;&#160;&#160;&#160; Fitness and wellness subsidy</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>$3,500 per year, based on actual amount incurred with invoice</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: -18pt; margin-left: 36pt;">&#8226;&#160;&#160;&#160;&#160;&#160; Retirement benefits (401(k) or other retirement plan as established by the Company)</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>3% automatic match; 100% match on first 3% EE contributions</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: -18pt; margin-left: 36pt;">&#8226;&#160;&#160;&#160;&#160;&#160; Car allowance</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>$1,500 per month or $18,000 per year</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: -18pt; margin-left: 36pt;">&#8226;&#160;&#160;&#160;&#160;&#160; Club membership</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>One-time membership fees paid once (based on actual amount, with invoice)</div>
              <div>Monthly club membership fees thereafter (up to $2,500 per month, based on actual amount incurred with invoice)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: -18pt; margin-left: 36pt;">&#8226;&#160;&#160;&#160;&#160; Tax and estate planning</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>Based on actual expenses incurred</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: -18pt; margin-left: 36pt;">&#8226;&#160;&#160;&#160;&#160; Relocation benefits (if at the Company&#8217;s request)</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>Based on actual expenses incurred and will cover:</div>
              <div style="text-indent: -18pt; margin-left: 36pt;">1.&#160;&#160;&#160;&#160; One-way flight costs for employee, spousal equivalent and dependents</div>
              <div style="text-indent: -18pt; margin-left: 36pt;">2.&#160;&#160;&#160;&#160; One-month temporary housing, based on actual amount, with invoice</div>
              <div style="text-indent: -18pt; margin-left: 36pt;">3.&#160;&#160;&#160;&#160; Moving costs (sea freight) for personnel effects, based on actual amount, with invoice</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;">Exhibit C</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">Form of Indemnification Agreement</div>
      <div>&#160;</div>
      <div style="text-align: center;">(attached)</div>
      <div style="text-align: center;"> <br>
      </div>
      <div style="text-align: center;"> <br>
      </div>
      <div style="text-align: center;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;"> </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.60
<SEQUENCE>15
<FILENAME>ef20050548_ex10-60.htm
<DESCRIPTION>EXHIBIT 10.60
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">




  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: right;"> <font style="font-weight: bold;">Exhibit 10.60</font><br>
    </div>
    <div> <br>
    </div>
    <div>
      <div style="text-align: center; font-weight: bold;">XCF Global, Inc.</div>
      <div style="text-align: center; font-weight: bold;">Employment Agreement</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">This Employment Agreement (this &#8220;Agreement&#8221;), dated as of June 6, 2025, is made by and between XCF Global, Inc. (the &#8220;Company&#8221;) and Gregory P. Savarese (&#8220;Executive&#8221;) (the Company and Executive are
        collectively referred to herein as the &#8220;Parties,&#8221; or each individually referred to as a &#8220;Party&#8221;).</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">RECITALS</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold;">WHEREAS</font>, Executive has been serving as the Chief Marketing Officer of XCF Global Capital, Inc. (&#8220;XCF Global Capital&#8221;);</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold;">WHEREAS</font>, on March 11, 2024, XCF Global Capital, Focus Impact BH3 Acquisition Company (&#8220;Focus Impact&#8221;), Focus Impact BH3 NewCo, Inc. (&#8220;NewCo&#8221;), Focus Impact
        BH3 Merger Sub 1, LLC and Focus Impact BH3 Merger Sub 2, Inc. entered into a business combination agreement (as it may be amended or restated from time to time, the &#8220;Business Combination Agreement&#8221;), pursuant to which Focus Impact agreed to combine
        with XCF Global Capital in a series of transactions that will result in NewCo becoming a publicly-traded company (collectively, the &#8220;Business Combination&#8221;), and at the closing of the Business Combination (the &#8220;Closing&#8221;), NewCo will change its name
        to &#8220;XCF Global, Inc.&#8221;; and</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold;">WHEREAS</font>, Executive and the Company desire to enter into this Agreement to set out the terms and conditions of the employment relationship between the Company
        and the Executive following the Closing of the Business Combination, with this Agreement to become effective upon the Closing of the Business Combination and continue until terminated by either Party in accordance with its terms (such period during
        which this Agreement is in effect, the &#8220;Term&#8221;) and will be null and void if the Closing of the Business Combination does not occur; and</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold;">WHEREAS</font>, except as otherwise provided herein, Executive and the Company intend and confirm that this Agreement supersedes in all respects all prior
        agreements, arrangements or understandings between Executive and the Company regarding the subject matter herein, including without limitation, any offer letter, employment agreement, consulting agreement or severance agreement as of the effective
        date of this Agreement.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold;">NOW, THEREFORE</font>, in consideration of the foregoing recitals, the mutual covenants and agreements set forth herein and for other good and valuable
        consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and Executive agree as follows:</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: #010000;">1.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <u>Employment</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>At-Will Employment</u>. Executive and the Company acknowledge that Executive&#8217;s employment is and shall continue to be at-will, as defined under
        applicable law, and that Executive&#8217;s employment with the Company may be terminated by either Party at any time for any or no reason (subject to the notice requirements of <u>Section </u>3(b)). If Executive&#8217;s employment terminates for any reason,
        Executive shall only be entitled to those payments, benefits, awards or compensation as specifically provided in this Agreement or as otherwise agreed to in writing by the Company, or as provided by applicable law, and Executive shall not be
        entitled to any other payments, benefits, damages, award or compensation.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Title; Responsibilities</u>. The Company shall continue to employ Executive in the position of [Chief Marketing Officer reporting to the Chief
        Executive Officer, and Executive hereby accepts such continued employment. During the Term, Executive shall have and perform such duties, responsibilities and authorities as are customarily associated with this position, as well as any other duties
        that may be assigned to Executive from time to time by the Chief Executive Officer or the Board of Directors (the &#8220;Board&#8221;) that are not inconsistent with service as an officer of the Company, including duties for any Company subsidiary or
        affiliate.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(c)</font>&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160; <u>Exclusive Employment</u>. During the Term, Executive shall devote substantially all of Executive&#8217;s business time, skills and best efforts to
        Executive&#8217;s employment hereunder and may not, without the prior written consent of the Board, participate in the management, operation, or control of, or act as an employee, officer, director, consultant, advisor, agent or representative of, any
        other business or service (&#8220;Other Service&#8221;); provided, however, that Executive may (i) engage in civic and charitable activities (including service on the board of directors or advisory board of civic and charitable organizations), (ii) make and
        manage outside passive personal and family investments and manage personal and family affairs and (iii) serve on the board of directors of the for-profit businesses or trade organizations (including advisory boards), provided, that none of the
        foregoing (x) materially interferes with Executive&#8217;s performance of Executive&#8217;s duties hereunder, (y) poses an actual or perceived conflict of interest or violates any other obligations of Executive hereunder (including, without limitation, <u>Sections

        </u>5 and 6 hereof) or (z) is prohibited by or conflicts with any applicable law or regulation (including the rules of any securities exchange on which the Company&#8217;s securities are listed) or any Company policy applicable to Executive. Exhibit A
        hereto identifies (i) any Other Service with respect to which the Board had provided its consent and (ii) any board of directors of any for-profit businesses or trade organizations (including advisory boards) on which Executive serves (as such
        Exhibit may be amended from time to time during the Term by mutual agreement of the Executive and the Board).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>Compliance</u>. Executive agrees to comply with all applicable laws, rules, regulations and policies relating to the performance of Executive&#8217;s
        duties and responsibilities as an employee of the Company, including, without limitation, compliance with the Company&#8217;s Code of Ethics and Business Conduct. Executive is prohibited from receiving economic benefits from any other person or entity
        other than the Company in connection with the services provided to the Company hereunder (for purposes of clarity, receipt of economic benefits from ownership of securities of the Company would not be prohibited under this provision, but would, for
        the avoidance of doubt, be subject to any insider trading policy maintained by the Company).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(e)</font>&#160;&#160;&#160;&#160; &#160;&#160; <u>Employment Location</u>. Executive may work remotely from Executive&#8217;s residence or from such other location as Executive shall inform the
        Company. Notwithstanding the foregoing, Executive understands and agrees that in connection with the performance of Executive&#8217;s duties and responsibilities under this Agreement, the Company may require Executive to spend designated days per month
        in a designated Company office, provided, that the Company shall notify the Executive in advance of such requirement. In addition, Executive understands and agrees that in connection with the performance of Executive&#8217;s duties and responsibilities
        under this Agreement, Executive may be required to travel on Company business from time-to-time.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: #010000;">2.</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Compensation</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160; <u>Base Salary</u>. During the Term, Executive shall receive an annualized base salary in the amount of $300,000 (&#8220;Base Salary&#8221;), which will be
        paid in accordance with the Company&#8217;s customary payroll procedures as established and modified from time-to-time. The Base Salary will be reviewed annually and may be changed in the sole discretion of the Board and as recommended by the Board&#8217;s
        Compensation Committee (provided, however, if pursuant to the listing requirements of any securities exchange on which the Company&#8217;s securities are then listed, Executive&#8217;s compensation must be set or approved in a different manner, Executive&#8217;s
        compensation shall be set or approved in accordance with such requirements), and any such revised Base Salary shall then constitute &#8220;Base Salary&#8221; for purposes of this Agreement.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">2</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>Annual Bonus</u>. In addition to the Base Salary, Executive shall be eligible for an annual bonus for each completed fiscal year of employment
        during the Term (&#8220;Annual Bonus&#8221;).&#160; The terms of Executive&#8217;s initial Annual Bonus are as set forth on <u>Exhibit B</u> to this Agreement, and the terms of the Annual Bonus for subsequent years shall be determined by the Board, upon the
        recommendation of the Board&#8217;s Compensation Committee for each such subsequent year of employment as set forth herein. Executive understands and agrees that this Agreement does not guarantee the payment of any Annual Bonus and that the actual Annual
        Bonus payable will be based on the achievement of performance objectives and/or other criteria as determined by the Board and recommended by the Board&#8217;s Compensation Committee and such other factors as the Compensation Committee, in its discretion,
        deems relevant (provided, however, if pursuant to the listing requirements of any securities exchange on which the Company&#8217;s securities are then listed, Executive&#8217;s compensation, including any bonus compensation, must be set or approved in a
        different manner, Executive&#8217;s compensation shall be set or approved in accordance with such requirements). Unless otherwise agreed by the Parties and subject to <u>Section </u>4(c)(ii), if an Annual Bonus is awarded, such Annual Bonus shall be
        deemed &#8220;earned&#8221; and Executive is entitled to receive payment of such Annual Bonus only if Executive is employed by the Company on the date the Annual Bonus is paid. Any Annual Bonus payable in accordance with this <u>Section </u>2(b) shall be
        paid to Executive no later than March 15<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> of the calendar year following the year to which it relates. Executive&#8217;s Annual Bonus for 2025 (to the extent earned) will
        be prorated to reflect the portion of the year from the Closing of the Business Combination.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Equity Compensation</u>.&#160; As soon as practicable following the Closing of the Business Combination and subject to Board approval, Executive shall
        receive an initial award of restricted stock units as set forth on <u>Exhibit B</u>, subject to Executive&#8217;s continued employment through the date of grant, which award shall be subject in all respect to the term and conditions of the Company&#8217;s
        2025 Equity Incentive Plan (the &#8220;2025 Plan&#8221;) and the applicable award agreement to be delivered separately to Executive. In addition, Executive shall be eligible to receive additional equity compensation pursuant to the 2025 Plan or such other
        plans or arrangements as determined by the Board or Compensation Committee from time to time. The complete terms and conditions of any future equity compensation award made pursuant to the 2025 Plan or any other equity plan adopted by the Company,
        including vesting, exercise and forfeiture terms, shall be set forth in an award agreement and any such award shall be subject to the terms and conditions set forth in such award agreement and the 2025 Plan or such other equity plan adopted by the
        Company.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>Benefits</u>. During the Term, Executive shall be eligible to participate in such health, group insurance, welfare, pension, and other employee
        benefit plans, programs, and arrangements as are made generally available from time to time to senior executives of the Company (which shall include customary health, life insurance, and disability plans). Executive also shall be eligible to
        participate in the Company&#8217;s 2025 Employee Stock Purchase Plan or any similar or replacement plan adopted in the future during the Term. Executive also shall be eligible for 25 days of paid time off (&#8220;PTO&#8221;) per calendar year during the Term
        (prorated for partial years) in accordance with the Company&#8217;s vacation and PTO policy in effect from time to time, inclusive of vacation days and sick days and excluding standard paid Company holidays.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Expenses and Allowances</u>. Executive shall receive reimbursement from the Company for all reasonable, necessary, and documented business
        expenses incurred in connection with Executive&#8217;s employment hereunder, provided, that such expenses are timely submitted for reimbursement with supporting documentation in accordance with the Company&#8217;s expense reimbursement policies and procedures.
        In addition, Executive will receive reimbursement for the additional fees and expenses incurred by Executive as set forth on <u>Exhibit B</u> (subject to Executive provided sufficient documentation for such reimbursements).</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">3</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;"><font style="color: #010000;">3.</font>&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160; <u>Termination</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Termination Circumstances</u>.&#160; Executive&#8217;s employment hereunder may be terminated by the Company or Executive, as applicable, under the
        following circumstances, and the Term will end on the Date of Termination:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Death</font>. Executive&#8217;s employment hereunder shall terminate automatically upon Executive&#8217;s
        death.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Disability</font>. If Executive has incurred a Disability, the Company may terminate
        Executive&#8217;s employment.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Termination for Cause</font>. The Company may terminate Executive&#8217;s employment for Cause.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(iv)</font>&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Termination without Cause</font>. The Company may terminate Executive&#8217;s employment without Cause
        for any reason or no reason.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(v)</font>&#160;&#160; &#160; &#160;&#160; <font style="font-style: italic;">Resignation from the Company with Good Reason</font>. Executive may resign Executive&#8217;s
        employment with the Company with Good Reason.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(vi)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Resignation from the Company without Good Reason</font>. Executive may resign Executive&#8217;s
        employment with the Company for any reason other than Good Reason or for no reason.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(b)</font>&#160;&#160;&#160;&#160; &#160;&#160;&#160; <u>Notice of Termination</u>. Any termination of Executive&#8217;s employment by the Company or by Executive under this <u>Section </u>3 (other than
        termination as a result of Executive&#8217;s death) shall be communicated by a written notice by the terminating Party to the other Party hereto (i) indicating the specific termination provision in this Agreement being relied upon, (ii) setting forth in
        reasonable detail the facts and circumstances claimed to provide a basis for termination of employment under the provision so indicated, if applicable, and (iii) specifying a Date of Termination (such notice, a &#8220;Notice of Termination&#8221;).&#160; If the
        Notice of Termination is submitted by Executive, such Notice of Termination shall be given at least thirty (30) days prior to the Date of Termination; provided, however, that in the event that Executive delivers a Notice of Termination to the
        Company, the Company may, in its sole discretion, change the Date of Termination to any date that occurs following the date of the Company&#8217;s receipt of such Notice of Termination and which is prior to the date specified by Executive in such Notice
        of Termination, but such termination still shall be considered a resignation by Executive, unless the Company has determined that Cause exists as of such earlier Date of Termination. A Notice of Termination submitted by the Company may provide for
        a Date of Termination on the date Executive receives the Notice of Termination or any date thereafter elected by the Company. The failure by either Party to set forth in the Notice of Termination any fact or circumstance which contributes to a
        showing of Cause or Good Reason shall not waive any right of the Party hereunder or preclude the Party from asserting such fact or circumstance in enforcing the Party&#8217;s rights hereunder.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(c)</font>&#160;&#160;&#160; &#160; &#160; &#160; <u>Company Obligations upon Termination</u>. Upon termination of Executive&#8217;s employment pursuant to any of the circumstances set forth in this <u>Section

        </u>3, Executive (or Executive&#8217;s estate) shall be entitled to receive the sum of (i) the portion of Executive&#8217;s Base Salary earned for the applicable year through the Date of Termination, but not yet paid to Executive, payable on the pay date
        immediately following the Date of Termination in accordance with the Company&#8217;s regular payroll practices (or such earlier date as required by applicable law), (ii) any expense reimbursements owed to Executive pursuant to this Agreement, payable in
        accordance with the Company&#8217;s expense reimbursement policy and (iii) any amount accrued and arising from Executive&#8217;s participation in, or benefits accrued under any employee benefit plans, programs or arrangements, which amounts shall be payable in
        accordance with the terms and conditions of such employee benefit plans, programs or arrangements (the &#8220;Company Arrangements&#8221; and the entitlements referenced in the foregoing clauses (i) through (iii), collectively, the &#8220;Accrued Benefits&#8221;).</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">4</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(d)</font>&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>Effect on Equity Awards</u>. The effect of Executive&#8217;s termination on any equity awards received by Executive prior to such termination shall
        be determined in accordance with the terms of the 2025 Plan (or any other equity plan adopted by the Company pursuant to which such awards were made), the award agreement relating to any such award and/or <u>Section </u>4(b) below, and in the
        case of a termination relating to a Change in Control, <u>Section </u>4(c) below.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: #010000;">4.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>Severance Payments</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Termination Upon Death or Disability</u>. In the event of Executive&#8217;s termination of employment due to death or Disability (as defined below)
        during the Term, the Company shall pay to or for the benefit of Executive or Executive&#8217;s estate, as applicable, the Accrued Benefits and, to the extent unpaid as of the Date of Termination, the Company shall pay Executive the amount of Executive&#8217;s
        Annual Bonus for the prior year, paid as set forth in <u>Section </u>2(b) as if no such termination had occurred.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160; <u>Termination for Cause; Resignation from the Company Without Good Reason</u>. If Executive&#8217;s employment shall terminate for Cause, or due to
        Executive&#8217;s resignation from the Company without Good Reason, then Executive shall receive the Accrued Benefits.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Termination without Cause, or Resignation from the Company with Good Reason</u>. If Executive&#8217;s employment is terminated without Cause or due to
        Executive&#8217;s resignation with Good Reason (in each case, a &#8220;Qualifying Termination&#8221;) that does not occur during the CIC Period (as defined below), in addition to the Accrued Benefits, Executive shall be entitled to the following payments and
        benefits:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company shall pay Executive an amount in cash equal to, in the aggregate, 300% of the Executive&#8217;s annual base salary in
        effect as of the Date of the Termination, payable in equal monthly installments over the 12 month period following the Date of Termination, in accordance with the Company&#8217;s normal payroll practices;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160; To the extent unpaid as of the Date of Termination, the Company shall pay Executive the amount of Executive&#8217;s Annual Bonus for any
        unpaid prior period, paid as set forth in <u>Section </u>2(b) as if no such termination had occurred;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160; The Company shall pay Executive an amount in cash equal to three times the amount of the annual bonus that Executive would have
        earned for the year in which the Date of Termination occurs as if Executive had not been terminated and as if such annual bonus was fully earned (i.e., any relevant performance criteria shall be deemed fully achieved)(such payment, the
        (&#8220;Termination Bonus Payment&#8221;), which amount will be paid in a lump sum within thirty (30) days following the date Executive&#8217;s Release becomes effective and irrevocable, provided that to the extent the annual bonus for the year in which the Date of
        Termination occurs has been pro-rated to reflect that portion of the year from the Closing of the Business Combination to the end of such year, or in the event of any other partial-year calculation, the annual bonus amount for such year shall be
        adjusted for purposes of calculating the Termination Bonus Payment so as to reflect the bonus amount that would have been paid for a full year as if there had there been no such pro-ration (the &#8220;Full-Year Equivalent&#8221;) and in no event shall the
        Termination Bonus Payment be calculated based on an amount other than the Full-Year Equivalent, irrespective of partial-year employment;</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">5</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(iv)</font>&#160;&#160;&#160;&#160; &#160; If Executive timely elects continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended
        (&#8220;COBRA&#8221;), then the Company shall directly pay, or reimburse Executive for, the COBRA premiums for Executive&#8217;s and Executive&#8217;s covered dependents&#8217; continued participation under the Company&#8217;s group health plan (to the extent permitted under
        applicable law and the terms of such plan), less the amount Executive would have had to pay to receive such coverage as an active employee based on the cost sharing levels in effect on the Date of Termination, during the period commencing on the
        Date of Termination and ending upon the earliest of (A) eighteen (18) months following the Date of Termination, (B) the date that Executive and/or Executive&#8217;s covered dependents become no longer eligible for COBRA or (C) the date that Executive
        becomes eligible to receive group health benefits from a subsequent employer (and Executive agrees to promptly notify the Company of such eligibility); provided, that the Company may modify the continuation coverage contemplated this <u>Section </u>4(c)(iv)

        to the extent reasonably necessary, as determined by the Company in its sole discretion, to avoid potentially violating applicable law or incurring an excise tax for failure to comply with applicable law (including, without limitation, Section 2716
        of the Public Health Service Act; Section 105(h) of the Internal Revenue Code of 1986, as amended; the Patient Protection and Affordable Care Act of 2010, as amended; and/or the Health Care and Education Reconciliation Act of 2010, as amended, and
        in each case, the regulations and guidance promulgated thereunder (to the extent applicable)).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Qualifying Termination in Connection with Change in Control</u>. In the event of a Qualifying Termination that occurs (i) not more than three
        (3) months prior to a Change in Control or (ii) on or within twelve (12) months after a Change in Control (such period, the &#8220;CIC Period&#8221;), Executive shall be entitled to receive, in addition to the Accrued Benefits, the following payments and
        benefits set forth in (i) through (iv) below, in each case, subject to (v) below:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(i)</font>&#160;&#160;&#160;&#160;&#160; &#160; &#160; The Company shall pay Executive an amount in cash equal to, in the aggregate, 300% of the Executive&#8217;s annual base salary in
        effect as of the Date of the Termination, payable as a one-time payment to be made by the Company to the Executive (A) within thirty (30) days of the Release Effective Date, if the termination occurs following the Change of Control, or (B) within
        thirty (30) days of the consummation of the Change of Control (or such later date that is thirty (30) days following the Release Effective Date), if the termination occurred prior to the Change in Control;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; To the extent unpaid as of the Date of Termination (or, if later, the consummation of the Change in Control), the Company shall
        pay Executive the amount of Executive&#8217;s Annual Bonus for any unpaid prior period, paid as set forth in <u>Section </u>2(b), as if no such termination had occurred;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(iii)</font>&#160;&#160;&#160;&#160;&#160; The Company shall pay Executive an amount in cash equal to the Termination Bonus Payment, payable as a one-time payment to be made
        by the Company to the Executive (A) within thirty (30) days of the date Executive&#8217;s Release becomes effective and irrevocable, if the termination occurs following the Change of Control, or (B) within thirty (30) days of the date of the Change of
        Control (or such later date that is thirty (30) days following the date Executive&#8217;s Release becomes effective and irrevocable), if the termination occurred prior to the Change of Control, provided that to the extent the annual bonus for the year in
        which the Date of Termination occurs has been pro-rated to reflect that portion of the year from the Closing of the Business Combination to the end of such year, or in the event of any other partial-year calculation, the annual bonus amount for
        such year shall be adjusted for purposes of calculating the Termination Bonus Payment so as to reflect the bonus amount that would have been paid for a full year as if there had there been no such pro-ration (the &#8220;Full-Year Equivalent&#8221;) and in no
        event shall the Termination Bonus Payment be calculated based on an amount other than the Full-Year Equivalent, irrespective of partial-year employment;</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">6</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(iv)</font>&#160;&#160;&#160;&#160;&#160;&#160; Any restricted stock, restricted stock units, options, or other equity grants or awards not vested at the time of termination
        shall be accelerated and become immediately vested (and, for any such awards as to which vesting is based on meeting specified performance criteria, such awards will be considered vested as if the relevant performance criteria was fully achieved),
        such that Executive will thereafter be 100% vested in any restricted stock, restricted stock units, options, or other equity grants awarded by the Company to Executive during the Term; and</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(v)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The COBRA continuation benefits set forth in <u>Section </u>4(c)(iv).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(vi)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Non-Duplication of Payment or Benefits</font>.&#160; If (A) Executive&#8217;s Qualified Termination occurs
        prior to a Change in Control that qualifies the Executive for severance payments and benefits under <u>Section </u>4(d) and (B) a Change in Control occurs within the six (6)-month period following the Executive&#8217;s Qualified Termination that
        qualifies the Executive for severance payments and benefits under <u>Section </u>4(c), then (1) the Executive will cease receiving any further payments or benefits under <u>Section </u>4(c) and (2) the Executive will receive the payments and
        benefits under <u>Section </u>4(d) instead but each of the payments and benefits otherwise payable under <u>Section </u>4(d) will be offset by the corresponding payments or benefits the Executive already received under <u>Section </u>4(c).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(e)</font>&#160;&#160;&#160;&#160; &#160;&#160; <u>Release; Exclusive Remedy; Resignation</u>.&#160; Executive&#8217;s right to receive the payments and benefits specified in <u>Section </u>4(a), <u>Section

        </u>4(b) and <u>Section </u>4(c) (collectively, the &#8220;Severance Benefits&#8221;) are subject to (i) Executive&#8217;s continued compliance with all restrictive covenant obligations with respect to the Company and its affiliates (including, without limitation,
        <u>Sections </u>5 and 6 hereof) and (ii) Executive (or Executive&#8217;s estate, as applicable) signing and delivering to the Company and not revoking a separation agreement and release of any claims against the Company, its affiliates, and their
        employees, officers, directors, and shareholders arising out of Executive&#8217;s employment or termination in a form reasonably acceptable to the Company that becomes effective and irrevocable within sixty (60) days following the Date of Termination
        (such agreement, the &#8220;Release&#8221; and such date the Release becomes effective and irrevocable, the &#8220;Release Effective Date&#8221;). The first payment of any Severance Benefits will include all amounts that otherwise would have been due prior thereto under
        the terms of this Agreement had such payments commenced immediately upon the Date of Termination. Any delay in the payment of the Severance Benefits will not extend the period of time that the Severance Benefits are payable pursuant to <u>Section
        </u>4. During such time that the Executive is receiving the Severance Benefits, if (A) the Company discovers grounds constituting Cause existed before the Executive&#8217;s termination or (B) Executive breaches any of the covenants set forth in <u>Sections

        </u>5 and 6, the Executive&#8217;s right to receive the Severance Benefits will immediately cease and be forfeited.&#160; Except as otherwise expressly required by law (e.g., COBRA) or as specifically provided in this Agreement, all of Executive&#8217;s rights to
        salary, severance, benefits, bonuses and other compensatory amounts hereunder (if any) shall cease upon the termination of Executive&#8217;s employment hereunder, and the amounts payable to Executive following termination pursuant to <u>Sections </u>3
        and 4 hereof will be in full and complete satisfaction of Executive&#8217;s rights under this Agreement and any other claims that Executive may have in respect of employment with the Company or any of its affiliates, and Executive acknowledges that such
        amount amounts are fair and reasonable and are Executive&#8217;s sole and exclusive remedy, in lieu of all other remedies at law or in equity, with respect to the termination of the Term or any breach of this Agreement by the Company. Upon any
        termination of the Term, Executive will promptly resign, and will be deemed to have automatically resigned, from all positions that Executive holds as a member of the Board, officer, director or fiduciary of the Company or any of its affiliates,
        and Executive will take all actions reasonably requested by the Company or its affiliates to give effect to the foregoing.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">7</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;"><font style="color: #010000;">5.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <u>Confidentiality; Intellectual Property</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>Confidentiality</u>. Executive recognizes and acknowledges that the continued success of the Company depends upon the use and protection of
        Confidential Information, which constitutes valuable trade secrets of the Company. Executive agrees to use the Confidential Information only during the Term in connection with the proper performance of Executive&#8217;s duties as an employee hereunder;
        otherwise, Executive shall not, directly or indirectly, use or disclose the Confidential Information for any other purpose or to any third party. The restrictions set forth herein are in addition to and not in lieu of any obligations Executive may
        have by law with respect to the Confidential Information, including any fiduciary duties or other obligations Executive may owe under any applicable trade secrets statutes or other state or federal laws.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>Intellectual Property</u>. Executive acknowledges and agrees that all inventions, know-how, trade secrets, technology, programming, software,
        processes, innovations, ideas, improvements, developments, methods, algorithms, designs, analyses, writings, audiovisual works, works of authorship, concepts, drawings, reports and all similar, related, or derivative information or works (whether
        or not patentable or subject to copyright), including but not limited to all resulting patent applications, issued patents, copyrights, copyright applications and registrations in and to any of the foregoing, along with the right to practice,
        employ, exploit, use, develop, reproduce, copy, distribute copies, publish, license, or create works derivative of any of the foregoing, and the right to choose not to do or permit any of the aforementioned actions, that are conceived, authored,
        reduced to practice, created, or otherwise developed by Executive during the Term (whether alone or jointly with others) (collectively, the &#8220;Work Product&#8221;) belong to the Company, and not Executive; provided that Work Product excludes, and this <u>Section

        </u>5(b) does not apply to an invention for which no equipment, supplies, facilities, or trade secret information of the Company or its affiliates (whether existing now or in the future) and which was developed entirely on Executive&#8217;s own time,
        unless (i) the invention relates (A) to the business of the Company or its affiliates (whether existing now or in the future), or (B) to the Company&#8217;s (or its affiliates&#8217; (whether existing now or in the future)) actual or demonstrably anticipated
        research or development, or (ii) the invention results from any work performed by Executive for the Company or its affiliates (whether existing now or in the future). Executive further acknowledges and agrees that to the extent relevant, this
        Agreement constitutes a &#8220;work for hire agreement&#8221; under the United States Copyright Act of 1976, as amended (&#8220;Copyright Act&#8221;), and that any copyrightable work (&#8220;Creation&#8221;) constitutes a &#8220;work made for hire&#8221; under the Copyright Act such that the
        Company is the copyright owner of the Creation. Executive hereby irrevocably assigns and agrees to assign to the Company all right, title and interest in and to all Work Product and, to the extent any Creation or portion thereof is not a &#8220;work for
        hire&#8221;, all Creations. Executive will promptly disclose and deliver such Work Product and Creations to the Company and, at the Company&#8217;s expense, perform all actions reasonably requested by the Company (whether during or after the Term to
        effectuate, establish, confirm, record or protect such ownership, or to protect or enforce the Company&#8217;s rights therein (including, without limitation, the execution of assignments, copyright registrations, consents, licenses, powers of attorney
        and other instruments).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Permitted Disclosures</u>. Nothing in this Agreement shall be construed to prevent disclosure of Confidential Information as may be required by
        applicable law or regulation, or pursuant to the valid order of a court of competent jurisdiction or an authorized government agency, provided that the disclosure does not exceed the extent of disclosure required by such law, regulation, or order,
        or in connection with an investigation by or report to any regulatory agency with jurisdiction over the Company, law enforcement, or any other federal or state regulatory or self-regulatory authority. In compliance with 18 U.S.C. &#167; 1833(b), as
        established by the Defend Trade Secrets Act of 2016, Executive is given notice of the following: (i) that an individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret
        that (A) is made (1) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney; and (2) solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a
        complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal; and (ii) that an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade
        secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual (A) files any document containing the trade secret under seal; and (B) does not disclose the trade secret, except pursuant to
        court order.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">8</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160; <u>Return of Property</u>. Upon separation from employment or earlier request from the Company, Executive shall return to the Company any and all
        Company property, including keys, access cards, identification cards, credit cards, business cards, laptop, smartphone, other electronic equipment, reports, files, manuals, Work Product, Creations, emails, recordings, thumb drives or other
        removable information storage devices, and data and all Company documents and materials belonging to the Company and stored in any fashion, including but not limited to those that constitute or contain any Confidential Information or Work Product,
        Creations, that are in the possession or control of the Executive, relating to Executive&#8217;s employment by the Company. Without limiting the foregoing or Executive&#8217;s obligations under <u>Section </u>5(a), upon separation from employment or earlier
        request from the Company, Executive shall not retain possession or control of any Confidential Information and shall instead return such Confidential Information to the Company or destroy it.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: #010000;">6.</font>&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160;&#160; <u>Restrictive Covenants</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(a)</font>&#160;&#160;&#160; &#160; &#160;&#160; <u>No Solicitation of Customers</u>. Executive agrees that, both during the Term and for the period ending on the date that is eighteen (18) months
        from the date of the termination of the Executive&#8217;s employment with the Company at any time and for any reason (the &#8220;Restricted Period&#8221;), Executive will not solicit any Restricted Business (as defined below) from any person or entity that is, or in
        the prior twelve (12) months was a customer of the Company or any of its affiliates or any prospective customer of the Company or any of its affiliates with respect to which the Company or its affiliates actively solicits or has solicited the sale
        of Company products and services. For purposes of this Agreement, &#8220;Restricted Business&#8221; shall mean the business of manufacturing, marketing and selling renewable fuels (including, but not limited to, renewable diesel fuel and sustainable aviation
        fuel (SAF)) and constructing, acquiring, investing in and/or operation facilities for the production of renewable fuels (including, but not limited to, renewable diesel fuel and sustainable aviation fuel (SAF)). Notwithstanding the foregoing,
        Executive shall not be prohibited from the passive ownership of up to two percent (2%) of the securities of any entity engaged in any Restricted Business, where the securities of such entity are traded on a national securities exchange.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(b)</font>&#160;&#160; &#160; &#160;&#160;&#160; <u>No Solicitation of Employees</u>. Executive agrees that during the Restricted Period, Executive will not, directly or indirectly, on behalf of
        himself or any other person or entity, hire, solicit, take away or attempt to hire, solicit or take away any person who is (or in the preceding six months was), at the time of such solicitation, an employee, director or independent contractor of
        the Company or any of its affiliates, either on behalf of himself or any other person or entity. This includes, but is not limited to, inducing or attempting to induce, or influencing or attempting to influence, any person employed by the Company
        or its affiliates to terminate his or her employment with the Company or any such affiliate.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">9</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Importance of Executive&#8217;s Services; Intent of the Parties; Enforcement</u>. Executive acknowledges and agrees that the services to be provided by
        Executive under this Agreement are of a special, unique and extraordinary nature. Executive further acknowledges and agrees that the covenants and restrictions contained in <u>Section </u>5 and <u>Section </u>6 are necessary to prevent the use
        and disclosure of Confidential Information and to protect other legitimate business interests of the Company and its affiliates. Executive acknowledges that all of the covenants and restrictions in <u>Section </u>5 and <u>Section </u>6 are
        reasonable in all respects, including duration, territory and scope of activity. Executive acknowledges and agrees that the Company competes with businesses on a world-wide basis and that the geographic restrictions contained herein are therefore
        reasonable and necessary to protect the Company&#8217;s legitimate business interests. Executive agrees that the covenants and restrictions contained in <u>Section </u>5 and <u>Section </u>6 shall be construed as separate agreements independent of
        any other provision of this Agreement or any other agreement between Executive and the Company. Executive agrees that the existence of any claim or cause of action by Executive against the Company or its affiliates, whether predicated on this
        Agreement or otherwise, shall not constitute a defense to the enforcement by the Company of the covenants and restrictions in <u>Section </u>5 and <u>Section </u>6. Executive agrees that the restrictive covenants contained in <u>Section </u>5
        and <u>Section </u>6 are a material part of Executive&#8217;s obligations under this Agreement for which the Company has agreed to compensate the Executive as provided in this Agreement. The Executive agrees that the injury the Company will suffer in
        the event of the breach by Executive of any clause of <u>Section </u>5 and <u>Section </u>6 will cause the Company and its affiliates irreparable injury that cannot be adequately compensated by monetary damages alone. Therefore, Executive
        agrees that the Company, without limiting any other legal or equitable remedies available to it, shall be entitled to obtain equitable relief by injunction or otherwise from any court of competent jurisdiction, including, without limitation,
        injunctive relief to prevent Executives&#8217; failure to comply with the terms and conditions of <u>Section </u>5 and <u>Section </u>6. The time year periods referenced in <u>Section </u>5 and <u>Section </u>6 shall be extended on a day-for-day
        basis for each day during which Executive violates the provisions of <u>Section </u>5 and <u>Section </u>6 in any respect, so that Executive is restricted from engaging in the activities prohibited by <u>Section </u>5 and <u>Section </u>6
        for the full time period, as applicable.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Whistleblower Protection</u>.&#160; Notwithstanding anything to the contrary contained herein, no provision of this Agreement or any other agreement
        or Company policy will be interpreted so as to impede Executive (or any other individual) from (i) making any disclosure of relevant and necessary information or documents in any action, investigation, or proceeding relating to this Agreement, or
        as required by law or legal process, including with respect to possible violations of law, (ii) participating, cooperating, or testifying in any action, investigation, or proceeding with, or providing information to, any governmental agency,
        legislative body or any self-regulatory organization, including, but not limited to, the Department of Justice, the Securities and Exchange Commission, the Congress, and any agency Inspector General, (iii) seeking or accepting any U.S. Securities
        and Exchange Commission awards or other relief in connection with protected whistleblower activity, or (iv) making other disclosures under the whistleblower provisions of federal law or regulation. In addition, nothing in this Agreement or any
        other agreement or Company policy prohibits or restricts Executive from initiating communications with, or responding to any inquiry from, any administrative, governmental, regulatory or supervisory authority regarding any good faith concerns about
        possible violations of law or regulation. Executive does not need the prior authorization of the Company to make any such reports or disclosures and the Executive will not be required to notify the Company that such reports or disclosures have been
        made.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: #010000;">7.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Other Agreements</u>. Executive represents and agrees that Executive&#8217;s performance of Executive&#8217;s duties for the Company shall not violate any agreements,
        obligations or understandings that Executive may have with any third party or prior employer. Without limiting the foregoing, Executive represents and agrees that Executive is not bound by any non-compete or non-solicitation agreement or any other
        type of agreement that would prohibit Executive&#8217;s employment with the Company. Executive agrees not to make any unauthorized disclosure or use, on behalf of the Company, of any confidential information belonging to any of Executive&#8217;s former
        employers. Executive also represents that Executive is not in unauthorized possession of any materials containing a third party&#8217;s confidential and proprietary information.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: #010000;">8.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>Cooperation with Company</u>. During Executive&#8217;s employment by the Company and thereafter, Executive will cooperate with the Company and its affiliates in any
        internal investigation or administrative, regulatory or judicial proceeding that relates to events occurring during Executive&#8217;s employment hereunder and as reasonably requested by the Company (including being available upon reasonable notice from
        the Company for interviews and factual investigations and appearing at the Company&#8217;s request to give testimony without requiring service of a subpoena or other legal process, all at times and on schedules that are reasonably consistent with
        Executive&#8217;s other permitted activities and commitments). In the event the Company requires Executive&#8217;s cooperation in accordance with this <u>Section </u>8 following the termination of Executive&#8217;s employment, the Company (or its applicable
        affiliate) will reimburse Executive for reasonable expenses incurred by Executive in connection therewith.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">10</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;"><font style="color: #010000;">9.</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160; <u>Tax Provisions</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>Withholding</u>. All amounts payable to Executive under this Agreement will be subject to all required tax and other designated or required
        withholdings and deductions. In the event that the Company fails to withhold any taxes required to be withheld by applicable law or regulation, Executive agrees to indemnify the Company for any taxes of Executive that should have been withheld.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Section 280G</u>. To the extent that any amount payable to Executive hereunder, as well as any other &#8220;parachute payment&#8221; as such term is defined
        under Section 280G (collectively with the regulations promulgated thereunder, &#8220;Section 280G&#8221;) of the Code, payable to Executive ( the &#8220;Covered Payments&#8221;), exceeds the limitations&#160; of Section 280G such that an excise tax will be imposed under
        Section 4999 of the Code (the &#8220;Excise Tax&#8221;), then, before making the Covered Payments, a calculation will be made comparing (i) the Net Benefit (as defined below) to Executive of the Covered Payments after payment of the Excise Tax to (ii) the Net
        Benefit to Executive if the Covered Payments are limited to the extent necessary to avoid being subject to the Excise Tax. Only if the amount calculated under (i) above is less than the amount under (ii) above will the Covered Payments be reduced
        to the minimum extent necessary to ensure that no portion of the Covered Payments is subject to the Excise Tax. &#8220;Net Benefit&#8221; will mean the present value of the Covered Payments net of all federal, state, local, foreign income, employment and
        excise taxes. Any such reduction will be made by the Company in its sole discretion consistent with the requirements of Section 409A of the Code. If two economically equivalent amounts are subject to reduction but are payable at different times,
        the amounts will be reduced (but not below zero) on a pro rata basis. Notwithstanding the foregoing, the Board (or a committee of the Board composed entirely of independent directors) may, in its sole discretion and on a case-by-case basis, approve
        a gross-up payment (a &#8220;Limited Gross-Up&#8221;) to Executive in an amount sufficient to place Executive in the same after-tax position as if no Excise Tax had been imposed, but only to the extent the Excise Tax results from a reduced base amount due to
        (i) a limited period of service with the Company prior to the Change in Control, or (ii) other structural features not attributable to Executive&#8217;s actions or compensation demands. Any such Limited Gross-Up shall be subject to compliance with
        Section 409A of the Code, and may be conditioned upon Executive providing reasonable cooperation with tax planning or mitigation strategies.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(c)</font>&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Section 409A</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;To the extent required by Section 409A of the Code, all references to &#8220;termination of employment&#8221; and correlative phrases for
        purposes of this Agreement shall be construed to require a &#8220;separation from service&#8221; (as defined in Section 1.409A-1(h) of the Treasury regulations after giving effect to the presumptions contained therein).</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">11</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160; Notwithstanding any provision in this Agreement to the contrary, to the extent that (i) any payments or benefits to which
        Executive becomes entitled under this Agreement or any other agreement, policy, plan, program or arrangement with the Company, in connection with Executive&#8217;s termination of employment with the Company constitute &#8220;nonqualified deferred compensation&#8221;
        subject to Section 409A of the Code and (ii) Executive is deemed at the time of such termination of employment to be a &#8220;specified employee&#8221; under Section 409A of the Code, then such payments or benefits shall not be made or commence until the
        earliest of (1) the expiration of the six (6) month and one day period measured from the date of Executive&#8217;s separation from service (as defined in <u>Section </u>9(c)(i) above) from the Company or (2) the date of Executive&#8217;s death following such
        separation from service; provided, however, that such deferral shall only be effected to the extent required to avoid adverse tax treatment to Executive, including (without limitation) the additional twenty-percent (20%) tax for which Executive
        would otherwise be liable under Section 409A(a)(1)(b) of the Code in absence of such deferral. Upon the expiration of the applicable deferral period, any payments which would have otherwise been made during that period (whether in a single sum or
        in installments) in the absence of this <u>Section </u>9(b) shall be paid to Executive or Executive&#8217;s beneficiary in one lump sum. For purposes of this <u>Section </u>9(b), the term &#8220;specified employee&#8221; means an individual determined by the
        Company to be a specified employee under Treasury regulation Section 1.409A-1(i) in accordance with the policies of the Company.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(iii)</font>&#160; &#160; &#160;&#160; It is intended that each installment of any benefits or payments provided hereunder constitute a separate payment for purposes of
        Treasury Regulation Section 1.409A-2(b)(2)(i). The Company and Executive intend that all the benefits and payments provided under this Agreement shall be exempt from, or comply with, the requirements of Section 409A of the Code and the provisions
        of the Agreement shall be read in accordance with that intent. It is further intended that payments hereunder satisfy, to the greatest extent possible, the exemptions from the application of Section 409A of the Code (and any state law of similar
        effect) provided under Treasury Regulations Section 1.409A-1(b)(4) (as a &#8220;short-term deferral&#8221;) and Section 1.409A-1(b)(9) (as &#8220;separation pay due to involuntary separation&#8221;). To the extent that any provision hereof is modified in order to comply
        with Section 409A, such modification will be made in good faith and will, to the maximum extent reasonably possible, maintain the original intent and economic benefit to Executive and the Company of the applicable provision without violating the
        provisions of Section 409A. The Company makes no representation or warranty and shall have no liability to Executive or any other person if any provisions of this Agreement are determined to constitute deferred compensation subject to Section 409A
        of the Code but do not satisfy an exemption from, or comply with the conditions of, such Section.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(iv)</font>&#160;&#160;&#160;&#160;&#160; Except as otherwise expressly provided herein, to the extent any expense reimbursement or the provision of any in-kind benefit
        under this Agreement is determined to constitute &#8220;nonqualified deferred compensation&#8221; subject to Section 409A of the Code, the amount of any such expenses eligible for reimbursement, or the provision of any in-kind benefit, in one calendar year
        shall not affect the expenses eligible for reimbursement in any other taxable year (except for any lifetime or other aggregate limitation applicable to medical expenses), in no event shall any expenses be reimbursed after the last day of the
        calendar year following the calendar year in which Executive incurred such expenses, and in no event shall any right to reimbursement or the provision of any in-kind benefit be subject to liquidation or exchange for another benefit.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(v)</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160; Whenever a payment under this Agreement specifies a payment period with reference to a number of days, the actual date of payment
        within the specified period is within the sole discretion of the Company.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(vi)</font>&#160;&#160;&#160;&#160;&#160; Notwithstanding any provision in this Agreement to the contrary, to the extent that any payments or benefits to which Executive
        becomes entitled under this Agreement or any other agreement, policy, plan, program or arrangement with the Company, in connection with Executive&#8217;s termination of employment with the Company constitute &#8220;nonqualified deferred compensation&#8221; subject
        to Section 409A of the Code, then each such payment which is conditioned upon Executive&#8217;s execution of a release and which is to be paid or provided during a designated period that begins in one taxable year and ends in a second taxable year shall
        be paid or provided in the later of the two taxable years.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">12</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;"><font style="color: #010000;">10.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Certain Definitions</u>. As used in this Agreement, the following terms shall have the following meanings:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Cause</u>. &#8220;Cause&#8221; means any of the following: (i) Executive&#8217;s commission of an act of fraud, embezzlement or dishonesty, or the commission of
        some other illegal act by Executive, that could reasonably be expected to have an adverse impact on the Company or any successor or affiliate; (ii) Executive&#8217;s conviction of, or plea of &#8220;guilty&#8221; or &#8220;no contest&#8221; to, a felony or any crime involving
        fraud, dishonesty or moral turpitude under the laws of the United States or any state thereof (or international equivalent); (iii) any intentional, unauthorized use or disclosure by Executive of Confidential Information or trade secrets of the
        Company or any successor or affiliate; (iv) Executive&#8217;s gross negligence or material violation of any duty of loyalty to the Company or any successor or affiliate thereof, or any other demonstrable material misconduct on Executive&#8217;s part in
        connection with the performance of Executive&#8217;s duties for the Company; (v) Executive&#8217;s ongoing and repeated failure or refusal to perform or neglect of Executive&#8217;s duties as required by this Agreement or Executive&#8217;s ongoing and repeated failure or
        refusal to comply with the instructions given to Executive by the Board, which failure, refusal or neglect continues for fifteen (15) days following Executive&#8217;s receipt of written notice from the Board stating with specificity the nature of such
        failure, refusal or neglect; or (vi) Executive&#8217;s material breach of any material Company policy or any material provision of this Agreement, which breach is not cured (if capable of being cured) within fifteen (15) days following Executive&#8217;s
        receipt of written notice from the Board stating with specificity the nature of such material breach; provided, that the foregoing cure right shall not apply to any breach by Executive of <u>Section </u>5 or <u>Section </u>6 hereof.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Change in Control</u>. &#8220;Change in Control&#8221; shall have the meaning set forth in the 2025 XCF Global, Inc. Equity Incentive Plan. For purposes of
        clarity, consummation of (i) the transactions contemplated in the BCA or (ii) the New Rise Acquisitions (as defined in the BCA) shall not constitute a Change in Control.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Code</u>. &#8220;Code&#8221; shall mean the Internal Revenue Code of 1986, as amended, and the regulations and guidance promulgated thereunder.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Confidential Information</u>. &#8220;Confidential Information&#8221; means the Company&#8217;s trade secrets as defined under applicable law, as well as any other
        information or material which is not generally known to the public, and which: (i) is generated, collected by or utilized in the operations of the Company&#8217;s business and relates to the actual or anticipated business of the Company; or (ii) results
        from any task assigned to Executive by the Company, or work performed by Executive for or on behalf of the Company. Confidential Information shall not be considered generally known to the public if Executive or others improperly reveal such
        information to the public without the Company&#8217;s express written consent and/or in violation of an obligation of confidentiality owed to the Company. Confidential Information includes, without limitation, the information, observations and data
        obtained by Executive while employed by the Company concerning the business or affairs of the Company, including without limitation: information concerning investment or acquisition opportunities in or reasonably related to the Company; the
        identities of and other information (such as databases) relating to the current, former or prospective employees, customers, or investors of the Company; development, transition and transformation plans; methodologies and methods of doing business;
        strategic, marketing and expansion plans; financial and business plans, financial data; pricing information; employee, customer, or vendor lists and telephone numbers; investment terms; and requirements and costs of providing service. Confidential
        Information also includes information that the Company receives from third parties subject to a duty to maintain the confidentiality of such information and to use it only for certain limited purposes.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Date of Termination</u>. &#8220;Date of Termination&#8221; shall mean (i) if Executive&#8217;s employment is terminated by Executive&#8217;s death, the date of
        Executive&#8217;s death or (ii) if Executive&#8217;s employment is terminated pursuant to <u>Section </u>3(a)(ii) &#8211; (iv) either the date indicated in the Notice of Termination or the date specified by the Company pursuant to <u>Section </u>3(b), whichever
        is earlier.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">13</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Disability</u>. &#8220;Disability&#8221; shall mean, at any time the Company or any of its affiliates sponsors a long-term disability plan for the Company&#8217;s
        employees, &#8220;disability&#8221; as defined in such long-term disability plan for the purpose of determining a participant&#8217;s eligibility for benefits;&#160; provided, however, if the long-term disability plan contains multiple definitions of disability,
        &#8220;Disability&#8221; shall refer to that definition of disability which, if Executive qualified for such disability benefits, would provide coverage for the longest period of time. The determination of whether Executive has a Disability shall be made by
        the person or persons required to make disability determinations under the long-term disability plan. At any time the Company does not sponsor a long-term disability plan for its employees, &#8220;Disability&#8221; shall mean Executive&#8217;s inability to perform,
        with or without reasonable accommodation, the essential functions of Executive&#8217;s positions hereunder for a total of three months during any six-month period as a result of incapacity due to mental or physical illness as determined by the Board in
        its sole good faith discretion.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(g)</font>&#160; &#160; &#160;&#160; <u>Good Reason</u>. &#8220;Good Reason&#8221; means any of the following without Executive&#8217;s written consent: (i) a material diminution in Executive&#8217;s authority,
        duties or responsibilities; (ii) a material diminution in Executive&#8217;s base salary or target Annual Bonus (and Executive and the Company agree that any diminution of 10% or more shall be considered material for this purpose, regardless of whether
        such diminution occurs due to a single reduction or a series of reductions), other than in connection with an across-the-board reduction which applies in a comparable manner to other senior officers of the Company; (iii) any change in the Company&#8217;s
        remote work policy that would require Executive to be physically present in one of the Company&#8217;s offices more than 20 days each month, and (iv) the Company&#8217;s breach of a material provision of this Agreement. Notwithstanding the foregoing, no Good
        Reason will have occurred unless and until Executive has (A) provided the Company, within thirty (30) days of Executive&#8217;s knowledge of the occurrence of the facts and circumstances underlying the Good Reason event, written notice stating with
        specificity the applicable facts and circumstances underlying such finding of Good Reason, (B) provided the Company with an opportunity to cure the same within thirty (30) days after the receipt of such notice and (C) the Company shall have failed
        to so cure within such period. Executive&#8217;s termination of employment by reason of resignation from employment with the Company for Good Reason must occur within 30 days following the expiration of the foregoing 30-day cure period.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: #010000;">11.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Miscellaneous Provisions</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Contractor Period Payment</u>. The parties understand that the existing employment agreement between the Executive and XCF Global Capital, Inc.
        provides that the Executive is to be paid, at the Closing of the Business Combination the amount specified in such employment agreement for services the Executive provided to XCF Global Capital, Inc. as an independent contractor for the period
        January 1, 2024 until the date of execution of such employment agreement (the &#8220;Contractor Period Payment&#8221;).&#160; The parties further acknowledge and agree that upon Closing of the Business Combination, the Company shall (i) assume the obligation to
        make the Contractor Period Payment and shall make such payment in cash no later than September 30, 2025, unless the Company and Executive mutually agree in writing, on or before such date, to extend the payment deadline to no later than December
        31, 2025 due to the Company&#8217;s reasonable cash constraints. Any such extension shall not modify the Company&#8217;s obligation to make full payment nor be deemed a waiver of Executive&#8217;s rights. In addition, within 30 days after the Closing of the Business
        Combination, the Company shall issue to Executive a grant of restricted shares of the Company&#8217;s Class A Common Stock under the Company&#8217;s 2025 Equity Incentive Plan in aggregate value equal to the obligation assumed by the Company for the Contractor
        Period Payment. This grant shall be separate from, and not in lieu of, the Contractor Period Payment and be calculated based on the 20 day volume-weighted average price for the Company&#8217;s Class A Common Stock following the Closing of the Business
        Combination. The restricted shares shall vest ratably on a monthly basis over a period of three (3) years and shall be subject to the terms and conditions of the Company&#8217;s 2025 Equity Incentive Plan and the applicable award agreement.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">14</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Governing Law</u>. This Agreement shall be governed, construed, interpreted and enforced in accordance with its express terms, and otherwise in
        accordance with the substantive laws of the State of Delaware without reference to the principles of conflicts of law of the State of Delaware or any other jurisdiction that would result in the application of the laws of a jurisdiction other than
        the State of Delaware, and where applicable, the laws of the United States.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>Arbitration</u>. Any dispute, controversy, or claim arising out of or relating to this Agreement or any breach of this Agreement or Executive&#8217;s
        employment, whether the claim arises in contract, tort, or statute, shall be submitted to and decided by binding arbitration, except as set forth in <u>Section </u>6(c). Arbitration shall be administered exclusively by the American Arbitration
        Association at a location in Wilmington, Delaware and shall be conducted consistent with the employment arbitration rules, regulations, and requirements thereof as well as any requirements imposed by state law. Any arbitral award determination
        shall be final and binding upon the Parties, and judgment may be entered thereon in any court of competent jurisdiction. Notwithstanding anything to the contrary, this Agreement does not prevent Executive from filing a complaint or charge with the
        National Relations Labor Board, the Equal Employment Opportunity Commission, or any similar federal or state administrative agency, including claims for workers&#8217; compensation or unemployment insurance benefits. By entering into this Agreement, the
        Parties are waiving all rights to have their disputes heard or decided by a jury or in a court trial and the right to pursue any class or representative claims against each other in court, arbitration, or any other proceeding. The arbitrator shall
        have no jurisdiction or authority to compel any class or collective claim, or to consolidate different arbitration proceedings with or join any other party to an arbitration between the Parties. The arbitrator, and not any court, shall have
        exclusive authority to resolve any dispute relating to the enforceability or formation of this Agreement and the arbitrability of dispute between the parties, except for any dispute relating to the enforceability or scope of the class and
        collective action waiver, which shall be determined by a court of competent jurisdiction. THE PARTIES FULLY UNDERSTAND AND AGREE THAT THEY ARE GIVING UP CERTAIN RIGHTS OTHERWISE AFFORDED TO THEM BY CIVIL COURT ACTIONS, INCLUDING BUT NOT LIMITED TO
        THE RIGHT TO A JURY OR COURT TRIAL AND THE RIGHT TO BRING ANY CLAIM AS A CLASS OR COLLECTIVE ACTION. Costs of arbitration shall be split evenly between the parties, provided, that the arbitrator shall have the ability to award attorneys&#8217; fees and
        previously paid arbitration expenses to the prevailing party.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Venue; Waiver of Jury Trial</u>.&#160; Except for claims subject to the arbitration provisions herein, the Parties agree that all litigation arising
        out of or relating to this agreement must be brought exclusively in any state or federal court located in Wilmington, Delaware (collectively the &#8220;Designated Courts&#8221;). Each Party consents and submits to the exclusive jurisdiction of the Designated
        Courts with respect to litigation under this Agreement, each Party hereby irrevocably waives all claims or defenses of lack of personal jurisdiction or any other jurisdiction defense, and any objection which such Party may now or hereafter have to
        the laying of venue of any suit, action or proceeding in any Designated Court, including any right to object on the basis that any dispute, action, suit, or proceeding brought in the Designated Courts has been brought in an improper or inconvenient
        forum or venue.&#160; IN THE EVENT OF LITIGATION HEREUNDER, THE COMPANY AND EXECUTIVE EACH WAIVE THEIR RESPECTIVE RIGHT TO A TRIAL BY JURY OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF OR RELATED TO ANY ACTION, PROCEEDING, OR OTHER
        LITIGATION OF ANY TYPE BROUGHT BY ANY OF THE PARTIES AGAINST ANY OTHER PARTY OR ANY AFFILIATE OF ANY OTHER SUCH PARTY. THE COMPANY AND EXECUTIVE EACH AGREE THAT ANY SUCH CLAIM OR CAUSE OF ACTION WILL BE TRIED BY A COURT TRIAL WITHOUT A JURY.
        WITHOUT LIMITING THE FOREGOING, THE PARTIES FURTHER AGREE THAT THEIR RESPECTIVE RIGHT TO A TRIAL BY JURY IS WAIVED BY OPERATION OF THIS SECTION AS TO ANY ACTION, COUNTERCLAIM, OR OTHER PROCEEDING WHICH SEEKS, IN WHOLE OR IN PART, TO CHALLENGE THE
        VALIDITY OR ENFORCEABILITY OF THIS AGREEMENT. THIS WAIVER WILL APPLY TO ANY SUBSEQUENT AMENDMENTS, RENEWALS, SUPPLEMENTS, OR MODIFICATIONS TO THIS AGREEMENT.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">15</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Validity; Severability</u>. Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid
        under applicable law, but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability will not affect any
        other provision or any action in any other jurisdiction, but this Agreement will be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had never been contained herein.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(f)</font>&#160;&#160;&#160;&#160;&#160; &#160; <u>Notices</u>. Any notice, request, claim, demand, document and other communication hereunder to any Party shall be effective upon receipt (or
        refusal of receipt) and shall be in writing and delivered personally or sent by facsimile or certified or registered mail, postage prepaid, (i) if to the Company, to the Chief Executive Officer of the Company at the Company&#8217;s headquarters, (ii) if
        to Executive, to the last address that the Company has in its personnel records for Executive, or (iii) at any other address as any Party shall have specified by notice in writing to the other Party.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Counterparts</u>. This Agreement may be executed in several counterparts, each of which shall be deemed to be an original, but all of which
        together will constitute one and the same Agreement. Signatures delivered by facsimile or .pdf format shall be deemed effective for all purposes.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(h)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Entire Agreement</u>. The terms of this Agreement are intended by the Parties to be the final expression of their agreement with respect to the
        subject matter hereof and supersede all prior understandings and agreements, whether written or oral, including any prior employment offer letter, employment agreement or consulting agreement between Executive and the Company. The Parties further
        intend that this Agreement shall constitute the complete and exclusive statement of their terms and that no extrinsic evidence whatsoever may be introduced in any judicial, administrative, or other legal proceeding to vary the terms of this
        Agreement.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Amendments; Waivers</u>. This Agreement may not be modified, amended, or terminated except by an instrument in writing, signed by Executive and
        a duly authorized officer of Company. By an instrument in writing similarly executed, Executive or a duly authorized officer of the Company may waive compliance by the other Party with any specifically identified provision of this Agreement that
        such other Party was or is obligated to comply with or perform; provided, however, that such waiver shall not operate as a waiver of, or estoppel with respect to, any other or subsequent failure. No failure to exercise and no delay in exercising
        any right, remedy, or power hereunder will preclude any other or further exercise of any other right, remedy, or power provided herein or by law or in equity.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(j)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Successors and Assigns</u>. The Company may assign its rights and obligations under this Agreement to any of its affiliates or to any successor
        to all or substantially all of the business or the assets of the Company (by merger or otherwise, including, without limitation, to the surviving entity in the Business Combination), and may assign or encumber this Agreement and its rights
        hereunder as security for indebtedness of the Company and its affiliates. This Agreement shall be binding upon and inure to the benefit of the Company, Executive and their respective successors, assigns, personnel and legal representatives,
        executors, administrators, heirs, distributees, devisees, and legatees, as applicable. None of Executive&#8217;s rights or obligations may be assigned or transferred by Executive, other than Executive&#8217;s rights to payments hereunder, which may be
        transferred only by will or operation of law. Notwithstanding the foregoing, Executive shall be entitled, to the extent permitted under applicable law and applicable Company Arrangements, to select and change a beneficiary or beneficiaries to
        receive compensation hereunder following Executive&#8217;s death by giving written notice thereof to the Company.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(k)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Indemnification</u>. The Company and Executive shall enter into a Director and Officer Indemnification Agreement substantially in the form of <u>Exhibit

          B</u> attached hereto.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">16</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(l)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>D&amp;O Insurance</u>. The Company will cover Executive under directors&#8217; and officers&#8217; liability insurance policy (or policies) during the Term
        and thereafter to the same extent as the Company covers its other current or former directors or officers of the Company.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(m)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Clawback</u>. Notwithstanding any other provisions in this Agreement to the contrary, any incentive-based or other compensation paid to the
        Executive under this Agreement or any other agreement or arrangement with the Company that is subject to recovery under any applicable law, government regulation, or stock exchange rule or listing requirement will be subject to such deductions and
        clawback as may be required or permitted to be made pursuant to such law, government regulation, or stock exchange rule or listing requirement or any policy adopted by the Company.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(n)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Construction</u>. This Agreement shall be deemed drafted equally by both the Parties. Its language shall be construed as a whole and according to
        its fair meaning. Any presumption or principle that the language is to be construed against any Party shall not apply. The headings in this Agreement are only for convenience and are not intended to affect construction or interpretation. Any
        references to paragraphs, subparagraphs, sections or subsections are to those parts of this Agreement, unless the context clearly indicates to the contrary. Also, unless the context clearly indicates to the contrary, (i) the plural includes the
        singular and the singular includes the plural, (ii) &#8220;and&#8221; and &#8220;or&#8221; are each used both conjunctively and disjunctively, (iii) &#8220;any,&#8221; &#8220;all,&#8221; &#8220;each,&#8221; or &#8220;every&#8221; means &#8220;any and all,&#8221; and &#8220;each and every,&#8221; (iv) &#8220;includes&#8221; and &#8220;including&#8221; are each
        &#8220;without limitation,&#8221; (v) &#8220;herein,&#8221; &#8220;hereof,&#8221; &#8220;hereunder&#8221; and other similar compounds of the word &#8220;here&#8221; refer to the entire Agreement and not to any particular paragraph, subparagraph, section or subsection and (vi) all pronouns and any variations
        thereof shall be deemed to refer to the masculine, feminine, neuter, singular or plural as the identity of the entities or persons referred to may require.</div>
      <div>&#160;</div>
      <div style="text-align: center;">[SIGNATURE PAGE FOLLOWS]</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">17</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold;">IN WITNESS WHEREOF</font>, the Parties hereto have executed this Agreement as of the date first written above. The signatories below represent that they are duly
        authorized to enter into this Agreement.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="z86f80620cc0e4d41ad1950bf415bac20" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top;" rowspan="1" colspan="1"><br>
            </td>
            <td style="vertical-align: top;" rowspan="1" colspan="2">
              <div style="font-weight: bold;">XCF GLOBAL, INC.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;" rowspan="1" colspan="1"><br>
            </td>
            <td style="vertical-align: top;" rowspan="1" colspan="2"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;" colspan="1"><br>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div>By:</div>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div><u>/s/ Mihir Dange</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;" colspan="1"><br>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div>Name:</div>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div>Mihir Dange</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;" colspan="1"><br>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div>Title:</div>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div>Chief Executive Officer</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;" rowspan="1" colspan="1"><br>
            </td>
            <td style="vertical-align: top;" rowspan="1" colspan="2"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;" rowspan="1" colspan="1"><br>
            </td>
            <td style="vertical-align: top;" rowspan="1" colspan="2">
              <div style="font-weight: bold;">EXECUTIVE</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;" rowspan="1" colspan="1"><br>
            </td>
            <td style="vertical-align: top;" rowspan="1" colspan="2"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;" colspan="1"><br>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div>By:</div>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div><u>/s/ Gregory P. Savarese</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;" colspan="1"><br>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div>Name:</div>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div>Gregory P. Savarese</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">18</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;">Exhibit A</div>
      <div>&#160;</div>
      <div>Mr. Savarese has an existing business commitment for The Ricci Group Limited and its subsidiaries (a business that he founded); the Ricci Group is a Hong Kong-based holding company with investments across the coffee value chain in Mainland
        China. This includes oversight and strategic involvement over the Group&#8217;s coffee brands and subsidiaries.</div>
      <div>&#160;</div>
      <div>Current board roles:</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z0db85841155143ba8063717f7f8b230c" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div>The Ricci Group Limited and subsidiaries</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z8c48da91294e4746bae44a6a2e9d8cad" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div>SinoTaste Technology (Shanghai) Co., Ltd.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;">Exhibit B</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">Compensation Terms</div>
      <div>&#160;</div>
      <div style="text-align: center;">(attached)</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">Executive is solely responsible for any tax liability incurred as a result of any benefit set forth in this table being treated as a taxable benefit under federal, state or local law.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;">Gregory Savarese</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">Exhibit B &#8211; Compensation Terms</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="zea1a6068c5174559908aba73c9b80055" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>Base Salary</div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div>$300,000, Three Hundred Thousand Dollars; $380,000 upon repatriation back to US</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>Annual Bonus</div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>Target Bonus set at 100-200% of Base Salary</div>
              <div>If &lt;50% of key evaluation metrics achieved, Annual Bonus is 0% </div>
              <div>(in each case, pro-rated for partial year) </div>
              <div>&#160;</div>
              <div>Key evaluation metrics (subject to adjustment each year):</div>
              <div style="text-indent: -18pt; margin-left: 18pt;">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;25% discretionary established by the Board</div>
              <div style="text-indent: -18pt; margin-left: 18pt;">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;25% Individual performance metrics to be set by the Board</div>
              <div style="text-indent: -18pt; margin-left: 18pt;">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;50% Transaction success fee (de-SPAC/IPO) (first year only)</div>
              <div>&#160;</div>
              <div>Opportunity to elect cash or stock for bonus payment, subject to limits set by Board or Compensation Committee</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>Management Equity</div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>335,000 RSUs of common stock issued at closing of de-SPAC IPO</div>
              <div>&#160;</div>
              <div>Vesting Period: Three years monthly from start date, accelerated on termination without cause following a change-in-control</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>2025 Equity Incentive Plan Participation</div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>Executive eligible to receive additional equity compensation pursuant to the Company&#8217;s 2025 Equity Incentive Plan</div>
              <div>&#160;</div>
              <div>Target 300-600% of Base Salary with an initial grant of 90,000 shares; vesting period over three years (no vesting during the first six months (the &#8220;cliff period&#8221;)). After the six-month cliff period, the restricted stock units will vest
                in equal monthly installments over 30 months, subject to continued service with New XCF)</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>Contractor Period Payment</div>
              <div>&#160;</div>
              <div>Gregory Savarese</div>
              <div>(Cornell Management Group LLC)</div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>$337,500 payment in cash no later than September 30, 2025, unless the Company and Executive mutually agree in writing, on or before such date, to extend the payment deadline to no later than December 31, 2025</div>
              <div>&#160;</div>
              <div>$337,500 in restricted shares of the Company&#8217;s Class A Common Stock under the Company&#8217;s 2025 Equity Incentive Plan. Calculated based on the 20 day volume-weighted average price for the Company&#8217;s Class A Common Stock following the Closing
                of the Business Combination. The restricted shares shall vest ratably on a monthly basis over a period of three (3) years and shall be subject to the terms and conditions of the Company&#8217;s 2025 Equity Incentive Plan and the applicable award
                agreement</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>Benefits:</div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: -18pt; margin-left: 36pt;">&#8226;&#160;&#160;&#160;&#160;&#160; Health/Group insurance</div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>Minimum 80% of premiums paid by Company</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="zbe39e7d706204173b16d62ab64e41c33" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: -18pt; margin-left: 36pt;">&#8226;&#160;&#160;&#160;&#160;&#160; Life insurance</div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>Up to 2x Base Salary, not to exceed $1 million; Employee may elect to add additional coverage at their own expense</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: -18pt; margin-left: 36pt;">&#8226;&#160;&#160;&#160;&#160;&#160; Phone subsidy</div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>Based on actual and reasonable phone bill incurred each month, with invoice</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: -18pt; margin-left: 36pt;">&#8226;&#160;&#160;&#160;&#160;&#160; Fitness and wellness subsidy</div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>$3,500 per year, based on actual amount incurred with invoice</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: -18pt; margin-left: 36pt;">&#8226;&#160;&#160;&#160;&#160;&#160; Retirement benefits (401(k) or other retirement plan as established by the Company)</div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>3% automatic match; 100% match on first 3% EE contributions</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: -18pt; margin-left: 36pt;">&#8226;&#160;&#160;&#160;&#160;&#160; Car allowance</div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>$1,500 per month or $18,000 per year</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: -18pt; margin-left: 36pt;">&#8226;&#160;&#160;&#160;&#160;&#160; Tax and estate planning</div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>Based on actual expenses incurred</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: -18pt; margin-left: 36pt;">&#8226;&#160;&#160;&#160;&#160;&#160; Relocation benefits (if at the Company&#8217;s request)</div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div>Based on actual expenses incurred and will cover:</div>
              <div style="text-indent: -18pt; margin-left: 36pt;">1.&#160;&#160;&#160;&#160;&#160; One-way flight costs for employee, spousal equivalent and dependents</div>
              <div style="text-indent: -18pt; margin-left: 36pt;">2.&#160;&#160;&#160;&#160;&#160; One-month temporary housing, based on actual amount, with invoice</div>
              <div style="text-indent: -18pt; margin-left: 36pt;">3.&#160;&#160;&#160;&#160;&#160; Moving costs (sea freight) for personnel effects, based on actual amount, with invoice</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;">Exhibit C</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">Form of Indemnification Agreement</div>
      <div>&#160;</div>
      <div style="text-align: center;">(attached)</div>
      <div> <br>
      </div>
      <div> <br>
      </div>
      <div style="text-align: center;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;"> </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.61
<SEQUENCE>16
<FILENAME>ef20050548_ex10-61.htm
<DESCRIPTION>EXHIBIT 10.61
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">



  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; font-weight: bold;"> Exhibit 10.61<br>
      </div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-weight: bold;">XCF Global, Inc.</div>
      <div style="text-align: center; font-weight: bold;">Employment Agreement</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">This Employment Agreement (this &#8220;Agreement&#8221;), dated as of June 6, 2025, is made by and between XCF Global, Inc. (the &#8220;Company&#8221;) and Pamela Abowd (&#8220;Executive&#8221;) (the Company and Executive are
        collectively referred to herein as the &#8220;Parties,&#8221; or each individually referred to as a &#8220;Party&#8221;).</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">RECITALS</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold;">WHEREAS</font>, Executive has been serving as the Chief Accounting Officer of XCF Global Capital, Inc. (&#8220;XCF Global Capital&#8221;);</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold;">WHEREAS</font>, on March 11, 2024, XCF Global Capital, Focus Impact BH3 Acquisition Company (&#8220;Focus Impact&#8221;), Focus Impact BH3 NewCo, Inc. (&#8220;NewCo&#8221;), Focus Impact
        BH3 Merger Sub 1, LLC and Focus Impact BH3 Merger Sub 2, Inc. entered into a business combination agreement (as it may be amended or restated from time to time, the &#8220;Business Combination Agreement&#8221;), pursuant to which Focus Impact agreed to combine
        with XCF Global Capital in a series of transactions that will result in NewCo becoming a publicly-traded company (collectively, the &#8220;Business Combination&#8221;), and at the closing of the Business Combination (the &#8220;Closing&#8221;), NewCo will change its name
        to &#8220;XCF Global, Inc.&#8221;; and</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold;">WHEREAS</font>, Executive and the Company desire to enter into this Agreement to set out the terms and conditions of the employment relationship between the Company
        and the Executive following the Closing of the Business Combination, with this Agreement to become effective upon the Closing of the Business Combination and continue until terminated by either Party in accordance with its terms (such period during
        which this Agreement is in effect, the &#8220;Term&#8221;) and will be null and void if the Closing of the Business Combination does not occur; and</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold;">WHEREAS</font>, except as otherwise provided herein, Executive and the Company intend and confirm that this Agreement supersedes in all respects all prior
        agreements, arrangements or understandings between Executive and the Company regarding the subject matter herein, including without limitation, any offer letter, employment agreement, consulting agreement or severance agreement as of the effective
        date of this Agreement.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold;">NOW, THEREFORE</font>, in consideration of the foregoing recitals, the mutual covenants and agreements set forth herein and for other good and valuable
        consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and Executive agree as follows:</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: #010000;">1.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160; <u></u><u>Employment</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>At-Will Employment</u>. Executive and the Company acknowledge that Executive&#8217;s employment is and shall continue to be at-will, as defined under
        applicable law, and that Executive&#8217;s employment with the Company may be terminated by either Party at any time for any or no reason (subject to the notice requirements of <u>Section 3(b)</u>). If Executive&#8217;s employment terminates for any reason,
        Executive shall only be entitled to those payments, benefits, awards or compensation as specifically provided in this Agreement or as otherwise agreed to in writing by the Company, or as provided by applicable law, and Executive shall not be
        entitled to any other payments, benefits, damages, award or compensation.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Title; Responsibilities</u>. The Company shall continue to employ Executive in the position of Chief Accounting Officer reporting to Chief
        Financial Officer, and Executive hereby accepts such continued employment. During the Term, Executive shall have and perform such duties, responsibilities and authorities as are customarily associated with this position, as well as any other duties
        that may be assigned to Executive from time to time by the Chief Executive Officer or the Board of Directors (the &#8220;Board&#8221;) that are not inconsistent with service as an officer of the Company, including duties for any Company subsidiary or
        affiliate.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Exclusive Employment</u>. During the Term, Executive shall devote substantially all of Executive&#8217;s business time, skills and best efforts to
        Executive&#8217;s employment hereunder and may not, without the prior written consent of the Board, participate in the management, operation, or control of, or act as an employee, officer, director, consultant, advisor, agent or representative of, any
        other business or service (&#8220;Other Service&#8221;); provided, however, that Executive may (i) engage in civic and charitable activities (including service on the board of directors or advisory board of civic and charitable organizations), (ii) make and
        manage outside passive personal and family investments and manage personal and family affairs and (iii) serve on the board of directors of the for-profit businesses or trade organizations (including advisory boards), provided, that none of the
        foregoing (x) materially interferes with Executive&#8217;s performance of Executive&#8217;s duties hereunder, (y) poses an actual or perceived conflict of interest or violates any other obligations of Executive hereunder (including, without limitation, <u>Sections

          5</u> and <u>6</u> hereof) or (z) is prohibited by or conflicts with any applicable law or regulation (including the rules of any securities exchange on which the Company&#8217;s securities are listed) or any Company policy applicable to Executive. <u>Exhibit

          A</u> hereto identifies (i) any Other Service with respect to which the Board had provided its consent and (ii) any board of directors of any for-profit businesses or trade organizations (including advisory boards) on which Executive serves (as
        such Exhibit may be amended from time to time during the Term by mutual agreement of the Executive and the Board).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(d)</font>&#160;&#160;&#160;&#160;&#160; <u>Compliance</u>. Executive agrees to comply with all applicable laws, rules, regulations and policies relating to the performance of Executive&#8217;s
        duties and responsibilities as an employee of the Company, including, without limitation, compliance with the Company&#8217;s Code of Ethics and Business Conduct. Executive is prohibited from receiving economic benefits from any other person or entity
        other than the Company in connection with the services provided to the Company hereunder (for purposes of clarity, receipt of economic benefits from ownership of securities of the Company would not be prohibited under this provision, but would, for
        the avoidance of doubt, be subject to any insider trading policy maintained by the Company).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>Employment Location</u>. Executive may work remotely from Executive&#8217;s residence or from such other location as Executive shall inform the Company.
        Notwithstanding the foregoing, Executive understands and agrees that in connection with the performance of Executive&#8217;s duties and responsibilities under this Agreement, the Company may require Executive to spend designated days per month in a
        designated Company office, provided, that the Company shall notify the Executive in advance of such requirement. In addition, Executive understands and agrees that in connection with the performance of Executive&#8217;s duties and responsibilities under
        this Agreement, Executive may be required to travel on Company business from time-to-time.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: #010000;">2.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <u>Compensation</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(a)</font>&#160;&#160;&#160;&#160;&#160; &#160; <u>Base Salary</u>. During the Term, Executive shall receive an annualized base salary in the amount of $300,000 (&#8220;Base Salary&#8221;), which will be paid
        in accordance with the Company&#8217;s customary payroll procedures as established and modified from time-to-time. The Base Salary will be reviewed annually and may be changed in the sole discretion of the Board and as recommended by the Board&#8217;s
        Compensation Committee (provided, however, if pursuant to the listing requirements of any securities exchange on which the Company&#8217;s securities are then listed, Executive&#8217;s compensation must be set or approved in a different manner, Executive&#8217;s
        compensation shall be set or approved in accordance with such requirements), and any such revised Base Salary shall then constitute &#8220;Base Salary&#8221; for purposes of this Agreement.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>Annual Bonus</u>. In addition to the Base Salary, Executive shall be eligible for an annual bonus for each completed fiscal year of employment
        during the Term (&#8220;Annual Bonus&#8221;).&#160; The terms of Executive&#8217;s initial Annual Bonus are as set forth on <u>Exhibit B</u> to this Agreement, and the terms of the Annual Bonus for subsequent years shall be determined by the Board, upon the
        recommendation of the Board&#8217;s Compensation Committee for each such subsequent year of employment as set forth herein. Executive understands and agrees that this Agreement does not guarantee the payment of any Annual Bonus and that the actual Annual
        Bonus payable will be based on the achievement of performance objectives and/or other criteria as determined by the Board and recommended by the Board&#8217;s Compensation Committee and such other factors as the Compensation Committee, in its discretion,
        deems relevant (provided, however, if pursuant to the listing requirements of any securities exchange on which the Company&#8217;s securities are then listed, Executive&#8217;s compensation, including any bonus compensation, must be set or approved in a
        different manner, Executive&#8217;s compensation shall be set or approved in accordance with such requirements). Unless otherwise agreed by the Parties and subject to <u>Section 4(c)(ii)</u>, if an Annual Bonus is awarded, such Annual Bonus shall be
        deemed &#8220;earned&#8221; and Executive is entitled to receive payment of such Annual Bonus only if Executive is employed by the Company on the date the Annual Bonus is paid. Any Annual Bonus payable in accordance with this <u>Section 2(b)</u> shall be paid
        to Executive no later than March 15<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> of the calendar year following the year to which it relates. Executive&#8217;s Annual Bonus for 2025 (to the extent earned) will be
        prorated to reflect the portion of the year from the Closing of the Business Combination.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Equity Compensation</u>.&#160; As soon as practicable following the Closing of the Business Combination and subject to Board approval, Executive shall
        receive an initial award of restricted stock units as set forth on <u>Exhibit B</u>, subject to Executive&#8217;s continued employment through the date of grant, which award shall be subject in all respect to the term and conditions of the Company&#8217;s
        2025 Equity Incentive Plan (the &#8220;2025 Plan&#8221;) and the applicable award agreement to be delivered separately to Executive. In addition, Executive shall be eligible to receive additional equity compensation pursuant to the 2025 Plan or such other
        plans or arrangements as determined by the Board or Compensation Committee from time to time. The complete terms and conditions of any future equity compensation award made pursuant to the 2025 Plan or any other equity plan adopted by the Company,
        including vesting, exercise and forfeiture terms, shall be set forth in an award agreement and any such award shall be subject to the terms and conditions set forth in such award agreement and the 2025 Plan or such other equity plan adopted by the
        Company.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>Benefits</u>. During the Term, Executive shall be eligible to participate in such health, group insurance, welfare, pension, and other employee
        benefit plans, programs, and arrangements as are made generally available from time to time to senior executives of the Company (which shall include customary health, life insurance, and disability plans). Executive also shall be eligible to
        participate in the Company&#8217;s 2025 Employee Stock Purchase Plan or any similar or replacement plan adopted in the future during the Term. Executive also shall be eligible for 25 days of paid time off (&#8220;PTO&#8221;) per calendar year during the Term
        (prorated for partial years) in accordance with the Company&#8217;s vacation and PTO policy in effect from time to time, inclusive of vacation days and sick days and excluding standard paid Company holidays.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Expenses and Allowances</u>. Executive shall receive reimbursement from the Company for all reasonable, necessary, and documented business
        expenses incurred in connection with Executive&#8217;s employment hereunder, provided, that such expenses are timely submitted for reimbursement with supporting documentation in accordance with the Company&#8217;s expense reimbursement policies and procedures.
        In addition, Executive will receive reimbursement for the additional fees and expenses incurred by Executive as set forth on <u>Exhibit B</u> (subject to Executive provided sufficient documentation for such reimbursements).</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;"><font style="color: #010000;">3.</font>&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; <u>Termination</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>Termination Circumstances</u>.&#160; Executive&#8217;s employment hereunder may be terminated by the Company or Executive, as applicable, under the following
        circumstances, and the Term will end on the Date of Termination:</div>
      <div>&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Death</font>. Executive&#8217;s employment hereunder shall terminate automatically upon
        Executive&#8217;s death.</div>
      <div style="margin-left: 36pt; text-indent: 36pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Disability</font>. If Executive has incurred a Disability, the Company may terminate
        Executive&#8217;s employment.</div>
      <div style="margin-left: 36pt; text-indent: 36pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Termination for Cause</font>. The Company may terminate Executive&#8217;s employment for Cause.</div>
      <div style="margin-left: 36pt; text-indent: 36pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">(iv)</font>&#160;&#160; &#160;&#160; <font style="font-style: italic;">Termination without Cause</font>. The Company may terminate Executive&#8217;s employment without
        Cause for any reason or no reason.</div>
      <div style="margin-left: 36pt; text-indent: 36pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">(v)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Resignation from the Company with Good Reason</font>. Executive may resign Executive&#8217;s
        employment with the Company with Good Reason.</div>
      <div style="margin-left: 36pt; text-indent: 36pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; text-indent: 36pt;"><font style="color: rgb(1, 0, 0);">(vi)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Resignation from the Company without Good Reason</font>. Executive may resign Executive&#8217;s
        employment with the Company for any reason other than Good Reason or for no reason.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Notice of Termination</u>. Any termination of Executive&#8217;s employment by the Company or by Executive under this <u>Section 3</u> (other than
        termination as a result of Executive&#8217;s death) shall be communicated by a written notice by the terminating Party to the other Party hereto (i) indicating the specific termination provision in this Agreement being relied upon, (ii) setting forth in
        reasonable detail the facts and circumstances claimed to provide a basis for termination of employment under the provision so indicated, if applicable, and (iii) specifying a Date of Termination (such notice, a &#8220;Notice of Termination&#8221;).&#160; If the
        Notice of Termination is submitted by Executive, such Notice of Termination shall be given at least thirty (30) days prior to the Date of Termination; provided, however, that in the event that Executive delivers a Notice of Termination to the
        Company, the Company may, in its sole discretion, change the Date of Termination to any date that occurs following the date of the Company&#8217;s receipt of such Notice of Termination and which is prior to the date specified by Executive in such Notice
        of Termination, but such termination still shall be considered a resignation by Executive, unless the Company has determined that Cause exists as of such earlier Date of Termination. A Notice of Termination submitted by the Company may provide for
        a Date of Termination on the date Executive receives the Notice of Termination or any date thereafter elected by the Company. The failure by either Party to set forth in the Notice of Termination any fact or circumstance which contributes to a
        showing of Cause or Good Reason shall not waive any right of the Party hereunder or preclude the Party from asserting such fact or circumstance in enforcing the Party&#8217;s rights hereunder.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Company Obligations upon Termination</u>. Upon termination of Executive&#8217;s employment pursuant to any of the circumstances set forth in this <u>Section

          3</u>, Executive (or Executive&#8217;s estate) shall be entitled to receive the sum of (i) the portion of Executive&#8217;s Base Salary earned for the applicable year through the Date of Termination, but not yet paid to Executive, payable on the pay date
        immediately following the Date of Termination in accordance with the Company&#8217;s regular payroll practices (or such earlier date as required by applicable law), (ii) any expense reimbursements owed to Executive pursuant to this Agreement, payable in
        accordance with the Company&#8217;s expense reimbursement policy and (iii) any amount accrued and arising from Executive&#8217;s participation in, or benefits accrued under any employee benefit plans, programs or arrangements, which amounts shall be payable in
        accordance with the terms and conditions of such employee benefit plans, programs or arrangements (the &#8220;Company Arrangements&#8221; and the entitlements referenced in the foregoing clauses (i) through (iii), collectively, the &#8220;Accrued Benefits&#8221;).</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Effect on Equity Awards</u>. The effect of Executive&#8217;s termination on any equity awards received by Executive prior to such termination shall be
        determined in accordance with the terms of the 2025 Plan (or any other equity plan adopted by the Company pursuant to which such awards were made), the award agreement relating to any such award and/or <u>Section 4(b)</u> below, and in the case of
        a termination relating to a Change in Control, <u>Section 4(c)</u> below.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: #010000;">4.</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Severance Payments</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Termination Upon Death or Disability</u>. In the event of Executive&#8217;s termination of employment due to death or Disability (as defined below)
        during the Term, the Company shall pay to or for the benefit of Executive or Executive&#8217;s estate, as applicable, the Accrued Benefits and, to the extent unpaid as of the Date of Termination, the Company shall pay Executive the amount of Executive&#8217;s
        Annual Bonus for the prior year, paid as set forth in <u>Section </u>2(b) as if no such termination had occurred.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Termination for Cause; Resignation from the Company Without Good Reason</u>. If Executive&#8217;s employment shall terminate for Cause, or due to
        Executive&#8217;s resignation from the Company without Good Reason, then Executive shall receive the Accrued Benefits.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Termination without Cause, or Resignation from the Company with Good Reason</u>. If Executive&#8217;s employment is terminated without Cause or due to
        Executive&#8217;s resignation with Good Reason (in each case, a &#8220;Qualifying Termination&#8221;) that does not occur during the CIC Period (as defined below), in addition to the Accrued Benefits, Executive shall be entitled to the following payments and
        benefits:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Company shall pay Executive an amount in cash equal to, in the aggregate, 200% of the Executive&#8217;s annual base salary in
        effect as of the Date of the Termination, payable in equal monthly installments over the 12 month period following the Date of Termination, in accordance with the Company&#8217;s normal payroll practices;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160; To the extent unpaid as of the Date of Termination, the Company shall pay Executive the amount of Executive&#8217;s Annual Bonus for any
        unpaid prior period, paid as set forth in <u>Section 2(b)</u> as if no such termination had occurred;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(iii)</font>&#160; &#160; &#160;&#160; The Company shall pay Executive an amount in cash equal to two times the amount of the annual bonus that Executive would have
        earned for the year in which the Date of Termination occurs as if Executive had not been terminated and as if such annual bonus was fully earned (i.e., any relevant performance criteria shall be deemed fully achieved)(such payment, the
        (&#8220;Termination Bonus Payment&#8221;), which amount will be paid in a lump sum within thirty (30) days following the date Executive&#8217;s Release becomes effective and irrevocable, provided that to the extent the annual bonus for the year in which the Date of
        Termination occurs has been pro-rated to reflect that portion of the year from the Closing of the Business Combination to the end of such year, or in the event of any other partial-year calculation, the annual bonus amount for such year shall be
        adjusted for purposes of calculating the Termination Bonus Payment so as to reflect the bonus amount that would have been paid for a full year as if there had there been no such pro-ration (the &#8220;Full-Year Equivalent&#8221;) and in no event shall the
        Termination Bonus Payment be calculated based on an amount other than the Full-Year Equivalent, irrespective of partial-year employment;</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">5</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(iv)</font>&#160;&#160;&#160;&#160;&#160; If Executive timely elects continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended
        (&#8220;COBRA&#8221;), then the Company shall directly pay, or reimburse Executive for, the COBRA premiums for Executive&#8217;s and Executive&#8217;s covered dependents&#8217; continued participation under the Company&#8217;s group health plan (to the extent permitted under
        applicable law and the terms of such plan), less the amount Executive would have had to pay to receive such coverage as an active employee based on the cost sharing levels in effect on the Date of Termination, during the period commencing on the
        Date of Termination and ending upon the earliest of (A) eighteen (18) months following the Date of Termination, (B) the date that Executive and/or Executive&#8217;s covered dependents become no longer eligible for COBRA or (C) the date that Executive
        becomes eligible to receive group health benefits from a subsequent employer (and Executive agrees to promptly notify the Company of such eligibility); provided, that the Company may modify the continuation coverage contemplated this <u>Section
          4(c)(iv)</u> to the extent reasonably necessary, as determined by the Company in its sole discretion, to avoid potentially violating applicable law or incurring an excise tax for failure to comply with applicable law (including, without
        limitation, Section 2716 of the Public Health Service Act; Section 105(h) of the Internal Revenue Code of 1986, as amended; the Patient Protection and Affordable Care Act of 2010, as amended; and/or the Health Care and Education Reconciliation Act
        of 2010, as amended, and in each case, the regulations and guidance promulgated thereunder (to the extent applicable)).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Qualifying Termination in Connection with Change in Control</u>. In the event of a Qualifying Termination that occurs (i) not more than three
        (3) months prior to a Change in Control or (ii) on or within twelve (12) months after a Change in Control (such period, the &#8220;CIC Period&#8221;), Executive shall be entitled to receive, in addition to the Accrued Benefits, the following payments and
        benefits set forth in (i) through (iv) below, in each case, subject to (v) below:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Company shall pay Executive an amount in cash equal to, in the aggregate, 300% of the Executive&#8217;s annual base salary in
        effect as of the Date of the Termination, payable as a one-time payment to be made by the Company to the Executive (A) within thirty (30) days of the Release Effective Date, if the termination occurs following the Change of Control, or (B) within
        thirty (30) days of the consummation of the Change of Control (or such later date that is thirty (30) days following the Release Effective Date), if the termination occurred prior to the Change in Control;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; To the extent unpaid as of the Date of Termination (or, if later, the consummation of the Change in Control), the Company shall
        pay Executive the amount of Executive&#8217;s Annual Bonus for any unpaid prior period, paid as set forth in <u>Section 2(b)</u>, as if no such termination had occurred;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(iii)</font>&#160;&#160;&#160;&#160;&#160; The Company shall pay Executive an amount in cash equal to three times the amount of the annual bonus that Executive would have
        earned for the year in which the Date of Termination occurs as if Executive had not been terminated and as if such annual bonus was fully earned (i.e., any relevant performance criteria shall be deemed fully achieved)(such payment, the (&#8220;CIC
        Termination Bonus Payment&#8221;) payable as a one-time payment to be made by the Company to the Executive (A) within thirty (30) days of the date Executive&#8217;s Release becomes effective and irrevocable, if the termination occurs following the Change of
        Control, or (B) within thirty (30) days of the date of the Change of Control (or such later date that is thirty (30) days following the date Executive&#8217;s Release becomes effective and irrevocable), if the termination occurred prior to the Change of
        Control, provided that to the extent the annual bonus for the year in which the Date of Termination occurs has been pro-rated to reflect that portion of the year from the Closing of the Business Combination to the end of such year, or in the event
        of any other partial-year calculation, the annual bonus amount for such year shall be adjusted for purposes of calculating the CIC Termination Bonus Payment so as to reflect the bonus amount that would have been paid for a full year as if there had
        there been no such pro-ration (the &#8220;Full-Year Equivalent&#8221;) and in no event shall the CIC Termination Bonus Payment be calculated based on an amount other than the Full-Year Equivalent, irrespective of partial-year employment;</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">6</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(iv)</font>&#160;&#160;&#160; &#160;&#160; Any restricted stock, restricted stock units, options, or other equity grants or awards not vested at the time of termination
        shall be accelerated and become immediately vested (and, for any such awards as to which vesting is based on meeting specified performance criteria, such awards will be considered vested as if the relevant performance criteria was fully achieved),
        such that Executive will thereafter be 100% vested in any restricted stock, restricted stock units, options, or other equity grants awarded by the Company to Executive during the Term; and</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(v)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The COBRA continuation benefits set forth in <u>Section 4(c)(iv).</u></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(vi)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Non-Duplication of Payment or Benefits</font>.&#160; If (A) Executive&#8217;s Qualified Termination occurs
        prior to a Change in Control that qualifies the Executive for severance payments and benefits under <u>Section 4(d)</u> and (B) a Change in Control occurs within the six (6)-month period following the Executive&#8217;s Qualified Termination that
        qualifies the Executive for severance payments and benefits under <u>Section 4(c)</u>, then (1) the Executive will cease receiving any further payments or benefits under <u>Section 4(c)</u> and (2) the Executive will receive the payments and
        benefits under <u>Section 4(d)</u> instead but each of the payments and benefits otherwise payable under <u>Section 4(d)</u> will be offset by the corresponding payments or benefits the Executive already received under <u>Section 4(c)</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Release; Exclusive Remedy; Resignation</u>.&#160; Executive&#8217;s right to receive the payments and benefits specified in <u>Section 4(a)</u>, <u>Section

          4(b)</u> and <u>Section 4(c)</u> (collectively, the &#8220;Severance Benefits&#8221;) are subject to (i) Executive&#8217;s continued compliance with all restrictive covenant obligations with respect to the Company and its affiliates (including, without
        limitation, <u>Sections 5</u> and <u>6</u> hereof) and (ii) Executive (or Executive&#8217;s estate, as applicable) signing and delivering to the Company and not revoking a separation agreement and release of any claims against the Company, its
        affiliates, and their employees, officers, directors, and shareholders arising out of Executive&#8217;s employment or termination in a form reasonably acceptable to the Company that becomes effective and irrevocable within sixty (60) days following the
        Date of Termination (such agreement, the &#8220;Release&#8221; and such date the Release becomes effective and irrevocable, the &#8220;Release Effective Date&#8221;). The first payment of any Severance Benefits will include all amounts that otherwise would have been due
        prior thereto under the terms of this Agreement had such payments commenced immediately upon the Date of Termination. Any delay in the payment of the Severance Benefits will not extend the period of time that the Severance Benefits are payable
        pursuant to <u>Section 4</u>. During such time that the Executive is receiving the Severance Benefits, if (A) the Company discovers grounds constituting Cause existed before the Executive&#8217;s termination or (B) Executive breaches any of the
        covenants set forth in <u>Sections 5</u> and <u>6</u>, the Executive&#8217;s right to receive the Severance Benefits will immediately cease and be forfeited.&#160; Except as otherwise expressly required by law (e.g., COBRA) or as specifically provided in
        this Agreement, all of Executive&#8217;s rights to salary, severance, benefits, bonuses and other compensatory amounts hereunder (if any) shall cease upon the termination of Executive&#8217;s employment hereunder, and the amounts payable to Executive following
        termination pursuant to <u>Sections 3</u> and <u>4</u> hereof will be in full and complete satisfaction of Executive&#8217;s rights under this Agreement and any other claims that Executive may have in respect of employment with the Company or any of
        its affiliates, and Executive acknowledges that such amount amounts are fair and reasonable and are Executive&#8217;s sole and exclusive remedy, in lieu of all other remedies at law or in equity, with respect to the termination of the Term or any breach
        of this Agreement by the Company. Upon any termination of the Term, Executive will promptly resign, and will be deemed to have automatically resigned, from all positions that Executive holds as a member of the Board, officer, director or fiduciary
        of the Company or any of its affiliates, and Executive will take all actions reasonably requested by the Company or its affiliates to give effect to the foregoing.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">7</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify;"><font style="color: #010000;">5.</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Confidentiality; Intellectual Property</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>Confidentiality</u>. Executive recognizes and acknowledges that the continued success of the Company depends upon the use and protection of
        Confidential Information, which constitutes valuable trade secrets of the Company. Executive agrees to use the Confidential Information only during the Term in connection with the proper performance of Executive&#8217;s duties as an employee hereunder;
        otherwise, Executive shall not, directly or indirectly, use or disclose the Confidential Information for any other purpose or to any third party. The restrictions set forth herein are in addition to and not in lieu of any obligations Executive may
        have by law with respect to the Confidential Information, including any fiduciary duties or other obligations Executive may owe under any applicable trade secrets statutes or other state or federal laws.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>Intellectual Property</u>. Executive acknowledges and agrees that all inventions, know-how, trade secrets, technology, programming, software,
        processes, innovations, ideas, improvements, developments, methods, algorithms, designs, analyses, writings, audiovisual works, works of authorship, concepts, drawings, reports and all similar, related, or derivative information or works (whether
        or not patentable or subject to copyright), including but not limited to all resulting patent applications, issued patents, copyrights, copyright applications and registrations in and to any of the foregoing, along with the right to practice,
        employ, exploit, use, develop, reproduce, copy, distribute copies, publish, license, or create works derivative of any of the foregoing, and the right to choose not to do or permit any of the aforementioned actions, that are conceived, authored,
        reduced to practice, created, or otherwise developed by Executive during the Term (whether alone or jointly with others) (collectively, the &#8220;Work Product&#8221;) belong to the Company, and not Executive; provided that Work Product excludes, and this <u>Section

          5(b)</u> does not apply to an invention for which no equipment, supplies, facilities, or trade secret information of the Company or its affiliates (whether existing now or in the future) and which was developed entirely on Executive&#8217;s own time,
        unless (i) the invention relates (A) to the business of the Company or its affiliates (whether existing now or in the future), or (B) to the Company&#8217;s (or its affiliates&#8217; (whether existing now or in the future)) actual or demonstrably anticipated
        research or development, or (ii) the invention results from any work performed by Executive for the Company or its affiliates (whether existing now or in the future). Executive further acknowledges and agrees that to the extent relevant, this
        Agreement constitutes a &#8220;work for hire agreement&#8221; under the United States Copyright Act of 1976, as amended (&#8220;Copyright Act&#8221;), and that any copyrightable work (&#8220;Creation&#8221;) constitutes a &#8220;work made for hire&#8221; under the Copyright Act such that the
        Company is the copyright owner of the Creation. Executive hereby irrevocably assigns and agrees to assign to the Company all right, title and interest in and to all Work Product and, to the extent any Creation or portion thereof is not a &#8220;work for
        hire&#8221;, all Creations. Executive will promptly disclose and deliver such Work Product and Creations to the Company and, at the Company&#8217;s expense, perform all actions reasonably requested by the Company (whether during or after the Term to
        effectuate, establish, confirm, record or protect such ownership, or to protect or enforce the Company&#8217;s rights therein (including, without limitation, the execution of assignments, copyright registrations, consents, licenses, powers of attorney
        and other instruments).</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">8</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u></u><u>Permitted Disclosures</u>. Nothing in this Agreement shall be construed to prevent disclosure of Confidential Information as may be
        required by applicable law or regulation, or pursuant to the valid order of a court of competent jurisdiction or an authorized government agency, provided that the disclosure does not exceed the extent of disclosure required by such law,
        regulation, or order, or in connection with an investigation by or report to any regulatory agency with jurisdiction over the Company, law enforcement, or any other federal or state regulatory or self-regulatory authority. In compliance with 18
        U.S.C. &#167; 1833(b), as established by the Defend Trade Secrets Act of 2016, Executive is given notice of the following: (i) that an individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the
        disclosure of a trade secret that (A) is made (1) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney; and (2) solely for the purpose of reporting or investigating a suspected violation
        of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal; and (ii) that an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of
        law may disclose the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual (A) files any document containing the trade secret under seal; and (B) does not disclose the trade
        secret, except pursuant to court order.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Return of Property</u>. Upon separation from employment or earlier request from the Company, Executive shall return to the Company any and all
        Company property, including keys, access cards, identification cards, credit cards, business cards, laptop, smartphone, other electronic equipment, reports, files, manuals, Work Product, Creations, emails, recordings, thumb drives or other
        removable information storage devices, and data and all Company documents and materials belonging to the Company and stored in any fashion, including but not limited to those that constitute or contain any Confidential Information or Work Product,
        Creations, that are in the possession or control of the Executive, relating to Executive&#8217;s employment by the Company. Without limiting the foregoing or Executive&#8217;s obligations under <u>Section 5(a)</u>, upon separation from employment or earlier
        request from the Company, Executive shall not retain possession or control of any Confidential Information and shall instead return such Confidential Information to the Company or destroy it.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: #010000;">6.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>Restrictive Covenants</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>No Solicitation of Customers</u>. Executive agrees that, both during the Term and for the period ending on the date that is eighteen (18) months
        from the date of the termination of the Executive&#8217;s employment with the Company at any time and for any reason (the &#8220;Restricted Period&#8221;), Executive will not solicit any Restricted Business (as defined below) from any person or entity that is, or in
        the prior twelve (12) months was a customer of the Company or any of its affiliates or any prospective customer of the Company or any of its affiliates with respect to which the Company or its affiliates actively solicits or has solicited the sale
        of Company products and services. For purposes of this Agreement, &#8220;Restricted Business&#8221; shall mean the business of manufacturing, marketing and selling renewable fuels (including, but not limited to, renewable diesel fuel and sustainable aviation
        fuel (SAF)) and constructing, acquiring, investing in and/or operation facilities for the production of renewable fuels (including, but not limited to, renewable diesel fuel and sustainable aviation fuel (SAF)). Notwithstanding the foregoing,
        Executive shall not be prohibited from the passive ownership of up to two percent (2%) of the securities of any entity engaged in any Restricted Business, where the securities of such entity are traded on a national securities exchange.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>No Solicitation of Employees</u>. Executive agrees that during the Restricted Period, Executive will not, directly or indirectly, on behalf of
        himself or any other person or entity, hire, solicit, take away or attempt to hire, solicit or take away any person who is (or in the preceding six months was), at the time of such solicitation, an employee, director or independent contractor of
        the Company or any of its affiliates, either on behalf of himself or any other person or entity. This includes, but is not limited to, inducing or attempting to induce, or influencing or attempting to influence, any person employed by the Company
        or its affiliates to terminate his or her employment with the Company or any such affiliate.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">9</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(c)</font>&#160;&#160; &#160; &#160;&#160; <u>Importance of Executive&#8217;s Services; Intent of the Parties; Enforcement</u>. Executive acknowledges and agrees that the services to be provided by
        Executive under this Agreement are of a special, unique and extraordinary nature. Executive further acknowledges and agrees that the covenants and restrictions contained in <u>Section 5</u> and <u>Section 6</u> are necessary to prevent the use
        and disclosure of Confidential Information and to protect other legitimate business interests of the Company and its affiliates. Executive acknowledges that all of the covenants and restrictions in <u>Section 5</u> and <u>Section 6</u> are
        reasonable in all respects, including duration, territory and scope of activity. Executive acknowledges and agrees that the Company competes with businesses on a world-wide basis and that the geographic restrictions contained herein are therefore
        reasonable and necessary to protect the Company&#8217;s legitimate business interests. Executive agrees that the covenants and restrictions contained in <u>Section 5</u> and <u>Section 6</u> shall be construed as separate agreements independent of any
        other provision of this Agreement or any other agreement between Executive and the Company. Executive agrees that the existence of any claim or cause of action by Executive against the Company or its affiliates, whether predicated on this Agreement
        or otherwise, shall not constitute a defense to the enforcement by the Company of the covenants and restrictions in <u>Section 5</u> and <u>Section 6</u>. Executive agrees that the restrictive covenants contained in <u>Section 5</u> and <u>Section

          6</u> are a material part of Executive&#8217;s obligations under this Agreement for which the Company has agreed to compensate the Executive as provided in this Agreement. The Executive agrees that the injury the Company will suffer in the event of the
        breach by Executive of any clause of <u>Section 5</u> and <u>Section 6</u> will cause the Company and its affiliates irreparable injury that cannot be adequately compensated by monetary damages alone. Therefore, Executive agrees that the Company,
        without limiting any other legal or equitable remedies available to it, shall be entitled to obtain equitable relief by injunction or otherwise from any court of competent jurisdiction, including, without limitation, injunctive relief to prevent
        Executives&#8217; failure to comply with the terms and conditions of <u>Section 5</u> and <u>Section 6</u>. The time year periods referenced in <u>Section 5</u> and <u>Section 6</u> shall be extended on a day-for-day basis for each day during which
        Executive violates the provisions of <u>Section 5</u> and <u>Section 6</u> in any respect, so that Executive is restricted from engaging in the activities prohibited by <u>Section 5</u> and <u>Section 6</u> for the full time period, as
        applicable.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Whistleblower Protection</u>.&#160; Notwithstanding anything to the contrary contained herein, no provision of this Agreement or any other agreement
        or Company policy will be interpreted so as to impede Executive (or any other individual) from (i) making any disclosure of relevant and necessary information or documents in any action, investigation, or proceeding relating to this Agreement, or
        as required by law or legal process, including with respect to possible violations of law, (ii) participating, cooperating, or testifying in any action, investigation, or proceeding with, or providing information to, any governmental agency,
        legislative body or any self-regulatory organization, including, but not limited to, the Department of Justice, the Securities and Exchange Commission, the Congress, and any agency Inspector General, (iii) seeking or accepting any U.S. Securities
        and Exchange Commission awards or other relief in connection with protected whistleblower activity, or (iv) making other disclosures under the whistleblower provisions of federal law or regulation. In addition, nothing in this Agreement or any
        other agreement or Company policy prohibits or restricts Executive from initiating communications with, or responding to any inquiry from, any administrative, governmental, regulatory or supervisory authority regarding any good faith concerns about
        possible violations of law or regulation. Executive does not need the prior authorization of the Company to make any such reports or disclosures and the Executive will not be required to notify the Company that such reports or disclosures have been
        made.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: #010000;">7.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Other Agreements</u>. Executive represents and agrees that Executive&#8217;s performance of Executive&#8217;s duties for the Company shall not violate any agreements,
        obligations or understandings that Executive may have with any third party or prior employer. Without limiting the foregoing, Executive represents and agrees that Executive is not bound by any non-compete or non-solicitation agreement or any other
        type of agreement that would prohibit Executive&#8217;s employment with the Company. Executive agrees not to make any unauthorized disclosure or use, on behalf of the Company, of any confidential information belonging to any of Executive&#8217;s former
        employers. Executive also represents that Executive is not in unauthorized possession of any materials containing a third party&#8217;s confidential and proprietary information.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">10</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify;"><font style="color: #010000;">8.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Cooperation with Company</u>. During Executive&#8217;s employment by the Company and thereafter, Executive will cooperate with the Company and its affiliates in any
        internal investigation or administrative, regulatory or judicial proceeding that relates to events occurring during Executive&#8217;s employment hereunder and as reasonably requested by the Company (including being available upon reasonable notice from
        the Company for interviews and factual investigations and appearing at the Company&#8217;s request to give testimony without requiring service of a subpoena or other legal process, all at times and on schedules that are reasonably consistent with
        Executive&#8217;s other permitted activities and commitments). In the event the Company requires Executive&#8217;s cooperation in accordance with this <u>Section 8</u> following the termination of Executive&#8217;s employment, the Company (or its applicable
        affiliate) will reimburse Executive for reasonable expenses incurred by Executive in connection therewith.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: #010000;">9.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>Tax Provisions</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>Withholding</u>. All amounts payable to Executive under this Agreement will be subject to all required tax and other designated or required
        withholdings and deductions. In the event that the Company fails to withhold any taxes required to be withheld by applicable law or regulation, Executive agrees to indemnify the Company for any taxes of Executive that should have been withheld.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Section 280G</u>. To the extent that any amount payable to Executive hereunder, as well as any other &#8220;parachute payment&#8221; as such term is defined
        under Section 280G (collectively with the regulations promulgated thereunder, &#8220;Section 280G&#8221;) of the Code, payable to Executive ( the &#8220;Covered Payments&#8221;), exceeds the limitations&#160; of Section 280G such that an excise tax will be imposed under
        Section 4999 of the Code (the &#8220;Excise Tax&#8221;), then, before making the Covered Payments, a calculation will be made comparing (i) the Net Benefit (as defined below) to Executive of the Covered Payments after payment of the Excise Tax to (ii) the Net
        Benefit to Executive if the Covered Payments are limited to the extent necessary to avoid being subject to the Excise Tax. Only if the amount calculated under (i) above is less than the amount under (ii) above will the Covered Payments be reduced
        to the minimum extent necessary to ensure that no portion of the Covered Payments is subject to the Excise Tax. &#8220;Net Benefit&#8221; will mean the present value of the Covered Payments net of all federal, state, local, foreign income, employment and
        excise taxes. Any such reduction will be made by the Company in its sole discretion consistent with the requirements of Section 409A of the Code. If two economically equivalent amounts are subject to reduction but are payable at different times,
        the amounts will be reduced (but not below zero) on a pro rata basis. Notwithstanding the foregoing, the Board (or a committee of the Board composed entirely of independent directors) may, in its sole discretion and on a case-by-case basis, approve
        a gross-up payment (a &#8220;Limited Gross-Up&#8221;) to Executive in an amount sufficient to place Executive in the same after-tax position as if no Excise Tax had been imposed, but only to the extent the Excise Tax results from a reduced base amount due to
        (i) a limited period of service with the Company prior to the Change in Control, or (ii) other structural features not attributable to Executive&#8217;s actions or compensation demands. Any such Limited Gross-Up shall be subject to compliance with
        Section 409A of the Code, and may be conditioned upon Executive providing reasonable cooperation with tax planning or mitigation strategies.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Section 409A</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; To the extent required by Section 409A of the Code, all references to &#8220;termination of employment&#8221; and correlative phrases for
        purposes of this Agreement shall be construed to require a &#8220;separation from service&#8221; (as defined in Section 1.409A-1(h) of the Treasury regulations after giving effect to the presumptions contained therein).</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">11</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(ii)</font>&#160;&#160;&#160;&#160; &#160; Notwithstanding any provision in this Agreement to the contrary, to the extent that (i) any payments or benefits to which
        Executive becomes entitled under this Agreement or any other agreement, policy, plan, program or arrangement with the Company, in connection with Executive&#8217;s termination of employment with the Company constitute &#8220;nonqualified deferred compensation&#8221;
        subject to Section 409A of the Code and (ii) Executive is deemed at the time of such termination of employment to be a &#8220;specified employee&#8221; under Section 409A of the Code, then such payments or benefits shall not be made or commence until the
        earliest of (1) the expiration of the six (6) month and one day period measured from the date of Executive&#8217;s separation from service (as defined in <u>Section 9(c)(i)</u> above) from the Company or (2) the date of Executive&#8217;s death following such
        separation from service; provided, however, that such deferral shall only be effected to the extent required to avoid adverse tax treatment to Executive, including (without limitation) the additional twenty-percent (20%) tax for which Executive
        would otherwise be liable under Section 409A(a)(1)(b) of the Code in absence of such deferral. Upon the expiration of the applicable deferral period, any payments which would have otherwise been made during that period (whether in a single sum or
        in installments) in the absence of this <u>Section 9(b)</u> shall be paid to Executive or Executive&#8217;s beneficiary in one lump sum. For purposes of this <u>Section 9(b)</u>, the term &#8220;specified employee&#8221; means an individual determined by the
        Company to be a specified employee under Treasury regulation Section 1.409A-1(i) in accordance with the policies of the Company.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(iii)</font>&#160;&#160;&#160;&#160;&#160; It is intended that each installment of any benefits or payments provided hereunder constitute a separate payment for purposes of
        Treasury Regulation Section 1.409A-2(b)(2)(i). The Company and Executive intend that all the benefits and payments provided under this Agreement shall be exempt from, or comply with, the requirements of Section 409A of the Code and the provisions
        of the Agreement shall be read in accordance with that intent. It is further intended that payments hereunder satisfy, to the greatest extent possible, the exemptions from the application of Section 409A of the Code (and any state law of similar
        effect) provided under Treasury Regulations Section 1.409A-1(b)(4) (as a &#8220;short-term deferral&#8221;) and Section 1.409A-1(b)(9) (as &#8220;separation pay due to involuntary separation&#8221;). To the extent that any provision hereof is modified in order to comply
        with Section 409A, such modification will be made in good faith and will, to the maximum extent reasonably possible, maintain the original intent and economic benefit to Executive and the Company of the applicable provision without violating the
        provisions of Section 409A. The Company makes no representation or warranty and shall have no liability to Executive or any other person if any provisions of this Agreement are determined to constitute deferred compensation subject to Section 409A
        of the Code but do not satisfy an exemption from, or comply with the conditions of, such Section.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(iv)</font>&#160;&#160;&#160; &#160; Except as otherwise expressly provided herein, to the extent any expense reimbursement or the provision of any in-kind benefit
        under this Agreement is determined to constitute &#8220;nonqualified deferred compensation&#8221; subject to Section 409A of the Code, the amount of any such expenses eligible for reimbursement, or the provision of any in-kind benefit, in one calendar year
        shall not affect the expenses eligible for reimbursement in any other taxable year (except for any lifetime or other aggregate limitation applicable to medical expenses), in no event shall any expenses be reimbursed after the last day of the
        calendar year following the calendar year in which Executive incurred such expenses, and in no event shall any right to reimbursement or the provision of any in-kind benefit be subject to liquidation or exchange for another benefit.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(v)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; Whenever a payment under this Agreement specifies a payment period with reference to a number of days, the actual date of payment
        within the specified period is within the sole discretion of the Company.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #010000;">(vi)</font>&#160;&#160;&#160;&#160; Notwithstanding any provision in this Agreement to the contrary, to the extent that any payments or benefits to which Executive
        becomes entitled under this Agreement or any other agreement, policy, plan, program or arrangement with the Company, in connection with Executive&#8217;s termination of employment with the Company constitute &#8220;nonqualified deferred compensation&#8221; subject
        to Section 409A of the Code, then each such payment which is conditioned upon Executive&#8217;s execution of a release and which is to be paid or provided during a designated period that begins in one taxable year and ends in a second taxable year shall
        be paid or provided in the later of the two taxable years.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">12</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify;"><font style="color: #010000;">10.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Certain Definitions</u>. As used in this Agreement, the following terms shall have the following meanings:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>Cause</u>. &#8220;Cause&#8221; means any of the following: (i) Executive&#8217;s commission of an act of fraud, embezzlement or dishonesty, or the commission of
        some other illegal act by Executive, that could reasonably be expected to have an adverse impact on the Company or any successor or affiliate; (ii) Executive&#8217;s conviction of, or plea of &#8220;guilty&#8221; or &#8220;no contest&#8221; to, a felony or any crime involving
        fraud, dishonesty or moral turpitude under the laws of the United States or any state thereof (or international equivalent); (iii) any intentional, unauthorized use or disclosure by Executive of Confidential Information or trade secrets of the
        Company or any successor or affiliate; (iv) Executive&#8217;s gross negligence or material violation of any duty of loyalty to the Company or any successor or affiliate thereof, or any other demonstrable material misconduct on Executive&#8217;s part in
        connection with the performance of Executive&#8217;s duties for the Company; (v) Executive&#8217;s ongoing and repeated failure or refusal to perform or neglect of Executive&#8217;s duties as required by this Agreement or Executive&#8217;s ongoing and repeated failure or
        refusal to comply with the instructions given to Executive by the Board, which failure, refusal or neglect continues for fifteen (15) days following Executive&#8217;s receipt of written notice from the Board stating with specificity the nature of such
        failure, refusal or neglect; or (vi) Executive&#8217;s material breach of any material Company policy or any material provision of this Agreement, which breach is not cured (if capable of being cured) within fifteen (15) days following Executive&#8217;s
        receipt of written notice from the Board stating with specificity the nature of such material breach; provided, that the foregoing cure right shall not apply to any breach by Executive of <u>Section 5</u> or <u>Section 6</u> hereof.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Change in Control</u>. &#8220;Change in Control&#8221; shall have the meaning set forth in the 2025 XCF Global, Inc. Equity Incentive Plan. For purposes of
        clarity, consummation of (i) the transactions contemplated in the BCA or (ii) the New Rise Acquisitions (as defined in the BCA) shall not constitute a Change in Control.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Code</u>. &#8220;Code&#8221; shall mean the Internal Revenue Code of 1986, as amended, and the regulations and guidance promulgated thereunder.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Confidential Information</u>. &#8220;Confidential Information&#8221; means the Company&#8217;s trade secrets as defined under applicable law, as well as any other
        information or material which is not generally known to the public, and which: (i) is generated, collected by or utilized in the operations of the Company&#8217;s business and relates to the actual or anticipated business of the Company; or (ii) results
        from any task assigned to Executive by the Company, or work performed by Executive for or on behalf of the Company. Confidential Information shall not be considered generally known to the public if Executive or others improperly reveal such
        information to the public without the Company&#8217;s express written consent and/or in violation of an obligation of confidentiality owed to the Company. Confidential Information includes, without limitation, the information, observations and data
        obtained by Executive while employed by the Company concerning the business or affairs of the Company, including without limitation: information concerning investment or acquisition opportunities in or reasonably related to the Company; the
        identities of and other information (such as databases) relating to the current, former or prospective employees, customers, or investors of the Company; development, transition and transformation plans; methodologies and methods of doing business;
        strategic, marketing and expansion plans; financial and business plans, financial data; pricing information; employee, customer, or vendor lists and telephone numbers; investment terms; and requirements and costs of providing service. Confidential
        Information also includes information that the Company receives from third parties subject to a duty to maintain the confidentiality of such information and to use it only for certain limited purposes.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">13</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(e)</font>&#160;&#160;&#160;&#160; &#160; &#160; <u>Date of Termination</u>. &#8220;Date of Termination&#8221; shall mean (i) if Executive&#8217;s employment is terminated by Executive&#8217;s death, the date of
        Executive&#8217;s death or (ii) if Executive&#8217;s employment is terminated pursuant to <u>Section 3(a)(ii)</u> &#8211; <u>(iv)</u> either the date indicated in the Notice of Termination or the date specified by the Company pursuant to <u>Section 3(b)</u>,
        whichever is earlier.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>Disability</u>. &#8220;Disability&#8221; shall mean, at any time the Company or any of its affiliates sponsors a long-term disability plan for the Company&#8217;s
        employees, &#8220;disability&#8221; as defined in such long-term disability plan for the purpose of determining a participant&#8217;s eligibility for benefits;&#160; provided, however, if the long-term disability plan contains multiple definitions of disability,
        &#8220;Disability&#8221; shall refer to that definition of disability which, if Executive qualified for such disability benefits, would provide coverage for the longest period of time. The determination of whether Executive has a Disability shall be made by
        the person or persons required to make disability determinations under the long-term disability plan. At any time the Company does not sponsor a long-term disability plan for its employees, &#8220;Disability&#8221; shall mean Executive&#8217;s inability to perform,
        with or without reasonable accommodation, the essential functions of Executive&#8217;s positions hereunder for a total of three months during any six-month period as a result of incapacity due to mental or physical illness as determined by the Board in
        its sole good faith discretion.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>Good Reason</u>. &#8220;Good Reason&#8221; means any of the following without Executive&#8217;s written consent: (i) a material diminution in Executive&#8217;s authority,
        duties or responsibilities; (ii) a material diminution in Executive&#8217;s base salary or target Annual Bonus (and Executive and the Company agree that any diminution of 10% or more shall be considered material for this purpose, regardless of whether
        such diminution occurs due to a single reduction or a series of reductions), other than in connection with an across-the-board reduction which applies in a comparable manner to other senior officers of the Company; (iii) any change in the Company&#8217;s
        remote work policy that would require Executive to be physically present in one of the Company&#8217;s offices more than 20 days each month, and (iv) the Company&#8217;s breach of a material provision of this Agreement. Notwithstanding the foregoing, no Good
        Reason will have occurred unless and until Executive has (A) provided the Company, within thirty (30) days of Executive&#8217;s knowledge of the occurrence of the facts and circumstances underlying the Good Reason event, written notice stating with
        specificity the applicable facts and circumstances underlying such finding of Good Reason, (B) provided the Company with an opportunity to cure the same within thirty (30) days after the receipt of such notice and (C) the Company shall have failed
        to so cure within such period. Executive&#8217;s termination of employment by reason of resignation from employment with the Company for Good Reason must occur within 30 days following the expiration of the foregoing 30-day cure period.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><font style="color: #010000;">11.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Miscellaneous Provisions</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Not used.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>Governing Law</u>. This Agreement shall be governed, construed, interpreted and enforced in accordance with its express terms, and otherwise in
        accordance with the substantive laws of the State of Delaware without reference to the principles of conflicts of law of the State of Delaware or any other jurisdiction that would result in the application of the laws of a jurisdiction other than
        the State of Delaware, and where applicable, the laws of the United States.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">14</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>Arbitration</u>. Any dispute, controversy, or claim arising out of or relating to this Agreement or any breach of this Agreement or Executive&#8217;s
        employment, whether the claim arises in contract, tort, or statute, shall be submitted to and decided by binding arbitration, except as set forth in <u>Section 6(c)</u>. Arbitration shall be administered exclusively by the American Arbitration
        Association at a location in Wilmington, Delaware and shall be conducted consistent with the employment arbitration rules, regulations, and requirements thereof as well as any requirements imposed by state law. Any arbitral award determination
        shall be final and binding upon the Parties, and judgment may be entered thereon in any court of competent jurisdiction. Notwithstanding anything to the contrary, this Agreement does not prevent Executive from filing a complaint or charge with the
        National Relations Labor Board, the Equal Employment Opportunity Commission, or any similar federal or state administrative agency, including claims for workers&#8217; compensation or unemployment insurance benefits. By entering into this Agreement, the
        Parties are waiving all rights to have their disputes heard or decided by a jury or in a court trial and the right to pursue any class or representative claims against each other in court, arbitration, or any other proceeding. The arbitrator shall
        have no jurisdiction or authority to compel any class or collective claim, or to consolidate different arbitration proceedings with or join any other party to an arbitration between the Parties. The arbitrator, and not any court, shall have
        exclusive authority to resolve any dispute relating to the enforceability or formation of this Agreement and the arbitrability of dispute between the parties, except for any dispute relating to the enforceability or scope of the class and
        collective action waiver, which shall be determined by a court of competent jurisdiction. THE PARTIES FULLY UNDERSTAND AND AGREE THAT THEY ARE GIVING UP CERTAIN RIGHTS OTHERWISE AFFORDED TO THEM BY CIVIL COURT ACTIONS, INCLUDING BUT NOT LIMITED TO
        THE RIGHT TO A JURY OR COURT TRIAL AND THE RIGHT TO BRING ANY CLAIM AS A CLASS OR COLLECTIVE ACTION. Costs of arbitration shall be split evenly between the parties, provided, that the arbitrator shall have the ability to award attorneys&#8217; fees and
        previously paid arbitration expenses to the prevailing party.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Venue; Waiver of Jury Trial</u>.&#160; Except for claims subject to the arbitration provisions herein, the Parties agree that all litigation arising
        out of or relating to this agreement must be brought exclusively in any state or federal court located in Wilmington, Delaware (collectively the &#8220;Designated Courts&#8221;). Each Party consents and submits to the exclusive jurisdiction of the Designated
        Courts with respect to litigation under this Agreement, each Party hereby irrevocably waives all claims or defenses of lack of personal jurisdiction or any other jurisdiction defense, and any objection which such Party may now or hereafter have to
        the laying of venue of any suit, action or proceeding in any Designated Court, including any right to object on the basis that any dispute, action, suit, or proceeding brought in the Designated Courts has been brought in an improper or inconvenient
        forum or venue.&#160; IN THE EVENT OF LITIGATION HEREUNDER, THE COMPANY AND EXECUTIVE EACH WAIVE THEIR RESPECTIVE RIGHT TO A TRIAL BY JURY OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF OR RELATED TO ANY ACTION, PROCEEDING, OR OTHER
        LITIGATION OF ANY TYPE BROUGHT BY ANY OF THE PARTIES AGAINST ANY OTHER PARTY OR ANY AFFILIATE OF ANY OTHER SUCH PARTY. THE COMPANY AND EXECUTIVE EACH AGREE THAT ANY SUCH CLAIM OR CAUSE OF ACTION WILL BE TRIED BY A COURT TRIAL WITHOUT A JURY.
        WITHOUT LIMITING THE FOREGOING, THE PARTIES FURTHER AGREE THAT THEIR RESPECTIVE RIGHT TO A TRIAL BY JURY IS WAIVED BY OPERATION OF THIS SECTION AS TO ANY ACTION, COUNTERCLAIM, OR OTHER PROCEEDING WHICH SEEKS, IN WHOLE OR IN PART, TO CHALLENGE THE
        VALIDITY OR ENFORCEABILITY OF THIS AGREEMENT. THIS WAIVER WILL APPLY TO ANY SUBSEQUENT AMENDMENTS, RENEWALS, SUPPLEMENTS, OR MODIFICATIONS TO THIS AGREEMENT.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Validity; Severability</u>. Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid
        under applicable law, but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability will not affect any
        other provision or any action in any other jurisdiction, but this Agreement will be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had never been contained herein.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Notices</u>. Any notice, request, claim, demand, document and other communication hereunder to any Party shall be effective upon receipt (or
        refusal of receipt) and shall be in writing and delivered personally or sent by facsimile or certified or registered mail, postage prepaid, (i) if to the Company, to the Chief Executive Officer of the Company at the Company&#8217;s headquarters, (ii) if
        to Executive, to the last address that the Company has in its personnel records for Executive, or (iii) at any other address as any Party shall have specified by notice in writing to the other Party.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">15</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Counterparts</u>. This Agreement may be executed in several counterparts, each of which shall be deemed to be an original, but all of which
        together will constitute one and the same Agreement. Signatures delivered by facsimile or .pdf format shall be deemed effective for all purposes.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(h)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Entire Agreement</u>. The terms of this Agreement are intended by the Parties to be the final expression of their agreement with respect to the
        subject matter hereof and supersede all prior understandings and agreements, whether written or oral, including any prior employment offer letter, employment agreement or consulting agreement between Executive and the Company. The Parties further
        intend that this Agreement shall constitute the complete and exclusive statement of their terms and that no extrinsic evidence whatsoever may be introduced in any judicial, administrative, or other legal proceeding to vary the terms of this
        Agreement.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Amendments; Waivers</u>. This Agreement may not be modified, amended, or terminated except by an instrument in writing, signed by Executive and
        a duly authorized officer of Company. By an instrument in writing similarly executed, Executive or a duly authorized officer of the Company may waive compliance by the other Party with any specifically identified provision of this Agreement that
        such other Party was or is obligated to comply with or perform; provided, however, that such waiver shall not operate as a waiver of, or estoppel with respect to, any other or subsequent failure. No failure to exercise and no delay in exercising
        any right, remedy, or power hereunder will preclude any other or further exercise of any other right, remedy, or power provided herein or by law or in equity.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(j)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Successors and Assigns</u>. The Company may assign its rights and obligations under this Agreement to any of its affiliates or to any successor
        to all or substantially all of the business or the assets of the Company (by merger or otherwise, including, without limitation, to the surviving entity in the Business Combination), and may assign or encumber this Agreement and its rights
        hereunder as security for indebtedness of the Company and its affiliates. This Agreement shall be binding upon and inure to the benefit of the Company, Executive and their respective successors, assigns, personnel and legal representatives,
        executors, administrators, heirs, distributees, devisees, and legatees, as applicable. None of Executive&#8217;s rights or obligations may be assigned or transferred by Executive, other than Executive&#8217;s rights to payments hereunder, which may be
        transferred only by will or operation of law. Notwithstanding the foregoing, Executive shall be entitled, to the extent permitted under applicable law and applicable Company Arrangements, to select and change a beneficiary or beneficiaries to
        receive compensation hereunder following Executive&#8217;s death by giving written notice thereof to the Company.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(k)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Indemnification</u>. The Company and Executive shall enter into a Director and Officer Indemnification Agreement substantially in the form of <u>Exhibit

          C</u> attached hereto.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(l)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>D&amp;O Insurance</u>. The Company will cover Executive under directors&#8217; and officers&#8217; liability insurance policy (or policies) during the Term
        and thereafter to the same extent as the Company covers its other current or former directors or officers of the Company.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(m)</font>&#160;&#160;&#160;&#160; &#160;&#160; <u>Clawback</u>. Notwithstanding any other provisions in this Agreement to the contrary, any incentive-based or other compensation paid to the
        Executive under this Agreement or any other agreement or arrangement with the Company that is subject to recovery under any applicable law, government regulation, or stock exchange rule or listing requirement will be subject to such deductions and
        clawback as may be required or permitted to be made pursuant to such law, government regulation, or stock exchange rule or listing requirement or any policy adopted by the Company.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">16</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #010000;">(n)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Construction</u>. This Agreement shall be deemed drafted equally by both the Parties. Its language shall be construed as a whole and according to
        its fair meaning. Any presumption or principle that the language is to be construed against any Party shall not apply. The headings in this Agreement are only for convenience and are not intended to affect construction or interpretation. Any
        references to paragraphs, subparagraphs, sections or subsections are to those parts of this Agreement, unless the context clearly indicates to the contrary. Also, unless the context clearly indicates to the contrary, (i) the plural includes the
        singular and the singular includes the plural, (ii) &#8220;and&#8221; and &#8220;or&#8221; are each used both conjunctively and disjunctively, (iii) &#8220;any,&#8221; &#8220;all,&#8221; &#8220;each,&#8221; or &#8220;every&#8221; means &#8220;any and all,&#8221; and &#8220;each and every,&#8221; (iv) &#8220;includes&#8221; and &#8220;including&#8221; are each
        &#8220;without limitation,&#8221; (v) &#8220;herein,&#8221; &#8220;hereof,&#8221; &#8220;hereunder&#8221; and other similar compounds of the word &#8220;here&#8221; refer to the entire Agreement and not to any particular paragraph, subparagraph, section or subsection and (vi) all pronouns and any variations
        thereof shall be deemed to refer to the masculine, feminine, neuter, singular or plural as the identity of the entities or persons referred to may require.</div>
      <div>&#160;</div>
      <div style="text-align: center;">[SIGNATURE PAGE FOLLOWS]</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">17</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold;">IN WITNESS WHEREOF</font>, the Parties hereto have executed this Agreement as of the date first written above. The signatories below represent that they are duly
        authorized to enter into this Agreement.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z166694af2e3f4adbbf4cdca271bf43e7" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top;" rowspan="1" colspan="1">&#160;</td>
            <td style="vertical-align: top;" rowspan="1" colspan="2">
              <div style="font-weight: bold;">XCF GLOBAL, INC.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;" rowspan="1" colspan="1">&#160;</td>
            <td style="vertical-align: top;" rowspan="1" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top;">
              <div>By:</div>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div><u>/s/ Mihir Dange</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top;">
              <div>Name:</div>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div>Mihir Dange</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top;">
              <div>Title:</div>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div>Chief Executive Officer</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;" rowspan="1" colspan="1">&#160;</td>
            <td style="vertical-align: top;" rowspan="1" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;" rowspan="1" colspan="1">&#160;</td>
            <td style="vertical-align: top;" rowspan="1" colspan="2">
              <div style="font-weight: bold;">EXECUTIVE</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;" rowspan="1" colspan="1">&#160;</td>
            <td style="vertical-align: top;" rowspan="1" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top;">
              <div>By:</div>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div><u>/s/ Pamela Abowd</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top;">
              <div>Name:</div>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div>Pamela Abowd</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">18</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;">Exhibit A</div>
      <div>&#160;</div>
      <div>None.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;">Exhibit B</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">Compensation Terms</div>
      <div>&#160;</div>
      <div style="text-align: center;">(attached)</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">Executive is solely responsible for any tax liability incurred as a result of any benefit set forth in this table being treated as a taxable benefit under federal, state or local law.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;">Pamela Abowd</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">Exhibit B &#8211; Compensation Terms</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="z733a3c9999c54516957c7f97dc3284da" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div>Base Salary</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div>$300,000, Three Hundred Thousand Dollars</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div>Annual Bonus</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div>Target Bonus set at 50-100% of Base Salary</div>
              <div>If &lt;50% of key evaluation metrics achieved, Annual Bonus is 0% </div>
              <div>(in each case, pro-rated for partial year) </div>
              <div>&#160;</div>
              <div>Key evaluation metrics (subject to adjustment each year):</div>
              <div style="text-indent: -18pt; margin-left: 18pt;">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;25% discretionary established by the Board</div>
              <div style="text-indent: -18pt; margin-left: 18pt;">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;25% Individual performance metrics to be set by the Board</div>
              <div style="text-indent: -18pt; margin-left: 18pt;">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;50% Transaction success fee (de-SPAC/IPO) (first year only)</div>
              <div>&#160;</div>
              <div>Opportunity to elect cash or stock for bonus payment, subject to limits set by Board or Compensation Committee</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div>Management Equity</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div>45,000 RSUs of common stock issued at closing of de-SPAC IPO</div>
              <div>&#160;</div>
              <div>Vesting Period: Five years with twelve-month cliff vesting, then ratably over remaining vesting period, accelerated on termination without cause following a change from start date, accelerated on termination without cause following a
                change-in-control</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div>2025 Equity Incentive Plan </div>
              <div>Participation</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div>Executive eligible to receive additional equity compensation pursuant to the Company&#8217;s 2025 Equity Incentive Plan</div>
              <div>&#160;</div>
              <div>Target 200-400% of Base Salary with an initial grant of 60,000 shares; vesting period over three years (no vesting during the first six months (the &#8220;cliff period&#8221;)). After the six-month cliff period, the restricted stock units will vest
                in equal monthly installments over 30 months, subject to continued service with New XCF)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div>Benefits:</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: -18pt; margin-left: 36pt;">&#8226;&#160;&#160;&#160;&#160;&#160; Health/Group insurance</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div>Minimum 80% of premiums paid by Company</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: -18pt; margin-left: 36pt;">&#8226;&#160;&#160;&#160;&#160;&#160; Life insurance</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div>Up to 2x Base Salary, not to exceed $1 million; Employee may elect to add additional coverage at their own expense</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: -18pt; margin-left: 36pt;">&#8226;&#160;&#160;&#160;&#160;&#160; Phone subsidy</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div>Based on actual and reasonable phone bill incurred each month, with invoice</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: -18pt; margin-left: 36pt;">&#8226;&#160;&#160;&#160;&#160;&#160; Fitness and wellness subsidy</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div>$3,500 per year, based on actual amount incurred with invoice</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: -18pt; margin-left: 36pt;">&#8226;&#160;&#160;&#160;&#160;&#160; Retirement benefits (401(k) or other retirement plan as established by the Company)</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div>3% automatic match; 100% match on first 3% EE contributions</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: -18pt; margin-left: 36pt;">&#8226;&#160;&#160;&#160;&#160;&#160; Car allowance</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div>$830 per month or $9,960 per year</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: -18pt; margin-left: 36pt;">&#8226;&#160;&#160;&#160;&#160;&#160; Relocation benefits (if at the Company&#8217;s request)</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div>Based on actual expenses incurred and will cover:</div>
              <div style="text-indent: -18pt; margin-left: 36pt;">1.&#160;&#160;&#160;&#160;&#160; One-way flight costs for employee, spousal equivalent and dependents</div>
              <div style="text-indent: -18pt; margin-left: 36pt;">2.&#160;&#160;&#160;&#160;&#160; One-month temporary housing, based on actual amount, with invoice</div>
              <div style="text-indent: -18pt; margin-left: 36pt;">3.&#160;&#160;&#160;&#160;&#160; Moving costs (sea freight) for personnel effects, based on actual amount, with invoice</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;">Exhibit C</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">Form of Indemnification Agreement</div>
      <div>&#160;</div>
      <div style="text-align: center;">(attached)</div>
      <div>&#160;</div>
      <div> <br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.62
<SEQUENCE>17
<FILENAME>ef20050548_ex10-62.htm
<DESCRIPTION>EXHIBIT 10.62
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">



  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; font-weight: bold;"> Exhibit 10.62<br>
      </div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-weight: bold;">XCF Global, Inc.</div>
      <div style="text-align: center; font-weight: bold;">Employment Agreement</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">This Employment Agreement (this &#8220;Agreement&#8221;), dated as of June 6, 2025, is made by and between XCF Global, Inc. (the &#8220;Company&#8221;) and Jae Ryu (&#8220;Executive&#8221;) (the Company and Executive are collectively
        referred to herein as the &#8220;Parties,&#8221; or each individually referred to as a &#8220;Party&#8221;).</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">RECITALS</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold;">WHEREAS</font>, Executive has been serving as the Head of Land Development of XCF Global Capital, Inc. (&#8220;XCF Global Capital&#8221;);</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold;">WHEREAS</font>, on March 11, 2024, XCF Global Capital, Focus Impact BH3 Acquisition Company (&#8220;Focus Impact&#8221;), Focus Impact BH3 NewCo, Inc. (&#8220;NewCo&#8221;), Focus Impact
        BH3 Merger Sub 1, LLC and Focus Impact BH3 Merger Sub 2, Inc. entered into a business combination agreement (as it may be amended or restated from time to time, the &#8220;Business Combination Agreement&#8221;), pursuant to which Focus Impact agreed to combine
        with XCF Global Capital in a series of transactions that will result in NewCo becoming a publicly-traded company (collectively, the &#8220;Business Combination&#8221;), and at the closing of the Business Combination (the &#8220;Closing&#8221;), NewCo will change its name
        to &#8220;XCF Global, Inc.&#8221;; and</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold;">WHEREAS</font>, Executive and the Company desire to enter into this Agreement to set out the terms and conditions of the employment relationship between the Company
        and the Executive following the Closing of the Business Combination, with this Agreement to become effective upon the Closing of the Business Combination and continue until terminated by either Party in accordance with its terms (such period during
        which this Agreement is in effect, the &#8220;Term&#8221;) and will be null and void if the Closing of the Business Combination does not occur; and</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold;">WHEREAS</font>, except as otherwise provided herein, Executive and the Company intend and confirm that this Agreement supersedes in all respects all prior
        agreements, arrangements or understandings between Executive and the Company regarding the subject matter herein, including without limitation, any offer letter, employment agreement, consulting agreement or severance agreement as of the effective
        date of this Agreement.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold;">NOW, THEREFORE</font>, in consideration of the foregoing recitals, the mutual covenants and agreements set forth herein and for other good and valuable
        consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and Executive agree as follows:</div>
      <div>&#160;</div>
      <div style="text-align: justify;">1.&#160;&#160;&#160; &#160; &#160;&#160;&#160;&#160; <u>Employment</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>At-Will Employment</u>. Executive and the Company acknowledge that Executive&#8217;s employment is and shall continue to be at-will, as defined under applicable law, and that Executive&#8217;s
        employment with the Company may be terminated by either Party at any time for any or no reason (subject to the notice requirements of <u>Section 3(b)</u>). If Executive&#8217;s employment terminates for any reason, Executive shall only be entitled to
        those payments, benefits, awards or compensation as specifically provided in this Agreement or as otherwise agreed to in writing by the Company, or as provided by applicable law, and Executive shall not be entitled to any other payments, benefits,
        damages, award or compensation.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Title; Responsibilities</u>. The Company shall continue to employ Executive in the position of Head of Land Development reporting to the Chief Strategy Officer of the Company, and
        Executive hereby accepts such continued employment. During the Term, Executive shall have and perform such duties, responsibilities and authorities as are customarily associated with this position, as well as any other duties that may be assigned
        to Executive from time to time by the Chief Executive Officer or the Board of Directors (the &#8220;Board&#8221;) that are not inconsistent with service as an officer of the Company, including duties for any Company subsidiary or affiliate.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-align: justify; text-indent: 36pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Exclusive Employment</u>. During the Term, Executive shall devote substantially all of Executive&#8217;s business time, skills and best efforts to Executive&#8217;s employment hereunder and may
        not, without the prior written consent of the Board, participate in the management, operation, or control of, or act as an employee, officer, director, consultant, advisor, agent or representative of, any other business or service (&#8220;Other
        Service&#8221;); provided, however, that Executive may (i) engage in civic and charitable activities (including service on the board of directors or advisory board of civic and charitable organizations), (ii) make and manage outside passive personal and
        family investments and manage personal and family affairs and (iii) serve on the board of directors of the for-profit businesses or trade organizations (including advisory boards), provided, that none of the foregoing (x) materially interferes with
        Executive&#8217;s performance of Executive&#8217;s duties hereunder, (y) poses an actual or perceived conflict of interest or violates any other obligations of Executive hereunder (including, without limitation, <u>Sections 5</u> and <u>6</u> hereof) or (z)
        is prohibited by or conflicts with any applicable law or regulation (including the rules of any securities exchange on which the Company&#8217;s securities are listed) or any Company policy applicable to Executive. <u>Exhibit A</u> hereto identifies (i)
        any Other Service with respect to which the Board had provided its consent and (ii) any board of directors of any for-profit businesses or trade organizations (including advisory boards) on which Executive serves (as such Exhibit may be amended
        from time to time during the Term by mutual agreement of the Executive and the Board).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160; <u>Compliance</u>. Executive agrees to comply with all applicable laws, rules, regulations and policies relating to the performance of Executive&#8217;s duties and responsibilities as an
        employee of the Company, including, without limitation, compliance with the Company&#8217;s Code of Ethics and Business Conduct. Executive is prohibited from receiving economic benefits from any other person or entity other than the Company in connection
        with the services provided to the Company hereunder (for purposes of clarity, receipt of economic benefits from ownership of securities of the Company would not be prohibited under this provision, but would, for the avoidance of doubt, be subject
        to any insider trading policy maintained by the Company).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Employment Location</u>. Executive may work remotely from Executive&#8217;s residence or from such other location as Executive shall inform the Company. Notwithstanding the foregoing,
        Executive understands and agrees that in connection with the performance of Executive&#8217;s duties and responsibilities under this Agreement, the Company may require Executive to spend designated days per month in a designated Company office, provided,
        that the Company shall notify the Executive in advance of such requirement. In addition, Executive understands and agrees that in connection with the performance of Executive&#8217;s duties and responsibilities under this Agreement, Executive may be
        required to travel on Company business from time-to-time.</div>
      <div>&#160;</div>
      <div style="text-align: justify;">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Compensation</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Base Salary</u>. During the Term, Executive shall receive an annualized base salary in the amount of $200,000 (&#8220;Base Salary&#8221;), which will be paid in accordance with the Company&#8217;s
        customary payroll procedures as established and modified from time-to-time. The Base Salary will be reviewed annually and may be changed in the sole discretion of the Board and as recommended by the Board&#8217;s Compensation Committee (provided,
        however, if pursuant to the listing requirements of any securities exchange on which the Company&#8217;s securities are then listed, Executive&#8217;s compensation must be set or approved in a different manner, Executive&#8217;s compensation shall be set or approved
        in accordance with such requirements), and any such revised Base Salary shall then constitute &#8220;Base Salary&#8221; for purposes of this Agreement.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><a name="z_Ref196419530"></a>(b)&#160;&#160;&#160;&#160;&#160;&#160; <u>Annual Bonus</u>. In addition to the Base Salary, Executive shall be eligible for an annual bonus for each completed fiscal year of employment during the
        Term (&#8220;Annual Bonus&#8221;).&#160; The terms of Executive&#8217;s initial Annual Bonus are as set forth on <u>Exhibit B</u> to this Agreement, and the terms of the Annual Bonus for subsequent years shall be determined by the Board, upon the recommendation of the
        Board&#8217;s Compensation Committee for each such subsequent year of employment as set forth herein. Executive understands and agrees that this Agreement does not guarantee the payment of any Annual Bonus and that the actual Annual Bonus payable will be
        based on the achievement of performance objectives and/or other criteria as determined by the Board and recommended by the Board&#8217;s Compensation Committee and such other factors as the Compensation Committee, in its discretion, deems relevant
        (provided, however, if pursuant to the listing requirements of any securities exchange on which the Company&#8217;s securities are then listed, Executive&#8217;s compensation, including any bonus compensation, must be set or approved in a different manner,
        Executive&#8217;s compensation shall be set or approved in accordance with such requirements). Unless otherwise agreed by the Parties and subject to <u>Section 4(c)(ii)</u>, if an Annual Bonus is awarded, such Annual Bonus shall be deemed &#8220;earned&#8221; and
        Executive is entitled to receive payment of such Annual Bonus only if Executive is employed by the Company on the date the Annual Bonus is paid. Any Annual Bonus payable in accordance with this <u>Section 2(b)</u> shall be paid to Executive no
        later than March 15<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> of the calendar year following the year to which it relates. Executive&#8217;s Annual Bonus for 2025 (to the extent earned) will be prorated to reflect
        the portion of the year from the Closing of the Business Combination.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Equity Compensation</u>.&#160; As soon as practicable following the Closing of the Business Combination and subject to Board approval, Executive shall receive an initial award of
        restricted stock units as set forth on <u>Exhibit B</u>, subject to Executive&#8217;s continued employment through the date of grant, which award shall be subject in all respect to the term and conditions of the Company&#8217;s 2025 Equity Incentive Plan (the
        &#8220;2025 Plan&#8221;) and the applicable award agreement to be delivered separately to Executive. In addition, Executive shall be eligible to receive additional equity compensation pursuant to the 2025 Plan or such other plans or arrangements as determined
        by the Board or Compensation Committee from time to time. The complete terms and conditions of any future equity compensation award made pursuant to the 2025 Plan or any other equity plan adopted by the Company, including vesting, exercise and
        forfeiture terms, shall be set forth in an award agreement and any such award shall be subject to the terms and conditions set forth in such award agreement and the 2025 Plan or such other equity plan adopted by the Company.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160; <u>Benefits</u>. During the Term, Executive shall be eligible to participate in such health, group insurance, welfare, pension, and other employee benefit plans, programs, and
        arrangements as are made generally available from time to time to senior executives of the Company (which shall include customary health, life insurance, and disability plans). Executive also shall be eligible to participate in the Company&#8217;s 2025
        Employee Stock Purchase Plan or any similar or replacement plan adopted in the future during the Term. Executive also shall be eligible for 25 days of paid time off (&#8220;PTO&#8221;) per calendar year during the Term (prorated for partial years) in
        accordance with the Company&#8217;s vacation and PTO policy in effect from time to time, inclusive of vacation days and sick days and excluding standard paid Company holidays.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Expenses and Allowances</u>. Executive shall receive reimbursement from the Company for all reasonable, necessary, and documented business expenses incurred in connection with
        Executive&#8217;s employment hereunder, provided, that such expenses are timely submitted for reimbursement with supporting documentation in accordance with the Company&#8217;s expense reimbursement policies and procedures. In addition, Executive will receive
        reimbursement for the additional fees and expenses incurred by Executive as set forth on <u>Exhibit B</u> (subject to Executive provided sufficient documentation for such reimbursements).</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify;"><a name="z_Ref196419549"></a>3.&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Termination</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Termination Circumstances</u>.&#160; Executive&#8217;s employment hereunder may be terminated by the Company or Executive, as applicable, under the following circumstances, and the Term will
        end on the Date of Termination:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Death</font>. Executive&#8217;s employment hereunder shall terminate automatically upon Executive&#8217;s death.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><a name="z_Ref196420361"></a>(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Disability</font>. If Executive has incurred a Disability, the Company may terminate Executive&#8217;s
        employment.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Termination for Cause</font>. The Company may terminate Executive&#8217;s employment for Cause.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><a name="z_Ref196420380"></a>(iv)&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Termination without Cause</font>. The Company may terminate Executive&#8217;s employment without Cause for any
        reason or no reason.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Resignation from the Company with Good Reason</font>. Executive may resign Executive&#8217;s employment with the Company with Good Reason.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(vi)&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Resignation from the Company without Good Reason</font>. Executive may resign Executive&#8217;s employment with the Company for any reason
        other than Good Reason or for no reason.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><a name="z_Ref196419448"></a>(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Notice of Termination</u>. Any termination of Executive&#8217;s employment by the Company or by Executive under this <u>Section 3</u> (other than termination
        as a result of Executive&#8217;s death) shall be communicated by a written notice by the terminating Party to the other Party hereto (i) indicating the specific termination provision in this Agreement being relied upon, (ii) setting forth in reasonable
        detail the facts and circumstances claimed to provide a basis for termination of employment under the provision so indicated, if applicable, and (iii) specifying a Date of Termination (such notice, a &#8220;Notice of Termination&#8221;).&#160; If the Notice of
        Termination is submitted by Executive, such Notice of Termination shall be given at least thirty (30) days prior to the Date of Termination; provided, however, that in the event that Executive delivers a Notice of Termination to the Company, the
        Company may, in its sole discretion, change the Date of Termination to any date that occurs following the date of the Company&#8217;s receipt of such Notice of Termination and which is prior to the date specified by Executive in such Notice of
        Termination, but such termination still shall be considered a resignation by Executive, unless the Company has determined that Cause exists as of such earlier Date of Termination. A Notice of Termination submitted by the Company may provide for a
        Date of Termination on the date Executive receives the Notice of Termination or any date thereafter elected by the Company. The failure by either Party to set forth in the Notice of Termination any fact or circumstance which contributes to a
        showing of Cause or Good Reason shall not waive any right of the Party hereunder or preclude the Party from asserting such fact or circumstance in enforcing the Party&#8217;s rights hereunder.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Company Obligations upon Termination</u>. Upon termination of Executive&#8217;s employment pursuant to any of the circumstances set forth in this <u>Section 3</u>, Executive (or
        Executive&#8217;s estate) shall be entitled to receive the sum of (i) the portion of Executive&#8217;s Base Salary earned for the applicable year through the Date of Termination, but not yet paid to Executive, payable on the pay date immediately following the
        Date of Termination in accordance with the Company&#8217;s regular payroll practices (or such earlier date as required by applicable law), (ii) any expense reimbursements owed to Executive pursuant to this Agreement, payable in accordance with the
        Company&#8217;s expense reimbursement policy and (iii) any amount accrued and arising from Executive&#8217;s participation in, or benefits accrued under any employee benefit plans, programs or arrangements, which amounts shall be payable in accordance with the
        terms and conditions of such employee benefit plans, programs or arrangements (the &#8220;Company Arrangements&#8221; and the entitlements referenced in the foregoing clauses (i) through (iii), collectively, the &#8220;Accrued Benefits&#8221;).</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Effect on Equity Awards</u>. The effect of Executive&#8217;s termination on any equity awards received by Executive prior to such termination shall be determined in accordance with the
        terms of the 2025 Plan (or any other equity plan adopted by the Company pursuant to which such awards were made), the award agreement relating to any such award and/or <u>Section 4(b)</u> below, and in the case of a termination relating to a
        Change in Control, <u>Section 4(c)</u> below.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><a name="z_Ref196419944"></a>4.&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Severance Payments</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><a name="z_Ref196419879"></a>(a)&#160;&#160;&#160;&#160; &#160; &#160; <u>Termination Upon Death or Disability</u>. In the event of Executive&#8217;s termination of employment due to death or Disability (as defined below) during the
        Term, the Company shall pay to or for the benefit of Executive or Executive&#8217;s estate, as applicable, the Accrued Benefits and, to the extent unpaid as of the Date of Termination, the Company shall pay Executive the amount of Executive&#8217;s Annual
        Bonus for the prior year, paid as set forth in <u>Section 2(b)</u> as if no such termination had occurred.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><a name="z_Ref196419584"></a>(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Termination for Cause; Resignation from the Company Without Good Reason</u>. If Executive&#8217;s employment shall terminate for Cause, or due to Executive&#8217;s
        resignation from the Company without Good Reason, then Executive shall receive the Accrued Benefits.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><a name="z_Ref196419589"></a>(c)&#160;&#160;&#160;&#160; &#160; &#160; <u>Termination without Cause, or Resignation from the Company with Good Reason</u>. If Executive&#8217;s employment is terminated without Cause or due to
        Executive&#8217;s resignation with Good Reason (in each case, a &#8220;Qualifying Termination&#8221;) that does not occur during the CIC Period (as defined below), in addition to the Accrued Benefits, Executive shall be entitled to the following payments and
        benefits:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Company shall pay Executive an amount in cash equal to, in the aggregate, 100% of the Executive&#8217;s annual base salary in effect as of the Date of the Termination,
        payable in equal monthly installments over the 12 month period following the Date of Termination, in accordance with the Company&#8217;s normal payroll practices;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><a name="z_Ref196419502"></a>(ii)&#160;&#160;&#160;&#160;&#160;&#160; To the extent unpaid as of the Date of Termination, the Company shall pay Executive the amount of Executive&#8217;s Annual Bonus for any unpaid
        prior period, paid as set forth in <u>Section 2(b)</u> as if no such termination had occurred;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160; The Company shall pay Executive an amount in cash equal to 100% of the amount of the annual bonus that Executive would have earned for the year in which the Date of
        Termination occurs as if Executive had not been terminated and as if such annual bonus was fully earned (i.e., any relevant performance criteria shall be deemed fully achieved)(such payment, the (&#8220;Termination Bonus Payment&#8221;), which amount will be
        paid in a lump sum within thirty (30) days following the date Executive&#8217;s Release becomes effective and irrevocable, provided that to the extent the annual bonus for the year in which the Date of Termination occurs has been pro-rated to reflect
        that portion of the year from the Closing of the Business Combination to the end of such year, or in the event of any other partial-year calculation, the annual bonus amount for such year shall be adjusted for purposes of calculating the
        Termination Bonus Payment so as to reflect the bonus amount that would have been paid for a full year as if there had there been no such pro-ration (the &#8220;Full-Year Equivalent&#8221;) and in no event shall the Termination Bonus Payment be calculated based
        on an amount other than the Full-Year Equivalent, irrespective of partial-year employment;</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">5</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><a name="z_Ref196419671"></a>(iv)&#160;&#160;&#160;&#160;&#160; If Executive timely elects continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (&#8220;COBRA&#8221;),
        then the Company shall directly pay, or reimburse Executive for, the COBRA premiums for Executive&#8217;s and Executive&#8217;s covered dependents&#8217; continued participation under the Company&#8217;s group health plan (to the extent permitted under applicable law and
        the terms of such plan), less the amount Executive would have had to pay to receive such coverage as an active employee based on the cost sharing levels in effect on the Date of Termination, during the period commencing on the Date of Termination
        and ending upon the earliest of (A) eighteen (18) months following the Date of Termination, (B) the date that Executive and/or Executive&#8217;s covered dependents become no longer eligible for COBRA or (C) the date that Executive becomes eligible to
        receive group health benefits from a subsequent employer (and Executive agrees to promptly notify the Company of such eligibility); provided, that the Company may modify the continuation coverage contemplated this <u>Section 4(c)(iv)</u> to the
        extent reasonably necessary, as determined by the Company in its sole discretion, to avoid potentially violating applicable law or incurring an excise tax for failure to comply with applicable law (including, without limitation, Section 2716 of the
        Public Health Service Act; Section 105(h) of the Internal Revenue Code of 1986, as amended; the Patient Protection and Affordable Care Act of 2010, as amended; and/or the Health Care and Education Reconciliation Act of 2010, as amended, and in each
        case, the regulations and guidance promulgated thereunder (to the extent applicable)).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><a name="z_Ref196419765"></a>(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Qualifying Termination in Connection with Change in Control</u>. In the event of a Qualifying Termination that occurs (i) not more than three (3) months
        prior to a Change in Control or (ii) on or within twelve (12) months after a Change in Control (such period, the &#8220;CIC Period&#8221;), Executive shall be entitled to receive, in addition to the Accrued Benefits, the following payments and benefits set
        forth in (i) through (iv) below, in each case, subject to (v) below:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Company shall pay Executive an amount in cash equal to, in the aggregate, 200% of the Executive&#8217;s annual base salary in effect as of the Date of the Termination,
        payable as a one-time payment to be made by the Company to the Executive (A) within thirty (30) days of the Release Effective Date, if the termination occurs following the Change of Control, or (B) within thirty (30) days of the consummation of the
        Change of Control (or such later date that is thirty (30) days following the Release Effective Date), if the termination occurred prior to the Change in Control;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160; To the extent unpaid as of the Date of Termination (or, if later, the consummation of the Change in Control), the Company shall pay Executive the amount of
        Executive&#8217;s Annual Bonus for any unpaid prior period, paid as set forth in <u>Section 2(b),</u> as if no such termination had occurred;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(iii)&#160;&#160;&#160;&#160;&#160; The Company shall pay Executive an amount in cash equal to the Termination Bonus Payment, payable as a one-time payment to be made by the Company to the Executive (A)
        within thirty (30) days of the date Executive&#8217;s Release becomes effective and irrevocable, if the termination occurs following the Change of Control, or (B) within thirty (30) days of the date of the Change of Control (or such later date that is
        thirty (30) days following the date Executive&#8217;s Release becomes effective and irrevocable), if the termination occurred prior to the Change of Control, provided that to the extent the annual bonus for the year in which the Date of Termination
        occurs has been pro-rated to reflect that portion of the year from the Closing of the Business Combination to the end of such year, or in the event of any other partial-year calculation, the annual bonus amount for such year shall be adjusted for
        purposes of calculating the Termination Bonus Payment so as to reflect the bonus amount that would have been paid for a full year as if there had there been no such pro-ration (the &#8220;Full-Year Equivalent&#8221;) and in no event shall the Termination Bonus
        Payment be calculated based on an amount other than the Full-Year Equivalent, irrespective of partial-year employment;</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">6</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(iv)&#160; &#160; &#160;&#160; Any restricted stock, restricted stock units, options, or other equity grants or awards not vested at the time of termination shall be accelerated and become
        immediately vested (and, for any such awards as to which vesting is based on meeting specified performance criteria, such awards will be considered vested as if the relevant performance criteria was fully achieved), such that Executive will
        thereafter be 100% vested in any restricted stock, restricted stock units, options, or other equity grants awarded by the Company to Executive during the Term; and</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The COBRA continuation benefits set forth in <u>Section 4(c)(iv)</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(vi)&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Non-Duplication of Payment or Benefits</font>.&#160; If (A) Executive&#8217;s Qualified Termination occurs prior to a Change in Control that
        qualifies the Executive for severance payments and benefits under <u>Section 4(d)</u> and (B) a Change in Control occurs within the six (6)-month period following the Executive&#8217;s Qualified Termination that qualifies the Executive for severance
        payments and benefits under <u>Section 4(c)</u>, then (1) the Executive will cease receiving any further payments or benefits under <u>Section 4(c)</u> and (2) the Executive will receive the payments and benefits under <u>Section 4(d)</u>
        instead but each of the payments and benefits otherwise payable under <u>Section 4(d)</u> will be offset by the corresponding payments or benefits the Executive already received under <u>Section 4(c)</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Release; Exclusive Remedy; Resignation</u>.&#160; Executive&#8217;s right to receive the payments and benefits specified in Section 4(a), <u>Section 4(b)</u> and <u>Section 4(c)</u>
        (collectively, the &#8220;Severance Benefits&#8221;) are subject to (i) Executive&#8217;s continued compliance with all restrictive covenant obligations with respect to the Company and its affiliates (including, without limitation, <u>Sections 5</u> and <u>6</u>
        hereof) and (ii) Executive (or Executive&#8217;s estate, as applicable) signing and delivering to the Company and not revoking a separation agreement and release of any claims against the Company, its affiliates, and their employees, officers, directors,
        and shareholders arising out of Executive&#8217;s employment or termination in a form reasonably acceptable to the Company that becomes effective and irrevocable within sixty (60) days following the Date of Termination (such agreement, the &#8220;Release&#8221; and
        such date the Release becomes effective and irrevocable, the &#8220;Release Effective Date&#8221;). The first payment of any Severance Benefits will include all amounts that otherwise would have been due prior thereto under the terms of this Agreement had such
        payments commenced immediately upon the Date of Termination. Any delay in the payment of the Severance Benefits will not extend the period of time that the Severance Benefits are payable pursuant to <u>Section 4</u>. During such time that the
        Executive is receiving the Severance Benefits, if (A) the Company discovers grounds constituting Cause existed before the Executive&#8217;s termination or (B) Executive breaches any of the covenants set forth in <u>Sections 5</u> and <u>6</u>, the
        Executive&#8217;s right to receive the Severance Benefits will immediately cease and be forfeited.&#160; Except as otherwise expressly required by law (e.g., COBRA) or as specifically provided in this Agreement, all of Executive&#8217;s rights to salary, severance,
        benefits, bonuses and other compensatory amounts hereunder (if any) shall cease upon the termination of Executive&#8217;s employment hereunder, and the amounts payable to Executive following termination pursuant to <u>Sections 3</u> and <u>4</u> hereof
        will be in full and complete satisfaction of Executive&#8217;s rights under this Agreement and any other claims that Executive may have in respect of employment with the Company or any of its affiliates, and Executive acknowledges that such amount
        amounts are fair and reasonable and are Executive&#8217;s sole and exclusive remedy, in lieu of all other remedies at law or in equity, with respect to the termination of the Term or any breach of this Agreement by the Company. Upon any termination of
        the Term, Executive will promptly resign, and will be deemed to have automatically resigned, from all positions that Executive holds as a member of the Board, officer, director or fiduciary of the Company or any of its affiliates, and Executive
        will take all actions reasonably requested by the Company or its affiliates to give effect to the foregoing.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">7</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify;"><a name="z_Ref196419467"></a>5.&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Confidentiality; Intellectual Property</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><a name="z_Ref196420018"></a>(a)&#160;&#160;&#160;&#160;&#160;&#160; <u>Confidentiality</u>. Executive recognizes and acknowledges that the continued success of the Company depends upon the use and protection of Confidential
        Information, which constitutes valuable trade secrets of the Company. Executive agrees to use the Confidential Information only during the Term in connection with the proper performance of Executive&#8217;s duties as an employee hereunder; otherwise,
        Executive shall not, directly or indirectly, use or disclose the Confidential Information for any other purpose or to any third party. The restrictions set forth herein are in addition to and not in lieu of any obligations Executive may have by law
        with respect to the Confidential Information, including any fiduciary duties or other obligations Executive may owe under any applicable trade secrets statutes or other state or federal laws.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><a name="z_Ref196419999"></a>(b)&#160;&#160;&#160;&#160;&#160;&#160; <u>Intellectual Property</u>. Executive acknowledges and agrees that all inventions, know-how, trade secrets, technology, programming, software, processes,
        innovations, ideas, improvements, developments, methods, algorithms, designs, analyses, writings, audiovisual works, works of authorship, concepts, drawings, reports and all similar, related, or derivative information or works (whether or not
        patentable or subject to copyright), including but not limited to all resulting patent applications, issued patents, copyrights, copyright applications and registrations in and to any of the foregoing, along with the right to practice, employ,
        exploit, use, develop, reproduce, copy, distribute copies, publish, license, or create works derivative of any of the foregoing, and the right to choose not to do or permit any of the aforementioned actions, that are conceived, authored, reduced to
        practice, created, or otherwise developed by Executive during the Term (whether alone or jointly with others) (collectively, the &#8220;Work Product&#8221;) belong to the Company, and not Executive; provided that Work Product excludes, and this <u>Section
          5(b)</u> does not apply to an invention for which no equipment, supplies, facilities, or trade secret information of the Company or its affiliates (whether existing now or in the future) and which was developed entirely on Executive&#8217;s own time,
        unless (i) the invention relates (A) to the business of the Company or its affiliates (whether existing now or in the future), or (B) to the Company&#8217;s (or its affiliates&#8217; (whether existing now or in the future)) actual or demonstrably anticipated
        research or development, or (ii) the invention results from any work performed by Executive for the Company or its affiliates (whether existing now or in the future). Executive further acknowledges and agrees that to the extent relevant, this
        Agreement constitutes a &#8220;work for hire agreement&#8221; under the United States Copyright Act of 1976, as amended (&#8220;Copyright Act&#8221;), and that any copyrightable work (&#8220;Creation&#8221;) constitutes a &#8220;work made for hire&#8221; under the Copyright Act such that the
        Company is the copyright owner of the Creation. Executive hereby irrevocably assigns and agrees to assign to the Company all right, title and interest in and to all Work Product and, to the extent any Creation or portion thereof is not a &#8220;work for
        hire&#8221;, all Creations. Executive will promptly disclose and deliver such Work Product and Creations to the Company and, at the Company&#8217;s expense, perform all actions reasonably requested by the Company (whether during or after the Term to
        effectuate, establish, confirm, record or protect such ownership, or to protect or enforce the Company&#8217;s rights therein (including, without limitation, the execution of assignments, copyright registrations, consents, licenses, powers of attorney
        and other instruments).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Permitted Disclosures</u>. Nothing in this Agreement shall be construed to prevent disclosure of Confidential Information as may be required by applicable law or regulation, or
        pursuant to the valid order of a court of competent jurisdiction or an authorized government agency, provided that the disclosure does not exceed the extent of disclosure required by such law, regulation, or order, or in connection with an
        investigation by or report to any regulatory agency with jurisdiction over the Company, law enforcement, or any other federal or state regulatory or self-regulatory authority. In compliance with 18 U.S.C. &#167; 1833(b), as established by the Defend
        Trade Secrets Act of 2016, Executive is given notice of the following: (i) that an individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that (A) is made (1) in
        confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney; and (2) solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other
        document filed in a lawsuit or other proceeding, if such filing is made under seal; and (ii) that an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the
        attorney of the individual and use the trade secret information in the court proceeding, if the individual (A) files any document containing the trade secret under seal; and (B) does not disclose the trade secret, except pursuant to court order.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">8</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Return of Property</u>. Upon separation from employment or earlier request from the Company, Executive shall return to the Company any and all Company property, including keys,
        access cards, identification cards, credit cards, business cards, laptop, smartphone, other electronic equipment, reports, files, manuals, Work Product, Creations, emails, recordings, thumb drives or other removable information storage devices, and
        data and all Company documents and materials belonging to the Company and stored in any fashion, including but not limited to those that constitute or contain any Confidential Information or Work Product, Creations, that are in the possession or
        control of the Executive, relating to Executive&#8217;s employment by the Company. Without limiting the foregoing or Executive&#8217;s obligations under <u>Section 5(a)</u>, upon separation from employment or earlier request from the Company, Executive shall
        not retain possession or control of any Confidential Information and shall instead return such Confidential Information to the Company or destroy it.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><a name="z_Ref196419475"></a>6.&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>Restrictive Covenants</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>No Solicitation of Customers</u>. Executive agrees that, both during the Term and for the period ending on the date that is eighteen (18) months from the date of the termination of
        the Executive&#8217;s employment with the Company at any time and for any reason (the &#8220;Restricted Period&#8221;), Executive will not solicit any Restricted Business (as defined below) from any person or entity that is, or in the prior twelve (12) months was a
        customer of the Company or any of its affiliates or any prospective customer of the Company or any of its affiliates with respect to which the Company or its affiliates actively solicits or has solicited the sale of Company products and services.
        For purposes of this Agreement, &#8220;Restricted Business&#8221; shall mean the business of manufacturing, marketing and selling renewable fuels (including, but not limited to, renewable diesel fuel and sustainable aviation fuel (SAF)) and constructing,
        acquiring, investing in and/or operation facilities for the production of renewable fuels (including, but not limited to, renewable diesel fuel and sustainable aviation fuel (SAF)). Notwithstanding the foregoing, Executive shall not be prohibited
        from the passive ownership of up to two percent (2%) of the securities of any entity engaged in any Restricted Business, where the securities of such entity are traded on a national securities exchange.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>No Solicitation of Employees</u>. Executive agrees that during the Restricted Period, Executive will not, directly or indirectly, on behalf of himself or any other person or entity,
        hire, solicit, take away or attempt to hire, solicit or take away any person who is (or in the preceding six months was), at the time of such solicitation, an employee, director or independent contractor of the Company or any of its affiliates,
        either on behalf of himself or any other person or entity. This includes, but is not limited to, inducing or attempting to induce, or influencing or attempting to influence, any person employed by the Company or its affiliates to terminate his or
        her employment with the Company or any such affiliate.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">9</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><a name="z_Ref196420422"></a>(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Importance of Executive&#8217;s Services; Intent of the Parties; Enforcement</u>. Executive acknowledges and agrees that the services to be provided by
        Executive under this Agreement are of a special, unique and extraordinary nature. Executive further acknowledges and agrees that the covenants and restrictions contained in <u>Section 5</u> and <u>Section 6</u> are necessary to prevent the use
        and disclosure of Confidential Information and to protect other legitimate business interests of the Company and its affiliates. Executive acknowledges that all of the covenants and restrictions in <u>Section 5</u> and <u>Section 6</u> are
        reasonable in all respects, including duration, territory and scope of activity. Executive acknowledges and agrees that the Company competes with businesses on a world-wide basis and that the geographic restrictions contained herein are therefore
        reasonable and necessary to protect the Company&#8217;s legitimate business interests. Executive agrees that the covenants and restrictions contained in <u>Section 5</u> and <u>Section 6</u> shall be construed as separate agreements independent of any
        other provision of this Agreement or any other agreement between Executive and the Company. Executive agrees that the existence of any claim or cause of action by Executive against the Company or its affiliates, whether predicated on this Agreement
        or otherwise, shall not constitute a defense to the enforcement by the Company of the covenants and restrictions in <u>Section 5</u> and <u>Section 6</u>. Executive agrees that the restrictive covenants contained in <u>Section 5</u> and <u>Section
          6</u> are a material part of Executive&#8217;s obligations under this Agreement for which the Company has agreed to compensate the Executive as provided in this Agreement. The Executive agrees that the injury the Company will suffer in the event of the
        breach by Executive of any clause of <u>Section 5</u> and <u>Section 6</u> will cause the Company and its affiliates irreparable injury that cannot be adequately compensated by monetary damages alone. Therefore, Executive agrees that the Company,
        without limiting any other legal or equitable remedies available to it, shall be entitled to obtain equitable relief by injunction or otherwise from any court of competent jurisdiction, including, without limitation, injunctive relief to prevent
        Executives&#8217; failure to comply with the terms and conditions of <u>Section 5</u> and <u>Section 6</u>. The time year periods referenced in <u>Section 5</u> and <u>Section 6</u> shall be extended on a day-for-day basis for each day during which
        Executive violates the provisions of <u>Section 5</u> and <u>Section 6</u> in any respect, so that Executive is restricted from engaging in the activities prohibited by <u>Section 5</u> and <u>Section 6</u> for the full time period, as
        applicable.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Whistleblower Protection</u>.&#160; Notwithstanding anything to the contrary contained herein, no provision of this Agreement or any other agreement or Company policy will be interpreted
        so as to impede Executive (or any other individual) from (i) making any disclosure of relevant and necessary information or documents in any action, investigation, or proceeding relating to this Agreement, or as required by law or legal process,
        including with respect to possible violations of law, (ii) participating, cooperating, or testifying in any action, investigation, or proceeding with, or providing information to, any governmental agency, legislative body or any self-regulatory
        organization, including, but not limited to, the Department of Justice, the Securities and Exchange Commission, the Congress, and any agency Inspector General, (iii) seeking or accepting any U.S. Securities and Exchange Commission awards or other
        relief in connection with protected whistleblower activity, or (iv) making other disclosures under the whistleblower provisions of federal law or regulation. In addition, nothing in this Agreement or any other agreement or Company policy prohibits
        or restricts Executive from initiating communications with, or responding to any inquiry from, any administrative, governmental, regulatory or supervisory authority regarding any good faith concerns about possible violations of law or regulation.
        Executive does not need the prior authorization of the Company to make any such reports or disclosures and the Executive will not be required to notify the Company that such reports or disclosures have been made.</div>
      <div>&#160;</div>
      <div style="text-align: justify;">7.&#160;&#160;&#160; &#160;&#160; &#160;&#160;&#160; <u>Other Agreements</u>. Executive represents and agrees that Executive&#8217;s performance of Executive&#8217;s duties for the Company shall not violate any agreements, obligations or understandings that Executive
        may have with any third party or prior employer. Without limiting the foregoing, Executive represents and agrees that Executive is not bound by any non-compete or non-solicitation agreement or any other type of agreement that would prohibit
        Executive&#8217;s employment with the Company. Executive agrees not to make any unauthorized disclosure or use, on behalf of the Company, of any confidential information belonging to any of Executive&#8217;s former employers. Executive also represents that
        Executive is not in unauthorized possession of any materials containing a third party&#8217;s confidential and proprietary information.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><a name="z_Ref196420129"></a>8.&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Cooperation with Company</u>. During Executive&#8217;s employment by the Company and thereafter, Executive will cooperate with the Company and its affiliates in any internal
        investigation or administrative, regulatory or judicial proceeding that relates to events occurring during Executive&#8217;s employment hereunder and as reasonably requested by the Company (including being available upon reasonable notice from the
        Company for interviews and factual investigations and appearing at the Company&#8217;s request to give testimony without requiring service of a subpoena or other legal process, all at times and on schedules that are reasonably consistent with Executive&#8217;s
        other permitted activities and commitments). In the event the Company requires Executive&#8217;s cooperation in accordance with this <u>Section 8</u> following the termination of Executive&#8217;s employment, the Company (or its applicable affiliate) will
        reimburse Executive for reasonable expenses incurred by Executive in connection therewith.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">10</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify;">9.&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>Tax Provisions</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Withholding</u>. All amounts payable to Executive under this Agreement will be subject to all required tax and other designated or required withholdings and deductions. In the event
        that the Company fails to withhold any taxes required to be withheld by applicable law or regulation, Executive agrees to indemnify the Company for any taxes of Executive that should have been withheld.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><a name="z_Ref196420236"></a>(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Section 280G</u>. To the extent that any amount payable to Executive hereunder, as well as any other &#8220;parachute payment&#8221; as such term is defined under
        Section 280G (collectively with the regulations promulgated thereunder, &#8220;Section 280G&#8221;) of the Code, payable to Executive ( the &#8220;Covered Payments&#8221;), exceeds the limitations&#160; of Section 280G such that an excise tax will be imposed under Section 4999
        of the Code (the &#8220;Excise Tax&#8221;), then, before making the Covered Payments, a calculation will be made comparing (i) the Net Benefit (as defined below) to Executive of the Covered Payments after payment of the Excise Tax to (ii) the Net Benefit to
        Executive if the Covered Payments are limited to the extent necessary to avoid being subject to the Excise Tax. Only if the amount calculated under (i) above is less than the amount under (ii) above will the Covered Payments be reduced to the
        minimum extent necessary to ensure that no portion of the Covered Payments is subject to the Excise Tax. &#8220;Net Benefit&#8221; will mean the present value of the Covered Payments net of all federal, state, local, foreign income, employment and excise
        taxes. Any such reduction will be made by the Company in its sole discretion consistent with the requirements of Section 409A of the Code. If two economically equivalent amounts are subject to reduction but are payable at different times, the
        amounts will be reduced (but not below zero) on a pro rata basis. Notwithstanding the foregoing, the Board (or a committee of the Board composed entirely of independent directors) may, in its sole discretion and on a case-by-case basis, approve a
        gross-up payment (a &#8220;Limited Gross-Up&#8221;) to Executive in an amount sufficient to place Executive in the same after-tax position as if no Excise Tax had been imposed, but only to the extent the Excise Tax results from a reduced base amount due to (i)
        a limited period of service with the Company prior to the Change in Control, or (ii) other structural features not attributable to Executive&#8217;s actions or compensation demands. Any such Limited Gross-Up shall be subject to compliance with Section
        409A of the Code, and may be conditioned upon Executive providing reasonable cooperation with tax planning or mitigation strategies.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Section 409A</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><a name="z_Ref196420209"></a>(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; To the extent required by Section 409A of the Code, all references to &#8220;termination of employment&#8221; and correlative phrases for purposes of
        this Agreement shall be construed to require a &#8220;separation from service&#8221; (as defined in Section 1.409A-1(h) of the Treasury regulations after giving effect to the presumptions contained therein).</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">11</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160; Notwithstanding any provision in this Agreement to the contrary, to the extent that (i) any payments or benefits to which Executive becomes entitled under this
        Agreement or any other agreement, policy, plan, program or arrangement with the Company, in connection with Executive&#8217;s termination of employment with the Company constitute &#8220;nonqualified deferred compensation&#8221; subject to Section 409A of the Code
        and (ii) Executive is deemed at the time of such termination of employment to be a &#8220;specified employee&#8221; under Section 409A of the Code, then such payments or benefits shall not be made or commence until the earliest of (1) the expiration of the six
        (6) month and one day period measured from the date of Executive&#8217;s separation from service (as defined in <u>Section 9(c)(i)</u> above) from the Company or (2) the date of Executive&#8217;s death following such separation from service; provided,
        however, that such deferral shall only be effected to the extent required to avoid adverse tax treatment to Executive, including (without limitation) the additional twenty-percent (20%) tax for which Executive would otherwise be liable under
        Section 409A(a)(1)(b) of the Code in absence of such deferral. Upon the expiration of the applicable deferral period, any payments which would have otherwise been made during that period (whether in a single sum or in installments) in the absence
        of this <u>Section 9(b)</u> shall be paid to Executive or Executive&#8217;s beneficiary in one lump sum. For purposes of this <u>Section 9(b)</u>, the term &#8220;specified employee&#8221; means an individual determined by the Company to be a specified employee
        under Treasury regulation Section 1.409A-1(i) in accordance with the policies of the Company.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(iii)&#160; &#160;&#160; &#160; It is intended that each installment of any benefits or payments provided hereunder constitute a separate payment for purposes of Treasury Regulation Section
        1.409A-2(b)(2)(i). The Company and Executive intend that all the benefits and payments provided under this Agreement shall be exempt from, or comply with, the requirements of Section 409A of the Code and the provisions of the Agreement shall be
        read in accordance with that intent. It is further intended that payments hereunder satisfy, to the greatest extent possible, the exemptions from the application of Section 409A of the Code (and any state law of similar effect) provided under
        Treasury Regulations Section 1.409A-1(b)(4) (as a &#8220;short-term deferral&#8221;) and Section 1.409A-1(b)(9) (as &#8220;separation pay due to involuntary separation&#8221;). To the extent that any provision hereof is modified in order to comply with Section 409A, such
        modification will be made in good faith and will, to the maximum extent reasonably possible, maintain the original intent and economic benefit to Executive and the Company of the applicable provision without violating the provisions of Section
        409A. The Company makes no representation or warranty and shall have no liability to Executive or any other person if any provisions of this Agreement are determined to constitute deferred compensation subject to Section 409A of the Code but do not
        satisfy an exemption from, or comply with the conditions of, such Section.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(iv)&#160;&#160;&#160;&#160;&#160; Except as otherwise expressly provided herein, to the extent any expense reimbursement or the provision of any in-kind benefit under this Agreement is determined to
        constitute &#8220;nonqualified deferred compensation&#8221; subject to Section 409A of the Code, the amount of any such expenses eligible for reimbursement, or the provision of any in-kind benefit, in one calendar year shall not affect the expenses eligible
        for reimbursement in any other taxable year (except for any lifetime or other aggregate limitation applicable to medical expenses), in no event shall any expenses be reimbursed after the last day of the calendar year following the calendar year in
        which Executive incurred such expenses, and in no event shall any right to reimbursement or the provision of any in-kind benefit be subject to liquidation or exchange for another benefit.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Whenever a payment under this Agreement specifies a payment period with reference to a number of days, the actual date of payment within the specified period is
        within the sole discretion of the Company.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(vi)&#160;&#160;&#160;&#160; Notwithstanding any provision in this Agreement to the contrary, to the extent that any payments or benefits to which Executive becomes entitled under this Agreement or
        any other agreement, policy, plan, program or arrangement with the Company, in connection with Executive&#8217;s termination of employment with the Company constitute &#8220;nonqualified deferred compensation&#8221; subject to Section 409A of the Code, then each
        such payment which is conditioned upon Executive&#8217;s execution of a release and which is to be paid or provided during a designated period that begins in one taxable year and ends in a second taxable year shall be paid or provided in the later of the
        two taxable years.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">12</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify;">10.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Certain Definitions</u>. As used in this Agreement, the following terms shall have the following meanings:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160; <u>Cause</u>. &#8220;Cause&#8221; means any of the following: (i) Executive&#8217;s commission of an act of fraud, embezzlement or dishonesty, or the commission of some other illegal act by Executive,
        that could reasonably be expected to have an adverse impact on the Company or any successor or affiliate; (ii) Executive&#8217;s conviction of, or plea of &#8220;guilty&#8221; or &#8220;no contest&#8221; to, a felony or any crime involving fraud, dishonesty or moral turpitude
        under the laws of the United States or any state thereof (or international equivalent); (iii) any intentional, unauthorized use or disclosure by Executive of Confidential Information or trade secrets of the Company or any successor or affiliate;
        (iv) Executive&#8217;s gross negligence or material violation of any duty of loyalty to the Company or any successor or affiliate thereof, or any other demonstrable material misconduct on Executive&#8217;s part in connection with the performance of Executive&#8217;s
        duties for the Company; (v) Executive&#8217;s ongoing and repeated failure or refusal to perform or neglect of Executive&#8217;s duties as required by this Agreement or Executive&#8217;s ongoing and repeated failure or refusal to comply with the instructions given
        to Executive by the Board, which failure, refusal or neglect continues for fifteen (15) days following Executive&#8217;s receipt of written notice from the Board stating with specificity the nature of such failure, refusal or neglect; or (vi) Executive&#8217;s
        material breach of any material Company policy or any material provision of this Agreement, which breach is not cured (if capable of being cured) within fifteen (15) days following Executive&#8217;s receipt of written notice from the Board stating with
        specificity the nature of such material breach; provided, that the foregoing cure right shall not apply to any breach by Executive of <u>Section 5</u> or <u>Section 6</u> hereof.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Change in Control</u>. &#8220;Change in Control&#8221; shall have the meaning set forth in the 2025 XCF Global, Inc. Equity Incentive Plan. For purposes of clarity, consummation of (i) the
        transactions contemplated in the BCA or (ii) the New Rise Acquisitions (as defined in the BCA) shall not constitute a Change in Control.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <u>Code</u>. &#8220;Code&#8221; shall mean the Internal Revenue Code of 1986, as amended, and the regulations and guidance promulgated thereunder.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(d)&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>Confidential Information</u>. &#8220;Confidential Information&#8221; means the Company&#8217;s trade secrets as defined under applicable law, as well as any other information or material which is
        not generally known to the public, and which: (i) is generated, collected by or utilized in the operations of the Company&#8217;s business and relates to the actual or anticipated business of the Company; or (ii) results from any task assigned to
        Executive by the Company, or work performed by Executive for or on behalf of the Company. Confidential Information shall not be considered generally known to the public if Executive or others improperly reveal such information to the public without
        the Company&#8217;s express written consent and/or in violation of an obligation of confidentiality owed to the Company. Confidential Information includes, without limitation, the information, observations and data obtained by Executive while employed by
        the Company concerning the business or affairs of the Company, including without limitation: information concerning investment or acquisition opportunities in or reasonably related to the Company; the identities of and other information (such as
        databases) relating to the current, former or prospective employees, customers, or investors of the Company; development, transition and transformation plans; methodologies and methods of doing business; strategic, marketing and expansion plans;
        financial and business plans, financial data; pricing information; employee, customer, or vendor lists and telephone numbers; investment terms; and requirements and costs of providing service. Confidential Information also includes information that
        the Company receives from third parties subject to a duty to maintain the confidentiality of such information and to use it only for certain limited purposes.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Date of Termination</u>. &#8220;Date of Termination&#8221; shall mean (i) if Executive&#8217;s employment is terminated by Executive&#8217;s death, the date of Executive&#8217;s death or (ii) if Executive&#8217;s
        employment is terminated pursuant to <u>Section 3(a)(ii)</u> &#8211; <u>(iv)</u> either the date indicated in the Notice of Termination or the date specified by the Company pursuant to <u>Section 3(b)</u>, whichever is earlier.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">13</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Disability</u>. &#8220;Disability&#8221; shall mean, at any time the Company or any of its affiliates sponsors a long-term disability plan for the Company&#8217;s employees, &#8220;disability&#8221; as defined in
        such long-term disability plan for the purpose of determining a participant&#8217;s eligibility for benefits;&#160; provided, however, if the long-term disability plan contains multiple definitions of disability, &#8220;Disability&#8221; shall refer to that definition of
        disability which, if Executive qualified for such disability benefits, would provide coverage for the longest period of time. The determination of whether Executive has a Disability shall be made by the person or persons required to make disability
        determinations under the long-term disability plan. At any time the Company does not sponsor a long-term disability plan for its employees, &#8220;Disability&#8221; shall mean Executive&#8217;s inability to perform, with or without reasonable accommodation, the
        essential functions of Executive&#8217;s positions hereunder for a total of three months during any six-month period as a result of incapacity due to mental or physical illness as determined by the Board in its sole good faith discretion.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(g)&#160;&#160;&#160;&#160; &#160; <u>Good Reason</u>. &#8220;Good Reason&#8221; means any of the following without Executive&#8217;s written consent: (i) a material diminution in Executive&#8217;s authority, duties or responsibilities; (ii) a
        material diminution in Executive&#8217;s base salary or target Annual Bonus (and Executive and the Company agree that any diminution of 10% or more shall be considered material for this purpose, regardless of whether such diminution occurs due to a
        single reduction or a series of reductions), other than in connection with an across-the-board reduction which applies in a comparable manner to other senior officers of the Company; (iii) any change in the Company&#8217;s remote work policy that would
        require Executive to be physically present in one of the Company&#8217;s offices more than 20 days each month, and (iv) the Company&#8217;s breach of a material provision of this Agreement. Notwithstanding the foregoing, no Good Reason will have occurred
        unless and until Executive has (A) provided the Company, within thirty (30) days of Executive&#8217;s knowledge of the occurrence of the facts and circumstances underlying the Good Reason event, written notice stating with specificity the applicable
        facts and circumstances underlying such finding of Good Reason, (B) provided the Company with an opportunity to cure the same within thirty (30) days after the receipt of such notice and (C) the Company shall have failed to so cure within such
        period. Executive&#8217;s termination of employment by reason of resignation from employment with the Company for Good Reason must occur within 30 days following the expiration of the foregoing 30-day cure period.</div>
      <div>&#160;</div>
      <div style="text-align: justify;">11.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Miscellaneous Provisions</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Contractor Period Payment</u>. The parties understand that the existing employment agreement between the Executive and XCF Global Capital, Inc. provides that the Executive is to be
        paid, at the Closing of the Business Combination the amount specified in such employment agreement for services the Executive provided to XCF Global Capital, Inc. as an independent contractor for the period January 1, 2024 until the date of
        execution of such employment agreement (the &#8220;Contractor Period Payment&#8221;).&#160; The parties further acknowledge and agree that upon Closing of the Business Combination, the Company shall (i) assume the obligation to make the Contractor Period Payment
        and shall make such payment in cash no later than September 30, 2025, unless the Company and Executive mutually agree in writing, on or before such date, to extend the payment deadline to no later than December 31, 2025 due to the Company&#8217;s
        reasonable cash constraints. Any such extension shall not modify the Company&#8217;s obligation to make full payment nor be deemed a waiver of Executive&#8217;s rights. In addition, within 30 days after the Closing of the Business Combination, the Company
        shall issue to Executive a grant of restricted shares of the Company&#8217;s Class A Common Stock under the Company&#8217;s 2025 Equity Incentive Plan in aggregate value equal to the obligation assumed by the Company for the Contractor Period Payment. This
        grant shall be separate from, and not in lieu of, the Contractor Period Payment and be calculated based on the 20 day volume-weighted average price for the Company&#8217;s Class A Common Stock following the Closing of the Business Combination. The
        restricted shares shall vest ratably on a monthly basis over a period of three (3) years and shall be subject to the terms and conditions of the Company&#8217;s 2025 Equity Incentive Plan and the applicable award agreement.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">14</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Governing Law</u>. This Agreement shall be governed, construed, interpreted and enforced in accordance with its express terms, and otherwise in accordance with the substantive laws
        of the State of Delaware without reference to the principles of conflicts of law of the State of Delaware or any other jurisdiction that would result in the application of the laws of a jurisdiction other than the State of Delaware, and where
        applicable, the laws of the United States.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160; <u>Arbitration</u>. Any dispute, controversy, or claim arising out of or relating to this Agreement or any breach of this Agreement or Executive&#8217;s employment, whether the claim arises in
        contract, tort, or statute, shall be submitted to and decided by binding arbitration, except as set forth in <u>Section 6(c)</u>. Arbitration shall be administered exclusively by the American Arbitration Association at a location in Wilmington,
        Delaware and shall be conducted consistent with the employment arbitration rules, regulations, and requirements thereof as well as any requirements imposed by state law. Any arbitral award determination shall be final and binding upon the Parties,
        and judgment may be entered thereon in any court of competent jurisdiction. Notwithstanding anything to the contrary, this Agreement does not prevent Executive from filing a complaint or charge with the National Relations Labor Board, the Equal
        Employment Opportunity Commission, or any similar federal or state administrative agency, including claims for workers&#8217; compensation or unemployment insurance benefits. By entering into this Agreement, the Parties are waiving all rights to have
        their disputes heard or decided by a jury or in a court trial and the right to pursue any class or representative claims against each other in court, arbitration, or any other proceeding. The arbitrator shall have no jurisdiction or authority to
        compel any class or collective claim, or to consolidate different arbitration proceedings with or join any other party to an arbitration between the Parties. The arbitrator, and not any court, shall have exclusive authority to resolve any dispute
        relating to the enforceability or formation of this Agreement and the arbitrability of dispute between the parties, except for any dispute relating to the enforceability or scope of the class and collective action waiver, which shall be determined
        by a court of competent jurisdiction. THE PARTIES FULLY UNDERSTAND AND AGREE THAT THEY ARE GIVING UP CERTAIN RIGHTS OTHERWISE AFFORDED TO THEM BY CIVIL COURT ACTIONS, INCLUDING BUT NOT LIMITED TO THE RIGHT TO A JURY OR COURT TRIAL AND THE RIGHT TO
        BRING ANY CLAIM AS A CLASS OR COLLECTIVE ACTION. Costs of arbitration shall be split evenly between the parties, provided, that the arbitrator shall have the ability to award attorneys&#8217; fees and previously paid arbitration expenses to the
        prevailing party.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Venue; Waiver of Jury Trial</u>.&#160; Except for claims subject to the arbitration provisions herein, the Parties agree that all litigation arising out of or relating to this agreement
        must be brought exclusively in any state or federal court located in Wilmington, Delaware (collectively the &#8220;Designated Courts&#8221;). Each Party consents and submits to the exclusive jurisdiction of the Designated Courts with respect to litigation
        under this Agreement, each Party hereby irrevocably waives all claims or defenses of lack of personal jurisdiction or any other jurisdiction defense, and any objection which such Party may now or hereafter have to the laying of venue of any suit,
        action or proceeding in any Designated Court, including any right to object on the basis that any dispute, action, suit, or proceeding brought in the Designated Courts has been brought in an improper or inconvenient forum or venue.&#160; IN THE EVENT OF
        LITIGATION HEREUNDER, THE COMPANY AND EXECUTIVE EACH WAIVE THEIR RESPECTIVE RIGHT TO A TRIAL BY JURY OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF OR RELATED TO ANY ACTION, PROCEEDING, OR OTHER LITIGATION OF ANY TYPE BROUGHT BY ANY
        OF THE PARTIES AGAINST ANY OTHER PARTY OR ANY AFFILIATE OF ANY OTHER SUCH PARTY. THE COMPANY AND EXECUTIVE EACH AGREE THAT ANY SUCH CLAIM OR CAUSE OF ACTION WILL BE TRIED BY A COURT TRIAL WITHOUT A JURY. WITHOUT LIMITING THE FOREGOING, THE PARTIES
        FURTHER AGREE THAT THEIR RESPECTIVE RIGHT TO A TRIAL BY JURY IS WAIVED BY OPERATION OF THIS SECTION AS TO ANY ACTION, COUNTERCLAIM, OR OTHER PROCEEDING WHICH SEEKS, IN WHOLE OR IN PART, TO CHALLENGE THE VALIDITY OR ENFORCEABILITY OF THIS AGREEMENT.
        THIS WAIVER WILL APPLY TO ANY SUBSEQUENT AMENDMENTS, RENEWALS, SUPPLEMENTS, OR MODIFICATIONS TO THIS AGREEMENT.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">15</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Validity; Severability</u>. Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under applicable law, but if any
        provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability will not affect any other provision or any action in
        any other jurisdiction, but this Agreement will be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had never been contained herein.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Notices</u>. Any notice, request, claim, demand, document and other communication hereunder to any Party shall be effective upon receipt (or refusal of receipt) and shall be in
        writing and delivered personally or sent by facsimile or certified or registered mail, postage prepaid, (i) if to the Company, to the Chief Executive Officer of the Company at the Company&#8217;s headquarters, (ii) if to Executive, to the last address
        that the Company has in its personnel records for Executive, or (iii) at any other address as any Party shall have specified by notice in writing to the other Party.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(g)&#160;&#160;&#160;&#160;&#160; &#160; <u>Counterparts</u>. This Agreement may be executed in several counterparts, each of which shall be deemed to be an original, but all of which together will constitute one and the same
        Agreement. Signatures delivered by facsimile or .pdf format shall be deemed effective for all purposes.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Entire Agreement</u>. The terms of this Agreement are intended by the Parties to be the final expression of their agreement with respect to the subject matter hereof and supersede
        all prior understandings and agreements, whether written or oral, including any prior employment offer letter, employment agreement or consulting agreement between Executive and the Company. The Parties further intend that this Agreement shall
        constitute the complete and exclusive statement of their terms and that no extrinsic evidence whatsoever may be introduced in any judicial, administrative, or other legal proceeding to vary the terms of this Agreement.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Amendments; Waivers</u>. This Agreement may not be modified, amended, or terminated except by an instrument in writing, signed by Executive and a duly authorized officer of Company.
        By an instrument in writing similarly executed, Executive or a duly authorized officer of the Company may waive compliance by the other Party with any specifically identified provision of this Agreement that such other Party was or is obligated to
        comply with or perform; provided, however, that such waiver shall not operate as a waiver of, or estoppel with respect to, any other or subsequent failure. No failure to exercise and no delay in exercising any right, remedy, or power hereunder will
        preclude any other or further exercise of any other right, remedy, or power provided herein or by law or in equity.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Successors and Assigns</u>. The Company may assign its rights and obligations under this Agreement to any of its affiliates or to any successor to all or substantially all of the
        business or the assets of the Company (by merger or otherwise, including, without limitation, to the surviving entity in the Business Combination), and may assign or encumber this Agreement and its rights hereunder as security for indebtedness of
        the Company and its affiliates. This Agreement shall be binding upon and inure to the benefit of the Company, Executive and their respective successors, assigns, personnel and legal representatives, executors, administrators, heirs, distributees,
        devisees, and legatees, as applicable. None of Executive&#8217;s rights or obligations may be assigned or transferred by Executive, other than Executive&#8217;s rights to payments hereunder, which may be transferred only by will or operation of law.
        Notwithstanding the foregoing, Executive shall be entitled, to the extent permitted under applicable law and applicable Company Arrangements, to select and change a beneficiary or beneficiaries to receive compensation hereunder following
        Executive&#8217;s death by giving written notice thereof to the Company.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Indemnification</u>. The Company and Executive shall enter into a Director and Officer Indemnification Agreement substantially in the form of <u>Exhibit C</u> attached hereto.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">16</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">(l)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>D&amp;O Insurance</u>. The Company will cover Executive under directors&#8217; and officers&#8217; liability insurance policy (or policies) during the Term and thereafter to the same extent as
        the Company covers its other current or former directors or officers of the Company.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(m)&#160;&#160;&#160; &#160; &#160; <u>Clawback</u>. Notwithstanding any other provisions in this Agreement to the contrary, any incentive-based or other compensation paid to the Executive under this Agreement or any
        other agreement or arrangement with the Company that is subject to recovery under any applicable law, government regulation, or stock exchange rule or listing requirement will be subject to such deductions and clawback as may be required or
        permitted to be made pursuant to such law, government regulation, or stock exchange rule or listing requirement or any policy adopted by the Company.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(n)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Construction</u>. This Agreement shall be deemed drafted equally by both the Parties. Its language shall be construed as a whole and according to its fair meaning. Any presumption or
        principle that the language is to be construed against any Party shall not apply. The headings in this Agreement are only for convenience and are not intended to affect construction or interpretation. Any references to paragraphs, subparagraphs,
        sections or subsections are to those parts of this Agreement, unless the context clearly indicates to the contrary. Also, unless the context clearly indicates to the contrary, (i) the plural includes the singular and the singular includes the
        plural, (ii) &#8220;and&#8221; and &#8220;or&#8221; are each used both conjunctively and disjunctively, (iii) &#8220;any,&#8221; &#8220;all,&#8221; &#8220;each,&#8221; or &#8220;every&#8221; means &#8220;any and all,&#8221; and &#8220;each and every,&#8221; (iv) &#8220;includes&#8221; and &#8220;including&#8221; are each &#8220;without limitation,&#8221; (v) &#8220;herein,&#8221; &#8220;hereof,&#8221;
        &#8220;hereunder&#8221; and other similar compounds of the word &#8220;here&#8221; refer to the entire Agreement and not to any particular paragraph, subparagraph, section or subsection and (vi) all pronouns and any variations thereof shall be deemed to refer to the
        masculine, feminine, neuter, singular or plural as the identity of the entities or persons referred to may require.</div>
      <div>&#160;</div>
      <div style="text-align: center;">[SIGNATURE PAGE FOLLOWS]</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">17</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold;">IN WITNESS WHEREOF</font>, the Parties hereto have executed this Agreement as of the date first written above. The signatories below represent that they are duly
        authorized to enter into this Agreement.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z3481741560cc499b85159bbf2aaa07cd">

          <tr>
            <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
            <td colspan="2" rowspan="1" style="width: 5%; vertical-align: top;">
              <div style="font-weight: bold;">XCF GLOBAL, INC.</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
            <td colspan="2" rowspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 5%; vertical-align: top;">
              <div>By:</div>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div><u>/s/ Mihir Dange</u></div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 5%; vertical-align: top;">
              <div>Name:</div>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div>Mihir Dange</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 5%; vertical-align: top;">
              <div>Title:</div>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div>Chief Executive Officer</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
            <td colspan="2" rowspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
            <td colspan="2" rowspan="1" style="width: 5%; vertical-align: top;">
              <div style="font-weight: bold;">EXECUTIVE</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
            <td colspan="2" rowspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 5%; vertical-align: top;">
              <div>By:</div>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div><u>/s/ J. Ryu</u></div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 5%; vertical-align: top;">
              <div>Name:</div>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div>Jae Ryu</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">18</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;">Exhibit A</div>
      <div>&#160;</div>
      <div>None.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;">Exhibit B</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">Compensation Terms</div>
      <div>&#160;</div>
      <div style="text-align: center;">(attached)</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">Executive is solely responsible for any tax liability incurred as a result of any benefit set forth in this table being treated as a taxable benefit under federal, state or local law.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;">Jae Ryu</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">Exhibit B &#8211; Compensation Terms</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="zd433a8a770454d569188a5e80329394f">

          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div>Base Salary</div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div>$200,000, Two Hundred Thousand Dollars</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div>Annual Bonus</div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div>Target Bonus set at 50-100% of Base Salary</div>
              <div>If &lt;50% of key evaluation metrics achieved, Annual Bonus is 0% </div>
              <div>(in each case, pro-rated for partial year) </div>
              <div>&#160;</div>
              <div>Key evaluation metrics (subject to adjustment each year):</div>
              <div style="text-indent: -18pt; margin-left: 18pt;">&#8226;&#160;&#160;&#160;&#160;&#160; 25% discretionary established by the Board</div>
              <div style="text-indent: -18pt; margin-left: 18pt;">&#8226;&#160;&#160;&#160;&#160;&#160; 25% Individual performance metrics to be set by the Board</div>
              <div style="text-indent: -18pt; margin-left: 18pt;">&#8226;&#160;&#160;&#160;&#160;&#160; 50% Transaction success fee (de-SPAC/IPO) (first year only)</div>
              <div>&#160;</div>
              <div>Opportunity to elect cash or stock for bonus payment, subject to limits set by Board or Compensation Committee</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div>2025 Equity Plan </div>
              <div>Participation</div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div>Executive eligible to receive additional equity compensation pursuant to the Company&#8217;s 2025 Equity Incentive Plan</div>
              <div>&#160;</div>
              <div>Target 200-400% of Base Salary with an initial grant of 40,000 shares; vesting period over three years (no vesting during the first six months (the &#8220;cliff period&#8221;)). After the six-month cliff period, the restricted stock units will vest
                in equal monthly installments over 30 months, subject to continued service with New XCF)</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div>Contractor Period </div>
              <div>Payment</div>
              <div>&#160;</div>
              <div>Jae Ryu</div>
              <div>(WT Real Estate Advisors </div>
              <div>LLC)</div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div>$357,707 payment in cash no later than September 30, 2025, unless the Company and Executive mutually agree in writing, on or before such date, to extend the payment deadline to no later than December 31, 2025</div>
              <div>&#160;</div>
              <div>$357,707 in restricted shares of the Company&#8217;s Class A Common Stock under the Company&#8217;s 2025 Equity Incentive Plan. Calculated based on the 20 day volume-weighted average price for the Company&#8217;s Class A Common Stock following the Closing
                of the Business Combination. The restricted shares shall vest ratably on a monthly basis over a period of three (3) years and shall be subject to the terms and conditions of the Company&#8217;s 2025 Equity Incentive Plan and the applicable award
                agreement</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div>Benefits:</div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: -18pt; margin-left: 36pt;">&#8226;&#160;&#160;&#160;&#160;&#160; Health/Group insurance</div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div>Minimum 80% of premiums paid by Company</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: -18pt; margin-left: 36pt;">&#8226;&#160;&#160;&#160;&#160;&#160; Life insurance</div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div>Up to 2x Base Salary, not to exceed $1 million; Employee may elect to add additional coverage at their own expense</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: -18pt; margin-left: 36pt;">&#8226;&#160;&#160;&#160;&#160;&#160; Phone subsidy</div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div>Based on actual and reasonable phone bill incurred each month, with invoice</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: -18pt; margin-left: 36pt;">&#8226;&#160;&#160;&#160;&#160;&#160; Fitness and wellness subsidy</div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div>$3,500 per year, based on actual amount incurred with invoice</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: -18pt; margin-left: 36pt;">&#8226;&#160;&#160;&#160;&#160;&#160; Car allowance</div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div>$830 per month or $9,960 per year</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: -18pt; margin-left: 36pt;">&#8226;&#160;&#160;&#160;&#160;&#160; Retirement benefits (401(k) or other retirement plan as established by the Company)</div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div>3% automatic match; 100% match on first 3% EE contributions</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 24%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-indent: -18pt; margin-left: 36pt;">&#8226;&#160;&#160;&#160;&#160;&#160; Relocation benefits (if at the Company&#8217;s request)</div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 74%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div>Based on actual expenses incurred and will cover:</div>
              <div style="text-indent: -18pt; margin-left: 36pt;">1.&#160;&#160;&#160;&#160;&#160; One-way flight costs for employee, spousal equivalent and dependents</div>
              <div style="text-indent: -18pt; margin-left: 36pt;">2.&#160;&#160;&#160;&#160;&#160; One-month temporary housing, based on actual amount, with invoice</div>
              <div style="text-indent: -18pt; margin-left: 36pt;">3.&#160;&#160;&#160;&#160;&#160; Moving costs (sea freight) for personnel effects, based on actual amount, with invoice</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;">Exhibit C</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">Form of Indemnification Agreement</div>
      <div>&#160;</div>
      <div style="text-align: center;">(attached)</div>
      <div>&#160;</div>
      <div><br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.63
<SEQUENCE>18
<FILENAME>ef20050548_ex10-63.htm
<DESCRIPTION>EXHIBIT 10.63
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <!--PROfilePageNumberReset%Num%1%%%-->
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; margin-right: 0.05pt; margin-left: 0.05pt; font-weight: bold;">Exhibit 10.63</div>
      <div>&#160;</div>
      <div style="text-align: center; margin-right: 0.05pt; margin-left: 0.05pt;">XCF Global, Inc.</div>
      <div style="text-align: center; margin-right: 0.05pt;">2025 Equity Incentive Plan</div>
      <div><br>
      </div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z8b88e167fa8c474898b3bb6fc5e74c8b" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">

              <tr style="vertical-align: top;">
                <td style="text-align: right; vertical-align: top; width: 36pt;">
                  <div style="text-align: left;">1.</div>
                </td>
                <td style="text-align: left; vertical-align: top; width: auto;">
                  <div><u>General</u>.</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Plan Purpose</u>. XCF Global, Inc. (the &#8220;Company&#8221;), by means of the Plan, seeks to secure and retain the services of the Company&#8217;s Employees, Non-Employee Directors and Consultants, to provide
        incentives for such persons to exert maximum efforts for the success of the Company and any Affiliate of the Company and to provide a means by which such persons may be given an opportunity to benefit from increases in value of the Common Stock
        through the granting of Awards.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Available Awards under the Plan</u>. The Plan provides for the grant of the following forms of Awards: (i) Incentive Stock Options; (ii) Nonstatutory Stock Options; (iii) SARs; (iv) Restricted Stock
        Awards; (v) RSU Awards; (vi) Performance Awards; (vii) Other Awards; and (viii) Cash Awards.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Adoption Date; Effective Date</u>. The Plan will come into existence on its Adoption Date, but no Award under the Plan may become effective prior to the Effective Date.</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb2201dfea8a84a83b553dd09286b5595">

          <tr>
            <td style="width: 35.95pt; vertical-align: top;">2.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Shares Subject to the Plan</u>.</font></div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Share Reserve</u>. Subject to adjustment in accordance with <u>Section 2(c)</u> and any adjustments as necessary to implement any Capitalization Adjustments, the aggregate number of Shares that may be
        issued pursuant to Awards will not exceed that number of Shares equal to seven percent (7%) of the aggregate number of shares of the Company&#8217;s Class A Common Stock, as calculated on a fully-diluted basis immediately after the closing of the
        Business Combination with Focus Impact BH3 Acquisition Company (&#8220;Maximum Shares&#8221;). In addition, subject to any adjustments as necessary to implement any Capitalization Adjustments, such aggregate number of Shares will automatically increase on
        January 1 of each year for a period of ten years commencing on January 1, 2025 and ending on (and including) January 1, 2034, in an amount equal to five percent (5.0%) of the total number of shares of the Company&#8217;s Capital Stock outstanding on
        December 31 of the preceding year; <u>provided</u>, <u>however</u>, that the Board may act prior to January 1st of a given year to provide that the increase for such year will be a lesser number of Shares.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Aggregate Incentive Stock Option Limit</u>. Notwithstanding anything to the contrary in <u>Section 2(a)</u>, and subject to any adjustments as necessary to implement any Capitalization Adjustments, the
        aggregate maximum number of Shares that may be issued pursuant to the exercise of Incentive Stock Options is equal to the Maximum Shares.</div>
      <div>&#160;</div>
      <div>
        <div style="text-indent: 36pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Share Reserve Operation</u>.</div>
      </div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(i)&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>Limit Applies to Common Stock Issued Pursuant to Awards</u>. For clarity, the Share Reserve is a limit on the number of Shares that may be issued pursuant to Awards and does not
        limit the granting of Awards, except that the Company will keep available at all times the number of Shares reasonably required to satisfy its obligations to issue shares pursuant to such Awards. Shares may be issued in connection with a merger or
        acquisition as permitted by, as applicable, Nasdaq Listing Rule 5635(c), NYSE Listed Company Manual Section 303A.08, NYSE American Company Guide Section 711 or other rule or listing standard applicable to the Company, and any such issuance will not
        reduce the number of shares available for issuance under the Plan, except that shares acquired by exercise of Incentive Stock Options issued in connection with a merger or acquisition will count against the maximum number of shares that may be
        issued pursuant to the exercise of Incentive Stock Options under this Plan.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">1</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Actions that Do Not Constitute Issuance of Common Stock and Do Not Reduce</u>&#160;<u>Share Reserve</u>. The following actions do not result in an issuance of shares under the Plan and
        accordingly do not reduce the number of shares subject to the Share Reserve and available for issuance under the Plan: (A) the expiration or termination of any portion of an Award without the shares covered by such portion of the Award having been
        issued; (B) the settlement of any portion of an Award in cash (i.e., the Participant receives cash rather than Shares); (C) the withholding of Shares that would otherwise be issued by the Company to satisfy the exercise price, strike price or
        purchase price of an Award; or (D) the withholding of Shares that would otherwise be issued by the Company to satisfy a tax withholding obligation in connection with an Award.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(iii)&#160;&#160; &#160; &#160;&#160;&#160; <u>Reversion of Previously Issued Shares of Common Stock to Share Reserve</u>. The following Shares previously issued pursuant to an Award and accordingly initially deducted from the
        Share Reserve will be added back to the Share Reserve and again become available for issuance under the Plan: (A) any shares that are forfeited back to or repurchased by the Company because of a failure to meet a contingency or condition required
        for the vesting of such shares; (B) any shares that are reacquired by the Company to satisfy the exercise, strike or purchase price of an Award; and (C) any shares that are reacquired by the Company to satisfy a tax withholding obligation in
        connection with an Award.</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5ff5528d24b9416fb77786ee5d5c9c0c">

          <tr>
            <td style="width: 36pt; vertical-align: top;">3.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Eligibility; Limitations</u>.</font></div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Eligible Award Recipients</u>. Subject to the terms of the Plan, Employees, Non-Employee Directors and Consultants are eligible to receive Awards.</div>
      <div style="text-indent: 36pt;">&#160;</div>
      <div>
        <div style="text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Specific Award Limitations</u>.</div>
      </div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Limitations on Incentive Stock Option Recipients</u>. Incentive Stock Options may be granted only to Employees of the Company or a &#8220;parent corporation&#8221; or
        &#8220;subsidiary corporation&#8221; thereof (as such terms are defined in Sections 424(e) and (f) of the Code).</div>
      <div style="text-indent: 36pt; margin-left: 36pt;">&#160;</div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Limitations on Incentive Stock Option Dollar Value</u>. To the extent that the aggregate Fair Market Value (determined at the time of grant) of Common Stock with respect to which
        Incentive Stock Options are exercisable for the first time by any Optionholder during any calendar year (under all plans of the Company and any Affiliates) exceeds $100,000 (or such other limit established in the Code) or otherwise does not comply
        with the rules governing Incentive Stock Options, the Options or portions thereof that exceed such limit (according to the order in which they were granted) or otherwise do not comply with such rules will be treated as Nonstatutory Stock Options,
        notwithstanding any contrary provision of the applicable Option Agreement(s).</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Limitations on Incentive Stock Options Grants to Certain Stockholders</u>. A Ten Percent Stockholder may not be granted an Incentive Stock Option unless (A) the exercise price of
        such Option is at least 110% of the Fair Market Value on the date of grant of such Option and (B) the Option is not exercisable after the expiration of five years from the date of grant of such Option. In addition, if an eligible Employee does not
        remain employed by the Company or a &#8220;parent corporation&#8221; or &#8220;subsidiary corporation&#8221; thereof (as such terms are defined in Sections 424(e) and (f) of the Code) at all times from the time an Incentive Stock Option is granted until three (3) months
        prior to the date of exercise thereof (or such other period as required by Applicable Law), such Option shall be treated as a non-qualified stock Option.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Limitations on Nonstatutory Stock Options and SARs</u>. Nonstatutory Stock Options and SARs may not be granted to Employees, Non-Employee Directors and Consultants who are providing
        Continuous Service only to any &#8220;parent&#8221; of the Company (as such term is defined in Rule 405) unless the stock underlying such Awards is treated as &#8220;service recipient stock&#8221; under Section 409A because the Awards are granted pursuant to a corporate
        transaction (such as a spin off transaction) or unless such Awards otherwise comply with the distribution requirements of Section 409A.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Non-Employee Director Compensation Limit</u>. The aggregate value of all compensation granted or paid, as applicable, to any individual for service as a Non-Employee Director with respect to any fiscal
        year following the year in which the Business Combination Date occurs, including Awards granted and cash fees paid by the Company to such Non-Employee Director, will not exceed (1) $750,000 in total value or (2) in the event such Non-Employee
        Director is first appointed or elected to the Board during such fiscal year, $1,000,000 in total value, in each case, calculating the value of any equity awards based on the grant date fair value of such equity awards for financial reporting
        purposes. For avoidance of doubt, compensation will count towards this limit for the fiscal year in which it was granted or earned, and not later when distributed, in the event it is deferred.</div>
      <div><br>
      </div>
      <div>4.&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>Options; SARs</u>. Each Option and SAR will have such terms and conditions as determined by the Board. Each Option will be designated in writing as an Incentive Stock Option or Nonstatutory Stock Option at the time of grant; <u>provided</u>,
        <u>however</u>, that if an Option is not so designated or if an Option designated as an Incentive Stock Option fails to qualify as an Incentive Stock Option, then such Option will be a Nonstatutory Stock Option, and the Shares purchased upon
        exercise of each type of Option will be separately accounted for. Each SAR will be denominated in Shares equivalents. The terms and conditions of separate Options and SARs need not be identical; <u>provided</u>, <u>however</u>, that each Option
        Agreement and SAR Agreement will conform (through incorporation of provisions hereof by reference in the Award Agreement or otherwise) to the substance of each of the following provisions:</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Term</u>. Subject to <u>Section 3(b)</u> with respect to Ten Percent Stockholders, no Option or SAR will be exercisable after the expiration of ten years from the date of grant of such Award or such
        shorter period specified in the Award Agreement.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Exercise Price; Strike Price</u>. Subject to <u>Section 3(b)</u> with respect to Ten Percent Stockholders, the exercise or strike price of each Option or SAR will not be less than 100% of the Fair
        Market Value on the date of grant of the Award of such Option or SAR, as applicable. Notwithstanding the foregoing, an Option or SAR may be granted with an exercise or strike price lower than 100% of the Fair Market Value on the date of grant of
        such Award if such Award is granted pursuant to an assumption of or substitution for another option or stock appreciation right pursuant to a Corporate Transaction and in a manner consistent with the provisions of Sections 409A and, if applicable,
        424(a) of the Code.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Exercise of Option; Payment of Exercise Price</u>. In order to exercise an Option, the Participant must provide notice of exercise to the Plan Administrator in accordance with the procedures specified
        in the applicable Option Agreement or otherwise provided by the Company. The Board has the authority to grant Options that do not permit all of the following methods of payment (or otherwise restrict the ability to use certain methods) and to grant
        Options that require the consent of the Company to utilize a particular method of payment. The exercise price of an Option may be paid, to the extent permitted by Applicable Law and as determined by the Board, by one or more of the following
        methods of payment to the extent set forth in the Option Agreement:</div>
      <div><br>
      </div>
      <div>
        <div style="text-indent: 72pt;">
          <div>
            <div>(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; by cash or check, bank draft or money order payable to the Company;</div>
          </div>
        </div>
      </div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;pursuant to a &#8220;cashless exercise&#8221; program developed under Regulation T as promulgated by the Federal Reserve Board that, prior to the issuance of the Common Stock subject to the Option,
        results in either the receipt of cash (or check) by the Company or the receipt of irrevocable instructions to pay the exercise price to the Company from the sales proceeds;</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; by delivery to the Company (either by actual delivery or attestation) of Shares that are already owned by the Participant free and clear of any liens, claims, encumbrances or security
        interests, with a Fair Market Value on the date of exercise that does not exceed the exercise price, provided that (A) at the time of exercise the Common Stock is publicly traded, (B) any remaining balance of the exercise price not satisfied by
        such delivery is paid by the Participant in cash or other permitted form of payment, (C) such delivery would not violate any Applicable Law or agreement restricting the redemption of the Common Stock, (D) any certificated shares are endorsed or
        accompanied by an executed assignment separate from certificate and (E) such shares have been held by the Participant for any minimum period necessary to avoid adverse accounting treatment as a result of such delivery;</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; if the Option is a Nonstatutory Stock Option, by a &#8220;net exercise&#8221; arrangement pursuant to which the Company will reduce the number of Shares issuable upon exercise by the largest whole
        number of shares with a Fair Market Value on the date of exercise that does not exceed the exercise price, provided that (A) such shares used to pay the exercise price will not be exercisable thereafter and (B) any remaining balance of the exercise
        price not satisfied by such net exercise is paid by the Participant in cash or other permitted form of payment; or</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;in any other form of consideration that may be acceptable to the Board and permissible under Applicable Law.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Exercise of SARs; Payment of Appreciation Distribution</u>. In order to exercise any SAR, the Participant must provide notice of exercise to the Plan Administrator in accordance with the SAR Agreement.
        The appreciation distribution payable to a Participant upon the exercise of a SAR will not be greater than an amount equal to the excess of (i) the aggregate Fair Market Value on the date of exercise of a number of Shares equal to the number of
        Common Stock equivalents that are vested and being exercised under such SAR, over (ii) the strike price of such SAR. Such appreciation distribution may be paid to the Participant in the form of Common Stock or cash (or any combination of Common
        Stock and cash) or in any other form of payment, as determined by the Board and specified in the applicable SAR Agreement.<br>
        <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Transferability of Options and SARs</u>. Options and SARs may not be transferred to third party financial institutions for value. The Board may impose such additional limitations on the transferability
        of an Option or SAR as it determines. In the absence of any such determination by the Board, the following restrictions on the transferability of Options and SARs will apply, provided that except as explicitly provided herein, neither an Option nor
        a SAR may be transferred for consideration and provided, further, that if an Option is an Incentive Stock Option, such Option may be deemed to be a Nonstatutory Stock Option as a result of such transfer:</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Restrictions on Transfer</u>. An Option or SAR will not be transferable, except by will or by the laws of descent and distribution, and will be exercisable during the lifetime of
        the Participant only by the Participant; <u>provided</u>, <u>however</u>, that the Board may permit transfer of an Option or SAR in a manner that is not prohibited by Applicable Law upon the Participant&#8217;s request, including to a trust if the
        Participant is considered to be the sole beneficial owner of such trust (as determined under Section 671 of the Code and applicable state law) while such Option or SAR is held in such trust, provided that the Participant and the trustee enter into
        a transfer and other agreements required by the Company.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Domestic Relations Orders</u>. Notwithstanding the foregoing, subject to the execution of transfer documentation in a format acceptable to the Company and subject to the approval of
        the Board or a duly authorized Officer and Applicable Law, an Option or SAR may be transferred pursuant to a domestic relations order.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Vesting of Options and SARs</u>. The Board may impose such restrictions on or conditions to the vesting and/or exercisability of an Option or SAR as determined by the Board. Except as otherwise
        provided in the Award Agreement or other written agreement between a Participant and the Company or an Affiliate, vesting of Options and SARs will cease upon termination of the Participant&#8217;s Continuous Service.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(g)&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>Termination of Continuous Service for Cause</u>. Except as explicitly otherwise provided in the Award Agreement or other written agreement between a Participant and the Company or an Affiliate, if a
        Participant&#8217;s Continuous Service is terminated for Cause, the Participant&#8217;s Options and SARs will terminate and be forfeited immediately upon such termination of Continuous Service, and the Participant will be prohibited from exercising any portion
        (including any vested portion) of such Awards on and after the date of such termination of Continuous Service and the Participant will have no further right, title or interest in such forfeited Award, the Shares subject to the forfeited Award, or
        any consideration in respect of the forfeited Award.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Post-Termination Exercise Period Following Termination of Continuous Service for</u>&#160;<u>Reasons Other than Cause</u>. Subject to <u>Section 4(i)</u>, if a Participant&#8217;s Continuous Service terminates
        for any reason other than for Cause, the Participant may exercise his or her Option or SAR to the extent vested, but only within the following period of time or, if applicable, such other period of time provided in the Award Agreement or other
        written agreement between a Participant and the Company or an Affiliate; <u>provided</u>, <u>however</u>, that in no event may such Award be exercised after the expiration of its maximum term (as set forth in <u>Section 4(a)</u>):</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">5</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(i)&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; three months following the date of such termination if such termination is a termination without Cause (other than any termination due to the Participant&#8217;s Disability or death);</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 12 months following the date of such termination if such termination is due to the Participant&#8217;s Disability;</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160; 12 months following the date of such termination if such termination is due to the Participant&#8217;s death; or</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160; 12 months following the date of the Participant&#8217;s death if such death occurs following the date of such termination but during the period such Award is otherwise exercisable (as provided
        in (i) or (ii) above).</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">Following the date of such termination of Continuous Service for any reason other than for Cause, to the extent the Participant does not exercise such Award within the applicable Post-Termination Exercise Period (or,
        if earlier, prior to the expiration of the maximum term of such Award), such unexercised portion of the Award will terminate, and the Participant will have no further right, title or interest in the terminated Award, the Shares subject to the
        terminated Award, or any consideration in respect of the terminated Award.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(i)&#160;&#160;&#160; &#160; &#160;&#160;&#160;&#160; <u>Restrictions on Exercise; Extension of Exercisability</u>. A Participant may not exercise an Option or SAR at any time that the issuance of Shares upon such exercise would violate Applicable Law.
        Except as otherwise provided in the Award Agreement or other written agreement between a Participant and the Company or an Affiliate, if a Participant&#8217;s Continuous Service terminates for any reason other than for Cause and, at any time during the
        last thirty days of the applicable Post-Termination Exercise Period: (i) the exercise of the Participant&#8217;s Option or SAR would be prohibited solely because the issuance of Shares upon such exercise would violate Applicable Law; or (ii) the
        immediate sale of any Shares issued upon such exercise would violate the Company&#8217;s Trading Policy, then the applicable Post- Termination Exercise Period will be extended to the last day of the calendar month that commences following the date the
        Award would otherwise expire, with an additional extension of the exercise period to the last day of the next calendar month to apply if any of the foregoing restrictions apply at any time during such extended exercise period, generally without
        limitation as to the maximum permitted number of extensions; <u>provided</u>, <u>however</u>, that in no event may such Award be exercised after the expiration of its maximum term (as set forth in <u>Section 4(a)</u>).</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(j)&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>Non-Exempt Employees</u>. No Option or SAR, whether or not vested, granted to an Employee who is a non-exempt employee for purposes of the Fair Labor Standards Act of 1938, as amended, will be first
        exercisable for any Shares until at least six months following the date of grant of such Award. Notwithstanding the foregoing, in accordance with the provisions of the Worker Economic Opportunity Act, any vested portion of such Award may be
        exercised earlier than six months following the date of grant of such Award in the event of (i) such Participant&#8217;s death or Disability, (ii) a Corporate Transaction in which such Award is not assumed, continued or substituted, (iii) a Change in
        Control or (iv) such Participant&#8217;s retirement (as such term may be defined in the Award Agreement or another applicable agreement or, in the absence of any such definition, in accordance with the Company&#8217;s then current employment policies and
        guidelines). This <u>Section 4(j)</u> is intended to operate so that any income derived by a non-exempt employee in connection with the exercise or vesting of an Option or SAR will be exempt from his or her regular rate of pay.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">6</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt;">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Whole Shares</u>. Options and SARs may be exercised only with respect to whole Shares or their equivalents.</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z68ce2c4f2982491fa9e226bc4a1b0319">

          <tr>
            <td style="width: 36pt; vertical-align: top;">5.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Awards other than Options and SARs</u>.</font></div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Restricted Stock Awards and RSU Awards</u>. Each Restricted Stock Award and RSU Award will have such terms and conditions as determined by the Board; <u>provided</u>, <u>however</u>, that each
        Restricted Stock Award Agreement and RSU Award Agreement will conform (through incorporation of the provisions hereof by reference in the Award Agreement or otherwise) to the substance of each of the following provisions:</div>
      <div><br>
      </div>
      <div>
        <div style="font-size: 12pt; text-indent: 72pt;"><font style="font-size: 10pt;">(i)&#160;&#160; &#160; &#160; &#160;&#160;&#160; <u>Form of Award</u>.</font></div>
      </div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 72pt;">(A)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Restricted Stock Awards</u>. To the extent consistent with the Company&#8217;s bylaws, at the Board&#8217;s election, Shares subject to a Restricted Stock Award may be (1) held in book entry form
        subject to the Company&#8217;s instructions until such shares become vested or any other restrictions lapse or (2) evidenced by a certificate, which certificate will be held in such form and manner as determined by the Board. Unless otherwise determined
        by the Board, a Participant will have voting and other rights as a stockholder of the Company with respect to any shares subject to a Restricted Stock Award.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 72pt;">(B)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>RSU Awards</u>. An RSU Award represents a Participant&#8217;s right to be issued on a future date the number of Shares that is equal to the number of restricted stock units subject to the
        RSU Award. As a holder of an RSU Award, a Participant is an unsecured creditor of the Company with respect to the Company&#8217;s unfunded obligation, if any, to issue Shares in settlement of such Award and nothing contained in the Plan or any RSU Award
        Agreement, and no action taken pursuant to its provisions, will create or be construed to create a trust of any kind or a fiduciary relationship between a Participant and the Company or an Affiliate or any other person. A Participant will not have
        voting or any other rights as a stockholder of the Company with respect to any RSU Award (unless and until shares are actually issued in settlement of a vested RSU Award).</div>
      <div><br>
      </div>
      <div>
        <div style="text-indent: 72pt;">(ii) &#160; &#160; &#160; &#160;&#160; <u>Consideration</u>.</div>
      </div>
      <div>&#160;</div>
      <div style="text-indent: 36pt; margin-left: 72pt;">(A)&#160;&#160;&#160; &#160; &#160;&#160; <u>Restricted Stock Awards</u>. A Restricted Stock Award may be granted in consideration for (1) cash or check, bank draft or money order payable to the Company, (2) past services to the
        Company or an Affiliate or (3) any other form of consideration (including future services) as the Board may determine and permissible under Applicable Law.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 72pt;">(B)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>RSU Awards</u>. Unless otherwise determined by the Board at the time of grant, an RSU Award will be granted in consideration for the Participant&#8217;s services to the Company or an
        Affiliate, such that the Participant will not be required to make any payment to the Company (other than such services) with respect to the grant or vesting of the RSU Award, or the issuance of any Shares pursuant to the RSU Award. If, at the time
        of grant, the Board determines that any consideration must be paid by the Participant (in a form other than the Participant&#8217;s services to the Company or an Affiliate) upon the issuance of any Shares in settlement of the RSU Award, such
        consideration may be paid in any form of consideration as the Board may determine and permissible under Applicable Law.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">7</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(iii)&#160;&#160;&#160; &#160; &#160;&#160; <u>Vesting</u>. The Board may impose such restrictions on or conditions to the vesting of a Restricted Stock Award or RSU Award as determined by the Board. Except as otherwise provided
        in the Award Agreement or other written agreement between a Participant and the Company or an Affiliate, vesting of Restricted Stock Awards and RSU Awards will cease upon termination of the Participant&#8217;s Continuous Service.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Termination of Continuous Service</u>. Except as otherwise provided in the Award Agreement or other written agreement between a Participant and the Company or an Affiliate, if a
        Participant&#8217;s Continuous Service terminates for any reason, (A) the Company may receive through a forfeiture condition or a repurchase right any or all of the Shares held by the Participant under his or her Restricted Stock Award that have not
        vested as of the date of such termination as set forth in the Restricted Stock Award Agreement and (B) any portion of his or her RSU Award that has not vested will be forfeited upon such termination and the Participant will have no further right,
        title or interest in the RSU Award, the Shares issuable pursuant to the RSU Award, or any consideration in respect of the RSU Award.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Dividends and Dividend Equivalents</u>. Dividends or dividend equivalents may be paid or credited, as applicable, with respect to any Shares subject to a Restricted Stock Award or RSU
        Award, as determined by the Board and specified in the Award Agreement.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(vi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Settlement of RSU Awards</u>. An RSU Award may be settled by the issuance of Shares or cash (or any combination thereof) or in any other form of payment, as determined by the Board
        and specified in the RSU Award Agreement. At the time of grant, the Board may determine to impose such restrictions or conditions that delay such delivery to a date following the vesting of the RSU Award.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Performance Awards</u>. With respect to any Performance Award, the length of any Performance Period, the Performance Goals to be achieved during the Performance Period, the other terms and conditions of
        such Award, and the measure of whether and to what degree such Performance Goals have been attained will be determined by the Board.</div>
      <div style="text-indent: 36pt;">&#160;</div>
      <div style="text-indent: 36pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Other Awards</u>. Other forms of Awards valued in whole or in part by reference to, or otherwise based on, Common Stock, including the appreciation in value thereof (e.g., options or stock rights with
        an exercise price or strike price less than 100% of the Fair Market Value at the time of grant) may be granted either alone or in addition to Awards provided for under <u>Section 4</u> and the preceding provisions of this <u>Section 5</u>.
        Subject to the provisions of the Plan, the Board will have sole and complete discretion to determine the persons to whom and the time or times at which such Other Awards will be granted, the number of Shares (or the cash equivalent thereof) to be
        granted pursuant to such Other Awards and all other terms and conditions of such Other Awards.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Cash Awards</u>. Cash Awards may be granted from time to time in such amounts, on such terms and conditions, and for such consideration, including no consideration or such minimum consideration as may
        be required by Applicable Law, as the Board shall determine in its sole discretion. Cash Awards may be granted subject to the satisfaction of vesting conditions or may be awarded purely as a bonus and not subject to restrictions or conditions, and
        if subject to vesting conditions, the Board may accelerate the vesting of such Awards at any time in its sole discretion. The grant of a Cash Award shall not require a segregation of any of the Company&#8217;s assets for satisfaction of the Company&#8217;s
        payment obligation thereunder.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">8</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z80a39fee8ef5430286178046a50a2e0c">

          <tr>
            <td style="width: 35.95pt; vertical-align: top;">6.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Adjustments Upon Changes In Common Stock; Other Corporate Events</u>.</font></div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Capitalization Adjustments</u>. In the event of a Capitalization Adjustment, the Board shall appropriately and proportionately adjust: (i) the class(es) and maximum number of Shares subject to the Plan
        and the maximum number of shares by which the Share Reserve may annually increase pursuant to <u>Section 2(a)</u>; (ii) the class(es) and maximum number of shares that may be issued pursuant to the exercise of Incentive Stock Options pursuant to <u>Section
          2(b)</u>; and (iii) the class(es) and number of securities and exercise price, strike price or purchase price of Common Stock subject to outstanding Awards. The Board shall make such adjustments, and its determination shall be final, binding and
        conclusive. Notwithstanding the foregoing, no fractional shares or rights for fractional Shares shall be created in order to implement any Capitalization Adjustment. The Board shall determine an appropriate equivalent benefit, if any, for any
        fractional shares or rights to fractional shares that might be created by the adjustments referred to in the preceding provisions of this Section.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Dissolution or Liquidation</u>. Except as otherwise provided in the Award Agreement, in the event of a dissolution or liquidation of the Company, all outstanding Awards (other than Awards consisting of
        vested and outstanding Shares not subject to a forfeiture condition or the Company&#8217;s right of repurchase) will terminate immediately prior to the completion of such dissolution or liquidation, and the Shares subject to the Company&#8217;s repurchase
        rights or subject to a forfeiture condition may be repurchased or reacquired by the Company notwithstanding the fact that the holder of such Award is providing Continuous Service, provided, however, that the Board may determine to cause some or all
        Awards to become fully vested, exercisable and/or no longer subject to repurchase or forfeiture (to the extent such Awards have not previously expired or terminated) before the dissolution or liquidation is completed but contingent on its
        completion.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Corporate Transaction</u>. In the event of a Corporate Transaction, except as otherwise provided in the instrument evidencing the Award or any other written agreement between the Company or any
        Affiliate and the Participant, or unless otherwise expressly provided by the Board at the time of grant of an Award, outstanding Awards will be treated in accordance with one or more of the following methods as determined by the Board.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Awards May Be Assumed</u>. In the event of a Corporate Transaction, any surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#8217;s parent company)
        may assume or continue any or all Awards outstanding under the Plan or may substitute similar awards for Awards outstanding under the Plan (including but not limited to, awards to acquire the same consideration paid to the stockholders of the
        Company pursuant to the Corporate Transaction), and any reacquisition or repurchase rights held by the Company in respect of Common Stock issued pursuant to Awards may be assigned by the Company to the successor of the Company (or the successor&#8217;s
        parent company, if any), in connection with such Corporate Transaction. A surviving corporation or acquiring corporation (or its parent) may choose to assume or continue only a portion of an Award or substitute a similar award for only a portion of
        an Award, or may choose to assume or continue the Awards held by some, but not all Participants. The terms of any assumption, continuation or substitution will be set by the Board.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">9</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Awards Held by Current Participants</u>. In the event of a Corporate Transaction in which the surviving corporation or acquiring corporation (or its parent company) does not assume
        or continue such outstanding Awards or substitute similar awards for such outstanding Awards, then with respect to Awards that have not been assumed, continued or substituted and that are held by Participants whose Continuous Service has not
        terminated prior to the effective time of the Corporate Transaction (referred to as the &#8220;Current Participants&#8221;), the vesting of such Awards (and, with respect to Options and Stock Appreciation Rights, the time when such Awards may be exercised)
        will be accelerated in full to a date prior to the effective time of such Corporate Transaction (contingent upon the effectiveness of the Corporate Transaction) as the Board determines (or, if the Board does not determine such a date, to the date
        that is five days prior to the effective time of the Corporate Transaction), and such Awards will terminate if not exercised (if applicable) at or prior to the effective time of the Corporate Transaction, and any reacquisition or repurchase rights
        held by the Company with respect to such Awards will lapse (contingent upon the effectiveness of the Corporate Transaction). With respect to the vesting of Performance Awards that will accelerate upon the occurrence of a Corporate Transaction
        pursuant to this subsection (ii) and that have multiple vesting levels depending on the level of performance, unless otherwise provided in the Award Agreement, the vesting of such Performance Awards will accelerate at 100% of the target level upon
        the occurrence of the Corporate Transaction. With respect to the vesting of Awards that will accelerate upon the occurrence of a Corporate Transaction pursuant to this subsection (ii) and are settled in the form of a cash payment, such cash payment
        will be made no later than 30 days following the occurrence of the Corporate Transaction or such later date as required to comply with Section 409A of the Code.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(iii)&#160;&#160;&#160; &#160; &#160;&#160; <u>Awards Held by Persons other than Current Participants</u>. In the event of a Corporate Transaction in which the surviving corporation or acquiring corporation (or its parent
        company) does not assume or continue such outstanding Awards or substitute similar awards for such outstanding Awards, then with respect to Awards that have not been assumed, continued or substituted and that are held by persons other than Current
        Participants, such Awards will terminate if not exercised (if applicable) prior to the occurrence of the Corporate Transaction; provided, however, that any reacquisition or repurchase rights held by the Company with respect to such Awards will not
        terminate and may continue to be exercised notwithstanding the Corporate Transaction.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Payment for Awards in Lieu of Exercise</u>. Notwithstanding the foregoing, in the event an Award will terminate if not exercised prior to the effective time of a Corporate
        Transaction, the Board may provide, in its sole discretion, that the holder of such Award may not exercise such Award but will receive a payment, in such form as may be determined by the Board, equal in value, at the effective time, to the excess,
        if any, of (A) the value of the property the Participant would have received upon the exercise of the Award (including, at the discretion of the Board, any unvested portion of such Award), over (B) any exercise price payable by such holder in
        connection with such exercise.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Notwithstanding any other provision herein to the contrary, the Board may, in its sole discretion, provide for accelerated vesting or lapse of restrictions, of an Award at any time.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Appointment of Stockholder Representative</u>. As a condition to the receipt of an Award under this Plan, a Participant will be deemed to have agreed that the Award will be subject to the terms of any
        agreement governing a Corporate Transaction involving the Company, including, without limitation, a provision for the appointment of a stockholder representative that is authorized to act on the Participant&#8217;s behalf with respect to any escrow, any
        indemnities and any contingent consideration.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">10</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Restriction on Right to Undertake Transactions</u>. The grant of any Award under the Plan and the issuance of shares pursuant to any Award does not affect or restrict in any way the right or power of
        the Company or the stockholders of the Company to make or authorize any adjustment, recapitalization, reorganization or other change in the Company&#8217;s capital structure or its business, any merger or consolidation of the Company, any issue of stock
        or of options, rights or options to purchase stock or of bonds, debentures, preferred or prior preference stocks whose rights are superior to or affect the Common Stock or the rights thereof or which are convertible into or exchangeable for Common
        Stock, or the dissolution or liquidation of the Company, or any sale or transfer of all or any part of its assets or business, or any other corporate act or proceeding, whether of a similar character or otherwise.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(f)&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; <u>Compliance with Section 409(A); No Additional Rights</u>. Any adjustment to, or assumption or substitution of, an Award under this Section 6 shall be intended to comply with the requirements of
        Section 409A, to the extent applicable. Except as expressly provided in this <u>Section 6</u> or in the applicable Award Agreement, a Participant shall have no additional rights under this Plan by reason of any transaction or event described in
        this <u>Section 6</u>.</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1351056ba693498d98c98c2208bb30f5">

          <tr>
            <td style="width: 36pt; vertical-align: top;">7.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Administration</u>.</font></div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Administration by Board</u>. The Board will administer the Plan unless and until the Board delegates administration of the Plan to a Committee or Committees, as provided in subsection (c) below.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Powers of Board</u>. The Board will have the power, subject to, and within the limitations of, the express provisions of the Plan:</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; To determine from time to time (A) which of the persons eligible under the Plan will be granted Awards; (B) when and how each Award will be granted; (C) what type or combination of
        types of Award will be granted; (D) the provisions of each Award granted (which need not be identical), including the time or times when a person will be permitted to receive an issuance of Common Stock or other payment pursuant to an Award; (E)
        the number of Shares or cash equivalent with respect to which an Award will be granted to each such person; (F) the Fair Market Value applicable to an Award; and (G) the terms of any Performance Award that is not valued in whole or in part by
        reference to, or otherwise based on, the Common Stock, including the amount of cash payment or other property that may be earned and the timing of payment.</div>
      <div style="text-indent: 36pt; margin-left: 36pt;">&#160;</div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(ii)&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160; To construe and interpret the Plan and Awards granted under it, and to establish, amend and revoke rules and regulations for its administration. The Board, in the exercise of this
        power, may correct any defect, omission or inconsistency in the Plan or in any Award Agreement, in a manner and to the extent it deems necessary or expedient to make the Plan or Award fully effective.</div>
      <div><br>
      </div>
      <div>
        <div style="text-indent: 72pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; To settle all controversies regarding the Plan and Awards granted under it.</div>
      </div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(iv)&#160;&#160;&#160;&#160; &#160; &#160; To accelerate the time at which an Award may first be exercised or the time during which an Award or any part thereof will vest, notwithstanding the provisions in the Award Agreement
        stating the time at which it may first be exercised or the time during which it will vest.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">11</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;To prohibit the exercise of any Option, SAR or other exercisable Award during a period of up to 30 days prior to the consummation of any pending stock dividend, stock split, combination
        or exchange of shares, merger, consolidation or other distribution (other than normal cash dividends) of Company assets to stockholders, or any other change affecting the Shares or the share price of the Common Stock, including any Corporate
        Transaction, for reasons of administrative convenience.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(vi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; To suspend or terminate the Plan at any time. Suspension or termination of the Plan will not Materially Impair rights and obligations under any Award granted while the Plan is in effect
        except with the written consent of the affected Participant.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(vii)&#160;&#160;&#160;&#160;&#160;&#160;&#160; To amend the Plan in any respect the Board deems necessary or advisable; provided, however, that stockholder approval will be required for any amendment to the extent required by
        Applicable Law (including, for the avoidance of doubt, for any amendment that would (A) increase the Share Reserve or (B) change the classification of individuals eligible to receive Awards under this Plan). Except as provided above, rights under
        any Award granted before amendment of the Plan will not be Materially Impaired by any amendment of the Plan unless (A) the Company requests the consent of the affected Participant and (B) such Participant consents in writing. </div>
      <div><br>
      </div>
      <div>
        <div style="text-indent: 36pt; margin-left: 36pt;">(viii)&#160;&#160;&#160;&#160;&#160;&#160; To submit any amendment to the Plan for stockholder approval.</div>
      </div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(ix)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; To approve forms of Award Agreements for use under the Plan and to amend the terms of any one or more Awards, including, but not limited to, amendments to provide terms more favorable to
        the Participant than previously provided in the Award Agreement, subject to any specified limits in the Plan that are not subject to Board discretion; provided however, that, a Participant&#8217;s rights under any Award will not be Materially Impaired by
        any such amendment unless (A) the Company requests the consent of the affected Participant and (B) such Participant consents in writing.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(x)&#160;&#160;&#160;&#160;&#160;&#160;&#160; Generally, to exercise such powers and to perform such acts as the Board deems necessary or expedient to promote the best interests of the Company and that are not in
        conflict with the provisions of the Plan or Awards, in compliance with Applicable Law.</div>
      <div style="text-indent: 36pt; margin-left: 36pt;">&#160;</div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(xi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; To adopt such procedures and sub-plans as are necessary or appropriate to permit and facilitate participation in the Plan by, or take advantage of specific tax treatment for Awards
        granted to, Employees, Non-Employee Directors or Consultants who are foreign nationals or employed outside the United States (provided that Board approval will not be necessary for immaterial modifications to the Plan or any Award Agreement to
        ensure or facilitate compliance with the laws of the relevant foreign jurisdiction).</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(xii)&#160;&#160;&#160;&#160;&#160;&#160;&#160; To effect, at any time and from time to time, subject to the consent of any Participant whose Award is Materially Impaired by such action, (A) the reduction of the exercise price (or
        strike price) of any outstanding Option or SAR; (B) the cancellation of any outstanding Option or SAR and the grant in substitution therefor of (1) a new Option, SAR, Restricted Stock Award, RSU Award or Other Award, under the Plan or another
        equity plan of the Company, covering the same or a different number of Shares, (2) cash and/or (3) other valuable consideration (as determined by the Board); or (C) any other action that is treated as a repricing under generally accepted accounting
        principles.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">12</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zc49bcc0fdd5743a49494f4a162dd2a9f" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">

              <tr style="vertical-align: top;">
                <td style="width: 36pt;">&#160;</td>
                <td style="text-align: right; vertical-align: top; width: 36pt;">
                  <div style="text-align: left;">(c)</div>
                </td>
                <td style="text-align: left; vertical-align: top; width: auto;">
                  <div><u>Delegation to Committee</u>.</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>General</u>. The Board may delegate some or all of the administration of the Plan to a Committee or Committees. If administration of the Plan is delegated to a Committee, the
        Committee will have, in connection with the administration of the Plan, the powers theretofore possessed by the Board that have been delegated to the Committee, including the power to delegate to another Committee or a subcommittee of the Committee
        any of the administrative powers the Committee is authorized to exercise (and references in this Plan to the Board will thereafter be to the Committee or subcommittee), subject, however, to such resolutions, not inconsistent with the provisions of
        the Plan, as may be adopted from time to time by the Board. Each Committee may retain the authority to concurrently administer the Plan with the Committee or subcommittee to which it has delegated its authority hereunder and may, at any time,
        revest in such Committee some or all of the powers previously delegated. The Board may retain the authority to concurrently administer the Plan with any Committee and may, at any time, revest in the Board some or all of the powers previously
        delegated.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Rule 16b-3 Compliance</u>. To the extent an Award is intended to qualify for the exemption from Section 16(b) of the Exchange Act that is available under Rule 16b-3 of the Exchange
        Act, the Award will be granted by the Board or a Committee that consists solely of two or more Non-Employee Directors, as determined under Rule 16b-3(b)(3) of the Exchange Act and thereafter any action establishing or modifying the terms of the
        Award will be approved by the Board or a Committee meeting such requirements to the extent necessary for such exemption to remain available.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Effect of Board&#8217;s Decision</u>. All determinations, interpretations and constructions made by the Board or any Committee in good faith will not be subject to review by any person and will be final,
        binding and conclusive on all persons.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Delegation to Other Person or Body</u>. The Board or any Committee may delegate to one or more persons or bodies the authority to do one or more of the following to the extent permitted by Applicable
        Law: (i) designate recipients, other than Officers, of Options and SARs (and, to the extent permitted by Applicable Law, other Awards), provided that no person or body may be delegated authority to grant an Award to themself; (ii) determine the
        number of shares subject to such Awards; and (iii) determine the terms of such Awards; provided, however, that the Board or Committee action regarding such delegation will fix the terms of such delegation in accordance with Applicable Law,
        including without limitation Sections 152 and 157 of the Delaware General Corporation Law. Unless provided otherwise in the Board or Committee action regarding such delegation, each Award granted pursuant to this section will be granted on the
        applicable form of Award Agreement most recently approved for use by the Board or the Committee, with any modifications necessary to incorporate or reflect the terms of such Award. Notwithstanding anything to the contrary herein, neither the Board
        nor any Committee may delegate to any (x) person who is not a member of the Board or (y) body that is not comprised solely of members of the Board, in each case, the authority to determine the Fair Market Value.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">13</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd7419c29338242748275b5d45814cc32">

          <tr>
            <td style="width: 36pt; vertical-align: top;">8.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Tax Withholding</u>.</font></div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Withholding Authorization</u>. As a condition to acceptance of any Award under the Plan, a Participant authorizes withholding from payroll and any other amounts payable to such Participant, and
        otherwise agrees to make adequate provision for (including), any sums required to satisfy any U.S. federal, state, local and/or foreign tax or social insurance contribution withholding obligations of the Company or an Affiliate, if any, which arise
        in connection with the exercise, vesting or settlement of such Award, as applicable. Accordingly, a Participant may not be able to exercise an Award even though the Award is vested, and the Company shall have no obligation to issue Shares subject
        to an Award, unless and until such obligations are satisfied.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Satisfaction of Withholding Obligation</u>. To the extent permitted by the terms of an Award Agreement, the Company may, in its sole discretion, satisfy any U.S. federal, state, local and/or foreign tax
        or social insurance withholding obligation relating to an Award by any of the following means or by a combination of such means:</div>
      <div><br>
      </div>
      <div>
        <div style="text-indent: 36pt; margin-left: 36pt;">(i) &#160; &#160; &#160; &#160; &#160; causing the Participant to tender a cash payment;</div>
      </div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;withholding Shares from the Shares issued or otherwise issuable to the Participant in connection with the Award;</div>
      <div><br>
      </div>
      <div>
        <div style="text-indent: 36pt; margin-left: 36pt;">(iii) &#160; &#160; &#160; &#160; withholding cash from an Award settled in cash;</div>
      </div>
      <div><br>
      </div>
      <div>
        <div style="text-indent: 36pt; margin-left: 36pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; withholding payment from any amounts otherwise payable to the Participant;</div>
      </div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;by allowing a Participant to effectuate a &#8220;cashless exercise&#8221; pursuant to a program developed under Regulation T as promulgated by the Federal Reserve Board; or</div>
      <div><br>
      </div>
      <div>
        <div style="text-indent: 36pt; margin-left: 36pt;">(vi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; by such other method as may be set forth in the Award Agreement.</div>
      </div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(c)&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160; <u>No Obligation to Notify or Minimize Taxes; No Liability to Claims</u>. Except as required by Applicable Law, the Company has no duty or obligation to any Participant to advise such holder as to the
        time or manner of exercising such Award. Furthermore, the Company has no duty or obligation to warn or otherwise advise such holder of a pending termination or expiration of an Award or a possible period in which the Award may not be exercised. The
        Company has no duty or obligation to minimize the tax consequences of an Award to the holder of such Award and will not be liable to any holder of an Award for any adverse tax consequences to such holder in connection with an Award. As a condition
        to accepting an Award under the Plan, each Participant (i) agrees to not make any claim against the Company, or any of its Officers, Non-Employee Directors, Employees or Affiliates related to tax liabilities arising from such Award or other Company
        compensation and (ii) acknowledges that such Participant was advised to consult with his or her own personal tax, financial and other legal advisors regarding the tax consequences of the Award and has either done so or knowingly and voluntarily
        declined to do so. Additionally, each Participant acknowledges any Option or SAR granted under the Plan is exempt from Section 409A only if the exercise or strike price is at least equal to the &#8220;fair market value&#8221; of the Common Stock on the date of
        grant as determined by the Internal Revenue Service and there is no other impermissible deferral of compensation associated with the Award. Additionally, as a condition to accepting an Option or SAR granted under the Plan, each Participant agrees
        not make any claim against the Company, or any of its Officers, Non-Employee Directors, Employees or Affiliates in the event that the Internal Revenue Service asserts that such exercise price or strike price is less than the &#8220;fair market value&#8221; of
        the Common Stock on the date of grant as subsequently determined by the Internal Revenue Service.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">14</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Withholding Indemnification</u>. As a condition to accepting an Award under the Plan, in the event that the amount of the Company&#8217;s and/or its Affiliate&#8217;s withholding obligation in connection with such
        Award was greater than the amount actually withheld by the Company and/or its Affiliates, each Participant agrees to indemnify and hold the Company and/or its Affiliates harmless from any failure by the Company and/or its Affiliates to withhold the
        proper amount.</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z174c00fbbac24e679322e8190dd0e527">

          <tr>
            <td style="width: 36pt; vertical-align: top;">9.</td>
            <td style="width: auto; vertical-align: top;">
              <div>Miscellaneous.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Source of Shares</u>. The shares issuable under the Plan will be shares of authorized but unissued or reacquired Common Stock, including shares repurchased by the Company on the open market or
        otherwise.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Use of Proceeds from Sales of Common Stock</u>. Proceeds from the sale of Shares pursuant to Awards will constitute general funds of the Company.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Corporate Action Constituting Grant of Awards</u>. Corporate action constituting a grant by the Company of an Award to any Participant will be deemed completed as of the date of such corporate action,
        unless otherwise determined by the Board, regardless of when the instrument, certificate, or letter evidencing the Award is communicated to, or actually received or accepted by, the Participant. In the event that the corporate records (e.g., Board
        consents, resolutions or minutes) documenting the corporate action approving the grant contain terms (e.g., exercise price, vesting schedule or number of shares) that are inconsistent with those in the Award Agreement or related grant documents as
        a result of a clerical error in the Award Agreement or related grant documents, the corporate records will control and the Participant will have no legally binding right to the incorrect term in the Award Agreement or related grant documents.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Stockholder Rights</u>. No Participant will be deemed to be the holder of, or to have any of the rights of a holder with respect to, any Shares subject to such Award unless and until (i) such
        Participant has satisfied all requirements for exercise of the Award pursuant to its terms, if applicable, and (ii) the issuance of the Common Stock subject to such Award is reflected in the records of the Company.</div>
      <div style="text-indent: 36pt;">&#160;</div>
      <div style="text-indent: 36pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Employment or Other Service Rights</u>. Nothing in the Plan, any Award Agreement or any other instrument executed thereunder or in connection with any Award granted pursuant thereto will confer upon
        any Participant any right to continue to serve the Company or an Affiliate in the capacity in effect at the time the Award was granted or affect the right of the Company or an Affiliate to terminate at will and without regard to any future vesting
        opportunity that a Participant may have with respect to any Award (i) the employment of an Employee with or without notice and with or without cause, (ii) the service of a Consultant pursuant to the terms of such Consultant&#8217;s agreement with the
        Company or an Affiliate or (iii) the service of a Non-Employee Director pursuant to the bylaws of the Company or an Affiliate, and any applicable provisions of the corporate law of the state or foreign jurisdiction in which the Company or the
        Affiliate is incorporated, as the case may be. Further, nothing in the Plan, any Award Agreement or any other instrument executed thereunder or in connection with any Award will constitute any promise or commitment by the Company or an Affiliate
        regarding the fact or nature of future positions, future work assignments, future compensation or any other term or condition of employment or service or confer any right or benefit under the Award or the Plan unless such right or benefit has
        specifically accrued under the terms of the Award Agreement and/or Plan.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">15</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt;">(f)&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160; <u>Execution of Additional Documents</u>. As a condition to accepting an Award under the Plan, the Participant agrees to execute any additional documents or instruments necessary or desirable, as
        determined in the Plan Administrator&#8217;s sole discretion, to carry out the purposes or intent of the Award, or facilitate compliance with securities and/or other regulatory requirements, in each case at the Plan Administrator&#8217;s request.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Electronic Delivery</u>. Any reference herein or in an Award Agreement to a &#8220;written&#8221; agreement or document will include any agreement or document delivered electronically, filed publicly at www.sec.gov
        (or any successor website thereto) or posted on the Company&#8217;s intranet (or other shared electronic medium controlled by the Company to which the Participant has access). By accepting any Award the Participant consents to receive documents by
        electronic delivery and to participate in the Plan through any on-line electronic system established and maintained by the Plan Administrator or another third party selected by the Plan Administrator. The form of delivery of any Common Stock (e.g.,
        a stock certificate or electronic entry evidencing such shares) shall be determined by the Company.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Clawback</u>. All Awards granted under the Plan will be subject to recoupment in accordance with any clawback policy that the Company is required to adopt pursuant to the listing standards of any
        national securities exchange or association on which the Company&#8217;s securities are listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other Applicable Law and any clawback policy that the Company
        otherwise adopts, to the extent applicable and permissible under Applicable Law. In addition, the Board may impose such other clawback, recovery or recoupment provisions in an Award Agreement as the Board determines necessary or appropriate,
        including but not limited to a reacquisition right in respect of previously acquired Shares or other cash or property upon the occurrence of Cause. No recovery of compensation under such a clawback policy will be an event giving rise to a
        Participant&#8217;s right to voluntarily terminate employment upon a &#8220;resignation for good reason,&#8221; or for a &#8220;constructive termination&#8221; or any similar term under any plan of or agreement with the Company.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(i)&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>Securities Law Compliance</u>. A Participant will not be issued any shares in respect of an Award unless either (i) the shares are registered under the Securities Act or (ii) the Company has
        determined that such issuance would be exempt from the registration requirements of the Securities Act. Each Award also must comply with other Applicable Law governing the Award, and a Participant will not receive such shares if the Company
        determines that such receipt would not be in material compliance with Applicable Law.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(j)&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>Transfer or Assignment of Awards and Issued Shares</u>. Except as expressly provided in the Plan or the form of Award Agreement, Awards granted under the Plan may not be transferred or assigned by the
        Participant. After the vested shares subject to an Award have been issued, or in the case of a Restricted Stock Award and similar awards, after the issued shares have vested, the holder of such shares is free to assign, hypothecate, donate,
        encumber or otherwise dispose of any interest in such shares provided that any such actions are in compliance with the provisions herein, the terms of the Trading Policy and Applicable Law.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Effect on Other Employee Benefit Plans</u>. The value of any Award granted under the Plan, as determined upon grant, vesting or settlement, shall not be included as compensation, earnings, salaries, or
        other similar terms used when calculating any Participant&#8217;s benefits under any employee benefit plan sponsored by the Company or any Affiliate, except as such plan otherwise expressly provides. The Company expressly reserves its rights to amend,
        modify, or terminate any of the Company&#8217;s or any Affiliate&#8217;s employee benefit plans.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">16</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt;">(l)&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; <u>Deferrals</u>. To the extent permitted by Applicable Law, the Board, in its sole discretion, may determine that the delivery of Common Stock or the payment of cash, upon the exercise, vesting or
        settlement of all or a portion of any Award may be deferred and may also establish programs and procedures for deferral elections to be made by Participants. Deferrals will be made in accordance with the requirements of Section 409A.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(m)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Section 409A</u>. Unless otherwise expressly provided for in an Award Agreement, the Plan, all Awards and Award Agreements are intended to be exempt from or in compliance with Section 409A and will be
        limited, construed, and interpreted in accordance with such intent to the greatest extent possible. To the extent that any Award is not exempt from Section 409A, all actions taken by the Board with respect to such Award will comply with Section
        409A.. If the Board determines that any Award granted hereunder is not exempt from and is therefore subject to Section 409A, the Award Agreement evidencing such Award will incorporate the terms and conditions necessary to avoid the consequences
        specified in Section 409A(a)(1) of the Code, and to the extent an Award Agreement is silent on terms necessary for compliance, such terms are hereby incorporated by reference into the Award Agreement. Notwithstanding any other provision of the
        Plan, any provision of the Plan that is inconsistent with Section 409A will be deemed to be amended to comply with Section 409A and to the extent such provision cannot be amended to comply, such provision will be deemed to be null and void. The
        Company will have no liability to a Participant, or any other party, if an Award that is intended to be exempt from or compliant with Section 409A is not so exempt or compliant, or for any action taken by the Board or the Company and, in the event
        that any amount or benefit under the Plan becomes subject to penalties under Section 409A, responsibility for payment of such penalties will rest solely with the affected Participants and not with the Company. Notwithstanding anything to the
        contrary in this Plan (and unless the Award Agreement specifically provides otherwise), if the Shares are publicly traded, and if a Participant holding an Award that constitutes &#8220;deferred compensation&#8221; under Section 409A is a &#8220;specified employee&#8221;
        for purposes of Section 409A, no distribution or payment of any amount that is due because of a &#8220;separation from service&#8221; (as defined in Section 409A without regard to alternative definitions thereunder) will be issued or paid before the date that
        is six months and one day following the date of such Participant&#8217;s &#8220;separation from service&#8221; or, if earlier, the date of the Participant&#8217;s death, unless such distribution or payment can be made in a manner that complies with Section 409A, and any
        amounts so deferred will be paid in a lump sum on the day after such six month period elapses, with the balance paid thereafter on the original schedule.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(n)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Choice of Law</u>. This Plan and any controversy arising out of or relating to this Plan shall be governed by, and construed in accordance with, the internal laws of the State of Delaware, without
        regard to conflict of law principles that would result in any application of any law other than the law of the State of Delaware.</div>
      <div><br>
      </div>
      <div>10.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Covenants of the Company</u>. The Company will seek to obtain from each regulatory commission or agency, as may be deemed to be necessary, having jurisdiction over the Plan such authority as may be required to grant Awards and to
        issue and sell shares of Common Stock upon exercise or vesting of the Awards; <u>provided</u>, <u>however</u>, that this undertaking will not require the Company to register under the Securities Act the Plan, any Award or any Common Stock issued
        or issuable pursuant to any such Award. If, after reasonable efforts and at a reasonable cost, the Company is unable to obtain from any such regulatory commission or agency the authority that counsel for the Company deems necessary or advisable for
        the lawful issuance and sale of Common Stock under the Plan, the Company will be relieved from any liability for failure to issue and sell Common Stock upon exercise or vesting of such Awards unless and until such authority is obtained. A
        Participant is not eligible for the grant of an Award or the subsequent issuance of Common Stock pursuant to the Award if such grant or issuance would be in violation of any Applicable Law.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">17</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div>11.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Severability</u>. If all or any part of the Plan or any Award Agreement is declared by any court or governmental authority to be unlawful or invalid, such unlawfulness or invalidity shall not invalidate any portion of the Plan or
        such Award Agreement not declared to be unlawful or invalid. Any Section of the Plan or any Award Agreement (or part of such a Section) so declared to be unlawful or invalid shall, if possible, be construed in a manner which will give effect to the
        terms of such Section or part of a Section to the fullest extent possible while remaining lawful and valid.</div>
      <div><br>
      </div>
      <div>12.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Termination of the Plan</u>. The Board may suspend or terminate the Plan at any time. No Incentive Stock Options may be granted after the tenth anniversary of the earlier of: (i) the Adoption Date; or (ii) the date the Plan is
        approved by the Company&#8217;s stockholders. No Awards may be granted under the Plan while the Plan is suspended or after it is terminated.</div>
      <div><br>
      </div>
      <div>13.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Definitions</u>. As used in the Plan, the following definitions apply to the capitalized terms indicated below:</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160; &#8220;Acquiring Entity&#8221; means the surviving or acquiring corporation (or its parent company) in connection with a Corporate Transaction.</div>
      <div><br>
      </div>
      <div>
        <div style="text-indent: 36pt;">(b) &#160; &#160; &#160; &#160;&#160; &#8220;Adoption Date&#8221; means the date the Plan is first approved by the Board.</div>
      </div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Affiliate&#8221; means, at the time of determination, any &#8220;parent&#8221; or &#8220;subsidiary&#8221; of the Company as such terms are defined in Rule 405 promulgated under the Securities Act. The Board may determine the time or
        times at which &#8220;parent&#8221; or &#8220;subsidiary&#8221; status is determined within the foregoing definition.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Applicable Law&#8221; means the Code and any applicable securities, federal, state, foreign, material local or municipal or other law, statute, constitution, principle of common law, resolution, ordinance,
        code, edict, decree, rule, listing rule, regulation, judicial decision, ruling or requirement issued, enacted, adopted, promulgated, implemented or otherwise put into effect by or under the authority of any Governmental Body (including under the
        authority of any applicable self-regulating organization such as the Nasdaq Stock Market, New York Stock Exchange, or the Financial Industry Regulatory Authority).</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Award&#8221; means any right to receive Common Stock, cash or other property granted under the Plan (including an Incentive Stock Option, a Nonstatutory Stock Option, a Restricted Stock Award, an RSU Award, a
        SAR, a Performance Award, Other Award or Cash Award).</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(f)&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160; &#8220;Award Agreement&#8221; means a written or electronic agreement between the Company and a Participant evidencing the terms and conditions of an Award. The Award Agreement generally consists of the Grant Notice
        and the agreement containing the written summary of the general terms and conditions applicable to the Award and which is provided, including through electronic means, to a Participant along with the Grant Notice.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">18</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt;">(g)&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160; &#8220;Board&#8221; means the Board of Directors of the Company (or its designee). Any decision or determination made by the Board shall be a decision or determination that is made in the sole discretion of the Board
        (or its designee), and such decision or determination shall be final and binding on all Participants.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Business Combination Date&#8221; means the closing date of the Business Combination described in the Business Combination Agreement dated March 11, 2024, by and between the Company, Focus Impact BH3 Acquisition
        Company and the other parties thereto.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#8220;Cash Award&#8221; means an Award granted pursuant to Section 5(d) of the Plan and payable in cash at such time or times and subject to such terms and conditions as determined by the Board
        in its sole discretion.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">(j)&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; &#8220;Capital Stock&#8221; means each and every class of common stock of the Company, regardless of the number of votes per share.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Capitalization Adjustment&#8221; means any change that is made in, or other events that occur with respect to, the Common Stock subject to the Plan or subject to any Award after the Effective Date without the
        receipt of consideration by the Company through merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property other than cash, large nonrecurring cash dividend, stock split, reverse stock split,
        liquidating dividend, combination of shares, exchange of shares, change in corporate structure or any similar equity restructuring transaction, as that term is used in Statement of Financial Accounting Standards Board Accounting Standards
        Codification Topic 718 (or any successor thereto). Notwithstanding the foregoing, the conversion of any convertible securities of the Company will not be treated as a Capitalization Adjustment.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(l)&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; &#8220;Cause&#8221; has the meaning ascribed to such term in any written agreement between the Participant and the Company defining such term and, in the absence of such agreement, such term means, with respect to a
        Participant, the occurrence of any of the following events: (i) such Participant&#8217;s commission of any felony or any crime involving fraud, dishonesty or moral turpitude under the laws of the United States or any state thereof; (ii) such
        Participant&#8217;s attempted commission of, or participation in, a fraud or act of dishonesty against the Company; (iii) such Participant&#8217;s material violation of any contract or agreement between the Participant and the Company or of any statutory duty
        owed to the Company; (iv) such Participant&#8217;s unauthorized use or disclosure of the Company&#8217;s confidential information or trade secrets; (v) such Participant&#8217;s gross misconduct; (vi) such Participant&#8217;s failure or refusal to comply with a material
        directive from the Board, the Participant&#8217;s supervisor or, if applicable, the board of directors of any Affiliate; or (vii) such Participant&#8217;s breach of a fiduciary duty to the Company. The determination that a termination of the Participant&#8217;s
        Continuous Service is either for Cause or without Cause will be made by the Board with respect to Participants who are executive officers of the Company and by the Company&#8217;s Chief Executive Officer with respect to Participants who are not executive
        officers of the Company. Any determination by the Company that the Continuous Service of a Participant was terminated with or without Cause for the purposes of outstanding Awards held by such Participant will have no effect upon any determination
        of the rights or obligations of the Company or such Participant for any other purpose.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">(m)&#160;&#160;&#160; &#160; &#160;&#160; &#8220;Change in Control&#8221; or &#8220;Change of Control&#8221; means the occurrence, in a single transaction or in a series of related transactions, of any one or more of the following events:</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">19</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(i)&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; any Exchange Act Person becomes the Owner, directly or indirectly, of securities of the Company representing more than 50% of the combined voting power of the Company&#8217;s then outstanding
        securities other than by virtue of a merger, consolidation or similar transaction. Notwithstanding the foregoing, a Change in Control shall not be deemed to occur (A) on account of the acquisition of securities of the Company directly from the
        Company, (B) on account of the acquisition of securities of the Company by an investor, any affiliate thereof or any other Exchange Act Person that acquires the Company&#8217;s securities in a transaction or series of related transactions the primary
        purpose of which is to obtain financing for the Company through the issuance of equity securities, or (C) solely because the level of Ownership held by any Exchange Act Person (the &#8220;Subject Person&#8221;) exceeds the designated percentage threshold of
        the outstanding voting securities as a result of a repurchase or other acquisition of voting securities by the Company reducing the number of shares outstanding, provided that if a Change in Control would occur (but for the operation of this
        sentence) as a result of the acquisition of voting securities by the Company, and after such share acquisition, the Subject Person becomes the Owner of any additional voting securities that, assuming the repurchase or other acquisition had not
        occurred, increases the percentage of the then outstanding voting securities Owned by the Subject Person over the designated percentage threshold, then a Change in Control shall be deemed to occur;</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;there is consummated a merger, consolidation or similar transaction involving (directly or indirectly) the Company and, immediately after the consummation of such merger, consolidation
        or similar transaction, the stockholders of the Company immediately prior thereto do not Own, directly or indirectly, either (A) outstanding voting securities representing more than 50% of the combined outstanding voting power of the surviving
        Entity in such merger, consolidation or similar transaction or (B) more than 50% of the combined outstanding voting power of the parent of the surviving Entity in such merger, consolidation or similar transaction, in each case in substantially the
        same proportions as their Ownership of the outstanding voting securities of the Company immediately prior to such transaction;</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; the stockholders of the Company approve or the Board approves a plan of complete dissolution or liquidation of the Company, or a complete dissolution or liquidation of the Company shall
        otherwise occur, except for a liquidation into a parent corporation;</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; there is consummated a sale, lease, exclusive license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries, other than a sale,
        lease, license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries to an Entity, more than 50% of the combined voting power of the voting securities of which are Owned by stockholders of
        the Company in substantially the same proportions as their Ownership of the outstanding voting securities of the Company immediately prior to such sale, lease, license or other disposition; or</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;individuals who, on the date the Plan is adopted by the Board, are members of the Board (the &#8220;Incumbent Board&#8221;) cease for any reason to constitute at least a majority of the members of
        the Board; provided, however, that if the appointment or election (or nomination for election) of any new Board member was approved or recommended by a majority vote of the members of the Incumbent Board then still in office, such new member shall,
        for purposes of this Plan, be considered as a member of the Incumbent Board.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">20</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt;">Notwithstanding the foregoing or any other provision of this Plan, (1) the term Change in Control shall not include a sale of assets, merger or other transaction effected exclusively for the purpose of changing the
        domicile of the Company, (2) the definition of Change in Control (or any analogous term) in an individual written agreement between the Company or any Affiliate and the Participant shall supersede the foregoing definition with respect to Awards
        subject to such agreement; provided, however, that if no definition of Change in Control or any analogous term is set forth in such an individual written agreement, the foregoing definition shall apply and (3) with respect to any nonqualified
        deferred compensation that becomes payable on account of the Change in Control, the transaction or event described in clause (i), (ii), (iii), or (iv) also constitutes a Section 409A Change in Control if required in order for the payment not to
        violate Section 409A of the Code.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(n)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Code&#8221; means the Internal Revenue Code of 1986, as amended, including any applicable regulations and guidance thereunder.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(o)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Committee&#8221; means the Compensation Committee and any other committee of one or more members of the Board to whom authority has been delegated by the Board or Compensation Committee in accordance with the
        Plan.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(p)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Common Stock&#8221; means, as of the Business Combination Date, the Class A common stock of the Company with a par value of $0.0001 per share.</div>
      <div><br>
      </div>
      <div>
        <div style="text-indent: 36pt;">(q) &#160; &#160; &#160; &#160;&#160; &#8220;Company&#8221; means XCF Global, Inc.</div>
      </div>
      <div><br>
      </div>
      <div>
        <div style="text-indent: 36pt;">(r)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Compensation Committee&#8221; means the Compensation Committee of the Board.</div>
      </div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(s)&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#8220;Consultant&#8221; means any person, including an advisor, who is (i) engaged by the Company or an Affiliate to render consulting or advisory services and is compensated for such services, or (ii) serving as a
        member of the board of directors of an Affiliate and is compensated for such services. However, service solely as a Non-Employee Director, or payment of a fee for such service, will not cause a Non-Employee Director to be considered a &#8220;Consultant&#8221;
        for purposes of the Plan. Notwithstanding the foregoing, a person is treated as a Consultant under this Plan only if a Form S-8 Registration Statement under the Securities Act is available to register either the offer or the sale of the Company&#8217;s
        securities to such person.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(t)&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#8220;Continuous Service&#8221; means that the Participant&#8217;s service with the Company or an Affiliate, whether as an Employee, Non-Employee Director or Consultant, is not interrupted or terminated. A change in the
        capacity in which the Participant renders service to the Company or an Affiliate as an Employee, Non-Employee Director or Consultant or a change in the Entity for which the Participant renders such service, provided that there is no interruption or
        termination of the Participant&#8217;s service with the Company or an Affiliate, will not terminate a Participant&#8217;s Continuous Service; <u>provided</u>, <u>however</u>, that if the Entity for which a Participant is rendering services ceases to qualify
        as an Affiliate, as determined by the Board, such Participant&#8217;s Continuous Service will be considered to have terminated on the date such Entity ceases to qualify as an Affiliate. For example, a change in status from an Employee of the Company to a
        Consultant of an Affiliate or to a Non-Employee Director will not constitute an interruption of Continuous Service. To the extent permitted by law, the Board or the chief executive officer of the Company, in that party&#8217;s sole discretion, may
        determine whether Continuous Service will be considered interrupted in the case of (i) any leave of absence approved by the Board or chief executive officer, including sick leave, military leave or any other personal leave, or (ii) transfers
        between the Company, an Affiliate, or their successors. Notwithstanding the foregoing, a leave of absence will be treated as Continuous Service for purposes of vesting in an Award only to such extent as may be provided in the Company&#8217;s leave of
        absence policy, in the written terms of any leave of absence agreement or policy applicable to the Participant, or as otherwise required by law. In addition, to the extent required for exemption from or compliance with Section 409A, the
        determination of whether there has been a termination of Continuous Service will be made, and such term will be construed, in a manner that is consistent with the definition of &#8220;separation from service&#8221; as defined under Treasury Regulation Section
        1.409A-1(h) (without regard to any alternative definition thereunder).</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">21</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt;">(u)&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160; &#8220;Corporate Transaction&#8221; means the consummation, in a single transaction or in a series of related transactions, of any one or more of the following events:</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; a sale or other disposition of all or substantially all, as determined by the Board, of the consolidated assets of the Company and its Subsidiaries;</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a sale or other disposition of at least 50% of the outstanding securities of the Company;</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; a merger, consolidation or similar transaction following which the Company is not the surviving corporation; or</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; a merger, consolidation or similar transaction following which the Company is the surviving corporation but the Shares outstanding immediately preceding the merger, consolidation or
        similar transaction are converted or exchanged by virtue of the merger, consolidation or similar transaction into other property, whether in the form of securities, cash or otherwise.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;determine&#8221; or &#8220;determined&#8221; means as determined by the Board or the Committee (or its designee) in its sole discretion.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(w)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Disability&#8221; means, with respect to a Participant, such Participant is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be
        expected to result in death or which has lasted or can be expected to last for a continuous period of not less than 12 months, as provided in Section 22(e)(3) of the Code, and will be determined by the Board on the basis of such medical evidence as
        the Board deems warranted under the circumstances.</div>
      <div style="text-indent: 36pt;">&#160;</div>
      <div style="text-indent: 36pt;">(x)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Effective Date&#8221; means the Business Combination Date, subject to approval by the stockholders of the Company.</div>
      <div><br>
      </div>
      <div>
        <div style="text-indent: 36pt;">(y)&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#8220;Employee&#8221; means any person employed by the Company or an Affiliate.</div>
      </div>
      <div style="text-indent: 36pt;">&#160;</div>
      <div style="text-indent: 36pt;">(z)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Entity&#8221; means a corporation, partnership, limited liability company or other entity.</div>
      <div style="margin-right: 24.3pt; margin-left: 41.4pt;"> <br>
      </div>
      <div style="text-indent: 36pt;">(aa)&#160;&#160;&#160;&#160; &#160;&#160; &#8220;Exchange Act&#8221; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">22</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt;">(bb)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Exchange Act Person&#8221; means any natural person, Entity or &#8220;group&#8221; (within the meaning of Section 13(d) or 14(d) of the Exchange Act), except that &#8220;Exchange Act Person&#8221; will not include (i) the Company or
        any Subsidiary of the Company, (ii) any employee benefit plan of the Company or any Subsidiary of the Company or any trustee or other fiduciary holding securities under an employee benefit plan of the Company or any Subsidiary of the Company, (iii)
        an underwriter temporarily holding securities pursuant to a registered public offering of such securities, (iv) an Entity Owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their Ownership of
        stock of the Company, or (v) any natural person, Entity or &#8220;group&#8221; (within the meaning of Section 13(d) or 14(d) of the Exchange Act) that, as of the Effective Date, is the Owner, directly or indirectly, of securities of the Company representing
        more than 50% of the combined voting power of the Company&#8217;s then outstanding securities.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(cc)&#160;&#160; &#160; &#160;&#160;&#160; &#8220;Fair Market Value&#8221; means, as of any date, unless otherwise determined by the Board, the value of the Common Stock (as determined on a per share or aggregate basis, as applicable) determined as follows:</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; If the Common Stock is listed on any established securities exchange or traded on any established market, the Fair Market Value will be the closing sales price for such stock as quoted
        on such exchange or market (or the exchange or market with the greatest volume of trading in the Common Stock) on the date of determination, as reported in a source the Board deems reliable.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If there is no closing sales price for the Common Stock on the date of determination, then the Fair Market Value will be the closing selling price on the last preceding date for which
        such quotation exists.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-left: 36pt;">(iii)&#160;&#160;&#160; &#160; &#160;&#160; In the absence of such markets for the Common Stock, or if otherwise determined by the Board, the Fair Market Value will be determined by the Board in good faith and in a manner that
        complies with Sections 409A and 422 of the Code.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(dd)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Governmental Body&#8221; means any: (i) nation, state, commonwealth, province, territory, county, municipality, district or other jurisdiction of any nature; (ii) federal, state, local, municipal, foreign or
        other government; (iii) governmental or regulatory body, or quasi-governmental body of any nature (including any governmental division, department, administrative agency or bureau, commission, authority, instrumentality, official, ministry, fund,
        foundation, center, organization, unit, body or Entity and any court or other tribunal, and for the avoidance of doubt, any tax authority) or other body exercising similar powers or authority; or (iv) self-regulatory organization (including the
        Nasdaq Stock Market, New York Stock Exchange, and the Financial Industry Regulatory Authority).</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(ee)&#160;&#160;&#160; &#160; &#160;&#160; &#8220;Grant Notice&#8221; means the notice provided to a Participant that he or she has been granted an Award under the Plan and which includes the name of the Participant, the type of Award, the date of grant of the
        Award, number of Shares subject to the Award or potential cash payment right, (if any), the vesting schedule for the Award (if any) and other key terms applicable to the Award.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(ff)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Incentive Stock Option&#8221; means an option granted pursuant to <u>Section 4</u> of the Plan that is intended to be, and qualifies as, an &#8220;incentive stock option&#8221; within the meaning of Section 422 of the
        Code.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">23</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt;">(gg)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Materially Impair&#8221; means any amendment to the terms of the Award that materially adversely affects the Participant&#8217;s rights under the Award. A Participant&#8217;s rights under an Award will not be deemed to have
        been Materially Impaired by any such amendment if the Board, in its sole discretion, determines that the amendment, taken as a whole, does not materially impair the Participant&#8217;s rights. For example, the following types of amendments to the terms
        of an Award do not Materially Impair the Participant&#8217;s rights under the Award: (i) imposition of reasonable restrictions on the minimum number of shares subject to an Option or SAR that may be exercised; (ii) to maintain the qualified status of the
        Award as an Incentive Stock Option under Section 422 of the Code; (iii) to change the terms of an Incentive Stock Option in a manner that disqualifies, impairs or otherwise affects the qualified status of the Award as an Incentive Stock Option
        under Section 422 of the Code; (iv) to clarify the manner of exemption from, or to bring the Award into compliance with or qualify it for an exemption from, Section 409A; or (v) to comply with other Applicable Laws.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(hh)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Non-Employee Director&#8221; means a member of the Board who is not an Employee. (ii) &#8220;Non-Exempt Award&#8221; means any Award that is subject to, and not exempt from, Section 409A, including as the result of (i) a
        deferral of the issuance of the shares subject to the Award which is elected by the Participant or imposed by the Company, or (ii) the terms of any Non-Exempt Severance Arrangement.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(jj)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Non-Exempt Non-Employee Director Award&#8221; means a Non-Exempt Award granted to a Non-Employee Director.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(kk)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Non-Exempt Severance Arrangement&#8221; means a severance arrangement or other agreement between the Participant and the Company that provides for acceleration of vesting of an Award and issuance of the shares
        in respect of such Award upon the Participant&#8217;s termination of employment or separation from service (as such term is defined in Section 409A(a)(2)(A)(i) of the Code (and without regard to any alternative definition thereunder)) (&#8220;Separation from
        Service&#8221;) and such severance benefit does not satisfy the requirements for an exemption from application of Section 409A provided under Treasury Regulations Section 1.409A-1(b)(4), 1.409A-1(b)(9) or otherwise.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(ll)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Nonstatutory Stock Option&#8221; means any option granted pursuant to Section 4 of the Plan that does not qualify as an Incentive Stock Option.</div>
      <div style="text-indent: 36pt;">&#160;</div>
      <div style="text-indent: 36pt;">(mm)&#160;&#160;&#160;&#160;&#160; &#8220;Officer&#8221; means a person who is an officer of the Company within the meaning of Section 16 of the Exchange Act.</div>
      <div style="text-indent: 36pt;">&#160;</div>
      <div style="text-indent: 36pt;">(nn)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Option&#8221; means an Incentive Stock Option or a Nonstatutory Stock Option to purchase Shares granted pursuant to the Plan.</div>
      <div style="text-indent: 36pt;">&#160;</div>
      <div style="text-indent: 36pt;">(oo)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Option Agreement&#8221; means a written or electronic agreement between the Company and the Optionholder evidencing the terms and conditions of the Option grant. The Option Agreement includes the Grant Notice
        for the Option and the agreement containing the written summary of the general terms and conditions applicable to the Option and which is provided including through electronic means, to a Participant along with the Grant Notice. Each Option
        Agreement will be subject to the terms and conditions of the Plan.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(pp)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Optionholder&#8221; means a person to whom an Option is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding Option.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(qq)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Other Award&#8221; means an award based in whole or in part by reference to the Common Stock which is granted pursuant to the terms and conditions of <u>Section 5(c)</u>.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">24</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">(rr) &#160; &#160; &#160; &#160; &#8220;Other Award Agreement&#8221; means a written or electronic agreement between the Company and a holder of an Other Award evidencing the terms and conditions of an Other Award grant. Each
        Other Award Agreement will be subject to the terms and conditions of the Plan.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(ss)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Own,&#8221; &#8220;Owned,&#8221; &#8220;Owner,&#8221; &#8220;Ownership&#8221; means that a person or Entity will be deemed to &#8220;Own,&#8221; to have &#8220;Owned,&#8221; to be the &#8220;Owner&#8221; of, or to have acquired &#8220;Ownership&#8221; of securities if such person or Entity,
        directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, has or shares voting power, which includes the power to vote or to direct the voting, with respect to such securities.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(tt)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Participant&#8221; means an Employee, Non-Employee Director or Consultant to whom an Award is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding Award.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(uu)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Performance Award&#8221; means an Award that may vest or may be exercised or a cash award that may vest or become earned and paid contingent upon the attainment during a Performance Period of certain Performance
        Goals and which is granted under the terms and conditions of Section 5(b) pursuant to such terms as are approved by the Board. In addition, to the extent permitted by Applicable Law and set forth in the applicable Award Agreement, the Board may
        determine that cash or other property may be used in payment of Performance Awards. Performance Awards that are settled in cash or other property are not required to be valued in whole or in part by reference to, or otherwise based on, the Common
        Stock.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(vv)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Performance Criteria&#8221; means the one or more criteria that the Board will select for purposes of establishing the Performance Goals for a Performance Period.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(ww)&#160;&#160;&#160; &#160; &#8220;Performance Goals&#8221; means, for a Performance Period, the one or more goals established by the Board for the Performance Period based upon the Performance Criteria.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(xx)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Performance Period&#8221; means the period of time selected by the Board over which the attainment of one or more Performance Goals will be measured for the purpose of determining a Participant&#8217;s right to
        vesting or exercise of an Award. Performance Periods may be of varying and overlapping duration, at the sole discretion of the Board.</div>
      <div style="text-indent: 36pt;">&#160;</div>
      <div style="text-indent: 36pt;">(yy)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Plan&#8221; means this XCF Global, Inc. 2025 Equity Incentive Plan, as amended from time to time.</div>
      <div style="text-indent: 36pt;">&#160;</div>
      <div style="text-indent: 36pt;">(zz)&#160;&#160;&#160; &#160; &#160;&#160; &#8220;Plan Administrator&#8221; means the person, persons, and/or third-party administrator designated by the Company to administer the day to day operations of the Plan and the Company&#8217;s other equity incentive
        programs.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(aaa)&#160;&#160;&#160;&#160; &#160; &#8220;Post-Termination Exercise Period&#8221; means the period following termination of a Participant&#8217;s Continuous Service within which an Option or SAR is exercisable, as specified in <u>Section</u>&#160;<u>4(h)</u>.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(bbb)&#160;&#160;&#160;&#160;&#160; &#8220;Restricted Stock Award&#8221; means an Award of Shares which is granted pursuant to the terms and conditions of <u>Section 5(a)</u>.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">25</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt;">(ccc)&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Restricted Stock Award Agreement&#8221; means a written or electronic agreement between the Company and a holder of a Restricted Stock Award evidencing the terms and conditions of a Restricted Stock Award grant.
        The Restricted Stock Award Agreement includes the Grant Notice for the Restricted Stock Award and the agreement containing the written summary of the general terms and conditions applicable to the Restricted Stock Award and which is provided
        including by electronic means, to a Participant along with the Grant Notice. Each Restricted Stock Award Agreement will be subject to the terms and conditions of the Plan.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(ddd)&#160;&#160;&#160;&#160;&#160; &#8220;RSU Award&#8221; or &#8220;RSU&#8221; means an Award of restricted stock units representing the right to receive an issuance of Shares which is granted pursuant to the terms and conditions of <u>Section 5(a)</u>.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(eee)&#160;&#160;&#160; &#160;&#160; &#8220;RSU Award Agreement&#8221; means a written or electronic agreement between the Company and a holder of an RSU Award evidencing the terms and conditions of an RSU Award grant. The RSU Award Agreement includes the
        Grant Notice for the RSU Award and the agreement containing the written summary of the general terms and conditions applicable to the RSU Award and which is provided including by electronic means, to a Participant along with the Grant Notice. Each
        RSU Award Agreement will be subject to the terms and conditions of the Plan.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(fff)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Rule 16b-3&#8221; means Rule 16b-3 promulgated under the Exchange Act or any successor to Rule 16b-3, as in effect from time to time.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(ggg)&#160;&#160;&#160;&#160;&#160; &#8220;Rule 405&#8221; means Rule 405 promulgated under the Securities Act.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(hhh)&#160;&#160;&#160;&#160;&#160; &#8220;SAR Agreement&#8221; means a written or electronic agreement between the Company and a holder of a SAR evidencing the terms and conditions of a SAR grant. The SAR Agreement includes the Grant Notice for the SAR
        and the agreement containing the written summary of the general terms and conditions applicable to the SAR and which is provided, including by electronic means, to a Participant along with the Grant Notice. Each SAR Agreement will be subject to the
        terms and conditions of the Plan.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Section 409A&#8221; means Section 409A of the Code and the regulations and other guidance thereunder.</div>
      <div style="text-indent: 36pt;">&#160;</div>
      <div style="text-indent: 36pt;">(jjj)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Securities Act&#8221; means the Securities Act of 1933, as amended.</div>
      <div style="text-indent: 36pt;">&#160;</div>
      <div style="text-indent: 36pt;">(kkk)&#160;&#160;&#160;&#160;&#160; &#8220;Share Reserve&#8221; means the number of shares available for issuance under the Plan as set forth in <u>Section 2(a)</u>.</div>
      <div style="text-indent: 36pt;">&#160;</div>
      <div style="text-indent: 36pt;">(lll) &#160; &#160; &#160; &#160; &#8220;Shares&#8221; means shares of Common Stock.</div>
      <div style="text-indent: 36pt;">&#160;</div>
      <div style="text-indent: 36pt;">(nnn)&#160;&#160;&#160;&#160;&#160; &#8220;Stock Appreciation Right&#8221; or &#8220;SAR&#8221; means a right to receive the appreciation on Common Stock that is granted pursuant to the terms and conditions of <u>Section 4</u>.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(ooo)&#160;&#160;&#160;&#160;&#160; &#8220;Subsidiary&#8221; means, with respect to the Company, (i) any corporation of which more than 50% of the outstanding capital stock having ordinary voting power to elect a majority of the board of directors of such
        corporation (irrespective of whether, at the time, stock of any other class or classes of such corporation will have or might have voting power by reason of the happening of any contingency) is at the time, directly or indirectly, Owned by the
        Company, and (ii) any partnership, limited liability company or other entity in which the Company has a direct or indirect interest (whether in the form of voting or participation in profits or capital contribution) of more than 50%.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">26</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt;">(ppp)&#160;&#160;&#160;&#160;&#160; &#8220;Ten Percent Stockholder&#8221; means a person who Owns (or is deemed to Own pursuant to Section 424(d) of the Code) stock possessing more than 10% of the total combined voting power of all classes of stock of the
        Company or any Affiliate.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(qqq)&#160;&#160;&#160;&#160;&#160; &#8220;Trading Policy&#8221; means the Company&#8217;s policy permitting certain individuals to sell Company shares only during certain &#8220;window&#8221; periods and/or otherwise restricts the ability of certain individuals to
        transfer or encumber Company shares, as in effect from time to time.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(rrr)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Unvested Non-Exempt Award&#8221; means the portion of any Non-Exempt Award that had not vested in accordance with its terms upon or prior to the date of any Corporate Transaction.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">(sss)&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Vested Non-Exempt Award&#8221; means the portion of any Non-Exempt Award that had vested in accordance with its terms upon or prior to the date of a Corporate Transaction.</div>
      <div><br>
      </div>
      <div><br>
      </div>
    </div>
  </div>
  <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">27</font>
    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.64
<SEQUENCE>19
<FILENAME>ef20050548_ex10-64.htm
<DESCRIPTION>EXHIBIT 10.64
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">


  <!--PROfilePageNumberReset%Num%1%%%-->
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 10.64</font><br>
    </div>
    <div>&#160;</div>
    <div style="text-align: center; margin-right: 0.05pt; margin-left: 0.9pt;">XCF Global, Inc.</div>
    <div style="text-align: center; margin-left: 0.9pt;">2025 Employee Stock Purchase Plan</div>
    <div><br>
    </div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="z4c9a8438951f413d851c58936475c886" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="text-align: right; vertical-align: top; width: 39pt;">
                <div style="text-align: left;">1.</div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>General</u>.</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;XCF Global, Inc. (the &#8220;Company&#8221;), by means of the Plan, seeks to secure and retain the services of Eligible Employees and to provide incentives for such persons to exert maximum efforts for the success of
      the Company and its Related Corporations. The Plan provides a means by which Eligible Employees of the Company and certain Designated Companies may be given an opportunity to purchase shares of Common Stock. The Plan permits the Company to grant a
      series of Purchase Rights to Eligible Employees under an Employee Stock Purchase Plan. In addition, the Plan permits the Company to grant a series of Purchase Rights to Eligible Employees that do not meet the requirements of an Employee Stock
      Purchase Plan.</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Plan includes two components: (i) a 423 Component and (ii) a Non-423 Component. The Company intends (but makes no undertaking or representation to maintain) the 423 Component to qualify as an Employee
      Stock Purchase Plan. The provisions of the 423 Component, accordingly, will be construed in a manner that is consistent with the requirements of Section 423 of the Code. This Plan also authorizes grants of Purchase Rights under the Non- 423 Component
      that do not meet the requirements of an Employee Stock Purchase Plan. Except as otherwise provided in the Plan or determined by the Board, the Non-423 Component will operate and be administered in the same manner as the 423 Component. In addition,
      the Company may make separate Offerings which vary in terms (provided that such terms are not inconsistent with the provisions of the Plan or the requirements of an Employee Stock Purchase Plan to the extent the Offering is made under the 423
      Component), and the Company will designate which Designated Company is participating in each separate Offering.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="zda4b445e02a84c64bf0f4201b6389521" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 39pt; vertical-align: top;">2.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Administration</u>.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-indent: 39pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Board will administer the Plan unless and until the Board delegates administration of the Plan to a Committee or Committees, as provided in <u>Section 2(c)</u>. References herein to the Board shall be
      deemed to refer to the Committee (if designated as administrator of the Plan) except where context dictates otherwise.</div>
    <div>&#160;</div>
    <div style="text-indent: 39pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Board will have the power, subject to, and within the limitations of, the express provisions of the Plan:</div>
    <div><br>
    </div>
    <div style="margin: 0px 0px 0px 39pt; text-indent: 36pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to determine how and when Purchase Rights will be granted and the provisions of each Offering (which need not be identical);</div>
    <div><br>
    </div>
    <div style="margin: 0px 0px 0px 39pt; text-indent: 36pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to designate from time to time (A) which Related Corporations of the Company will be eligible to participate in the Plan as Designated 423 Companies, (B) which Related Corporations
      or Affiliates will be eligible to participate in the Plan as Designated Non-423 Companies, (C) which Affiliates or Related Corporations may be excluded from participation in the Plan and (D) which Designated Companies will participate in each
      separate Offering (to the extent that the Company makes separate Offerings);</div>
    <div><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">1</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="margin: 0px 0px 0px 39pt; text-indent: 36pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160; to construe and interpret the Plan and Purchase Rights, and to establish, amend and revoke rules and regulations for its administration. The Board, in the exercise of this power,
      may correct any defect, omission or inconsistency in the Plan, in a manner and to the extent it deems necessary or expedient to make the Plan fully effective.</div>
    <div><br>
    </div>
    <div style="margin: 0px 0px 0px 39pt; text-indent: 36pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160; to settle all controversies regarding the Plan and Purchase Rights granted under the Plan;</div>
    <div><br>
    </div>
    <div>
      <div style="margin: 0px 0px 0px 39pt; text-indent: 36pt;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160; to suspend or terminate the Plan at any time as provided in <u>Section 12</u>;</div>
    </div>
    <div><br>
    </div>
    <div>
      <div style="margin: 0px 0px 0px 39pt; text-indent: 36pt;">(vi)&#160;&#160;&#160;&#160;&#160;&#160; to amend the Plan at any time as provided in <u>Section 12</u>;</div>
    </div>
    <div><br>
    </div>
    <div style="margin: 0px 0px 0px 39pt; text-indent: 36pt;">(vii)&#160;&#160;&#160;&#160;&#160;&#160; generally, to exercise such powers and to perform such acts as the Board deems necessary or expedient to promote the best interests of the Company and its Related Corporations and to
      carry out the intent that the Plan be treated as an Employee Stock Purchase Plan with respect to the 423 Component; and</div>
    <div><br>
    </div>
    <div style="margin: 0px 0px 0px 39pt; text-indent: 36pt;">(viii)&#160;&#160;&#160;&#160;&#160; to adopt such rules, procedures and sub-plans as are necessary or appropriate to permit or facilitate participation in the Plan by Employees who are foreign nationals or employed or
      located outside the United States. Without limiting the generality of, and consistent with, the foregoing, the Board specifically is authorized to adopt rules, procedures, and sub-plans regarding, without limitation, eligibility to participate in the
      Plan, the definition of eligible &#8220;earnings,&#8221; handling and making of Contributions, establishment of bank or trust accounts to hold Contributions, payment of interest, conversion of local currency, obligations to pay payroll tax, determination of
      beneficiary designation requirements, withholding procedures and handling of share issuances, any of which may vary according to applicable requirements, and which, if applicable to a Designated Non-423 Company, do not have to comply with the
      requirements of Section 423 of the Code.</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Board may delegate some or all of the administration of the Plan to a Committee or Committees. If administration is delegated to a Committee, the Committee will have, in connection with the
      administration of the Plan, the powers theretofore possessed by the Board that have been delegated to the Committee, including the power to delegate to a subcommittee any of the administrative powers the Committee is authorized to exercise (and
      references in this Plan and any applicable Offering Document to the Board will thereafter be to the Committee or subcommittee), subject, however, to such resolutions, not inconsistent with the provisions of the Plan, as may be adopted from time to
      time by the Board. Further, to the extent not prohibited by Applicable Law, the Board or Committee may, from time to time, delegate some or all of its authority under the Plan to one or more officers of the Company or other persons or groups of
      persons as it deems necessary, appropriate or advisable under conditions or limitations that it may set at or after the time of the delegation. The Board may retain the authority to concurrently administer the Plan with the Committee (or its
      delegate) and may, at any time, revest in the Board some or all of the powers previously delegated. Whether or not the Board has delegated administration of the Plan to a Committee (or a delegate of the Committee), the Board will have the final power
      to determine all questions of policy and expediency that may arise in the administration of the Plan.</div>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">2</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-indent: 39pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160; All determinations, interpretations and constructions made by the Board in good faith will not be subject to review by any person and will be final, binding and conclusive on all persons.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="zd57b5e8b9ccb4cc8a03bf4de0bf35719" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 39pt; vertical-align: top;">3.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Shares subject to the Plan.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Subject to the provisions of <u>Section 11(a)</u> relating to Capitalization Adjustments, the maximum number of shares of Common Stock that may be issued under the Plan will not exceed 250,000 shares of
      Common Stock, plus the number of shares of Common Stock that are automatically added on January 1st of each year for a period of up to ten years, commencing on January 1, 2025 and ending on (and including) January 1, 2034 in an amount equal to the
      lesser of (i) one percent (1%) of the total number of shares of Capital Stock outstanding on December 31st of the preceding calendar year and (ii) 750,000 shares of Common Stock. Notwithstanding the foregoing, the Board may act prior to the first day
      of any calendar year to provide that there will be no January 1st increase in the share reserve for such calendar year or that the increase in the share reserve for such calendar year will be a lesser number of shares of Common Stock than would
      otherwise occur pursuant to the preceding sentence. For the avoidance of doubt, up to the maximum number of shares of Common Stock reserved under this <u>Section 3(a)</u> may be used to satisfy purchases of Common Stock under the 423 Component and
      any remaining portion of such maximum number of shares may be used to satisfy purchases of Common Stock under the Non-423 Component.</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(b)&#160;&#160;&#160;&#160;&#160; &#160;&#160; If any Purchase Right granted under the Plan terminates without having been exercised in full, the shares of Common Stock not purchased under such Purchase Right will again become available for issuance under
      the Plan.</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The stock purchasable under the Plan will be shares of authorized but unissued or reacquired Common Stock, including shares repurchased by the Company on the open market.</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z055dc263cdb142b9abb260722fea25b8" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 39pt; vertical-align: top;">4.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Grant of Purchase Rights; Offering</u>.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-indent: 39pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Board may from time to time grant or provide for the grant of Purchase Rights to Eligible Employees under an Offering (consisting of one or more Purchase Periods) on an Offering Date or Offering Dates
      selected by the Board. Each Offering will be in such form and will contain such terms and conditions as the Board will deem appropriate, and with respect to the 423 Component, will comply with the requirement of Section 423(b)(5) of the Code that all
      Employees granted Purchase Rights will have the same rights and privileges. The terms and conditions of an Offering shall be incorporated by reference into the Plan and treated as part of the Plan. The provisions of separate Offerings need not be
      identical, but each Offering will include (through incorporation of the provisions of this Plan by reference in the document comprising the Offering or otherwise) the period during which the Offering will be effective, which period will not exceed 27
      months beginning with the Offering Date, and the substance of the provisions contained in <u>Section 5</u> through <u>Section 8</u>, inclusive.</div>
    <div style="text-indent: 45pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">3</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-indent: 39pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If a Participant has more than one Purchase Right outstanding under the Plan, unless such Participant otherwise indicates in forms delivered to the Company or a third party designated by the Company (each, a
      &#8220;Company Designee&#8221;), then (i) each form will apply to all of such Participant&#8217;s Purchase Rights under the Plan and (ii) a Purchase Right with a lower exercise price (or an earlier-granted Purchase Right, if different Purchase Rights have identical
      exercise prices) will be exercised to the fullest possible extent before a Purchase Right with a higher exercise price (or a later-granted Purchase Right if different Purchase Rights have identical exercise prices) will be exercised.</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Board will have the discretion to structure an Offering so that if the Fair Market Value of a share of Common Stock on the first Trading Day of a new Purchase Period within that Offering is less than or
      equal to the Fair Market Value of a share of Common Stock on the Offering Date for that Offering, then (i) that Offering will terminate immediately as of that first Trading Day and (ii) the Participants in such terminated Offering will be
      automatically enrolled in a new Offering beginning on the first Trading Day of such new Purchase Period.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="zea89d53ef94045388681ed11cecb2070" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 39pt; vertical-align: top;">5.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Eligibility</u>.</font></div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Purchase Rights may be granted only to Employees of the Company or, as the Board may designate in accordance with <u>Section 2(b)</u>, to Employees of an Affiliate. Except as provided in <u>Section 5(b)</u>
      or as required by Applicable Law, an Employee will not be eligible to be granted Purchase Rights unless, on the Offering Date, the Employee has been in the employ of the Company, the Related Corporation or the Affiliate, as the case may be, for such
      continuous period preceding such Offering Date as the Board may (unless prohibited by Applicable Law) require, but in no event will the required period of continuous employment be equal to or greater than two years. The Board may also provide (unless
      prohibited by Applicable Law) that no Employee will be eligible to be granted Purchase Rights under the Plan unless, on the Offering Date, such Employee&#8217;s customary employment with the Company, the Related Corporation or the Affiliate is more than 20
      hours per week and more than five months per calendar year or such other criteria as the Board may determine consistent with Section 423 of the Code with respect to the 423 Component. The Board may also exclude (unless prohibited by Applicable Law)
      from participation in the Plan or any Offering Employees who are &#8220;highly compensated employees&#8221; (within the meaning of Section 423(b)(4)(D) of the Code) of the Company, a Related Corporation or an Affiliate, or a subset of such highly compensated
      employees.</div>
    <div><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">4</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-indent: 39pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Board may provide that each person who, during the course of an Offering, first becomes an Eligible Employee will, on a date or dates specified in the Offering which coincides with the day on which such
      person becomes an Eligible Employee or which occurs thereafter, receive a Purchase Right under that Offering, which Purchase Right will thereafter be deemed to be a part of that Offering. Such Purchase Right will have the same characteristics as any
      Purchase Rights originally granted under that Offering, as described herein, except that (i) the date on which such Purchase Right is granted will be the &#8220;Offering Date&#8221; of such Purchase Right for all purposes, including determination of the exercise
      price of such Purchase Right, (ii) the period of the Offering with respect to such Purchase Right will begin on its Offering Date and end coincident with the end of such Offering and (iii) the Board may provide that if such person first becomes an
      Eligible Employee within a specified period of time before the end of the Offering, such individual will not receive any Purchase Right under that Offering.</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;No Employee will be eligible for the grant of any Purchase Rights under the 423 Component if, immediately after any such Purchase Rights are granted, such Employee owns stock possessing five percent or more
      of the total combined voting power or value of all classes of stock of the Company or of any Related Corporation. For purposes of this <u>Section 5(c)</u>, the rules of Section 424(d) of the Code will apply in determining the stock ownership of any
      Employee, and stock which such Employee may purchase under all outstanding Purchase Rights and options will be treated as stock owned by such Employee.</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;As specified by Section 423(b)(8) of the Code, an Eligible Employee may be granted Purchase Rights under the 423 Component only if such Purchase Rights, together with any other rights granted under all
      Employee Stock Purchase Plans of the Company and any Related Corporations, do not permit such Eligible Employee&#8217;s rights to purchase stock of the Company or any Related Corporation to accrue at a rate which, when aggregated, exceeds $25,000 of Fair
      Market Value of such stock (determined at the time such rights are granted, and which, with respect to the Plan, will be determined as of their respective Offering Dates) for each calendar year in which such rights are outstanding at any time. </div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Officers of the Company and any Designated Company, if they are otherwise Eligible Employees, will be eligible to participate in Offerings under the Plan. Notwithstanding the foregoing, the Board may (unless
      prohibited by Applicable Law) provide in an Offering that Employees who are &#8220;highly compensated employees&#8221; (within the meaning of Section 423(b)(4)(D) of the Code) will not be eligible to participate.</div>
    <div>&#160;</div>
    <div style="text-indent: 39pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Notwithstanding anything in this <u>Section 5</u> to the contrary, in the case of an Offering under the Non-423 Component, an Eligible Employee (or group of Eligible Employees) may be excluded from
      participation in the Plan or an Offering if the Board has determined, in its sole discretion, that participation of such Eligible Employee(s) is not advisable or practical for any reason.</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z0146f89a24b44c3a90f60df39fa773ba" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 39pt; vertical-align: top;">6.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Purchase Rights; Purchase Price</u>.</font></div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On each Offering Date, each Eligible Employee, pursuant to an Offering made under the Plan, will be granted a Purchase Right to purchase up to that number of shares of Common Stock purchasable either with a
      percentage of earnings (as defined by the Board in each Offering) or with a maximum dollar amount, as designated by the Board, but in either case not exceeding 15% of such Employee&#8217;s earnings (as defined by the Board in each Offering) during the
      period that begins on the Offering Date (or such later date as the Board determines for a particular Offering) and ends on the date stated in the Offering, which date will be no later than the end of the Offering.</div>
    <div><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">5</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-indent: 39pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Board will establish one or more Purchase Dates during an Offering on which Purchase Rights granted for that Offering will be exercised and shares of Common Stock will be purchased in accordance with such
      Offering.</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; In connection with each Offering made under the Plan, the Board may specify (i) a maximum number of shares of Common Stock that may be purchased by any Participant on any Purchase Date during such Offering,
      (ii) a maximum aggregate number of shares of Common Stock that may be purchased by all Participants pursuant to such Offering and/or (iii) a maximum aggregate number of shares of Common Stock that may be purchased by all Participants on any Purchase
      Date under the Offering. If the aggregate purchase of shares of Common Stock issuable upon exercise of Purchase Rights granted under the Offering would exceed any such maximum aggregate number, then, in the absence of any Board action otherwise, a
      pro rata (based on each Participant&#8217;s accumulated Contributions) allocation of the shares of Common Stock (rounded down to the nearest whole share) available will be made in as nearly a uniform manner as will be practicable and equitable.</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The purchase price of shares of Common Stock acquired pursuant to Purchase Rights will be no less than the lesser of (i) an amount equal to 85% of the Fair Market Value of the shares of Common Stock on the
      Offering Date or (ii) an amount equal to 85% of the Fair Market Value of the shares of Common Stock on the applicable Purchase Date. For each Offering under the 423 Component, the Committee shall specify the maximum number of shares of Common Stock
      that may be purchased by a Participant during an Offering (which, in the absence of contrary designation by the Committee, shall be 7,500 shares of Common Stock).</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="zc32e54eda3ed44fb825f477de65fc603" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 39pt; vertical-align: top;">7.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Participation; Withdrawal; Termination</u>.</font></div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; An Eligible Employee may elect to participate in an Offering and authorize payroll deductions as the means of making Contributions by completing and delivering to the Company or a Company Designee, within the
      time specified in the Offering, an enrollment form provided by the Company or Company Designee. The enrollment form will specify the amount of Contributions not to exceed the maximum amount specified by the Board. Each Participant&#8217;s Contributions
      will be credited to a bookkeeping account for such Participant under the Plan and will be deposited with the general funds of the Company except where Applicable Law requires that Contributions be deposited with a third party. If permitted in the
      Offering, a Participant may begin such Contributions with the first payroll occurring on or after the Offering Date (or, in the case of a payroll date that occurs after the end of the prior Offering but before the Offering Date of the next new
      Offering, Contributions from such payroll will be included in the new Offering). If permitted in the Offering, a Participant may thereafter reduce (including to zero) or increase such Participant&#8217;s Contributions. If required under Applicable Law or
      if specifically provided in the Offering and to the extent permitted by Section 423 of the Code with respect to the 423 Component, in addition to or instead of making Contributions by payroll deductions, a Participant may make Contributions through
      the payment by cash, check or wire transfer prior to a Purchase Date.</div>
    <div><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">6</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-indent: 39pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; During an Offering, a Participant may cease making Contributions and withdraw from the Offering by delivering to the Company or a Company Designee a withdrawal form provided by the Company. The Company may
      impose a deadline before a Purchase Date for withdrawing. Upon such withdrawal, such Participant&#8217;s Purchase Right in that Offering will immediately terminate and the Company will distribute as soon as practicable to such Participant all of such
      Participant&#8217;s accumulated but unused Contributions and such Participant&#8217;s Purchase Right in that Offering shall thereupon terminate. A Participant&#8217;s withdrawal from that Offering will have no effect upon such Participant&#8217;s or her eligibility to
      participate in any other Offerings under the Plan, but such Participant will be required to deliver a new enrollment form to participate in subsequent Offerings.</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Unless otherwise required by Applicable Law, Purchase Rights granted pursuant to any Offering under the Plan will terminate immediately if the Participant either (i) is no longer an Employee for any reason or
      for no reason (subject to any post-employment participation period required by Applicable Law) or (ii) is otherwise no longer eligible to participate. The Company will distribute as soon as practicable to such individual all of such Participant&#8217;s
      accumulated but unused Contributions.</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Unless otherwise determined by the Board, a Participant whose employment transfers or whose employment terminates with an immediate rehire (with no break in service) by or between the Company and a Designated
      Company or between Designated Companies will not be treated as having terminated employment for purposes of participating in the Plan or an Offering; however, if a Participant transfers from an Offering under the 423 Component to an Offering under
      the Non-423 Component, the exercise of the Participant&#8217;s Purchase Right will be qualified under the 423 Component only to the extent such exercise complies with Section 423 of the Code. If a Participant transfers from an Offering under the Non-423
      Component to an Offering under the 423 Component, the exercise of the Purchase Right will remain non-qualified under the Non-423 Component. The Board may establish different and additional rules governing transfers between separate Offerings within
      the 423 Component and between Offerings under the 423 Component and Offerings under the Non-423 Component.</div>
    <div style="text-indent: 45pt;">&#160;</div>
    <div style="text-indent: 39pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; During a Participant&#8217;s lifetime, Purchase Rights will be exercisable only by such Participant. Purchase Rights are not transferable by a Participant, except by will, by the laws of descent and distribution.</div>
    <div style="text-indent: 45pt;">&#160;</div>
    <div style="text-indent: 39pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Unless otherwise specified in the Offering or as required by Applicable Law, the Company will have no obligation to pay interest on Contributions.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="zeef59ee664e34ba9b1371ecde16304bf" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 39pt; vertical-align: top;">8.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Exercise of Purchase Rights</u>.</font></div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; On each Purchase Date, each Participant&#8217;s accumulated Contributions will be applied to the purchase of shares of Common Stock, up to the maximum number of shares of Common Stock permitted by the Plan and the
      applicable Offering, at the purchase price specified in the Offering. No fractional shares will be issued unless specifically provided for in the Offering.</div>
    <div><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">7</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-indent: 39pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160; &#160; Unless otherwise provided in the Offering, if any amount of accumulated Contributions remains in a Participant&#8217;s account after the purchase of shares of Common Stock and such remaining amount is less than the
      amount required to purchase one share of Common Stock on the final Purchase Date of an Offering, then such remaining amount will be held in such Participant&#8217;s account for the purchase of shares of Common Stock under the next Offering under the Plan,
      unless such Participant withdraws from or is not eligible to participate in such next Offering, in which case such amount will be distributed to such Participant after the final Purchase Date without interest (unless the payment of interest is
      otherwise required by Applicable Law). If the amount of Contributions remaining in a Participant&#8217;s account after the purchase of shares of Common Stock is at least equal to the amount required to purchase one whole share of Common Stock on the final
      Purchase Date of an Offering, then such remaining amount will be distributed in full to such Participant after the final Purchase Date of such Offering without interest (unless otherwise required by Applicable Law).</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; No Purchase Rights may be exercised to any extent unless the shares of Common Stock to be issued upon such exercise under the Plan are covered by an effective registration statement pursuant to the Securities
      Act and the Plan is in material compliance with all applicable U.S. federal and state, foreign and other securities, exchange control and other laws applicable to the Plan. If on a Purchase Date the shares of Common Stock are not so registered or the
      Plan is not in such compliance, no Purchase Rights will be exercised on such Purchase Date, and, subject to Section 423 of the Code with respect to the 423 Component, the Purchase Date will be delayed until the shares of Common Stock are subject to
      such an effective registration statement and the Plan is in material compliance, except that the Purchase Date will in no event be more than 27 months from the Offering Date. If, on the Purchase Date, as delayed to the maximum extent permissible, the
      shares of Common Stock are not registered and the Plan is not in material compliance with all Applicable Laws, as determined by the Company in its sole discretion, no Purchase Rights will be exercised and all accumulated but unused Contributions will
      be distributed to the Participants without interest (unless the payment of interest is otherwise required by Applicable Law).</div>
    <div><br>
    </div>
    <div>9.&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#160; <u>Covenants</u>. The Company will seek to obtain from each U.S. federal or state, foreign or other regulatory commission, agency or other Governmental Body having jurisdiction over the Plan such authority as may be required to
      grant Purchase Rights and issue and sell shares of Common Stock thereunder unless the Company determines, in its sole discretion, that doing so is not practical or would cause the Company to incur costs that are unreasonable. If, after commercially
      reasonable efforts, the Company is unable to obtain the authority that counsel for the Company deems necessary for the grant of Purchase Rights or the lawful issuance and sale of Common Stock under the Plan, and at a commercially reasonable cost, the
      Company will be relieved from any liability for failure to grant Purchase Rights and/or to issue and sell Common Stock upon exercise of such Purchase Rights.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z9b1d492d00f944a89be264b2f0e2dd54" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 39pt; vertical-align: top;">10.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Designation of Beneficiary</u>.</font></div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Company may, but is not obligated to, permit a Participant to submit a form designating a beneficiary who will receive any shares of Common Stock and/or Contributions from the Participant&#8217;s account under
      the Plan if the Participant dies before such shares and/or Contributions are delivered to the Participant. The Company may, but is not obligated to, permit the Participant to change such designation of beneficiary. Any such designation and/or change
      must be on a form approved by the Company.</div>
    <div style="text-indent: 36pt; margin-right: 14.85pt; margin-left: 6pt;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">8</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-indent: 39pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; If a Participant dies, and in the absence of a valid beneficiary designation, the Company will deliver any shares of Common Stock and/or Contributions to the executor or administrator of the estate of the
      Participant. If no executor or administrator has been appointed (to the knowledge of the Company), the Company, in its sole discretion, may deliver such shares of Common Stock and/or Contributions, without interest (unless the payment of interest is
      otherwise required by Applicable Law), to the Participant&#8217;s spouse, dependents or relatives, or if no spouse, dependent or relative is known to the Company, then to such other person as the Company may designate.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="zec3e9554d72540c09a74f9de1e74a838" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 39pt; vertical-align: top;">11.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Adjustments Upon Changes In Common Stock; Corporate Transactions</u>.</font></div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; In the event of a Capitalization Adjustment, the Board will appropriately and proportionately adjust (i) the class(es) and maximum number of securities subject to the Plan pursuant to <u>Section 3(a)</u>,
      (ii) the class(es) and maximum number of securities by which the share reserve is to increase automatically each year pursuant to Section 3(a), (iii) the class(es) and number of securities subject to, and the purchase price applicable to outstanding
      Offerings and Purchase Rights and (iv) the class(es) and number of securities that are the subject of the purchase limits under each ongoing Offering. The Board will make these adjustments, and its determination will be final, binding and conclusive.</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; In the event of a Corporate Transaction, then (i) any surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#8217;s parent company) may assume or continue outstanding Purchase
      Rights or may substitute similar rights (including a right to acquire the same consideration paid to the stockholders in the Corporate Transaction) for outstanding Purchase Rights or (ii) if any surviving or acquiring corporation (or its parent
      company) does not assume or continue such Purchase Rights or does not substitute similar rights for such Purchase Rights, then the Participants&#8217; accumulated Contributions will be used to purchase shares of Common Stock (rounded down to the nearest
      whole share) within ten business days (or such other period specified by the Board) prior to the Corporate Transaction under the outstanding Purchase Rights, and the Purchase Rights will terminate immediately after such purchase.</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z49e9832c503d49778d84dd3baf8acc11" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 39pt; vertical-align: top;">12.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Amendment, Termination or Suspension of the Plan</u>.</font></div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Board may amend the Plan at any time in any respect the Board deems necessary or advisable. However, except as provided in <u>Section 11(a)</u> relating to Capitalization Adjustments, stockholder
      approval will be required for any amendment of the Plan for which stockholder approval is required by Applicable Law.</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Board may suspend or terminate the Plan at any time. No Purchase Rights may be granted under the Plan while the Plan is suspended or after it is terminated.</div>
    <div><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">9</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-indent: 39pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Any benefits, privileges, entitlements and obligations under any outstanding Purchase Rights granted before an amendment, suspension or termination of the Plan will not be materially impaired by any such
      amendment, suspension or termination except (i) with the consent of the person to whom such Purchase Rights were granted, (ii) as necessary to facilitate compliance with any laws, listing requirements, or governmental regulations (including, without
      limitation, the provisions of Section 423 of the Code and the regulations and other interpretive guidance issued thereunder relating to Employee Stock Purchase Plans) including without limitation any such regulations or other guidance that may be
      issued or amended after the date the Plan is adopted by the Board or (iii) as necessary to obtain or maintain favorable tax, listing, or regulatory treatment. For purposes of clarity, the Board may amend outstanding Purchase Rights without a
      Participant&#8217;s consent if such amendment is necessary to ensure that the Purchase Right and/or the Plan complies with the requirements of Section 423 of the Code with respect to the 423 Component or with respect to other Applicable Laws.
      Notwithstanding anything in the Plan or any Offering Document to the contrary, the Board will be entitled to (i) establish the exchange ratio applicable to amounts withheld in a currency other than U.S. dollars, (ii) permit Contributions in excess of
      the amount designated by a Participant in order to adjust for mistakes in the Company&#8217;s processing of properly completed Contribution elections, (iii) establish reasonable waiting and adjustment periods and/or accounting and crediting procedures to
      ensure that amounts applied toward the purchase of Common Stock for each Participant properly correspond with amounts withheld from the Participant&#8217;s Contributions, (iv) amend any outstanding Purchase Rights or clarify any ambiguities regarding the
      terms of any Offering to enable the Purchase Rights to qualify under and/or comply with Section 423 of the Code with respect to the 423 Component and (v) establish other limitations or procedures as the Board determines in its sole discretion
      advisable that are consistent with the Plan. The actions of the Board pursuant to this paragraph will not be considered to alter or impair any Purchase Rights granted under an Offering as they are part of the initial terms of each Offering and the
      Purchase Rights granted under each Offering.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="zf95096ac83a04dd5b11fce6380c8a061" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 39pt; vertical-align: top;">13.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Tax Qualification; Tax Withholding</u>.</font></div>
          </td>
        </tr>

    </table>
    <div style="text-indent: 45pt;">&#160;</div>
    <div style="text-indent: 39pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Although the Company may endeavor to (i) qualify a Purchase Right for special tax treatment under the laws of the United States or jurisdictions outside of the United States or (ii) avoid adverse tax
      treatment, the Company makes no representation to that effect and expressly disavows any covenant to maintain special or to avoid unfavorable tax treatment, notwithstanding anything to the contrary in this Plan. The Company will be unconstrained in
      its corporate activities without regard to the potential negative tax impact on Participants.</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Each Participant will make arrangements, satisfactory to the Company and any applicable Related Corporation, to enable the Company or the Related Corporation to fulfill any withholding obligation for
      Tax-Related Items. Without limitation to the foregoing, in the Company&#8217;s sole discretion and subject to Applicable Law, such withholding obligation may be satisfied in whole or in part by (i) withholding from the Participant&#8217;s salary or any other
      cash payment due to the Participant from the Company or a Related Corporation, (ii) withholding from the proceeds of the sale of shares of Common Stock acquired under the Plan, either through a voluntary sale or a mandatory sale arranged by the
      Company or (iii) any other method deemed acceptable by the Board. The Company shall not be required to issue any shares of Common Stock under the Plan until such obligations are satisfied.</div>
    <div style="margin-right: 7.75pt; margin-left: 6pt;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">10</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-indent: 39pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The 423 Component is exempt from the application of Section 409A of the Code, and any ambiguities herein shall be interpreted to so be exempt from Section 409A of the Code. The Non-423 Component is intended
      to be exempt from the application of Section 409A of the Code under the short-term deferral exception and any ambiguities shall be construed and interpreted in accordance with such intent. In furtherance of the foregoing and notwithstanding any
      provision in the Plan to the contrary, if the Board determines that a Purchase Right granted under the Plan may be subject to Section 409A of the Code or that any provision in the Plan would cause a Purchase Right under the Plan to be subject to
      Section 409A, the Board may amend the terms of the Plan and/or of an outstanding Purchase Right granted under the Plan, or take such other action the Board determines is necessary or appropriate, in each case, without the participant&#8217;s consent, to
      exempt any outstanding Purchase Right or future Purchase Right that may be granted under the Plan from or to allow any such Purchase Rights to comply with Section 409A of the Code, but only to the extent any such amendments or action by the Board
      would not violate Section 409A of the Code. Notwithstanding the foregoing, the Company shall have no liability to a participant or any other party if the Purchase Right under the Plan that is intended to be exempt from or compliant with Section 409A
      of the Code is not so exempt or compliant or for any action taken by the Board with respect thereto.</div>
    <div><br>
    </div>
    <div>
      <div>
        <div> 14.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Effective Date</u>. The Plan will become effective immediately upon approval of the Board and the shareholders of the Company, provided, however, that no Purchase Rights under the Plan shall be granted prior to the Business
          Combination Date. No Purchase Rights will be exercised unless and until the Plan has been approved by the stockholders of the Company, which approval must be within 12 months before or after the date the Plan is adopted (or if required under <u>Section
            12(a)</u> above, materially amended) by the Board.</div>

      </div>
    </div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z2038bdaa44c44332a07d7071af2b8e94" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 39pt; vertical-align: top;">15.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Miscellaneous Provisions</u>.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-indent: 39pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Proceeds from the sale of shares of Common Stock pursuant to Purchase Rights will constitute general funds of the Company.</div>
    <div style="text-indent: 45pt;">&#160;</div>
    <div style="text-indent: 39pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; A Participant will not be deemed to be the holder of, or to have any of the rights of a holder with respect to, shares of Common Stock subject to Purchase Rights unless and until the Participant&#8217;s shares of
      Common Stock acquired upon exercise of Purchase Rights are recorded in the books of the Company (or its transfer agent).</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Plan and Offering do not constitute an employment contract. Nothing in the Plan or in the Offering will in any way alter the at will nature of a Participant&#8217;s employment or amend a Participant&#8217;s
      employment contract, if applicable, or be deemed to create in any way whatsoever any obligation on the part of any Participant to continue in the employ of the Company or a Related Corporation or an Affiliate, or on the part of the Company, a Related
      Corporation or an Affiliate to continue the employment of a Participant.</div>
    <div><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">11</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-indent: 39pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The provisions of the Plan will be governed by the laws of the State of Delaware without resort to that state&#8217;s conflicts of laws rules.</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; If any particular provision of the Plan is found to be invalid or otherwise unenforceable, such provision will not affect the other provisions of the Plan, but the Plan will be construed in all respects as if
      such invalid provision were omitted.</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If any provision of the Plan does not comply with Applicable Law, such provision shall be construed in such a manner as to comply with Applicable Law.</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Each Participant shall give prompt notice to the Company of any disposition or other transfer of any shares of Common Stock purchased upon exercise of a right under the Section 423 Component of this Plan if
      such disposition or transfer is made: (a) within two (2) years from the Offering Date of the Offering Period in which the shares of Common Stock were purchased or (b) within one (1) year after the Purchase Date on which such shares of Common Stock
      were purchased. Such notice shall specify the date of such disposition or other transfer and the amount realized, in cash, other property, assumption of indebtedness or other consideration, by the Participant in such disposition or other transfer.</div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="z062fde6bcacb4c9bb01a0b8a7d0c8146" class="DSPFListTable">

          <tr style="vertical-align: top;">
            <td style="text-align: right; vertical-align: top; width: 39pt;">
              <div style="text-align: left;">16.</div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div><u>Definitions</u>. As used in the Plan, the following definitions will apply to the capitalized terms indicated below:</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;423 Component&#8221; means the part of the Plan, which excludes the Non-423 Component, pursuant to which Purchase Rights that satisfy the requirements for an Employee Stock Purchase Plan may be granted to Eligible
      Employees.</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Affiliate&#8221; means any entity, other than a Related Corporation, whether now or subsequently established, which is at the time of determination, a &#8220;parent&#8221; or &#8220;subsidiary&#8221; of the Company as such terms are
      defined in Rule 405 promulgated under the Securities Act. The Board may determine the time or times at which &#8220;parent&#8221; or &#8220;subsidiary&#8221; status is determined within the foregoing definition.</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Applicable Law&#8221; means shall mean the Code and any applicable securities, federal, state, foreign, material local or municipal or other law, statute, constitution, principle of common law, resolution,
      ordinance, code, edict, decree, rule, listing rule, regulation, judicial decision, ruling or requirement issued, enacted, adopted, promulgated, implemented or otherwise put into effect by or under the authority of any Governmental Body (or under the
      authority of the New York Stock Exchange, Nasdaq Stock Market or the Financial Industry Regulatory Authority).</div>
    <div><br>
    </div>
    <div>
      <div style="text-indent: 39pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Board&#8221; means the Board of Directors of the Company.</div>
    </div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Business Combination Date&#8221; means the closing date of the Business Combination described in the Business Combination Agreement dated March 11, 2024, by and between the Company, Focus Impact BH3 Acquisition
      Company and the other parties thereto.</div>
    <div><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">12</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-indent: 39pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Capital Stock&#8221; means each and every class of common stock of the Company, regardless of the number of votes per share.</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Capitalization Adjustment&#8221; means any change that is made in, or other events that occur with respect to, the Common Stock subject to the Plan or subject to any Purchase Right after the date the Plan is
      adopted by the Board without the receipt of consideration by the Company through merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property other than cash, large nonrecurring cash dividend, stock
      split, liquidating dividend, combination of shares, exchange of shares, change in corporate structure or other similar equity restructuring transaction, as that term is used in Financial Accounting Standards Board Accounting Standards Codification
      Topic 718 (or any successor thereto). Notwithstanding the foregoing, the conversion of any convertible securities of the Company will not be treated as a Capitalization Adjustment.</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Code&#8221; means the U.S. Internal Revenue Code of 1986, as amended, including any applicable regulations and guidance thereunder.</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Committee&#8221; means a committee of one or more members of the Board to whom authority has been delegated by the Board in accordance with <u>Section 2(c)</u>.</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Common Stock&#8221; means, as of the Business Combination Date, the Class A common stock of the Company with a par value of $0.0001 per share.</div>
    <div><br>
    </div>
    <div>
      <div style="text-indent: 39pt;">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Company&#8221; means XCF Global, Inc.</div>
    </div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(l)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Contributions&#8221; means the payroll deductions and other additional payments specifically provided for in the Offering that a Participant contributes to fund the exercise of a Purchase Right. A Participant may
      make additional payments into such Participant&#8217;s account if specifically provided for in the Offering, and then only if the Participant has not already had the maximum permitted amount withheld during the Offering through payroll deductions and, with
      respect to the 423 Component, to the extent permitted by Section 423.</div>
    <div>&#160;</div>
    <div style="text-indent: 39pt;">(m)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Corporate Transaction&#8221; means the consummation, in a single transaction or in a series of related transactions, of any one or more of the following events:</div>
    <div>&#160;</div>
    <div style="margin: 0px 0px 0px 39pt; text-indent: 36pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a sale or other disposition of all or substantially all, as determined by the Board in its sole discretion, of the consolidated assets of the Company and its subsidiaries;</div>
    <div><br>
    </div>
    <div style="margin: 0px 0px 0px 39pt; text-indent: 36pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; a sale or other disposition of more than 50% of the outstanding securities of the Company;</div>
    <div><br>
    </div>
    <div style="margin: 0px 0px 0px 39pt; text-indent: 36pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160; a merger, consolidation or similar transaction following which the Company is not the surviving corporation; or</div>
    <div><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">13</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="margin-left: 45pt; text-indent: 36pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160; a merger, consolidation or similar transaction following which the Company is the surviving corporation but the shares of Common Stock outstanding immediately preceding the merger,
      consolidation or similar transaction are converted or exchanged by virtue of the merger, consolidation or similar transaction into other property, whether in the form of securities, cash or otherwise.</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(n)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Designated 423 Company&#8221; means any Related Corporation selected by the Board as participating in the 423 Component.</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(o)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Designated Company&#8221; means any Designated Non-423 Company or Designated 423 Company; <u>provided</u>, <u>however</u>, that at any given time, a Related Corporation participating in the 423 Component shall
      not be a Related Corporation participating in the Non-423 Component.</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(p)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Designated Non-423 Company&#8221; means any Related Corporation or Affiliate selected by the Board as participating in the Non-423 Component.</div>
    <div><br>
    </div>
    <div>
      <div style="text-indent: 39pt;">(q)&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#8220;Director&#8221; means a member of the Board.</div>
    </div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(r)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Eligible Employee&#8221; means an Employee who meets the requirements set forth in the document(s) governing the Offering for eligibility to participate in the Offering, provided that such Employee also meets the
      requirements for eligibility to participate set forth in the Plan.</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(s)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Employee&#8221; means any person, including an Officer or Director, who is &#8220;employed&#8221; for purposes of Section 423(b)(4) of the Code by the Company or a Related Corporation or solely with respect to the Non-423
      Component, an Affiliate. However, service solely as a Director, or payment of a fee for such services, will not cause a Director to be considered an &#8220;Employee&#8221; for purposes of the Plan.</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(t)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Employee Stock Purchase Plan&#8221; means a plan that grants Purchase Rights intended to be options issued under an &#8220;employee stock purchase plan,&#8221; as that term is defined in Section 423(b) of the Code.</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(u)&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#8220;Exchange Act&#8221; means the Securities Exchange Act of 1934, as amended and the rules and regulations promulgated thereunder.</div>
    <div>&#160;</div>
    <div style="text-indent: 39pt;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#8220;Fair Market Value&#8221; means, as of any date, the value of the Common Stock determined as follows:</div>
    <div><br>
    </div>
    <div style="margin: 0px 0px 0px 39pt; text-indent: 36pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If the Common Stock is listed on any established stock exchange or traded on any established market, the Fair Market Value of a share of Common Stock will be, unless otherwise
      determined by the Board, the closing sales price for such stock as quoted on such exchange or market (or the exchange or market with the greatest volume of trading in the Common Stock) on the date of determination, as reported in such source as the
      Board deems reliable. Unless otherwise provided by the Board, if there is no closing sales price for the Common Stock on the date of determination, then the Fair Market Value will be the closing sales price on the last preceding date for which such
      quotation exists.</div>
    <div style="margin-right: 13.45pt; margin-left: 42pt;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">14</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="margin: 0px 0px 0px 39pt; text-indent: 36pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In the absence of such markets for the Common Stock, the Fair Market Value will be determined by the Board in good faith in compliance with Applicable Laws and regulations and, to
      the extent applicable as determined in the sole discretion of the Board, in a manner that complies with Sections 409A of the Code.</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(w)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Governmental Body&#8221; means any (a) nation, state, commonwealth, province, territory, county, municipality, district or other jurisdiction of any nature, (b) federal, state, local, municipal, foreign or other
      government, (c) governmental or regulatory body, or quasi- governmental body of any nature (including any governmental division, department, administrative agency or bureau, commission, authority, instrumentality, official, ministry, fund,
      foundation, center, organization, unit, body or entity and any court or other tribunal, and for the avoidance of doubt, any tax authority) or other body exercising similar powers or authority or (d) self-regulatory organization (including the New
      York Stock Exchange, the Nasdaq Stock Market and the Financial Industry Regulatory Authority).</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(x)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Non-423 Component&#8221; means the part of the Plan, which excludes the 423 Component, pursuant to which Purchase Rights that are not intended to satisfy the requirements for an Employee Stock Purchase Plan may
      be granted to Eligible Employees.</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(y)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Offering&#8221; means the grant to Eligible Employees of Purchase Rights, with the exercise of those Purchase Rights automatically occurring at the end of one or more Purchase Periods. The terms and conditions of
      an Offering will generally be set forth in the &#8220;Offering Document&#8221; approved by the Board for that Offering.</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(z)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Offering Date&#8221; means a date selected by the Board for an Offering to commence. (aa) &#8220;Officer&#8221; means a person who is an officer of the Company or a Related Corporation within the meaning of Section 16 of the
      Exchange Act.</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(aa)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Participant&#8221; means an Eligible Employee who holds an outstanding Purchase</div>
    <div style="margin-left: 6pt;">Right.</div>
    <div>&#160;</div>
    <div style="text-indent: 39pt;">(bb)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Plan&#8221; means this XCF Global, Inc. 2025 Employee Stock Purchase Plan, as amended from time to time, including both the 423 Component and the Non-423 Component.</div>
    <div>&#160;</div>
    <div style="text-indent: 39pt;">(cc)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Purchase Date&#8221; means one or more dates during an Offering selected by the Board on which Purchase Rights will be exercised and on which purchases of shares of Common Stock will be carried out in accordance
      with such Offering.</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(dd)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Purchase Period&#8221; means a period of time specified within an Offering, generally beginning on the Offering Date or on the first Trading Day following a Purchase Date, and ending on a Purchase Date. An
      Offering may consist of one or more Purchase Periods.</div>
    <div style="text-indent: 36pt; margin-right: 10.3pt; margin-left: 5.95pt;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">15</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%16%%%-->
    <div style="text-indent: 39pt;">(ee)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Purchase Right&#8221; means an option to purchase shares of Common Stock granted pursuant to the Plan.</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(ff)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Related Corporation&#8221; means any &#8220;parent corporation&#8221; or &#8220;subsidiary corporation&#8221; of the Company whether now or subsequently established, as those terms are defined in Sections 424(e) and (f), respectively,
      of the Code.</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(gg)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Securities Act&#8221; means the Securities Act of 1933, as amended.</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(hh)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;Tax-Related Items&#8221; means any income tax, social insurance, payroll tax, fringe benefit tax, payment on account or other tax-related items arising out of or in relation to a Participant&#8217;s participation in the
      Plan, including, but not limited to, the exercise of a Purchase Right and the receipt of shares of Common Stock or the sale or other disposition of shares of Common Stock acquired under the Plan.</div>
    <div><br>
    </div>
    <div style="text-indent: 39pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;Trading Day&#8221; means any day on which the exchange(s) or market(s) on which shares of Common Stock are listed, including but not limited to the New York Stock Exchange, Nasdaq Global Select Market, the
      Nasdaq Global Market, the Nasdaq Capital Market or any successors thereto, is open for trading.</div>
  </div>
  <div> <br>
  </div>
  <br>
  <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 0%; color: #000000; text-align: center;">
  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">16</font></div>
  <div style="text-align: center;" class="BRPFPageNumberArea">
    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;"> </font></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.65
<SEQUENCE>20
<FILENAME>ef20050548_ex10-65.htm
<DESCRIPTION>EXHIBIT 10.65
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">



  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> Exhibit 10.65<br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">XCF Global, Inc.</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Employment Agreement</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">This Employment Agreement (this &#8220;Agreement&#8221;), dated as of June 6, 2025, is made by and between XCF Global, Inc. (the &#8220;Company&#8221;) and Jonathan Seeley
      (&#8220;Executive&#8221;) (the Company and Executive are collectively referred to herein as the &#8220;Parties,&#8221; or each individually referred to as a &#8220;Party&#8221;).</div>
    <div>&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">RECITALS</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">WHEREAS</font>, Executive has been serving as the Vice President,
      Treasurer of XCF Global Capital, Inc. (&#8220;XCF Global Capital&#8221;);</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">WHEREAS</font>, on March 11, 2024, XCF Global Capital, Focus Impact
      BH3 Acquisition Company (&#8220;Focus Impact&#8221;), Focus Impact BH3 NewCo, Inc. (&#8220;NewCo&#8221;), Focus Impact BH3 Merger Sub 1, LLC and Focus Impact BH3 Merger Sub 2, Inc. entered into a business combination agreement (as it may be amended or restated from time to
      time, the &#8220;Business Combination Agreement&#8221;), pursuant to which Focus Impact agreed to combine with XCF Global Capital in a series of transactions that will result in NewCo becoming a publicly-traded company (collectively, the &#8220;Business Combination&#8221;),
      and at the closing of the Business Combination (the &#8220;Closing&#8221;), NewCo will change its name to &#8220;XCF Global, Inc.&#8221;; and</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">WHEREAS</font>, Executive and the Company desire to enter into this
      Agreement to set out the terms and conditions of the employment relationship between the Company and the Executive following the Closing of the Business Combination, with this Agreement to become effective upon the Closing of the Business Combination
      and continue until terminated by either Party in accordance with its terms (such period during which this Agreement is in effect, the &#8220;Term&#8221;) and will be null and void if the Closing of the Business Combination does not occur; and</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">WHEREAS</font>, except as otherwise provided herein, Executive and
      the Company intend and confirm that this Agreement supersedes in all respects all prior agreements, arrangements or understandings between Executive and the Company regarding the subject matter herein, including without limitation, any offer letter,
      employment agreement, consulting agreement or severance agreement as of the effective date of this Agreement.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">NOW, THEREFORE</font>, in consideration of the foregoing recitals,
      the mutual covenants and agreements set forth herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and Executive agree as follows:</div>
    <div>&#160;</div>
    <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">1.</font>&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Employment</u></font>.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(a)</font>&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>At-Will Employment</u></font>. Executive and the Company acknowledge that Executive&#8217;s employment is and shall continue to be at-will, as defined under applicable law, and that Executive&#8217;s employment with the
        Company may be terminated by either Party at any time for any or no reason (subject to the notice requirements of <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 3(b)</u></font>). If Executive&#8217;s employment terminates for
        any reason, Executive shall only be entitled to those payments, benefits, awards or compensation as specifically provided in this Agreement or as otherwise agreed to in writing by the Company, or as provided by applicable law, and Executive shall
        not be entitled to any other payments, benefits, damages, award or compensation.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Title; Responsibilities</u></font>. The Company shall continue to employ Executive in the position of Vice President, Treasurer reporting to Chief Financial Officer, and Executive hereby accepts such continued
        employment. During the Term, Executive shall have and perform such duties, responsibilities and authorities as are customarily associated with this position, as well as any other duties that may be assigned to Executive from time to time by the
        Chief Executive Officer or the Board of Directors (the &#8220;Board&#8221;) that are not inconsistent with service as an officer of the Company, including duties for any Company subsidiary or affiliate.</font></div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%%%-->
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Exclusive Employment</u></font>. During the Term, Executive shall devote substantially all of Executive&#8217;s business time, skills and best efforts to Executive&#8217;s employment hereunder and may not, without the
        prior written consent of the Board, participate in the management, operation, or control of, or act as an employee, officer, director, consultant, advisor, agent or representative of, any other business or service (&#8220;Other Service&#8221;); provided,
        however, that Executive may (i) engage in civic and charitable activities (including service on the board of directors or advisory board of civic and charitable organizations), (ii) make and manage outside passive personal and family investments
        and manage personal and family affairs and (iii) serve on the board of directors of the for-profit businesses or trade organizations (including advisory boards), provided, that none of the foregoing (x) materially interferes with Executive&#8217;s
        performance of Executive&#8217;s duties hereunder, (y) poses an actual or perceived conflict of interest or violates any other obligations of Executive hereunder (including, without limitation, <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Sections 5</u></font> and <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>6</u></font> hereof) or (z) is prohibited by or conflicts with any applicable law or regulation (including the rules of any securities
        exchange on which the Company&#8217;s securities are listed) or any Company policy applicable to Executive. <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Exhibit A</u></font> hereto identifies (i) any Other Service with respect to
        which the Board had provided its consent and (ii) any board of directors of any for-profit businesses or trade organizations (including advisory boards) on which Executive serves (as such Exhibit may be amended from time to time during the Term by
        mutual agreement of the Executive and the Board).</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(d</font>) &#160;&#160; &#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Compliance</u></font>. Executive agrees to comply with all applicable laws, rules, regulations and policies relating to the performance of Executive&#8217;s duties and responsibilities as an employee of the Company,
        including, without limitation, compliance with the Company&#8217;s Code of Ethics and Business Conduct. Executive is prohibited from receiving economic benefits from any other person or entity other than the Company in connection with the services
        provided to the Company hereunder (for purposes of clarity, receipt of economic benefits from ownership of securities of the Company would not be prohibited under this provision, but would, for the avoidance of doubt, be subject to any insider
        trading policy maintained by the Company).</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Employment Location</u></font>. Executive may work remotely from Executive&#8217;s residence or from such other location as Executive shall inform the Company. Notwithstanding the foregoing, Executive understands and
        agrees that in connection with the performance of Executive&#8217;s duties and responsibilities under this Agreement, the Company may require Executive to spend designated days per month in a designated Company office, provided, that the Company shall
        notify the Executive in advance of such requirement. In addition, Executive understands and agrees that in connection with the performance of Executive&#8217;s duties and responsibilities under this Agreement, Executive may be required to travel on
        Company business from time-to-time.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">2.</font>&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Compensation</u></font>.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Base Salary</u></font>. During the Term, Executive shall receive an annualized base salary in the amount of $260,000 (&#8220;Base Salary&#8221;), which will be paid in accordance with the Company&#8217;s customary payroll
        procedures as established and modified from time-to-time. The Base Salary will be reviewed annually and may be changed in the sole discretion of the Board and as recommended by the Board&#8217;s Compensation Committee (provided, however, if pursuant to
        the listing requirements of any securities exchange on which the Company&#8217;s securities are then listed, Executive&#8217;s compensation must be set or approved in a different manner, Executive&#8217;s compensation shall be set or approved in accordance with such
        requirements), and any such revised Base Salary shall then constitute &#8220;Base Salary&#8221; for purposes of this Agreement.</font></div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">2</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Annual Bonus</u></font>. In addition to the Base Salary, Executive shall be eligible for an annual bonus for each completed fiscal year of employment during the Term (&#8220;Annual Bonus&#8221;).&#160; The terms of Executive&#8217;s
        initial Annual Bonus are as set forth on <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Exhibit B</u></font> to this Agreement, and the terms of the Annual Bonus for subsequent years shall be determined by the Board, upon the
        recommendation of the Board&#8217;s Compensation Committee for each such subsequent year of employment as set forth herein. Executive understands and agrees that this Agreement does not guarantee the payment of any Annual Bonus and that the actual Annual
        Bonus payable will be based on the achievement of performance objectives and/or other criteria as determined by the Board and recommended by the Board&#8217;s Compensation Committee and such other factors as the Compensation Committee, in its discretion,
        deems relevant (provided, however, if pursuant to the listing requirements of any securities exchange on which the Company&#8217;s securities are then listed, Executive&#8217;s compensation, including any bonus compensation, must be set or approved in a
        different manner, Executive&#8217;s compensation shall be set or approved in accordance with such requirements). Unless otherwise agreed by the Parties and subject to <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 4(c)(ii)</u></font>,
        if an Annual Bonus is awarded, such Annual Bonus shall be deemed &#8220;earned&#8221; and Executive is entitled to receive payment of such Annual Bonus only if Executive is employed by the Company on the date the Annual Bonus is paid. Any Annual Bonus payable
        in accordance with this <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 2(b)</u></font> shall be paid to Executive no later than March 15<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>
        of the calendar year following the year to which it relates. Executive&#8217;s Annual Bonus for 2025 (to the extent earned) will be prorated to reflect the portion of the year from the Closing of the Business Combination.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(c)</font>&#160;&#160;&#160; &#160; &#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Equity Compensation</u></font>.&#160; As soon as practicable following the Closing of the Business Combination and subject to Board approval, Executive shall receive an initial award of restricted stock units as set
        forth on <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Exhibit B</u></font>, subject to Executive&#8217;s continued employment through the date of grant, which award shall be subject in all respect to the term and conditions of the
        Company&#8217;s 2025 Equity Incentive Plan (the &#8220;2025 Plan&#8221;) and the applicable award agreement to be delivered separately to Executive. In addition, Executive shall be eligible to receive additional equity compensation pursuant to the 2025 Plan or such
        other plans or arrangements as determined by the Board or Compensation Committee from time to time. The complete terms and conditions of any future equity compensation award made pursuant to the 2025 Plan or any other equity plan adopted by the
        Company, including vesting, exercise and forfeiture terms, shall be set forth in an award agreement and any such award shall be subject to the terms and conditions set forth in such award agreement and the 2025 Plan or such other equity plan
        adopted by the Company.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(d)</font>&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Benefits</u></font>. During the Term, Executive shall be eligible to participate in such health, group insurance, welfare, pension, and other employee benefit plans, programs, and arrangements as are made
        generally available from time to time to senior executives of the Company (which shall include customary health, life insurance, and disability plans). Executive also shall be eligible to participate in the Company&#8217;s 2025 Employee Stock Purchase
        Plan or any similar or replacement plan adopted in the future during the Term. Executive also shall be eligible for 25 days of paid time off (&#8220;PTO&#8221;) per calendar year during the Term (prorated for partial years) in accordance with the Company&#8217;s
        vacation and PTO policy in effect from time to time, inclusive of vacation days and sick days and excluding standard paid Company holidays.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Expenses and Allowances</u></font>. Executive shall receive reimbursement from the Company for all reasonable, necessary, and documented business expenses incurred in connection with Executive&#8217;s employment
        hereunder, provided, that such expenses are timely submitted for reimbursement with supporting documentation in accordance with the Company&#8217;s expense reimbursement policies and procedures. In addition, Executive will receive reimbursement for the
        additional fees and expenses incurred by Executive as set forth on <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Exhibit B</u></font> (subject to Executive provided sufficient documentation for such reimbursements).</font></div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">3</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">3.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Termination</u></font>.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Termination Circumstances</u></font>.&#160; Executive&#8217;s employment hereunder may be terminated by the Company or Executive, as applicable, under the following circumstances, and the Term will end on the Date of
        Termination:</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Death</font>. Executive&#8217;s employment hereunder shall terminate automatically upon Executive&#8217;s death.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Disability</font>. If Executive has incurred a Disability, the Company may terminate Executive&#8217;s employment.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Termination for Cause</font>. The Company may terminate Executive&#8217;s employment for Cause.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(iv)</font>&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Termination without Cause</font>. The Company may terminate Executive&#8217;s employment without Cause for any reason or no reason.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(v)</font>&#160;&#160;&#160; &#160; &#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Resignation from the Company with Good Reason</font>. Executive may resign Executive&#8217;s employment with the Company with Good Reason.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(vi)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Resignation from the Company without Good Reason</font>. Executive may resign Executive&#8217;s employment with the Company for any reason other than Good Reason or for no
        reason.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(b)</font>&#160;&#160; &#160; &#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Notice of Termination</u></font>. Any termination of Executive&#8217;s employment by the Company or by Executive under this <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 3</u></font>
        (other than termination as a result of Executive&#8217;s death) shall be communicated by a written notice by the terminating Party to the other Party hereto (i) indicating the specific termination provision in this Agreement being relied upon, (ii)
        setting forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of employment under the provision so indicated, if applicable, and (iii) specifying a Date of Termination (such notice, a &#8220;Notice of
        Termination&#8221;).&#160; If the Notice of Termination is submitted by Executive, such Notice of Termination shall be given at least thirty (30) days prior to the Date of Termination; provided, however, that in the event that Executive delivers a Notice of
        Termination to the Company, the Company may, in its sole discretion, change the Date of Termination to any date that occurs following the date of the Company&#8217;s receipt of such Notice of Termination and which is prior to the date specified by
        Executive in such Notice of Termination, but such termination still shall be considered a resignation by Executive, unless the Company has determined that Cause exists as of such earlier Date of Termination. A Notice of Termination submitted by the
        Company may provide for a Date of Termination on the date Executive receives the Notice of Termination or any date thereafter elected by the Company. The failure by either Party to set forth in the Notice of Termination any fact or circumstance
        which contributes to a showing of Cause or Good Reason shall not waive any right of the Party hereunder or preclude the Party from asserting such fact or circumstance in enforcing the Party&#8217;s rights hereunder.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Company Obligations upon Termination</u></font>. Upon termination of Executive&#8217;s employment pursuant to any of the circumstances set forth in this <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section

            3</u></font>, Executive (or Executive&#8217;s estate) shall be entitled to receive the sum of (i) the portion of Executive&#8217;s Base Salary earned for the applicable year through the Date of Termination, but not yet paid to Executive, payable on the pay
        date immediately following the Date of Termination in accordance with the Company&#8217;s regular payroll practices (or such earlier date as required by applicable law), (ii) any expense reimbursements owed to Executive pursuant to this Agreement,
        payable in accordance with the Company&#8217;s expense reimbursement policy and (iii) any amount accrued and arising from Executive&#8217;s participation in, or benefits accrued under any employee benefit plans, programs or arrangements, which amounts shall be
        payable in accordance with the terms and conditions of such employee benefit plans, programs or arrangements (the &#8220;Company Arrangements&#8221; and the entitlements referenced in the foregoing clauses (i) through (iii), collectively, the &#8220;Accrued
        Benefits&#8221;).</font></div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">4</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(d)</font>&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Effect on Equity Awards</u></font>. The effect of Executive&#8217;s termination on any equity awards received by Executive prior to such termination shall be determined in accordance with the terms of the 2025 Plan
        (or any other equity plan adopted by the Company pursuant to which such awards were made), the award agreement relating to any such award and/or <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 4(b)</u></font> below, and
        in the case of a termination relating to a Change in Control, <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 4(c)</u></font> below.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">4.</font>&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Severance Payments</u></font>.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(a)</font>&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Termination Upon Death or Disability</u></font>. In the event of Executive&#8217;s termination of employment due to death or Disability (as defined below) during the Term, the Company shall pay to or for the benefit
        of Executive or Executive&#8217;s estate, as applicable, the Accrued Benefits and, to the extent unpaid as of the Date of Termination, the Company shall pay Executive the amount of Executive&#8217;s Annual Bonus for the prior year, paid as set forth in <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 2(b)</u></font> as if no such termination had occurred.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Termination for Cause; Resignation from the Company Without Good Reason</u></font>. If Executive&#8217;s employment shall terminate for Cause, or due to Executive&#8217;s resignation from the Company without Good Reason,
        then Executive shall receive the Accrued Benefits.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(c)</font>&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Termination without Cause, or Resignation from the Company with Good Reason</u></font>. If Executive&#8217;s employment is terminated without Cause or due to Executive&#8217;s resignation with Good Reason (in each case, a
        &#8220;Qualifying Termination&#8221;) that does not occur during the CIC Period (as defined below), in addition to the Accrued Benefits, Executive shall be entitled to the following payments and benefits:</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The Company shall
        pay Executive an amount in cash equal to, in the aggregate, 200% of the Executive&#8217;s annual base salary in effect as of the Date of the Termination, payable in equal monthly installments over the 12 month period following the Date of Termination, in
        accordance with the Company&#8217;s normal payroll practices;</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">To the extent
        unpaid as of the Date of Termination, the Company shall pay Executive the amount of Executive&#8217;s Annual Bonus for any unpaid prior period, paid as set forth in <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 2(b)</u></font>
        as if no such termination had occurred;</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(iii)</font>&#160;&#160;&#160; &#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">The Company shall
        pay Executive an amount in cash equal to two times the amount of the annual bonus that Executive would have earned for the year in which the Date of Termination occurs as if Executive had not been terminated and as if such annual bonus was fully
        earned (i.e., any relevant performance criteria shall be deemed fully achieved)(such payment, the (&#8220;Termination Bonus Payment&#8221;), which amount will be paid in a lump sum within thirty (30) days following the date Executive&#8217;s Release becomes
        effective and irrevocable, provided that to the extent the annual bonus for the year in which the Date of Termination occurs has been pro-rated to reflect that portion of the year from the Closing of the Business Combination to the end of such
        year, or in the event of any other partial-year calculation, the annual bonus amount for such year shall be adjusted for purposes of calculating the Termination Bonus Payment so as to reflect the bonus amount that would have been paid for a full
        year as if there had there been no such pro-ration (the &#8220;Full-Year Equivalent&#8221;) and in no event shall the Termination Bonus Payment be calculated based on an amount other than the Full-Year Equivalent, irrespective of partial-year employment;</font></div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">5</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(iv)</font>&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">If Executive timely
        elects continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (&#8220;COBRA&#8221;), then the Company shall directly pay, or reimburse Executive for, the COBRA premiums for Executive&#8217;s and Executive&#8217;s covered
        dependents&#8217; continued participation under the Company&#8217;s group health plan (to the extent permitted under applicable law and the terms of such plan), less the amount Executive would have had to pay to receive such coverage as an active employee
        based on the cost sharing levels in effect on the Date of Termination, during the period commencing on the Date of Termination and ending upon the earliest of (A) eighteen (18) months following the Date of Termination, (B) the date that Executive
        and/or Executive&#8217;s covered dependents become no longer eligible for COBRA or (C) the date that Executive becomes eligible to receive group health benefits from a subsequent employer (and Executive agrees to promptly notify the Company of such
        eligibility); provided, that the Company may modify the continuation coverage contemplated this <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 4(c)(iv)</u></font> to the extent reasonably necessary, as determined by the
        Company in its sole discretion, to avoid potentially violating applicable law or incurring an excise tax for failure to comply with applicable law (including, without limitation, Section 2716 of the Public Health Service Act; Section 105(h) of the
        Internal Revenue Code of 1986, as amended; the Patient Protection and Affordable Care Act of 2010, as amended; and/or the Health Care and Education Reconciliation Act of 2010, as amended, and in each case, the regulations and guidance promulgated
        thereunder (to the extent applicable)).</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Qualifying Termination in Connection with Change in Control</u></font>. In the event of a Qualifying Termination that occurs (i) not more than three (3) months prior to a Change in Control or (ii) on or within
        twelve (12) months after a Change in Control (such period, the &#8220;CIC Period&#8221;), Executive shall be entitled to receive, in addition to the Accrued Benefits, the following payments and benefits set forth in (i) through (iv) below, in each case,
        subject to (v) below:</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">The Company shall
        pay Executive an amount in cash equal to, in the aggregate, 300% of the Executive&#8217;s annual base salary in effect as of the Date of the Termination, payable as a one-time payment to be made by the Company to the Executive (A) within thirty (30) days
        of the Release Effective Date, if the termination occurs following the Change of Control, or (B) within thirty (30) days of the consummation of the Change of Control (or such later date that is thirty (30) days following the Release Effective
        Date), if the termination occurred prior to the Change in Control;</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">To the extent
        unpaid as of the Date of Termination (or, if later, the consummation of the Change in Control), the Company shall pay Executive the amount of Executive&#8217;s Annual Bonus for any unpaid prior period, paid as set forth in <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 2(b)</u></font>, as if no such termination had occurred;</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">The Company shall
        pay Executive an amount in cash equal to three times the amount of the annual bonus that Executive would have earned for the year in which the Date of Termination occurs as if Executive had not been terminated and as if such annual bonus was fully
        earned (i.e., any relevant performance criteria shall be deemed fully achieved)(such payment, the (&#8220;CIC Termination Bonus Payment&#8221;) payable as a one-time payment to be made by the Company to the Executive (A) within thirty (30) days of the date
        Executive&#8217;s Release becomes effective and irrevocable, if the termination occurs following the Change of Control, or (B) within thirty (30) days of the date of the Change of Control (or such later date that is thirty (30) days following the date
        Executive&#8217;s Release becomes effective and irrevocable), if the termination occurred prior to the Change of Control, provided that to the extent the annual bonus for the year in which the Date of Termination occurs has been pro-rated to reflect that
        portion of the year from the Closing of the Business Combination to the end of such year, or in the event of any other partial-year calculation, the annual bonus amount for such year shall be adjusted for purposes of calculating the CIC Termination
        Bonus Payment so as to reflect the bonus amount that would have been paid for a full year as if there had there been no such pro-ration (the &#8220;Full-Year Equivalent&#8221;) and in no event shall the CIC Termination Bonus Payment be calculated based on an
        amount other than the Full-Year Equivalent, irrespective of partial-year employment;</font></div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">6</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(iv)</font>&#160; &#160; &#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">Any restricted
        stock, restricted stock units, options, or other equity grants or awards not vested at the time of termination shall be accelerated and become immediately vested (and, for any such awards as to which vesting is based on meeting specified
        performance criteria, such awards will be considered vested as if the relevant performance criteria was fully achieved), such that Executive will thereafter be 100% vested in any restricted stock, restricted stock units, options, or other equity
        grants awarded by the Company to Executive during the Term; and</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(v)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">The COBRA
        continuation benefits set forth in <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 4(c)(iv)</u></font>.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(vi)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Non-Duplication of Payment or Benefits</font>.&#160; If (A) Executive&#8217;s Qualified Termination occurs prior to a Change in Control that qualifies the Executive for severance
        payments and benefits under <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 4(d)</u></font> and (B) a Change in Control occurs within the six (6)-month period following the Executive&#8217;s Qualified Termination that qualifies
        the Executive for severance payments and benefits under <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 4(c)</u></font>, then (1) the Executive will cease receiving any further payments or benefits under <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 4(c)</u></font> and (2) the Executive will receive the payments and benefits under <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 4(d)</u></font>
        instead but each of the payments and benefits otherwise payable under <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 4(d)</u></font> will be offset by the corresponding payments or benefits the Executive already received
        under <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 4(c)</u></font>.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Release; Exclusive Remedy; Resignation</u></font>.&#160; Executive&#8217;s right to receive the payments and benefits specified in <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 4(a)</u></font>,
        <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 4(b)</u></font> and <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 4(c)</u></font> (collectively, the &#8220;Severance Benefits&#8221;) are subject to (i)
        Executive&#8217;s continued compliance with all restrictive covenant obligations with respect to the Company and its affiliates (including, without limitation, <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Sections 5</u></font> and <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>6</u></font> hereof) and (ii) Executive (or Executive&#8217;s estate, as applicable) signing and delivering to the Company and not revoking a separation agreement and release of any claims
        against the Company, its affiliates, and their employees, officers, directors, and shareholders arising out of Executive&#8217;s employment or termination in a form reasonably acceptable to the Company that becomes effective and irrevocable within sixty
        (60) days following the Date of Termination (such agreement, the &#8220;Release&#8221; and such date the Release becomes effective and irrevocable, the &#8220;Release Effective Date&#8221;). The first payment of any Severance Benefits will include all amounts that
        otherwise would have been due prior thereto under the terms of this Agreement had such payments commenced immediately upon the Date of Termination. Any delay in the payment of the Severance Benefits will not extend the period of time that the
        Severance Benefits are payable pursuant to <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 4</u></font>. During such time that the Executive is receiving the Severance Benefits, if (A) the Company discovers grounds
        constituting Cause existed before the Executive&#8217;s termination or (B) Executive breaches any of the covenants set forth in <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Sections 5</u></font> and <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>6</u></font>, the Executive&#8217;s right to receive the Severance Benefits will immediately cease and be forfeited.&#160; Except as otherwise expressly required by law (e.g., COBRA) or as specifically provided in this
        Agreement, all of Executive&#8217;s rights to salary, severance, benefits, bonuses and other compensatory amounts hereunder (if any) shall cease upon the termination of Executive&#8217;s employment hereunder, and the amounts payable to Executive following
        termination pursuant to <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Sections 3</u></font> and <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>4</u></font> hereof will be in full and complete satisfaction of
        Executive&#8217;s rights under this Agreement and any other claims that Executive may have in respect of employment with the Company or any of its affiliates, and Executive acknowledges that such amount amounts are fair and reasonable and are Executive&#8217;s
        sole and exclusive remedy, in lieu of all other remedies at law or in equity, with respect to the termination of the Term or any breach of this Agreement by the Company. Upon any termination of the Term, Executive will promptly resign, and will be
        deemed to have automatically resigned, from all positions that Executive holds as a member of the Board, officer, director or fiduciary of the Company or any of its affiliates, and Executive will take all actions reasonably requested by the Company
        or its affiliates to give effect to the foregoing.</font></div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">7</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">5.</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Confidentiality; Intellectual Property</u></font>.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Confidentiality</u></font>. Executive recognizes and acknowledges that the continued success of the Company depends upon the use and protection of Confidential Information, which constitutes valuable trade
        secrets of the Company. Executive agrees to use the Confidential Information only during the Term in connection with the proper performance of Executive&#8217;s duties as an employee hereunder; otherwise, Executive shall not, directly or indirectly, use
        or disclose the Confidential Information for any other purpose or to any third party. The restrictions set forth herein are in addition to and not in lieu of any obligations Executive may have by law with respect to the Confidential Information,
        including any fiduciary duties or other obligations Executive may owe under any applicable trade secrets statutes or other state or federal laws.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(b)</font> &#160; &#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Intellectual Property</u></font>. Executive acknowledges and agrees that all inventions, know-how, trade secrets, technology, programming, software, processes, innovations, ideas, improvements, developments,
        methods, algorithms, designs, analyses, writings, audiovisual works, works of authorship, concepts, drawings, reports and all similar, related, or derivative information or works (whether or not patentable or subject to copyright), including but
        not limited to all resulting patent applications, issued patents, copyrights, copyright applications and registrations in and to any of the foregoing, along with the right to practice, employ, exploit, use, develop, reproduce, copy, distribute
        copies, publish, license, or create works derivative of any of the foregoing, and the right to choose not to do or permit any of the aforementioned actions, that are conceived, authored, reduced to practice, created, or otherwise developed by
        Executive during the Term (whether alone or jointly with others) (collectively, the &#8220;Work Product&#8221;) belong to the Company, and not Executive; provided that Work Product excludes, and this <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 5(b)</u></font> does not apply to an invention for which no equipment, supplies, facilities, or trade secret information of the Company or its affiliates (whether existing now or in the future) and which was developed entirely
        on Executive&#8217;s own time, unless (i) the invention relates (A) to the business of the Company or its affiliates (whether existing now or in the future), or (B) to the Company&#8217;s (or its affiliates&#8217; (whether existing now or in the future)) actual or
        demonstrably anticipated research or development, or (ii) the invention results from any work performed by Executive for the Company or its affiliates (whether existing now or in the future). Executive further acknowledges and agrees that to the
        extent relevant, this Agreement constitutes a &#8220;work for hire agreement&#8221; under the United States Copyright Act of 1976, as amended (&#8220;Copyright Act&#8221;), and that any copyrightable work (&#8220;Creation&#8221;) constitutes a &#8220;work made for hire&#8221; under the Copyright
        Act such that the Company is the copyright owner of the Creation. Executive hereby irrevocably assigns and agrees to assign to the Company all right, title and interest in and to all Work Product and, to the extent any Creation or portion thereof
        is not a &#8220;work for hire&#8221;, all Creations. Executive will promptly disclose and deliver such Work Product and Creations to the Company and, at the Company&#8217;s expense, perform all actions reasonably requested by the Company (whether during or after the
        Term to effectuate, establish, confirm, record or protect such ownership, or to protect or enforce the Company&#8217;s rights therein (including, without limitation, the execution of assignments, copyright registrations, consents, licenses, powers of
        attorney and other instruments).</font></div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">8</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(c)</font>&#160; &#160; &#160; &#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Permitted Disclosures</u></font>. Nothing in this Agreement shall be construed to prevent disclosure of Confidential Information as may be required by applicable law or regulation, or pursuant to the valid
        order of a court of competent jurisdiction or an authorized government agency, provided that the disclosure does not exceed the extent of disclosure required by such law, regulation, or order, or in connection with an investigation by or report to
        any regulatory agency with jurisdiction over the Company, law enforcement, or any other federal or state regulatory or self-regulatory authority. In compliance with 18 U.S.C. &#167; 1833(b), as established by the Defend Trade Secrets Act of 2016,
        Executive is given notice of the following: (i) that an individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that (A) is made (1) in confidence to a Federal,
        State, or local government official, either directly or indirectly, or to an attorney; and (2) solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document filed in a lawsuit or
        other proceeding, if such filing is made under seal; and (ii) that an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use
        the trade secret information in the court proceeding, if the individual (A) files any document containing the trade secret under seal; and (B) does not disclose the trade secret, except pursuant to court order.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Return of Property</u></font>. Upon separation from employment or earlier request from the Company, Executive shall return to the Company any and all Company property, including keys, access cards,
        identification cards, credit cards, business cards, laptop, smartphone, other electronic equipment, reports, files, manuals, Work Product, Creations, emails, recordings, thumb drives or other removable information storage devices, and data and all
        Company documents and materials belonging to the Company and stored in any fashion, including but not limited to those that constitute or contain any Confidential Information or Work Product, Creations, that are in the possession or control of the
        Executive, relating to Executive&#8217;s employment by the Company. Without limiting the foregoing or Executive&#8217;s obligations under <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 5(a)</u></font>, upon separation from
        employment or earlier request from the Company, Executive shall not retain possession or control of any Confidential Information and shall instead return such Confidential Information to the Company or destroy it.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">6.</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Restrictive Covenants</u></font>.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(a)</font>&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>No Solicitation of Customers</u></font>. Executive agrees that, both during the Term and for the period ending on the date that is eighteen (18) months from the date of the termination of the Executive&#8217;s
        employment with the Company at any time and for any reason (the &#8220;Restricted Period&#8221;), Executive will not solicit any Restricted Business (as defined below) from any person or entity that is, or in the prior twelve (12) months was a customer of the
        Company or any of its affiliates or any prospective customer of the Company or any of its affiliates with respect to which the Company or its affiliates actively solicits or has solicited the sale of Company products and services. For purposes of
        this Agreement, &#8220;Restricted Business&#8221; shall mean the business of manufacturing, marketing and selling renewable fuels (including, but not limited to, renewable diesel fuel and sustainable aviation fuel (SAF)) and constructing, acquiring, investing
        in and/or operation facilities for the production of renewable fuels (including, but not limited to, renewable diesel fuel and sustainable aviation fuel (SAF)). Notwithstanding the foregoing, Executive shall not be prohibited from the passive
        ownership of up to two percent (2%) of the securities of any entity engaged in any Restricted Business, where the securities of such entity are traded on a national securities exchange.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>No Solicitation of Employees</u></font>. Executive agrees that during the Restricted Period, Executive will not, directly or indirectly, on behalf of himself or any other person or entity, hire, solicit, take
        away or attempt to hire, solicit or take away any person who is (or in the preceding six months was), at the time of such solicitation, an employee, director or independent contractor of the Company or any of its affiliates, either on behalf of
        himself or any other person or entity. This includes, but is not limited to, inducing or attempting to induce, or influencing or attempting to influence, any person employed by the Company or its affiliates to terminate his or her employment with
        the Company or any such affiliate.</font></div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">9</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(c)</font>&#160; &#160; &#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Importance of Executive&#8217;s Services; Intent of the Parties; Enforcement</u></font>. Executive acknowledges and agrees that the services to be provided by Executive under this Agreement are of a special, unique
        and extraordinary nature. Executive further acknowledges and agrees that the covenants and restrictions contained in <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 5</u></font> and <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 6</u></font> are necessary to prevent the use and disclosure of Confidential Information and to protect other legitimate business interests of the Company and its affiliates. Executive acknowledges that
        all of the covenants and restrictions in <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 5</u></font> and <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 6</u></font> are reasonable in all
        respects, including duration, territory and scope of activity. Executive acknowledges and agrees that the Company competes with businesses on a world-wide basis and that the geographic restrictions contained herein are therefore reasonable and
        necessary to protect the Company&#8217;s legitimate business interests. Executive agrees that the covenants and restrictions contained in <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 5</u></font> and <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 6</u></font> shall be construed as separate agreements independent of any other provision of this Agreement or any other agreement between Executive and the Company. Executive agrees that the
        existence of any claim or cause of action by Executive against the Company or its affiliates, whether predicated on this Agreement or otherwise, shall not constitute a defense to the enforcement by the Company of the covenants and restrictions in <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 5</u></font> and <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 6</u></font>. Executive agrees that the restrictive covenants contained in <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 5</u></font> and <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 6</u></font> are a material part of Executive&#8217;s obligations under this Agreement for
        which the Company has agreed to compensate the Executive as provided in this Agreement. The Executive agrees that the injury the Company will suffer in the event of the breach by Executive of any clause of <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 5</u></font> and <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 6</u></font> will cause the Company and its affiliates irreparable injury that cannot be adequately
        compensated by monetary damages alone. Therefore, Executive agrees that the Company, without limiting any other legal or equitable remedies available to it, shall be entitled to obtain equitable relief by injunction or otherwise from any court of
        competent jurisdiction, including, without limitation, injunctive relief to prevent Executives&#8217; failure to comply with the terms and conditions of <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 5</u></font> and <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 6</u></font>. The time year periods referenced in <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 5</u></font> and <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 6</u></font> shall be extended on a day-for-day basis for each day during which Executive violates the provisions of <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 5</u></font>
        and <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 6</u></font> in any respect, so that Executive is restricted from engaging in the activities prohibited by <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 5</u></font> and <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 6</u></font> for the full time period, as applicable.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(d)</font>&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Whistleblower Protection</u></font>.&#160; Notwithstanding anything to the contrary contained herein, no provision of this Agreement or any other agreement or Company policy will be interpreted so as to impede
        Executive (or any other individual) from (i) making any disclosure of relevant and necessary information or documents in any action, investigation, or proceeding relating to this Agreement, or as required by law or legal process, including with
        respect to possible violations of law, (ii) participating, cooperating, or testifying in any action, investigation, or proceeding with, or providing information to, any governmental agency, legislative body or any self-regulatory organization,
        including, but not limited to, the Department of Justice, the Securities and Exchange Commission, the Congress, and any agency Inspector General, (iii) seeking or accepting any U.S. Securities and Exchange Commission awards or other relief in
        connection with protected whistleblower activity, or (iv) making other disclosures under the whistleblower provisions of federal law or regulation. In addition, nothing in this Agreement or any other agreement or Company policy prohibits or
        restricts Executive from initiating communications with, or responding to any inquiry from, any administrative, governmental, regulatory or supervisory authority regarding any good faith concerns about possible violations of law or regulation.
        Executive does not need the prior authorization of the Company to make any such reports or disclosures and the Executive will not be required to notify the Company that such reports or disclosures have been made.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">7.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Other Agreements</u></font>. Executive represents and agrees that Executive&#8217;s performance of Executive&#8217;s duties for the Company shall not violate any agreements, obligations or understandings that Executive may have with any third
        party or prior employer. Without limiting the foregoing, Executive represents and agrees that Executive is not bound by any non-compete or non-solicitation agreement or any other type of agreement that would prohibit Executive&#8217;s employment with the
        Company. Executive agrees not to make any unauthorized disclosure or use, on behalf of the Company, of any confidential information belonging to any of Executive&#8217;s former employers. Executive also represents that Executive is not in unauthorized
        possession of any materials containing a third party&#8217;s confidential and proprietary information.</font></div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">10</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">8.</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Cooperation with Company</u></font>. During Executive&#8217;s employment by the Company and thereafter, Executive will cooperate with the Company and its affiliates in any internal investigation or administrative, regulatory or judicial
        proceeding that relates to events occurring during Executive&#8217;s employment hereunder and as reasonably requested by the Company (including being available upon reasonable notice from the Company for interviews and factual investigations and
        appearing at the Company&#8217;s request to give testimony without requiring service of a subpoena or other legal process, all at times and on schedules that are reasonably consistent with Executive&#8217;s other permitted activities and commitments). In the
        event the Company requires Executive&#8217;s cooperation in accordance with this <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 8</u></font> following the termination of Executive&#8217;s employment, the Company (or its applicable
        affiliate) will reimburse Executive for reasonable expenses incurred by Executive in connection therewith.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">9.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Tax Provisions</u></font>.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Withholding</u></font>. All amounts payable to Executive under this Agreement will be subject to all required tax and other designated or required withholdings and deductions. In the event that the Company
        fails to withhold any taxes required to be withheld by applicable law or regulation, Executive agrees to indemnify the Company for any taxes of Executive that should have been withheld.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 280G</u></font>. To the extent that any amount payable to Executive hereunder, as well as any other &#8220;parachute payment&#8221; as such term is defined under Section 280G (collectively with the regulations
        promulgated thereunder, &#8220;Section 280G&#8221;) of the Code, payable to Executive ( the &#8220;Covered Payments&#8221;), exceeds the limitations&#160; of Section 280G such that an excise tax will be imposed under Section 4999 of the Code (the &#8220;Excise Tax&#8221;), then, before
        making the Covered Payments, a calculation will be made comparing (i) the Net Benefit (as defined below) to Executive of the Covered Payments after payment of the Excise Tax to (ii) the Net Benefit to Executive if the Covered Payments are limited
        to the extent necessary to avoid being subject to the Excise Tax. Only if the amount calculated under (i) above is less than the amount under (ii) above will the Covered Payments be reduced to the minimum extent necessary to ensure that no portion
        of the Covered Payments is subject to the Excise Tax. &#8220;Net Benefit&#8221; will mean the present value of the Covered Payments net of all federal, state, local, foreign income, employment and excise taxes. Any such reduction will be made by the Company in
        its sole discretion consistent with the requirements of Section 409A of the Code. If two economically equivalent amounts are subject to reduction but are payable at different times, the amounts will be reduced (but not below zero) on a pro rata
        basis. Notwithstanding the foregoing, the Board (or a committee of the Board composed entirely of independent directors) may, in its sole discretion and on a case-by-case basis, approve a gross-up payment (a &#8220;Limited Gross-Up&#8221;) to Executive in an
        amount sufficient to place Executive in the same after-tax position as if no Excise Tax had been imposed, but only to the extent the Excise Tax results from a reduced base amount due to (i) a limited period of service with the Company prior to the
        Change in Control, or (ii) other structural features not attributable to Executive&#8217;s actions or compensation demands. Any such Limited Gross-Up shall be subject to compliance with Section 409A of the Code, and may be conditioned upon Executive
        providing reasonable cooperation with tax planning or mitigation strategies.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 409A</u></font>.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">To the extent
        required by Section 409A of the Code, all references to &#8220;termination of employment&#8221; and correlative phrases for purposes of this Agreement shall be construed to require a &#8220;separation from service&#8221; (as defined in Section 1.409A-1(h) of the Treasury
        regulations after giving effect to the presumptions contained therein).</font></div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">11</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">Notwithstanding any
        provision in this Agreement to the contrary, to the extent that (i) any payments or benefits to which Executive becomes entitled under this Agreement or any other agreement, policy, plan, program or arrangement with the Company, in connection with
        Executive&#8217;s termination of employment with the Company constitute &#8220;nonqualified deferred compensation&#8221; subject to Section 409A of the Code and (ii) Executive is deemed at the time of such termination of employment to be a &#8220;specified employee&#8221; under
        Section 409A of the Code, then such payments or benefits shall not be made or commence until the earliest of (1) the expiration of the six (6) month and one day period measured from the date of Executive&#8217;s separation from service (as defined in <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 9(c)(i)</u></font> above) from the Company or (2) the date of Executive&#8217;s death following such separation from service; provided, however, that such deferral shall only be
        effected to the extent required to avoid adverse tax treatment to Executive, including (without limitation) the additional twenty-percent (20%) tax for which Executive would otherwise be liable under Section 409A(a)(1)(b) of the Code in absence of
        such deferral. Upon the expiration of the applicable deferral period, any payments which would have otherwise been made during that period (whether in a single sum or in installments) in the absence of this <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 9(b)</u></font> shall be paid to Executive or Executive&#8217;s beneficiary in one lump sum. For purposes of this <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 9(b)</u></font>,
        the term &#8220;specified employee&#8221; means an individual determined by the Company to be a specified employee under Treasury regulation Section 1.409A-1(i) in accordance with the policies of the Company.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(iii)</font>&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">It is intended that
        each installment of any benefits or payments provided hereunder constitute a separate payment for purposes of Treasury Regulation Section 1.409A-2(b)(2)(i). The Company and Executive intend that all the benefits and payments provided under this
        Agreement shall be exempt from, or comply with, the requirements of Section 409A of the Code and the provisions of the Agreement shall be read in accordance with that intent. It is further intended that payments hereunder satisfy, to the greatest
        extent possible, the exemptions from the application of Section 409A of the Code (and any state law of similar effect) provided under Treasury Regulations Section 1.409A-1(b)(4) (as a &#8220;short-term deferral&#8221;) and Section 1.409A-1(b)(9) (as
        &#8220;separation pay due to involuntary separation&#8221;). To the extent that any provision hereof is modified in order to comply with Section 409A, such modification will be made in good faith and will, to the maximum extent reasonably possible, maintain
        the original intent and economic benefit to Executive and the Company of the applicable provision without violating the provisions of Section 409A. The Company makes no representation or warranty and shall have no liability to Executive or any
        other person if any provisions of this Agreement are determined to constitute deferred compensation subject to Section 409A of the Code but do not satisfy an exemption from, or comply with the conditions of, such Section.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(iv)</font>&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">Except as otherwise
        expressly provided herein, to the extent any expense reimbursement or the provision of any in-kind benefit under this Agreement is determined to constitute &#8220;nonqualified deferred compensation&#8221; subject to Section 409A of the Code, the amount of any
        such expenses eligible for reimbursement, or the provision of any in-kind benefit, in one calendar year shall not affect the expenses eligible for reimbursement in any other taxable year (except for any lifetime or other aggregate limitation
        applicable to medical expenses), in no event shall any expenses be reimbursed after the last day of the calendar year following the calendar year in which Executive incurred such expenses, and in no event shall any right to reimbursement or the
        provision of any in-kind benefit be subject to liquidation or exchange for another benefit.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(v)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">Whenever a payment
        under this Agreement specifies a payment period with reference to a number of days, the actual date of payment within the specified period is within the sole discretion of the Company.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(vi)</font>&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">Notwithstanding any
        provision in this Agreement to the contrary, to the extent that any payments or benefits to which Executive becomes entitled under this Agreement or any other agreement, policy, plan, program or arrangement with the Company, in connection with
        Executive&#8217;s termination of employment with the Company constitute &#8220;nonqualified deferred compensation&#8221; subject to Section 409A of the Code, then each such payment which is conditioned upon Executive&#8217;s execution of a release and which is to be paid
        or provided during a designated period that begins in one taxable year and ends in a second taxable year shall be paid or provided in the later of the two taxable years.</font></div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">12</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">10.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Certain Definitions</u></font>. As used in this Agreement, the following terms shall have the following meanings:</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(a)</font>&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Cause</u></font>. &#8220;Cause&#8221; means any of the following: (i) Executive&#8217;s commission of an act of fraud, embezzlement or dishonesty, or the commission of some other illegal act by Executive, that could reasonably
        be expected to have an adverse impact on the Company or any successor or affiliate; (ii) Executive&#8217;s conviction of, or plea of &#8220;guilty&#8221; or &#8220;no contest&#8221; to, a felony or any crime involving fraud, dishonesty or moral turpitude under the laws of the
        United States or any state thereof (or international equivalent); (iii) any intentional, unauthorized use or disclosure by Executive of Confidential Information or trade secrets of the Company or any successor or affiliate; (iv) Executive&#8217;s gross
        negligence or material violation of any duty of loyalty to the Company or any successor or affiliate thereof, or any other demonstrable material misconduct on Executive&#8217;s part in connection with the performance of Executive&#8217;s duties for the
        Company; (v) Executive&#8217;s ongoing and repeated failure or refusal to perform or neglect of Executive&#8217;s duties as required by this Agreement or Executive&#8217;s ongoing and repeated failure or refusal to comply with the instructions given to Executive by
        the Board, which failure, refusal or neglect continues for fifteen (15) days following Executive&#8217;s receipt of written notice from the Board stating with specificity the nature of such failure, refusal or neglect; or (vi) Executive&#8217;s material breach
        of any material Company policy or any material provision of this Agreement, which breach is not cured (if capable of being cured) within fifteen (15) days following Executive&#8217;s receipt of written notice from the Board stating with specificity the
        nature of such material breach; provided, that the foregoing cure right shall not apply to any breach by Executive of <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 5</u></font> or <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 6</u></font> hereof.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(b)</font>&#160;&#160; &#160; &#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Change in Control</u></font>. &#8220;Change in Control&#8221; shall have the meaning set forth in the 2025 XCF Global, Inc. Equity Incentive Plan. For purposes of clarity, consummation of (i) the transactions contemplated
        in the BCA or (ii) the New Rise Acquisitions (as defined in the BCA) shall not constitute a Change in Control.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Code</u></font>. &#8220;Code&#8221; shall mean the Internal Revenue Code of 1986, as amended, and the regulations and guidance promulgated thereunder.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Confidential Information</u></font>. &#8220;Confidential Information&#8221; means the Company&#8217;s trade secrets as defined under applicable law, as well as any other information or material which is not generally known to
        the public, and which: (i) is generated, collected by or utilized in the operations of the Company&#8217;s business and relates to the actual or anticipated business of the Company; or (ii) results from any task assigned to Executive by the Company, or
        work performed by Executive for or on behalf of the Company. Confidential Information shall not be considered generally known to the public if Executive or others improperly reveal such information to the public without the Company&#8217;s express
        written consent and/or in violation of an obligation of confidentiality owed to the Company. Confidential Information includes, without limitation, the information, observations and data obtained by Executive while employed by the Company
        concerning the business or affairs of the Company, including without limitation: information concerning investment or acquisition opportunities in or reasonably related to the Company; the identities of and other information (such as databases)
        relating to the current, former or prospective employees, customers, or investors of the Company; development, transition and transformation plans; methodologies and methods of doing business; strategic, marketing and expansion plans; financial and
        business plans, financial data; pricing information; employee, customer, or vendor lists and telephone numbers; investment terms; and requirements and costs of providing service. Confidential Information also includes information that the Company
        receives from third parties subject to a duty to maintain the confidentiality of such information and to use it only for certain limited purposes.</font></div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">13</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(e)</font>&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Date of Termination</u></font>. &#8220;Date of Termination&#8221; shall mean (i) if Executive&#8217;s employment is terminated by Executive&#8217;s death, the date of Executive&#8217;s death or (ii) if Executive&#8217;s employment is terminated
        pursuant to <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 3(a)(ii)</u></font> &#8211; <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>(iv)</u></font> either the date indicated in the Notice of Termination
        or the date specified by the Company pursuant to <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 3(b)</u></font>, whichever is earlier.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(f)</font>&#160;&#160;&#160; &#160; &#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Disability</u></font>. &#8220;Disability&#8221; shall mean, at any time the Company or any of its affiliates sponsors a long-term disability plan for the Company&#8217;s employees, &#8220;disability&#8221; as defined in such long-term
        disability plan for the purpose of determining a participant&#8217;s eligibility for benefits;&#160; provided, however, if the long-term disability plan contains multiple definitions of disability, &#8220;Disability&#8221; shall refer to that definition of disability
        which, if Executive qualified for such disability benefits, would provide coverage for the longest period of time. The determination of whether Executive has a Disability shall be made by the person or persons required to make disability
        determinations under the long-term disability plan. At any time the Company does not sponsor a long-term disability plan for its employees, &#8220;Disability&#8221; shall mean Executive&#8217;s inability to perform, with or without reasonable accommodation, the
        essential functions of Executive&#8217;s positions hereunder for a total of three months during any six-month period as a result of incapacity due to mental or physical illness as determined by the Board in its sole good faith discretion.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(g)</font>&#160; &#160; &#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Good Reason</u></font>. &#8220;Good Reason&#8221; means any of the following without Executive&#8217;s written consent: (i) a material diminution in Executive&#8217;s authority, duties or responsibilities; (ii) a material diminution
        in Executive&#8217;s base salary or target Annual Bonus (and Executive and the Company agree that any diminution of 10% or more shall be considered material for this purpose, regardless of whether such diminution occurs due to a single reduction or a
        series of reductions), other than in connection with an across-the-board reduction which applies in a comparable manner to other senior officers of the Company; (iii) any change in the Company&#8217;s remote work policy that would require Executive to be
        physically present in one of the Company&#8217;s offices more than 20 days each month and (iv) the Company&#8217;s breach of a material provision of this Agreement. Notwithstanding the foregoing, no Good Reason will have occurred unless and until Executive has
        (A) provided the Company, within thirty (30) days of Executive&#8217;s knowledge of the occurrence of the facts and circumstances underlying the Good Reason event, written notice stating with specificity the applicable facts and circumstances underlying
        such finding of Good Reason, (B) provided the Company with an opportunity to cure the same within thirty (30) days after the receipt of such notice and (C) the Company shall have failed to so cure within such period. Executive&#8217;s termination of
        employment by reason of resignation from employment with the Company for Good Reason must occur within 30 days following the expiration of the foregoing 30-day cure period.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">11.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Miscellaneous Provisions</u></font>.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(a)</font>&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Contractor Period Payment</u></font>. The parties understand that the existing employment agreement between the Executive and XCF Global Capital, Inc. provides that the Executive is to be paid, at the Closing
        of the Business Combination the amount specified in such employment agreement for services the Executive provided to XCF Global Capital, Inc. as an independent contractor for the period January 1, 2024 until the date of execution of such employment
        agreement (the &#8220;Contractor Period Payment&#8221;).&#160; The parties further acknowledge and agree that upon Closing of the Business Combination, the Company shall (i) assume the obligation to make the Contractor Period Payment and shall make such payment in
        cash no later than September 30, 2025, unless the Company and Executive mutually agree in writing, on or before such date, to extend the payment deadline to no later than December 31, 2025 due to the Company&#8217;s reasonable cash constraints. Any such
        extension shall not modify the Company&#8217;s obligation to make full payment nor be deemed a waiver of Executive&#8217;s rights. In addition, within 30 days after the Closing of the Business Combination, the Company shall issue to Executive a grant of
        restricted shares of the Company&#8217;s Class A Common Stock under the Company&#8217;s 2025 Equity Incentive Plan in aggregate value equal to the obligation assumed by the Company for the Contractor Period Payment. This grant shall be separate from, and not
        in lieu of, the Contractor Period Payment and be calculated based on the 20 day volume-weighted average price for the Company&#8217;s Class A Common Stock following the Closing of the Business Combination. The restricted shares shall vest ratably on a
        monthly basis over a period of three (3) years and shall be subject to the terms and conditions of the Company&#8217;s 2025 Equity Incentive Plan and the applicable award agreement.</font></div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">14</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(b)</font>&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Governing Law</u></font>. This Agreement shall be governed, construed, interpreted and enforced in accordance with its express terms, and otherwise in accordance with the substantive laws of the State of
        Delaware without reference to the principles of conflicts of law of the State of Delaware or any other jurisdiction that would result in the application of the laws of a jurisdiction other than the State of Delaware, and where applicable, the laws
        of the United States.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Arbitration</u></font>. Any dispute, controversy, or claim arising out of or relating to this Agreement or any breach of this Agreement or Executive&#8217;s employment, whether the claim arises in contract, tort, or
        statute, shall be submitted to and decided by binding arbitration, except as set forth in <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 6(c)</u></font>. Arbitration shall be administered exclusively by the American
        Arbitration Association at a location in Wilmington, Delaware and shall be conducted consistent with the employment arbitration rules, regulations, and requirements thereof as well as any requirements imposed by state law. Any arbitral award
        determination shall be final and binding upon the Parties, and judgment may be entered thereon in any court of competent jurisdiction. Notwithstanding anything to the contrary, this Agreement does not prevent Executive from filing a complaint or
        charge with the National Relations Labor Board, the Equal Employment Opportunity Commission, or any similar federal or state administrative agency, including claims for workers&#8217; compensation or unemployment insurance benefits. By entering into this
        Agreement, the Parties are waiving all rights to have their disputes heard or decided by a jury or in a court trial and the right to pursue any class or representative claims against each other in court, arbitration, or any other proceeding. The
        arbitrator shall have no jurisdiction or authority to compel any class or collective claim, or to consolidate different arbitration proceedings with or join any other party to an arbitration between the Parties. The arbitrator, and not any court,
        shall have exclusive authority to resolve any dispute relating to the enforceability or formation of this Agreement and the arbitrability of dispute between the parties, except for any dispute relating to the enforceability or scope of the class
        and collective action waiver, which shall be determined by a court of competent jurisdiction. THE PARTIES FULLY UNDERSTAND AND AGREE THAT THEY ARE GIVING UP CERTAIN RIGHTS OTHERWISE AFFORDED TO THEM BY CIVIL COURT ACTIONS, INCLUDING BUT NOT LIMITED
        TO THE RIGHT TO A JURY OR COURT TRIAL AND THE RIGHT TO BRING ANY CLAIM AS A CLASS OR COLLECTIVE ACTION. Costs of arbitration shall be split evenly between the parties, provided, that the arbitrator shall have the ability to award attorneys&#8217; fees
        and previously paid arbitration expenses to the prevailing party.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Venue; Waiver of Jury Trial</u></font>.&#160; Except for claims subject to the arbitration provisions herein, the Parties agree that all litigation arising out of or relating to this agreement must be brought
        exclusively in any state or federal court located in Wilmington, Delaware (collectively the &#8220;Designated Courts&#8221;). Each Party consents and submits to the exclusive jurisdiction of the Designated Courts with respect to litigation under this
        Agreement, each Party hereby irrevocably waives all claims or defenses of lack of personal jurisdiction or any other jurisdiction defense, and any objection which such Party may now or hereafter have to the laying of venue of any suit, action or
        proceeding in any Designated Court, including any right to object on the basis that any dispute, action, suit, or proceeding brought in the Designated Courts has been brought in an improper or inconvenient forum or venue.&#160; IN THE EVENT OF
        LITIGATION HEREUNDER, THE COMPANY AND EXECUTIVE EACH WAIVE THEIR RESPECTIVE RIGHT TO A TRIAL BY JURY OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF OR RELATED TO ANY ACTION, PROCEEDING, OR OTHER LITIGATION OF ANY TYPE BROUGHT BY ANY
        OF THE PARTIES AGAINST ANY OTHER PARTY OR ANY AFFILIATE OF ANY OTHER SUCH PARTY. THE COMPANY AND EXECUTIVE EACH AGREE THAT ANY SUCH CLAIM OR CAUSE OF ACTION WILL BE TRIED BY A COURT TRIAL WITHOUT A JURY. WITHOUT LIMITING THE FOREGOING, THE PARTIES
        FURTHER AGREE THAT THEIR RESPECTIVE RIGHT TO A TRIAL BY JURY IS WAIVED BY OPERATION OF THIS SECTION AS TO ANY ACTION, COUNTERCLAIM, OR OTHER PROCEEDING WHICH SEEKS, IN WHOLE OR IN PART, TO CHALLENGE THE VALIDITY OR ENFORCEABILITY OF THIS AGREEMENT.
        THIS WAIVER WILL APPLY TO ANY SUBSEQUENT AMENDMENTS, RENEWALS, SUPPLEMENTS, OR MODIFICATIONS TO THIS AGREEMENT.</font></div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">15</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Validity; Severability</u></font>. Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this
        Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability will not affect any other provision or any action in any other
        jurisdiction, but this Agreement will be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had never been contained herein.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Notices</u></font>. Any notice, request, claim, demand, document and other communication hereunder to any Party shall be effective upon receipt (or refusal of receipt) and shall be in writing and delivered
        personally or sent by facsimile or certified or registered mail, postage prepaid, (i) if to the Company, to the Chief Executive Officer of the Company at the Company&#8217;s headquarters, (ii) if to Executive, to the last address that the Company has in
        its personnel records for Executive, or (iii) at any other address as any Party shall have specified by notice in writing to the other Party.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(g)</font>&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Counterparts</u></font>. This Agreement may be executed in several counterparts, each of which shall be deemed to be an original, but all of which together will constitute one and the same Agreement. Signatures
        delivered by facsimile or .pdf format shall be deemed effective for all purposes.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(h)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Entire Agreement</u></font>. The terms of this Agreement are intended by the Parties to be the final expression of their agreement with respect to the subject matter hereof and supersede all prior
        understandings and agreements, whether written or oral, including any prior employment offer letter, employment agreement or consulting agreement between Executive and the Company. The Parties further intend that this Agreement shall constitute the
        complete and exclusive statement of their terms and that no extrinsic evidence whatsoever may be introduced in any judicial, administrative, or other legal proceeding to vary the terms of this Agreement.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(i)</font>&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Amendments; Waivers</u></font>. This Agreement may not be modified, amended, or terminated except by an instrument in writing, signed by Executive and a duly authorized officer of Company. By an instrument in
        writing similarly executed, Executive or a duly authorized officer of the Company may waive compliance by the other Party with any specifically identified provision of this Agreement that such other Party was or is obligated to comply with or
        perform; provided, however, that such waiver shall not operate as a waiver of, or estoppel with respect to, any other or subsequent failure. No failure to exercise and no delay in exercising any right, remedy, or power hereunder will preclude any
        other or further exercise of any other right, remedy, or power provided herein or by law or in equity.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(j)</font>&#160;&#160;&#160;&#160; &#160; &#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"> <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Successors and Assigns</u></font>. The Company may assign its rights and obligations under this Agreement to any of its affiliates or to any successor to all or substantially all of the business or the assets
        of the Company (by merger or otherwise, including, without limitation, to the surviving entity in the Business Combination), and may assign or encumber this Agreement and its rights hereunder as security for indebtedness of the Company and its
        affiliates. This Agreement shall be binding upon and inure to the benefit of the Company, Executive and their respective successors, assigns, personnel and legal representatives, executors, administrators, heirs, distributees, devisees, and
        legatees, as applicable. None of Executive&#8217;s rights or obligations may be assigned or transferred by Executive, other than Executive&#8217;s rights to payments hereunder, which may be transferred only by will or operation of law. Notwithstanding the
        foregoing, Executive shall be entitled, to the extent permitted under applicable law and applicable Company Arrangements, to select and change a beneficiary or beneficiaries to receive compensation hereunder following Executive&#8217;s death by giving
        written notice thereof to the Company.</font></div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">16</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(k)</font>&#160; &#160; &#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Indemnification</u></font>. The Company and Executive shall enter into a Director and Officer Indemnification Agreement substantially in the form of <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Exhibit C</u></font> attached hereto.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(l)</font>&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>D&amp;O Insurance</u></font>. The Company will cover Executive under directors&#8217; and officers&#8217; liability insurance policy (or policies) during the Term and thereafter to the same extent as the Company covers its
        other current or former directors or officers of the Company.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(m)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Clawback</u></font>. Notwithstanding any other provisions in this Agreement to the contrary, any incentive-based or other compensation paid to the Executive under this Agreement or any other agreement or
        arrangement with the Company that is subject to recovery under any applicable law, government regulation, or stock exchange rule or listing requirement will be subject to such deductions and clawback as may be required or permitted to be made
        pursuant to such law, government regulation, or stock exchange rule or listing requirement or any policy adopted by the Company.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #010000;">(n)</font>&#160;&#160; &#160; &#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Construction</u></font>. This Agreement shall be deemed drafted equally by both the Parties. Its language shall be construed as a whole and according to its fair meaning. Any presumption or principle that the
        language is to be construed against any Party shall not apply. The headings in this Agreement are only for convenience and are not intended to affect construction or interpretation. Any references to paragraphs, subparagraphs, sections or
        subsections are to those parts of this Agreement, unless the context clearly indicates to the contrary. Also, unless the context clearly indicates to the contrary, (i) the plural includes the singular and the singular includes the plural, (ii)
        &#8220;and&#8221; and &#8220;or&#8221; are each used both conjunctively and disjunctively, (iii) &#8220;any,&#8221; &#8220;all,&#8221; &#8220;each,&#8221; or &#8220;every&#8221; means &#8220;any and all,&#8221; and &#8220;each and every,&#8221; (iv) &#8220;includes&#8221; and &#8220;including&#8221; are each &#8220;without limitation,&#8221; (v) &#8220;herein,&#8221; &#8220;hereof,&#8221; &#8220;hereunder&#8221;
        and other similar compounds of the word &#8220;here&#8221; refer to the entire Agreement and not to any particular paragraph, subparagraph, section or subsection and (vi) all pronouns and any variations thereof shall be deemed to refer to the masculine,
        feminine, neuter, singular or plural as the identity of the entities or persons referred to may require.</font></div>
    <div>&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[SIGNATURE PAGE FOLLOWS]</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">17</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">IN WITNESS WHEREOF</font>, the Parties hereto have executed this
      Agreement as of the date first written above. The signatories below represent that they are duly authorized to enter into this Agreement.</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="za8547cea2c3f4c53917aedd39594912f">

        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td colspan="2" style="vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">XCF GLOBAL, INC.</div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">By:</div>
          </td>
          <td style="width: 45%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><u>/s/ Mihir Dange</u></div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Name:</div>
          </td>
          <td style="width: 45%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Mihir Dange</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Title:</div>
          </td>
          <td style="width: 45%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Chief Executive Officer</div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td colspan="2" style="vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">EXECUTIVE</div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">By:</div>
          </td>
          <td style="width: 45%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><u>/s/ Jonathan Seeley</u></div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Name:</div>
          </td>
          <td style="width: 45%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Jonathan Seeley</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">18</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit A</div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">None.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit B</div>
    <div>&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Compensation Terms</div>
    <div>&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(attached)</div>
    <div>&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Executive is solely responsible for any tax liability incurred as a result of any benefit set forth in this table being treated as a taxable benefit
      under federal, state or local law.</div>
    <div>&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Jonathan Seeley</div>
    <div>&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit B &#8211; Compensation Terms</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zd7ba0ac71382486c882ff82b8fba0fa3">

        <tr>
          <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Base Salary</div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">$260,000, Two Hundred Sixty Thousand Dollars</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Annual Bonus</div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Target Bonus set at 50-100% of Base Salary</div>
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">If &lt;50% of key evaluation metrics achieved, Annual Bonus is 0% </div>
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(in each case, pro-rated for partial year) </div>
            <div>&#160;</div>
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Key evaluation metrics (subject to adjustment each year):</div>
            <div style="text-align: left; text-indent: -18pt; margin-left: 18pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8226;</font>&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">25% discretionary established by
                the Board</font></div>
            <div style="text-align: left; text-indent: -18pt; margin-left: 18pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8226;</font>&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">25% Individual performance
                metrics to be set by the Board</font></div>
            <div style="text-align: left; text-indent: -18pt; margin-left: 18pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8226;</font>&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">50% Transaction success fee
                (de-SPAC/IPO) (first year only)</font></div>
            <div>&#160;</div>
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Opportunity to elect cash or stock for bonus payment, subject to limits set by Board or Compensation Committee</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Management Equity</div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">39,000 RSUs of common stock issued at closing of de-SPAC IPO</div>
            <div>&#160;</div>
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Vesting Period: Five years with twelve-month cliff vesting, then ratably over remaining vesting period, accelerated on termination without cause following a change
              from start date, accelerated on termination without cause following a change-in-control</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">2025 Equity Incentive Plan Participation</div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Executive eligible to receive additional equity compensation pursuant to the Company&#8217;s 2025 Equity Incentive Plan</div>
            <div>&#160;</div>
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Target 200-400% of Base Salary with an initial grant of 52,000 shares; vesting period over three years (no vesting during the first six months (the &#8220;cliff
              period&#8221;)). After the six-month cliff period, the restricted stock units will vest in equal monthly installments over 30 months, subject to continued service with New XCF)</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Benefits:</div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        </tr>
        <tr>
          <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left; text-indent: -18pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8226;</font>&#160; &#160; &#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">Health/Group insurance</font></div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Minimum 80% of premiums paid by Company</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left; text-indent: -18pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8226;</font> &#160; &#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">Life insurance</font></div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Up to 2x Base Salary, not to exceed $1 million; Employee may elect to add additional coverage at their own expense</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left; text-indent: -18pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8226;</font>&#160; &#160; &#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">Phone subsidy</font></div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Based on actual and reasonable phone bill incurred each month, with invoice</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left; text-indent: -18pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8226;</font>&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">Fitness and wellness subsidy</font></div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">$3,500 per year, based on actual amount incurred with invoice</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left; text-indent: -18pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8226;</font>&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">Retirement benefits (401(k) or
                other retirement plan as established by the Company)</font></div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">3% automatic match; 100% match on first 3% EE contributions</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left; text-indent: -18pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8226;</font>&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">Relocation benefits (if at the
                Company&#8217;s request)</font></div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 74%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Based on actual expenses incurred and will cover:</div>
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -18pt; margin-left: 36pt;">1.&#160;&#160;&#160;&#160; One-way flight costs for employee, spousal equivalent and dependents</div>
            <div style="text-align: left; text-indent: -18pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">2.&#160;&#160;&#160;&#160; One-month temporary housing, based on actual amount, with invoice</div>
            <div style="text-align: left; text-indent: -18pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">3.&#160;&#160;&#160;&#160; Moving costs (sea freight) for personnel effects, based on actual amount, with invoice</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit C</div>
    <div>&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Form of Indemnification Agreement</div>
    <div>&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(attached)</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div>&#160;</div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.66
<SEQUENCE>21
<FILENAME>ef20050548_ex10-66.htm
<DESCRIPTION>EXHIBIT 10.66
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">



  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: right;"> <font style="font-weight: bold;">Exhibit 10.66</font><br>
    </div>
    <div> <br>
    </div>
    <div>
      <div style="text-align: center; margin-right: 70.5pt; margin-left: 70.5pt; font-weight: bold; font-size: 10pt;"><u>FORBEARANCE AGREEMENT</u></div>
      <font style="font-size: 10pt;"> </font>
      <div style="font-size: 10pt;">&#160;</div>
      <font style="font-size: 10pt;"> </font>
      <div style="text-align: justify; font-size: 12pt; text-indent: 45pt;"><font style="font-size: 10pt; font-weight: bold;">THIS FORBEARANCE AGREEMENT </font><font style="font-size: 10pt;">(this &#8220;Agreement&#8221;) is entered into as of this 12th day of June,
          2025 (the &#8220;Effective Date&#8221;), by and among <font style="font-weight: bold;">NEW RISE RENEWABLES RENO, LLC</font>, a Delaware limited liability company (&#8220;Tenant&#8221; or &#8220;New Rise&#8221;), <font style="font-weight: bold;">XCF Global, Inc.</font>, a Delaware
          corporation (&#8220;XCF&#8221;) and <font style="font-weight: bold;">TWAIN GL XXVIII, LLC</font>, a Missouri limited liability company (&#8220;Landlord&#8221;). For purposes of this Agreement, Tenant, XCF and Landlord are sometimes referred to herein collectively as
          the &#8220;Parties&#8221; and individually as a &#8220;Party;&#8221; provided, however, that XCF will be considered a &#8220;Party&#8221; only for purposes of Section 3 and matters related directly thereto. Capitalized terms not otherwise defined herein shall have the meanings
          given to such terms in the Lease Documents (as defined below).</font></div>
      <font style="font-size: 10pt;"> </font>
      <div><font style="font-size: 10pt;"><br>
        </font> </div>
      <font style="font-size: 10pt;"> </font>
      <div style="text-align: center; margin-right: 70.5pt; margin-left: 70.5pt; font-weight: bold; font-size: 10pt;">I.</div>
      <font style="font-size: 10pt;"> </font>
      <div><font style="font-size: 10pt;"><br>
        </font> </div>
      <font style="font-size: 10pt;"> </font>
      <div style="text-align: center; font-weight: bold; font-size: 10pt;"><u>RECITALS AND STIPULATIONS</u></div>
      <font style="font-size: 10pt;"> </font>
      <div><font style="font-size: 10pt;"><br>
        </font> </div>
      <font style="font-size: 10pt;"> </font>
      <div style="text-align: justify; font-size: 12pt; text-indent: 45pt;"><font style="font-size: 10pt; font-weight: bold;">A.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; Tenant and Landlord are parties to a certain GROUND LEASE, dated March 29, 2022 (as
          amended, modified, supplemented, restated or replaced from time to time, the &#8220;Lease&#8221;);</font></div>
      <font style="font-size: 10pt;"> </font>
      <div style="font-size: 10pt;">&#160;</div>
      <font style="font-size: 10pt;"> </font>
      <div style="text-align: justify; font-size: 12pt; text-indent: 45pt;"><font style="font-size: 10pt; font-weight: bold;">B.</font><font style="font-size: 10pt;">&#160;&#160; &#160; In connection with the Lease, the Tenant and Landlord executed between themselves
          and/or with third parties certain agreements which include a Completion and Rent Payment Guaranty (as amended, modified, supplemented, restated or replaced from time to time, the &#8220;Guaranty&#8221;), and a Pledge and Security Agreement (as amended,
          modified, supplemented, restated or replaced from time to time, the &#8220;Pledge&#8221;, and together with the Lease and the Guaranty, are collectively herein the &#8220;Lease Documents&#8221;); and</font></div>
      <font style="font-size: 10pt;"> </font>
      <div style="font-size: 10pt;">&#160;</div>
      <font style="font-size: 10pt;"> </font>
      <div style="text-align: justify; font-size: 12pt; text-indent: 45pt;"><font style="font-size: 10pt; font-weight: bold;">C.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; Tenant has requested that Landlord forbear from exercising any of its rights and
          remedies under the Lease Documents and applicable law in respect of certain claimed Events of Default under the Lease Documents, and Landlord has agreed to so forbear upon the terms and subject to the conditions set forth in this Agreement.</font></div>
      <font style="font-size: 10pt;"> </font>
      <div style="font-size: 10pt;">&#160;</div>
      <font style="font-size: 10pt;"> </font>
      <div style="text-align: justify; font-size: 12pt; text-indent: 45pt;"><font style="font-size: 10pt; font-weight: bold;">D.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; Landlord understands that XCF Global Capital, Inc., which acquired all of the
          membership interests of New Rise, is party to that certain Business Combination Agreement between Focus Impact BH3 Acquisition Company, Focus Impact BH3 Newco, Inc. (&#8220;<font style="font-weight: bold;">NewCo</font>&#8221;), Focus Impact BH3 Merger Sub I,
          LLC, Focus Impact BH3 Merger Sub II, Inc. and XCF Global Capital, Inc. (as amended, the &#8220;Business Combination Agreement&#8221;), and that at the closing of the transactions contemplated by the Business Combination Agreement, XCF Global Capital, Inc.
          was merged into NewCo, NewCo changed its name to XCF Global, Inc., XCF is continuing the business operations of XCF Global Capital, Inc. and the shares of Class A Common Stock of XCF are listed on Nasdaq.</font></div>
      <font style="font-size: 10pt;"> </font>
      <div style="font-size: 10pt;">&#160;</div>
      <font style="font-size: 10pt;"> </font>
      <div style="text-align: justify; font-size: 12pt; text-indent: 45pt;"><font style="font-size: 10pt; font-weight: bold;">NOW, THEREFORE</font><font style="font-size: 10pt;">, in consideration of the recitals and stipulations set forth above and the
          mutual promises and covenants contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Tenant, XCF and Landlord hereby agree as follows:</font></div>
      <font style="font-size: 10pt;"> </font>
      <div style="text-align: justify; font-size: 10pt;"> <br>
      </div>
      <font style="font-size: 10pt;"> </font></div>
    <font style="font-size: 10pt;"> </font>

    <font style="font-size: 10pt;"> </font>
    <div><font style="font-size: 10pt;"> </font>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt; font-size: 8pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="text-align: left; margin-left: 1pt; font-weight: bold;">CONFIDENTIAL FORBEARANCE AGREEMENT</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="text-align: right; margin-left: 9.5pt; font-weight: bold;">PAGE 1</div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; text-indent: -0.1pt; margin-right: 200.55pt; margin-left: 200.6pt; font-weight: bold; font-size: 10pt;">II. </div>
      <font style="font-size: 10pt;"> </font>
      <div style="font-weight: bold;"> <font style="font-size: 10pt;"><br>
        </font> </div>
      <font style="font-size: 10pt;"> </font>
      <div style="text-align: center; text-indent: -0.1pt; margin-right: 200.55pt; margin-left: 200.6pt; font-weight: bold; font-size: 10pt;"><u>AGREEMENT</u></div>
      <font style="font-size: 10pt;"> </font>
      <div style="text-align: center; font-weight: bold; font-size: 10pt;"><u> <br>
        </u></div>
      <font style="font-size: 10pt;"> </font>
      <div>
        <div style="text-align: justify; font-size: 10pt; text-indent: 45pt;">1.&#160;&#160;&#160; &#160; &#160; <font style="font-weight: bold;"><u>General Acknowledgment</u>. </font>The Parties acknowledge and agree to the following:</div>
        <font style="font-size: 10pt;"> </font></div>
      <font style="font-size: 10pt;"> </font>
      <div style="font-size: 10pt;">&#160;</div>
      <font style="font-size: 10pt;"> </font>
      <div style="text-align: justify; margin-left: 45pt; text-indent: 27pt; font-size: 10pt;"><a name="za_The_Parties_hereby_acknowledge_the_a"></a><font style="font-weight: bold;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160; The Parties hereby acknowledge the accuracy of the
        representations set forth in the Recitals and Stipulations of this Agreement;</div>
      <font style="font-size: 10pt;"> </font>
      <div style="text-align: justify; margin-left: 45pt; text-indent: 27pt; font-size: 10pt;">&#160;</div>
      <font style="font-size: 10pt;"> </font>
      <div style="text-align: justify; margin-left: 45pt; text-indent: 27pt; font-size: 10pt;"><a name="zb_Neither_this_Agreement_nor_any_other"></a><font style="font-weight: bold;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160; Neither this Agreement nor any other agreement executed
        in connection herewith pursuant to the terms hereof, nor any actions taken pursuant to this Agreement or such other agreement shall be deemed to be an admission of default or to be a cure of any Event of Default which may exist under the Lease
        Documents;</div>
      <font style="font-size: 10pt;"> </font>
      <div style="font-size: 10pt;">&#160;</div>
      <font style="font-size: 10pt;"> </font>
      <div style="text-align: justify; margin-left: 45pt; text-indent: 27pt; font-size: 10pt;"><a name="zc__Neither_this_Agreement_nor_any_othe"></a><font style="font-weight: bold;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160; Neither this Agreement nor any other agreement executed
        in connection herewith pursuant to the terms hereof, nor any actions taken pursuant to this Agreement or such other agreement shall be deemed to be a waiver by Landlord of any Event of Default under the Lease Documents or to be a waiver by Tenant
        to any defense or of any Party&#8217;s rights or remedies in connection therewith or with respect hereto, evidencing the Parties&#8217; intention that the Parties&#8217; mutual obligations, rights and remedies under the Lease Documents shall remain in full force and
        effect other than as expressly set forth herein.</div>
      <font style="font-size: 10pt;"> </font>
      <div style="font-size: 10pt;">&#160;</div>
      <font style="font-size: 10pt;"> </font>
      <div style="text-align: justify; font-size: 12pt; text-indent: 45pt;"><font style="font-size: 10pt;"><a name="z2._Consent_Forbearance.___Landlord_agre"></a><font style="font-weight: bold;">2.</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Consent; Forbearance</u>. </font>Landlord agrees that, until the expiration or earlier termination of the Forbearance Period (as defined below), the Landlord will forbear from exercising its rights and remedies
          under the Lease Documents and/or applicable law with respect to any alleged defaults or alleged Events of Defaults arising before or after the Effective Date, provided that the Tenant complies with all terms and conditions contained in this
          Agreement. Landlord&#8217;s obligation to so forbear will commence on the Effective Date and will terminate on September 3, 2025 (such period of forbearance being the &#8220;Forbearance Period&#8221;). Notwithstanding anything in this Agreement to the contrary,
          the parties hereto hereby acknowledge and agree that (i) the Forbearance Period shall not apply to any actions taken by Landlord pursuant to that certain Collateral Assignment dated as of March 30, 2022, and (ii) the Forbearance Period shall
          immediately terminate and be of no further force and effect in the event that Greater Nevada Credit Union institutes foreclosure proceedings against any property covered by the Lease or owned by Tenant.</font></div>
      <font style="font-size: 10pt;"> </font>
      <div><font style="font-size: 10pt;"><br>
        </font> </div>
      <font style="font-size: 10pt;"> </font>
      <div style="text-align: justify; font-size: 10pt; text-indent: 45pt;"><a name="z3._Conditions_to_Forbearance.__As_a_mate"></a><font style="font-weight: bold;">3.</font>&#160;&#160; &#160;&#160;&#160; <font style="font-weight: bold;"><u>Conditions to Forbearance</u></font><font style="font-weight: bold; font-style: italic;">. </font>As a material inducement for the Landlord to enter this Agreement and to forbear from enforcing its rights under the Lease Documents during the Forbearance Period on the terms set forth in
        this Agreement, and as an express condition of such forbearance, the Parties agree as follows:</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt; font-size: 8pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="text-align: left; margin-left: 1pt; font-weight: bold;">CONFIDENTIAL FORBEARANCE AGREEMENT</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="text-align: right; margin-left: 9.5pt; font-weight: bold;">PAGE 2</div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-left: 45pt; text-indent: 27pt;"><font style="font-weight: bold; font-size: 10pt;">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; No later than one business day following the Effective Date, XCF shall issue to
          the Landlord 4,000,000 shares of its Class A Common Stock (the &#8220;Landlord Shares&#8221;), and will use its reasonable best efforts to file a registration statement on appropriate form with the Securities and Exchange Commission (the &#8220;SEC&#8221;) to register
          for resale such Landlord Shares (or, if permitted under SEC rules and any other agreement XCF has to register its securities for resale by other XCF equityholders, include such Landlord Shares in such registration statement) and cause the SEC to
          declare such registration statement effective within a reasonable period of time following such filing; it being understood and agreed by the Landlord that such Landlord Shares will be &#8220;restricted securities&#8221; under the Securities Act of 1933, as
          amended (the &#8220;Securities Act&#8221;) and until the above-referenced registration statement has been declared effective, such Landlord Shares will not be able to be resold or transferred unless an exemption from the registration requirement of the
          Securities Act is available to Landlord for any such resale or transfer;</font></div>
      <font style="font-size: 10pt;"> </font>
      <div><font style="font-size: 10pt;"><br>
        </font> </div>
      <font style="font-size: 10pt;"> </font>
      <div style="text-align: justify; margin-left: 45pt; text-indent: 27pt; font-size: 10pt;"><a name="zb_Following_receipt_of_the_Landlord_Sh"></a><font style="font-weight: bold;">(b)</font>&#160;&#160;&#160;&#160; Following receipt of the Landlord Shares, to the extent
        Landlord sells Landlord Shares in public or private transactions, Landlord covenants and agrees (i) to inform New Rise of such sales, including the date of each sale and the net proceeds of each sale; and (ii) that the net proceeds of the sales of
        any Landlord Shares are to be credited on a dollar-for-dollar basis against any remaining principal, interest, and penalties owed by Tenant to Landlord pursuant to the Lease Documents;</div>
      <font style="font-size: 10pt;"> </font>
      <div><font style="font-size: 10pt;"><br>
        </font> </div>
      <font style="font-size: 10pt;"> </font>
      <div style="text-align: justify; margin-left: 45pt; text-indent: 27pt; font-size: 10pt;"><a name="zc_In_the_event_that_the_aggregate_net_"></a><font style="font-weight: bold;">(c)</font>&#160;&#160;&#160; &#160; In the event that the aggregate net proceeds received by
        the Landlord from the sale of the Landlord Shares exceeds the aggregate amount of principal, interest, penalties and repurchase premium owed by Tenant to Landlord pursuant to the Lease Documents, the Landlord shall immediately transfer to XCF any
        Landlord Shares remaining in its possession at that time, and upon such transfer Landlord will have no further rights in and to such Landlord Shares.</div>
      <font style="font-size: 10pt;"> </font>
      <div><font style="font-size: 10pt;"><br>
        </font> </div>
      <font style="font-size: 10pt;"> </font>
      <div style="text-align: justify; margin-left: 45pt; text-indent: 27pt; font-size: 10pt;"><a name="zd_In_connection_with_such_transfer_th"></a><font style="font-weight: bold;">(d)</font>&#160;&#160;&#160; &#160; In connection with such transfer, the Landlord grants XCF a
        limited power of attorney solely for the purpose of effectuating the foregoing transfer of Landlord Shares to Landlord, and agrees to take any and all action reasonably requested by XCF or XCF&#8217;s transfer agent necessary to effectuate such transfer;
        and</div>
      <font style="font-size: 10pt;"> </font>
      <div><font style="font-size: 10pt;"><br>
        </font> </div>
      <font style="font-size: 10pt;"> </font>
      <div style="text-align: justify; margin-left: 45pt; text-indent: 27pt; font-size: 10pt;"><a name="ze_The_Parties_hereby_waive_any_notice_"></a><font style="font-weight: bold;">(e)</font>&#160;&#160;&#160;&#160; The Parties hereby waive any notice and/or cure periods set
        forth in the Lease Documents solely with respect to the Forbearance Period.</div>
      <font style="font-size: 10pt;">  </font>
      <div style="font-size: 10pt;">&#160;</div>
      <font style="font-size: 10pt;"> </font>
      <div>
        <div style="text-align: justify; font-size: 10pt; text-indent: 45pt;"><a name="z4._Representations_and_Warranties."></a><font style="font-weight: bold;">4.&#160;&#160;&#160;&#160;&#160;&#160; <u>Representations and Warranties</u>.</font></div>
      </div>
      <font style="font-size: 10pt;"> </font>
      <div style="font-size: 10pt;">&#160;</div>
      <font style="font-size: 10pt;"> </font>
      <div style="text-align: justify; margin-left: 45pt; text-indent: 27pt; font-size: 10pt;"><a name="za_Organization.__Tenant_is_a_limited_l"></a><font style="font-weight: bold;">(a)</font>&#160;&#160;&#160;&#160;&#160; Organization. Tenant is a limited liability company
        organized, existing and in good standing under the laws of the State of Delaware. Landlord is a limited liability company organized, validly existing, and in good standing under the laws of the State of Missouri.</div>
      <font style="font-size: 10pt;"> </font>
      <div style="text-align: justify; font-size: 10pt;">&#160;</div>
      <font style="font-size: 10pt;"> </font>
      <div style="text-align: justify; margin-left: 45pt; text-indent: 27pt; font-size: 10pt;"><a name="zb_Authority.__Tenant_and_Landlord_have"></a><font style="font-weight: bold;">(b)</font>&#160;&#160;&#160;&#160;&#160; Authority. Tenant and Landlord have full company power and
        authority to execute, deliver, and perform this Agreement and have taken all company action required by law and their governing documents to authorize the execution and delivery of this Agreement. This Agreement is a valid and binding agreement of
        the Parties enforceable against each Party in accordance with its terms.</div>
      <font style="font-size: 10pt;"> </font>
      <div><font style="font-size: 10pt;"><br>
        </font> </div>
      <font style="font-size: 10pt;"> </font>
      <div style="text-align: justify; font-size: 10pt; text-indent: 45pt;"><a name="z5._Remedies_in_Event_of_Default.__Immedi"></a><font style="font-weight: bold;">5.</font>&#160;&#160; &#160;&#160; <font style="font-weight: bold;"><u>Remedies in Event of Default</u>. </font>Immediately
        upon the occurrence of an Agreement Default which remains uncured past any applicable cure period, and notwithstanding anything to the contrary set forth herein, the Forbearance Period shall immediately terminate and be of no further force and
        effect and Landlord shall have all the rights and remedies set forth in the Lease Documents, subject to Landlord&#8217;s obligations and restrictions under the Lease Documents.</div>
      <font style="font-size: 10pt;"> </font>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt; font-size: 8pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="text-align: left; margin-left: 1pt; font-weight: bold;">CONFIDENTIAL FORBEARANCE AGREEMENT</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="text-align: right; margin-left: 9.5pt; font-weight: bold;">PAGE 3</div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; font-size: 12pt; text-indent: 45pt;"><font style="font-size: 10pt; font-weight: bold;">6.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Incorporation of Other Documents</u>. </font>The
          Lease Documents and all other agreements, documents and writings between or among Tenant and Landlord are expressly reaffirmed and incorporated herein by this reference and shall remain in full force and effect and continue to govern and control
          the relationship between the Parties hereto except to the extent they are inconsistent with, amended or superseded by this Agreement. To the extent of any inconsistency, amendment or superseding provision, this Agreement shall govern and control.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 45pt;"><a name="z7._Notice.___All_notices_requests_and_"></a><font style="font-weight: bold;">7.</font>&#160;&#160; &#160;&#160; <font style="font-weight: bold;"><u>Notice</u>. </font>All notices, requests, and demands to
        or upon the respective Parties hereto shall be given in accordance with the Lease Documents.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 45pt;"><a name="z8._Successors_and_Assigns.__This_Agreeme"></a><font style="font-weight: bold;">8.</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Successors and Assigns</u>. </font>This Agreement
        shall be binding in all respects on, and shall inure to the benefit of, the Parties and their respective administrators, representatives, successors, and assigns.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 45pt;"><a name="z9._Integration_Clause._This_Agreement_a"></a><font style="font-weight: bold;">9.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Integration Clause</u>. </font>This Agreement, and any
        agreements, documents and instruments executed and delivered pursuant hereto or in connection herewith, or incorporated herein by reference, contains the entire agreement of the Parties hereto and no Party shall be bound by anything not expressed
        in writing.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 45pt;"><a name="z10._Amendment_of_Agreement.__This_Agreem"></a><font style="font-weight: bold;">10.</font>&#160;&#160; &#160; <font style="font-weight: bold;"><u>Amendment of Agreement</u>. </font>This Agreement may
        be amended only by written agreement signed by each of the Parties, and a breach of this Agreement may be waived only by written waiver signed by the Party granting the waiver. The waiver of any breach of this Agreement shall not operate or be
        construed as a waiver of any similar or prior or subsequent breach of this Agreement.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 45pt;"><a name="z11._Adequate_Consideration.__The_Parties"></a><font style="font-weight: bold;">11.</font>&#160;&#160; <font style="font-weight: bold;"><u>Adequate Consideration</u>. </font>The Parties expressly
        acknowledge and agree that the consideration given in connection with this Agreement constitutes adequate consideration for all agreements and obligations under this Agreement.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 45pt;"><a name="z12._Governing_Law_and_Venue._The_Agreeme"></a><font style="font-weight: bold;">12.</font>&#160;&#160;&#160; <font style="font-weight: bold;"><u>Governing Law and Venue</u>. </font>The Agreement and
        any rights, remedies, or obligations provided for in this Agreement shall be construed and enforced in accordance with the laws of the State of Nevada without giving effect to principles of conflicts of laws. Should any disputes arise under this
        Agreement, the Parties agree that the exclusive venue for such disputes shall be in Nevada state or federal court.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 45pt;"><a name="z13._Attorney_Fees.__The_Parties_shall_be"></a><font style="font-weight: bold;">13.</font>&#160; &#160; <font style="font-weight: bold;"><u>Attorney Fees</u>. </font>The Parties shall bear their
        own attorney fees, expenses, and costs in connection with this Agreement. Notwithstanding the foregoing, if any Party sues to enforce any provision of this Agreement, the prevailing Party shall be entitled to all damages, fees, expenses, and costs
        (including reasonable and necessary attorney fees) incurred in the enforcement of its rights hereunder.</div>
      <div><br>
      </div>
      <div style="text-align: justify; font-size: 12pt; text-indent: 45pt;"><a name="z14._Review_by_Counsel.__It_is_expressly_"></a><font style="font-weight: bold; font-size: 10pt;">14.</font><font style="font-size: 10pt;">&#160;&#160;&#160; <font style="font-weight: bold;"><u>Review by Counsel</u>. </font>It is expressly understood and agreed by each of the Parties that they have each carefully reviewed this Agreement, that they had the opportunity to seek legal advice with respect to this Agreement, and
          that they have relied wholly upon their own judgment and knowledge or advice of their own counsel in executing this Agreement.</font></div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt; font-size: 8pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="text-align: left; margin-left: 1pt; font-weight: bold;">CONFIDENTIAL FORBEARANCE AGREEMENT</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="text-align: right; margin-left: 9.5pt; font-weight: bold;">PAGE 4</div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; font-size: 12pt; text-indent: 45pt;"><font style="font-size: 10pt; font-weight: bold;">15.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Partial Invalidity</u>. </font>In the event
          any portion of this Agreement is deemed unenforceable, void, voidable, or of no force and effect, no other portion will be thereby affected, and the remainder of this Agreement will continue in full force and effect.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 45pt;"><a name="z16._No_Construction_Against_the_Parties."></a><font style="font-weight: bold;">16.</font>&#160;&#160;&#160; <font style="font-weight: bold;"><u>No Construction Against the Parties</u>. </font>Each of
        the Parties hereto acknowledges that such Party has read the Agreement, and the Agreement accurately expresses the entire agreement regarding the matters set forth herein. This Agreement shall not be strictly construed against any Party hereto.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 45pt;"><a name="z17._No_Waiver.__The_failure_of_a_Party_t"></a><font style="font-weight: bold;">17.</font>&#160;&#160;&#160; <font style="font-weight: bold;"><u>No Waiver</u>. </font>The failure of a Party to insist
        upon strict adherence to any term of this Agreement on any occasion shall not be considered a waiver thereof or deprive that Party of the right thereafter to insist upon strict adherence to that term or any other term of this Agreement.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 45pt;"><a name="z18._Further_Actions.__All_Parties_agree_"></a><font style="font-weight: bold;">18.</font>&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Further Actions</u>. </font>All Parties agree they will
        each execute such other and further instruments and documents or take such other steps as may become necessary to carry out the terms and provisions of this Agreement.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 45pt;"><a name="z19._Paragraph_Headings_and_Recitals._The"></a><font style="font-weight: bold;">19.</font>&#160;&#160; &#160; <font style="font-weight: bold;"><u>Paragraph Headings and Recitals</u>. </font>The
        paragraph headings utilized in this Agreement are for purposes of convenience and reference only, and shall not be used to construe, modify, alter or supplement the language following such headings; provided, however, that the Recitals shall be
        deemed to be a part of this Agreement and the Parties agree to the accuracy thereof.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 45pt;"><a name="z20._Two_or_More_Counterparts.__This_Agre"></a><font style="font-weight: bold;">20.</font>&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Two or More Counterparts</u>. </font>This Agreement may
        be executed simultaneously or in two or more counterparts and said counterparts together shall constitute one and the same instrument. Signatures received by facsimile, Portable Document Format (&#8220;PDF&#8221;), e-mail, Docusign, or photocopy shall have the
        same force and effect as original signatures.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 45pt;"><a name="z21._Jury_Trial_Waiver.___The_Parties_kno"></a><font style="font-weight: bold;">21.</font>&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Jury Trial Waiver</u>. </font>The Parties knowingly,
        voluntarily and intentionally waive the right they may have to a trial by jury in respect to any litigation based hereon, or arising out of, under or in connection with this Agreement, any document contemplated to be executed, or any underlying
        matter, course of dealing, statement (whether verbal or written) or action of the Parties.</div>
      <div style="text-align: justify; text-indent: 45pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 45pt;"><a name="z22._Tax_Consequences._This_Agreement_is_"></a><font style="font-weight: bold;">22.</font>&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Tax Consequences</u>. </font>This Agreement is
        enforceable regardless of its tax consequences. The Parties make no representations regarding the tax consequences of the Agreement.</div>
      <div><br>
      </div>
      <div style="text-align: center; margin-right: 70.5pt; margin-left: 70.5pt; font-style: italic; font-weight: bold;">Signatures on following page.</div>
      <div style="text-align: center; margin-right: 70.5pt; margin-left: 70.5pt; font-style: italic; font-weight: bold;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt; font-size: 8pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="text-align: left; margin-left: 1pt; font-weight: bold;">CONFIDENTIAL FORBEARANCE AGREEMENT</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="text-align: right; margin-left: 9.5pt; font-weight: bold;">PAGE 5</div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-right: 5.85pt; margin-left: 6pt;"><a name="IN_WITNESS_WHEREOF_the_Parties_have_rea"></a><font style="font-weight: bold;">IN WITNESS WHEREOF, </font>the Parties have read and understand the
        terms of this Agreement, agree to be bound by all its provisions, and have executed this Agreement on the date shown by their signatures below.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-right: 5.85pt; margin-left: 6pt;"> <br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z5975e83447c64f80abdc5442494379da">

          <tr>
            <td colspan="1" style="width: 40%; vertical-align: top;"><br>
            </td>
            <td colspan="1" style="width: 5%; vertical-align: top;"><br>
            </td>
            <td style="width: 40%; vertical-align: top;">
              <div style="font-weight: bold;"><u><a name="TENANT:"></a>TENANT:</u></div>
            </td>
            <td style="width: 15%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 40%; vertical-align: top;"><br>
            </td>
            <td colspan="1" style="width: 5%; vertical-align: top;"><br>
            </td>
            <td style="width: 40%; vertical-align: top;"><br>
            </td>
            <td style="width: 15%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 40%; vertical-align: top;"><br>
            </td>
            <td colspan="1" style="width: 5%; vertical-align: top;"><br>
            </td>
            <td style="width: 40%; vertical-align: top;">
              <div><a name="NEW_RISE_RENEWABLES_RENO_LLC"></a><a name="a_Delaware_limited_liability_company"></a>NEW RISE RENEWABLES RENO, LLC,</div>
            </td>
            <td style="width: 15%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 40%; vertical-align: top;"><br>
            </td>
            <td colspan="1" style="width: 5%; vertical-align: top;"><br>
            </td>
            <td style="width: 40%; vertical-align: top;">
              <div>a Delaware limited liability company</div>
            </td>
            <td style="width: 15%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 40%; vertical-align: top;"><br>
            </td>
            <td colspan="1" style="width: 5%; vertical-align: top;"><br>
            </td>
            <td style="width: 40%; vertical-align: top;"><br>
            </td>
            <td style="width: 15%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 40%; vertical-align: top; padding-bottom: 2px;"><br>
            </td>
            <td colspan="1" style="width: 5%; vertical-align: top; padding-bottom: 2px;">
              <div>By:</div>
            </td>
            <td style="width: 40%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
            <td style="width: 15%; vertical-align: top; padding-bottom: 2px;"><br>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 40%; vertical-align: top;"><br>
            </td>
            <td colspan="1" style="width: 5%; vertical-align: top;"><br>
            </td>
            <td style="width: 40%; vertical-align: top;"><br>
            </td>
            <td style="width: 15%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 40%; vertical-align: top;"><br>
            </td>
            <td colspan="1" style="width: 5%; vertical-align: top;"><br>
            </td>
            <td style="width: 40%; vertical-align: top;">
              <div style="font-weight: bold;"><u><a name="LANDLORD:"></a>LANDLORD:</u></div>
            </td>
            <td style="width: 15%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 40%; vertical-align: top;"><br>
            </td>
            <td colspan="1" style="width: 5%; vertical-align: top;"><br>
            </td>
            <td style="width: 40%; vertical-align: top;"><br>
            </td>
            <td style="width: 15%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 40%; vertical-align: top;"><br>
            </td>
            <td colspan="1" style="width: 5%; vertical-align: top;"><br>
            </td>
            <td style="width: 40%; vertical-align: top;">
              <div><a name="TWAIN_GL_XXVIII_LLC"></a>TWAIN GL XXVIII, LLC,</div>
            </td>
            <td style="width: 15%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 40%; vertical-align: top;"><br>
            </td>
            <td colspan="1" style="width: 5%; vertical-align: top;"><br>
            </td>
            <td style="width: 40%; vertical-align: top;">
              <div><a name="a_Missouri_limited_liability_company"></a>a Missouri limited liability company</div>
            </td>
            <td style="width: 15%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 40%; vertical-align: top;"><br>
            </td>
            <td colspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
            <td style="width: 40%; vertical-align: top;">&#160;</td>
            <td style="width: 15%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 40%; vertical-align: top; padding-bottom: 2px;"><br>
            </td>
            <td colspan="1" style="width: 5%; vertical-align: top; padding-bottom: 2px;">
              <div><a name="Nick_Theodore_Vice_President"></a>By:</div>
            </td>
            <td style="width: 40%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">/s/ Nick Theodore, Vice President</td>
            <td style="width: 15%; vertical-align: top; padding-bottom: 2px;"><br>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" style="width: 40%; vertical-align: top;"><br>
            </td>
            <td rowspan="1" colspan="1" style="width: 5%; vertical-align: top;"><br>
            </td>
            <td rowspan="1" style="width: 40%; vertical-align: top;">Nick Theodore, Vice President</td>
            <td rowspan="1" style="width: 15%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" style="width: 40%; vertical-align: top;"><br>
            </td>
            <td rowspan="1" colspan="1" style="width: 5%; vertical-align: top;"><br>
            </td>
            <td rowspan="1" style="width: 40%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 15%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 40%; vertical-align: top;"><br>
            </td>
            <td colspan="1" style="width: 5%; vertical-align: top;"><br>
            </td>
            <td style="width: 40%; vertical-align: top;">
              <div style="font-weight: bold;"><a name="XCF:"></a>XCF:</div>
            </td>
            <td style="width: 15%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 40%; vertical-align: top;"><br>
            </td>
            <td colspan="1" style="width: 5%; vertical-align: top;"><br>
            </td>
            <td style="width: 40%; vertical-align: top;">&#160;</td>
            <td style="width: 15%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 40%; vertical-align: top;"><br>
            </td>
            <td colspan="1" style="width: 5%; vertical-align: top;"><br>
            </td>
            <td style="width: 40%; vertical-align: top;">
              <div><a name="FOR_PURPOSES_OF_SECTION_3_ONLY"></a>FOR PURPOSES OF SECTION 3 ONLY</div>
            </td>
            <td style="width: 15%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 40%; vertical-align: top;"><br>
            </td>
            <td colspan="1" style="width: 5%; vertical-align: top;"><br>
            </td>
            <td style="width: 40%; vertical-align: top;">&#160;</td>
            <td style="width: 15%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 40%; vertical-align: top;"><br>
            </td>
            <td colspan="1" style="width: 5%; vertical-align: top;"><br>
            </td>
            <td style="width: 40%; vertical-align: top;">
              <div><a name="XCF_Global_Inc."></a>XCF Global, Inc.,</div>
            </td>
            <td style="width: 15%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 40%; vertical-align: top;"><br>
            </td>
            <td colspan="1" style="width: 5%; vertical-align: top;"><br>
            </td>
            <td style="width: 40%; vertical-align: top;">
              <div><a name="a_Delaware_corporation"></a>a Delaware corporation</div>
            </td>
            <td style="width: 15%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" style="width: 40%; vertical-align: top;"><br>
            </td>
            <td rowspan="1" colspan="1" style="width: 5%; vertical-align: top;"><br>
            </td>
            <td rowspan="1" style="width: 40%; vertical-align: top;"><br>
            </td>
            <td rowspan="1" style="width: 15%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 40%; vertical-align: top; padding-bottom: 2px;"><br>
            </td>
            <td colspan="1" style="width: 5%; vertical-align: top; padding-bottom: 2px;"><br>
            </td>
            <td style="width: 40%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">/s/ Mihir Dange, Chief Executive Officer</td>
            <td style="width: 15%; vertical-align: top; padding-bottom: 2px;"><br>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 40%; vertical-align: top;"><br>
            </td>
            <td colspan="1" style="width: 5%; vertical-align: top;">
              <div><a name="By:____________________________________"></a><a name="Mihir_Dange_Chief_Executive_Officer"></a>By:</div>
            </td>
            <td style="width: 40%; vertical-align: top;">Mihir Dange, Chief Executive Officer</td>
            <td style="width: 15%; vertical-align: top;"><br>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div><br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 50.00%;">
                <div style="text-align: left; margin-left: 1pt; font-size: 8pt; font-weight: bold;">CONFIDENTIAL FORBEARANCE AGREEMENT</div>
              </td>
              <td style="width: 50.00%;">
                <div style="text-align: right; margin-left: 9.5pt; font-size: 8pt; font-weight: bold;">PAGE 6</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-14.1
<SEQUENCE>22
<FILENAME>ef20050548_ex14-1.htm
<DESCRIPTION>EXHIBIT 14.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <!--PROfilePageNumberReset%Num%1%%%-->
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 14.1</font><br>
  </div>
  <div><br>
    <div style="text-align: center; font-weight: bold;">XCF Global, Inc.</div>
    <div style="text-align: center; font-weight: bold;">Code of Ethics and Business Conduct</div>
    <div><br>
    </div>
    <div style="text-align: center;">Adopted: June 8, 2025</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">XCF Global, Inc. (including our subsidiaries, &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; or the &#8220;Company&#8221;) believes that our culture requires our team members to conduct our business with honesty and integrity and in full compliance with the
      law. This applies to everything we do, every decision we make and with everyone with whom we interact, including each other. This is of paramount importance in maintaining our good reputation within the marketplace, for the benefit of all of our team
      members, stockholders, customers, suppliers, business partners and other stakeholders.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">This Code of Ethics and Business Conduct (the &#8220;Code&#8221;) communicates our responsibilities to conduct our business with honesty and integrity and in full compliance with the law. This Code applies to all of our employees
      (including employees of our subsidiaries) and our Board of Directors. Our Board of Directors adopted this Code as a reference for those who represent the Company as employees and Directors. The standards set forth in this Code and in any other
      policies and procedures that we communicate to you must guide your actions as employees and Directors.</div>
    <div><br>
    </div>
    <div style="text-indent: 19pt;">Each of us is responsible and accountable for understanding and meeting these standards. Our reputation and our success depend upon the personal commitment of each of us to uphold these values.</div>
    <div>&#160;</div>
    <div style="margin-left: 19pt; font-weight: bold;">Mihir Dange</div>
    <div style="margin-left: 19pt;">Chairman and Chief Executive Officer</div>
    <div style="margin-left: 19pt;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">1</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: center; font-weight: bold;">XCF Global, Inc.</div>
    <div style="text-align: center; font-weight: bold;">Code of Ethics and Business Conduct</div>
    <div style="text-align: center; font-weight: bold;"> <br>
    </div>
    <div style="font-weight: bold;"><u>Introduction</u></div>
    <div style="font-weight: bold;"><u> <br>
      </u></div>
    <div style="text-indent: 36pt;">This Code serves as a source of guiding principles, and the Company expects all employees and Directors to use their own judgment at all times to follow the high ethical standards to which we are committed. While the
      Code covers multiple topics in detail, it cannot cover every situation. To live up to the spirit of the Code, ask yourself the following questions when considering your actions:</div>
    <div style="text-indent: 36pt;"> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z4026f85876c64e20932f090ce78a58b8">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>Is it legal?</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z97d9b2870dfb46358a1ae90947334881">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>Is it consistent with the spirit and letter of the Code?</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="zb98cb72cbdd34ad5ad16816686a4417f">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>Is it consistent with the spirit and letter of our other policies and procedures?</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z34be233cd00b4c9aa8598db6102d39b1">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>Does it protect the Company&#8217;s interests?</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="zed663ab9fd24454fa0b3c1903d6d6908">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>Does it protect your colleagues?</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="zd29a7f38ee2048d8be2bed5fb0353fb8">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>Does it protect the Company&#8217;s customers, suppliers and business partners?</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z6310949929ba4396a87ba80477fd233f">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>Can you justify it to our customers, coworkers and family?</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z435b709af978433793462f1c35a97e07">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>Would you feel comfortable if it ended up on the front page of the newspaper?</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div style="text-indent: 36pt;">If the answer to any of those questions is &#8220;No,&#8221; then you should not do it.&#160; You are expected to exhibit the highest standard of business and professional integrity, and seek to avoid even the appearance of improper
      behavior. If you have any doubt, ask for support before you act. Ask your manager for advice before moving forward if you are unsure of the right course of action or have questions about this Code or compliance with the law. In addition to your
      manager, you can also speak with our Chief Legal Officer or anyone else on the legal team.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">You are expected to read the policies included in this Code and ensure that you understand them and comply with them. Any questions about this Code or the appropriate course of conduct in a particular situation should be
      directed to the legal department, who may consult with the Company&#8217;s external legal counsel or the Board, as appropriate.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">This Code is not the exclusive source of guidance and information regarding the conduct of our business, nor does it constitute a complete list of the types of conduct that can result in disciplinary action, up to and
      including termination or discharge. This Code should be read in conjunction with other policies applicable to our employees and Directors. Any determination with respect to the applicability of the provisions of this Code with respect to Company
      officers or Directors may be made only by the Board or an authorized committee of the Board. This Code is intended to supplement, not replace, any other of the Company&#8217;s policies, guidelines and/or employee handbook.</div>
    <div><br>
    </div>
    <div style="font-weight: bold;"><u>Conflicts of Interest</u></div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">A conflict of interest occurs when the private interests of a Company employee or Director interfere, or appear to interfere, with the interests of the Company as a whole. For example, a conflict of interest can arise
      when a Company employee or Director takes actions or has personal interests that may make it difficult to perform his or her duties as a Company employee or Director objectively and effectively. A conflict of interest may also arise when a Company
      employee or Director, or a member of his or her immediate family<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup> receives improper personal benefits as a result of his or her position at the Company.</div>
    <br>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">2</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-indent: 36pt;">Conflicts of interest can also occur indirectly. For example, a conflict of interest may arise when a Company employee or Director is also, or has an immediate family member who is, an executive officer, a significant
      stockholder or a significant LLC membership interest holder, or has a significant financial or other interest in a company or organization doing business with the Company.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">Each Company employee and Director has an obligation to conduct the Company&#8217;s business in an honest and ethical manner, including the ethical handling of actual or apparent conflicts of interest between personal and
      professional relationships. Any situation that involves, or may reasonably be expected to involve, a conflict of interest with the Company, should be disclosed promptly in writing to the Company&#8217;s legal department or by following such other
      procedures as may be set forth in any applicable Conflicts of Interest Policy we adopt. Potential conflicts of interest should be disclosed and approved in advance of the activity that may give rise to the conflict whenever possible. If a potential
      conflict of interest is disclosed after the activity has already occurred or is in process, Company employees and Directors should be aware that the Company may prescribe steps to mitigate the impact of the conflict of interest that have significant
      consequences to you, including the divestiture of assets or investments, adjustments to job responsibilities or, if such adjustments are not feasible, termination of an employee&#8217;s employment.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">Although the Code does not attempt to describe all possible conflicts of interest that could develop, some examples of common conflicts from which Company employee and Director must refrain are included below:</div>
    <div style="text-indent: 36pt;"> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="zfd3d6db391d14585945c98bcab040c76">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>Approving a contract for a supplier, vendor, customer or business partner with which you have a personal relationship or in which you have a financial or economic interest.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z90d3681a33c045438af7039c38e89aee">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>Accepting compensation, in any form, for services performed for the Company from any source other than the Company.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="zff8e008541914ef29bdd1ab80e581a46">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>Taking on any management or other employment, consulting or advisory position with, or have any material interest in, any company or business that is in direct or indirect competition with the Company.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">There may be certain situations involving Directors that may be considered to fall within the terms of this Code that also may fall within the terms of Article XI of our Amended and Restated Certificate of Incorporation.
      In the event of any conflict or inconsistency between this Code and Article XI, the provisions of Article XI will control.</div>
    <div><br>
    </div>
    <div style="font-weight: bold;"><u>Disclosures</u></div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">The information in the Company&#8217;s public communications, including in all reports and documents filed with, furnished to or otherwise submitted to the SEC, must be full, fair, accurate, timely and understandable. To
      ensure the Company meets this standard, all employees that are involved in the Company&#8217;s disclosure process are required to maintain familiarity with the disclosure requirements, processes and procedures applicable to the Company commensurate with
      their duties. Employees of the Company and are prohibited from knowingly misrepresenting, omitting or causing others to misrepresent or omit, material facts about the Company to others, including the Company&#8217;s independent auditors, governmental
      regulators and self- regulatory organization.
      <div><br>
      </div>
      <hr noshade="noshade" align="left" style="height: 2px; width: 25%; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); margin-left: 0px; margin-right: auto; border: medium none;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup> &#8220;Immediate family member&#8221; means a person&#8217;s child, stepchild, parent, stepparent, spouse, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law or sister-in-law, or any person (other than a tenant or
      employee) sharing the person&#8217;s household.
      <div> <br>
      </div>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">3</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="font-weight: bold;"><u>Compliance with Laws, Rules and Regulations</u></div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">The Company is obligated to comply with all applicable laws, rules and regulations. It is the personal responsibility of all Company employees and Directors to adhere to the requirements imposed by these laws, rules and
      regulations in the performance of their duties on behalf of the Company. In addition, the Company&#8217;s Chief Executive Officer, Chief Financial Officer and Chief Accounting Officer or Controller (or persons performing similar functions) (the &#8220;Senior
      Financial Officers&#8221;) are required to promote compliance by all employees with the Code and to abide by Company standards, policies and procedures.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">Any Company employees located outside of the United States or acting on behalf of the Company with foreign persons must comply with laws, regulations, rules and regulatory orders of the United States, including the
      Foreign Corrupt Practices Act (&#8220;FCPA&#8221;) and U.S. export control laws, in addition to applicable local laws, in performing their duties for the Company.</div>
    <div><br>
    </div>
    <div style="font-weight: bold;"><u>Insider Trading</u></div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">Trading on inside information is a violation of federal securities law. Company employees and Directors in possession of material non-public information about the Company or companies with whom we do business must
      abstain from trading or advising others to trade in the respective company&#8217;s securities from the time that they obtain such inside information until adequate public disclosure of the information. Material information is information of such importance
      that it can reasonably be expected to affect the judgment of investors as to whether or not to buy, sell, or hold the securities in question. To use non-public information for personal financial benefit or to &#8220;tip&#8221; others, including family members,
      who might make an investment decision based on this information is not only unethical but also illegal. You should refer to the Company&#8217;s Insider Trading Policy for additional information and requirements related to the purchase or sale of Company
      securities and the misuse of non-public, insider information.</div>
    <div><br>
    </div>
    <div style="font-weight: bold;"><u>Reporting, Accountability and Enforcement</u></div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">The Company promotes ethical behavior at all times and encourages Company employees to talk to supervisors, managers and other appropriate personnel, including our officers and Directors when in doubt about the best
      course of action in a particular situation.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">Company employees should promptly report suspected violations of laws, rules, regulations or the Code to appropriate personnel, including our officers and Directors. Reports may be made anonymously, including through the
      Company&#8217;s whistleblower hotline. If requested, confidentiality will be maintained to the extent possible, subject to applicable law, regulations and legal proceedings.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">Depending on the circumstances, the Audit Committee of the Board, the Chief Legal Officer, or both will investigate and determine, or shall designate appropriate persons to investigate and determine, the legitimacy of
      such reports. Depending on the circumstances, the Audit Committee of the Board, the Chief Legal Officer, or both, alone, together and/or in consultation with members of senior management or the Board, as necessary or advisable, will then determine
      any appropriate corrective and/or disciplinary action. Disciplinary action may include, but is not limited to, written warning, termination or discharge, and possible civil and criminal prosecution.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">To encourage employees to report any and all violations, the Company will not tolerate retaliation for reports made in good faith. Retaliation or retribution against any employee for a report made in good faith of any
      suspected violation of laws, rules, regulations or this Code is cause for appropriate disciplinary action.</div>
    <div style="text-indent: 36pt;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">4</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="font-weight: bold;"><u>Corporate Opportunities</u></div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">All Company employees and Directors owe a duty to the Company to advance the legitimate interests of the Company when carrying out their job duties. Company employees and Directors (except as otherwise noted herein) are
      prohibited from directly or indirectly;</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z2fe1279c091448899d13a32affd2a239">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>taking personally for themselves opportunities that are discovered through the use of Company property, information or positions;</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="zb7e4d374473c471ba075c4e1f08e3d04">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>using Company property, information or positions for personal gain; or</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z9b3cee1126ec43488d92ebe31c642fda">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>competing with the Company for business opportunities.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">Note, however, that if the Company&#8217;s disinterested Directors determine that the Company will not pursue an opportunity that relates to the Company&#8217;s business, a Company employee or Director may do so, after providing
      written notification to the Board of the proposed actions to be taken and receiving approval from a majority of the disinterested Directors.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">There may be certain situations involving Directors that may be considered to fall within the terms of this Code that also may fall within the terms of Article XI of our Amended and Restated Certificate of Incorporation.
      In the event of any conflict or inconsistency between this Code and Article XI, the provisions of Article XI will control.</div>
    <div><br>
    </div>
    <div style="font-weight: bold;"><u>Confidentiality</u></div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">In carrying out the Company&#8217;s business, Company employees and Directors may become aware of&#160; confidential or proprietary information about the Company, its customers, suppliers, business partners or other persons or
      entities with whom the Company has relationships. Confidential or proprietary information includes all non-public information relating to the Company, or other persons or entities, that would be harmful, if disclosed, to the Company or the relevant
      customers, suppliers, business partners or other persons or entities with whom the Company has relationships or non-public information relating to the Company, or other persons or entities, that could be useful or helpful to competitors Company or
      the relevant customers, suppliers, business partners or other persons or entities with whom the Company has relationships if disclosed.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">Company employees and Directors must maintain the confidentiality of all confidential information so entrusted to them, except when disclosure is authorized or legally mandated. Company employees and Directors must
      safeguard confidential information by keeping it secure, limiting access to those who have a need to know in order to do their job, and avoiding discussion of confidential information in public areas. This prohibition includes, but is not limited to,
      inquiries made by the press, analysts, or investors, or customers or partners who should not otherwise by privy to the confidential information. Company employees and Directors also may not use such information for personal gain. These
      confidentiality obligations continue even after employment with the Company ends.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">The following procedures are designed to maintain confidentiality with respect to the Company&#8217;s business operations and activities. Company employees and Directors should take all steps and precautions necessary to
      restrict access to, and secure, material, non-public information by, among other things:</div>
    <div style="text-indent: 36pt;"> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z47efcf37bcc04daba22982afac358376">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>maintaining the confidentiality of Company-related transactions;</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z8a70b4b52cf7447fab486e355cd73845">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>conducting their business and social activities so as not to risk inadvertent disclosure of confidential information (for example, review of confidential documents in public places should be conducted so as to prevent access by
              unauthorized persons);</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">5</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="zb07a13ad5b6146c696d75ea615d7de93">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>restricting access to documents and files (including computer files) containing material, non-public information to individuals on a need-to-know basis (including maintaining control over the distribution of documents and drafts of
              documents);</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="ze5f1713ff56342b585e0d9127bc429e0">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>promptly removing and cleaning up all confidential documents and other materials from conference rooms following the conclusion of any meetings (including erasing any whiteboards or other viewable information);</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="zc38e3fe652d142239d065222267a5507">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>disposing of all confidential documents and other papers, after there is no longer any business or other legally required need, through shredders when appropriate;</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z3ee7cbf1b37c426fa272e3d2871ca77d">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>restricting access to areas likely to contain confidential documents or material, non-public information, including individual offices that may contain such information;</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="zcd726288a87848639baea6b3dc851060">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>safeguarding laptop computers, mobile devices, tablets, memory sticks and other items that contain confidential information, including complying with the Company&#8217;s information technology policies to prevent unauthorized access to devices
              and/or electronic information to which Company employees and Directors have access;</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="zd1f82a46df174e579b971067f5ab79de">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>avoiding the discussion of material, non-public information in places where the information could be overheard by others such as in elevators, restrooms, hallways, restaurants, airplanes or taxicabs; and</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="zac51fbba025848728d5cd157a6f4ceb6">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>abiding by the terms of all Company employee confidentiality agreements.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="font-weight: bold;"><u>Fair Dealing</u></div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">Each Company employee and Director should endeavor to deal fairly with the Company&#8217;s employees, customers, service providers, suppliers and business partners. No Company employee or Director should take unfair advantage
      of anyone through manipulation, concealment, abuse of confidential or privileged information, misrepresentation of material facts, or any unfair dealing practice. Inappropriate use of proprietary information, misusing trade secret information that
      was obtained without the owner&#8217;s consent, or inducing such disclosures by past or present employees of other companies is also prohibited.</div>
    <div><br>
    </div>
    <div style="font-weight: bold;"><u>Protection and Proper Use of Company Assets</u></div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">All Company employees should protect the Company&#8217;s assets and ensure their efficient use. Theft, carelessness, and waste have a direct impact on the Company&#8217;s profitability. All Company assets should be used only for
      legitimate business purposes. The obligation of Company employees to protect the Company&#8217;s assets includes its proprietary information. Proprietary information includes intellectual property such as trade secrets, patents, trademarks and copyrights,
      as well as business, marketing and service plans, engineering and</div>
    <div>manufacturing ideas, designs, databases, records, salary information of other employees, and any unpublished financial data and reports.</div>
    <div><br>
    </div>
    <div style="font-weight: bold;"><u>Accuracy of Business Records</u></div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">All financial books, records and accounts must accurately reflect transactions and events, and conform both to generally accepted accounting principles (&#8220;GAAP&#8221;) and to the Company&#8217;s system of internal controls. No entry
      may be made that intentionally hides or disguises the true nature of any transaction. Company employees should therefore attempt to be as clear, concise, truthful and accurate as possible when recording any information.</div>
    <div style="text-indent: 36pt;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">6</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="font-weight: bold;"><u>Gifts</u></div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">The purpose of business gifts and entertainment in a commercial setting is to create goodwill and sound working relationships, not to gain unfair advantage with customers, suppliers, business partners or others. Company
      employees and Directors must act in a fair and impartial manner in all business dealings. Gifts and entertainment should further the business interests of the Company and not be construed as potentially influencing business judgment or creating an
      obligation.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">The Foreign Corrupt Practices Act (&#8220;FCPA&#8221;) prohibits giving anything of value, directly or indirectly, to officials of foreign governments or foreign political candidates in order to obtain or retain business. It is
      strictly prohibited to make illegal payments to government officials of any country. In addition, the promise, offer or delivery to an official or employee of the U.S. government of a gift, favor or other gratuity in violation of these rules would
      not only violate Company policy but could also be a criminal offense. State and local governments, as well as foreign governments, may have similar rules.</div>
    <div><br>
    </div>
    <div style="font-weight: bold;"><u>Antitrust and Competition Laws</u></div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">The purpose of antitrust and other competition laws is to preserve fair and open competition and a free market economy, which are goals that the Company fully supports. Company employees and Directors must not directly
      or indirectly enter into any formal or informal agreement with competitors that fixes or controls prices, divides or allocates markets, limits the production or sale of products, boycotts certain suppliers or customers, eliminates competition or
      otherwise unreasonably restrains trade.</div>
    <div><br>
    </div>
    <div style="font-weight: bold;"><u>Political Contributions</u></div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">Company employees and Directors may participate in the political process as individuals on their own time. However, Company employees and Directors must make every effort to ensure that they do not create the impression
      that they speak or act on behalf of the Company with respect to political matters. Company contributions to any political candidate or party or to any other organization that might use the contributions for a political candidate or party are
      prohibited. Company employees and Directors may not receive any reimbursement from corporate funds for a personal political contribution.</div>
    <div><br>
    </div>
    <div style="font-weight: bold;"><u>Discrimination and Harassment</u></div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">The Company is an equal opportunity employer and will not tolerate illegal discrimination or harassment of any kind. The Company is committed to providing a workplace free of discrimination and harassment based on race,
      color, religion, age, gender, national origin, ancestry, sexual orientation, disability, veteran status, or any other basis prohibited by applicable law. Company employees should refer to the Company&#8217;s Employee Handbook for further detail on the
      Company&#8217;s policies prohibiting discrimination and harassment.</div>
    <div><br>
    </div>
    <div style="font-weight: bold;"><u>Environmental Protection</u></div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">The Company is committed to managing and operating its assets in a manner that is protective of human health and safety and the environment. It is our policy to comply with both the letter and the spirit of the
      applicable health, safety and environmental laws and regulations and to attempt to develop a cooperative attitude with government inspection and enforcement officials. Company employees are encouraged to report conditions that they perceive to be
      unsafe, unhealthy or hazardous to the environment.</div>
    <div style="text-indent: 36pt;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">7</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="font-weight: bold;"><u>Social Media Policy</u></div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">Company employees and Directors should take care when presenting themselves in public settings, as well as online and in web-based forums or networking sites. The Company understands that Company employees and Directors
      may wish to create and maintain a personal presence online using various forms of social media. However, in so doing Company employees and Directors should always make it clear that the views expressed therein do not necessarily reflect the views of
      the Company. Company employees and Directors should be aware that even after a posting is deleted, certain technology may still make that content available to readers.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">In addition, Company employees and Directors are prohibited from using or disclosing confidential, proprietary, sensitive or trade secret information of the Company, its customers, suppliers, business partners and
      service providers and other third parties with which the Company does business.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">Company employees and Directors may not provide any content to Company social media sites that may be construed as political lobbying or solicitation of contributions, or use the sites to link to any sites sponsored by
      or endorsing political candidates or parties, or to discuss political campaigns, political issues or positions on any legislation or law. Company employees and Directors should refer to the Company&#8217;s Social Media Policy for more information.</div>
    <div><br>
    </div>
    <div style="font-weight: bold;"><u>Waivers</u></div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">Before a Company employee or Director, or an immediate family member of any such employee or Director engages in any activity that may be prohibited by the Code, the employee or Director should disclose the activity and
      seek prior written approval by contacting the Company&#8217;s Chief Legal Officer (or Chief Financial Officer if there is no Chief Legal Officer). Depending on the circumstances and the nature of the request, a written submission to the independent
      Directors may be required and a written waiver from the disinterested directors provided before such activity may be undertaken. In certain cases, any waiver may be required to be disclosed to the Company&#8217;s stockholders, along with the reasons for
      granting the waiver.</div>
    <div><br>
    </div>
    <div style="font-weight: bold;"><u>No Rights Created</u></div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">This Code is a statement of certain fundamental principles, policies and procedures that govern Company employees and Directors in the conduct of the Company&#8217;s business. It is not intended to and does not create any
      rights in any employee, customer, client, visitor, supplier, competitor, stockholder or any other person or entity.</div>
    <div><br>
    </div>
    <div style="font-weight: bold;"><u>Amendments</u></div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">The Company is committed to regularly reviewing and updating our policies and procedures. The Company therefore reserves the right to amend, alter or terminate this Code at any time and for any reason, subject to
      applicable law. It is your responsibility to ensure that you are consulting the latest version of this Code to guide your conduct in the course of our business. Any amendments to this Code (other than technical, administrative, or other
      non-substantive amendments) made in the 12 months preceding the most recent effective date of this Code will be summarized in this section of this Code.</div>
    <div> <br>
    </div>
    <div> <br>
    </div>
    <div style="text-align: center;"> <font style="font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">8</font></div>
    <div style="text-indent: 36pt;">
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-19.1
<SEQUENCE>23
<FILENAME>ef20050548_ex19-1.htm
<DESCRIPTION>EXHIBIT 19.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">

  <!--PROfilePageNumberReset%Num%1%%%-->
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 19.1</font><br>
    </div>
    <div><br>
    </div>
    <div>
      <div style="text-align: center; font-weight: bold;">XCF Global, Inc.</div>
      <div style="text-align: center; font-weight: bold;">Insider Trading Policy</div>
      <div><br>
      </div>
      <div style="text-align: center;">As of June 8, 2025</div>
      <div><br>
      </div>
      <div style="font-weight: bold;"><u>Purpose of the Policy</u></div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">This XCF Global, Inc. Insider Trading Policy (the &#8220;Policy&#8221;) provides guidelines with respect to transactions in the securities of XCF Global, Inc. (the &#8220;Company&#8221;) and the handling of confidential information about the
        Company and the companies with which the Company <a name="z_cp_change_24"></a>engages in transactions or does business. The Board of Directors of the Company has adopted this Policy to promote compliance with <a name="z_cp_change_25"></a>U.S.
        federal, state and foreign securities laws that prohibit certain persons who are aware of material <a name="z_cp_change_26"></a>nonpublic information about a company from (i) engaging in transactions in securities of that company or (ii) providing
        material nonpublic information to other persons who may engage in transactions in such securities on the basis of that information.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;"><a name="z_cp_change_28"></a>Please note that references in this Policy to the &#8220;Company&#8221; include subsidiaries of the Company, unless the context otherwise requires.</div>
      <div><br>
      </div>
      <div style="font-weight: bold;"><a name="z_cp_change_30"></a><u>Persons Subject to the Policy</u><a name="z_cp_change_29"></a></div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">This Policy applies to all officers of the Company and its subsidiaries, all members of the Company&#8217;s Board of Directors<a name="z_cp_change_33"></a>, all members of the board of directors or board of managers or
        similar governing board of any subsidiary of the Company, and all employees of the Company and any subsidiary of the Company. The Company may also determine that other persons should be subject to this Policy, such as <a name="z_cp_change_34"></a>contractors
        or consultants who have access to material nonpublic information. This Policy also applies to family members, other members of a person&#8217;s household and entities controlled by any person subject to this Policy, as described below.</div>
      <div><br>
      </div>
      <div style="font-weight: bold;"><a name="z_cp_change_37"></a><u>Transactions Subject to the Policy</u></div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">This Policy applies to transactions in the Company&#8217;s securities (collectively referred to in this Policy as &#8220;Company Securities&#8221;), including the Company&#8217;s common stock, warrants to purchase common stock, options to
        purchase common stock, or any other type of securities that the Company has issued or may issue in the future, including (but not limited to) preferred stock, convertible debt securities and warrants, as well as derivative securities that are not
        issued by the Company, including, without limitation, exchange-traded put or call options or swaps relating to the Company&#8217;s Securities. Transactions in securities subject to this Policy include, but are not limited to, purchases, sales and bona
        fide gifts of Company Securities.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">1</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="font-weight: bold;"><u>Individual Responsibility</u></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">Persons subject to this Policy have ethical and legal obligations to maintain the confidentiality of information about the Company, to not engage in transactions in Company Securities while in possession of material
        nonpublic information and to avoid the appearance of illegal or improper trading. Each individual is responsible for making sure that he or she complies with this Policy, and that any family member, household member or entity whose transactions are
        subject to this Policy, as discussed below, also comply with this Policy. In all cases, the responsibility for determining whether an individual is in possession of material nonpublic information rests with that individual, and any action on the
        part of the Company, the Compliance Officer, or any other employee or any director pursuant to this Policy (or otherwise) does not in any way constitute legal advice or insulate an individual from liability under applicable securities laws. You
        could be subject to severe legal penalties and disciplinary action by the Company for any conduct prohibited by this Policy or applicable securities laws, as described below in more detail under the heading &#8220;Consequences of Violations.&#8221;</div>
      <div>&#160;</div>
      <div style="font-weight: bold;"><u>Administration of the Policy</u></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">The Company&#8217;s Corporate Secretary shall serve as the Compliance Officer for the purposes of this Policy, unless the Board shall have appointed another officer to serve as the Compliance Officer, and in his or her
        absence, the Company&#8217;s Chief Executive Officer or another employee designated by the Company&#8217;s Chief Executive Officer or Compliance Officer shall be responsible for administration of this Policy. All determinations and interpretations by the
        Compliance Officer shall be final and not subject to further review.</div>
      <div>&#160;</div>
      <div style="font-weight: bold;"><u>Statement of Policy</u></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">It is the policy of the Company that no director, officer or other employee of the Company (or any other person designated <a name="z_Hlk190264218"></a>by this Policy or by the Compliance Officer as subject to this
        Policy) who is aware of material nonpublic information relating to the Company may, directly, or indirectly through family members or other persons or entities:</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd98335efb32943879defeb9b6ae42fcd">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">1.</td>
            <td style="width: auto; vertical-align: top;">
              <div>Engage in transactions in Company Securities, except as otherwise specified in this Policy under the headings &#8220;Transactions Under Company Plans,&#8221; &#8220;Transactions Not Involving a Purchase or Sale&#8221; and &#8220;Rule 10b5-1 Plans;&#8221;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2a0cee08d92c4b7982625479e5f5b013">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">2.</td>
            <td style="width: auto; vertical-align: top;">
              <div>Recommend that others engage in transactions in any Company Securities;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze7cfdcfec1db4287bdfe1ab7a754daaa">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">3.</td>
            <td style="width: auto; vertical-align: top;">
              <div>Disclose material nonpublic information to persons within the Company whose jobs do not require them to have that information, or outside of the Company to other persons, including, but not limited to, family, friends, business
                associates, investors and expert consulting firms, unless any such disclosure is made in accordance with the Company&#8217;s policies regarding the protection or authorized external disclosure of information regarding the Company; or</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9f0bc299523b45baafe203b00c18e28f">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">4.</td>
            <td style="width: auto; vertical-align: top;">
              <div>Assist anyone engaged in the above activities.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">In addition, it is the policy of the Company that no director, officer or other employee of the Company (or any other person designated by this Policy or by the Compliance Officer as subject to this Policy) who, in the
        course of working for the Company, learns of material nonpublic information about a company with which the Company does business, including, but not limited to, a customer or supplier of the Company or a company that is involved in a potential
        transaction or similar potential business relationship with the Company, may engage in transactions in that company&#8217;s securities until the information becomes public or is no longer material.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">2</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt;">There are no exceptions to this Policy, except as specifically noted herein. Transactions that may be necessary or justifiable for independent reasons (such as the need to raise money for an emergency expenditure), or
        small transactions, are not exempt from this Policy. The securities laws do not recognize any mitigating circumstances, and, in any event, even the appearance of an improper transaction must be avoided to preserve the Company&#8217;s reputation for
        adhering to the highest standards of conduct.</div>
      <div>&#160;</div>
      <div style="font-weight: bold;"><u>Definition of Material Nonpublic Information</u></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-style: italic;">Material Information.</font><font style="font-size: 10pt;"> Information is considered &#8220;material&#8221; if a reasonable investor would consider that
          information important in making a decision to buy, hold or sell securities. Any information that could be expected to affect the price of a company&#8217;s securities, whether it is positive or negative, should be considered material. There is no
          bright-line standard for assessing materiality; rather, materiality is based on an assessment of all of the facts and circumstances, and is often evaluated by enforcement authorities with the benefit of hindsight. While it is not possible to
          define all categories of &#8220;material&#8221; information, some examples of information that ordinarily would be regarded as material are:</font></div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze17cac2491ad4031a692a76492d058df">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div> Projections of future earnings or losses, or other earnings guidance;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z49ad011f88f64b4595b9582629dfd9f8">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div> Changes to previously announced earnings guidance, or the decision to suspend earnings guidance;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z172ef6e9753a4356837c9ee86d8e12ef">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div> Significant regulatory developments impacting the Company;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z113497d8361d4ab49f8c3cf6f07e88b4">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div> A pending or proposed merger, acquisition or tender offer;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze892e9566af9410aa9ba5fc63d7d8240">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div> A pending or proposed acquisition or disposition of a significant asset;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf69e7b9a61d24db0878a9ca7bec0b0dd">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div> A pending or proposed joint venture;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9afbd19958ca43e3ae6ffaeff0803c9f">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div> A Company restructuring;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5728523e3f314305bfa1050a8f84a417">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div> Significant related party transactions;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z05c9460de7264db0bd36eb1b287bdcad">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div> A change in dividend policy, the declaration of a stock split, or an offering of additional securities;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2a5776caa2644c3e9c3a68b62d4308ba">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div> Borrowings or other financing transactions out of the ordinary course;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z004bc9026e994366a246a3b58115a165">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div> The establishment, amendment or termination of a repurchase program for Company Securities;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z49da447e8a0c43d2a65e0709331d699e">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div> A change in the Company&#8217;s pricing or cost structure;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8b04771c5e914579832525b30c08fb7d">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div> Major marketing changes;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbe460c8c75404d1f97ec3038e8d8fc1d">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div> A change in executive management;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf42d7eba083d42af9dce1e3d699a2f6d">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div> A change in auditors or notification that the auditor&#8217;s reports may no longer be relied upon;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3ba7d6a0a03446eaa4412581390559d3">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div> Development of a significant new product, process, or service or the termination of a significant product, process, or service;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">3</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3baaf365e952418bb121a3d4ee834ec8">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div> Pending or threatened significant litigation or regulatory action, or the resolution of such litigation or regulatory action;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdc4c3494467e43918eb4df6350ef28a8">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div> Impending bankruptcy or the existence of severe liquidity problems;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze6209a1b860d408f891efb1278038ada">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div> The gain or loss of a significant customer or supplier;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z61087ba1067d4884be87cb3ad49b1802">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div>A significant cybersecurity incident, such as a data breach, or any other significant disruption in the company&#8217;s operations or loss, potential loss, breach or unauthorized access of its property or assets, whether at its facilities or
                through its information technology infrastructure; or</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdf855215b54945119f7c94d48960cdc7">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div> The imposition of a ban on engaging in transactions in Company Securities or the securities of another company.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-style: italic;">When Information is Considered Public.</font><font style="font-size: 10pt;"> Information that has not been disclosed to the public is generally
          considered to be nonpublic information. In order to establish that the information has been disclosed to the public, it may be necessary to demonstrate that the information has been widely disseminated.&#160; Information generally would be considered
          widely disseminated if it has been disclosed through the newswire services, Dow Jones &#8220;broad tape,&#8221; a broadcast on widely-available radio or television programs, publication in a widely-available newspaper, magazine or news website, or public
          disclosure documents such as a Current Report on Form 8-K filed with or furnished to the SEC that are available on the SEC&#8217;s website.</font></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">By contrast, information would likely not be considered widely disseminated if it is available only to the Company&#8217;s employees, or if it is only available to a select group of analysts, brokers and institutional
        investors.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">Once information is widely disseminated, it is still necessary to afford the investing public with sufficient time to absorb the information. As a general rule, information should not be considered fully absorbed by
        the marketplace until after the second trading day after the day on which the information is released. If, for example, the Company were to make an announcement before the Nasdaq Stock Market opens on a Monday, you should not engage in transactions
        in Company Securities until Wednesday. Depending on the particular circumstances, the Company may determine that a longer or shorter period should apply to the release of specific material nonpublic information.</div>
      <div>&#160;</div>
      <div style="font-weight: bold;"><u>Transactions by Family Members and Others</u></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">This Policy applies to your family members who reside with you (including a spouse, a child, a child away at college, stepchildren, grandchildren, parents, stepparents, grandparents, siblings and in-laws), anyone else
        who lives in your household, and any family members who do not live in your household but whose transactions in Company Securities are directed by you or are subject to your influence or control, such as parents or children who consult with you
        before they engage in transactions in Company Securities (collectively referred to as &#8220;Family Members&#8221;). You are responsible for the transactions of Family Members and therefore should make them aware of the need to confer with you before they
        engage in transactions in Company Securities, and you should treat all such transactions for the purposes of this Policy and applicable securities laws as if the transactions were for your own account. This Policy does not, however, apply to
        personal securities transactions of Family Members where the purchase or sale decision is made by a third party not controlled by, influenced by or related to you or your Family Members.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">4</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="font-weight: bold;"><u>Transactions by Entities that You Influence or Control</u></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">This Policy applies to any entities that you influence or control, including any corporations, partnerships or trusts (collectively referred to as &#8220;Controlled Entities&#8221;), and transactions by these Controlled Entities
        should be treated for the purposes of this Policy and applicable securities laws as if they were for your own account.</div>
      <div>&#160;</div>
      <div style="font-weight: bold;"><u>Transactions under Company Plans</u></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">This Policy does not apply in the case of the following transactions, except as specifically noted:</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-style: italic;">Stock Option Exercises. </font><font style="font-size: 10pt;">This Policy does not apply to the exercise of an employee stock option acquired
          pursuant to the Company&#8217;s plans, or to the exercise of a tax withholding right pursuant to which a person has elected to have the Company withhold shares subject to an option to satisfy tax withholding requirements. This Policy does apply,
          however, to any sale of stock as part of a broker-assisted cashless exercise of an option, or any other market sale for the purpose of generating the cash needed to pay the exercise price of an option.&#160; In addition, this exception for stock
          option exercises does not include the subsequent sale of shares acquired pursuant to the exercise of the option.</font></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-style: italic;">Restricted Stock Awards (Including Restricted Stock Units). </font><font style="font-size: 10pt;">This Policy does not apply to the vesting of
          restricted stock or restricted stock units, or the exercise of a tax withholding right pursuant to which you elect to have the Company withhold shares of stock to satisfy tax withholding requirements upon the vesting of any restricted stock or
          restricted stock units. The Policy does apply, however, to any market sale of shares restricted stock or the shares vesting from restricted stock units once vesting has occurred.</font></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-style: italic;">401(k) Plan. </font><font style="font-size: 10pt;">If the Company maintains a 401(k) plan that permits investment in Company Securities, this Policy
          does not apply to purchases of Company Securities in the Company&#8217;s 401(k) plan resulting from your periodic contribution of money to the plan pursuant to your payroll deduction election. This Policy does apply, however, to certain elections you
          may make under the 401(k) plan, including: (a) an election to increase or decrease the percentage of your periodic contributions that will be allocated to the Company stock fund; (b) an election to make an intra-plan transfer of an existing
          account balance into or out of the Company stock fund; (c) an election to borrow money against your 401(k) plan account if the loan will result in a liquidation of some or all of your Company stock fund balance; and (d) an election to pre-pay a
          plan loan if the pre-payment will result in allocation of loan proceeds to the Company stock fund.</font></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-style: italic;">Employee Stock Purchase Plan. </font><font style="font-size: 10pt;"> If the Company maintains an Employee Stock Purchase Plan, this Policy does not
          apply to purchases of Company Securities in the Employee Stock Purchase Plan resulting from your periodic contribution of money to the plan pursuant to the election you made at the time of your enrollment in the plan. This Policy does apply,
          however, to your election to participate in the plan for any enrollment period, any changes to your election, and to your sales of Company Securities purchased pursuant to the plan.</font></div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">5</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="font-weight: bold;"><u>Transactions Not Involving a Purchase or Sale</u></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-style: italic;">Bona fide </font><font style="font-size: 10pt;">gifts of Company Securities are not transactions subject to this Policy, unless the person making the
          gift has reason to believe that the recipient intends to sell the Company Securities while the officer, director or employee is aware of material nonpublic information, or the person making the gift is subject to the trading restrictions
          specified below under the heading &#8220;Additional Procedures&#8221; and the sales by the recipient of the Company Securities occur during a Blackout Period.</font></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-style: italic;">Mutual fund </font><font style="font-size: 10pt;">transactions that are invested in Company Securities are not transactions subject to this Policy.</font></div>
      <div>&#160;</div>
      <div style="font-weight: bold;"><u>Special and Prohibited Transactions</u></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">The Company has determined that there is a heightened legal risk and/or the appearance of improper or inappropriate conduct if the persons subject to this Policy engage in certain types of transactions. It therefore is
        the Company&#8217;s policy that any persons covered by this Policy may not engage in any of the following transactions, or should otherwise consider the Company&#8217;s preferences as described below:</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-style: italic;">Short-Term Trading. </font><font style="font-size: 10pt;">Short-term trading of Company Securities may be distracting to the person and may unduly
          focus the person on the Company&#8217;s short-term stock market performance instead of the Company&#8217;s long-term business objectives. For these reasons, any director, officer or other employee of the Company who purchases Company Securities in the open
          market may not sell any Company Securities of the same class during the six months following the purchase (or vice versa).</font></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-style: italic;">Short Sales. </font><font style="font-size: 10pt;">Short sales of Company Securities (<font style="font-style: italic;">i.e., </font>the sale of a
          security that the seller does not own) may evidence an expectation on the part of the seller that the securities will decline in value, and therefore have the potential to signal to the market that the seller lacks confidence in the Company&#8217;s
          prospects. In addition, short sales may reduce a seller&#8217;s incentive to seek to improve the Company&#8217;s performance. For these reasons, short sales of Company Securities are prohibited. In addition, Section 16(c) of the Securities Exchange Act of
          1934, as amended (the &#8220;Exchange Act&#8221;) prohibits officers and directors from engaging in short sales. (Short sales arising from certain types of hedging transactions are governed by the paragraph below captioned &#8220;Hedging Transactions&#8221;).</font></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-style: italic;">Publicly-Traded Options. </font><font style="font-size: 10pt;">Given the relatively short term of publicly-traded options, transactions in options
          may create the appearance that a director, officer or employee is trading based on material nonpublic information and focus a director&#8217;s, officer&#8217;s or other employee&#8217;s attention on short-term performance at the expense of the Company&#8217;s long-term
          objectives. Accordingly, transactions in put options, call options or other derivative securities related to Company Securities, on an exchange or in any other organized market, are prohibited by this Policy. (Option positions arising from
          certain types of hedging transactions are by the paragraph below captioned &#8220;Hedging Transactions&#8221;).</font></div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">6</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-style: italic;">Hedging Transactions. </font><font style="font-size: 10pt;">Hedging or monetization transactions can be accomplished through a number of possible
          mechanisms, including through the use of financial instruments such as prepaid variable forwards, equity swaps, collars and exchange funds. Such hedging transactions may permit a director, officer or employee to continue to own Company Securities
          obtained through employee benefit plans or otherwise, but without the full risks and rewards of ownership. When that occurs, the director, officer or employee may no longer have the same objectives as the Company&#8217;s other shareholders. Therefore,
          the Company prohibits any persons covered by this Policy from engaging in such transactions.</font></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-style: italic;">Margin Accounts and Pledged Securities. </font><font style="font-size: 10pt;">Securities held in a margin account as collateral for a margin loan may
          be sold by the broker without the customer&#8217;s consent if the customer fails to meet a margin call. Similarly, securities pledged (or hypothecated) as collateral for a loan may be sold in foreclosure if the borrower defaults on the loan. Because a
          margin sale or foreclosure sale may occur at a time when the pledgor is aware of material nonpublic information or otherwise is not permitted to engage in transactions in Company Securities, any persons subject to this Policy are prohibited from
          holding Company Securities in a margin account or otherwise pledging Company Securities as collateral for a loan except in very limited circumstances where it is clearly demonstrated that the director, officer, or employee has the capacity to
          repay the loan without selling the pledged securities. Any person wishing to pledge Company Securities as collateral for a loan must first submit the proposed transaction for approval by the Compliance Officer. Any request for pre-clearance of an
          arrangement involving the pledge of Company Securities as collateral for a loan must be submitted in writing to the Compliance Officer at least two weeks prior to the proposed execution of documents evidencing the proposed transaction and must
          set forth a justification for the proposed transaction and evidence of the person&#8217;s ability to repay the loan. Pledges of Company Securities must also be submitted to the Company&#8217;s Board of Directors for approval. (Pledges of Company Securities
          arising from certain types of hedging transactions are governed by the paragraph above captioned &#8220;Hedging Transactions&#8221;).</font></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-style: italic;">Standing and Limit Orders. </font><font style="font-size: 10pt;">Standing and limit orders (except standing and limit orders under approved Rule
          10b5-1 Plans, as described below) create heightened risks for insider trading violations similar to the use of margin accounts. There is no control over the timing of purchases or sales that result from standing instructions to a broker, and as a
          result the broker could execute a transaction when a director, officer or other employee is in possession of material nonpublic information. The Company therefore discourages placing standing or limit orders on Company Securities. If a person
          subject to this Policy determines that they must use a standing order or limit order, the order should be limited to short duration and should otherwise comply with the restrictions and procedures outlined below under the heading &#8220;Additional
          Procedures.&#8221; No standing or limit order may be entered into during a Blackout Period.</font></div>
      <div>&#160;</div>
      <div style="font-weight: bold;"><u>Additional Procedures</u></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">The Company has established additional procedures in order to assist the Company in the administration of this Policy, to facilitate compliance with laws prohibiting insider trading while in possession of material
        nonpublic information, and to avoid the appearance of any impropriety. These additional procedures are applicable only to those individuals described below.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">7</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-style: italic;">Pre-Clearance Procedures. </font><font style="font-size: 10pt;">The directors of the Company, the directors of any subsidiary of the Company, the
          executive officers of the Company, the executive officers of any subsidiary of the Company, and all other persons designated by the Compliance Officer as being subject to these procedures, as well as the Family Members and Controlled Entities of
          such persons, may not engage in any transaction in Company Securities without first obtaining pre-clearance of the transaction from the Compliance Officer. A request for pre-clearance should be submitted in writing to the Compliance Officer at
          least two business days in advance of the proposed transaction. A form for such purposes is attached as Exhibit A (Trading Clearance Application. The Compliance Officer is under no obligation to approve a transaction submitted for pre-clearance,
          and may determine not to permit the transaction. If a person seeks pre-clearance and permission to engage in the transaction is denied, then he or she should refrain from initiating any transaction in Company Securities, and should not inform any
          other person of the restriction.</font></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">When a request for pre-clearance is made, the requestor should carefully consider whether he or she may be aware of any material nonpublic information about the Company, and should describe fully those circumstances to
        the Compliance Officer. To the extent applicable, the requestor should also indicate whether he or she has effected any non-exempt &#8220;opposite-way&#8221; transactions within the past six months, and should be prepared to report the proposed transaction on
        an appropriate Form 4 or Form 5. The requestor should also be prepared to comply with SEC Rule 144 and file a Form 144 with the SEC, if necessary, at the time of any sale.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">Transactions that have received pre-clearance from the Compliance Officer must be completed within 5 trading days (a &#8220;trading day&#8221; is a day on which the Nasdaq Stock Market is open for trading). Transactions that have
        not been effected within the 5 day period must be resubmitted for pre-clearance.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-style: italic;">Quarterly Trading Restrictions. </font><font style="font-size: 10pt;">The persons designated by the Compliance Officer as subject to this
          restriction, as well as their Family Members or Controlled Entities, may not conduct any transactions involving the Company&#8217;s Securities (other than as specified by this Policy), during a &#8220;Blackout Period&#8221; beginning fifteen (15) days prior to the
          end of each fiscal quarter and ending after the second full trading day following the public release of the Company&#8217;s earnings results for that quarter. In other words, these persons may only conduct transactions in Company Securities during the
          &#8220;Window Period&#8221; beginning after second full trading day following the public release of the Company&#8217;s quarterly earnings and ending fifteen (15) days prior to the close of the next fiscal quarter.</font></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">Under certain very limited circumstances, a person subject to this restriction may be permitted to engage in transactions in Company Securities during a Blackout Period, but only if the Compliance Officer concludes
        that the person does not in fact possess material nonpublic information. Persons wishing to engage in transaction in Company Securities pursuant to this paragraph during a Blackout Period must contact the Compliance Officer for approval at least
        two business days in advance of any proposed transaction involving Company Securities.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">8</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-style: italic;">Event-Specific Trading Restriction Periods. </font><font style="font-size: 10pt;">From time to time, an event may occur that is material to the
          Company and is known by only by certain persons subject to this Policy. So long as the event remains material and nonpublic, the persons designated by the Compliance Officer may not engage in transactions in Company Securities. In addition, the
          Company&#8217;s financial results may be sufficiently material in a particular fiscal quarter that, in the judgment of the Compliance Officer, designated persons should refrain from engaging in transactions in Company Securities even sooner than the
          typical Blackout Period described above. In that situation, the Compliance Officer may notify these persons that they should not engage in transactions in Company Securities, without disclosing the reason for the restriction. The existence of an
          event-specific trading restriction period or extension of a Blackout Period will not be announced to the Company as a whole, and should not be communicated to any other person. Even if the Compliance Officer has not designated you as a person who
          should not engage in transactions in Company Securities due to an event-specific restriction, you should not engage in transactions in Company Securities while aware of material nonpublic information. The Compliance Officer is not authorized to,
          and will not grant, exceptions during an event-specific trading restriction period.</font></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-style: italic;">Exceptions. </font><font style="font-size: 10pt;">The quarterly trading restrictions and event-driven trading restrictions do not apply to those
          transactions to which this Policy does not apply, as described above under the headings &#8220;Transactions under Company Plans&#8221; and &#8220;Transactions Not Involving a Purchase or Sale.&#8221; Further, the requirement for pre-clearance, the quarterly trading
          restrictions and event-driven trading restrictions do not apply to transactions conducted pursuant to approved Rule 10b5-1 plans, described under the heading &#8220;Rule 10b5-1 Plans.&#8221;</font></div>
      <div>&#160;</div>
      <div style="font-weight: bold;"><u>Rule 10b5-1 Plans</u></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">Rule 10b5-1 under the Exchange Act provides a defense from insider trading liability under Rule 10b-5. In order to be eligible to rely on this defense, a person subject to this Policy must enter into a Rule 10b5-1 plan
        for transactions in Company Securities that meets certain conditions specified in the Rule (a &#8220;Rule 10b5-1 Plan&#8221;). If the plan meets the requirements of Rule 10b5-1, Company Securities may be purchased or sold without regard to certain insider
        trading restrictions. To comply with the Policy, a Rule 10b5-1 Plan must be approved by the Compliance Officer and meet the requirements of Rule 10b5-1 and the Company&#8217;s &#8220;Guidelines for Rule 10b5-1 Plans,&#8221; which may be obtained from the Compliance
        Officer.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">In general, a Rule 10b5-1 Plan must be entered into at a time when the person entering into the plan is not aware of material nonpublic information. Once the plan is adopted, the person must not exercise any influence
        over the amount of securities to be traded, the price at which they are to be traded or the date of the trade. The plan must either specify the amount, pricing and timing of transactions in advance, include a formula or similar method for
        determining the amount, price and date, or delegate exclusive discretion on these matters to an independent third party. The plan must include a cooling-off period before trading can commence that, for directors or officers, ends on the later of 90
        days after the adoption of the Rule 10b5-1 Plan or two business days following the disclosure of the Company&#8217;s financial results in an SEC periodic report (Form 10-Q, or Form 10-K for plans adopted in the fourth quarter) for the fiscal quarter in
        which the plan was adopted (but in any event, the required cooling-off period is subject to a maximum of 120 days after adoption of the plan), and for persons other than directors or officers, 30 days following the adoption or modification of a
        Rule 10b5-1 Plan. A person may not enter into overlapping Rule 10b5-1 plans (subject to certain exceptions) and may only enter into one single-trade Rule 10b5-1 plan during any 12-month period (subject to certain exceptions). In addition, each
        director or officer must include a representation in his or her Rule 10b5-1 Plan certifying that: (i) he or she is not aware of any material nonpublic information; and (ii) he or she is adopting the plan in good faith and not as part of a plan or
        scheme to evade the prohibitions in Rule 10b-5. All persons entering into a Rule 10b5-1 Plan must act in good faith with respect to that plan.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">9</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt;">Any new Rule 10b5-1 Plan, or amendment to a 10b5-1 Plan, must be submitted to the Compliance Officer for approval five business days prior to the entry into the Rule 10b5-1 Plan or amendment.&#160; Any Rule 10b5-1 Plan that
        was entered into prior to the effective date of this Policy must be submitted to the Compliance Officer for approval no fewer than five business days prior to any transaction in securities under such Rule 10b5-1 Plan during a Blackout Period or
        while in possession of material nonpublic information.&#160; Once a Rule 10b5-1 Plan or amendment is approved by the Compliance Officer, no further pre-approval of transactions conducted pursuant to such Rule 10b5-1 Plan will be required.</div>
      <div>&#160;</div>
      <div style="font-weight: bold;"><u>Post-Termination Transactions</u></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">This Policy continues to apply to transactions in Company Securities even after termination of service to the Company. If an individual is in possession of material nonpublic information when his or her service
        terminates, that individual may not engage in transactions in Company Securities until that information has become public or is no longer material. The pre-clearance procedures specified under the heading &#8220;Additional Procedures&#8221; above, however,
        will cease to apply to transactions in Company Securities upon the expiration of any Blackout Period or other Company-imposed trading restrictions applicable at the time of the termination of service. The Compliance Officer may provide a letter to
        a director, executive officer, or other designated employee, at the Compliance Officer&#8217;s discretion, reminding them of their continued obligations under the Policy.</div>
      <div>&#160;</div>
      <div style="font-weight: bold;"><u>Consequences of Violations</u></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">Transactions in securities while aware of material nonpublic information, or the disclosure of material nonpublic information to others, who then engage in transactions in Company Securities, are prohibited by the
        federal and state laws. Insider trading violations are pursued vigorously by the SEC, U.S. Attorneys and state enforcement authorities as well as the laws of foreign jurisdictions. Punishment for insider trading violations is severe, and could
        include, but is not limited to, significant fines, imprisonment, and bans on employment or directorships with public companies. While the regulatory authorities concentrate their efforts on the individuals who trade, or who tip inside information
        to others who trade, the federal securities laws also impose potential liability on companies and other &#8220;controlling persons&#8221; if they fail to take reasonable steps to prevent insider trading by company personnel.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">In addition, an individual&#8217;s failure to comply with this Policy may subject the individual to Company imposed sanctions, including dismissal for cause, whether or not the employee&#8217;s failure to comply results in a
        violation of law. Needless to say, a violation of law, or even an SEC investigation that does not result in prosecution, can tarnish a person&#8217;s reputation and irreparably damage a career.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">10</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="font-weight: bold;"><u>Company Assistance</u></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">Any person who has a question about this Policy or its application to any proposed transaction may obtain additional guidance from the Compliance Officer.</div>
      <div>&#160;</div>
      <div style="font-weight: bold;"><u>Certification</u></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">All persons subject to this Policy must certify their understanding of, and intent to comply with, this Policy. A Form of Certification is attached to this Policy as <font style="font-weight: bold;"><u>Schedule I</u></font>.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">11</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;">Schedule I</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">CERTIFICATION<a name="z_Hlk194610330"></a></div>
      <div>&#160;</div>
      <div>I certify that:</div>
      <div>&#160;</div>
      <div>1. I have read and understand the XCF Global, Inc. Trading Policy (the &#8220;Policy&#8221;). I understand that the Compliance Officer is available to answer any questions I have regarding the Policy.</div>
      <div>&#160;</div>
      <div>2. Since I have been a person subject to the Policy, I have complied with the Policy.</div>
      <div>&#160;</div>
      <div>3. I will continue to comply with the Policy for as long as I am subject to the Policy.</div>
      <div>&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" id="z9b0477d05916406494b4e52c9fbfccaf" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 8%; font-weight: bold; padding-bottom: 2px;">Signature: <br>
              </td>
              <td style="width: 30%; font-weight: bold; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
              <td style="width: 62%; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="3" rowspan="1"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 10%; font-weight: bold; padding-bottom: 2px;">Print Name:</td>
              <td style="width: 28%; font-weight: bold; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
              <td style="width: 62%; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td rowspan="1" colspan="3"><br>
              </td>
            </tr>
            <tr>
              <td style="font-weight: bold; padding-bottom: 2px; width: 5%;">Date:</td>
              <td style="font-weight: bold; border-bottom: 2px solid rgb(0, 0, 0); width: 30%;">&#160;</td>
              <td style="width: 65%; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
            </tr>

        </table>
      </div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">12</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;">XCF Global, Inc.</div>
      <div style="text-align: center; font-weight: bold;">Guidelines for Rule 10b5-1 Plans</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) provides an affirmative defense from insider trading liability under Rule 10b-5.&#160; In order to be eligible to rely on this defense,
        a person subject to this Policy must enter into a Rule 10b5-1 plan for transactions in Company Securities (as defined in the XCF Global, Inc. Insider Trading Policy (the &#8220;Policy&#8221;)) that meets certain conditions specified in Rule 10b5-1 (a &#8220;Rule
        10b5-1 Plan&#8221;). If the plan meets the requirements of Rule 10b5-1, Company Securities may be purchased or sold as provided in the Rule 10b5-1 Plan without regard to certain insider trading restrictions.&#160; In general, a Rule 10b5-1 Plan must be
        entered into at a time when the person entering into the plan is not aware of material nonpublic information.&#160; Once the plan is adopted, the person must not exercise any influence over the amount of securities to be traded, the price at which they
        are to be traded or the date of the trade.&#160; The plan must either specify the amount, pricing and timing of transactions in advance or delegate discretion on these matters to an independent third party.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">As specified in the Policy, a Rule 10b5-1 Plan, or amendment to a 10b5-1 Plan, must be approved by the Compliance Officer and meet the requirements of Rule 10b5-1 and these guidelines. Any new Rule 10b5-1 Plan or
        amendment must be submitted to the Compliance Officer for approval five business days prior to the entry into the Rule 10b5-1 Plan or amendment.&#160; Any Rule 10b5-1 Plan that was entered into prior to the effective date of the Policy must be submitted
        to the Compliance Officer for approval no fewer than five business days prior to any transaction in securities under such Rule 10b5-1 Plan during a Blackout Period or while in possession of material nonpublic information.&#160; No further pre-approval
        of transactions conducted pursuant to the Rule 10b5-1 Plan or amendment will be required once such plan is approved by the Compliance Officer.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">The following guidelines apply to all Rule 10b5-1 Plans (Note: capitalized terms used but not defined in the Guidelines have the meanings ascribed to such terms in the Policy):</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-style: italic;">Blackout Periods.</font><font style="font-size: 10pt;"> You may not enter into, modify or terminate a Rule 10b5-1 Plan during a quarterly Blackout
          Period, an event-specific trading restriction period or while in possession of material nonpublic information.</font></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-style: italic;">Duration.&#160; </font><font style="font-size: 10pt;">All Rule 10b5-1 Plans must have a duration of at least 6 months and no more than 2 years.</font></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-style: italic;">Termination. </font><font style="font-size: 10pt;">If a Rule 10b5-1 Plan is terminated:</font></div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7cf159d8c9b4469fbd03b193a2a70429">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div>you must wait at least 30 days before trading outside of the Rule 10b5-1 Plan; and</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z467e97f4500c44d2a6c7762260bc0287">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div>you must wait until the commencement of the next Window Period (as defined in the Policy) before a new Rule 10b5-1 Plan may be adopted;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">13</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-style: italic;">Cooling-Off Period. </font><font style="font-size: 10pt;">There is a minimum &#8220;cooling-off period&#8221; between the date a Rule 10b5-1 Plan is adopted or
          modified and when trading under the Rule 10b5-1 Plan may commence.</font></div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf601477b6af04d99b47f4b031174a4ed">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt; font-style: italic;">Directors and Officers. </font><font style="font-size: 10pt;">With respect to directors and officers, the applicable cooling-off period is the later of (i) 90
                  days after the adoption or modification of the trading plan or (ii) two business days following the filing of the Company&#8217;s Form 10-Q or Form 10-K for the fiscal quarter in which the plan was adopted or modified. In any event, the
                  required cooling-off period is not to exceed 120 days following adoption or modification of the plan.</font></div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4ca792ee00a945be911accfc5f068cca">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt; font-style: italic;">Issuers. </font><font style="font-size: 10pt;">With respect to the Company itself (i.e., the issuer), there is no cooling off period.</font></div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc1f528a6d179477b8188f7b4a35a2b51">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-size: 12pt;"><font style="font-size: 10pt; font-style: italic;">All Other Persons. </font><font style="font-size: 10pt;">With respect to persons other than the Company, directors or Section 16 officers, the applicable
                  cooling-off period is 30 days after the adoption or modification of the trading plan.</font></div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-style: italic;">Representations</font><font style="font-size: 10pt;">.&#160; When adopting a new or modified Rule 10b5-1 Plan, the person subject to this Policy will be
          required to include in the plan written representations certifying that he or she (i) is not aware of material nonpublic information about the Company or its securities and (ii) is adopting or modifying the plan in good faith and not as part of a
          plan or scheme to evade the prohibitions of Exchange Act Rule 10b-5.</font></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-style: italic;">Multiple Plans Prohibited</font><font style="font-size: 10pt;">. Persons subject to the Policy, other than the Company itself, are prohibited from
          having more than one Rule 10b5-1 trading plan.</font></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-style: italic;">Single-Trade Plans</font><font style="font-size: 10pt;">. In any 12-month period, each person subject to this Policy, other than the Company, is
          limited to one &#8220;single-trade plan&#8221; (i.e., a 10b5-1 Plan designed to effect the open market purchase or sale of the total amount of the securities subject to the plan as a single transaction).</font></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-style: italic;">Good Faith</font><font style="font-size: 10pt;">.&#160; 10b5-1 Plans may only be entered into in good faith. (As an example, the SEC notes that influencing
          the timing of an issuer&#8217;s disclosure so that trades under a plan are more profitable would run afoul of this ongoing good faith requirement).</font></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-style: italic;">Disclosure of 10b5-1</font><font style="font-size: 10pt;">&#160;<font style="font-style: italic;">Plans on Forms 10-Q/10-K</font>.&#160; The Company will be
          required to report, for each quarter:</font></div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8f74720a14df493bacf3fb66a26725e3">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">(i)</td>
            <td style="width: auto; vertical-align: top;">
              <div>whether any director or Section 16 officer has adopted, modified or terminated a Rule 10b5-1 plan or non-Rule 10b5-1 trading arrangement, and</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcd588e6b8d124fa3a22b27435b322112">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">(ii)</td>
            <td style="width: auto; vertical-align: top;">
              <div>a description of the material terms of each plan, including:</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5c1a839561e946b5be0ce77e0a5047b6">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">a.</td>
            <td style="width: auto; vertical-align: top;">
              <div>the name and title of the director or Section 16 officer;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z90dc070221354cf79ee584dcfb9eedfb">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">b.</td>
            <td style="width: auto; vertical-align: top;">
              <div>the date the plan was adopted, modified or terminated;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">14</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zba8f10800aff4349b2884d783eaab946">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">c.</td>
            <td style="width: auto; vertical-align: top;">
              <div>the plan&#8217;s duration; and</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z963fa9b93f1740f899a78d177e1b4437">

          <tr>
            <td style="width: 72pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">d.</td>
            <td style="width: auto; vertical-align: top;">
              <div>the total amount of securities to be purchased or sold under the plan.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">(Note that the Company is not required to disclose pricing terms of any 10b5-1 Plan).</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-style: italic;">Section 16 Obligations.&#160; </font><font style="font-size: 10pt;">Each director, officer and other person who is or becomes subject to reporting under
          Section 16 of the Exchange Act understands that the approval or adoption of a pre-planned selling program in no way reduces or eliminates such person&#8217;s obligations under Section 16, including such person&#8217;s disclosure obligations (filings of Forms
          4 and 5) and short-swing trading profit liabilities/disgorgement thereunder.&#160; If any questions arise, persons seeking to adopt a plan should consult with their own counsel in implementing a Rule 10b5-1 Plan.</font></div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">15</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;">EXHIBIT A</div>
      <div style="text-align: center; font-weight: bold;">Form of Trading Clearance Application</div>
      <div><br>
      </div>
      <div>Capitalized terms used in this <a name="z_Hlk180065749"></a>Trading Clearance Application are defined in the XCF Global, Inc. Insider Trading Policy.</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z9786aa9d703d4115aa8c6a372ffc00ef">

          <tr>
            <td style="width: 40%; vertical-align: top; padding-bottom: 2px;">
              <div style="font-size: 12pt;"><u><font style="font-size: 10pt;">Name</font></u><font style="font-size: 10pt;">:</font></div>
            </td>
            <td style="width: 45%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div><br>
              </div>
            </td>
            <td style="width: 15%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 40%; vertical-align: top;">&#160;</td>
            <td style="width: 45%; vertical-align: top;">&#160;</td>
            <td style="width: 15%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 40%; vertical-align: top; padding-bottom: 2px;">
              <div><u><a name="z_Hlk190270568"></a>Title</u>:</div>
            </td>
            <td style="width: 45%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div><br>
              </div>
            </td>
            <td style="width: 15%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 40%; vertical-align: top;">&#160;</td>
            <td style="width: 45%; vertical-align: top;">&#160;</td>
            <td style="width: 15%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 40%; vertical-align: top; padding-bottom: 2px;">
              <div style="font-size: 12pt;"><u><font style="font-size: 10pt;">Proposed Trade Date</font></u><font style="font-size: 10pt;">:</font></div>
            </td>
            <td style="width: 45%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div><br>
              </div>
            </td>
            <td style="width: 15%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 40%; vertical-align: top;">&#160;</td>
            <td style="width: 45%; vertical-align: top;">&#160;</td>
            <td style="width: 15%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 40%; vertical-align: top; padding-bottom: 2px;">
              <div>Type of Security to be Traded <u>(Common Stock/Option)</u>:</div>
            </td>
            <td style="width: 45%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
            <td style="width: 15%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 40%; vertical-align: top;">&#160;</td>
            <td style="width: 45%; vertical-align: top;">&#160;</td>
            <td style="width: 15%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 40%; vertical-align: top; padding-bottom: 2px;">
              <div style="font-size: 12pt;"><u><font style="font-size: 10pt;">Type of Trade (Purchase/Sale/Option Exercise)</font></u><font style="font-size: 10pt;">:</font></div>
            </td>
            <td style="width: 45%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
            <td style="width: 15%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 40%; vertical-align: top;">&#160;</td>
            <td style="width: 45%; vertical-align: top;">&#160;</td>
            <td style="width: 15%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 40%; vertical-align: top; padding-bottom: 2px;">
              <div><u>Number of Shares to be Traded (if applicable):</u></div>
            </td>
            <td style="width: 45%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div><br>
              </div>
            </td>
            <td style="width: 15%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div style="text-align: center; font-weight: bold;">Certification</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">I hereby certify that I am not in possession of any material non-public information about the Company (including its subsidiaries).&#160; I understand that material non-public information is information concerning the
        Company that (a) is not generally known to the public; and (b) if publicly known, would be likely to affect either the market price of Company securities or a person&#8217;s decision to buy, sell or hold Company securities.&#160; I understand that if I trade
        while in possession of material non-public information, I may be subject to severe civil or criminal penalties, and may be subject to discipline by the Company up to and including termination for cause.</div>
      <div style="text-indent: 36pt;"> <br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" id="z6bf1bc0bd9714f60a484002975b56194" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 3%; padding-bottom: 2px;">By:&#160; <br>
              </td>
              <td style="width: 27%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
              <td style="width: 20%; padding-bottom: 2px;">&#160;</td>
              <td style="width: 50%; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td colspan="3">Name:</td>
              <td style="width: 50.00%;">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td colspan="3">Date:</td>
              <td style="width: 50.00%;">
                <div>&#160;</div>
              </td>
            </tr>

        </table>
      </div>
      <div><br>
      </div>
      <div style="text-align: center; font-weight: bold;">Review and Decision</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt;">The undersigned has reviewed the foregoing application and approves/prohibits (circle one) the proposed trade(s).</div>
      <div><br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" id="z548cf4cd12294be18068241363cefece" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 30%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
              <td style="width: 70%; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td colspan="2">Name:</td>
            </tr>
            <tr>
              <td colspan="2">Date:</td>
            </tr>

        </table>
      </div>
      <div> <br>
      </div>
      <div>
        <div style="text-align: center;"> <br>
        </div>
        <div style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">16</font></div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>24
<FILENAME>ef20050548_ex21-1.htm
<DESCRIPTION>EXHIBIT 21.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  <div>
    <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit 21.1</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">XCF GLOBAL, INC.</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">List of Subsidiaries</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" id="z7ec154fe1f00478a887d39caec842d33" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>Company Name</u></div>
          </td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>State of Incorporation/Organization</u></div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">XCF Global Capital, Inc.</div>
          </td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Nevada</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">New Rise Renewables, LLC</div>
          </td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Delaware</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">New Rise Renewables Reno, LLC</div>
          </td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Delaware</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
  </div>
  <div><br>
  </div>
  <div>
    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>25
<FILENAME>ef20050548_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <!--PROfilePageNumberReset%Num%1%%%-->
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 99.1</font><br>
  </div>
  <div><br>
    <div style="text-align: center; font-weight: bold;"><img src="image01.jpg">
      <div><br>
      </div>
    </div>
    <div style="text-align: center; font-weight: bold;">XCF Global and Focus Impact BH3 Acquisition Company Announce Closing of Business Combination</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z9754d45266054c438bd81b067aa95ed8" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>XCF Global set to begin trading on Nasdaq under the ticker symbol &#8220;SAFX&#8221;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z3941d20ffeae400fb51469451aa37b44" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>First publicly traded pure-play SAF producer in the United States</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z434ef9e3460440718613e940ba8d3a92" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>XCF Global&#8217;s New Rise Reno facility is operational and revenue-generating, positioning XCF as a leading North American SAF producer poised for growth </div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Reno, NV, and New York, NY, June 6, 2025 &#8211;</font> XCF Global Capital, Inc. (&#8220;XCF Global&#8221;), a key player in decarbonizing the aviation industry through Synthetic Aviation Fuel (&#8220;SAF&#8221;),
      today announced the successful completion of its business combination (the &#8220;Business Combination&#8221;) with Focus Impact BH3 Acquisition Company (OTC PINK: BHAC) (&#8220;Focus Impact BH3&#8221;), a special purpose acquisition company. </div>
    <div><br>
    </div>
    <div style="text-align: justify;">The combined company will operate under the name XCF Global, Inc. and its Class A common stock is expected to commence trading on the Nasdaq Capital Market (&#8220;Nasdaq&#8221;) under the ticker symbol &#8220;SAFX&#8221; on June 9, 2025. </div>
    <div><br>
    </div>
    <div style="text-align: justify;">&#8220;The completion of this transaction marks a transformational step for XCF Global and the decarbonization of the aviation industry,&#8221; said Mihir Dange, Chief Executive Officer of XCF Global. &#8220;With commercial production
      underway, first deliveries completed, and a proven business model in place, we are entering the public markets with momentum and a clear path to growth. XCF Global is positioned as a market leader at the intersection of aviation and decarbonization &#8211;
      standing at the forefront of a high-growth opportunity in synthetic aviation fuel. We offer the public capital markets access to one of the fastest-growing sectors in the global energy transition, and we are proud to be leading the shift toward a
      lower-carbon future for aviation.&#8221;</div>
    <div><br>
    </div>
    <div style="text-align: justify;">&#8220;We are thrilled to have completed the Business Combination with XCF Global and bring this transformative SAF platform to the public markets,&#8221; said Carl Stanton, CEO of Focus Impact BH3. &#8220;With strong macro tailwinds, a
      repeatable site development model, and a world-class management team, XCF Global is uniquely positioned to scale SAF production and drive meaningful impact in the energy transition while creating long-term value for shareholders.&#8221;</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-weight: bold;">Highlights</div>
    <table cellspacing="0" cellpadding="0" id="z5a56a1a4e0a24354aa8c7cbd779475da" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>XCF Global&#8217;s New Rise Reno facility began commercial production of neat SAF in February 2025, with a nameplate production capacity of 38 million gallons of neat SAF per year</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zb5986e84ddaf4d2e821d26a6829ddd23" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>First customer deliveries of neat SAF completed in March 2025, marking a major operational milestone</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z094a4f5990f24bbe823fa1f8b8ff570e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Advancing a pipeline of production sites in Nevada, North Carolina, and Florida to expand SAF capacity and support long-term growth</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">1</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; font-weight: bold;">Advisors</div>
    <div><br>
    </div>
    <div style="text-align: justify;">Cohen &amp; Company Capital Markets, a division of J.V.B. Financial Group, LLC, acted as exclusive financial advisor and joint capital markets advisor to XCF. Height Capital Markets served as joint capital markets
      advisor to XCF Global. BTIG, LLC acted as capital markets advisor to Focus Impact BH3. Stradley Ronon Stevens &amp; Young, LLP and Kirkland &amp; Ellis LLP served as legal counsel to XCF and Focus Impact BH3, respectively. Alliance Advisors Investor
      Relations served as investor relations and public relations advisor for the transaction.</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-weight: bold;">About Focus Impact BH3 Acquisition Co.</div>
    <div><br>
    </div>
    <div style="text-align: justify;">Focus Impact BH3 Acquisition Co. is a special purpose acquisition company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business
      combination with one or more businesses. Focus Impact BH3 is sponsored by Focus Impact Partners, LLC, a private investment firm dedicated to bringing capital and expertise to socially forward companies and helping those companies realize their growth
      and development objectives. To learn more, visit <u>https://focus-impact.com/</u>.</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-weight: bold;">About XCF Global Capital, Inc.</div>
    <div><br>
    </div>
    <div style="text-align: justify;">XCF Global Capital, Inc. is a pioneering sustainable aviation fuel company dedicated to accelerating the aviation industry&#8217;s transition to net-zero emissions. XCF is developing and operating state-of-the-art clean fuel
      SAF production facilities engineered to the highest levels of compliance, reliability, and quality. XCF is actively building partnerships across the energy and transportation sectors to accelerate the adoption of SAF on a global scale. To learn more,
      visit <u>www.xcf.global.</u></div>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">2</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; font-weight: bold;">Forward Looking Statements</div>
    <div><br>
    </div>
    <div style="text-align: justify;">This Press Release includes &#8220;forward-looking statements&#8221; within the meaning of the &#8220;safe harbor&#8221; provisions of the United States Private Securities Litigation Reform Act of 1995. In some cases, you can identify
      forward-looking statements by terminology such as &#8220;may&#8221;, &#8220;should&#8221;, &#8220;expect&#8221;, &#8220;intend&#8221;, &#8220;will&#8221;, &#8220;estimate&#8221;, &#8220;anticipate&#8221;, &#8220;believe&#8221;, &#8220;predict&#8221;, &#8220;potential&#8221; or &#8220;continue&#8221;, or the negatives of these terms or variations of them or similar terminology.
      These forward-looking statements, including, without limitation, Focus Impact BH3&#8217;s and XCF&#8217;s expectations with respect to future performance and anticipated financial impacts of the Business Combination, estimates and forecasts of other financial
      and performance metrics and projections of market opportunity and market share, are subject to risks and uncertainties, which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These
      forward-looking statements are based upon estimates and assumptions that, while considered reasonable by Focus Impact BH3 and its management, and XCF and its management, as the case may be, are inherently uncertain and subject to material change.
      These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. New
      risks and uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: (1) changes in
      domestic and foreign business, market, financial, political, and legal conditions; (2) the occurrence of any event, change or other circumstances that could give rise to the termination of negotiations and any agreements with regard to XCF&#8217;s offtake
      arrangements; (3) the outcome of any legal proceedings that may be instituted against Focus Impact BH3, XCF, Focus Impact BH3 NewCo, Inc. (&#8220;NewCo&#8221;) or others; (4) the ability to meet Nasdaq&#8217;s continued listing standards; (5) the ability of XCF to
      integrate the operations of New Rise Renewables, LLC (&#8220;New Rise&#8221;) and implement its business plan on its anticipated timeline; (6) the ability of New Rise to produce the anticipated quantities of SAF without interruption or material changes to the
      SAF production process; (7) XCF&#8217;s ability to resolve current disputes between New Rise and its landlord with respect to the ground lease for the New Rise Reno facility; (8) XCF&#8217;s ability to resolve current disputes between New Rise and its primary
      lender with respect to loans outstanding that were used in the development of the New Rise Reno facility; (9)the risk of disruption to the current plans and operations of XCF as a result of the consummation of the Business Combination; (10) the
      ability to recognize the anticipated benefits of the Business Combination, which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth profitably, maintain relationships with customers and
      suppliers and retain its management and key employees; (11) costs related to the Business Combination; (12) changes in applicable laws or regulations; (13) risks related to extensive regulation, compliance obligations and rigorous enforcement by
      federal, state, and non-U.S. governmental authorities; (14) the possibility that the combined company may be adversely affected by other economic, business, and/or competitive factors; (15) the availability of tax credits and other federal, state or
      local government support; (16) risks relating to XCF&#8217;s and New Rise&#8217;s key intellectual property rights; and (17) various factors beyond management&#8217;s control, including general economic conditions and other risks, uncertainties and factors set forth
      in the section entitled &#8220;Risk Factors&#8221; and &#8220;Cautionary Note Regarding Forward-Looking Statements&#8221; in the final prospectus relating to the initial public offering of Focus Impact BH3, dated October 4, 2021, and other filings with the Securities and
      Exchange Commission (&#8220;SEC&#8221;) from time to time, including the registration statement on Form S-4, as amended, initially filed with the SEC by NewCo on July 31, 2024.&#160;If any of the risks actually occur, either alone or in combination with other events
      or circumstances, or Focus Impact BH3&#8217;s or XCF&#8217;s assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that Focus Impact BH3 or XCF does not
      presently know or that it currently believes are not material that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect Focus Impact BH3&#8217;s or XCF&#8217;s
      expectations, plans or forecasts of future events and views as of the date of this Press Release. These forward-looking statements should not be relied upon as representing Focus Impact BH3&#8217;s or XCF&#8217;s assessments as of any date subsequent to the date
      of this Press Release. Accordingly, undue reliance should not be placed upon the forward-looking statements. While Focus Impact BH3 or XCF may elect to update these forward-looking statements at some point in the future, Focus Impact BH3 and XCF
      specifically disclaim any obligation to do so.</div>
    <div><br>
    </div>
    <div style="font-weight: bold;">Contacts</div>
    <div><br>
    </div>
    <div style="font-weight: bold;">XCF Global Capital, Inc.:</div>
    <div>Chris Santa Cruz</div>
    <div><u>invest@xcf.global </u></div>
    <div><br>
    </div>
    <div style="font-weight: bold;">For Media:</div>
    <div>Fatema Bhabrawala</div>
    <div style="text-align: justify;"><u>fbhabrawala@allianceadvisors.com</u></div>
    <div style="text-align: justify;"><u> <br>
      </u></div>
    <div style="text-align: justify;"><u> <br>
      </u></div>
    <div style="text-align: center;"><font style="font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">3</font></div>
    <div style="text-align: justify;">
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"><u> </u></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>26
<FILENAME>ef20050548_ex99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <!--PROfilePageNumberReset%Num%1%%%-->
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 99.2</font><br>
  </div>
  <div>
    <div style="text-align: center;"><br>
      <img src="image02.jpg">
      <div><br>
      </div>
    </div>
    <div style="text-align: center; font-weight: bold;">XCF Global Begins Trading on Nasdaq Under Ticker Symbol &#8220;SAFX&#8221;</div>
    <div>&#160;</div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Reno, NV, and New York, NY, June 9, 2025 &#8211;</font> XCF Global, Inc.
      (&#8220;XCF&#8221;) (Nasdaq: SAFX), a key player in decarbonizing the aviation industry through Synthetic Aviation Fuel (&#8220;SAF&#8221;), announced that its Class A common stock will begin trading at market open today on the Nasdaq Capital Market under the ticker symbol
      &#8220;SAFX.&#8221; The announcement follows the closing of XCF&#8217;s business combination with Focus Impact BH3 Acquisition Company on June 6, 2025.</div>
    <div><br>
    </div>
    <div style="text-align: justify;">&#8220;We&#8217;re proud to begin our journey as a public company and to raise awareness to the growing need for low-carbon aviation solutions,&#8221; said Mihir Dange, Chief
      Executive Officer of XCF. &#8220;The public listing enables us to accelerate development of our SAF platform and expand production to meet the aviation sector&#8217;s growing demand for low-carbon fuel solutions. Our public debut aligns with a new era of growing
      demand and transformative opportunity &#8211; a mission that has never been more urgent.&#8221;</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-weight: bold;">About XCF Global, Inc.</div>
    <div><br>
    </div>
    <div style="text-align: justify;">XCF Global, Inc. is a pioneering sustainable aviation fuel company dedicated to accelerating the aviation industry&#8217;s transition to net-zero emissions. XCF is
      developing and operating state-of-the-art clean fuel SAF production facilities engineered to the highest levels of compliance, reliability, and quality. XCF is actively building partnerships across the energy and transportation sectors to accelerate
      the adoption of SAF on a global scale. To learn more, visit <u>www.xcf.global.</u></div>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" class="BRPFPageNumber">1</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: justify; font-weight: bold;">Forward Looking Statements</div>
    <div><br>
    </div>
    <div>This Press Release includes &#8220;forward-looking statements&#8221; within the meaning of the &#8220;safe harbor&#8221; provisions of the United States Private Securities Litigation
      Reform Act of 1995. In some cases, you can identify forward-looking statements by terminology such as &#8220;may&#8221;, &#8220;should&#8221;, &#8220;expect&#8221;, &#8220;intend&#8221;, &#8220;will&#8221;, &#8220;estimate&#8221;, &#8220;anticipate&#8221;, &#8220;believe&#8221;, &#8220;predict&#8221;, &#8220;potential&#8221; or &#8220;continue&#8221;, or the negatives of these
      terms or variations of them or similar terminology. These forward-looking statements, including, without limitation, XCF&#8217;s expectations with respect to future performance and anticipated financial impacts of the Business Combination, estimates and
      forecasts of other financial and performance metrics and projections of market opportunity and market share, are subject to risks and uncertainties, which could cause actual results to differ materially from those expressed or implied by such
      forward-looking statements. These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by XCF and its management are inherently uncertain and subject to material change. These forward-looking
      statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. New risks and
      uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: (1) changes in domestic
      and foreign business, market, financial, political, and legal conditions; (2) the occurrence of any event, change or other circumstances that could give rise to the termination of negotiations and any agreements with regard to XCF&#8217;s offtake
      arrangements; (3) the outcome of any legal proceedings that may be instituted against XCF or others; (4) XCF&#8217;s ability to meet Nasdaq&#8217;s continued listing standards; (5) XCF&#8217;s ability to integrate the operations of New Rise Renewables, LLC (&#8220;New
      Rise&#8221;) and implement its business plan on its anticipated timeline; (6) the ability of New Rise to produce the anticipated quantities of SAF without interruption or material changes to the SAF production process; (7) XCF&#8217;s ability to resolve current
      disputes between New Rise and its landlord with respect to the ground lease for the New Rise Reno facility; (8) XCF&#8217;s ability to resolve current disputes between New Rise and its primary lender with respect to loans outstanding that were used in the
      development of the New Rise Reno facility; (9) the risk of disruption to the current plans and operations of XCF as a result of the consummation of the Business Combination; (10) the ability to recognize the anticipated benefits of the Business
      Combination, which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its management and key employees; (11)
      costs related to the Business Combination; (12) changes in applicable laws or regulations; (13) risks related to extensive regulation, compliance obligations and rigorous enforcement by federal, state, and non-U.S. governmental authorities; (14) the
      availability of tax credits and other federal, state or local government support; (15) risks relating to XCF&#8217;s and New Rise&#8217;s key intellectual property rights; and (16) various factors beyond management&#8217;s control, including general economic
      conditions and other risks, uncertainties and factors set forth in XCF&#8217;s filings with the Securities and Exchange Commission (&#8220;SEC&#8221;) , including the final proxy statement/prospectus relating to the Business Combination dated registration statement on
      Form S-4, as amended, initially filed with the SEC on February 6, 2025. If any of the risks actually occur, either alone or in combination with other events or circumstances, or XCF&#8217;s assumptions prove incorrect, actual results could differ
      materially from the results implied by these forward-looking statements. There may be additional risks that XCF does not presently know or that it currently believes are not material that could also cause actual results to differ from those contained
      in the forward-looking statements. In addition, forward-looking statements reflect XCF&#8217;s expectations, plans or forecasts of future events and views as of the date of this Press Release. These forward-looking statements should not be relied upon as
      representing XCF&#8217;s assessments as of any date subsequent to the date of this Press Release. Accordingly, undue reliance should not be placed upon the forward-looking statements. While&#160; XCF may elect to update these forward-looking statements at some
      point in the future, XCF specifically disclaim any obligation to do so.</div>
    <div>&#160;</div>
    <div style="font-weight: bold;">Contacts</div>
    <div><br>
    </div>
    <div style="font-weight: bold;">XCF Global, Inc.:</div>
    <div>Chris Santa Cruz</div>
    <div><u>invest@xcf.global</u> </div>
    <div><br>
    </div>
    <div style="font-weight: bold;">For Media:</div>
    <div>Fatema Bhabrawala</div>
    <div style="text-align: justify;"><u>fbhabrawala@allianceadvisors.com</u></div>
    <div style="text-align: justify;"><u> <br>
      </u></div>
    <u> <br>
    </u>
    <div style="text-align: center;"><font style="font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" class="BRPFPageNumber">2</font></div>
    <div style="text-align: justify;">
      <hr noshade="noshade" align="center" style="height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); text-align: center; border: medium none;"><u> </u></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>27
<FILENAME>none-20250612.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 25.5.1.5318 Broadridge-->
<xs:schema targetNamespace="http://bh3ac.com/20250612" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:none="http://bh3ac.com/20250612" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:srt-types="http://fasb.org/srt-types/2025">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="none-20250612_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="none-20250612_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="none-20250612_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://bh3ac.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2025" schemaLocation="https://xbrl.sec.gov/currency/2025/currency-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2025" schemaLocation="https://xbrl.sec.gov/exch/2025/exch-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2025" schemaLocation="https://xbrl.sec.gov/naics/2025/naics-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2025" schemaLocation="https://xbrl.sec.gov/sic/2025/sic-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2025" schemaLocation="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>28
<FILENAME>none-20250612_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 25.5.1.5318 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:t1="http://xbrl.org/2005/xbrldt">
  <link:roleRef roleURI="http://bh3ac.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="none-20250612.xsd#DocumentAndEntityInformation" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:definitionLink xlink:type="extended" xlink:role="http://bh3ac.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressesLineItems" xlink:label="EntityAddressesLineItems" xlink:title="EntityAddressesLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="DocumentType" xlink:title="definition: EntityAddressesLineItems to DocumentType" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="AmendmentFlag" xlink:title="definition: EntityAddressesLineItems to AmendmentFlag" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="DocumentPeriodEndDate" xlink:title="definition: EntityAddressesLineItems to DocumentPeriodEndDate" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="CurrentFiscalYearEndDate" xlink:title="CurrentFiscalYearEndDate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="CurrentFiscalYearEndDate" xlink:title="definition: EntityAddressesLineItems to CurrentFiscalYearEndDate" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="DocumentFiscalYearFocus" xlink:title="definition: EntityAddressesLineItems to DocumentFiscalYearFocus" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="DocumentFiscalPeriodFocus" xlink:title="definition: EntityAddressesLineItems to DocumentFiscalPeriodFocus" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="EntityFileNumber" xlink:title="definition: EntityAddressesLineItems to EntityFileNumber" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="EntityRegistrantName" xlink:title="definition: EntityAddressesLineItems to EntityRegistrantName" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="EntityCentralIndexKey" xlink:title="definition: EntityAddressesLineItems to EntityCentralIndexKey" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="EntityIncorporationStateCountryCode" xlink:title="definition: EntityAddressesLineItems to EntityIncorporationStateCountryCode" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="EntityTaxIdentificationNumber" xlink:title="definition: EntityAddressesLineItems to EntityTaxIdentificationNumber" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="EntityAddressAddressLine1" xlink:title="definition: EntityAddressesLineItems to EntityAddressAddressLine1" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="EntityAddressAddressLine2" xlink:title="definition: EntityAddressesLineItems to EntityAddressAddressLine2" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="EntityAddressAddressLine3" xlink:title="definition: EntityAddressesLineItems to EntityAddressAddressLine3" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="EntityAddressCityOrTown" xlink:title="definition: EntityAddressesLineItems to EntityAddressCityOrTown" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="EntityAddressStateOrProvince" xlink:title="definition: EntityAddressesLineItems to EntityAddressStateOrProvince" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="EntityAddressCountry" xlink:title="definition: EntityAddressesLineItems to EntityAddressCountry" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="EntityAddressPostalZipCode" xlink:title="definition: EntityAddressesLineItems to EntityAddressPostalZipCode" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="CityAreaCode" xlink:title="definition: EntityAddressesLineItems to CityAreaCode" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="LocalPhoneNumber" xlink:title="definition: EntityAddressesLineItems to LocalPhoneNumber" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="Security12bTitle" xlink:title="definition: EntityAddressesLineItems to Security12bTitle" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="TradingSymbol" xlink:title="definition: EntityAddressesLineItems to TradingSymbol" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="NoTradingSymbolFlag" xlink:title="definition: EntityAddressesLineItems to NoTradingSymbolFlag" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="SecurityExchangeName" xlink:title="definition: EntityAddressesLineItems to SecurityExchangeName" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="EntityEmergingGrowthCompany" xlink:title="definition: EntityAddressesLineItems to EntityEmergingGrowthCompany" order="25.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="EntityExTransitionPeriod" xlink:title="EntityExTransitionPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="EntityExTransitionPeriod" xlink:title="definition: EntityAddressesLineItems to EntityExTransitionPeriod" order="26.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="WrittenCommunications" xlink:title="definition: EntityAddressesLineItems to WrittenCommunications" order="27.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="SolicitingMaterial" xlink:title="definition: EntityAddressesLineItems to SolicitingMaterial" order="28.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="PreCommencementTenderOffer" xlink:title="definition: EntityAddressesLineItems to PreCommencementTenderOffer" order="29.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="definition: EntityAddressesLineItems to PreCommencementIssuerTenderOffer" order="30.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="EntityInformationFormerLegalOrRegisteredName" xlink:title="EntityInformationFormerLegalOrRegisteredName" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="EntityInformationFormerLegalOrRegisteredName" xlink:title="definition: EntityAddressesLineItems to EntityInformationFormerLegalOrRegisteredName" order="31.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressesTable" xlink:label="EntityAddressesTable" xlink:title="EntityAddressesTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="EntityAddressesLineItems" xlink:to="EntityAddressesTable" xlink:title="definition: EntityAddressesLineItems to EntityAddressesTable" order="32.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="EntityAddressesAddressTypeAxis" xlink:title="EntityAddressesAddressTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="EntityAddressesTable" xlink:to="EntityAddressesAddressTypeAxis" xlink:title="definition: EntityAddressesTable to EntityAddressesAddressTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AddressTypeDomain" xlink:label="AddressTypeDomain" xlink:title="AddressTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="EntityAddressesAddressTypeAxis" xlink:to="AddressTypeDomain" xlink:title="definition: EntityAddressesAddressTypeAxis to AddressTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AddressTypeDomain" xlink:label="AddressTypeDomain_2" xlink:title="AddressTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="EntityAddressesAddressTypeAxis" xlink:to="AddressTypeDomain_2" xlink:title="definition: EntityAddressesAddressTypeAxis to AddressTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_FormerAddressMember" xlink:label="FormerAddressMember" xlink:title="FormerAddressMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AddressTypeDomain" xlink:to="FormerAddressMember" xlink:title="definition: AddressTypeDomain to FormerAddressMember" order="1.0" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>29
<FILENAME>none-20250612_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 25.5.1.5318 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract" xml:lang="en-US" id="dei_CoverAbstract">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract" xlink:title="label: CoverAbstract to dei_CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType" xml:lang="en-US" id="dei_DocumentType">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType" xlink:title="label: DocumentType to dei_DocumentType" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications" xml:lang="en-US" id="dei_WrittenCommunications">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications" xlink:title="label: WrittenCommunications to dei_WrittenCommunications" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial" xml:lang="en-US" id="dei_SolicitingMaterial">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer" xml:lang="en-US" id="dei_PreCommencementTenderOffer">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag" xml:lang="en-US" id="dei_AmendmentFlag">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag" xlink:title="label: AmendmentFlag to dei_AmendmentFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus" xml:lang="en-US" id="dei_DocumentFiscalYearFocus">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate" xml:lang="en-US" id="dei_DocumentPeriodEndDate">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName" xml:lang="en-US" id="dei_EntityRegistrantName">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey" xml:lang="en-US" id="dei_EntityCentralIndexKey">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber" xml:lang="en-US" id="dei_EntityFileNumber">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber" xlink:title="label: EntityFileNumber to dei_EntityFileNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="CurrentFiscalYearEndDate" xlink:title="CurrentFiscalYearEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CurrentFiscalYearEndDate" xml:lang="en-US" id="dei_CurrentFiscalYearEndDate">Current Fiscal Year End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate" xlink:title="label: CurrentFiscalYearEndDate to dei_CurrentFiscalYearEndDate" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="EntityExTransitionPeriod" xlink:title="EntityExTransitionPeriod" />
    <link:label xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityExTransitionPeriod" xml:lang="en-US" id="dei_EntityExTransitionPeriod">Entity Ex Transition Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod" xlink:title="label: EntityExTransitionPeriod to dei_EntityExTransitionPeriod" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="EntityInformationFormerLegalOrRegisteredName" xlink:title="EntityInformationFormerLegalOrRegisteredName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityInformationFormerLegalOrRegisteredName" xml:lang="en-US" id="dei_EntityInformationFormerLegalOrRegisteredName">Entity Information, Former Legal or Registered Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityInformationFormerLegalOrRegisteredName" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName" xlink:title="label: EntityInformationFormerLegalOrRegisteredName to dei_EntityInformationFormerLegalOrRegisteredName" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressesTable" xlink:label="EntityAddressesTable" xlink:title="EntityAddressesTable" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressesTable" xml:lang="en-US" id="dei_EntityAddressesTable">Entity Addresses [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressesTable" xlink:to="dei_EntityAddressesTable" xlink:title="label: EntityAddressesTable to dei_EntityAddressesTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="EntityAddressesAddressTypeAxis" xlink:title="EntityAddressesAddressTypeAxis" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressesAddressTypeAxis" xml:lang="en-US" id="dei_EntityAddressesAddressTypeAxis">Entity Addresses, Address Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressesAddressTypeAxis" xlink:to="dei_EntityAddressesAddressTypeAxis" xlink:title="label: EntityAddressesAddressTypeAxis to dei_EntityAddressesAddressTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AddressTypeDomain" xlink:label="AddressTypeDomain" xlink:title="AddressTypeDomain" />
    <link:label xlink:type="resource" xlink:label="dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AddressTypeDomain" xml:lang="en-US" id="dei_AddressTypeDomain">Address Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AddressTypeDomain" xlink:to="dei_AddressTypeDomain" xlink:title="label: AddressTypeDomain to dei_AddressTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_FormerAddressMember" xlink:label="FormerAddressMember" xlink:title="FormerAddressMember" />
    <link:label xlink:type="resource" xlink:label="dei_FormerAddressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_FormerAddressMember" xml:lang="en-US" id="dei_FormerAddressMember">Former Address [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FormerAddressMember" xlink:to="dei_FormerAddressMember" xlink:title="label: FormerAddressMember to dei_FormerAddressMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressesLineItems" xlink:label="EntityAddressesLineItems" xlink:title="EntityAddressesLineItems" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressesLineItems" xml:lang="en-US" id="dei_EntityAddressesLineItems">Entity Addresses [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressesLineItems" xlink:to="dei_EntityAddressesLineItems" xlink:title="label: EntityAddressesLineItems to dei_EntityAddressesLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1" xml:lang="en-US" id="dei_EntityAddressAddressLine1">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2" xml:lang="en-US" id="dei_EntityAddressAddressLine2">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3" xml:lang="en-US" id="dei_EntityAddressAddressLine3">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown" xml:lang="en-US" id="dei_EntityAddressCityOrTown">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince" xml:lang="en-US" id="dei_EntityAddressStateOrProvince">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry" xml:lang="en-US" id="dei_EntityAddressCountry">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode" xml:lang="en-US" id="dei_EntityAddressPostalZipCode">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode" xml:lang="en-US" id="dei_CityAreaCode">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode" xlink:title="label: CityAreaCode to dei_CityAreaCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber" xml:lang="en-US" id="dei_LocalPhoneNumber">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle" xml:lang="en-US" id="dei_Security12bTitle">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle" xlink:title="label: Security12bTitle to dei_Security12bTitle" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag" xml:lang="en-US" id="dei_NoTradingSymbolFlag">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol" xml:lang="en-US" id="dei_TradingSymbol">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol" xlink:title="label: TradingSymbol to dei_TradingSymbol" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName" xml:lang="en-US" id="dei_SecurityExchangeName">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>30
<FILENAME>none-20250612_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 25.5.1.5318 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://bh3ac.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="none-20250612.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://bh3ac.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressesTable" xlink:label="EntityAddressesTable" xlink:title="EntityAddressesTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="EntityAddressesAddressTypeAxis" xlink:title="EntityAddressesAddressTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AddressTypeDomain" xlink:label="AddressTypeDomain" xlink:title="AddressTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_FormerAddressMember" xlink:label="FormerAddressMember" xlink:title="FormerAddressMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AddressTypeDomain" xlink:to="FormerAddressMember" xlink:title="presentation: AddressTypeDomain to FormerAddressMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesAddressTypeAxis" xlink:to="AddressTypeDomain" xlink:title="presentation: EntityAddressesAddressTypeAxis to AddressTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesTable" xlink:to="EntityAddressesAddressTypeAxis" xlink:title="presentation: EntityAddressesTable to EntityAddressesAddressTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressesLineItems" xlink:label="EntityAddressesLineItems" xlink:title="EntityAddressesLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="DocumentType" xlink:title="presentation: EntityAddressesLineItems to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="AmendmentFlag" xlink:title="presentation: EntityAddressesLineItems to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: EntityAddressesLineItems to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="CurrentFiscalYearEndDate" xlink:title="CurrentFiscalYearEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="CurrentFiscalYearEndDate" xlink:title="presentation: EntityAddressesLineItems to CurrentFiscalYearEndDate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: EntityAddressesLineItems to DocumentFiscalYearFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: EntityAddressesLineItems to DocumentFiscalPeriodFocus" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="EntityFileNumber" xlink:title="presentation: EntityAddressesLineItems to EntityFileNumber" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="EntityRegistrantName" xlink:title="presentation: EntityAddressesLineItems to EntityRegistrantName" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="EntityCentralIndexKey" xlink:title="presentation: EntityAddressesLineItems to EntityCentralIndexKey" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: EntityAddressesLineItems to EntityIncorporationStateCountryCode" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: EntityAddressesLineItems to EntityTaxIdentificationNumber" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: EntityAddressesLineItems to EntityAddressAddressLine1" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: EntityAddressesLineItems to EntityAddressAddressLine2" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: EntityAddressesLineItems to EntityAddressAddressLine3" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: EntityAddressesLineItems to EntityAddressCityOrTown" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: EntityAddressesLineItems to EntityAddressStateOrProvince" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="EntityAddressCountry" xlink:title="presentation: EntityAddressesLineItems to EntityAddressCountry" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: EntityAddressesLineItems to EntityAddressPostalZipCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="CityAreaCode" xlink:title="presentation: EntityAddressesLineItems to CityAreaCode" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="LocalPhoneNumber" xlink:title="presentation: EntityAddressesLineItems to LocalPhoneNumber" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="Security12bTitle" xlink:title="presentation: EntityAddressesLineItems to Security12bTitle" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="TradingSymbol" xlink:title="presentation: EntityAddressesLineItems to TradingSymbol" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: EntityAddressesLineItems to NoTradingSymbolFlag" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="SecurityExchangeName" xlink:title="presentation: EntityAddressesLineItems to SecurityExchangeName" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: EntityAddressesLineItems to EntityEmergingGrowthCompany" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="EntityExTransitionPeriod" xlink:title="EntityExTransitionPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="EntityExTransitionPeriod" xlink:title="presentation: EntityAddressesLineItems to EntityExTransitionPeriod" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="WrittenCommunications" xlink:title="presentation: EntityAddressesLineItems to WrittenCommunications" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="SolicitingMaterial" xlink:title="presentation: EntityAddressesLineItems to SolicitingMaterial" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: EntityAddressesLineItems to PreCommencementTenderOffer" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: EntityAddressesLineItems to PreCommencementIssuerTenderOffer" order="29.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="EntityInformationFormerLegalOrRegisteredName" xlink:title="EntityInformationFormerLegalOrRegisteredName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="EntityInformationFormerLegalOrRegisteredName" xlink:title="presentation: EntityAddressesLineItems to EntityInformationFormerLegalOrRegisteredName" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesTable" xlink:to="EntityAddressesLineItems" xlink:title="presentation: EntityAddressesTable to EntityAddressesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressesTable" xlink:title="presentation: CoverAbstract to EntityAddressesTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>image01.jpg
<TEXT>
begin 644 image01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" !M 5@# 2(  A$! Q$!_\0
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MFU^SS>9^\QC&",<?6N+*<IJX*JYS:::.C$XJC*C*,9:LZ?\ 92_YFC_MU_\
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MV[3(V.<]3]:XO0_A;<^&]4\-7^C:]>W+Z8AM9H+YE,;V[C+JFQ 0=X##.>]
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M[HKM*SE>^IWT%!02IJRU_,****1L%%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
#'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>image02.jpg
<TEXT>
begin 644 image02.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" !L %P# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#ZIKG_ /A-
M?"W_ $,NB?\ @?%_\5705\#6EO+=W45O;H7FE8(BCJ2>@JX0YCAQN+EAN7E5
M[GVS_P )KX6_Z&71/_ ^+_XJI+?Q=X;N)5BM_$.CRR-T1+V)B?P#5\I_\*K\
M9_\ 0#N/S7_&H+WX;>+[.$RS:%>; ,DHN['Y5?LX]SE_M#$+5T_S/LY6#*"I
M!!Y!'>EKXS\$>/\ 7_!5X$MII)+-6Q)8SDE.O.!_"?<?CFOK+PAXCLO%6@V^
MJ:<Q\J489#]Z-AU4^XJ)0<3LPN-AB-%H^QM5%<W,%K"9;J:.&(=7D8*!^)KA
MOBU\0H/!&F(L")<:M<@^1"QX4=W;V]N]?+^I:GXA\;ZP&N9+O4KQR=D2 L$]
ME4< ?2G&FY:D8K'QH2Y(J\CZ_/C3PL#@^)=$!_Z_XO\ XJD_X37PM_T,NB?^
M!\7_ ,57RK'\+O&4B!AH5T,]FP#^6:BU#X;^*]/LIKN[T>>*WA0O(Y(PH'?K
M5>SCW.;^T,1O[/\ ,^M[#Q1H&HW:6NGZYI=U=29V0P7<;NV!DX4')X!/X5L5
M\@? 7_DK&A?]M_\ T1)7U_43CRNQVX/$O$0<VK:A7PUX,_Y&W1_^ON+_ -"%
M?<M?#&G%M#\5P?:@ ]E> 2 \8*/@_P JNEU.+-=)4WZ_H?4WC76+^RUQHK6Z
MDCCV*=JGBL>T\5ZM;RAFN6E&>5?D&M#X@6QDO+?4(?GMKB)=KCIT_P ,5R77
MI7P6/KUZ.*FE)K7NSU&]2+XV>&K'7?":^+=-MQ#?0,%NU1>'7.,GW!(Y]#6)
M^S'KDMMXFO=&=F-M=PF95[+(F.?Q4G\A7H/B6REM/@QK[3 JTT6\*?3<N*\C
M_9U_Y*7;_P#7M-_Z#7VN"J3JX6,JF]CR:\53QD)1TO\ \,<]\2M8G\2^/M3N
M"6<&X-O OHBG:H ]^OU)KZ!T+3+3X;^%[.ULH(VUBYC#W$[KSG'/X \ >U?-
MY_Y'@_\ 80_]J5]0_$FRE%U!=J"8F783Z$5SYQ6J4<*Y4MPRZ*G.=26_^9@R
M>)M7=RWVV4>P.!6A>7]U?_#;Q0]Y,\K+;L 6.<?+7+UN:ZXT3X1:[<W?R&[C
M\N)6.-Q;@?U/X5\UDM6M5Q:YI-K6^K/2J.T)-]F>-_ 7_DK&A_\ ;?\ ]$25
M]?5\C_L^VTD_Q3TR2,96WCFED]E,3)_-A7UQ7VE7XCDRE?N7Z_H@KYD_:$\#
M3:7KDGB*PB+:??-NGVKQ%+W)]FZY]<^U?3=1W,$5U \-Q&DL,@VNCC(8>A%1
M&7*[G7BL.L1#D9\Q?#OXO'1])31O$MH=0TV,;8I!@R(OH<]0.W>NVM_BA\.H
M9O-2VOBV<@-!D#\-U.\9? O1;MY;O1M0.DYRS12CS(1].05'XGZ5PO\ PII/
M^AQT+_OO_P"O1.A0JM2G%-^AYB>-H+DLFCU'Q;XMTSQA\(_$MYH_G>3%'Y;>
M:FTYRI]:\'^$/B.P\*^,XM3U7S1;+#(A\I-QR1QQ7J/]BVGA#X.^)],?7--O
MIYQYB>1*,]5&,9R>E>+>#= 'B36TT\W]M8!D9_.N#A!@=*VBE9KH8XJ=1U:<
MOM6_&YZI_;OPA^W?:_L&I^?YOG;MI^]G.?O>M=Q/\;O!<\313+?21L,%6M@0
M?UKYB6R+:L+%9%8F?R1(.A^;&?I7J]Y\#Y;*7R[OQ3I$$F,A9<J<>N":4H1>
MD@H8G$._LHKST_X)UK?%'X>VY:>WL;Z:4<K&T7&?Q:O*_B9\1;_QO<10^4+3
M3(#F*V0YR?5CW-=);_!99IXXQXOT4EF PAW,?H,\FO5O GPAT#PQ-'>3,^J7
MZ\K-.H"(?54''YDUE3I4:'\.*7H;.&+Q2Y)62,S]GWP/+X>TB76-3B,>H7ZA
M4C<8:*+J,^A8X)'L*]<HHI-W=V>M1I1HP4(] K@OBM\0[;P/IZ+&BW&JW /D
MP$\*/[[>W\Z[VOBGQ]K,_BOQUJ%WNWB:X,-N,\",':@'X8/U)-53CS/4YL?B
M70I^[NQFK:WXE\;ZD1<S7FH2L=RP1@E$^B#@5:'PU\8D9_X1^^_[XKZ%T?3]
M/^&OANVL;"WCDU69 T\S#)9NY)],\ >U16_C754F#2M'*G="@&?RYK@Q.=8?
M#5/9/?RZ'''+%)<U63N?/_\ PK7QC_T+]]_WQ1_PK3QC_P!"_??]\5].>-/$
M,J_#75=8TF5H+F.#<C#!,;;@#_.O*?@KX]\2>(/'4-CJVI27%JT$C&-E &0.
M.@KT:=;VD/:1V,JF"H4ZD:3;N_0\;T>-X?$-G%*I61+I%93U!##(KVGX]^#_
M !!KWC&*ZT?2KF[MQ;*ADC7(SD\5Y$?^1X/_ &$/_:E?8GBK7UT6W01J)+F3
M[BGH!ZFIQ.(AAX^UF[)!@:$:U.<)/2Z_4^2;KX>>+;6%I9M!OUC7J1'G'Y5>
M\%?$;Q#X-O%B\^6XLT.V2RN22 /09Y4_2O=8O&NJK,&=XG3.2A0 '\N:YWXU
M>&].\1^#V\5Z; L%_:X^T;0!O7(!W>I&1@^E<>#S:AC9.$=_,NI@'0C[2C)W
M1ZQX/\1V/BK0;?5--;,4@PZ$_-&XZJ?<5M5\Q_LSZ]+9^+;C1G?_ $:_A9U0
MGI*@SD?\!W9^@]*^G*ZYQY78]/"5_;TE-[]0KX9\&@'Q9HX(R/M<?_H0K[FK
MX3\-745CX@TZZN"5AAN$D<@9P P)K2ELS@S7XJ?S_0^G/B&Q/B!@2<"-<"N9
MK7U/XC?#S4KHW%U=W32$ 9$+ <?A5"X^(?PZL5\ZW2]O)!G;$(R 3[YQQ7R6
M)R/$UJ\JBM9O^NAVO$T=^=?>7O%\@TOX+ZPUX67[81'"I[DD8_D?RKS']G*)
MY/B3&R*2([65G([#@9_,C\ZQ?B5\0+_QO>Q!XQ:Z;!_J+5#D+[GU->W_ +/W
M@F7P[H<NJZG$8]1U #;&PPT40Y /H3U/X5]/AZ"PN'5*^QYRG];Q<90VB?.N
MHDV'C6Z-RI4V^H,9%[C;(<C]*^F_'X-U)8ZC"2]K/"I1NP[_ ,C7E_[1'@F;
M3M;?Q'8Q,UA>$?:-HXBEZ9/LW\\^M4/AO\5_[$TM=$\26K:AI"\1LO\ K(1Z
M#/4>G2LLQPGUW#^SB[,6'J+"59TJNB?4[&M]3GX8^*0>1Y#'!_W:RX_'7PVD
M0.9KV,MSM:)LC^=1:]\0_!(\'ZSIVD7=P9KN!D56B;EL8'->'EN3XG#8B-6=
MK+^NQZ$\12Y':2V[GF/P%_Y*QH?_ &W_ /1$E?7U?(/P%_Y*QH?_ &W_ /1$
ME?7U?35=S#*?X+]?T05\Q_\ #/WB;_H(Z-_W]E_^-U].5Y?KGQ+OM$U?4=$O
M='#ZSYJ+ID<)9DNT<X#$XXQW_&I@VMCHQE.C-)UCS/\ X9^\3?\ 01T;_O[+
M_P#&Z=#^S[XC,BB;4](6//S,CR,0/8;!G\Z];UKQ7KS:[;^'=!L;*36EM1<W
MDDTC"&#/\([M536/'NM:/X+EU+4M#2VU.&^%DT4LA$4F3CS$;KMJ^>9R/"X1
M7NGIZD/@/X-:)X:N([W4)#JNH)AE:5 L4;>JISS[DG\*]0KD_!6N:QK%Q<C5
M(='6"-1M:PO!.=V>C8Z<50\1>*M9E\5R^'/"5C;37EM"L]U<7;E8X@V-J@#J
M2#6;NWJ=M-TJ--."LGY:G;7=M!>6LMM=PQS6\JE7CD4,K ]B#7BWBWX!V%Y<
M/<>&[\V!8D_9IU+QC_=;J!]<UUDWC76M/\*7%]J^BK:ZC;7L=HR%\Q2AG"[T
M/7'-;>N>//#NAZG]@U+45BN5 ,@",PB!Z;R!A?QIKFCL355"NOWGXZ;_ /#'
MA7_#/WB;_H(Z-_W]E_\ C='_  S]XF_Z".C?]_9?_C=>LZM\3+#1?&UUI&J^
M7%I\=DES%<H&=I&8CC '3!)S[5N:MX\\.Z7965U<Z@K17D?FP>2AD+IW; '0
M57/,Y5@\&[Z[>9YC\-/@_KOA;QMINLW][IDMM;>9O2&20N=T;(,90#JP[U[K
M7%2>.(Y?%_AC3--2&YT_6H)IEN@Q!4(C,,#_ (#CFNUJ)-O5G;AJ=*G%QI;7
M_1!7C6N>"O%/B'5]1\43M]@UBSD4:-9B5& C0Y^<@D9;/KUSGC%>RT4D[;&E
M6C&JK2/,M0T?Q5;>)+?Q9H^G6LM_=62VU]IMQ.J[&'='!(/YU4\2>%_%VN^!
M&M=9>WO=3GU)+G[-&RK';P[LE QQNQSU)]!TR?6**?,9O#1::;=F9NCZ%I6B
MB4:1IUK9"7!?R(PF['3.*X3Q5X<URR\6ZIK&B:=%K.GZQ9BTOK W0MI!A=H9
M'/ X_'D_6O3:*2;1I.C&45':W8\/TSX>^(+?PKK$1LHH9KZ_M)X;%;OS3!'&
M^6!=C@\'L3TK2\1>&/$T%]XLM=*T>RU&S\0L&%X]PL9M<C!#*>6 ZC'UKUZB
MJYV8_4X)63?]7_S/&QX5\3>'/$IO=*T>'6;=-$ATH;KI(2S*%!<!O3;T..M4
MI_ WB[3]%T#3+1&O+2.UE2Y2VO5MC'*YS\SD;F0#'RCKS7N-%'.P>#AW9X_X
M3\&:[8ZUX!N+NR6*+2+>ZANSYR'8660+C!Y!W#IZ\U[!114MW-J5&-)6C_6E
$OT/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jun. 12, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 12,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-42687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">XCF GLOBAL, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0002019793<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">33-4582264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2500 CityWest Blvd<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 150-138<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Houston<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">77042<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">346<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">630-4724<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SAFX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationFormerLegalOrRegisteredName', window );">Entity Information, Former Legal or Registered Name</a></td>
<td class="text">Focus Impact BH3 NewCo, Inc.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_FormerAddressMember', window );">Former Address [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">345 Avenue of the Americas<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">33rd Floor<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10105<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationFormerLegalOrRegisteredName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Former Legal or Registered Name of an entity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationFormerLegalOrRegisteredName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_FormerAddressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_FormerAddressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>26</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ef20050548_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bh3ac.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ef20050548_8k.htm">ef20050548_8k.htm</File>
    <File>none-20250612.xsd</File>
    <File>none-20250612_def.xml</File>
    <File>none-20250612_lab.xml</File>
    <File>none-20250612_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="31">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>40
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ef20050548_8k.htm": {
   "nsprefix": "none",
   "nsuri": "http://bh3ac.com/20250612",
   "dts": {
    "inline": {
     "local": [
      "ef20050548_8k.htm"
     ]
    },
    "schema": {
     "local": [
      "none-20250612.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/currency/2025/currency-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/exch/2025/exch-2025.xsd",
      "https://xbrl.sec.gov/naics/2025/naics-2025.xsd",
      "https://xbrl.sec.gov/sic/2025/sic-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "none-20250612_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "none-20250612_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "none-20250612_pre.xml"
     ]
    }
   },
   "keyStandard": 26,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2025": 3
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 37,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 31
   },
   "report": {
    "R1": {
     "role": "http://bh3ac.com/role/DocumentAndEntityInformation",
     "longName": "000100 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c20250612to20250612",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20050548_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20250612to20250612",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20050548_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://bh3ac.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://bh3ac.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://bh3ac.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://bh3ac.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://bh3ac.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://bh3ac.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://bh3ac.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://bh3ac.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://bh3ac.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://bh3ac.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://bh3ac.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://bh3ac.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://bh3ac.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://bh3ac.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://bh3ac.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://bh3ac.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://bh3ac.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://bh3ac.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://bh3ac.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://bh3ac.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://bh3ac.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://bh3ac.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://bh3ac.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://bh3ac.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://bh3ac.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://bh3ac.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_FormerAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "FormerAddressMember",
     "presentation": [
      "http://bh3ac.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Address [Member]",
        "documentation": "Former address for entity"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://bh3ac.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://bh3ac.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://bh3ac.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://bh3ac.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://bh3ac.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://bh3ac.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://bh3ac.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://bh3ac.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://bh3ac.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "249",
   "Section": "308",
   "Subsection": "a"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Number": "249",
   "Section": "308"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>41
<FILENAME>0001140361-25-022325-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-25-022325-xbrl.zip
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MY4W-YQCKLR+,<5/G</SG,HNA/QIT^H->9[@[N@9)\9P9,P #@0L6!C7BU&;
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M9=:/$+">%\W>!/%\V!V>LDF88N:R+3CRWV/=0KP,]FW90+H,"7*C?+B)WDT
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ME!T.?*E][7P:3*G!<.[TY(G,"=TAL*Y ,2IPTS@<3J_J_Q:7;!J7 4"@B*4
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M37"ZJ+KKT%D*U(>>4W;AIY@*U1\$,\"/"[]W"HZZ0!70Z9':"_9Z"IHW*<:
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MF;\1LP#T.23,?\ /$:S[E5QS* ,]EVS0O%I\!)8'N'<>/(?_+=PLY!,XX M
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M6FBE:YTH(.S\ 2L;[4T>5>O(T[9'%L;S.: 7)<FZQL!)3/.*C+^[LLM*G).
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MMT7P;?$)FK8297/*R,("<<HA)0\WIMQ=JC@APL[2QH%=Z4D1EP\A)$OQUY;
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MFY?K&((RZ6,<.3OU)_&>=K/]UV>^(7ZNT!G/=+*78F'(/\^SWMUK9;Y<=KM
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MY!=;T#&\V#&N,?7=N$H>K1-3LC30E2'9;M QV[VVV1YTV_WNFTF[W>F8W0E
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M;E]_V'2I@:8<FI8JO=[3!^EI34MK6@<%P.AP)EX90(/@@;6MOBH[WM?9!O4
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MVX7UEKEG5. \O<'-,_N!GQJ&L!;L4]/OQ$N8A0D<5J-UYND4K?,\V+B91'(
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M)"<5,+<M+S3&*<$@> T#(P1T)A1C@NN:%53?#@T=' 2(Y! >JT+5QF:Q9]@
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M6%SU"Y6Z4>YR#;Y+0+PZQ8;E]9>MT5/4-EUCP)_*<SF@UPD?N*T*7BA%UM&
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M\B44R=ECWN]MS^/ZT@6G@VITB(^H5I]"_/?0Z2',GR3 @ UL>R!@\G+,'1]
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MB5K8<H_%99UZU.R<D5&-DL!1-CY)8[?I9LE?*_.6:9H'63Q7IF$29RNL7RT
MMOI"YB0#S" >< 6-MI*L.8EPF$J)M=H\SGV$QJ:.$%^XGE316<NJ<IZY\G?K
M!O9 >_NM4J^>KF9*UZMY5[6,#>F/.K0B9!T_NQNEJ2WT07 >/L@0/.=>"])Z
MFA E((Y)72,492'K5I,\K"B.)E#&YE03>KU4<IML!S2P4Y/S< /')D^I+HI'
M^_+0\7L&O9<4C-NL1,7*>$F;DV.->MZ\./.KOZZV1A7$R-UY/YY4@2J7KCYR
M"AA$4R$".V6AYB&?HV;:]4%HNLZ-@<W@)EW ?W*:"LH$&&I.!7(D-O*@<;Z:
MY,>Q77L\U*"/9L15J4&MSKQ NA<M@.$7BR+J^'V9F7DO_JH"JN(#0 ;C'$NL
M%H=WV<3=**9=1XU#LZL)T,<S:C?H5YB@44Y+21JF36ZEP+1O+38![UE/-AT\
M5U \?AB@/+">SKTM!RCK1_4 9F]E>9::O$NFO<G5GMG:0) TV=*;:VYCAWNU
M+$X=O#5MA67^'$>4B%E%@M4E:EB"*^S^39@)"[/R59."0@*E"J+0:D["46 *
MWB!UUDJ;!F>I/)F::@ 8!KI2T#;L(Y42#Y97^!E$#IN>NJI4]<?(=LRL >P;
MNQJ6(YU&-\=B^L@"-A/1G_*UU:6GD;U;.9"TJ$Q'#F_;;H,VTTQU<#R&8B*P
M\Q!@!" 26+UQ6"N:5>LTW!I4^L4:E7[XZJ$KY^2N4$.T/CCT'583K2VR&I1]
M#C5=PC[9Q[CH1J>E")BDTO@D6G[!WO8^1[!ZY9PT,=9RSKU!:4E0D3#Y4L>"
MM[]2;KAIWS!Q'*D*HF "Z[;>!E<APU@%!<==<1!;T&ILJB?5#=05E&HLK(FO
ME9I[UG^J-,]D&JSVYGUF0E.^AP;MW4/]&?CF&7>]V13D<=JDV,"XG\VGZ6T4
M,<AMVIY8_&$0)=$X+K!@/MC#I$LZ]7ARB6,'5,/3,!BH< 4M%C>LY0QGO\6%
M.W[2..%0)?DTI7HV]G>B=:"AQS;ZK+:=K#.I4$=VPB@:%"UX"QEVU_*D "XG
M^%R47JMB_[A8FRL<[B5G6E<*I+*JA:H*N809H3?+U_(F=+T"'Z;Y:73/-YL0
M<RRE;O/HE:<^=$E4U7 %G@NJE%7/NFDV[.MSCDRL2=[+ ]LXHJC:,(L';&M+
MJ()<^=MY5"KD4BI79&S:U&+^S-\JN/4>AU"0\X#L!15<Z5E4'!-/S6;;%3!!
MTDY @@NE54=#:./KS<"V1E*5QY8O(Z$'<W3"%HFT7"E'/NK$$),;ESE?N$<:
MW4?):7(57*S5)U_<C;UY=](F+2DYB)*\(9Q:ZV)5>)EPKC8JQOE]LSZLCO9Q
M^)9*!IX&K]?7U3OJDOFZ(2R56]# J]%EPE;[9HAA#CS=*AQ8@EI6KHW=F81@
MMK=A;'X>><.*Z9(+_G%OX:,J7E%IN0J)4:6E J*<?$G)C925:<BJ7&%1-XEM
M5&HK;$EIZDMJU+;E1#;445XN/TO%*M+Q2HRQ)75:S>+7<<?:56UW7I?AIZU&
M'//YR*LPR%9U*2J%MP[O5WEK);]E!?>NPD!J=M_N34&J))_Q[6SB$S9RE&H9
ME<8>:*44-]S)%:E)7SUD6\]+VA LE%_O9:O?;1S.\.'BDVS=-?-E$-.E<"TC
M\J64P15#FB:13#EOG8PJ-V\47.3+]!Q.W&PKV?DUTE?M])S2:336R0;P*M6S
M<_00\>CZ;;$Y#5Z278?-JI]-1YI7+;O+)@-J4E=E$IKCU19[)NV2O%Q3=#N
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MO=K;X:)(RZ4S^7=L\-DQ-APU\Z\??QBDHUOZQZ283>$?_Q]02P,$%     @
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MB[*IX9;V"'>XLU8 #+T H6"/.I;%N$6-C'DP46&7J"$BT$NX2L[R?CA1[7M
MZ-I,D:FA$K2@,:?Y;8PRAD*']+5%$40H#M>6P=X6=8M>M_F-\@YW$846$'$'
MF2<A&HIF7-M*+.KMCK>*A*K_H-UB; _</7=="V-S%W:=[/NMWN,>'C+,RM*U
M"0/05BGZ<W>YC%70*<NTH\2"E=!T?38Y(Z2T1*[J31!=8CB#SI(^R76PB^$,
M'8*[*:GU05+@X"ZQ; 'E<!PDPU9EUZH2#9[.JJHA7W/Q,W3ZX04K[+FP'T>S
MW/ KFT?4K;"::(^[[];;=X,,6LEEFUX'+#Y>Y.1RXKE@5V3N.C]#%E<&[ZQ
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MGX-?SL[_'M)S9Q\O@W>#GW#&_;=O^\>7P>49S>3X_=G@F%Z 5H*S<^SM[<D
M'I"/SC^>P&S@BP_G9S\-+@8P&!H5%EW"#G_JGW[L!V_A 6RN=TP%%BY[?^^?
M4L=N]K :'Z3CKIEC"S*!\^!M_TW_O'<" _IX?HE3;YW>U[SO.SB@]K\ZH!Z
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M>#S!!Y0& \.+U0#L:,Y#E:@"=)WV% LP VQ'=@T$T!BV)TS%J&?WD 6N"DL
M-@-.(VKREL'S.6T& )9/[K)[1J>K:R7 %K%CR:,5(N'[*HB:OBX?6$5RCZH
M,YO "B&R\C):55!C@+/L) ?,";A\7&^]* F+5C+ZF@^J-T 7JJ4R[ 5:@9'
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MQ*M@LL'&3K#*AA+9RH;\UI)3;4@CE?FI!)D83<3I!"5V729+4S>-H5.#5R4
M!X5E6.RM#7RRRXB"OJ/%)!BPNF#OR1]JRO&4Q\$"YB :A3P8#WDX'D['H3Q?
MA!,93T;S1RK'RW^N'.\.TSN!1D$V(GWC OB@D:%I$,^\E2C 9'YE7*WO]0?)
MZ6$%/^,S]JXL2O!*WBE,%),Y!KMG+ YBGLQ6HGZ2UTK>?',9T Z_U*$J6OD(
MXW)"%+&A:0TSHC&L&SOB!C ->HF!'5Y7R6+21\.C2Q51\:8MI"# YY(]KN"T
M49!EZ  ?I$R,G>0,D88"A8;Q:ZMWBHQ:XO @=*FK^B]S>^ !J*CF5ST%Q[6A
MIG(#W"225_ L+3'6A()IFL@E+W+;'?GH,8$= QI4>BUSA"M41H)\H">]>F$[
M?)M4P[(HEND:):'?B>]FVG.L3_97H)G2,RI:0/1ID&8JEUF!^3H<QS++ .!Q
M!U,I5UF/OPM5^_)L[0"%X8;PJD6T*>BW#F6"^0=&510&J2$H-Y'2P]K#>&>:
MH[1U$C%8UHAUP80-07KP-5NK J/5MB;5+YG$9F5"M9/8L"I\/E0%/@IKY6$B
M^ZH;[RB6?ZJ3>* ZB8Z*PO2R2:H9E\?(0([%[%8OF"J_0F?&M>PJ*U_5#*IX
M"C>EH"C]I&@0.$484=&$DT);02CD!N$-1EJ.Y=GR;.!K%Z2N?J2@C#WZ71;Y
MX^10V^Y9S[W*_1=/ZAFK$IVT;0)<"@ST60OF=^4513?\5K.JO?1BPDUI6@S>
M%^!#<)-%277U[ NJ@\J992(#LC$^E8"N-EZG:,>2E@ S-?#6+EJ*7>6X3$WE
M$^)$ QZK'0;8O?4YHU8MN2F+0F8+NW/OL&+_^YO7R1G[1>4($GDJ,]R8\2WF
M\X>!GD$PFHS/$7D&03"93O@TBL=B-I,R/ _%5#Y2Z/E01:#OXX8Y :'OKZ/P
MXA#-W'D3J39-TQ:7C(H;D5F;[2JH;6V"#E1A*7=DO6V0!T/+9^QO6(%OXQ<P
MQ :RH1CROC!;-VA1QT=<D:<+C_3F*/,=!4^T@)'GI,^DT7S^]B&LF-C":F]'
MZLA'I$"0C==9?Y%J4 OJW94$4;Q[G0GHH\JS8K0=:2'6=,$K9]<<0&($,*2G
M/L-M!&['\1VS01566]-ZBV0+BS,;!;,#OV+6EC_M*WS(],YT</J["F7A5HP"
MT9]X<(QI;VPRO:"_OT'XMEN:N,WU&&!>96^K*%NCY+^2*H^^9FS/I]819S C
M7=D *D/!)^HH1$9@!R5&X-(3.]8.V9ONZ%NU+$_!B8:%&$WB6,X6?!C+>1 ,
M>3@Z'\X6X606#F?CQ6+V2"W$[Z[R9/W;7WK-QIM2N^)!D$V5B5[Q4U0S)YWW
MV-CS==*_[C"\W2PWKW,+)KI]N\&C#F#AJ74(ELBJH(CG*^/U9>DI?4%$!4]:
MK61B@ 4A0B'7*>DP>1N5('W5#BKCP5+D9$GM]JC-*@1OB]7,.Q6Q?7O0^H:*
M6)*4/:SRI#!.,GAIDGRW;:W>++4U4-8-JB.$B93[<#5Y%&+?9<+,'C'AU#K,
MMT'F@%'SHG)[:X#<'3X8L<&WVSNS3\W4Y36&56USS@T)W@[*FY4T);$X)L,7
M97:I<4K\*@L(,KWDJ2V3!2Y6L)EYP0EW\03\E=M(;HH6)Z@AFA9;]M=E ,V6
M(7J#OE*1-]%-5DEQB(=CF)D%X(#;'@H3@G;QGCOFUOD1*85UP(?C9A>:J:VE
MPDI# <[P!A:AS9X4V<GN,J,[=]1XF?CNX'UL""](VA0'HZ8%1T&<GL5GBFS+
M_160E>-#Y061R4MQ;\])7Z5N%5&[ @D&,XRB[X%1P6T2#83PG0QUB?9[M# '
M6PS<#O=0%C?2@HWN5LD^Y 02)VE/X%.I99_]/)\+>1Z<B_- C((@FL^'83@\
MC^))*,5X'O%':C\?JM3R2S.P:-0_MK+FA0VM5/5+]69Z!WLCR6GS+R56FVFL
M9CB_"O'ATU0FTRB];NKA1OT+R\J"-F7MV3!PSQ+MY[OM99\BZML(.,%-@V8O
MH#AQW(+>MDY5N\U^HE85=G >43T:YC@_ 9>F@BW>CG"@ F_N<?W@]A^;D7X*
MHSYM-_LM&,OX?!2%\7 A B%X&/.YB$:Q"*0$K?I8MYL]5-7HEPZ(1B^B2FY6
MD-$J-X/H8]"8LKZ6*!O  ".>EYJ"PE0AA ?=X.:+;D6A7]B":3% ER@_V'J]
M^;5"^BV8TN^6VUW!S1! <X^PR^MT%2KI*,+]L!H[>:I=&NRYY[A4I[94<1K=
MW/.\6Q':5-_6<F+0X]E4,1-WH$3%M&VS'(TPMV@Z>_LFK\<9Z9G-BC-$J?-.
MJ;:L\.QBKF[9\>R$;4%MY":<1D- 8DP(3:457VT<"X]3P8E:JYR2 EF$B3Y*
MFM(-B\$SKY4GA-BGV,;#Q3@Z#\\C,8X"O@AY&,XFT^E\&DRC(.*/-0;_<'6C
M#82([CBX664AC9MC2MJ]D\!V>2P^;NS+7SL,!\ 3(PZFTLX&&3'"* 4J)8K#
MH" +E8."HUK.@8DD.I1H?.K:9;?XJ_]0JN\@\S]V/#$0L]ED-@XD!VD?A6(>
MS">3X7P>@"&/%G+X2*7]H8KV6ADGD'911H4]N^CTJP)Q!,DKM I+9XU0)C'&
M5.2[_!-3R&#-"$HG1MKI,];#%%M;$CRPVS5L\YB+QCM['!]XW203."R;7S,-
M;9T"F55]1+4!J_?UOM [+-R53-J55[T[*!I\Z O^^_$8>2MUA$DB7- R!?,7
M>:F25C)_B<5AL@H$^B<YT4I_JK_MW_ @1EB@*(4(>!!,)XL%_+L8X8H6X7PT
M?J1+^:'J%C]D!=J9*GA 1H .C;FA742MFBJ;XP1!C4I[=A]%T!O6@YD0YJ!Q
M3=YB<"-W)[$9"&MR"#W!%>C#E$^X/H2QJ;HTX>)V00CVY >K/Q<VJ.T*-7IV
MD.*+65FPI:+-4"8>Z*(CT2H#X(HMV H/Z#Y.E$&2>$F7B2F#\;9+-)(%YCA<
M![9=!AN0==\)$)AFZ;+ Q$I*7>P>5]LI4'$+(W3'_6NI52Z4S7)>N[B\I1 H
MP>H_W(=W&R5E3@<_N.3HWU*%=X@*@-R -K!:QI X:#13C6$E[5%EW???D&X$
M2J^P@6KO1G79&^:3,NLOPHYC,>.+R4*&/)@##)^>BPG \,5B%O#Q[+'BDM4#
MAA><ON$1'O,*AG5IS*FG=6Q51*1T5*Y1\V$ ,I3;S !PI5W!G4TNN!O591#,
MQOF1 _"*%66G?$N<PE]\C-(Q6!@"\S9H'MK7/2'2.0$)S+1W8F2-37IW[K1C
MPE>TC?RR52V>,F30!YX+_@][[1>NO\KB_@?PFI>[1ZG6=<"(X:I=1^WC"FFG
M!D]3RRDW5XC$:&=2O3.C49BS_VB/LRX_OJ % GTB!ZWL8!6WMH%G[,$ELG%W
M\=Z\VK%14,HF XU_=U)K?2Q[QO197QUC/483AA)U!PTFN:-)BTHB[+DB59F3
MEZ:,.9Z!UU<4A4>#;FOI:M1Y>O7EQ&$K$,?64MF-8RX)F]=;9-S90";R9(X:
MZ,M(>*]0B20FIL6)/Z9&5[92J0KKTQ[>GBT4=U:/]T'U3JTU])HFV[IL/=V;
M3"6NU+-]8L\=-)NCD6X.8G%YXDT@;4@B*U_O#07LXPA&0] YI[8Z"M@>"3%@
MQZ_;;5J".UL*<0"FMJ@[_)XMF!U-L5(R9F\)SV$J^*\F8'?8 5R_\)2;:@O+
M0RG;YW#1(KDZ::^].]<<IS!L)<@]/7E'-=(BR7?4B^%BP?I[<_+8)E%-].AE
MGG:N%A/3[!$!:B#$ DCTA94)FIHS/HI*5HVT[Q,VY4^SKQ8LMKJ[!0>[]N?]
MT1BYHZY#BF1KMP!=K9K*G@YG_/^2+:.#_A26_N,9;OLKS?] Z&M9@0?,\4T.
MS[A/]T+%A'_CR52&\V <B#D/1J-A.)S+612/PLDP'L_CL#EM;;S9!K9]&-20
M>C\,>G>A?ONW"OI66#_ ?M:#V/OIU]D-3%WZ\FAT=,!8=I]T?/^>?R_G7KT&
M,7I1OOI%K0!CO4&H\>)9^>HAF/2[2?W UR"Q#4H?(95?4.5?[#+R3]+G,VOO
M499_^?3V[1MV^0'^7EV]_?CE[9N+QSCA=_YDR_U^U.G[#.;'%06GB/S?CGK4
M>FC7CUP]$B*M&KHL"R 1X(!@GPFY9GK[[?1ZH*6--0_]P;.^'X]P/P5G, S>
MOV!TBF\$X_P?0S^Z$P@1$5-_QGKAGR6E9>MH]NFN7PS[WT-V M[UTU8>*[[A
M!_,.19[?[P?S_*'4G]VG%\_P]P?I@_TMQ?\#4$L#!!0    ( ,J%S%H51JG"
M40H  *LT   6    968R,# U,#4T.%]E>#$P+34T+FAT;>U;;6_;.!+^?L#]
M!YZ+W4T V[&=>)LZ+T!BNVWNTB1(T[LN#O>!EBB+&UGTDE0<[Z^_&8J2*,=R
M;3?HRZ+!;FM1Y+S/,S-T<QSJ273Z][\1<APRZIM/\%ES';'3X[WT;[OXCT:#
M7'*/Q8KY1(L>.9>"^I+[8Y;N,#\#X243%FOB248U[$P4C\?.7G)S>QWPB)%.
MM]EMMIO=_?:A<[XOIG/)QZ$F[5>ONJ1!.JU.USW>:*3R[EF!CT?"GY/1V!.1
MD">U%X'YJ1&EYQ$[J04BUHV 3G@T[Y%?[OB$*7+%9N163&C\RQ$Q[Q7_D_5(
MNS751T2S1]V@$1_'/1*Q %8,Y1YYT3(_1[64O\\?,LN$DL1"A=0'?O9#C1@2
M)S6PEV8R%R=DJ%N/'$P?GQ F(^K=CZ5(8K^Q^,J5*B5Y1"94CGG<0"%[A"9:
MY$LR99*NC83T&="*1<RL\"7QTX=,0)>1(6---+."CT3D Y7A8\A'')S4:G8/
MCO<6J9T>CV2Q\.1U-3.@_''8_W!W<7U%^M<WOVU,^O2?2<S(KW43-YN?_MA_
M3=Y$8D2C.KF(O>:2+9UNJT7Z7,__PY0FY]&#7R?O$ZX9:7=;C?;^X9(S;T6B
MM(CKY.XC>?FR==#97+)+ZG.(71K[Y T$0,0@RWJ;D[D+&8$ 8U*!U2$]02SO
M/@2G,FG7-;!01(=4DT5KU DE Q;1&94,HE=.A:2:BYCL!$).F(SFY#X6LYA0
M15X#$"AR,9E2#ZST=A^SKB\R.AK$^/G%8:?3.CK&^"JEZT*L]040B>?'>_CR
MU)QJ'^V2$)B83  M>*P%Y(74E /SL61H'6VUX+$7);X#4E,I'K@"N161;$RE
MCPB%$L5BPN-4([2S9)Z8 "$_70(="8N89QZ 'YXX%W"<B( ,..S60BI\P#=6
M:K*SB:J&W**B0'"'[^;J\1C\R/V$1@JE&#'B,W2F0=O1_*GAWT]!4R'KY/*R
MOYDX]N2"0'4R3:1**)RU5@ G3(SBU+$^\8U$U+PP6=E-LQ)$UC/&XI*9T-[X
M;%EN839RRZ:2*>"<NNL6MRARELFS:%;DN,/!L.]DLXB-=SSDD@PH)(?9 2_)
M&X@2(>>0Y9)IS<KZ#R?32,R-PF=%X&VL.Z->B)N1WX#&XX*[Y;J9199*M6"!
M9>#V"?2XB"'MX]CFP(SKT%4$";=?'H'2(\!TXP65@HJ3*Y_P4AX(2S6HE^R&
M""#9'PG@,+8DF.MZ!;R9R$27/0@PITK X,[K7'BHWQ*!%D69DPEC&N%!!$6,
M.*<6T[U.('8UO0?W11&A7FH#R,J9Y.!$8SY4'K*81)PE:=+,4VDR7J#6A,XQ
ML\'23"DJ@2[(,PLY[$(L0(YIUC.6BY"E#H*S13(#C2 &8+5/8X\5+LM3=FW/
M%/J#B_8P16WR%/&*JV[(;B9)E@*P""D(HDPQSAXJ0P'HF2,>50P? OH _(&
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M5.R@U/,2%GAL]<RWT;]^SO[U[V<<'709'"40ZWSZH-='[5 A@5B<*BO?J.,
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MX75B%EOFHDG"8WF59=M+E3-852O2HE/TJ#WW+CI?L%,W$  %P)?>G# Y?'6
M1-&J%]VZRY<%(/R.5N$40*>6"A;7,EB%?L)',-(I1S^"@$:0OC$($-+FE,25
MPL*I>'[5R[+K0C4N%3B1;CD\9E:BR-H>-2(Q EP+_9[5/?;:)4*C8] 8026U
MFL/UEN?AXZV<%7["BR+-EG$0N)SQ*!'_CY=IZ"YC=HBW[KOZ1@;^Z4/&6[,:
M$BN@HK05=0<:=LZXVZ\4S+BK06FB6L[,#DO616KK0C)UV(XZR6,0T4.-/-+&
ME(:B!(@0N>=EQ4_)[]']:V&$';E 2&,#/%U5W6*IGP+5WJP6=:[N=+K<1$AB
M,1<70B1!K&.6+E%K&T."6LM.$<-D#GXSB<'/)HH)V#+%:U^WF,0>XX0I9W5+
M;80UBL=L!-@)7;GAEZU\CL;\V&J$VA2BZVLB0=S#6%:2;):G1%$HW?J<:!\M
MA:%.4XF-/$-(3FZSK(A0XE;K>FR)Q=O;-_4L.XHL4I$2[R4@)H]9'(9#,/(!
M@I&K0S!RSE8)\C!><F&<%*$?+,,D7D6<><N(%Y['5^YSI^Q[0%OE[!YM%9UU
MR71:3V+VV:#+6Z-3> ,>N!YPLI $QJHI^)64F:H7+5Q00YP.W _ZJ#VK"7Y-
MW'.Z*Y0,>1B-Q&5^!JL?VJ'I(+PYX;$1MY$%BC0%8;/SNB2Y*Q4?%A=!V9*8
M=->H:8I?FMU6,V/L-I"A9>6&2J,JL32GTG[X8)(6T9I^^W*AN2,QTC+9)Q-S
M!M=:BDQJ'%+;:O$L>LG>V*Y7]@MK#WI+[\-]4QIUF-=-#<'SJX4A88+N#=?X
MN$]RWCRJ:TU\[DT50R:4?,3K[:U)VY@GA51[<+^5!4'F^G$:Y4$:N%F<9J[+
M\H)E!??R('GNW'8/J O*>]0%H^#BB-6T;M2'>,S%^6S;'5*-"G].$IL"GQ#6
MWRNILR!>^,5(E^!.ET)#_(J^I1!PXB3 ,S9BZLC)#WY7@X^ $P@1X7-6X5W[
M .D11+:W6 K2GT\AP,4Q:9'Y95CA.Y4"VOLY1B*]3GAXA9*>X),5!;K;9Z-6
MYT/=,?:N]J$"QY?G)54X@3.X'WIAU0W[ !B+*0+#VD#N*DP&).C&T0?<"0VT
MFQ0JVA2$=J1)/L0:27;^5-,&3:[1#I?J* 7U&+M-Q2Z$<'X$*&0$?=I=[@:,
M!VF^2HMELG*YGQ1N%$7)(?>^[^H;B;@_'L#<U?*CMW$L.X^PUJJ.$NP3%#Y\
MU QYU'%X*CJ/L-BHKDB4;="2N_>&Q7OMG;W=B]\K\[>7XE!,CCU6644F^[!_
ML<'4_/#\(P5S$P^L#QX&49K%4;",W"1=+C.VY.Q H75G!_//!SB8%^447D'D
M N46U*G$[9I]4SNT#NJ+C?+;'GX/YG[&6%S$B<N609[[,>-QG$3,S9)\*4SA
M9[X';[*+5D^/V_D3P'_*O@E;+\V0Q^6Q",-#SXV%7 M6JR4+6%J(]Y=R87,L
MN9<$PO1XYIOJ&3"[3@- !/ZR9YWW83$4U,]"$'XMIO]K5ML16LO>S4/=57*T
M#(9L\2EL<PCM<U"4=9OZ-@B7*]?N6TK@I^LMT08;81 !W"!Q+1F?6V%7)GE:
M170W69:R[1LL3/$]MLX2MUH2SUICKY9DCR.],(-\EC=&F,.[>&O[ASA]:V/
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MD6YZ!/1)-T[XL"&>@13<4XQ%/&8S8E>>C>%)Z%3WR-Z(D?[U9 UGETFX[-V
M,O2ZZTZ^(+84:YQU#1QF %COFV1IA-2-WL3CK28L9+\,J+WZM:@N>_0_SNID
M>FP..8)ICB YY AF<P3Q,LL*/TA87@1)G"1%M@R])(K\U%T%_(#=WW?UD^'X
MU'5<LHI4-E8UB$00'CKQWWO#?.#+WR+*KIV'?3W=+30@V)ZP<\[%/*%W7TDM
M;K&+ +D 5&YN[==#K8BZ<KNK)#A0 W+[]A5@7?+^#\H/028*.62U>L!HJJ(A
M6'E$TQE3O?0%TP_N<?M\%06!GT;AR@O<.&=)[C, AZ79TD_20T;OSD[K?5'
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MQ#S(5WX1+GTW#7GVS _?,TCP]<I(B7_L<JJ0FP:)1BW!F;-X[WF]T9,6]\=
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MF1;L8^=-_XN%NKEG+#WCE2K'$G)9#!NRV15U^D9V>;.W^JAHN@<\Z"";@[?
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MYP/3;"6.##T4"QT:74*]@&JE>_,<"$>@5^L'QR<=1W47/N\<TG2DVTLV[<2
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MU/)+H^VZJ;D,Q<*%&Y[J%S#::RCI/@/&_SWQ<M.M-%ESHW9VYM1-T='(AZJ
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MK>)DF<'S\C<V*4 MR586+^-FC_/;"Y0[UX'O6]55BFL,&^GH5HN'F(6_\BJ
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MKO2(W7G9F/!/CS'ANRG"KA(3_L9IZ@MT4(X7DD@7IX9KKBSPPD>$\,6/]VT
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M['5I)L2YKJ6+ =IH4K0FQ?M"\]%[&G16S]2"D@Q)DS)OAON &EK'%#H R(,
MQ@.),^1?. >LQ]^28>0>V+R3(4JO2NY@RG#62T4JJ$9U)4_2M&N0#BL]#<+!
M@>U5Z0CBLDP@P-#K6R37FDSH.<YU1[2>[Y@;QGON<HD>4RU$+!J[O"8V+W&6
MB5<Z+SO9U6D^E=Z&S];)KG<$9']-V!4I7])6G=98BE'VL!"X)@/OJ<$/%!=
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M/E++5E$5\Y,MVO=GL=:=/*/",SD6'6:)%-K6P(+\.I>.YB67M%+'"S8.J*D
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M,Z7.H!WLH.?(V%^VB8 2/1,3]:!S7>]:"0,%#+W]SX>]_>,TSHDE#.QI6G(
M1?JYA'7T4\TH>YG<'>=<#\>U#1D=$]'F==.:4) L>U\@\(VN*QKC2=;<?PPD
MTMI%ST&-V>>BH@LSN 4@.YQ4HRR+Y,!V,ZT:C<)%J>TX; S4=I@_&/EY59&L
M=&S &3'^.39B/#<4)\E<'##^B.K]:ACIP,]1<FKMRN7)NKH\'RJ\S=X<KR\.
M]7/CJ,K#W:2P$EI=[KE N&A%)-OL"24)#SI,VY$3RR%PIG3]*</&ANP/+UC%
MX3@',URCVAK& EUR5[D@;LB=<-,R/1X9]* ",K+!@EPE9S^SJ</J"HY]JG*8
M;JOVH% C=(,Y>NK+$B[.IEAYA*@$P%6;L\V8'3;KY#8UN@^7;C/QP1X)?TR'
M?5 ."RLS$M,1J"FVIF)L=*R8@UA2/)?]?Z@EJ+))X +05*=-_X(4Z&I.(DDS
MZ?*LF+-^&09AIZRQSE30,DR?4\_GZ,AWMU[!#1SEQB_J<*6-Z$H#T2>,U06+
M2,% )EJ%&5#(%0_];Y!\>W2N9#V=HA6[GFY@HZBB%@1>9,30D^"G(@RLP?DD
M6KW:*NQ7[U'X#ZD6CE68?BZKTT)E,R5]X'M6.'-E35'^3I.\%K7&U(1@+MVA
M<TM0>5.0O6'R=[1!"/%7Y*JC^Q&/ \T"?4G5IUN+E1?G=CRHR ;;5;NS!Z>!
MI:.^'=VJ& &=/%&?)?W");KU7@%LDSC!!# \O7KO2*XS=)B6TJ_PR#] D#IG
M;V!C52,\OL%N0'6N8<3)0F'PTD3SJZ3.C&88&UVP1V0_S;,NS1$MZ==0T'S[
MYVX4#FLDGT5AD;/GJ(8H)SG$T2_D$A@:,"$S2C)BU*;AEA'.X$=FWZ\8;?[Q
M,=K\[9D^GST IL^]J@0APUE0(+1?4MX0.4D0!O2QKD#?]SDD'ZK'\#[5V@Y6
MS3.+O+HMU:R$OK/FV5<:6IOGI\C$Q+RZ\*KA+,G&:IR=*.5+FRK&0#O3)=A$
M%(IG!Y0IP,+V$[S\)"DZU$0"T%.-^,M&89Y>V MW6)P,B?</]H0?&GYW5)5P
MQ061<X*.!AE%9-C27O=@!,.EP^!/U4C>K4FX-:KU2VN.]%-SP):.;9IT>-MC
MX2S^*HXT<QW8H45UWC U.$, ?@S%BR0F2%Z>O.8D:*F]8WR0J U8RQ('@0ZD
M6H7)0MJ!YFJ!^$+';3F@!8OM-: 'ABPE8WO'^#8YSF74(5D$@Z<8[TAUJIR:
M#TY:IK_=T+M(>],T2?Y&(J=5\&OH& SEX=),WB0EZFU+OW.OJ#%+B:2@2 ^4
M?PDY]!#)R? <?'1CCMEKWN: /U4Z+V'B9BM3C&-!#O>FFK:G<%[H8Y2>J(+G
M95F=)-(F[.L$_V>!#@8I)!)X@C$COUI*C9&%:N=5AHI\,:MJ.#D+^'=&5@=I
M]TFQHI=@?4+H GX&!P3+[^%LG%;U9_P2_X<.:0>MU<T\7V+ACA(])MA<G9SR
M;VN%D&29&2QXEL/,(X28F-_1S$$AI.H<QT-VK2-<:WG/VNE<\2FL24@L$T15
M<_&<VHF=!$6ZJN6*[.UU]YCKHCP4P6 K3((F7=%RS-1-X-63W#1,\]#R))JV
MW7][OQ&;>):#()1/<DYY]JLK&?,&%Z2"]YO[POBX-/5@++=!C&ZHHLI;DN*Q
M7M]@U6'FZPK$F>(>XK702(4R_"#'-5YB!G@SCV$V4JR;0ZL!6Q(%$T^]LS1:
M)/?[+:X>T^%T7N']@-.,?-[$P,W$%FX+"3:QX+.!B+M4YII/3JUX/V%,.I9M
MAO^"_^I274Q2SPMW.0M1<;7CN9-)"@L_A'>WV6JX&+2]_H1!MCKKGMIKUL\(
M]/T!TX8R WII8=V8@=H+&L7FTC/=>1ED$;B-L<LDLV&@ZW C/ NBH(9!%K?P
MBK>HE5QT_[.6A<CT?W7YDOV638<['KLT33#MOJ5_HU[@B#?_3/?<#&&T42\
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M">K&XZ=W(-_+3K7#[Z#3*TJ=DL98'YWG-LA*  -?4-151^(TBTGE;PGMGQE
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M3TBB'$(KTCF"HJ1FFBE3UPC/(O'*VR1'/HYN3WU*6F,PC?E(*<*ZZ(I9(GF
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M  RM@G9!A@:DV3:'H]MF!S8\7"6P>3B?U$4)NCY''$1D.$\HB5MWN9<<V!_
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M59V#Z_!:4B:5':M%O+DT<9($4^ET&)^(%3-Q1H?N]<$MOC2Z6IO1[L@9,#6
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M^PXL5-+H<ZO)%$+,EV;1)'G1P!O91V:^P+0B26>:$S- #S=#L#5B'(3'P #
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MW$:2+OS]C3C_ <<[WB4C0)JD+I8MCR,HBK(Y*TLZ)#7>B1/O!W2CFH2%!GH
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M?8ZL]3-N0ETEOV0-$,SN+MV.AVET;2] CK7)$1#OM$N>_?P@V9_^>UFT15?
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MK$O][>&3G10FZBQ6]5:?8\&JGL2L/<$MLB*/A=!CXMPZ&E?HG@9#'8.S]=2
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MANP%I(3% 2M$OQ68'MOP:>_>V]L<-4K@9[W=VP,!%]D'LFN"I(6J3C!T(HY
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M@3OX;)F?@=YTC+BK4VKB@+_>9]?S[G=/'K'?B'%;AG+NX/6SXWTOT\AF'ZJ
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M)@Z%X>RINFZ(XM>$_J>RK?7!Q$^CJ,+5Z!PFGJM/9%/)OIFF'0WRZ)<E"!5
M5&RHJF7^46SAR6WE)QW4/K;/[;KX0)D_"$+<#?+=+#<6..M! -8J<L.^]%$_
M0@^2J;#]Y<+"$+Q!/4$8BK[?0/.:%E8U-9(LD'6N$+:31L"MM+T0#_&5B_=
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M97JZ:5#F1X.$:2QAXXJN/.N;D:B$8^%@55W]VS5&Q!1D<D-K%4&8F8('\FK
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M]Y5[!1057:82-"&<TPB&0.2MJ0L#7LU6T+%"G2 44%ENF%^Y@/(0V<BRK>'
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MH<;>M4^"WK6JF;=.CH3/SM!9B#(R7GKT1>)MZ<V,*U:]#8X_%%H"2D?P_IQ
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MT)?H/A*YQ)\QY2+F765H?6I-_M_V7S]\,ZGS%?WCO)N7\(__!U!+ P04
M" #*A<Q:2/B?@3UB   V[@$ %@   &5F,C P-3 U-#A?97@Q,"TV,"YH=&WM
MO6MSVT:V+OS]5+W_ 2=[LK=4!2F293MVG$F5+,N)9CNVCR1/]M2I\P$DFB)B
M$.  H&3FU[_KUMVK@29%V?(MT:YS)A8)-OJR>MW7LWZ<=K/RI__O?R7)CU.3
MY?0O^'=7=*7YZ<?O^+_RX?_>V4E>%&-3M29/NOJ'Y&E39WE3Y!>&GZ#_>U:/
M%S-3=<FX,5D'3R[:HKI0SR:O3U]-BM(D]Q[L/MC=WWUPL/](_?ZHGB^;XF+:
M)?N/'S](=I)[>_<>Z)_O[/!\OY,)_SBJ\V4RNAC79=W\_9O_F-#_?9.TW;(T
M?_]F4E?=SB2;%>7RA^2_SHN9:9.7YBHYK6=9]5]/$OJ^+?XP/R3[>_/N2=*9
M=]U.5A87U0]):2;P"8W\0_(?>_1_3[ZA]_?__X]Y<6EW:MHD5=U.LQS>+__X
M)J$A__X-[%]G&C>]J<&U_I#<G[\;O"@99>.W%TV]J/*=_E=ZECSDDV26-1=%
MM8.3_B')%EWM/FKX)?S9J&YR V-5=65D,3Q].R<]-OT2GDI^Q(T*-O5*ICZJ
MRQR>.'XW+48%'-O>[L.]'[_#1W[Z<=38\;]3^X/_3-9\9\EAU:3L@F/3^)^C
MY\G/93W*RC0YJ<:[>O#W&_%X-B_K)='TX45C#/YK..I/__D?^P_WGFSVNM\7
M;5=,EG*,197#D#\D!P_GN-7GTZ)-8B]-MCK\ZC__X]&]>WM/W,?T]_Z3[33)
MZ<)E;5)/DG\L*I,\3.GZI G\; 94F(R625;ER<AT5\9427^S\ W&ON"HGLVS
M:FF'IQ_^W)B+NEDFKW>3L^PR:TQKDBUY_OB=&2^ZXM*X7]!H,@S]W#V2P$_]
MI0?B+LT8/R^726,FIFF(Q213TYBBPA6I>;W.FJXP;2JO2>HF,=EXFL V%I=%
MOLC*WBCP\TS_V"TI0APW.L9U5'-Z?'1R?OCB[&-2RK5W\K=?CD^/#\_D-J9J
M_Z>P*2,D@=8TE\B@98^/IH69)+]FS5O3X<>O)A-@^0U2E">6Y"B;%YTG&MG;
MX0-VHR.+_8R[4%>X0*"8_7VZ'_?3Z-J>@R1KDQ.@WG&7//WE(#D<_WM1M$57
MP "6JNW:]</^0@Z& ,ES5/>VC3Z+_\9?$?SQKZ:Y@*,X6XP2F/B+%T=TIP;O
M4(_=DU<1G<)E*"J\#LD(9;)I6[AXLU%19;2BS+,9H 5@Y+,,Q"K<5/@LA]_"
M-8/KWA&+F33U+.E EN+UPO^F^H(^M<,?J>$C[&J^:-I%!B^$0:ZF!1Q(L!::
M$%U@GJ9B&%=%-XV<68*\ BD:V -2;-=D50M#P?N1NK,.?EB6N(Q%V>'#M/6P
M2'@!W0&8TJ@LQN5R!WZ*BQ[;8]8LZMK%^B7B <%K\?EQ69,FA/."/Z.;%+!?
M?MZ/Q9.E%8RG606J4-&U207GXS<&-FMP&9D&9)PG.*4OZC8JF0";I25&;MJB
M(1(C^F7J)1'H12)\TIHNJ1>\R?#8K*6!QC6( SYYV7'C16IC2MKP=EK,G3!4
MK_8;:N?D9SD!2JBO\"3I!]>?:LKD.IPXT1W,:S)ARDH6\[K:=%2[2.#2"_@E
M_+>DU>/70+@@Z V\%7:-)![=C/$8-+^L&AN>$%(/[]=6NX#+-X=[4^=)OFC@
MU>JNT<WLS1[^@!%YYL%U.(<! XV!Z!782+6 _^('EW4!C&BR\3KS&BYS5<,9
MC\>+YLNC7_-N;.8=:5VXWU<%J$3SI@9-!(Z!%9AU1 Y$;9!)\&E.BF;&G*JW
MX>T"C@<,+T,;GS$7F\/NM_3''(ZN451K?]<""VH:9!;T%S)QL"9@I Y>"#O?
M.NI?/4-0^;(FMP3?+D:_PVM!.G1X)^T"BVI<+N@AI"V\CF4Q Y[,%P"'J8%8
M&K"H\&>IOHQNLBGN +)FXL5NZ3#GUER:ABC7?YSYBVTOD-\ U(3Y:[V+'ZKO
M?1CAO'SU6YJ<(_4\?W5Z[.@'CA.7#>32,,'+JB8UZMJX%8T9HW1K^:+-%AVH
MN/";2U-E>*8D8]R!$SN$W\(%M]HS? \?,'DF%W7-U':9E8ML5 9JN)H&OPQ>
M;0JD;OA!NT!=L##5& ]3^ +H\?0>-"S&;ZOZJC1@I.=ILD;UQ[GB\3$G;7^X
MI5/I'8&SF/?%:M_?E3WGP3?_WT3^\^-"V8(_?K?XZ=/1TV Q6]GV^ZX&EG'8
M[?R&?+FWG#5,0!TN\Z? VMO__DFKKW3!5-E.D3<Y(44B#]2A'90)*5) ;B;
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M"&@-M4L[NUS=@-WD&2F;]!+4'-,!44PS84:@_L EF?%@^8(\0*0#Z:UA6;B
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M@_9H?$_MB.^H'6VC[9H^;U:VWJO.V4[P[)EIY!9-1#4*UBM )1&=#F\9I44
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M^+@9#2Q1^A>JH,[*<GR"'[AP>>2<!1XT6K^$342RRYD=93 Y$!:4(X[!&&(
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MSOW 01=T^KCD,6/U"B0RY6\"BMEH#LI_)]XVJCAG3%WQ=@1 +%]9;P%<\&_
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M3WXNZQ%*IY-JO)L<(YH7XJ:@L8#;_!JLW$&X5_'8,FL(N@3-T<7,=_NU113
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MP?Q/R0W-8I*[!66OHP .%>Y&CC]27-6_Q+X>2"4DB"T+UB0H]TO'1B?&],@
MQ4A1+PAH">$1]#P=B(['R\;>?DAV=#._VEJ1?V+MS)/D-^=.^P?R['/DTKH7
M^[&_>\*'>[Z('CNS:&(.J,JSIR ,#F=6>MA]4715:OQJC=<[GBEF!"0T K,5
MQ8G6^X2'LM"MO2#FFTOZ'=MR4?4N[%>D_-O//$C'$8[D>@CM)L<HEUX3MY9,
M!G'BD#+L",CSVE#.,)/RXVN?$[YHT&Q=;5\,WR5E0<D3PM, QE4T0+WUF'Q2
MQ.E:.@@Y6!+B$Z9VLAK';RFCFU*98.L&<C%N-LH8OE=Y3?3B\P#(2\SS0@VR
MJJD'F.LP*G>Y#BW&,EN*8XZ+OAPJ& )Y96Y.JAVH4$#_Q+2N%8!/\32MIY&]
M="IE0PPUVY">7QR^T=*AF,D#6J$X.H'DJB>SRE7*L,:$B *F*@)H);A^A)3+
MB[=W$P0$<N;C?QZ_/$]>/0<.?W[R\R$RW03DQ3%)G)0>.7KUZVODV,C,C__G
M^.@-,>CCPZ-?DM\.\9_PT,EI<GI\]EJ8MY(*+ = T+!X>*YX/S+\PS<@E_!3
M8O?)T\,S$#)O7L,_X=O#TY,S%!>OWM ,7^$[7ARR&*)Q^%=I\OKTU='Q,0JL
M%)\BB>?7KU8F[S__U^MC$$6OWN TG_Z+/H.OM-P]_!E$Z-DY?X7CT3<DX.C-
MSY^?O#B!N=@A^9FS-[ I].#N=5NG9#@^0;]<N2^_G;R 33S&W835XXP#,?O;
MR?DON$DLA%6,TGY!XANW$B<%2L#QSZ]HLT)-XY36$"H7&Q[LR1G3 DWNU>OC
M4[??Y[_ =V?'O X0][VC@V6\/#\^I97[PU,GFOSVRPELS=GQ\7^39@)_OWIQ
MC$_"OW'N*0YY],LAJ XO?R9B].O_Y^&+DV<G?&S'+V'A1\>'3^'@SO_EID;+
M_14NP2[_3<LXY1T_?/T:E"^9\=F;IV?'_^<-7I=#>/X9_@9F='K\\OBWPQ?P
MK[,W\/BQ? PO_/75LY/G)T>T$V>L<P7ONW./KW>//[ASCW^Q-4"D!,($<E"7
MGR1GF"<>Y.$[9$&/HTL:Q9IT--\!43G/;>:#I/EE-J^"$9)MLL8ESJ0/0]JO
M*$; V#YP;606!:J?I6T]6E0T=NI0A-AU8HW%TEA-P>I6MOUWM%/IPC^OM9[4
MUI%=RHZZUXDIJMXH2>]%B"Z:Z;;HSG5AURCS&5NG9%SWXAU:<2:-X6)A%>48
M!#9H$8$VQQW1].+6;*1"A<[RA*F']!W?6(CM@L]I-6U8IJ*Z:G%55^O=]IQW
ME]KFZJEU^W [-/AO/5XX?P<?$Z:[+RH;-?&)ZX( PNJPAVAW=T/ZQW/>WU8,
MY89R#>C[[= M[1-'Q =?%MS&T6KT)3M)))%ODHW):\GM2@R8;)2X1";8A76M
MS\#V18A(L*LHWFXX.TI*_\*\$0=H>30MC*[M>,69O;V(]:H.]E.3Y?]>P/Y0
M\:Z4^079C!H/K!9K 2S#+,\;Z=P9UI"B&BZ]"WDK*H.U*AB68\>K&I K"S&#
MJ--PF3*T^./UZ9'U$E3Y29:F.@Z;CT%CO?[<;H2+]\1OP0PWX/(P_38:7[7A
M =I,X2\D9<@*=[\5L4()[#VG&Z7\2/^+R@&W,Y>C/B^3?INEKK[@V!5Q/869
M@GG;UOM(V;8JA_J,S#1JA^@O2?]&[,[SB?@V!U/TUY5\E)B]] 54!T\_1#,X
MIAZ@?I=\JB8GG\31XEV?!@F[6<\/GR%EZU*028+EWO%1* C:@:<C"%-8]Q.<
M SD+)$!&CA:\S0;[4N )4&M,GT_J^IN[][0^TFD3QPDY RDL]!'P6"K:4J,S
M/RD-3B&-9T76W#D$J^EPE$&^ZLIJ$=[EUV%NI(;-\.U HAT^%-%S% UF9SHC
MX +6^42.,=6T&0[ 9Q79EL- <TU1M<4X,>B!I90%^*JM2;++_2XP<LV]39UB
ME&-?'=C&,-J5>IQS5B"4[P2.^9+Z'O<I3$5IWRLKZ98OU:VTL,1T ,0H(BJT
M/MC53-2V$I/^&JD'.*H;7<\N<9+1DK.!4<>SN:DN@U3P90+$D< 9CL@)F'OJ
MD1QK+ZX=B3Y=_0X;^\2VR<+ZTUXSBG6OT((:%T]^2MTQ5EB+$IZVO&+I:CM(
MMV&@!T8A7V,M(+'W:J:"L3/RC!8N4]5V0/# @ESOB;+AFC9EDKOJ\V(9@\AP
M&:++;*5S17R2.88:>]PP56H(5<:.6M1",8N<$?\PL.Y@$2DQV#34E)B#@2CB
M,O*/RQ>!W]UY1%&Y!='&V2AS6$JCE%82KL#!"; CG(_-Y79O%4<M/[!JZ%Y_
M"TIR7EJ;"Z=*^8N?\][__B'"],RB@S)[/224I]:+5$WO# %%RJE$WLF(<*F[
M;1S-7>R(8>%[[6P,AU$:*,^D1S4^ XTSS\O2WD6-,$3QGK;UD*QNYEMP7#/3
M7# 1N,0W)4A70";5DO_67$IW6L0%6CH,O$B*_[9O!BU[A;>E&G/'@DC V6^E
MBO4[6J:<H_&BL<7T2!8CN.01&"\WFM_>U4F%00X-][Z0"TF[*KTK^EA- ZV@
M:.S=)ZGM""F5Q6-\U-DP^!N6K&$*A>XXSSR91_#2F?[&M[6$*<S]P*DR/ ?1
MWQJ;^U-2<CG]U2KW"/*<:@7BK% QDH4B8E$>'.!9W0B\$J/ZARC/JO9TY?B8
M2S+H"V8#^?PV1??J5=PL4APR.$O7+)Q3)Z^ML?1GYNUWZ;S0[^DP1V%-B7$Q
M!Q>KI_XC2W:'OO%"2R.VIF2746Y+8+.@G:'#A, _6?_N(:**2'7I1+J2?C5B
M+8/MP%Y)*^E>O:7-5NO!J7U&KOWV0[CV";QJ5KFN9$-V'9;M\.&3LYVSK1 X
M C:[J[E3@_5Z](;5O"/@P<("&529P&"/WTV+$39KTA[PIS@OS'( (UH$:%??
M!2:N"4P\O M,?.R[5]X6.-E_9K/YDU=P;R3#<7@1Q=ES&6"W,#O+Y0JZ]!_2
MI@1:P'[F^^;Y-$H!"M@B'94[I&[[OK:& +ZTWBSYKU)>5GM'D^W1%I;\T6Q;
MTB;$0<Q0AC:#3D\]68V&\#F9Z^P]_88@Z9!H^1AC39-ZT8]VD]Y)W(Q RIMV
MI&BL\<YW+^IL>^# J]0GFXUZ)5W7%(DMOR)(F4(W,YS\<F64*95R%!K19X=+
MICV6K+F69A2,$@!'W#N5%NZB/NK5T@S:8GKT4B'E5)!.13=SV$5LW_J,?@M_
MI"'K&.?JUJ8O&RZ7,,OK>3>H5OR<M%^]K\_<]Q]87Y,DGN6\08:2<QTGZZG(
MSL.LWQ-@(B5LZ0)C,@&$C$3YR+LP10PBTC"I (F=;B%,$>+'6D1UCG2A%;&0
M=IR4["1%1CZHXE[L"N;5BR5ENQ\C<0#XS,8QPD/NV>$]IPHE!\%I,Z,$\P*_
MY/)2VQVXMM'4L=IH]B%(0%I*-P]UM-754HD5T< -S^;3%H.ZH^!/8W&IQ/%B
M;Y(U[!#"C8(:L?8'JO";@.+?=2RA2==C(,FVS]A@IF5;O]]O4P=2/R\7#36\
M%835T*$.6[\HI9T822W[@7Y>QI  G&1#PB\<ZAW\6#ZM&_<A[ L%=ZCK$A$N
M3.YW@O>BS$J*2Q:M_R25:)M[P3*U@]F/RK+_$;["?5:[#COH?7,X9HQ,Y8=E
M E)CJ070E,E=CB.X)PBU1QZQ6Q/YM?-X]'=A )L7<8BX=_E7229M;\W26";R
M*0D6/2]!59**%)2%J"TZ3>(*F('^O?VI N]C@U:'@UQE@?B6&*:0J,9=F/#Z
MN-L37AX&K\%>)!RTJ2N87.MR1R_!?F6/09 .2F9F)% 8S'F6M3"CHC)I,C$$
MJ C_JLR"8C:.R)&K\?40#4VPJ1V$F7%(U1K63YP'!%G@"K(^5")9B^BG_WMV
M\O/+P_,WIYC;]S/F^[UX\>JWL_]W9]:M-^N^OS/K;E?S"?9^5)<Y/( )G"?G
M+X_/SI+?,,_XU7/9]3#;GST1G _A<@#ZXMUQ(2J2FA0-: O6JY2-0)-D#8$3
MJ6OR98U,65]Y!Z?31);<KWRAN\VK$!-&0KQOI@>CMNF]ZAC\Q)1EBS"1U<7?
MO]G[AOZ>(^"(_,TG3?\L\K]_\\>CAY-'>P_O[8W'>^9^?G\_R_<?/]@;3>[O
M/X!COK?W3;#;DPP8]?*'Y+_."VSB2OUBZEE6_9<E>KHI?$=C!(:E"]F\A6?L
MO^2<Y?"Q]^V WC25!_3>-0']XR>YG:Z\_0&^_!(3AL99:=\"C 180%-?P495
M?_]F_QM\H_WW3S^.!L-^U^6KWW2#T>]]TQLFO 8Q@B9<I1>OGAZ^H+JIW3[W
MB,X//@C7\%5NU0:CW_9"/V1Q=O15@T>/_J>GRQ\V.M+8J^[?\%U@Y'W7?I?\
M6DS!E'J&=B[:>9^%HC[]1K_,9N;3;76PQW^)_3W'H-*GV^ 5>9MW[/'/M]";
MBDQ7"75'#'\N%O,99.7/&$EOELGKW>0LNT0,M3N9^;&V/+K7-]]G;VZ2111:
M3GK?[OP2Y)=X=.>7N('_*XE*'$Y^2 YOX /[Z=?&TSDW\Z@\G+#+;*,&])U#
MXD6'PVDQ'A? F>K%/'DA';]L]A<Z+XM<,FNV,C\.>2(H90-]L/DV-;T+AD+X
M@N27&E[^W]B=@\.44U@@(?]HL'#?=ZT59'WQ[4\FQH)[CJ?8D S^WZ_PWS((
MYX'J5F4277)N? HY4[D[I<O;#G327EX";Y<"_$435FWNZ;VC)D//L< :N%VX
MB=_SIR,)=$N3@+HT[0^WZW\AI\M>/GKTX-']_?T'#_;O'XRR1WL/#[[?_W[R
M_>31Z-[!WMCQ@6=GKY^_ )(XQ[%OR17S4?TM^X_83_=^XHE^O4)DD.O_X9.-
MQLD677TSXV7-M=+$=.ORZ$,IZ='X_J,\>[Q_[_%]<__[^P]'F;E_/WN8W3./
M\T?C++^CI$],26=%59]G;8=)..-IA:TWE\G6&685 $?<3H[JW31YT?71_S\6
M*7TRI>9.4;B)HO#T=H)QT7<<Z80BS 1K;^=EV&E!,CFW/^+T@RX'V)NJ7/H^
M2:5Q2&M=]B[(C9-.,;VF680Z*OGL 7PG!5F8T8X,Y9L >79V !A<ON*?2OHQ
MXS2E'KD)L9I*2L3^XJ*?=Q=R$VJS-F?<X+QEPI:[[_JVOO]-?;]8G\GVLX=[
M#Q^-'^Q_?__!@\>/]QYEH^S[@_'CT:.]O0</OKI8G_*(].7_"M>#G1S=)B#%
MA$ PD^9BM+67)OC_MMTS]GY=\QBN8^5#W[CSVT#9N'?_%F;=N&OV 6M;Y8##
M;G-GU&WN!EZA/]DI?7\;I[3AK-<?YHI3^MO!WEX*ERD%$QM!#7\!MHJB\7Q:
M+UJT:)[A?<0&ZG\[>$1/6B2/>=9)2A-Q9,Q+>'-VF[[.]R>%M>>W,57?YF7\
MF!=--W#\)#?MDV_OM;?H8V[O.;?)Y/Z8J!9F'<JNG7M[V.]RDES#YV24DTGR
MGV7WY '_YJU9)@9]7WQ_9@9;KZ!_;%J82ZRV"YIR@O()/ULS^!96%F.NYSC#
M4M5Y4^\TI)^B_DL9C3 6=F/97C=*3'D('OCO^*RW5&I^EF-*%CG@:$+TTFA4
M(*(7V?RM'3;(17-E:A,+7\SQ#ZG$N??@6]6V%JL,38LJ4M%.>]UOO[AIGU3P
M[B)'RI Z?:KPL0?!6>M(HE_L*I#^S[%F51# I X8L8R3K=SLG+T^//KNY/6K
M[62+<^B0@"AQ?OM#*/=5V*Z2JTZI]9>KYJ#^XW3=I/HVU24GE-G<VKWEWLCP
M@T I)_3\KC.WFL3Q%7'ISRH$?\VJ3*J7N$?4G22\]3T^.'A "N#IV1OIS4/]
MQ_C^4!,Y1"D'(]SU'I,;G<"-_I#K^T_#@2[NL?:#J*K<7LQV(Z.&&<#(FTY:
M"6; 64K#<A"QD%7O5UNO,,X6K6[MG4D5.C##'6YD4][=Y4]/9VLZO5%.]KB8
M2R'[W16_Y:WW#E4#+R8?*M=Z$M*"[46)P&=\/&%!JBJCC $@KC[7#V$.HI^#
M';OS<*B2NX[5!0A_5(-=7\O';,URL\,GU.>0FB%((T,.'WL^LU75[AE5/<U:
M2EN\8T;4!DUDQV4QF<B(%E\?&S^YSIWPNQWZ7:(?Y?(#W9!16FD6A)XO31G[
MFY$(OA"LT?)$K%G,RI*#[[2B@SV99Z#=(*\K*F3?TKR7=PV]>/]S]#RJ>=WQ
MP(][$=>TFG[_J[+>@1T\NG6$S4: U)1B)>'N%T>;4<17=^"?E?/^[>#@^_0!
M,*2ONQ&SZ[_\(73J]J*H/D/[X=WDZ/-V[1UR]C6-PO^\W7N'VY!Y$-<[B?2I
M&=13:<=WDQS?KVAO/Q7S7S&E.V*]36+=V+,II<(;>3:37TQ6=M/O) /6HSC=
M78?;=N:!L39;S))';,[-&S,K%K.6$8]&2RM<_I0)_W_!5)SW2U 9F8/'YOO\
M>RQ(O[___<%H_V'^\%XV>GC?W-\?'QS<):C<):A\>AGQHIB83RP;OLC3OY7$
MEX\I8][,T8RY]TX["U.+!(0 ]&!*_6T_ :Y1@EWS1%IF&T,P.1Q I'AWKKVB
M!(F'IB C>11-4E^YUJMW1LN?1 ]\/46,:"[UN(LS?IS,0?*Y9&/T6Y&# '0>
M;/5$S;EH^T?H!W>9W)1L0JZ-U)6=U<6&#/CNSGWY=^YYT9'G"VGA"C1#^N/N
M"GX\;S3[HDU#?L#4^T'MG9QAYRM_ >\NW9_PTIV:SN+82G%+FVS=W]O?>KOM
M,8D;_]"<W+EM+*%.3/:[R-%'2,OYEBH/9QF\';N)C:=/R';E?^.=Y2 U/'=\
MS*"JV!0#O?5W-_5/<E./,FK75U_=>20_CCS<=_*0\S6 _?UM_Q%ED%@A>7>9
M_B27Z3Q[QZC)7+J)4@V!Q.^NU4>W],13TCJ]\NY._4GNU*G!\F>N%G.J)+9
MC_=*EH;4=^KB9[AS;&.[3C2W4;TCI+*_>PV5O*K,SE6V3"8EH?N,Z[;C1M9&
MO*]ITLYKZA:.":B766DAW',S-S2!J$[[?M.]M\ET61WH8((U]BI(L&Z2,JOB
M%O/U[JGWF^O!=7/]M;YD;";<TJW69,FDH=#>-E>)N=Y[W .Z??\%W(5@DZ\N
M!/L!$ 5''Q$&X;GTC%O9:NZ3H)4DZXGRNN_7OEB17I1BZ'D@:WK>$=#[4D3
M.1BN2#X2B<.?,04B[E]E8([!FOR_[;]^_&Y4YTOZQ[2;E?"/_Q]02P,$%
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MWNB!2$:U4H&FQEA2'N[M1"?*7^ELVXHIL3X)PI5)]8--FEIY&TRUNUYBP+^
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MN$0HFEFGTP\WVXUUR39\FM><30P\/-E7#^C\3]*-^-KQCPFW&VM%?<S>@4Z
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MPK7E $,<6.]&D:UV@ )V"LR4(>$YI3 &H5&X4BNZHS%%D /. J/DQ,/F*U2
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MUEV9)P8=KY2C E]U#2EV<K]+#%ASIS.G%W.+[G34RKN)=)26%MX-6  M4TU
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M"X,N9#CTU=HP4BH5)C2B3_N5%.HF?^];6E"T26!]N,>UR_=U81WU:ND%:"M
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MAT7""^@2P)1&13XN5COP4USTV!ZS9E;7+M8O$0\(7HO/CXN*E".<%_P9W:2
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M<?(^$Y"!*PVT UF$A=6U8>%N)H7+8Z&9-3HQ;+/=&,J5X-.\X6QBP,7)H7I
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ML^P""T'#=:+CT<E1\I:1SOL,,V5@A[#JLDL-\?Q<9;N':1D6"#7,I;7FU[]
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M)1U:#L=>&Z*TK</MA*XMBIRM_<?;;&)U]9GHY+:>;7MEIZ."BB]]$TJQ/=9
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M'<[O!=]-R4GIN+2P'&BJ@]R8)1=8<B>"RW8K@L?K7D6TF_01^O:20VH2@C7
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M"=9N4:I2W/R^WJWV<7.]=]U<?ZVH#0-OZ59CLF1:D]C:YC(3UQB$&\4U'[^
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MQ[+"H_6.@FN'90M62[Q6- /RR[Q<-+Q'NQ*VV<^HW574ZB3 "<59N+T:'<]
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M>S6Y1#LM_X-X:KLM]5LPP?(Z^T^$FXAAIF&+%M?'Q>M\W/F'O*RS?^;U)[!
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M(>QG@"E#F-M !/W.=>_8%G#A55=%_:@0!B 82*(F(E)Y,(;+:RDB2)[G1).
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M&>O4WVJM_!(-?%E8SP1T1'HT?2'[:_1*I@1=*L+3I_Q/.\E_Y?CMB\?X[?W
M ?MTM=1;';2VBFRH'BT/%WK)OF=I51H#]S! &/-NNX7JOLR"JX,VR-E:MQ%7
M7OW92*:]RZUZ(4U#UXI+'X@G1ONJ:NPRUR(=M %]ZV?RP7Q+:7'+==2>"E6T
M61_-&&L5DR7L.7*DNP50:( "RN[B,O*]\,X8S4':=)<HKU).F?R]':Z3 S+"
MQJ J/+S!E3FEJ]'VA% :]&,?EM(8"F85'(58KW6U,WS2VV-?.-T5EE:7%#D4
M\:9_9>]\7HX/N?\=%@#HSRRMD#6L4'U0^*;H]@1*N?9[!&)9P43HL?WI>^Z1
M\K]GI6[7JO!#8.=N# _* K!E[.8@@5W<1*74<K[E3H1)MLXQ,?6)W!"\2=)/
M[#/ ,636:[V$I@M1]!6SW"%3/-=I+BV) M10GU/VI36%^+6HB:  E]9NB?]*
M'*_.;WEFX=Q>ME?J6]D?_2JX11*\YO,?JYS[W!#YW559(&;&U#STW4.<PW1_
M&)LXT<"KA\[/01^OF.A:X7E"]7W#2XM[2'!0G9%Z+L^\E=BM[VF3-DP/TRS]
M?IGJN2S6KOHO[HPV+OW7,!T3=V B] 6?:61Q"O.I;34,B>"U>]<P(FDU3"Q7
M$;<>W)C;>K7::;)X>OET*"TI&M^30B+ J :LH.APJ<<=.'I;BX0D>NGVUU'P
M4;F69D*E7GI\,>XLF3YGQ*)MR-:819D1Q$RW*<Y$,0FSR3S($)MV3NOE7_Q#
MF"OLXB@QR6 %H4GYXY+R:9HO9["=D4IHC, _?@LC+KD<J1%?#C;#W%/*<$VQ
M]"7-6PM<M/LL#M,-TYFD(PE=D8+QYH'7*R0\#) OT?*D^VPJ_T?#>9,<Z5[W
MI7%LOL%)L<?6?!!O4681I_J3BO]7$[5,--D,,VLNQ_/! G0JK9!"D]6>8S"@
M0W-6KU!RXTY0#,9I<KQ%UM\X=AC&T+AQK-^5\#Z41<1M['?NQDF),NO,6BM9
M-=@ JKOMMJ@=62O>D7<:]3S##-2H6JP:3?+9N_=;%,,0B$H%@^ZR[@!B&P;9
MA&8,0XVL#<MX82L,^J;IHP\E8SS&SYI,-+Z1=KS(P2IDWE&9*5/J$.=.\P8L
M2/:'X_E-_-S/A ;'?<J5#ST)SL=H:"H:^O(Q&OK?$]/Y\CA_]FI:%"^+Z?G9
ML^/3E\]/7KP\/GN>GQ_GI\7Q^$Z8SO.GK\[[89W/OT!8Y^3W5=,RR]QO&,3A
MPH4&"3FM_?A:E+.OF7AW[2(,?T70YYM\6;8P]?]B<6CFR?%FM[8*!:5XSQ7#
MCB(EJCFPC:6%)Y-^2B1./J.K?7TD;>BC0IHE:457QX2+E"P:H*%'WYH*M0Z)
M/I)>.@)_NJ-K 4/Z;[$0=,8"42Q-&&\SAO*IU)&]]K33V\;?&#"3*'W!@,0Q
M/5LIFN8_;7K&9;?AJ?17?,W!T#(]3C,^[ETBQ2R=)@$AJW;M&KQZGNV^UCC5
MJG7U6F+YFEP/;Q=*8@L'K]N&;"6B>1$2Y/(E5'RVR&?#;%0NA*S+F#Y@Y( 5
MV<#,;:T:PS!MS79$[L ZE4,#4<]G_[WN0QW$6+K*EX9FOD271P+1Z_YCTYT'
MF\6U9\@Z*TP1VGK(F"0'_+MO>ILV];*\*2D18-Y((@]F1=@K%^"!!,PV^I:R
M+[^T\-1;.'G5;*4NQ3]*F-V)QS7=)FD4M=4F>3D)'S/SCXGLU2'[CYV#$H W
MY"-!&+-=WDVH(,K.W$=V:^1 ]*>&4C8W9X@(::FG?A S^5GBOH#)0MQ_6T#9
M/RV=-M);P,I^0'XB9)]SV>*6%Q8Y[&]#$7S8_N,D&RU.8U>0Y-0#4"(['C 8
M%E?R[L%K4NR%GA!;ZAN21,=!A)GK_YN*XR.P?:*D@P1"":T]7:%.TX+AH*<Q
M$Y&"!)Q58!35H9?I9'Q5V_D[BCKU&==0$WTH%:Y+>,?96FKE:68]=<< QH8B
MF'-__>>$R)(Y@#0A#ALN3+VD,T:^IQ7YNM4.+&_N'!)-UN'V6EFI'SO:[HTR
MB<'[I'@$<Z^[U*6G?,ZD/[G=264;W>+QB(G<)P5J5S'Z#C8 G.7&\LIO1>$)
M'EM3FUW)J &_UJO?N)!W4R=*UX!R PKD'@"M=R6!EY?_)TB#[V%1N5I[SXW$
M== @>:XY&&3JFV"M2?+%7VC<U%_6]U,GFI=YS?4PM(T&?@.1G4T#E] 5U9E;
M ((6XIE%Y_BV&OP:-_-UZ5E3@JN=UQQ'8YMM^VT,5!9%"\HM(KP@^V:H]T+U
M,?:]69M\7D1Q1]LQQL#&-4K>A?;&%G]RI0:L#07V@2-HG)J.\1LA3D,?$R;_
MH[Y_'=<C#&IRA[JN"G2%:V-L'M0M@/!;17Z0BL79K:%V[&"8*F,GY9*<'@1S
MWV(;4S$##8#S+N.KJN*V3HE-2;7"N460J$P*:1$PA&DW(.V_SL5!0LF#-K:.
MPLEOO\JH]X=NT^*A,5)8_"L.O$LXU7=I=]P.)J)N&K:K7$7,S39I^!@C??48
M([T[8O2NUI6<C?^0L_%&:#KLB=A+17J"E%#GW4+&./WGR03Y@!OLNSGI3)7<
M-79"89/0=3T7"K56#&I2!\%"\P2(L(W_1:P^Z=&FXLA.-29PFR*%9Q2,G0'!
M>2:_D/UP.D4=<.UMPEXEF1W9D(1D]*2M9VHC2'O/P7!3@NN(V.'B60O8 !CS
M92$&[TD/#[TI>X-3;V\;4U$8HTBEKD_ D46+CIO! FV9I'Y=F1T9M\EW$-0[
M+*0-8+\I$N9*36G&D1!^FR]UHWMWE0-[] Z.<Q/_,#M!2CRG^#Y$M7?;#2%6
MDYWW.%0Q#>@5,39J"<NI>3(&.&\Y@'VL-C\!*?,MWH"==^(BZ[NN;1>5%1V-
M+IB+UXN;BOF4L7LX,=/6CG<I_5QC#P;6<$E1GT:,0":R6E@<\7PU:TMP]-T0
M9]C_'=VX9<'"3X9!GQ,JT+_ L.N>;@WLI21%8D[BZ8#Q6C!0BWU^6QD43I7=
M_?&<]:[6UL4ZW +MMBYY[4&=48?,G'$V#I/)6 _S45?^S7/JNIK-?//29\<L
M$$(@Y([3Y0 C?$.2HGD3U,]1U$@.FT-/';^Z\/>=/$01Q%YU,Y'%\ZN@ITRP
M^$LR@L((7<H:^DL80<O>54A6?C3#.RFI0#WM>!I>]P::[Q!DV*JETB:?9$G7
MQLVM0J*N5+ ]+1._U!(E[5%MHE%PJOY1%BO#!%WLU"8N2"ZY(,2V3;/%AC%'
MWZ]08,J$"0C9/<,>U)=)6B33(!UB:TOUNA)UI55,N=<;(0>,LZ-[PK9#X0E1
MR*\K.0[?WY"_8YPJ)&6GL!2BA*7,BK'#GOX)CGK;+8EBDF"2)?(6DW2[;F]E
M^ BD&Z:!R593^UIXV%:+3:2D VV%+95/$6A9*0E&4FT@BV09/)/A-[W-EUXP
M%!\A0PRBF6EI:.N3DXNVSNMUM-'[-[@VAJ>4N_'5G %6*_/1-$!I#H/8H0%0
M?FD@8'!I0>"T6M+SP9"@O%>"GQP/D93X($[5YU-E6FGW+X,<C@N]@QG)H/$$
MY5+0Q)?.$>6F3-O1D),AR@[;@*>)M;KTUB4>C@7MC%Z;Y[J:77MEHP%J?TBU
M:8TGQL8W\?M+V2#R<!Y#.IDZF$GG_)JNFY1S:-612=6+CHJK?#9-UJL5L%\K
M:L]II@%WRGSA\3U2*JB.8Y#0>(SUIF*])\>/P=Z]A-&=>\7_7+DZ2])U$F3#
M??X;BA.DJK+GUS1I-4GD=22!)/FGZ6M;@MAT*4S\]=YG(4."+60>G18CPDJS
M &3$#"@>L++K+&ZW:W+K/2E#FVXC;!SJ&Q4/G- QX$N0MP'$##^IZLM\H9 S
M5] ^5M+N))Q&[I(Q R#5M;$?-UHU&.UKV B9%_4E\]"CU*AFO9BFA=!<T=3B
M2P91;_A0RJ^&!K2C%5GPXL[[X-(LOF0$R@8NF!0C>'488H-*64/ +FRW].5C
M=+%&I97@"X,6*^I_0.8QSBXOJKR 3Y3*&BEZ3LK'X%-VCG/&$Q&4&6TK['J-
MWX)525/MF/#YIJ:TBFO6Y/9[(,4$P\$M.>JP[3FW<V<RH)JV?]FZF@GXQJ]C
M@ 09.V68CR7V68V+0C2>MAV8FBPGO!R""'D7N%#:@W5QWDPSBE,U*ST.Q$1U
MP*!_C:T5+GR_#H[;:\6R/5A:>>ASIYUL:34=)DT<UY+=XT0MU[N-.;'!1/$H
MQEA::6$#4G&[*A\-B/H+QV ;.NUAH=]S*@_DVD(Q5[0TJA/^# TU?A^E-S!]
M3^2$1'8>EW)R'QX6QFT8G6./=H(V2SFBP5I9F1CU7Y6)^^39^<GQ^?-1_OS5
ML[-7+R>O7H[A_T]/CU^.1L^.I^?WQ<3]XDLLV<#Z/M!"EFKP+U. D77>$ \)
M.9\Q$1('\.6WUGCI4$S:Y-P,2^G0S \?8DIV.:>(*@DA@*1'W!\-%49:X6'#
M_F,$;LZJ@U(!'H1P  TMLI[Z)Y*$%D5P\,=#XSYRSLZT]//N74,RGL4N2=:>
M*NC;-^V]5\S@1UMIW:W:Q0 7&S(:W)(@=@'GV[#'N8T3TR%R6/,UA9PHX8T3
M>57=,)EYDD(1?OQFP/P([7HIL7_/\1$8R_"]IPQ(W.CM0$-R9DG,HW681_R2
MBX+CRJ2/<<)1E@UBYH"PZ)S?2B;&]Y1WO:\(*2TQRT7@3<1VI,2B)"@<.AD\
M7GBC=X/05^@40"D_BJD(Z7:S(--TD9XV_ 5-$07W^+W@P3_P5"8X"[QM$ R5
MRHI^''1"+]W<J(MP$,/2)MH' ^/?A?\AMM8['!!4C$[LB2;M:-;"AW)]51;X
MOPN7XZ'=(*E5N7PO$H[D43X8BKA?)/2WJOQ8.;IFKJ_"* E(MC9TC25?H7N&
MQ4 I;-&X@QK4IF5S->2F8/1Y75Q7X*S6JYE$F;AU$,O1J3B3H5HR4MIG.8)8
M>6FAHRRY.6\$+M^8(ZF3 ITWV"9$>LF&);9N$"[^\3HFQ19_/57#DSN*^<4D
MLKC+EN*3L(\+S!D@A36Y>DMPE81YE9QU^R1^!%=@N S$?3,ZWX+-";8%I_')
MBZ3 .(9+&XP78FU^[0[5MBVRG1;ZP9)S7648,1R0J'>T(DYBXOZBSG91ZZ#:
M7R2\0M&%UOO66 &)7TP0#),I3:.[T@ 4O_(-FB162;F1E^W>8RY;/[+'@&\R
MX'OR&/#]<S-Z<&"U]VU',> Y^T40[=C$SBEU6]\FD5O>][EV8(6K5TN4UHHM
MBBH6%\UJ/@_82!19QI%(91@<RM\-&$CMT%JQ0:!38X$^PCR4&.HPCJ#J.TQ0
M/Y:CE:!I/**$-R>;,SJ,9B#6YE*0_@77^=JX<ASQXP%QT%-%2M#^C$?JJ[LW
MF5I4Y+P%23#EPLI&;'1K!%Q+"'51HKWW99(=HGI<-;@-@CI&HQ!-3C?[0#]5
M2R3%O>M\*32)_XG@M)*(!WZ"12Q](XJ%;1*BP35ON:CJ!8D^,V.ASI)B;?CE
MD )"%W34^C_<@H:IG/<$W-1$_1YB3?99%-+D9'7Z=UX(B$F\(!,/Z5AL^>2:
MY4,_(,JF:ZD.']P6YT@Y^*#2\M)8+/F^&(R&?<I44 8T5 $$Q&6/KZMRHF[D
MI%J-VF'J683Q)- )^O&.L\*=9<=M43$F1$X]"3G43=QQ2;8EDBC 5*R0F=!Y
M_\:Y%6LOBN\.;.S9!8WR$=B.PR D;(N?XNTKI<#^S9*G!":^<U"DI50P+?9B
MB9/%=,FX+F#V-$[>;]G_CD\X[FBK%].!PP,%R_AT?Y-W%^M^\^'9,3A$8FPT
M+]OTMJ4Y(RAE8OL_N%W_^59BFH=;1'23WIQF1Q2+YU,)82M7@J"&+2967*DY
MN<GZ49U>SF8*=(CO2O>9PCFO); 21GWL%B.];^KIM^+5+>\!9@H=Q2T-K@E\
M88=BC1@B1'8ZZ).7E*&@C-)#(6=$5V%M/\RAG!!*0=VF?\IQOMM&%]\$<XKE
M=!VU6MRP^_?9_-F/Q0)\6IA)RA&&^,HE1\9E=TLIA$SLF)M=;52607@#-L&\
M$K-GQ*SE3%_> 2X$$&E<\0AF.)TA;F)#B_8@@-)(<7"8V-W:T^1/BLM]OIV!
MF4^JI=!I4 )^LJHEC 8'\\D2YH-;D^&$!N:,X0GB)68!/T%N$FP(3[5CNLL5
MW._F>,2@ @+3@&4$QR 77X4%QQB^^LP\"Q&:V2^H#RT/LW?2E1S6[.=J\43_
MS-Z6&*^KZH;33>!DS5HM&*270B, #DO&IC+:(;C]^')FM2'Y">/^;5$R\SKE
MN8Z<:*(-)Z02@=$F(L=/&P4CT<DC$03B>.*,H2;0AE6=BA0& ALL?<'*F/F.
M]RIEE?(;M[WK8E;@7+NW_AV<U&922DW6O6O7SWL;W.Q/# /Z3]ID<59I& ,S
MC4BF_(#%?1(LQ]'D]!AX*JU*V_L"OEL%Y)\1W/FH,D:GI2\;.)UN:D5^<0"/
M#Q?O.9]%0\<5G,U":M*^RUS.@-%GDCIU8!$*"$X9QH2]Y'+8CS<VAC'L:2LP
M-*ST<+DA$1XFF#'R!?GX9G^"$]*"W4#?1VBB,09Y-0! U!9X!U#\4TJ_M)W\
M$W>PH_B#D =A4SJ.*F!JA^$684>Z?HZ5P6OR3=[8MG;:AU)R1DKP0I2XB)PM
MQY[*XU(5'P5VE_2[\1B3/O ;DS: 5QQCS> =2)?_TI'.T\=(YQ:?+'R;W5!%
M&] ^X[-7H_'X>#J9G+\X>Y:?O8+_FY[E)\]/)Y/3_-7T,)"D&)K3 >JTM3YG
M-V1/+[C(&T\=+%%TE=W'Y"6D4459>/?N+?MM;<)>$6U7"B[$J[W/*!G+M6F0
M!([J'R1BFMXR+$>J)!S:)H%HVS+,"-V$_XG 3P'*J;.UOTB8"DR0^#"I7G *
M:;)T=\Z_NQW("9M1;KJV;-Q3)]&-"';@I]<_P(&,DDQ&FP<[], D01FW%07%
MEE73@,T:<Z;YLE4J60W&JJ%Z&6T(B6!$.C5@D$FE, &KWF"R<K1>QOZ3:7CC
MT%%/K,:U?1]SZTZEB[/;CA@R(,"/Q@%7=37]ZW/A(TX3J2(B@HM>7+"Z[@4&
MSBRUL=[*]>@1^'4S%&_5H0?ZO-0H8L-%39X_"YVY9*>$J--@3J0=.FANY(;=
M8'@^>:+:-:.&%USFVQ)]<A<5Z,;9.PD>'51RSS._<0B:X1[GN/&U3C>P^TVU
M9%U<2_<RH1_1)R7.JFP'$\MRCX^/_-WF@!-2.I+D&YB!^VVURYC]J_O!/P ]
MP%T!DN]78+"</!\]>99Y?+P(VQ!6OO#NF,6L8U%M.5V[' 6<6@'%TQ97C/;)
M\Z/10"?OG68^+Y0C%0__=5[.<H\M-".++C,YD['P<*01;8%H)-'E5Y\>*X>9
M*SIG+*YN*A?03<<IXBYB\7#A1<GW2;RK.((JGB@@QO/C<%-2+DJ1A[5#=6C(
M.5 QX4M+@'OS6\^+@O*Z(MU,>4&8H0HC(EKN*PM+V9\YGD.W9E]:O>H[J<42
MW*^+/[\MQB2HI:[#4&OG(N4=[BWWM$X"C)/.*D1&TIGD0+3 U%Q6%0;:4.S8
M4%- I'M=@L4NB2H!DC+@V/*8^_4VA.:&QQSKWU P"43WP"MQYV*]T,#E& 43
MD^"T?5]-UK%IUYG-P-;#.BJ3<W'L&J#LX<@435<W3*K-E*_ASO<(WJ UD%^%
M?^0WW)U@4B 5)HX)V;Z6)7/3&U#&+]-I.6:0Q32D";MXKVQB.SV<^Q)5/K[3
M##PY-$NR1:4[B&=B[>D05),'D\*A*"?4>1CSIIA-I7=!T(C+OWVG<8'9T(;B
MPW87"%MZ.5$6_'H[T[4UTU5H>@"BMDG4K49':%I^3CS2_"I!#AQ-NG]Q;RYW
M:[U5RS79R?DIO?G)^0O=:'  D(RFT&R,@\3@A9B?R'[C])5;4 ]I#JR0O69@
MF(*[=YF;G"<2*DZ.2AI3WL^*LCC%D>]YU;0$"F 33)61)E5C>1DY(\X\"R/N
M7@U18P%?D$BHH>E,(1V)3=6E3H';MU?FP"O+@Y _@($O'?;<0,VVWRJ4B.3V
M\\ 5!%Q5BFS/0>OJH0GFX&@]X*-J<?"8(*@)HNEM$KZ^"6Y SB2M\3AOV/F,
MQ%YP[#KX_<>(9S+B^>PQXOG?LTYR\N+LY-7X]-6S9R]/STY?G+T\?7$^.I^<
MG;\\.1N/GYW>5YWDRR^O3O)C_IGH !&H RMTKX62^^?&#]&CRKQ==B%!(].G
MI4L_PVD@A<[UD3_$1<TN'L6=7_6)Y-@N\W5=81FFD*9(DHK;7#I.);6*@F8(
M04,BK^R)D:9QU2(@%\"W;HN(1<;C @?*V3\/F0NY 2)[%;\]_? TFQ:8<YL-
MJ5  5,6L@BVH:3K-,V,R'UV]:EP22U:SJFFZ2$LJY-C.@@6@1B /4I:^)81O
M2:3D"*7MS-(3%-7PW]"R*#5!9_&@]7(35+Y?D%T'5R'X)5Q5Y1M#GUG6R(4:
MG4&,]><9VGF75R;  #I:VZ5H3E??.2R M_TD*V&["'O7F#"AKYX;=BMXF;W0
MS#615- 2EX<-,1VBWO9#U'S3'M1?W$NDXDN!ZQ/![-+<JSKS&YFY;GT8 JA^
MYU2D#P*B-Z04QZ^I.OB)5B.Y.*YK$E>VUE7:V>(O]J\@OB-L%%RV9#(F_!]L
M-.1*ORPL$5:UX AQ4%T9ZX@O/#1J%U@.+H?L?4&$],H(:E"ISE>$2CPS/7*.
MRV8??)'++<ML)X#6D5[?;6K#[8O?WG5U[_HVMR#BM"^H%<#RCFNGQPT=M-?H
MT<(^],Z^6^T4"AN50'E\<AG+159'KG3YN+RDDU1)"E=^6*F.5LIEG<_![;PN
M9M72Q\5=J6_V48H!YJO9I>TD^ .+9%>60/XM(H >'C"__S92&!K;?]P^RN3[
ML%\*:!4XZVE8]OVAYS<V*.NO V=^M5\"^^7G"D'**.G^B0W6D6L,?(RB(<ZD
M?Y3Y"-&-%'1X,\O+>1-W2]S4;=UJ<NX$D4U6+3TL-*)BB"!^A 4[1<!:FFLF
MP]A7PML@]=O(!,$[V87-)&#TPZK&1<0H\1[C@FL7H1)(#(M8LK1:,"C\JKD1
MGD$2FIIA2O-3Q8V4* ;LVR%]KBWOI7!Z@$78_AYS75HROL ;('CF'RO.N=N1
MB0A,DOFZ_(4,"1P QQ"QMK.A-W/U2Q,L*T\\65TH1TO;T:)ZK]CQ"TUL\@ Y
M#MCC_%$TS6XQ-(6\5X9OQ)X9<F3B1H<O<^RM%V(GM:*26=9\$J OF^B T01K
M5Z>I86-2H!LP*3,Y9\346?/N)7UE9M\5BLI@++1^CJ6'O-H2FX>7&W]:5#>@
MQR^UVVNG].$&'2O:T$)11@!MGG@,(<,CB0;N9B&A3Q#D,-PA9:\69#93N2(-
M"\.E,[X= KY# H'4GO/;G ADD,B,8[033.DTE*K%5R!'CWYS7<U <\,$A2GY
M\8QRM9P.:JJGANH-/<3.T@<SXVN*%=$;DAM8>!"G2</D-_<-P+Y?901)IIHJ
MTT$9\^#8#"*'3<5\U7+81!E/,8P[YS N,::H,DZ4XBI-+'4WL+@4R?VDT+<_
M83B5Z._0 4:G59KTN,PUQZEE/<LYN6TBHR;$MY@31B+<;PTY4%22&IB]\3+D
M/8$;.;:[K$%J+>D(VV#^PQ[D@*3=I;7ZI[H!,ZBUYS%"L"<V#1EHE'3<;;.$
M(*4-N\9O%J+[PJ/9SM9[[)S'/$,RSW#VF&=X6$2(C43]Q*37FF?<'#3>:#*D
MC[;GES+RQ&%0)-:$,L4)"?=E3V"IIP5F!PN4(^].X;ODF-'DZ-C-A%XTU;$C
M-:ZF5YQR1I;G<2WT;K/)]AN"$J_G)*Z<LPUR:H:54KN,ARQNF:/0S&?2+GG;
MORP;Z(NS\?'Q= 2'[O2L>/[BU;/3T^+ER:OCR>2X.#]]<5]9KE?WD^7Z[I]E
M0W54BZ):Q= E7:G_7C2>/A1>K6I.-W&\T,.<&A\_-'A' U65-@;"NS*UN&@L
M*%\M?.C1-*7OHV&1^]AN]M%)T_9?8+&IO6"+Y.Z+R/G.V8;?F/+G5Z:E%HGR
M(9_QK-GYX,D/?]A2:=O,+%&J[S&M!@$ N<&4E)9E4UBU./'UY?:7OV#%\4;?
M _?%C\J%SV_*4_3&<G[C)6-[22[F8+Q_PN! IY@S;.)!);"%U.[)!*JUR;W@
MHC$8%%:G2U]OMQ_V+6?2YI#8.O';DI"<G$0:HYPB(Z @8Q\&A8JS(/JDL;JE
M+O.':'DX>N-<*YJKVBM5U]FGJGW-X4@ZR%C*G+#1FC,9_#O#G2KJ-EH\O7PZ
MC(%(RD0PM+4)%-TJ%[ ]&^RA-J;WT_''LRG8+/V:%Q2SO 2LIZ2;/#IT.WP>
MMAE?%9,5<W3&>,!!YJK[4[42E0>UQ0 R$F8<\> QZ8M@=;N!HN&+8P2"0FI@
M8=:H:C)P/#UM^>ZW'O9,OI[ZMJYF+M7;V=.:[:6P!FP"!>C6VHZ"=YQ24N+D
M[C_$+PU:'?3^,23Y/U=;.O>,BC!LR/0"VM''9TBUZ0.NK_PX8K)EX,.'#0#4
M;AX=8WFAR6Q'BY$EEU0G.'4 CI]6=9;NU&4U!EJJ=( 8\. "W4,?<*,-8;B
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M];>T*6^ND#"NE6V[QV1[%)4N\'5<%5W@HI,K;FD8G"-NL$T-S9\Z?3A?0_Q
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ML_V"/T.6(TO&/D*XD @EBNM=PY:9B-.OWRPH[.B^Q4M] DP^U*2-"0:;$9M
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MA]ZP)[";(!*H=+9+BB=3ER23LS'\H 1,P_D^M,L%0.@4H&AS"*7 P=,20%I
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M+$R:6( /VB%G')?U>#7'%<(H_7X[CS?3GKOU\R$.<D@5DR [Z\\D6A(:BFC
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M-U(MN4G@)GOOIS]HZU5#X R5E9ZI19MN&M>8[8M\<9@Q"-;/S@ _ 0/=:,?
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M\,WB7)W;WU+(S"OAL'=^MX,B!/MC?FA;.M]>L>QFMVK:)Q]-*N^=GKHMDL7
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ML:.3<<^V"3YB9T,$?VQ$2C"\'2P+^+T_9 \D1G",20$RO >C(9R0M,CP,_#
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MR)RU("D+H SKU3#Y6'-75#O:$=;]XA$*&D,*+Z+)ZKW]GP^_3XP+)D;Q0<2
M1;=2-[JM[WG*MZ#$ARJ#T61(J<#MH"6#/W'B\5;,'+%\J!1<CU(/;B]P],B
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M&"$K=8>P'2F2*4G=NC3L9U]/"^&L&KP@/FZP"PT!6=\0_BJ7\#3Z8=W@+.+
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M^6U29FY&:/)0@HB+']*PH?8(2/S,.?M(K6N/R303][[6Z)?W@0626E6"N M
MX-/H>R]TSK )8(C$+\EI:FU%# ](S%<ZLIR-18.N>5Y5';6MEA*><^&-6UV5
ML7FCYWN03H? YP"RZ6AN=4GT/&CMN2P-!1S=C0P:C#:T6!1%\#?\#0X:)G!7
ME.I&Z?RF00IPA+PEJ E_)4"87<&\!!;+1L/?66OL(W8^7W3!>4#50#;(0'J
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MNI[/9]GEV7PV22?7R>4LO\[45%V"KGC^Q35)G$X_+^U0])_F".OO2 ZW6(9
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MY;;%PGAZ'%>XMSDPV[<TDEWPL@$F9C"SPM3=\*9FH[?%J=-I,&UMGN,] K>
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M;.][G>\21S\F;9;\IC_^6]*\4YT),_R!:(AD>%-E:[!5-L!";$+4*_.*_:H
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M:GFR25@5"A*F@"'1G=V818)< 61"F$6QPCT_-%24W+$_ $(P//U WO<U(+<
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M)^-])K1(A^QC![(PELL+<_#Z6;DN.9IFYHM9+KT;JQ)P^32O.)NQ1GW1KGI
ME].0GLC7CG],+?(08L9GPSG(0]#SNT:PW^SEH7.)HY6]H79Y=U7AG.R[:K=W
M'=ETG]=A\SH>W^=UK(WB<D[N\YHV!N&T3PS%<D;Z+K4?&&# 2WKHJ,AM0WN
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MQ8 F9HI&&<YAR7=H&2GWC1C!C&A,&8VK?\@ )]RPR()32[Y30P2VL;L9$=]
M0;BQ\VR3+>V^NC4ZIXT7FUX7"Q5C9?!P''<ER2A*$:V-,%>K\H326Q52%),G
M-J;<6_E>J_B-0@X&]-1KL:;QM>40X44A@J[O=@>:PGR!]TIU,_(MD7K:%T^%
MXDNZP6TTZ)2$*<34%60IQ#+&3?!3G"!KD3=;[\$@Q:>; _AT=^-<H<,R@"\:
M05D<9DBORG_'<#HV< ,=&-_!_6&Y$2N5*PQZBW+I-(-0(X(6(ARVR2<B$IOT
MW&])& YR4<-69\;_N//4I21W$Q@B^HW)QW;P!#[]W#V^\^#)QFQS@-EY@ H,
M0@X=HH[8&=<S$+C[4\W=GTMN<DLX/^]KV(_4W>)=;#&=T1+V$*1)),1#$(7A
M&'+C<"B9+#U/M)QU@D<V+F[Z@\56OU7>:!RWW\7QI)/^>W@QN@)=B$H6M*J;
M8$A._E@V[UR3O0MQ&]<W2#<>/I!<E@!;;)#E<FX0/HE6C*SK5C ;$GT;\XK
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M(^,@'[4JFT:.ND%V/]:6F+U#>I8:N+A1ZOKX^BFLA#:AOBF8PEH1-#1[3YO
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MJ\I[+LT'K/1K@AQ\*SXUH M=\+R$5_--0Y#;KG18$(Y&%?:^P$#D)5Z])8W
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MD@31^><DBS2 D,4?&Y[P"@G8%WTWIY+]!"HF:3$J3Q\='YO#V"F:'0\W+UA
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MD;LBWEE,$CYEW%6!AURUC[Z"2R6>T#QDG412>P%%Z7 \9NVPYM3(*^5-7!1
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M(*Q1:0*BM__ZY8=)E2WI'[-V7L __A]02P,$%     @ RH7,6JH9)4I+'P
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MH=C=04J2\2RPH@3"[^4"![N]HO(#*O3>.:!M\G=N[UE#6[$D)\GH>K/UMPP
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MT;RB%T\*NC++EXA.[/(03$] (UFRH*M=)K063K_BS&E.PMK?X20LCC4\TC?
MYBY>3_!TP(@(:+5O.,R0U+\$:*#,B,57(L!R?F,%*9*U!/@'J@_)0-^XDI$4
MAQF,78C?$R0HG0 C+4"MP-A#IC!:B"HFT'JH%.X?QOXEWD7H@NM (I17?$5)
MM29JR <6!? LX:M\-G[&3-3;^4YJX;)/PL5P@Z!(&R*FEP<RF,!&K2A=]MND
MB[B[8+%L"LB](5V6QO7:_%OX\TM!V= AC%U)IAZF<>/R,@T'!Y!4ALP$, CG
MB1$ @)QH36[!*50- 9,@_3?DRW(Y$I69Y60MQ]#+9G'="H[&V4B.)_Z#G-ZJ
M6#7#QW-*/-7AI!U7-VR+^C5]TF^O"<AM(EF;2-:/%,G:VT2ROF,DZW8^DS:;
MZ:9H1NT#OE=FI76.I(*T++9AT\1)_L%RM,K_WZJJ8YX%*WPZSTL,&C15RTK:
M/.D @O%_)TD(94EKHI!;ZU:-<$[/^1E8I'&7('M(+($42A/B?4,%BA0H:B!8
M2-)2>:Z$.RYU7AC#C%*-V?.2H+(**E>&NB *DDF=.VS2FK7)=>E_X<0J MCX
M$%UPS_N'5<T93,PSJLS%RX@\)+D$D$AP-58H'J591^@1&@D375#%,4E:&%ID
M96P :7-=X7Y@&JDS,6$FK]?@3#ZT ^!CZJ]2%_,QT)S*\DZ5=MX*()96X?5V
M='*M72AQ6PB! +9/&!'HOU35MGP0HV4CJ>%.8&:\N[^U_42)X365LB:@8_C\
M"I9N3"J3D6F3CTR6K=6I*X4(E?C6!=LJ-[/'F(&9Z1!WIL:L+72KM2*'<GJ<
M++S[8A_LP-9:$9^(O">]&L;:QT I6MM4#XAV:;0,DT@00\SR-&B/:MQVKEDN
MFG#H%T1TLXL0?@+R()<A9C>:.L0RB9%9D&JF)E.:G%/V*97+ 0GSMW5FCMQ"
MEFL#6Z#_R2NI8SN_F^U-M&^(ARC9 6EME3$/T1):1S#IR)Z5P.39!>F(8I"5
MZ^U\O+9@DJAFJ[+ZC..K07,=ZZ2 Y2C7]US=EZ,ZV\:*IN40;""D >#?5\C
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MBV\^O/\>M;IO0(>]N8+_]^*M8V+J8N\Q5O[HN3O/_$.]B17/^>90R^Q2O])
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M&TX8C,\L%K/8:)RJX6B4R7X_'6<+(>:3Q5RFTT%_*$>+]&D(JV^U(B8#)FE
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MZ3RW0$6I\&UTIO<HE+P6.[+PVS(R[_?U(:"@,K@QN T,H=8@CNR(*9[=HV!
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M1W.1S_JC13::J_E"*/4TN#?+U(;4'%1_554+=O]9700]!)P&ADCJ H\MZS<
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M8JU-?O4)_+DN5NK#)T&4B:KZX<F/;]_\A-;]CZ44'Y[#_SUY9B=++VE\D=T
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M;-:&=C(EA9 /X]:91H_>H],H;?9A\]PK]XNN1\(X#5(*S!@Z4"KS<27A3%%
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M)+Q0M=)@=>B6+,>#]W!?(A%@N3Y64YO4Y6;]M44DK6^D<BG%.]1?ZPCR#/5
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M=F65>X5JU"Z;_RRW34G@,B(<EJ1@FO!>%7S_*;'I+-9X02AY1K38458BG*'
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M<&L1'*;1]E_M1BHM=>U0?*0K/9@!-"O<N8IK&##/RYOZY7W"<G^/A[K=WY<
MG2(>:P- ;[<JJPW@EIV70.,^MWAPRRVJR]:.4#"F<+2 +\!\LR+.Y;2R1/ F
M*WS<N\F:$>.5!GG;Q-4,G[%(UHUQ\+OW<96,A)">;X^"9V:QQVZQ+5S<E@4L
MA?^S%?!7X3^7(\"<(]!24B':<UTWI*P<A\#N!\ &,#F,NQ6<5LTY1[\WHPS.
M:5#"*5?\?(T_=B0=XX@U'?2D*J^S&A9JF4W7L<"80/?I- ?Z3\L)+B K5)S
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MUD6&O@S9%WR23I,F0E$[+D7Y5W'3Q%E!/@\Y@0'Z/' =\*T<3MUQ.E\1M^\
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M?CB,LVX7H>&Z#DO'<0'(BYPU0D;F"B[8M<)^ELCGNLMK,)QH<R'K^6(,8=O
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MD?C%XB2IIA33BBO0E"+QJ9G(OCVJ:,$A[:FW<[=;M4X,0_ZV-38,+&6@?M+
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MD9%$(7+-E];GL\A&$=!;:D)-M$BJ4+7%3NOUK+6QBDA"-0;_D J:$:$XKVH
M&XI,[3:"I]5A:)Z&[>IJ7ZK$$@D@24G&7%:CN4>10DXF06G8TJO^F )6I%GB
M">F.&4WSR,Y1TU)SZ,W4#)@[%DPV[7ISH.Z&:ITN5!K/:J]Y,#>HD$T;2X$
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MN%N'F+("$TIKVH!+6O5K_$#V+[K5)"CQ<:KQ*HYO^*!C^*0\*^F^1_/O03.
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M_N6]B_[9 =!?W1(CE;=K0D*9#56=N5; HLC@(DUE1C'RGQ_LQ<8&,^+ 92M
M0;/8AC6<GF&\;D&&C61"I)""LB>N?,(\: 1 <9@/2S_0P"PYF==2SM/)&O54
M<XE1RSM%0U(Y&TZ\P?]RA!4MLD="%I#.IG*=J,+G*-GGUL?E3$6O42J7A^C
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MZ<WOK2O1]&[3P4^'!"^0/(<YD(.MHUC6((P54EDU,3_>3D0UN ;U+*I(6ZU
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MP;AI<H:M@<)I17U*X%R*++N?L!U\V7*,&3\V*>MR7BG*-AVU]'D$6(<S:F2
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M.42K?/SI&2Q((AI,LS34886O%IDXRI:(6\G&KPS+1ZH'E:5.B4D\122[_$A
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M?_]O_=?W7TS (Z!_G/7+!?SC_P-02P,$%     @ RH7,6J,A)-LN#   W$
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MO]F=(0Y4Q5,#G]3*?BU0B>LIJNJ7*ZZGXF:SM>7.\ 4 4??;>!2>A=#<##8
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M3[ P=3J!VVA81&PBWA#H J 9T.,HGA"/0H/<E$HD(?F0LR_N)$.B>TQXNEN
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M[B"WCYKKDEZKO[_>X2/V;0LY#_<1^Y,8^=7%J?@[ /(B^YL&_P-02P,$%
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M]0=2=55%RXONNR^>SP^W^QI%54=X?G'</W?(V7#0?.&"Y\ %_VX6L% Q]V(
MGY"\);K^;FGZ8O]>--]3X79?^S>X&%Z?#4^&U_US,KJ^&/P/N;[J#T>G)U?V
M&]177T;7+_'A<^*1?S?KJ$L[R=^I!Y',BX%\2@I72?N[)>L/MI%_Q^/EEY+A
M![&BY"%TM5=+=6)W5X851KECKP4W451M%Y:@8#H?]]W6_>V&?ZS;-:C?Q:@L
M;_G^KLQ\L>D#_CC)?;<-GNZ/DY3^.$AV;:\.W^+??%$7YN_7_#]02P,$%
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M"A3JJEW.% A8I6;<$(F'110#FFKH^TMI=>"Y_LNRSZ)Z"AW%(WC/$]Q\$(.
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MS5&-"#5;<XEV;CT/KZ/FJLUQ"05RW=QQ)T/"12;>'&X<U9LM21K;DBUDVEB
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M;,'<S@R:PRVX90B)4F]SI*3[&E4*!"2&OD2:SGD).A.H+?4(G-FH=9@APN@
M0;4Z/+H1"4$E6AH+I,,4"$IG5Y$A4;WG[_ =, PA$;E+RLX(!"KWJ*3!;'S$
MP#[.46B1NYR/7* ABA._.<5/;9()W*&#:X4PMTNE*$ZFT_VD?FZ) _).J[.2
M778_7*LUDC;/F<M4<L&,&EFYBS+3?"3<4"X'ZZ-95*!#5 +ZR:/!68RP615[
MIJB6GEG$&9WI(,3BD3.H1:F ?*I73 U"V3+6C'^?O)N(F;U1SM!4HK,=\DOH
MR$BJ)_M#[,L;";H_<)R\I7=\1<A[1>+&:YL)/LE$L1SLP\X !Z8=GJ[IS>&W
M7J?26XN4C'F0O$0IL*I4X P !2('8O$+*LA.CSV:(NU2YT(F*2/GR-32]I@B
M:=;*C;/5H#\1,SJAPO((&6/K%5=85?N!XJS':(-',:N(6WM%+P <L E(#'4L
M85*JIHQ;3MNKOI@6>'D;&0- EHYD^_<A+R_Z&C44G98ATL*VN5VN6.%C?.?L
MUZT;?1>:1<%X! 1UX+W\5J6GF'V[?DG-^KOQDQ&GK)K9+PFDV\C<P.^+@8HO
M+ZAF7JK,=92>T_L*\2IPC9@8(H=D+V,1IE3HTS1;7%;6,,)@SZVW)<$IS+@X
MX-9(%O>^:S ;-"3$]_FDQ"(]Y^!K&\0T<+/ 39/VVTV6ZN</NJOV,UT3-R:H
M/"FO%@%F,I%IKDU4%@JK(OG&+J'YN3;(EUQ9^558JBYT$!M.$'Q/BWNZ,.":
MLO+V<T1\T#]2M$A*V<D"\8SH/MU>F5ZCT7VMHU,E!?;.DX!1K)A0=JTYCP<"
MT><4.3=:+<BY"4X%IR2ZWCP9^X*.-AP(;31OW-S*OD8Z%1U"SVX #+O%IM(G
M1LWRH$_UZF-'X13C\#XQSW+@DD*<"B X51=$X8*P+B&,E"<)/^>:/ZC]#J?>
MC"_N_ZK(D;JFB&SZ,RU_RZ=SR1:-U425X^;L&S[=$91^=$DM%, )6I174M<A
MZON*QJA#[VRWW_'<_Y[\KN/4"P)K_E6'I_<MM_FRZ&AKW8LYXE6\ [N2XL)U
MG[8W[DY#L__SZE4$O8G8/L3]-A&1C<6O*,UR6[9+\I<4YW.9.;F0E?S*7QQT
MIV76/_LS?,C8D\6-]JAR$R3BNUZI?'91L?Z+C8T5UN[3W2_]V<C__[W(X1WO
M13YO@5[S;_BMT+>_PKCK5R_IYT UX-/5Z5=![($UKZ2KD\?T^RN^B+\E^R]0
M2P,$%     @ RH7,6G,)UL-- P  !1   !$   !N;VYE+3(P,C4P-C$R+GAS
M9,U776_3,!1]1^(_F+SGJUW16JV=0-O0I,'0 (DWY#I.:^'8P7:V]M]C.W&:
M](NF 8DWQ_>><\^]OKEQKJY7&07/6$C"V=2+@\@#F"&>$+:8>H7TH42$>->S
MUZ^NWOC^!\RP@ HG8+X&[P6'B2#) H//3X\IH1@,1L$HB(/1,+YLF'W?P%=R
M(M$29Q H*!98?8(9ECE$>.HME<HG83A?#B$*$,_"030816_C@19#<8:9NN,B
MN\$I+*B:>K\*2$E*<.(!K9[)R4K6'"\O+\'+,.!BH4FB./S^\>&+C>I\&6?'
M(Y9NE+"?+=+57%!'.PR->0XEKA7L^%<BXO%X'%IK[:J)R!%JPJ2"#.&F?Z)J
M0--Y%)9&YYI@TO:3& 4+_AQJ@\VP=E3"5^L<R_TZM#DT9H.Y\*/8'\8.J5NB
M#4RAG%N0L[0"2:$.^=>F$J!;! #3)) QKJ#2_6BWJLT\)RSEU8[>,Q6=N%-X
MPBFP-9X8PJDG29934T"[MQ0XG7KFW'UWRC]R@0.MT+D(3O&1(S'F4$.D[D2K
M[&$3V%% @798=GI D_ <"T5TUIL6"O]:6@E.NZ:E(821_SDI"N==D](03/]M
M/H;GJ\X F,6WI_L],\5*N>&H,!/L'4MNF2)J?:_[6&2VC3Q DJEWU*..ZN)N
MSFL6Z0$71< 'CJ&YA"P!)1UH\%V%VR3;_(7$R2.;V?5VRU?HRN48$D&*"GH&
ML-V.^W'5KCL!-R;"K3E1;K2GB9DENN&X4(#M?'^:HVP!85Y-LO*K]<"1I2F]
MI9NP>S$AIDJZ'=O(P4HFKH>.:C@PMH]JV'8WBQY1$2^8$NLND9L0]]!'02&$
MOH5TD]#$U$\]1. 56G814/O;58_ #!(DNT3> ,IEC]B2H"Z1G;M9=(NZ/;C'
MY;1D>&&NE_O#;\.H$"V4;WC\>.#';_OK4)TUJ'/BM\NI<M&I_,[?KOH=0//B
M>4KB%F*>?(<SZ0]-^L/X;!47H3!?ZQ,%6&\35E]2+_TXZE;UG4OTB5$=P 0^
MO=Z'[LD]OBZ6IN]K5UV)M#ZD?+S**610<;&^T\^GOP)-EML-R3EO1/,'H5.-
MG']9'_-[T:DTAWY,SH[>]WCV_H4=$O,GI'V6&R'V<E22S7X#4$L#!!0    (
M ,J%S%H,_= N" <  .Q(   5    ;F]N92TR,#(U,#8Q,E]D968N>&ULU9Q=
M<]HX%(;O=V;_ \M>@P-LNDVFM)--DPZS:9-)LK,?-QUA'T!36\K()B'_?B4C
M ;(E6Q"BF)O$H-='Y_4CR;8L\^'3(HE;C\!23,FPW>L>M5M 0AIA,AVVYVD'
MI2'&[4\??_[IPR^=SA<@P% &46O\W/J#410Q'$VA=7-[/<$QM/K'W>-NKWL\
MZ+W?*.YTQ.XQ)C].Q9\Q2J'%JR7IZ2+%P_8LRQY.@^#IZ:G[-.A2-@WZ1T>]
MX)^O5W?A#!+4P23-$ FAW>+ZTS3_\HJ&*,MSWMA],6:Q"C (5G59%>)31\DZ
MXJM.K]\9]+J+-&K+%$6Q0R5*OBCII:?>R<E)D)>NI#P0K@B]83O79[V5>%-X
MG'^*LC8_R*W6\C S&L,M3%KB_U^WH]5^X]D A=V0)H$H"3[3<)X R<Y(=$$R
MG#V/R(2R)#^PO-8\5/;\ ,-VBI.'&-1W,P:389M0(@Y:__CH7:\O#MFOU?&"
MC001"U6.<G,SS94]3+(@PDD@-0&*X_J\+ =4'2?!^3A/-X^VAZSX-A#1@3H1
M3- \SO:8HR'V?C.F"<(.L'=)6(;>1[YYJ$X"R1C8/I/5X^XATQE/BH7S,716
M!V*/^1JC;V;-&PDF6/2W*_Y1JQ@6&9 ((E6U2'>G@2&O3E48TU"K)1;C,F5E
M?ZDZ:BF$W2E]#"+ @1@]Q$8^C"R) /Z^K/(LBABD*:3<"8PR2%(5-$9CB(?M
M.ADO%0[MLN#5G:CC>,\C%K(W%<F,]2(]RS7@,Z;GRUN@BB,;XX[]:L)HXG!T
M::6'=9ZG+5NH5D9;>@C*(F#R,N3UZ9SQBB-1^66,I@4\QC+IK5#68$!5+EP)
M%6)(1'T_B%3SN &&*1^+HL_\ZM/2DXR:0I<J:!J,SL75MIVL$$NB'/A!>3YG
M3+0BG(8H_A<0,].LDTGK=EF#F3IZ<\5J#R?)_N:WDZX3N>3?%$_7-:I"1RVI
M&HS5S=FVG;4434(]?@NHRY&C'JM!9P2KZ0X&K=W=;G"U>!+O.S]XETE>XAB^
MS3</C79M72[6KJDWBQO,L,:+*[IR&$GL=Y_$;F&*TXPADGU#2?'<6271R!4E
MC:=7Z6D[@L50DN)[GQ3/^1# 4#SB]^.+/^'9B-&BT3B6-(T'6>UJ.Y*E6!+E
MB4^4(Q)2]D!9/C=RE_'+KW,ZYWD]G]/(W#^=]M PU^S1>.C;.-ZN"=1$5O,)
M1SY;Q#U:C"+>-/$$+Y]15)QA:[1:*[!J&\_?S>5VY*TQ%7-/DTA:IO*?2+=7
M-5MITIFF*W5=XSG7N]N.L3&>XNMI!LJ62=^1;]^1;_\@^1;=O91O?\W7T[24
M+9.!(]^!(]_!0?(MNGLIW\&:KZ?)*2V3<[YYS>[I$ZFB6U:9V&ZJ#H6LU=E.
M7#>C*:J>9J>T//+KOFMVP^@C7JZ7L**U2$U\2])#@5SM<2?2I9 *M]?9*M7L
MEE?XE3U8EQB[KY(<"E:SI]TZK@JE,'J=PI))W- T0_%_^,%ZHUPE-"$M" \%
M;)6_G? 6 BK(GF:XQ%GAC $R8#45J>=Y6E&#T55X<'YNIX50>#S-6HF%D_'-
MC!+SQ+^M6%HL%S<858T75USE,&H-A*=II3L(YXRGU^N/[T7J!62V8FFS7-Q@
M9#5>7)&5PRADGF:%[AD22ZCOGI,QC0N\C&728*&LP:2J7+AB*L10C#S-['RC
M6OV&16 5"NG4J&@PM7I'KNR,D11!3W,WJIM?+,(9(E,P/!*MDA0&2%W28(@.
MGK8=*/50"J/7*9J+!-B4MZ<OC#YELW.:/"!BOLFK5&HW!A9E@]FZ.]SNUL 2
M49'V.FUSL>!#!TGSW)=+8,R8K3*=L4'6?,!UWK:D:PBGT'J:HOF;#R,9$-ZR
MDCF1C^2*:\4J-=*X1=-@HBZN7'%:8BF6GN9I[FB,0YXMF7Y%&6].J'@):Q>H
M<ZI!T&"$M7Z<SZ>&0 J>I_F7&P:B^0 )(7^Q0KSTPZXGD]*M?KU0FJ\2-ABJ
MLS]7N%4!%61/LSB%5$9I.@?FC-HJ-P,WR \'>YW7'>$;PJK7*;PN-MIX,>^2
M;P"[@BF*K]ERE2,PB*SK1+?;5;OF<MVUP<WD!<=@VR5J;E6HYO,6ZY8@O4?C
MTL1BE<3T_&4E>4WL&Z^ [_B\Q>QDIR<MJU *7CYUE?5.PYBF$ W;&9O#\@M*
M,EAD%W$^>@S;*4S%QAN0EAOBA<NS!:YYJ=8B-M,OB5^S'52\:&UL%SKS<INH
M=EK1.O+ AI91"NCYY=9U]9^U=_S5"ZZV<NG84/ZJH[GE%PF,+&VL:+VM"I"%
MJ/F[K^5H#:?XO;@B[^TXZK^%\6*0)6<O1/E]O=;0TP.'Y>E?)O(5#$]?*Q32
MM%'Q1I=9]KY&7:QL\BN%$LB,(<K][T-0L,W/US_$+PXMOQ=_Q"_T?/P?4$L#
M!!0    ( ,J%S%I(K.IY8PH  &1M   5    ;F]N92TR,#(U,#8Q,E]L86(N
M>&ULS9UM;]NZ%<??#]AWX+PW&U#'M8T.2]#H(DN;BV!I$C2^V$,Q#++,.,)D
M,:#DQOGV(_5@B^3A0TJQUIO6YOGS')+G1XFB:>?C+[M-AKYC6J0D/Q]-3]Z/
M$,X3LDKS]?EH6XSC(DG3T2_1[W_W\0_C\:\XQS0N\0HM7]'?*(E7-%VM,;K_
M>O>89AC-/IQ\.)F>?)A/_]HQC\>\>I;F_SOC_RSC B,6-B_.=D5Z/GHJR^>S
MR>3EY>7D97Y"Z'HR>_]^.OGGEYN'Y EOXG&:%V6<)WB$F/ZLJ IO2!*759L[
MU7=+FK4.YI-]+*V"OQNWLC$O&D]GX_GT9%>L1DT3N=DA2"O?*?JF3]/3T]-)
M9=U+F:/4X'K?;39Z"-7C1TF&O^)'Q/__[>NUMO;IA"LF.2YOXB7.6,BJ>OGZ
MC,]'1;IYSG!;]D3Q(^PGHW3OAH_.*1^=Z5_XZ/SQX'GBT[PUAVE!RCCKIYV5
M/[6M2AC_1M_V-;2F)M_V.<ILDN.?,,J=,/Z-OL<T):O/^2I\P^50?37^H8SI
M3T!%#>;?@?"M!IJ:\:(;]DJ(BW<ESE=XU4;FO@W7SBIT=;&M/.]]DT3PFO&[
M"*%J=PKFM?)8X.1D3;Y/5CAEGF<?^(LQ?U'U@KWY[R5AM\^+95'2."E;3U4G
MSD>@K4Q+WG;)-A$;RNL+3:6X(%N:8"F"M@5. R3DMVX6Y'"3L7!\08#S\6\/
M(Y2N(%U4O47?VH+_?)P<6JKV[H**N8AITC:%O;0TOU%,$L)ND,_E6.C)(R4;
MW=@3PY U(U#Y.D."!)4$ ?4FP>GZ1)+M!N?E@GF44@^9FBZ()@^TH!@^9$G^
M=& )LJA]A_C;XT(%CCG1CY6(5%?1$F5,50"@_D'3DEU*+\EFL\W3>A%=2)DW
M:IHN:30>K!FC^D"G<ZRC#]9'33$2RX_+HSE3Q&%@14)!:8NJ6\H#,/M LC1)
M2_9,^H4M&F@:9Q(^>D'3/4C@@:H^G@^GH%<=I( X.I2AMO"X>!KR0FPC*8*I
MZEHJ'5(; ,E[BOD\P*SKU=6;+T[IW>,CIA(N=F'349/0 U5[?!]DC=YUZ!HJ
M1<PV3CI&5%M193XNS Z9)*YC+L*MU[>0OP&.\+!?%\464V?DM7(8?$#>'_[:
MMO0X": 8CE-!K:I.B%HSW'FA3S<\.VQXP'-$J:69*7:: LR7"Q9YQ:-?9?%:
M@A*T-5V5;![8@U%\&)<=ZH 6=='^+>+OC\LI//+$,& B@8*DQ<V<LH ; E=I
MD<39OW!,KUB)_ 1G44G;!(JJAQT#3>0^-@]4U[9]!+G&84NAMB!N0I5M&/L+
MNKP1IT&&=QTDL;P!88,@.,OU#K:=9D '\BSH>B,:B-X?TZ)S-ZJ[=12N:^/P
MR(9R"+*M3S9(=T<.\VV"(B#A^P^7/K%G5 W=H$8B6]+T0#48M0^B9<<VFD7]
M@>0&869 W#(,BN%<$8>AA>D5I#*YYJ0'H/9SSEKY^A6O4_Y!1U[>QAL9(9.D
MZ2(L\4#6%-.'6(U?';"@/*I+T:$8\?+CTFI,$K$/JL@JI&Q1=<IU,%(OV22A
M<7;-'O)V?\>O(*H:C<"JHO&&51/5GU;5L1E76=_RVI2CRH"890C$ZG)%'(86
M8E:2BM#:DAZ,VJLTP[?;S5+9/].9!5:[9F],U5C^A H^S7!VI"V7O C594,@
M$D@&,0\@Q.%!)2)HR&4P^A;Q[GK%T$\?FT_R#"A:M *76JTWI)96^!.K#V#&
M5U>O99G9D2@8$-FVW)(WI !B7E-%G "NT 2;#==Y0N@SH57PAY*MLR_)EMT7
M7B_)"E[Z.M409H:EAO?\<&J1_RRQA3'/%7/M=L8(JG>HTB%"4:-%7#R$R>,&
M 7ESEJ")9*PH3J>WD1;B3.264F%+$=[YL,G:DY):F<^A24MLK_.3>M_:HY2Z
M*E%C$7:JA[$98DT?<1MJZ=RE1KT_@NE*0[";Q><-INLT7_]*R4OY=$DVSW$.
M/W0:E<+-0:/TOBD86^!_,]"Y-]\$X%KMQ;^UHMJ,&OL0KO?F?!+G@8>N[V %
M\;KN!DDX[G<+&N=%RN\J]9XD#+U6)A(/R/QQU\;N@77(MP5TM<J>\ATZV)I-
M[D$@KL\><1MI$&Y%+9%MAR'@VO^1T$VU5KIB+S"]P>LXNZ/U;B:F>*7=_WY;
M5>EIP*UJ#X\%;VEC'\\'CO%L#PI.;@Y/#'OY.U170%4-_MAPJ#.83?DWDD-^
M/*/PLX2+!_FAXH> #39M+U8KQGZ!BT6\S.#I"4N$:2A+O*<;'--_6BE^S=-'
MDK?39%^,OE6&(W]'RY@F8A]6B&U1*3)LR79X5IL7_,L^%[M4/N?B)H;Y5<3]
MD:QI1X],JQ$<Z98K*IR_:U]67QY#W[AJ6-#KL@SC;V8"G@A2'<V4L $4XISL
M(>0GLHG37&)1:V^Z"]A]SLSJHGF=FP6<:L_.*MI(A+<N/3*^^J00RSB*D"JR
M_9%::U8#H%@O:9K07S#P49A!T70,5'@ :8CH@R3L5@<EI(Z:!79+Y[>Z_,A@
MFA)$K",JP@D(6SQ=LAQ^(7&3YOBZQ!O+$D*1P8N'CJR_98,2N\<%0]>WXU+A
M4 58#',CJJS#6ARH^8.7!;H\PPN"O5JS%-#C$!KLYC_>@*F);$@'H2WJ^F(;
MBMX;W))S)[J%.A+>AQ5P!?E=/HC]#U,>(<0-"8<8[\I!R(U@_$3*9XZ4SQPI
MGP6A?!:2\MD/4#ZS4+YX(<.D?.9*N9QP"^4S&^4J&#^1\KDCY7-'RN=!*)^'
MI'S^ Y3/;92S) WT:CYWY5Q.N87SN8US%8W0G%^REW=T05[D[0N+"F*\J^J+
M<#5R;WP+KIWH[M10V.8V_G$-MPZ(:B!S$-/:!$-$'\0@SP8,0M-<'1>[H_>4
M?$]S!2X7*<2U(NT+;DT;>B-<]>^$N5Q-87U_I+&5# AX75XAZLT,0.A+-4#^
M;;@$OZ37QR6-UW-1 E[,6TEO5W(Q9G^7\;U?MVMX(U<OX+5A0"C+60(OW& F
MP:MV<_P8O&1KDAT:U7M2E''V[_19>U+=)(2PE81]P0O&[PUAV;L3R&(E!>?:
MC)A], ?.C;F$X#9E'4)<T(.@F_$(<9B<QZ8X!@"'3$WG1)//07$@AM?A<-&?
M]D!X5Q952V/^=@ D@H-.](,ETM95[(]TFW(5@"C^QP.R^R>2P]^_U)F;CJAF
M#[ITL7P( WSJ*%.D456"JJ)!?$M-FPQB'D"1.EG5DF?-98A?,\7)EC+BI[/E
M@C=2HD)G;CJDFGU^QU03R^M73%6?VM\PE:51]1\BCV@Z^]/RSZ@5'/E73'49
M(>91%!&45?O?+[4E- ""MV1!8_XW7AY>-TN2 3]39U TW0(5'BP:(OK@"+O5
M$0FIHUN"FE)4%P_@Q^Q,^2'6 17)!(0MG"Y)#L"G$%1B!;0U'9)L'C2"47PX
ME!WJ"!1UD0C><9F#1YX8!DSD3)"TA)E3%O#V^WF7/+$$8.#+'2:)=!L6)3W<
MBJ&8?=R.);^V6[(@C]I2U!8/X'L4QB01^Z#"=^>N4KY#0[GNCL$->\7_TEE3
ME-9_&2SZ/U!+ P04    " #*A<Q:HU#^#10'  #X40  %0   &YO;F4M,C R
M-3 V,3)?<')E+GAM;-U<77/B-A1][TS_@TN?P0&:[2:SV1W*)CM,LTDFH=./
MEXZP!7C6EAC9).3?5[(E@FQ)EH&D\KXD@(Z/[KGW6+8OQA\^;9+8>X0DC3"Z
MZ/1[)QT/H@"'$5I<=-9I%Z1!%'4^??SQAP\_=;M?((($9##T9L_>;P2#D$3A
M GIW][?S*(;>X+1WVNOW3H?]]SO#W2[;/([0MW/V9P92Z-%I47J^2:.+SC++
M5N>^__3TU'L:]C!9^(.3D[[_U]?KAV )$]"-4)H!%,".1_'G:?[A-0Y EL>\
ML_EF1F)!,/2W<VD1[%U7P+KLHVY_T!WV>YLT[/ 0V;#%) *^J>"YIO[9V9F?
MCVZAE"@R4&]ET^QY7I$_@F-X#^<>^__'_42[]9G/$#Z"V368P9A.F6^>/:_@
M12>-DE4,Q6=+ N=JGIB0+0W+SAG+3O\=R\[/+\S^(>$MF)FF. /Q<>+,^:JQ
M5J8Y/.B;8Z76%/+-,;-,=W+X!EG>F>;PH.\@B7!XB<+7#[P\U;&"?\@ >0.K
M5"<[7,#K1]T@U-ER"()>@)."]S,.U@E$V0C1FF51]CQ!<TR2_*!0'S+"B"WX
M@].3=_U!'I"9;S? %8$I!>8CU_0#:3*XR2 *82BF8['N)2&?4$P9XT":)69'
M/TRJ94CI+'D-4ACT%OC1#V'D,YWL12XX%TO?_#O&]+ _FJ49 4$FF&)6CXN.
M<HQ&R+24QOQ7#[3(S2@,:=Y3F$[![*6:/%X3A(>MAKQY]/S%E/*/-E%JUJ$!
MJQ55P*^O;6?*SS@!$2K)T8YS!8KQUP_ZBNYBU,#%U%]A,H.D%+8!P0-7(N30
M=U>)$9%E !((0OI26B*JIX$<X:\ H7S=8!G%V]5E3G!B2C.V$;,;Z;E7(?,R
M["E), DAN>B<L&L&RC&'A/ %W: FEQ+OKOK_0\(L=S-<[V Y=V9>ED@%WW>3
M1GG5Q0U7,V,F<VJ6OSK*(R?S#0X(] P"3C*8U!P**C#U06 ']OI*Q/D+2W\I
M>M40CU@><L6\U?QBHPJC7;=DS+(R20L,.J+1ABSBJQ@LRD=TU9@XFLMC3E?6
MI,.^M"467MN^P[459MQ>['ZF5V&:?5>)*>W$)8S3-;?1U7RW+K%Q#PP<]L!X
M35@:KZ(T /'?$!"U#>I@XG)0"W/:#);J[/V@)^26&#IL"6'FE^BOZ"?E4Y(:
M5&EIJ*"<]H.=MN;+0X6/N^&7UKBA6.#J_:# *1TAX5KD";V^?5TA,7)?G#KL
MBT+9513#F[6B;:(;EJY4=H>=+GZ-&ON:5XEXJ=\Y7^I[N(A8GQ=E-R!1]US5
M$*GD94@+RFY4U;3T93)>_E^=+_^8JB0@GJ 0;GZ'S\KZ:S"2 2J8%CC K*NI
M!2ILW /OG?? ! 68K##)I3Y0Q7",UU3,\QB'ZA7!:@O)'S5;M, M330W]4X-
M-W?2F?-.FH+-)*3"HWE4W+IC.(FHP4KNT6);X!L[G4T=HV45#2J7NX^2//Z/
M:>R;^N,JG*I!+N-:8)!Z?4W-H604QG"Y=:D+?V!IC(&E,08M-499W^'&&+P8
MP^5^IB[\H:4QAI;&&+;4&&5]AQMC^&(,E[N:4OAC^O*63/%3^2:5&I3*%+NH
M]EA"JVU/0^SR"3NXW-:4@L]/I&_)'<&/47%KN=83&JC*&!5H>]QA5KFG12JD
MPB?NMSF%R8MK+>.:(4.4"X: M,</:E7[+A6"3-3?_=XGC_P.IQF(_XE6VGZ'
M":CR0@G8'D>8%.[IBQ*E<(?+K5%VU!L1"!1^4 V);\FE(:=K;E#1X-MPB434
MU>5V)_M!67RWQ$C]Y99NF&>F.NQTC6O4V->Y2B1J[7)#\@$&:T(U]0>S*5-<
MJK5NF&>G.NQTK6O4V->Z2B1N=G*YGS@E@/V8]>$YF>&X5&CE&,]+:<SI$IMT
MV->WQ"**ZW)/\ 9+02MN6#4@>(*4"*?+7:_)ONA*+E%ZE[M^8C6ZW 1+@!90
M<8>""5):RV6(T]6W4-5\39?)1/W=;^Y=)I LJ'N_$/R4+<<X60&DOE@W(J7K
M- W2:5/8:VQZI:;A%!9QO^%WN:$K'$HC)KBXXT[M#RU,-H<"U@9GU*EK; L%
MH?"$R\V]/^EJET%$?9RL$?]ZO'Q?JQ'#\Z7!.&T%&UWV/M"P"1.XW.%[P'$4
M4.NBQ5>04?."\H6!'B#.&Q0 IVM?JZC!.8."2E3=Y<[='8',K! %,/\]'GM.
M [F=SRN]GGH@SYD)Z+0;K!7:N\)$*=SA<O^O%/\D3=>06'M$"U<[10%ODU_J
MU.[M&@6Q\([+_<1+?J/F]NDMQ?,2KN$"Q+>DN/\;TJBU=]$WVU0Z(;7=U&E_
M'9"%YK?3VDTB?K7W_3^7H5J1 Y[(L$-VY)]#OV$"U8\_JF9.]9PA.6L2DR)=
MG.%(3P7XX%<R1>OQC3U]L1AA?]C3"C_^!U!+ 0(4 Q0    ( ,J%S%KL:9:O
M0:$  .+F!0 1              "  0    !E9C(P,#4P-30X7SAK+FAT;5!+
M 0(4 Q0    ( ,J%S%I5WDY_-%T  $LQ @ 6              "  7"A  !E
M9C(P,#4P-30X7V5X,3 M-3$N:'1M4$L! A0#%     @ RH7,6DP>18T&.P
M#2,! !8              ( !V/X  &5F,C P-3 U-#A?97@Q,"TU,BYH=&U0
M2P$"% ,4    " #*A<Q:XWQK'0D8  !4<0  %@              @ $2.@$
M968R,# U,#4T.%]E>#$P+34S+FAT;5!+ 0(4 Q0    ( ,J%S%H51JG"40H
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M=&U02P$"% ,4    " #*A<Q:7<P/)#]B   .[P$ %@              @ %
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M+FAT;5!+ 0(4 Q0    ( ,J%S%IN0:6:J&P  ,<R @ 6              "
M < )! !E9C(P,#4P-30X7V5X,3 M-C,N:'1M4$L! A0#%     @ RH7,6L[*
MKN=V/@  \C@! !8              ( !G'8$ &5F,C P-3 U-#A?97@Q,"TV
M-"YH=&U02P$"% ,4    " #*A<Q:A@4@-,IC  !E. ( %@
M@ %&M00 968R,# U,#4T.%]E>#$P+38U+FAT;5!+ 0(4 Q0    ( ,J%S%JJ
M&25*2Q\  /:\   6              "  409!0!E9C(P,#4P-30X7V5X,3 M
M-C8N:'1M4$L! A0#%     @ RH7,6C?*-NOK*   3[T  !4
M ( !PS@% &5F,C P-3 U-#A?97@Q-"TQ+FAT;5!+ 0(4 Q0    ( ,J%S%K>
M^.\R\ST   =B 0 5              "  >%A!0!E9C(P,#4P-30X7V5X,3DM
M,2YH=&U02P$"% ,4    " #*A<Q:6!48KZ,"  !Q#   %0
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M &5F,C P-3 U-#A?97@T+3,N:'1M4$L! A0#%     @ RH7,6ME543OH$P
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M,#(U,#8Q,E]D968N>&UL4$L! A0#%     @ RH7,6DBLZGEC"@  9&T  !4
M             ( !X7X& &YO;F4M,C R-3 V,3)?;&%B+GAM;%!+ 0(4 Q0
M   ( ,J%S%JC4/X-% <  /A1   5              "  7>)!@!N;VYE+3(P
D,C4P-C$R7W!R92YX;6Q02P4&     !X '@#>!P  OI &

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>ef20050548_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="none-20250612.xsd" xlink:type="simple"/>
    <context id="c20250612to20250612">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002019793</identifier>
        </entity>
        <period>
            <startDate>2025-06-12</startDate>
            <endDate>2025-06-12</endDate>
        </period>
    </context>
    <context id="c20250612to20250612_EntityAddressesAddressTypeAxis_FormerAddressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002019793</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:FormerAddressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-12</startDate>
            <endDate>2025-06-12</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20250612to20250612"
      id="Fact_7c2e3c621d784798969845408fdbacdc">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="c20250612to20250612"
      id="Fact_a6ecb5d6d7714eecac4d22fa43703cdb">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityCentralIndexKey
      contextRef="c20250612to20250612"
      id="Fact_b8b82106a2ef4415b4816cca3515efd2">0002019793</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="c20250612to20250612"
      id="Fact_63aa2dfb42e34d92afa2f0d261cd8115">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20250612to20250612"
      id="Fact_b3d134ac11f24caead496e3c0b486f17">2025-06-12</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20250612to20250612"
      id="Fact_2f680ad08bc54072a5521e49366e36a5">XCF GLOBAL, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20250612to20250612"
      id="Fact_49473010d7d34465ad83f87bcc3cb91e">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20250612to20250612"
      id="Fact_d492ee6e08f344faa65a9f7d92798d7c">001-42687</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20250612to20250612"
      id="Fact_7d13ade3e94f4df5bde6d14f60739f9d">33-4582264</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20250612to20250612"
      id="Fact_08051322919d497ba6db10cefada67a7">2500 CityWest Blvd</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="c20250612to20250612"
      id="Fact_94d67de56f3348db813ee5cd797ca52f">Suite 150-138</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="c20250612to20250612"
      id="Fact_752c079c3ca2443699b03b2b0be7d261">Houston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20250612to20250612"
      id="Fact_2c79a203ce7442fc8a7fa82348e5714c">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20250612to20250612"
      id="Fact_e1085a2dee1e411a99c212cedc8ce836">77042</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20250612to20250612"
      id="Fact_cfb54ab18f734839b66b45d14b0d827e">346</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20250612to20250612"
      id="Fact_0c09c5919a4b4d2eb927c3afa2f0d2c4">630-4724</dei:LocalPhoneNumber>
    <dei:EntityInformationFormerLegalOrRegisteredName
      contextRef="c20250612to20250612"
      id="Fact_9f837030c3de46788eb82b7224d47d20">Focus Impact BH3 NewCo, Inc.</dei:EntityInformationFormerLegalOrRegisteredName>
    <dei:EntityAddressAddressLine1
      contextRef="c20250612to20250612_EntityAddressesAddressTypeAxis_FormerAddressMember"
      id="Fact_5a52859e01134cb0a0bfbd63a4bb7587">345 Avenue of the Americas</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="c20250612to20250612_EntityAddressesAddressTypeAxis_FormerAddressMember"
      id="Fact_f690fa624f8e45e5b0be0f647a6458bd">33rd Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="c20250612to20250612_EntityAddressesAddressTypeAxis_FormerAddressMember"
      id="Fact_f732edc5329f408c88d35afe4df50a4d">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20250612to20250612_EntityAddressesAddressTypeAxis_FormerAddressMember"
      id="Fact_60342a28170942eeacef0c49208a5bfd">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20250612to20250612_EntityAddressesAddressTypeAxis_FormerAddressMember"
      id="Fact_73c00f970d6c4790841205781251957e">10105</dei:EntityAddressPostalZipCode>
    <dei:WrittenCommunications
      contextRef="c20250612to20250612"
      id="Fact_550d77537ba640c9a0be027700ff0913">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20250612to20250612"
      id="Fact_cf868b0f6e6a4d9f89f68dda2af7c3da">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20250612to20250612"
      id="Fact_8e0e7cd4c396499db488f5feb12bde21">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20250612to20250612"
      id="Fact_caa5da7aaa4148c397589409863e84e2">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20250612to20250612"
      id="Fact_233753cc5e854d2ab9b2cb4d685aa145">Class A Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20250612to20250612"
      id="Fact_569e1628a5d848f28b0caaa8dd4b4bae">SAFX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20250612to20250612"
      id="Fact_2ddc42a3faa44045bcdcd83fe11f537d">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20250612to20250612"
      id="Fact_507ed48adf55436788e0469429b725d1">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="c20250612to20250612"
      id="Fact_7c77b3466c2f494b831469c11d452d3e">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
